Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353499	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	180	"liver: 299.6"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1227.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.1;Hep G2: 4.9;REH: 6.6;U-266/70: 4.9"					"Not detected"	"Not detected"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	49000000000			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	299.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.1	0.0	1.0	0.7	0.0	0.7	0.1	1.3	0.0	0.3	0.6	2.0	0.0	0.0	0.0	0.2	0.0	1.8	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.9	5.1	2.6	0.0	4.9	0.0	1.0	0.4	0.2	0.4	0.0	0.0	1.2	0.0	1.5	0.8	0.0	0.0	1.8	0.9	1.7	0.3	0.2	0.4	6.6	3.2	1.3	0.0	0.0	0.0	0.4	0.7	0.2	0.8	0.0	1.1	1.1	0.0	1.8	0.3	0.0	0.0	4.9	2.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.5	0.5	0.6	0.0	0.3	0.0	0.0	0.0	1.6	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	13.1	48.0	2.3	7.8	2.9	0.4	17.8	14.7	14.8	21.0	2.0	0.9	6.6	0.8	0.5	9.8	0.0	0.0	7.9	7.4	27.9	11.0	16.3	1227.5	26.2	7.9	1.2	36.8	96.4	1.9	1.1	50.1	109.6	47.7	0.0	2.2	8.5	0.0	1.1	1.3	5.2	25.8	52.4	1.4	5.1	3.1	1.6	34.8	0.1	0.6
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 495.9;Hepatocytes: 596.0;Horizontal cells: 643.6;Ito cells: 555.5;Sertoli cells: 329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Group enriched"	"Detected in some"	5	"AF22: 113.6;ASC diff: 33.7;Hep G2: 91.5;SK-MEL-30: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	113.6	0.0	33.7	2.4	0.3	13.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	91.5	0.0	0.1	0.1	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.9	0.5	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0	11.9	137.3	25.5	1.9	17.3	5.4	90.3	28.1	8.1	12.5	1.8	7.9	1.9	0.0	0.1	16.7	495.9	0.0	23.3	4.5	3.0	24.6	4.2	25.6	596.0	196.9	643.6	0.0	555.5	100.3	27.1	71.7	64.0	21.9	65.9	0.0	4.7	0.2	0.0	133.0	0.0	18.6	329.8	207.9	1.8	1.1	12.3	3.4	16.7	0.0	2.2
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822472-8887001	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 131.6;lymphoid tissue: 67.9;tongue: 54.7"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 11.0;Urothelial cells: 4.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 12.3;hTCEpi: 6.2;SK-BR-3: 15.4"									"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	NA	NA		34000000			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.1	0.6	31.3	0.1	0.1	0.1	0.0	0.6	0.2	131.6	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	1.3	0.1	0.2	0.1	0.1	17.3	0.1	0.1	18.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	1.2	0.1	54.7	67.9	0.3	28.7	1.0	1.2	1.8	2.0	1.5	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.7	12.3	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	15.4	0.0	1.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.7	0.4	0.9	1.0	0.7	0.9	0.4	0.4	0.3	1.0	0.5	0.6	1.7	1.5	2.0	1.2	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.4	0.0	11.0	0.1	0.0	0.0	4.9
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 26.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.0
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567137	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	22.6	3.5	4.9	6.0	3.2	5.4	21.6	2.9	4.1	3.8	8.8	4.2	4.4	8.5	4.2	3.1	4.1	4.3	7.8	6.6	2.1	1.9	8.4	21.2	5.6	12.7	2.7	3.9	2.8	10.9	8.8	8.5	3.2	4.3	4.0	5.0	3.6	4.5	4.6	2.1	3.4	12.7	5.5	3.3	9.1	6.3	1.4	4.6	1.6	5.2	2.7	6.0	5.6	9.1	2.0	17.0	11.1	0.4	7.2	5.0	0.7	3.8	15.0	1.9	5.3	20.6	9.0	7.9	5.3	5.9	5.3	4.9	3.4	2.0	5.7	3.9	5.7	9.4	10.6	6.6	2.3	2.9	17.7	5.0	2.3	7.4	4.3	6.3	5.9	10.7	6.7	6.2	5.1	0.9	3.9	3.8	3.4	3.0	5.5	2.8	5.2	5.6	6.9	0.4	13.0	4.5	13.1	7.3	13.2	9.5	5.9	1.3	2.2	8.0	3.6	2.0	2.1	9.1	13.7	4.7	3.1	3.9	7.7	4.6	9.3	6.2	3.0	6.1	3.7	6.5	11.1	0.4	1.8	1.9	0.2	5.0	1.0	1.0	1.7	1.0	2.0	0.3	1.0	0.5	7.2	0.2	17.0	0.9	0.7	4.9	3.2	2.9	4.1	2.1	1.9	2.7	3.9	4.3	4.6	3.0	5.5	5.6	1.1	1.1	0.0	2.0	5.1	5.3	4.5	7.0	0.0	0.9	0.0	2.8	0.2	1.4	8.3	0.0	6.6	1.0	3.8	1.2	2.3	25.3	6.6	1.6	6.9	3.7	6.7	0.2	4.4	8.2	5.0	3.6	6.3	0.9	4.8	0.0	4.2	5.4	0.7	0.0	2.0	0.5	0.4	2.0	0.2	14.4	6.3	1.1
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 53.6;Club cells: 70.5;Leydig cells: 90.0;Muller glia cells: 112.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 48.4;hTEC/SVTERT24-B: 86.0;hTERT-HME1: 87.3;HUVEC TERT2: 35.5;TIME: 187.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.0;basal ganglia: 15.3;cerebellum: 5.8;cerebral cortex: 13.1;olfactory region: 13.7"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		570000000			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	35.3	5.2	2.7	24.7	9.0	0.0	16.1	1.2	3.3	45.0	15.8	9.7	6.9	1.7	29.4	23.6	23.4	16.9	44.1	28.1	4.2	2.9	6.6	2.2	34.5	8.2	4.4	3.6	33.5	3.8	0.5	4.3	45.8	4.7	23.0	19.4	80.6	10.5	4.2	8.7	9.8	10.2	39.2	8.0	3.8	22.3	12.3	5.3	0.2	23.2	23.7	25.3	38.5	19.1	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.5	48.4	0.0	9.9	9.7	18.2	8.6	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	28.9	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.0	2.8	0.1	86.0	87.3	0.3	35.5	0.0	0.0	0.1	15.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	187.0	3.9	0.0	32.9	1.9	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.0	1.2	2.4	4.2	2.9	4.4	3.6	4.7	5.3	53.6	5.6	0.0	1.5	14.2	1.0	10.3	2.5	5.3	70.5	17.4	2.0	0.5	0.0	0.0	7.2	9.0	0.0	0.0	0.3	0.6	43.8	1.1	3.5	0.0	0.8	0.0	1.2	11.1	1.2	7.8	90.0	2.9	18.6	0.0	0.5	112.5	1.1	4.5	26.2	6.5	3.5	0.0	18.6	0.1	0.2	17.3	0.6	0.0	0.6	2.5
ABO	"A3GALNT, A3GALT1"	ENSG00000175164	"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase"		9	133250401-133275219	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	8	"B-cells: 2.2;granulocytes: 3.0"	"Group enriched"	"Detected in some"	6	"K-562: 20.4;RT4: 8.0"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (2.78e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.30e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.04e-2)"	1.6	1.0	0.1	5.8	0.1	0.3	0.4	0.0	0.6	1.0	15.0	0.0	2.3	1.7	1.6	0.8	3.0	0.3	7.6	0.3	0.0		10.7	0.3	3.6	0.3	0.0	0.0	3.2	2.6	0.3	0.0	0.3	0.2	1.5	2.4	1.0	2.2	0.3	1.4	0.3	28.2	0.6	0.0	0.3	0.3	2.0	0.0	0.0	10.1	4.2	5.8	1.0	1.4	2.2	0.1	3.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.2											29.8	22.2	0.5	3.6	0.0	0.0	2.8	17.8	56.2	27.3	45.4	0.0	0.7	0.0	3.7	3.3	6.8	68.1	0.0	0.3	0.2	0.8	6.5	0.0	0.0	0.2	0.0	24.6	3.1	0.6	6.7	14.1	0.3	0.0	1.0	54.8	0.0	8.2	49.5	6.3	19.5	0.1	6.5	0.6	0.5	1.5	0.0	0.6	0.0	61.3	15.2
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 7.4;U-251 MG: 10.6"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038925: AB_2676272"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.9	0.2	0.1	0.2	0.0	1.9	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	1.1	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.2	0.5	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.4	0.1	0.5	0.0	0.2	0.4	0.0	2.7	2.3	0.7	10.6	0.5	2.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Not detected"	"Not detected"											"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"	"Cell line enriched"	"Detected in some"	8	"REH: 56.1"														"Secreted to blood"	NA	NA																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	7.4	0.1	0.1	0.0	0.0	56.1	0.6	1.2	0.0	0.0	0.0	3.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAN	"AGC1, CSPG1, CSPGCP, MSK16"	ENSG00000157766	Aggrecan		15	88803442-88875354	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	28	"Extravillous trophoblasts: 120.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016377, HPA038241, HPA038242"	Enhanced				"Secreted to extracellular matrix"	NA	NA					"CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910"	"unprognostic (2.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.27e-2)"	5.0	1.2	2.7	3.2	4.6	0.8	0.9	0.6	6.6	9.2	1.6	3.4	0.1	0.9	5.3	3.9	1.0	1.4	3.0	6.5	2.0	6.2	6.3	0.8	4.2	0.8	2.5	0.9	2.2	1.2	0.6	2.1	1.9	3.7	2.4	1.7	1.1	1.1	11.2	1.8	1.5	0.8	2.1	5.7	1.3	1.2	4.9	2.3	0.0	1.9	1.8	0.6	5.9	4.4	0.2	0.3	1.5	0.4	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	4.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	1.5	0.2	0.2	0.3	0.4	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.6	0.5	0.1	0.3	0.2	0.1	2.7	4.6	0.6	6.6	2.0	6.2	2.5	0.9	3.7	2.3	0.0	0.0	0.0	0.4	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	120.0	0.8	0.2	1.1	0.0	2.3	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	2.8	0.4	3.0	0.0	0.0	0.3
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 21.5;U-87 MG: 28.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.5	0.3	3.2	0.0	0.0	0.0	21.5	0.2	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745334	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"testis: 106.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 388.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.0;Hep G2: 1.8;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048687	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048687: AB_2680494"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	0.9	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	1.2	0.0	106.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	1.5	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.8	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	8.6	0.0	86.9	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	28.8	1.7	0.0	0.0	0.0	1.5	0.1
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.0	0.0	13.2	3.0	11.6	3.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.2	0.1	6.3	0.0	0.1	0.0	0.0	12.5	4.4	0.1	22.3	0.5	0.0	20.7	1.5	10.3	0.0	0.0	0.4	0.0	3.2	0.0	3.9	5.9	0.1	0.0	0.1	0.0	10.6	0.0	5.9	1.4	0.0	0.1	0.1	0.0	12.8	1.1	0.7	0.1	21.0	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	28.1	20.5	5.2	0.0	0.4	6.6	2.3	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.0	4.7	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA			"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	5.0	0.7	2.0	0.0	6.0	12.4	0.0	13.2	1.1	4.5	11.3	0.0	0.0	0.0	0.0	47.3	9.5	0.0	0.0	0.4	4.9	0.5	0.1	0.0	8.0	0.0	0.9	0.0	10.5	15.2	0.0	29.7	0.9	8.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	1.3	0.1	13.5	0.1	9.0	1.5	0.0	0.2	0.8	0.0	0.0	0.0	16.3	5.4	29.3	26.2	0.0	0.1	0.0	22.5	0.0	10.0	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6	0.0	3.4	0.0	0.4	1.3	0.8	1.4	0.0	1.4	0.0	0.0	96.2	12.1	0.0	7.6	6.3	1.1	0.4	0.0	1.0	348.4	2.0	0.6	49.5	0.0	14.2	6.4	0.0	2.5	0.3	1.1	15.5	0.7	1.7	15.4	0.2	5.5	1.9	0.0	0.7	0.0	31.5	0.0	1.2	5.1	5.5	0.5	108.0	3.1	0.7	0.5
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 126.7;lymphoid tissue: 46.3"	"Group enriched"	"Detected in some"	16	"Hofbauer cells: 15.6;Kupffer cells: 10.4;Macrophages: 9.5;monocytes: 9.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.5"	"Group enriched"	"Detected in many"	7	"B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		22000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.6	0.3	46.3	0.3	0.0	0.4	0.3	0.3	0.4	57.4	0.1	0.1	30.4	0.3	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.5	0.4	1.4	30.0	0.3	0.1	0.4	0.4	0.0	0.4	0.9	0.1	0.4	52.2	0.2	0.8	0.1	0.3	0.5	126.7	1.7	0.4	5.2	0.8	0.4	0.1	1.9	0.5	0.5	5.4	5.0	0.4	2.7	0.4	4.5	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	15.6	3.6	0.0	0.0	0.0	0.0	0.0	2.0	4.5	0.0	2.1	0.0	2.7	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	10.4	0.0	0.0	9.5	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	62.1	15.4	3.8	72.4	25.3	12.5	8.3	0.0	0.0	0.0	5.0	22.9	0.3	1.3	0.8	3.7	22.1	0.0	23.0	0.0	7.5	0.0	11.9	2.9	0.0	17.2	0.0	49.9	45.5	3.0	5.1	0.7	1.2	0.0	37.1	0.0	0.3	0.0	4.1	0.0	2.9	0.0	28.6	0.2	42.4	4.0	0.0	5.6	3.4	0.0	0.4	2.7	0.1	0.7	5.2	17.8	0.9	27.8	10.7	0.1	0.0	0.0	14.7	0.0	5.4	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4	6.0	31.4	0.0	31.2	107.6	0.5	151.1	7.6	5.3	14.8	54.1	0.0	44.4	1.7	29.9	1.3	165.7	0.0	0.0	18.6	211.3	148.2	23.5	2.3	1.3	14.7	0.0	0.0	124.0	6.0	2.2	100.9	4.8	50.6	1.0	0.0	31.7	24.2	0.0	39.3	2.2	2.2	207.0	366.0	0.5	1.0	36.4	45.9	5.0	0.0	13.3
ADAMTS10	ADAM-TS10	ENSG00000142303	"ADAM metallopeptidase with thrombospondin type 1 motif 10"	Q9H324	19	8580242-8610735	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 7.6;Ductal cells: 6.3;Leydig cells: 6.9;Sertoli cells: 6.5;Smooth muscle cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.5;hTERT-RPE1: 5.9;NB-4: 28.4;REH: 7.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 5.4"	"Low region specificity"	"Detected in all"			HPA040223	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA040223: AB_10795376"	"unprognostic (2.60e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.91e-4)"	"unprognostic (4.98e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (6.86e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-2)"	13.8	7.1	15.2	8.5	8.0	6.0	8.2	1.8	14.0	10.2	5.7	5.5	3.2	3.9	13.4	5.1	3.4	8.5	7.7	7.0	12.5	8.2	6.9	5.4	8.0	11.1	6.8	11.5	8.0	7.1	1.8	3.8	6.8	7.6	7.6	2.8	10.6	4.8	6.7	9.2	10.0	6.4	6.3	7.6	7.5	3.5	3.0	5.7	5.7	5.5	3.0	5.7	4.6	8.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	3.6	1.9	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	4.5	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	5.9	0.1	0.2	0.1	0.0	0.0	0.0	0.3	28.4	1.4	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.0	0.1	0.3	1.7	2.6	3.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.5	0.0	0.0	0.0	0.1	15.2	8.0	1.8	14.0	12.5	8.2	6.8	11.5	7.6	5.7	0.0	0.0	0.0	0.6	1.4	0.1	1.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	4.0	0.0	0.0	0.4	0.0	4.2	0.1	0.0	0.9	0.9	0.0	0.0	4.9	2.1	1.4	6.9	2.8	0.0	1.0	0.1	0.8	0.6	0.0	5.6	0.0	0.1	6.5	6.2	0.1	0.4	0.6	0.3	1.3	0.0	0.3
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	16	"Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.3	10.4	0.0	15.4	7.3	0.0	5.4	13.9	7.1	8.8	0.0	0.0	0.0	0.0	3.7	12.6	0.3	0.2	7.0	10.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	5.8	0.0	20.2	5.3	36.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	12.2	15.6	0.1	3.2	1.8	1.3	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	3.3	0.4	0.0	0.0	0.2	0.2	12.8	0.1	0.0	0.0	0.5	0.0	0.0	17.8	0.3	2.5	20.4	0.0	6.8	0.0	0.0	6.7	0.2	0.0	16.6	2.2	0.2	51.8	14.2	0.2	1.7	0.6	0.7	0.0	0.0	0.1
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"SuSa: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	38000000	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.3	3.3	4.6	2.7	2.4	1.2	1.1	0.9	0.4	0.6	0.5	3.6	0.4	1.5	0.8	1.1	0.6	0.3	0.6	0.1	1.9	3.0	0.4	1.3	0.7	1.9	0.1	1.1	6.4	1.6	0.5	1.2	2.2	0.3	2.3	0.1	1.4	0.5	5.5	0.1	1.5	3.5	1.9	2.0	0.4	0.4	1.6	1.5	1.4	2.1	6.8	2.3	1.3	1.8	7.1	5.8	0.6	0.8	2.4	1.4	1.6	0.0	2.5	0.6	0.5	2.0	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4	0.0	1.3	0.0	0.1	0.2	1.4	3.6	7.6	0.0	3.4	0.0	0.0	0.1	1.7	0.6	20.6	0.3	1.0	0.0	0.3	0.2	0.8	0.4	0.0	1.5	0.2	3.2	1.2	8.0	0.0	10.2	0.9	0.0	0.0	0.0	1.3	1.9	0.3	1.4	1.4	0.7	1.7	0.0	0.4	4.7	3.8	0.4	0.1	0.0	0.6	0.3
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672803-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;gallbladder: 12.3;placenta: 13.5"	"Group enriched"	"Detected in some"	6	"granulocytes: 4.6;Paneth cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;CAPAN-2: 10.4;K-562: 11.6;RH-30: 6.3;U-138 MG: 10.5"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	1.7	0.5	4.6	5.4	10.7	1.1	0.6	1.0	4.7	1.3	3.3	13.4	1.0	4.1	1.4	1.0	1.8	1.1	12.3	2.8	7.2	3.0	0.7	0.5	2.7	2.0	8.1	5.7	0.7	0.5	0.2	0.4	13.5	4.0	1.1	3.6	2.6	1.6	0.4	0.4	2.5	5.7	3.9	4.6	0.8	2.6	0.9	5.9	0.5	0.4	2.3	2.3	6.7	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	4.8	0.0	1.2	3.7	0.3	2.0	0.0	10.4	0.0	0.8	1.9	0.5	0.8	0.0	0.0	0.1	4.0	0.0	0.4	0.0	0.3	0.0	0.0	2.7	0.4	0.1	0.9	0.2	1.2	0.0	0.0	11.6	0.0	1.5	0.0	0.0	1.0	0.4	0.1	0.0	0.0	6.3	0.2	0.0	0.0	4.0	0.7	0.0	0.1	0.3	0.2	0.0	0.0	0.0	10.5	0.1	0.9	0.5	1.0	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	10.7	1.0	4.7	7.2	3.0	8.1	5.7	4.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.6	22.1	0.0	1.3	2.6	0.5	0.1	0.2	0.6	0.0	18.4	0.1	1.3	3.4	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.2	0.0	0.3	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	2.8	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.9	0.0	0.0	2.7	1.9	0.0	0.0	0.3	4.3	3.5	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6	0.0	0.0	0.0	0.1	0.5	0.0	9.6	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.5	8.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.3	0.0	0.5	0.0	0.7	0.0	0.7	0.8	0.0	0.0	3.3	0.1	0.3	0.3	0.7	0.0	2.1	0.0
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.5	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.1	3.3	0.0	4.7	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.8	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.2	0.7	0.0	0.3	0.8	0.4	1.1	0.1	0.1	0.3	1.7	0.1	2.5	0.5	3.2	0.1	0.1	0.0	1.1	0.1	0.1	0.1	0.2	5.6	0.1	0.2	0.1	3.2	4.8	8.9	2.1	0.5	0.2	0.1	4.6	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971589-100342005	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HEK 293: 7.4;JURKAT: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	1.2	2.0	3.6	2.7	3.1	1.5	1.9	0.7	4.5	1.9	2.1	2.9	6.4	2.5	4.9	1.9	5.1	2.9	1.9	2.2	3.4	1.6	2.2	15.7	10.5	2.0	1.6	1.0	3.0	12.2	0.3	3.5	1.6	1.7	1.9	2.1	2.7	8.3	4.7	13.5	5.0	2.8	6.6	2.1	2.5	3.6	4.0	2.0	20.1	1.9	2.7	2.1	2.7	2.1	0.1	0.0	1.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	1.3	0.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	25.8	0.0	0.1	0.1	0.6	2.2	0.4	0.2	1.2	1.1	0.0	0.6	2.8	0.0	0.3	2.3	0.4	0.3	2.8	3.7	0.6	0.0	0.4	0.4	0.0	0.9	0.7	0.0	0.4	0.0	0.0	0.0	0.5	3.4	1.4	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.0	0.1	0.5	0.5	0.4	0.2	0.1	0.0	0.0	0.1	3.6	3.1	0.7	4.5	3.4	1.6	1.6	1.0	1.7	2.0	0.0	0.0	0.0	0.6	0.9	0.9	3.4	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	111.4	0.7	0.1	0.0	0.7	0.0	0.8	1.7	0.0	3.9	6.1	20.6	0.0	0.0	0.6	51.8	2.0	0.0	0.0	0.0	0.3	2.3	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	1.4	0.5	0.1	1.3	0.3	0.8
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	6	"Muller glia cells: 16.4;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.5	0.0	0.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 12.0;SH-SY5Y: 27.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA			"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	12.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	15.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.0	0.0
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	14.0	14.0	0.0	12.3	2.1	4.7	5.0	0.0	0.0	0.0	0.1	14.5	0.3	0.0	0.7	0.0	2.0	0.0	0.7	0.0	0.0	0.9	45.5	0.0	0.0	36.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.5	0.0	0.0	0.1	0.8	0.0	4.0	0.0	7.9	1.2	10.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5	0.0	0.6	0.0	0.3	1.9	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.1	13.5	0.2	1.1	0.5	3.9	0.0	0.0	28.8	58.6	2.1	4.6	2.9	0.0	0.0	0.0	0.0	0.8	0.0	12.0	0.0	0.0	25.8	16.1	0.5	2.6	2.4	0.0	0.0	0.0	0.1
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43551921	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3"	"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 2.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;SuSa: 4.4;U-266/70: 7.4;U-266/84: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.2	0.0	0.7	0.1	1.4	0.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.2	0.0	3.6	5.1	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.3	1.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.2	0.0	0.0	2.9	5.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	4.4	1.4	0.0	0.0	0.0	0.7	0.0	0.0	7.4	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.2	0.3	0.7	0.6	0.0	5.1	1.1	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	7.3	0.1	0.3	0.1	0.6	2.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.6	0.0	1.8	0.0	1.6	12.9	1.0	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.1	0.0	0.0	11.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	3.8	0.0	2.5	0.0	4.3	0.0	0.5	6.6	0.0	0.5	0.2	1.4	0.1	0.1	0.1	5.4	8.1	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3	0.0	4.3	0.0	1.0	0.5	0.8	0.8	0.0	0.0	2.3	1.8	13.7	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.2	1.6	0.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	1.3	18.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.2	0.2	11.9	0.0	0.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917912-26966513	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.2;placenta: 20.9"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 51.0;Leydig cells: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.9;ASC TERT1: 10.1;fHDF/TERT166: 9.5;RH-30: 25.2;U-87 MG: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		18000	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655"	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.15e-1)"	14.1	0.4	1.0	1.6	0.6	0.0	21.2	2.5	0.9	5.5	2.3	0.4	7.2	0.3	10.7	8.2	1.2	3.3	1.0	6.9	1.0	0.0	1.6	0.8	1.2	0.4	1.1	0.4	14.9	0.4	0.1	0.4	20.9	1.5	2.2	0.8	2.3	1.8	9.7	11.0	3.3	2.4	6.2	1.1	6.4	1.8	2.3	0.4	0.6	5.3	1.5	0.6	2.8	3.1	0.0	0.2	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.9	10.1	0.0	1.3	0.2	1.4	0.5	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.3	0.0	2.5	0.1	0.0	5.5	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.2	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.3	1.3	0.6	0.0	0.0	0.0	9.1	0.1	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.6	2.5	0.9	1.0	0.0	1.1	0.4	1.5	0.4	0.0	0.3	0.0	0.1	2.6	1.9	2.6	0.0	0.0	1.2	3.5	0.0	0.8	0.0	0.0	4.8	7.1	0.0	0.0	0.2	1.4	51.0	0.2	0.0	0.0	1.8	0.0	1.7	2.5	0.0	0.8	58.1	0.8	3.3	0.0	0.0	0.0	0.0	0.0	8.5	2.2	0.0	12.9	13.7	0.0	0.5	2.6	2.3	0.0	0.0	0.1
ADAMTS6	ADAM-TS6	ENSG00000049192	"ADAM metallopeptidase with thrombospondin type 1 motif 6"	Q9UKP5	5	65148736-65481920	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 32.4"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 16.4;Cytotrophoblasts: 28.3;Muller glia cells: 28.3;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.8;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	13	"B-cells: 4.8;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 10.0;HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;hTERT-HME1: 12.2;TIME: 11.5;U-2197: 13.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043441	Enhanced				"Secreted to extracellular matrix"	NA	Yes					"HPA043441: AB_2678484"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-6)"	"unprognostic (3.23e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.02e-4)"	"unprognostic (4.18e-3)"	2.2	0.7	0.9	2.0	0.8	0.3	1.8	0.2	1.8	2.9	1.4	0.8	1.6	0.6	5.1	3.0	1.0	2.7	6.3	2.3	0.8	0.9	1.5	0.5	2.3	1.7	0.8	1.4	1.8	0.5	0.4	2.0	32.4	2.9	2.3	0.9	1.4	0.6	0.9	0.4	0.8	2.4	5.4	3.2	3.4	1.8	1.9	0.7	3.3	0.9	1.2	1.9	3.6	1.7	4.8	0.2	0.0	0.0	0.0	1.4	0.1	2.1	0.0	0.5	0.5	0.0	1.7	0.0	10.0	5.9	6.2	7.4	0.0	0.2	0.0	0.0	3.8	4.4	0.4	0.1	1.9	11.0	1.5	0.0	0.1	3.7	0.2	0.3	0.0	0.5	0.7	0.0	10.2	12.2	3.0	5.5	1.0	0.0	0.0	3.8	0.0	0.5	0.0	0.0	0.2	0.0	0.3	2.1	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	1.4	0.0	0.0	11.5	2.4	3.7	13.1	8.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.0	1.3	0.0	1.0	4.8	0.3	0.5	0.0	3.6	1.3	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.8	0.2	1.4	0.8	0.9	0.8	1.4	2.9	0.7	0.0	0.0	16.4	0.0	0.2	7.8	2.2	0.0	0.0	0.0	3.5	0.0	28.3	0.0	0.7	12.3	9.9	0.0	0.0	0.0	3.5	4.0	0.1	1.1	0.0	2.2	0.0	0.0	5.5	0.0	6.4	11.2	2.9	0.0	0.0	0.6	28.3	1.7	0.0	17.0	0.8	0.7	6.5	4.1	4.9	1.3	0.0	11.9	0.0	0.2	0.0
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 9.0;Early spermatids: 3.9;Endothelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 77.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	2.2	2.1	2.5	6.2	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.3	0.1	0.1	0.5	0.0	0.0	0.2	0.6	0.1	0.0	2.1	0.0	77.9	1.0	0.6	0.5	0.3	1.6	7.1	0.0	0.0	0.2	1.6	0.0	0.0	1.4	1.4	0.0	0.4	4.9	2.2	0.0	0.1	0.2	0.0	7.1	1.4	0.0	0.1	1.2	0.9	0.1	8.7	2.8	0.3	1.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6	0.0	0.0	0.0	0.1	0.3	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.9	4.5	0.0	0.0	0.0	0.2	3.1	0.2	3.5	0.0	0.6	0.0	0.0	3.1	0.0	2.2	1.4	0.0	1.7	0.0	0.0	1.3	0.2	0.0	1.8	0.0	0.0	0.0	1.6	3.0	1.3	0.1	0.2	0.0	0.0	0.2
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404925-130428993	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 13.0;lung: 21.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 1.1;Bipolar cells: 1.1;Cardiomyocytes: 2.5;Ciliated cells: 4.0;Club cells: 2.3;Fibroblasts: 2.6;granulocytes: 1.1;Melanocytes: 1.7;Peritubular cells: 1.4;Smooth muscle cells: 3.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HeLa: 1.8;HMC-1: 5.8;NTERA-2: 2.9;U-2 OS: 13.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2"	HPA066349	Approved				"Secreted to extracellular matrix"	NA	NA		2200000			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	2.1	0.1	1.5	10.2	2.5	0.0	0.5	0.6	4.4	1.3	5.3	0.5	0.2	1.1	2.6	1.5	3.1	1.7	13.0	3.9	1.6	0.6	2.1	0.2	21.0	0.2	0.7	0.2	1.0	0.7	0.0	0.8	2.7	0.9	2.9	0.5	0.7	0.3	5.7	0.4	0.1	1.6	7.4	0.8	0.9	5.6	0.2	0.4	0.2	0.4	0.2	0.4	3.8	3.4	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.5	0.6	3.2	1.6	0.6	0.7	0.2	0.9	0.4	0.0	1.1	0.0	0.2	0.3	1.1	2.5	0.0	4.0	2.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.4	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 62.4;Ductal cells: 67.2;Endothelial cells: 76.0;Glandular cells: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.4;RPTEC TERT1: 11.2;SH-SY5Y: 52.5;SuSa: 17.3;WM-115: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA			Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	3.6	1.0	0.0	0.0	0.2	0.0	9.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.4	0.0	0.0	1.0	0.0	11.2	0.1	0.0	52.5	0.0	0.0	0.0	17.3	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9	3.0	4.5	0.0	62.4	15.5	0.0	5.9	5.1	0.0	4.5	36.6	2.0	0.6	0.0	67.2	0.8	76.0	0.0	0.0	2.9	0.5	35.3	51.3	0.0	0.0	5.8	0.0	1.2	23.4	0.3	0.0	2.3	3.0	25.3	0.0	1.4	0.0	27.6	0.0	2.1	6.3	0.0	0.0	38.9	0.3	0.2	11.8	1.4	0.0	0.4	26.6
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 50.7;retina: 39.3"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.5;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.1;HSkMC: 17.8;hTEC/SVTERT24-B: 18.4;LHCN-M2: 18.1;TIME: 57.9;U-138 MG: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		74000000	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	6.3	7.6	0.5	5.9	0.8	0.0	4.4	3.9	1.5	14.3	5.2	0.6	6.5	1.6	50.7	12.0	9.0	5.2	4.4	2.9	1.6	1.0	3.4	1.0	1.9	2.2	0.4	1.2	4.9	1.3	0.1	3.9	0.8	0.9	8.4	4.6	39.3	3.1	5.6	0.5	2.0	2.7	13.3	0.7	0.9	5.0	2.3	0.0	0.0	2.0	1.7	1.5	2.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.0	5.1	35.1	0.0	1.0	4.5	4.1	9.5	0.0	0.0	0.0	0.0	12.3	1.5	0.0	1.8	0.2	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	17.8	0.0	18.4	0.0	15.9	7.7	0.0	0.0	0.0	18.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.9	28.2	0.7	0.7	4.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.9	1.5	1.6	1.0	0.4	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.5	0.8	1.3	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	1.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.4	1.9	0.9	0.1	0.1	0.0	0.8	0.0
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		67000000	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.4	0.0	0.9	0.6	8.2	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8	0.0	0.3	0.0	0.1	0.1	1.8	2.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.9	0.2	0.0	5.1	8.0	0.0	0.7	4.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	2.8	0.6	0.3	6.5	1.6	0.0	0.2	0.3	0.0	0.0	0.7	0.1
ADAMTSL3	"KIAA1233, punctin-2"	ENSG00000156218	"ADAMTS like 3"	P82987	15	83654086-84039842	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 131.0;Alveolar cells type 2: 92.7;Ciliated cells: 103.1;Club cells: 111.5;granulocytes: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 12.3;hTERT-RPE1: 3.7;RPTEC TERT1: 14.3;TIME: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034773, HPA034774"	Uncertain		Uncertain	Vesicles	"Secreted in other tissues"	NA	NA		110000	Vesicles		"HPA034773: AB_10601965, HPA034774: AB_2674326"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (5.92e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.00e-3)"	"unprognostic (4.62e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.95e-5)"	6.9	5.0	1.5	6.2	2.9	0.0	5.3	2.8	2.8	8.7	14.3	4.4	1.8	1.5	12.0	3.7	5.4	5.6	4.7	15.9	3.1	1.3	3.8	12.1	10.6	1.5	5.1	2.9	2.0	12.9	1.1	2.6	12.0	7.2	8.1	3.7	19.9	4.7	8.7	2.6	2.2	3.1	26.8	3.6	2.0	7.5	2.9	4.2	0.2	4.6	2.2	0.5	8.0	13.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	14.3	0.0	0.0	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.9	2.8	2.8	3.1	1.3	5.1	2.9	7.2	4.2	131.0	92.7	0.0	4.4	6.3	0.1	6.1	0.0	103.1	111.5	1.8	0.0	0.1	0.0	0.4	12.0	3.6	0.0	0.0	1.9	0.1	1.6	1.8	58.1	8.6	0.2	6.4	0.0	1.3	0.6	13.4	45.8	0.6	0.0	0.0	0.0	0.0	1.5	0.0	15.9	0.6	0.2	25.8	0.5	1.8	1.3	1.0	0.1	0.0	0.0	1.7
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.7	0.1	0.1	1.2	6.2	30.2	63.6	6.5	5.7	3.9	2.2	0.5	2.6	0.0	1.3	4.4	0.0	3.4	0.2	0.9	1.6	0.5	0.1	1.9	0.7	2.7	5.0	0.0	0.9	14.2	0.2	0.9	2.2	3.3	0.0	0.0	20.3	0.2	0.6	0.1	0.0	0.3	1.1	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	5.0	0.0	3.3	1.4	3.5	1.2	0.2	1.8	2.7	0.1	0.6	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1	0.0	1.0	0.8	2.1	2.2	1.0	2.0	7.6	1.4	0.0	0.0	0.0	113.3	0.0	1.1	0.4	3.5	0.0	0.0	0.5	39.4	15.5	1.3	2.3	9.2	28.7	0.0	0.0	1.3	22.6	0.0	27.9	16.5	3.3	25.2	0.0	2.4	7.4	0.0	3.2	0.0	2.4	0.0	1.4	0.0	0.9	2.5	83.2	0.0	0.1	1.7
ADAMTSL5	THSD6	ENSG00000185761	"ADAMTS like 5"		19	1505018-1513604	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 19.3"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 8.1;Leydig cells: 17.8;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044050			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA044050: AB_10962625"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-3)"	1.0	1.0	1.2	1.7	1.5	0.0	1.5	1.3	1.2	19.3	5.0	0.5	2.2	7.8	14.4	6.2	7.0	2.7	2.3	13.5	1.9	0.8	0.9	2.8	1.4	0.2	0.9	0.2	1.7	0.9	0.0	1.5	5.2	1.8	4.0	0.7	8.6	4.0	3.9	10.5	1.0	10.0	9.9	0.8	0.8	1.0	3.7	0.3	0.0	1.0	8.1	5.1	1.6	7.2	0.2	0.1	0.8	1.8	0.1	4.7	1.1	6.4	2.9	0.1	0.2	3.4	2.5	3.1	11.9	8.1	4.6	6.8	16.4	3.2	0.0	3.0	9.9	1.3	5.5	2.9	3.5	3.4	6.2	0.4	1.2	8.5	3.0	3.9	0.2	8.5	1.5	3.7	1.1	2.9	6.1	0.0	2.2	3.8	8.2	0.4	6.0	0.3	0.4	0.1	1.9	1.6	0.2	0.6	1.6	3.6	0.0	0.2	0.4	2.8	0.3	3.3	1.6	7.5	2.4	0.8	0.0	4.5	9.1	0.5	5.1	3.2	0.8	0.1	0.6	2.0	0.4	0.1	0.8	3.4	1.1	2.2	0.1	3.7	2.5	0.1	0.2	4.7	3.2	0.2	0.1	1.8	0.1	1.1	1.1	1.2	1.5	1.3	1.2	1.9	0.8	0.9	0.2	1.8	0.3	0.0	0.6	0.0	2.2	0.3	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.5	0.0	1.7	0.0	1.5	1.9	5.4	0.7	0.0	1.6	0.2	0.0	0.0	0.0	0.0	2.2	17.8	0.2	1.7	0.0	1.0	3.4	4.3	0.8	17.0	0.3	2.0	0.0	3.5	0.5	1.4	0.4	0.6	0.5	0.6	3.0
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Uncertain	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA051012: AB_2681310, HPA055014: AB_2682672"	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic favorable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	7.2	11.0	11.0	7.0	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19.0	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6.0	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15.0	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5.0	4.0	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.3	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.8	3.0	8.0	7.3	5.5	6.0	5.7	6.4	17.8	5.4	2.0	4.2	5.6	1.9	3.4	4.9	8.3	2.8	4.1	5.8	10.1	1.2	3.9	3.2	4.4	6.4	7.0	4.5	4.0	16.8	3.4	5.6	6.4	12.3	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4.0	6.6	9.3	4.0	5.1	13.3	6.2	3.9	2.9	2.3	5.9	3.1	4.6	5.0	4.2	4.4	4.9	3.8	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4.0	2.5	4.6	0.4	3.4	2.8	7.0	3.7	3.1	11.0	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15.0	11.5	0.0	3.0	0.8	1.8	0.8	5.0	4.8	0.0	1.4	1.2	0.0	19.6	6.8	3.3	3.6	1.2	1.2	2.1	0.0	4.3	3.6	2.0	1.3	1.1	5.8	8.2	7.9	1.7	1.8	5.1	0.4	1.4	5.4	0.0	1.0	3.6	3.2	3.0	0.0	1.8	3.3	8.8	0.0	1.9	1.7	9.7	1.3	4.5	1.8	4.9	0.9
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904943-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;lymphoid tissue: 16.5"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065887	Supported	Supported			"Secreted in other tissues"	NA	NA					"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	2.1	0.5	2.5	16.5	7.7	0.1	1.6	2.1	12.5	3.4	2.6	0.8	0.0	0.1	4.0	0.1	2.2	0.5	12.3	1.0	1.2	18.4	0.6	0.3	1.7	1.6	2.8	6.2	0.2	7.7	0.1	4.5	0.3	33.8	1.4	1.4	2.5	2.2	1.0	0.3	0.9	1.3	1.5	5.9	0.2	1.8	3.6	0.2	0.1	0.3	0.0	1.4	3.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	2.1	12.1	1.2	18.4	2.8	6.2	33.8	0.2	3.0	1.1	0.0	0.0	0.6	0.1	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	42.7	0.0	0.1	0.0	0.0	0.6	0.0	1.0	0.3	0.3	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.0	0.1
ADGRB1	BAI1	ENSG00000181790	"Adhesion G protein-coupled receptor B1"	O14514	8	142449430-142545009	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 27.4"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 119.2"	"Cancer enhanced"	"Detected in many"		"glioma: 11.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (9.57e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.50e-3)"	"unprognostic (9.98e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.30e-11)"	"unprognostic (6.27e-2)"	"unprognostic (7.42e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.29e-2)"	1.0	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2.0	1.0	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11.0	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1.0	2.3	3.7	1.5	2.1	3.2	0.0	0.9	0.0	1.0	0.9	0.4	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	5.8	1.8	0.2	0.0	0.1	0.0	16.3	0.0	0.0	3.1	3.1	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	18.1	5.4	19.5	11.0	11.9	8.7	9.2	9.1	3.2	0.0	0.0	0.0	0.2	0.0	13.1	5.3	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	119.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	3.8	0.1	0.0	12.7	0.0	0.6	6.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 32.5"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"	NA	NA					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	930000	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	17.7	8.9	2.5	23.0	4.0	55.3	14.3	1.1	5.2	21.7	15.9	12.9	0.5	12.9	56.9	18.5	11.6	19.1	27.1	16.4	3.0	2.4	10.7	15.5	30.3	41.1	6.3	3.2	10.7	16.2	2.4	3.3	18.2	5.9	11.3	9.0	6.9	17.0	3.6	12.5	6.0	22.2	36.2	4.2	56.9	15.0	6.9	4.9	24.3	8.6	3.7	22.5	34.7	12.4	3.9	13.3	95.3	43.2	22.8	25.8	23.3	30.8	21.9	0.2	21.0	9.3	15.3	3.3	21.4	34.5	15.4	16.9	6.2	31.3	3.5	21.7	27.5	22.0	7.3	5.7	10.4	6.9	19.2	6.4	6.9	32.5	2.7	11.5	14.9	32.3	6.7	0.3	15.7	5.4	5.0	1.5	6.1	9.0	27.7	16.8	6.9	0.9	20.0	0.6	24.5	27.3	2.0	9.2	16.1	5.2	2.7	0.2	0.7	12.2	17.5	15.2	0.5	4.5	13.8	3.7	5.2	8.7	21.7	35.2	0.0	0.1	0.2	18.7	26.7	19.5	42.0	18.6	95.3	25.8	36.7	17.3	3.9	13.1	17.8	13.3	2.6	9.4	12.8	82.7	22.8	43.2	6.4	9.0	23.3	2.5	4.0	1.1	5.2	3.0	2.4	6.3	3.2	5.9	4.9	32.8	102.4	15.9	7.4	0.0	0.2	3.1	12.7	50.9	31.8	0.0	0.0	2.7	0.0	15.1	0.0	4.5	10.2	23.3	19.1	36.8	4.8	9.8	70.9	1.5	47.0	0.0	4.7	26.4	83.8	1.0	6.1	50.6	0.0	2.8	34.7	2.3	17.9	21.0	4.6	0.7	1.2	25.8	17.2	0.5	5.7	0.0	6.6	152.3	31.8	14.1
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997703-47042363	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.4"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038438	Approved				"Secreted - unknown location"	NA	NA					"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	6.5	6.1	0.0	3.7	0.1	1.3	4.2	15.7	0.8	10.0	0.0	0.0	0.0	27.4	0.1	5.4	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.6	0.0	7.5	0.2	0.0	3.2	1.9	0.1	0.1	5.5	2.1	0.1	0.1	1.5	1.3	0.0	0.0	11.3	5.6	12.3	16.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.7	0.0	0.0	8.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	13.0	0.0	0.0	0.0	18.3	45.7	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.9	0.0	12.6	0.0	0.0	0.4	15.3	26.8	25.0	102.9	0.0	0.0	19.9	25.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	30.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.4	305.8
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 182.4;Exocrine glandular cells: 149.7;Proximal tubular cells: 129.8;Syncytiotrophoblasts: 156.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 48.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 48.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.7;SK-BR-3: 54.1;SK-MEL-30: 55.7;TIME: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		22000			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	18.9	5.6	39.3	5.1	32.3	6.5	19.7	9.1	70.9	15.2	14.2	28.2	14.6	10.3	10.0	34.5	16.8	20.3	26.7	8.7	33.4	15.9	82.1	1.9	15.4	2.2	24.2	22.8	3.1	25.2	13.5	6.7	38.1	27.2	13.0	13.4	6.3	34.3	24.7	5.7	32.6	7.7	7.8	32.0	4.9	18.1	22.1	28.9	12.1	81.4	8.7	7.2	17.8	14.2	0.1	0.1	1.0	0.2	8.7	48.1	8.4	7.7	8.5	2.5	0.1	0.0	0.0	25.0	1.4	0.8	2.5	0.5	6.4	41.7	0.0	20.9	1.3	36.3	28.5	0.0	19.4	1.0	0.3	0.0	0.8	10.4	7.3	0.0	0.0	0.4	0.5	28.0	4.5	1.9	3.1	20.6	0.2	0.0	0.3	0.5	9.7	20.6	0.1	0.3	26.8	8.3	0.7	0.2	5.7	39.2	24.6	7.2	0.2	0.4	54.1	55.7	1.8	23.9	0.1	44.7	4.7	7.7	0.3	17.3	0.0	0.3	0.1	38.7	0.1	11.3	0.6	0.2	0.0	48.1	0.1	0.5	0.1	3.3	18.3	0.0	0.0	1.7	14.1	1.0	8.7	0.1	0.1	0.0	8.4	39.3	32.3	9.1	35.0	33.4	15.9	24.2	22.8	27.2	28.9	8.9	14.0	0.5	24.7	0.0	0.6	2.8	20.4	30.8	39.8	75.0	0.0	182.4	23.2	27.8	68.9	52.5	2.5	0.0	149.7	10.0	3.2	15.7	4.7	0.6	19.2	0.0	19.9	30.7	3.3	24.2	2.8	4.6	0.0	0.0	32.9	3.5	83.2	3.5	0.0	129.8	0.5	0.0	3.9	1.6	0.7	0.0	156.0	24.9	29.5	13.1
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell type enriched"	"Detected in single"	12	"Distal tubular cells: 1.7"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	670	"ASC diff: 86.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	1000000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	86.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADM	AM	ENSG00000148926	Adrenomedullin	P35318	11	10304680-10307397	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 133.1"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 624.9;Extravillous trophoblasts: 468.6;Syncytiotrophoblasts: 907.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 62.3"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 62.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 110.1;fHDF/TERT166: 55.0;HSkMC: 67.3;U-138 MG: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016075, HPA068955"	Approved				"Secreted to blood"	NA	NA	31000	46000			"CAB016075: AB_628693, HPA068955: "	"unprognostic (1.67e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (9.70e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.62e-2)"	65.2	18.3	6.8	18.3	12.4	21.1	52.1	2.5	15.0	28.3	23.3	5.9	1.6	4.8	11.6	8.0	26.5	7.9	18.7	28.3	4.7	3.5	17.3	26.1	34.3	15.2	8.0	2.0	19.0	16.0	10.8	8.4	133.1	14.2	13.8	7.0	23.5	9.6	2.1	92.3	28.7	8.0	11.8	12.7	14.6	10.7	11.6	9.9	0.3	15.9	13.3	10.1	76.1	32.4	0.1	0.6	62.3	3.2	0.0	0.0	0.4	5.4	4.3	5.2	1.4	110.1	47.3	8.2	41.6	39.0	39.4	27.2	21.9	6.7	0.0	1.9	55.0	22.5	7.8	1.5	6.4	33.1	0.1	1.7	0.1	2.1	2.6	14.0	0.2	0.1	67.3	5.2	4.5	7.2	14.6	8.9	0.0	0.0	0.0	9.8	0.1	0.0	1.2	9.8	1.2	1.7	0.1	0.1	7.7	2.4	7.4	0.1	0.4	15.8	3.4	0.0	5.9	4.8	0.0	2.5	58.0	0.8	36.2	6.0	0.4	4.4	1.5	17.3	0.0	17.2	0.0	1.7	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	62.3	0.0	3.2	0.0	0.0	0.4	6.8	12.4	2.5	15.0	4.7	3.5	8.0	2.0	14.2	9.9	8.9	20.1	28.2	624.9	170.6	2.1	75.8	28.1	13.4	39.8	3.5	7.9	112.5	13.3	103.4	0.5	81.7	87.8	0.0	27.4	468.6	90.7	189.9	9.2	14.1	64.4	3.2	64.8	117.9	65.7	0.5	122.8	65.2	38.8	8.2	96.0	4.3	56.7	31.5	18.0	50.7	14.1	0.0	70.6	5.1	1.9	109.8	907.2	6.9	24.6	220.0
ADM2	"AM2, FLJ21135"	ENSG00000128165	"Adrenomedullin 2"	Q7Z4H4	22	50481556-50486440	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 30.2;salivary gland: 32.2"	"Cell type enhanced"	"Detected in some"	13	"Exocrine glandular cells: 8.8;Pancreatic endocrine cells: 8.9;Proximal tubular cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 22.1;hTCEpi: 13.8;Karpas-707: 22.0;SK-MEL-30: 14.5;U-266/70: 16.1"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	61300					"unprognostic (1.30e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.26e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.41e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.06e-2)"	0.5	0.5	0.4	2.9	0.4	0.1	0.7	0.4	0.4	0.8	1.2	0.0	1.3	3.7	0.5	2.9	2.2	0.6	5.6	0.4	0.4	0.4	11.4	6.6	0.8	4.1	0.4	0.0	0.4	30.2	0.0	0.6	0.7	0.2	2.6	0.4	0.1	32.2	2.2	0.4	0.5	5.2	0.0	0.5	2.0	4.3	0.6	0.0	1.6	11.7	1.7	4.0	0.5	0.6	0.9	0.5	2.0	0.5	0.4	1.4	0.2	1.0	0.2	0.3	1.1	0.7	1.3	4.1	5.2	0.5	0.7	1.7	2.1	0.9	0.0	0.8	4.4	0.9	0.8	1.1	0.7	0.2	9.9	0.0	0.0	0.2	1.5	22.1	2.1	1.4	4.4	13.8	2.4	5.0	0.0	0.0	5.8	1.3	22.0	0.1	3.2	0.2	0.4	0.7	6.0	3.3	0.0	0.0	8.2	1.0	0.1	0.5	2.4	0.0	3.2	14.5	0.7	4.4	6.9	0.0	0.0	4.9	0.0	0.0	16.1	2.2	2.8	0.4	0.0	1.2	0.7	0.5	0.4	0.6	0.2	0.3	0.6	0.5	0.6	0.0	0.9	1.4	1.1	2.0	0.4	0.5	0.5	0.3	0.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0	0.0	4.0	2.4	0.6	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	3.3	2.7	0.0	0.0	3.2	0.0	8.8	0.6	0.4	2.7	0.0	1.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.7	1.0	5.2	0.0	8.9	0.3	0.0	19.2	0.0	0.0	0.0	0.2	0.7	0.4	0.8	0.7	1.2	0.7
ADM5	"AM5, C19orf76"	ENSG00000224420	"Adrenomedullin 5 (putative)"	C9JUS6	19	49688664-49690575	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 5.5;Early spermatids: 5.7;Melanocytes: 5.0;Suprabasal keratinocytes: 5.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.9"														"Secreted - unknown location"	NA	NA						"unprognostic (2.34e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.21e-11)"	"unprognostic (2.39e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.92e-3)"	"prognostic favorable (6.74e-4)"	5.5	0.9	1.0	1.8	1.2	3.2	4.2	2.6	1.5	1.8	1.1			2.2	3.1	1.0	2.0	3.9	1.8	0.7	0.7	1.0	1.5	0.7	3.5	2.7	1.0		1.4	1.0	0.4	1.7	2.2		2.6	0.6		1.6	1.1	2.4	6.5	1.6	2.3	0.9	5.0	1.1	1.6			1.5		2.0	1.3	2.1	0.6	0.2	0.0	0.3	0.0	1.1	0.0	3.0	5.1	3.0	2.1	0.1	0.0	3.6	0.3	0.2	1.0	0.5	5.9	2.8	4.6	1.1	0.2	0.2	0.9	5.4	1.7	0.4	5.3	10.3	5.1	1.2	3.7	0.1	1.5	3.5	0.5	3.9	0.7	0.4	0.8	1.0	4.9	3.7	3.4	0.2	4.8	2.3	15.9	4.1	0.5	1.5	6.5	2.3	4.7	0.5	5.3	1.9	0.8	0.7	1.5	1.3	0.8	3.3	2.2	0.8	1.7	6.2	0.9	1.2	11.7	9.1	5.2	1.1	8.9	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	1.0	0.0	0.9	5.5	3.9	0.0	2.5	1.4	1.2	0.0	0.0	0.4	0.0	0.4	5.7	3.3	0.5	0.0	1.0	0.4	1.4	0.7	0.0	0.0	0.2	0.0	1.2	4.3	1.8	2.3	0.6	1.1	5.0	0.0	1.2	0.9	0.4	0.0	0.7	0.0	2.0	0.0	0.3	0.9	0.3	5.5	0.1	0.0	1.6	0.9
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481683-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 169.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 272.5"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	5000000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	2.5	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	272.5	0.1	0.0	0.0	4.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 99.9;Proximal tubular cells: 38.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	190	"Hep G2: 219.7"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.3	0.0	2.4	0.7	0.3	0.0	0.0	99.9	2.1	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
AGGF1	"FLJ10283, GPATC7, GPATCH7, HSU84971, VG5Q"	ENSG00000164252	"Angiogenic factor with G-patch and FHA domains 1"	Q8N302	5	77029251-77065234	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA						"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.21e-2)"	12.7	17.9	21.1	14.3	24.8	10.8	14.2	20.3	26.8	13.1	13.6	13.0	12.6	18.2	13.3	29.8	14.0	11.5	11.6	12.9	19.6	19.5	17.4	17.7	12.4	16.1	22.7	20.7	14.8	13.0	24.4	18.1	14.4	26.7	13.5	15.6	9.6	14.4	12.6	17.4	16.3	17.6	12.0	18.7	17.6	12.9	20.3	20.9	26.1	15.0	10.9	17.7	13.6	11.3	14.4	13.8	26.0	13.9	12.7	16.5	8.4	14.5	10.0	13.0	16.3	15.1	15.7	12.7	12.3	13.1	9.2	11.7	6.6	16.2	9.8	15.5	8.5	16.1	13.3	6.9	12.6	14.4	14.8	12.0	9.9	11.9	9.0	11.4	10.5	16.2	11.1	15.6	9.4	11.0	12.5	11.1	15.0	11.8	8.3	13.0	14.6	18.2	10.7	0.0	6.2	7.3	14.6	21.4	23.1	15.5	11.8	13.2	16.0	13.2	10.5	14.5	11.7	19.9	13.8	10.5	8.3	10.5	13.5	14.0	16.7	18.9	2.3	15.1	16.9	15.4	12.9	13.9	26.0	15.2	11.9	12.0	12.7	14.0	13.9	12.3	14.4	16.5	13.7	12.5	12.7	11.2	13.8	14.6	8.4	21.1	24.8	20.3	26.8	19.6	19.5	22.7	20.7	26.7	20.9	26.8	20.0	18.2	15.0	6.4	50.0	37.2	22.9	14.7	2.3	5.2	33.4	25.2	6.6	10.3	20.0	25.9	24.7	0.0	12.5	17.7	14.9	24.6	13.9	29.2	28.9	31.8	14.5	27.6	41.6	6.2	27.0	19.4	10.1	11.8	28.6	39.2	10.8	29.4	29.7	11.6	59.5	32.3	10.8	73.8	35.1	8.5	10.8	13.8	28.9	15.7
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		15000000	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	27.0	16.8	3.3	10.9	0.5	0.7	29.4	13.7	4.4	9.2	5.6	14.1	46.4	0.5	54.1	2.1	4.5	47.1	1.1	16.9	1.1	1.0	6.4	0.0	22.0	14.8	3.9	0.3	5.5	2.4	7.3	2.9	6.4	12.8	1.6	0.4	5.6	0.1	0.7	22.2	0.2	3.8	7.0	8.7	12.3	4.3	6.4	4.0	16.1	12.1	0.8	6.5	27.8	30.1	26.5	3.3	26.5	2.1	23.9	11.3	40.0	1.5	11.0	0.3	0.2	1.0	7.1	2.5	3.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1	23.8	9.1	2.4	7.5	13.4	0.8	2.2	79.0	5.3	14.8	148.3	7.9	1.1	1.7	85.5	0.1	17.9	18.6	0.0	14.5	4.6	5.6	15.4	2.3	8.9	3.9	4.8	6.4	13.5	2.1	0.8	5.2	3.1	23.6	27.1	10.4	10.0	62.9	14.0	2.5	11.3	5.4	6.5	8.5	0.5	9.6	5.3	1.0	1.0	18.4	13.7
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 3.3;Hofbauer cells: 9.2;Leydig cells: 2.8;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.8;HeLa: 1.5;Hep G2: 2.2;HMC-1: 1.8"	"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"	NA	NA	255000				"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.8	0.8	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.2	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.2	0.0	1.5	0.1	1.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	1.0	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in many"	12	"Cholangiocytes: 828.0;Hepatocytes: 2051.9"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 111.1;THP-1: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	111.1	0.3	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	42.4	0.0	0.0	0.2	0.0	0.2	0.6	7.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9	0.0	1.7	34.4	0.9	0.6	4.5	43.1	828.0	0.0	0.0	3.5	33.4	0.1	21.6	119.6	56.8	0.5	0.0	116.8	8.6	0.1	2.8	19.4	0.0	2051.9	1.8	3.2	0.0	34.4	50.3	31.9	3.7	0.0	8.5	1.0	0.0	89.3	18.7	0.0	3.2	123.3	42.2	12.9	6.4	0.4	0.4	0.0	0.6	4.5	0.0	1.3
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 986.2"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 215.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	215.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.1	3.3	0.1	4.6	0.0	0.0	46.7	0.5	0.6	0.0	0.0	0.0	986.2	1.2	0.0	0.0	29.4	29.9	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349226	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000		Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	30.7	26.6	20.2	25.7	24.5	42.2	30.3	22.5	22.9	29.9	33.7	17.0	33.6	27.7	29.3	28.4	35.0	25.6	23.7	23.6	21.2	18.4	40.4	35.3	23.4	24.6	29.8	21.8	35.9	27.2	24.1	44.0	27.3	26.5	29.8	28.4	14.1	25.6	32.1	67.8	22.6	39.1	32.8	30.1	26.9	25.2	15.9	29.4	31.3	35.9	40.6	25.8	41.2	25.9	28.2	35.9	24.6	32.7	23.7	33.4	16.6	22.9	14.7	15.5	21.9	18.6	27.9	26.0	30.7	23.6	24.0	28.8	25.3	33.9	40.7	23.2	25.5	18.9	23.0	23.6	29.1	34.4	22.6	14.8	24.0	19.0	40.2	35.7	47.5	27.8	21.5	33.6	25.5	41.4	17.9	20.8	22.4	41.0	22.0	26.5	16.6	32.0	22.6	17.6	31.7	14.7	26.3	31.4	36.6	29.7	20.0	24.9	18.5	19.6	54.2	27.6	22.8	25.9	33.4	17.7	31.7	29.0	23.5	35.7	25.0	35.0	41.6	26.4	37.2	34.0	22.4	26.9	24.6	21.8	29.0	26.0	27.7	27.3	21.8	27.6	28.2	28.5	25.9	3.7	23.7	32.7	35.9	33.4	16.6	20.2	24.5	22.5	22.9	21.2	18.4	29.8	21.8	26.5	29.4	65.5	48.1	80.4	112.4	44.6	44.9	91.2	84.1	77.6	91.0	62.8	33.4	105.8	132.6	104.1	59.3	50.6	74.9	23.3	110.5	122.1	61.9	108.3	78.4	110.0	97.3	23.8	70.9	63.3	84.2	9.9	91.7	82.1	30.4	91.0	106.7	52.5	101.3	87.7	80.2	119.0	35.9	58.2	70.0	117.4	69.1	43.8	126.2	64.5	109.4	153.1
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 49859.9"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 315.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	315.9	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	683.8	0.0	0.0	0.0	0.1	12066.1	0.0	0.0	36.6	0.0	0.8	61.3	4.3	2.0	0.0	0.0	1612.0	237.4	2.3	0.2	0.1	0.0	49859.9	8.2	0.0	1.7	1417.3	1529.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	261.7	0.0	0.0	442.7	0.0	0.0	0.4	0.2	0.2	0.1	17.7	22.3	0.0	0.0
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565507	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9"	"Cell type enhanced"	"Detected in some"	28	"Club cells: 2.3;Distal tubular cells: 5.0;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 1.6;NTERA-2: 1.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"	NA	NA					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.3	1.6	0.2	0.0	0.0	0.0	0.4	3.2	3.0	0.0	0.0	1.5	0.1	0.0	3.9	0.6	8.7	0.0	0.1	0.2	0.3	1.1	1.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	6.8	0.3	0.0	2.4	0.0	0.0	0.2	2.2	4.6	0.2	0.0	1.0	0.4	0.3	0.3	6.0	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKAL2	"AUGA, FAM150B"	ENSG00000189292	"ALK and LTK ligand 2"	Q6UX46	2	279558-288851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.8;retina: 81.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 8.3;Ductal cells: 31.1;Proximal tubular cells: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"AF22: 56.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.39e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.35e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.19e-2)"	"unprognostic (3.68e-1)"	5.7	70.8	1.6	1.2	4.9	0.1	6.7	0.4	1.2	4.5	2.7	2.2	3.3	1.2	8.2	8.6	2.2	6.8	7.4	1.4	1.3	1.1	36.8	1.8	8.6	6.9	0.4	1.0	24.7	30.3	1.3	3.0	3.9	2.4	1.8	2.3	81.0	2.0	2.9	1.1	4.9	2.6	3.7	3.0	2.9	3.4	22.2	0.6	0.9	2.5	1.4	1.4	2.9	1.8	1.3	0.9	0.0	0.6	1.0	1.9	0.5	0.0	0.0	56.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.4	0.6	1.1	1.3	0.9	0.8	0.1	0.5	1.9	0.9	0.0	1.0	0.0	0.9	1.5	0.5	1.6	4.9	0.4	1.2	1.3	1.1	0.4	1.0	2.4	0.6	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.3	31.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 9824.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	154	"Hep G2: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		71000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	168.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	42.0	0.6	1.3	0.0	0.0	2035.7	0.0	1.2	1.8	0.0	0.0	3.3	105.1	19.2	0.0	0.4	256.9	25.3	0.3	0.1	0.4	0.0	9824.4	0.7	0.0	2.4	175.6	182.3	40.5	0.6	0.0	0.0	6.4	0.9	0.0	22.8	1.1	0.0	9.9	0.0	0.0	0.0	0.2	0.1	0.4	1.1	3.8	1.0	0.3
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.1;OE19: 1.5"														"Secreted in other tissues"	NA	NA								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMELY	AMGL	ENSG00000099721	"Amelogenin, Y-linked"	Q99218	Y	6865918-6874027	"Predicted secreted proteins"	Biomineralization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA																	"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0		0.0	0.9	0.0	0.0	0.2		1.2	0.0		0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8			2.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AMH	MIS	ENSG00000104899	"Anti-Mullerian hormone"	P03971	19	2249309-2252073	"Disease related genes, Predicted secreted proteins"	"Differentiation, Gonadal differentiation"	"Growth factor"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.3;Horizontal cells: 7.9;Late spermatids: 6.0;Muller glia cells: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 17.8;NTERA-2: 6.8;REH: 7.1;SH-SY5Y: 8.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA066973			Approved	Vesicles,Aggresome	"Secreted to blood"	NA	NA		56000	"Vesicles, Aggresome"		"HPA066973: AB_2732754"	"unprognostic (8.10e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (8.73e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.34e-2)"	"unprognostic (8.73e-8)"	"unprognostic (4.64e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.76e-1)"	0.3	0.2	1.0	0.3	2.8	0.3	0.3	4.8	1.4	0.3	0.5	0.3	0.3	0.2	0.4	0.6	0.3	0.2	0.3	0.3	0.5	1.3	0.3	0.3	0.4	0.5	0.3	0.3	1.1	0.7	0.2	3.5	0.4	0.3	0.3	0.2	0.3	0.3	0.3	2.6	0.4	0.6	0.3	0.3	0.5	0.6	35.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.1	0.4	0.0	0.0	4.5	0.7	0.0	0.0	0.0	0.1	0.2	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	17.8	0.1	0.6	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	0.5	0.0	0.5	0.1	1.3	6.8	0.0	1.6	7.1	1.5	0.9	0.0	0.2	0.5	8.2	0.1	0.0	1.5	0.0	0.9	0.0	0.8	0.6	1.4	0.9	2.5	5.0	3.6	0.8	0.3	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	4.8	1.4	0.5	1.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.1	14.3	0.8	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.6	0.1	0.5	0.0	0.2	0.2	0.4	0.1	0.0	0.2	0.1	7.9	1.2	0.6	0.0	6.0	1.4	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.4	0.2	2.2	0.0	0.1	0.5	0.4	0.1	0.0	0.0	0.6	0.1
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518540-70532742	"Disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.1;Urothelial cells: 1.3"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 14.9;hTERT-RPE1: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.8	12.9	0.0	0.0	0.5	0.0	0.0	0.6	0.0	6.7	0.2	0.0	0.0	0.9	0.9	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	21.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell type enriched"	"Detected in some"	11	"Ciliated cells: 38.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;SH-SY5Y: 2.4"									"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		68000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7											3.0	2.1	0.0	0.8	0.6	0.0	2.4	0.0	38.8	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 34.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.2	0.0	0.1	0.2	0.0	0.7	0.0	34.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 33.4;Ciliated cells: 95.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.7"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											3.0	33.4	0.0	0.0	0.0	0.0	0.4	0.0	95.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell type enriched"	"Detected in some"	68	"Exocrine glandular cells: 849.6"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.3"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		77000000			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	849.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 31.4;Exocrine glandular cells: 124.1"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.5;EFO-21: 11.8;HSkMC: 7.8"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		75000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.3	0.0	6.4	11.5	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.8	0.3	0.0	1.4	0.1	1.4	1.6	1.4	1.8	2.1	4.4	0.9	1.0	2.6	2.8	7.8	7.7	0.8	1.3	2.0	0.2	3.3	0.0	3.5	0.9	0.0	2.1	0.5	0.1	0.1	1.6	0.6	0.0	5.1	6.6	2.1	3.2	0.6	2.7	1.3	0.8	2.1	0.1	1.5	0.9	0.4	1.0	0.5	0.7	4.0	0.1	0.3	2.2	2.0	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8	11.9	16.1	3.2	2.8	4.1	10.0	6.9	5.1	17.4	18.2	1.8	31.4	0.3	0.0	0.7	4.8	1.5	3.6	0.0	124.1	0.2	1.4	1.2	3.5	5.9	1.5	9.5	4.7	1.8	7.0	2.3	2.3	3.1	5.0	1.8	2.5	2.4	1.3	1.4	1.8	0.4	16.2	0.0	2.2	1.7	0.6	2.6	0.2	0.8	2.5	0.9
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell type enriched"	"Detected in many"	21	"Hepatocytes: 4646.2"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 52.5;OE19: 40.2"					"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	230000000	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.3	3.4	0.8	0.0	8.6	10.3	0.1	1.4	3.0	0.4	1.4	2.0	1.8	0.1	0.4	4.2	2.9	1.3	0.9	1.0	0.4	5.8	1.3	0.3	1.9	52.5	1.8	1.3	0.1	8.3	0.8	0.5	1.8	4.3	2.0	1.5	0.0	9.6	1.2	0.2	0.2	0.4	0.2	40.2	3.8	0.2	1.3	3.9	0.8	1.0	0.0	0.1	1.5	0.6	2.3	1.9	1.4	0.2	1.7	0.5	1.0	0.5	0.2	2.0	1.6	0.2	1.1	0.6	1.6	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4	26.8	12.4	18.0	36.0	24.2	0.0	0.6	219.1	60.2	18.2	10.4	0.0	1.5	10.0	27.6	0.7	12.2	37.1	23.3	27.7	3.3	31.0	52.1	0.0	4646.2	15.9	0.0	68.2	70.0	110.5	1.1	65.9	16.0	21.9	1.0	138.3	9.1	26.8	17.3	22.6	45.5	0.6	12.9	18.6	0.7	1.0	45.8	7.8	12.1	44.2	29.8
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Smooth muscle cells: 33.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.8;HEL: 17.3;HSkMC: 51.3;U-138 MG: 24.8;WM-115: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	NA	NA	32000000				"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	23.3	3.9	3.4	5.4	2.3	0.4	5.9	14.2	2.6	9.1	3.8	5.1	22.3	1.4	2.9	8.0	7.3	3.2	11.2	5.8	8.5	2.1	8.0	1.4	25.1	0.8	2.4	4.3	7.3	1.5	1.2	35.0	14.2	6.2	23.8	2.3	13.0	7.6	28.5	14.1	1.9	2.6	5.2	4.7	7.4	5.2	2.3	4.7	0.7	5.2	3.1	0.7	5.8	5.6	0.3	0.5	9.3	2.2	0.3	0.4	1.1	0.0	0.8	3.2	1.8	30.8	10.7	2.4	10.3	8.7	2.8	4.1	2.0	0.0	0.0	0.0	5.3	0.0	0.0	1.4	0.0	3.6	0.0	0.5	17.3	0.2	0.0	8.8	0.2	0.0	51.3	0.0	1.7	0.2	2.6	0.2	0.0	9.2	1.8	3.6	0.0	0.3	2.6	3.3	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.3	0.2	0.0	4.2	0.7	0.0	0.1	24.8	0.3	0.8	0.2	0.1	1.0	0.0	3.5	0.3	16.1	0.3	2.0	0.0	0.3	2.2	0.4	0.1	0.3	0.3	0.5	0.3	0.1	0.1	9.3	0.3	0.9	0.5	0.1	1.1	3.4	2.3	14.2	2.6	8.5	2.1	2.4	4.3	6.2	4.7	0.0	2.9	0.0	9.4	0.6	0.1	2.8	0.0	0.0	3.4	7.0	0.0	5.0	1.7	0.2	6.3	2.4	0.0	0.0	0.0	6.3	9.1	1.5	0.0	0.0	0.4	0.0	0.0	1.8	0.8	1.7	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	1.7	0.0	6.5	33.0	0.9	4.9	0.1	2.3	0.0	0.0	0.8
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499651-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 123.7;Smooth muscle cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"HMC-1: 10.2;HSkMC: 24.2;HUVEC TERT2: 37.4;WM-115: 12.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	31000			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.8	0.8	5.3	5.0	20.6	0.6	17.9	10.4	19.5	9.3	3.5	0.5	2.2	1.6	6.2	2.8	3.8	5.8	7.2	10.1	6.1	5.9	3.0	4.1	4.6	8.3	13.1	1.0	3.0	1.2	1.9	1.1	20.0	20.8	4.3	2.7	0.5	2.8	4.4	17.7	3.3	2.6	9.9	9.4	2.3	2.3	1.4	12.4	2.9	10.5	2.2	3.9	14.8	8.1	1.9	1.1	5.4	0.7	0.8	1.2	0.2	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.5	0.0	10.2	24.2	0.0	0.0	0.0	0.0	37.4	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.2	5.4	0.7	0.6	0.9	0.4	0.9	0.7	0.8	0.8	0.1	1.9	0.9	1.2	0.8	0.8	0.4	1.1	0.2	0.2	5.3	20.6	10.4	19.5	6.1	5.9	13.1	1.0	20.8	12.4	8.9	0.0	11.1	2.5	7.2	6.9	1.5	5.1	1.4	0.0	0.0	27.5	1.4	0.0	1.2	3.4	123.7	1.1	0.0	0.5	1.1	8.9	8.1	4.6	0.8	0.6	36.5	13.2	31.3	2.8	3.6	40.3	2.7	15.1	1.0	1.3	3.2	1.1	0.0	3.5	1.0	12.6	0.0	107.9	1.4	1.4	6.9	25.6	8.2	1.1	2.7
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 21.4;Late spermatids: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	40	"ASC diff: 21.6;BEWO: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"	NA	NA					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.6	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	0.1	0.0	0.0	0.0	21.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	13.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	1.1	0.0	0.0	0.0
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849705-178871052	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Leydig cells: 394.4;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.3;naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Group enriched"	"Detected in some"	18	"ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"	NA	NA		100000			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	17.7	16.3	1.2	8.5	1.1	0.0	14.4	0.7	1.4	26.3	36.2	0.9	9.6	2.6	34.6	46.5	33.6	29.7	16.6	12.9	1.0	0.6	15.9	7.1	12.4	15.8	0.6	2.5	35.7	6.4	0.0	2.2	42.0	1.6	16.7	8.7	0.9	14.2	4.2	20.0	4.5	28.2	22.7	1.8	7.0	13.1	24.7	0.4	0.9	19.3	57.5	2.8	25.5	13.7	2.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	48.7	19.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	21.1	0.0	0.0	48.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.7	1.4	1.0	0.6	0.6	2.5	1.6	0.4	0.0	0.0	0.5	0.0	3.3	2.2	3.1	30.6	1.4	0.0	1.8	5.9	0.5	1.7	0.7	0.8	2.9	0.0	0.0	0.4	0.6	51.8	0.1	0.0	0.9	1.3	0.0	0.0	11.6	0.0	1.9	394.4	0.0	3.3	0.0	0.0	36.6	0.0	0.0	199.4	0.0	12.4	38.8	35.0	0.7	0.7	3.1	1.1	0.0	0.0	0.1
ANGPTL2	"ARP2, HARP"	ENSG00000136859	"Angiopoietin like 2"	Q9UKU9	9	127087332-127122883	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 66.4;Leydig cells: 19.2;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.4;ASC TERT1: 28.2;BJ hTERT+: 58.2;HSkMC: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040933, HPA041299"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	2510000	770000	"Golgi apparatus"		"HPA040933: AB_10795530, HPA041299: AB_10794552"	"unprognostic (5.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.07e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.15e-2)"	56.6	4.9	3.3	13.5	4.7	0.0	29.0	8.2	16.5	34.9	26.8	19.5	4.4	6.2	29.9	19.8	12.6	13.1	34.9	28.4	4.6	3.4	4.3	6.1	8.3	3.8	9.3	2.9	38.4	2.2	1.6	1.5	8.7	9.6	22.9	7.8	3.4	7.1	12.1	41.9	11.4	10.0	37.4	6.3	26.6	12.7	8.7	8.5	1.7	6.4	27.0	6.4	38.7	20.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.9	0.0	41.4	28.2	2.5	2.1	58.2	2.6	2.4	0.0	0.0	0.0	1.9	5.8	0.5	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	28.4	0.0	5.3	0.0	8.3	7.5	0.6	0.0	0.0	1.8	0.0	0.0	1.1	5.2	0.0	0.2	4.3	7.6	0.4	0.6	0.0	2.5	2.8	0.0	0.0	0.0	1.0	0.0	0.0	2.3	9.6	1.2	13.6	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.7	8.2	9.0	4.6	3.4	9.3	2.9	9.6	8.5	8.9	3.7	0.0	6.6	12.7	14.5	12.9	0.0	2.7	0.0	0.0	2.0	0.8	0.0	0.2	0.7	11.7	0.0	0.0	0.0	0.7	66.4	1.3	0.0	0.0	1.2	0.0	0.0	2.5	0.0	1.3	19.2	0.3	6.8	0.0	0.0	1.6	1.0	0.0	6.0	1.4	0.3	0.0	25.2	0.2	0.0	9.7	2.2	0.0	0.0	0.6
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597487-62606159	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 276.6"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 523.1;Proximal tubular cells: 240.8"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;HL-60: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	45000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	276.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	1.1	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.9	0.3	7.6	0.0	0.0	5.2	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	523.1	0.1	0.0	0.0	7.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	240.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	1500000	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.4	3.6	0.1	1.2	0.1	0.2	0.0	0.0	6.0	0.0	9.0	2.5	1.3	0.8	0.0	65.4	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.7	0.2	10.0	0.2	1.8	5.0	0.1	0.3	0.2	17.7	0.5	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.2	3.2	1.2	0.0	0.1	7.5	0.8	1.1	0.4	1.9	0.1	33.0	19.4	0.1	9.8	0.0	0.0	0.0	0.0	13.3	0.0	3.6	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7	35.7	4.3	0.5	32.6	12.5	0.1	3.6	2.5	4.0	10.3	14.0	0.0	5.4	0.0	91.5	0.5	17.6	26.4	0.0	15.3	96.9	44.0	38.8	2.3	145.0	7.4	0.0	0.0	20.9	1.6	0.4	81.4	6.1	8.5	3.6	8.6	4.1	173.2	7.0	123.8	3.7	0.0	32.3	98.2	0.0	0.9	10.0	33.5	1.9	1.7	72.4
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.4;ovary: 24.9"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 5.6;Leydig cells: 25.6;Melanocytes: 6.8;Peritubular cells: 14.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"ASC diff: 7.9;ASC TERT1: 2.2"					"Low region specificity"	"Detected in all"			HPA038516	Uncertain				"Secreted in other tissues"	NA	NA					"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	9.4	0.3	0.2	0.0	0.3	0.0	6.4	0.2	0.7	1.3	0.3	0.0	0.6	0.1	0.1	5.0	1.0	0.4	0.3	3.7	0.2	0.2	0.1	0.2	1.0	0.1	2.0	0.5	24.9	0.0	0.0	0.3	0.1	0.8	1.4	0.2	0.0	0.5	0.3	1.9	3.5	0.5	1.3	1.7	0.0	0.2	6.2	0.3	0.2	2.4	2.9	0.0	1.8	1.1	0.7	1.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	7.9	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.2	0.3	0.2	0.7	0.2	0.2	2.0	0.5	0.8	0.3	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	0.0	6.8	0.0	0.0	0.2	0.0	0.0	14.2	0.0	0.3	0.0	1.4	0.2	0.0	4.8	0.1	0.0	0.0	0.0
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 31.8"	"Cell type enhanced"	"Detected in some"	14	"Cholangiocytes: 2.5;Hepatocytes: 4.9;Hofbauer cells: 2.3;Ito cells: 8.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 36.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	450000	550000				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.7	2.1	1.6	2.6	0.3	0.7	2.7	0.2	0.5	0.7	0.5	0.7	0.1	0.2	0.7	0.7	0.9	0.7	0.6	0.7	0.9	31.8	0.5	3.3	1.6	0.2	0.4	1.2	0.0	0.4	2.3	1.4	0.2	0.4	0.1	0.5	0.0	0.1	0.3	2.9	0.2	0.9	3.0	1.6	1.3	0.5	0.3	0.3	0.0	3.4	0.6	0.9	2.9	0.6	0.0	1.4	1.3	2.6	0.9	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.0	0.3	36.9	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.8	2.8	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	1.7	0.1	0.4	0.4	0.0	1.3	0.0	2.6	1.4	1.8	2.9	1.6	1.8	0.6	2.8	1.0	1.6	0.0	1.3	0.7	0.4	2.0	0.9	0.7	1.6	0.7	2.7	0.6	0.7	1.6	0.2	1.4	0.5	0.0	0.0	1.5	0.1	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.9	2.3	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.5	4.1	0.0	0.2	1.3	0.0	0.0
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189341-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.9"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"	NA	NA		490000				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	12.8	3.7	0.1	2.0	0.2	0.0	4.8	3.2	0.2	5.4	8.0	0.3	9.3	1.3	1.4	4.3	7.0	1.7	5.9	10.4	0.1	0.3	6.5	0.4	2.1	1.0	0.1	0.4	1.9	0.6	0.0	7.8	0.9	0.5	4.7	2.4	5.3	4.2	11.4	22.9	5.9	2.6	16.5	3.5	0.4	2.2	3.9	0.5	0.1	0.7	13.8	1.4	6.2	4.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	0.2	0.1	0.3	0.1	0.4	0.5	0.5	3.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 81.0"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 96.9"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"Hep G2: 26.8;MCF7: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	320000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	8.0	0.1	0.0	0.6	0.0	0.0	5.1	0.0	0.1	0.1	5.7	0.0	0.0	0.2	0.1	0.8	0.1	0.1	1.0	0.6	0.0	0.0	1.5	81.0	0.1	3.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.7	26.8	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.2	0.0	0.2	0.3	0.7	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	96.9	0.1	0.0	0.0	6.7	5.9	1.3	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958700	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.1"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.9	12.4	7.9	3.7	9.5	3.2	2.3	7.9	9.4	4.3	2.2	0.6	3.5	1.9	4.7	7.6	5.1	5.9	3.9	3.6	8.3	3.9	2.0	1.3	4.4	6.3	4.2	9.8	5.8	7.6	3.5	4.4	5.4	3.5	3.3	0.5	2.4	3.3	4.2	1.5	4.9	2.4	6.5	3.0	14.2	2.6	8.6	1.1	0.0	3.8	0.9	1.6	5.1	4.0	1.0	1.5	1.4	1.9	6.8	4.0	0.8	1.0	2.9	1.4	1.3	2.2	1.7	5.7	1.3	3.5	1.4	2.0	1.6	1.4	1.3	1.5	2.9	1.2	1.4	2.9	0.2	1.1	0.7	0.8	1.4	3.0	1.1	1.6	1.1	2.3	1.3	0.4	0.9	0.5	0.8	1.0	1.3	0.2	19.2	0.4	2.7	0.5	2.1	1.7	0.5	1.3	0.8	0.8	9.1	0.1	14.4	2.9	3.5	0.7	1.0	1.3	1.3	1.1	1.1	1.4	2.6	2.7	2.3	1.3	5.3	18.6	1.0	2.9	2.6	0.8	1.0	0.9	0.1	2.1	1.9	0.8	1.0	1.1	3.2	1.5	0.7	0.8	0.8	1.4	6.8	1.8	0.0	4.0	0.8	7.9	9.5	7.9	9.4	8.3	3.9	4.2	9.8	3.5	1.1	0.0	2.2	0.0	4.9	4.9	9.4	1.2	0.0	0.0	1.2	0.0	11.8	2.7	0.0	0.7	0.8	8.0	0.0	0.0	1.9	4.6	7.0	2.2	5.7	0.0	4.9	3.2	1.2	1.3	5.4	0.9	57.2	7.9	10.1	0.0	0.0	36.1	4.2	0.0	73.9	0.0	6.6	12.9	13.9	1.4	1.1	3.1	1.8	4.1	0.0	4.1
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732186	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;lung: 37.1;parathyroid gland: 27.7"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 1: 223.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3"														"Secreted in brain"	NA	NA						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	5.4	4.0	13.8	1.3	14.0	0.6	3.6	1.3	18.0	4.5	1.0	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6.0	0.9	0.8	27.7	1.0	1.4	19.3	4.1	1.3	6.0	2.8	4.5	10.9	3.0	0.9	1.1	25.5	1.1	1.1	5.0	8.5	1.3	8.5	1.0	1.2	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.4	2.6	0.1	3.5	0.3	3.8	0.0	0.0	0.0	1.0	0.0	1.9	0.2	0.1	25.9	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	1.1	0.3	0.0	3.2	0.0	0.6	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.0	1.3	7.6	11.1	7.9	5.7	6.0	19.3	8.5	223.4	9.3	0.0	4.2	0.0	6.4	6.2	0.0	6.7	36.4	0.0	3.9	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	1.5	2.9	1.1	0.0	5.2	0.0	0.0	2.5	2.2	0.0	0.6	1.4	0.0	0.0	0.0	21.4	0.8	0.0	1.1	0.0	1.5	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.1	0.8
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	66.2	104.7	4.7	4.9	66.8	63.6	0.3	114.8	71.8	47.5	32.2	3.0	59.9	0.1	38.0	100.1	105.0	81.6	10.1	69.5	37.7	37.5	0.7	5.1	31.1	0.1	53.3	11.0	2.5	36.6	57.6	48.0	94.4	44.0	67.3	6.0	21.0	2.8	58.5	0.2	19.5	6.0	5.9	26.5	42.6	0.0	26.7	0.2	106.8	14.0	0.0	0.0	39.5	1.0	26.5	65.5	0.2	1.7	83.1	55.7	35.1	76.5	58.9	0.4	0.1	0.2	128.7	10.3	83.8	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1	541.9	512.9	7.3	2232.0	752.1	0.0	11.9	17.8	1060.0	889.5	59.3	0.0	1215.0	0.0	156.6	6.3	398.1	0.8	0.0	20.0	1352.9	735.1	1709.3	2387.0	2.5	570.9	0.0	5.1	113.5	449.6	2.3	206.0	1058.5	291.8	475.3	1.8	0.2	431.7	0.0	8.9	3.1	0.0	64.7	275.6	0.7	2.9	522.6	5914.0	282.4	0.5	4139.3
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	144.7	161.6	8.5	3.8	116.8	187.4	37.1	173.0	111.6	109.9	96.5	76.6	69.9	0.3	142.5	223.8	82.7	154.9	38.0	324.9	120.6	30.8	4.0	2.9	77.8	29.7	70.4	0.1	2.1	91.5	88.7	78.1	168.4	132.2	204.9	2.1	11.5	16.9	234.8	16.8	0.6	8.5	18.5	123.9	125.9	1.7	46.9	8.1	194.9	88.2	11.2	6.3	68.4	15.6	67.9	92.0	33.4	6.0	233.6	93.8	127.8	314.4	169.8	6.3	20.7	2.8	88.3	1.6	186.5	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1	1989.1	372.8	135.8	2699.6	2231.6	2.1	19.9	922.3	1675.6	1452.5	532.1	0.0	1604.6	11.6	3597.2	77.7	904.5	724.0	23.3	2130.9	2200.2	1229.1	3363.5	101.8	70.0	1517.4	0.0	99.2	465.3	432.0	90.7	714.0	1131.8	1344.5	1757.5	521.7	18.0	3399.7	582.2	600.4	22.4	6.8	181.1	774.1	7.0	17.7	2032.4	961.8	162.4	580.5	3656.9
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	21.3	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8	0.0	14.0	8.8	0.0	0.7	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.2	1.7	0.2	0.4	0.5	5.8	0.0	0.0	0.2	0.5	0.1	4.7	0.6	31.1	0.0	14.9	3.1	110.3	0.4	0.0	54.2	0.0	19.0	0.4	3.2	0.0	1.5	0.4	0.3	0.2	0.0	0.9	0.0	0.0	0.3	0.1	51.7	0.5	0.1
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"	"Group enriched"	"Detected in some"	5	"HEL: 2.9;K-562: 7.3"														"Secreted - unknown location"	NA	NA																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP002347.1		ENSG00000285231			11	59878809-59896481	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 7.4;testis: 2.5"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	24	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.1"														"Secreted - unknown location"	NA	NA																							0.0	0.0		0.5		0.7	0.0		0.3	0.0	0.3			0.6	0.1	0.0	0.2	0.0	0.0	0.0			0.5	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.6	0.0	0.6	0.0	0.0	0.0		0.0	0.4	2.5			0.0		0.0	0.0		0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.9	1.4	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.4	0.3	0.4	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.5	0.4	0.7	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	3.1	0.0	0.2	0.3	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 3479.3"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	76000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.7	4.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	451.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	70.0	5.1	0.0	0.0	0.0	0.0	3479.3	0.0	0.0	0.0	63.8	73.6	0.0	0.0	0.0	0.0	5.4	0.0	0.0	16.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 27.8;SuSa: 17.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0											0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	22.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654937	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 52.0"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 2.2;Cardiomyocytes: 5.5;Glandular cells: 1.5;Melanocytes: 1.7"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 106.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (9.32e-4)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	3.8	9.7	10.0	2.8	8.0	0.7	2.3	2.0	10.9	0.9	1.2	21.8	0.0	1.5	1.4	1.0	1.3	0.9	1.1	8.3	9.7	10.3	5.2	1.0	13.6	0.8	13.9	7.6	12.5	0.9	0.9	4.3	52.0	14.5	1.5	1.0	0.0	1.3	1.2	2.9	1.2	1.0	2.5	19.3	1.1	1.1	1.6	10.7	0.0	1.6	0.2	0.9	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	0.1	0.4	0.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.3	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	1.7	0.0	1.5	0.0	0.0	106.9	0.3	0.0	0.4	0.5	0.0	0.0	0.1	0.3	0.0	5.7	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.1	18.1	0.4	0.0	7.8	0.4	0.1	0.0	0.0	7.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.0	2.0	8.1	9.7	10.3	13.9	7.6	14.5	10.7	0.0	2.2	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	1.2	1.5	1.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.0	0.0
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell type enriched"	"Detected in many"	33	"Hepatocytes: 19896.2"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 253.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	220000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	253.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.3	1.6	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.5	174.9	0.2	0.1	0.6	24.6	596.2	0.0	2.3	0.0	0.0	0.4	0.0	0.1	30.6	1.9	0.9	256.9	1.0	1.1	1.5	0.1	2.3	19896.2	3.1	0.0	1.7	472.6	569.9	110.5	20.8	0.6	0.0	0.0	0.5	0.1	0.2	0.3	4.6	2.2	0.6	6.5	0.7	10.3	9.1	0.5	3.5	2.9	0.3	0.3
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	321	"liver: 932.2"	"Cell type enriched"	"Detected in some"	61	"Hepatocytes: 43650.4"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 610.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	210000000000			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.0	2.9	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	67.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	610.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.8	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	153.8	0.0	0.0	0.0	0.0	647.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	1.2	0.0	0.0	186.9	0.5	1.1	0.0	0.0	0.0	43650.4	4.6	0.0	0.0	550.0	711.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.5	0.0	4.7	0.0	0.0	0.0
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell type enriched"	"Detected in single"	618	"Hepatocytes: 61.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	140000000000	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"liver: 112.2"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 1283.4"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	65	"Hep G2: 36.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	114000000	15000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.0	1283.4	0.0	0.0	0.0	13.5	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 2874.2"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 155.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	14.6	293.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	2874.2	0.1	0.0	0.0	51.5	53.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 702.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 27093.4"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"myeloid DC: 8.9"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in many"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	26000000000			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	1.5	58.9	6.6	1.6	30.0	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1.0	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2.0	0.4	1.2	1.4	1.0	0.5	11.7	9.6	1.3	1.0	5.2	1.0	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0.0	0.6	0.2	0.0	0.6	0.4	4.7	2.1	0.9	6.9	7.2	20.3	0.2	0.3	0.8	1.3	9.9	8.9	1.4	1.7	0.1	0.6	0.3	2.8	0.3	0.4	0.0	11.4	6.4	0.6	100.3	6.1	4.7	3.3	62.1	0.5	0.8	0.3	1.7	0.2	0.3	26.1	0.1	0.3	0.6	0.2	0.3	20.4	1.8	1.0	1.0	2.9	0.1	1.3	0.3	0.9	0.6	3.3	0.0	46.2	7.2	0.4	17.4	0.7	0.0	0.3	0.0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.6	6.6	30.0	0.6	3.1	4.1	7.8	20.2	1.0	6.6	5.2	107.2	247.1	115.1	4.2	15.0	1.6	0.7	451.0	44.2	99.0	1.8	0.0	32.3	41.4	3.4	0.9	5.6	0.5	186.9	3.5	299.0	64.1	1.9	139.7	27093.4	5056.0	0.0	2.4	451.8	716.3	1.3	250.8	243.1	28.7	215.6	2.2	120.9	3.3	0.0	244.0	10.9	8.3	19.4	5.9	1.4	3.0	15.6	59.8	137.1	2.1	4.9
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44945982-44949565	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	78	"liver: 506.5"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 936.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"NK-cell: 6.5"	"Lineage enriched"	"Detected in single"	21	"NK-cells: 6.5"	"Group enriched"	"Detected in some"	4	"Hep G2: 84.9;THP-1: 156.9"					"Not detected"	"Not detected"			HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	110000000000			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0.0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0.0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0.0	0.2	0.0	0.7	0.3	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.7	0.2	84.9	0.0	1.8	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	14.1	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	0.0	156.9	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1	0.0	2.9	1.5	0.0	0.6	0.0	0.1	12.7	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.4	936.4	35.6	0.0	0.0	18.4	13.7	0.0	0.0	11.1	6.8	3.6	0.0	0.0	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	1.3	0.0	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Cell type enriched"	"Detected in some"	60	"Hepatocytes: 64257.6"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 28.5;Hep G2: 77.0"					"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	28.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	77.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	100.1	0.0	0.0	0.0	0.0	858.6	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	1074.6	0.4	0.3	0.0	0.0	0.0	64257.6	1.0	0.0	0.0	825.6	1072.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.2	0.0	0.0
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942238-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"liver: 126.0"	"Cell type enriched"	"Detected in single"	34	"Hepatocytes: 3.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.2;SK-MEL-30: 6.5;TIME: 3.1"									HPA062671	Approved				"Secreted to blood"	NA	NA	1000000000	1500000000			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	126.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0.0	0.0	0.8	0.0	0.9	1.6	0.0	0.0	1.1	0.2	0.0	0.2	1.1	0.1	0.0	0.2	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0.0	2.6	0.0	0.3	1.2	2.5	0.3	0.0	0.4	0.1	0.0	1.3	1.2	1.9	0.8	1.0	0.4	0.0	0.0	0.1	0.5	0.0	0.6	0.8	0.0	1.5	0.5	0.2	0.7	0.8	6.5	0.2	1.4	0.0	3.1	0.6	0.3	0.4	0.0	0.8	0.9	2.0	0.2	1.3	0.0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in many"	5	"Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 239.5;ASC TERT1: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	220000000000	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	239.5	129.1	0.3	2.0	0.5	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.5	1.4	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	2.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.9	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5	0.0	8.3	0.0	14.6	128.8	0.0	31.1	0.0	40.2	104.6	5.2	0.0	4.1	0.0	0.2	9.1	55.0	0.0	0.0	0.0	5.0	271.0	22.1	0.0	0.0	12.4	0.0	44.5	30.1	0.3	22.5	1923.5	6.2	975.2	1.8	0.9	0.0	1.9	0.0	934.8	0.1	0.0	19.4	80.9	3.8	3.8	89.6	4.9	0.0	0.6	37.7
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 7873.9;Hofbauer cells: 6293.2;Muller glia cells: 7584.1;Peritubular cells: 4660.8;Proximal tubular cells: 5645.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 167.1;CACO-2: 39.6;Hep G2: 77.6;HSkMC: 122.5;SK-MEL-30: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	63000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	167.1	6.8	6.0	0.1	0.3	0.7	0.1	39.6	0.2	0.1	0.8	0.0	0.8	0.5	1.1	0.1	0.0	0.1	0.3	0.2	0.1	77.6	17.2	0.5	0.2	122.5	0.2	1.3	0.1	1.3	0.0	0.0	10.2	0.2	0.1	0.2	0.1	0.2	20.9	0.2	0.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	0.3	0.1	155.3	12.1	14.3	4.4	0.2	1.1	0.2	0.1	0.1	0.5	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9	0.0	10.9	128.8	14.4	830.7	52.9	1.6	384.7	0.0	5.7	216.3	39.3	36.4	578.6	1.8	57.6	21.1	0.3	163.5	0.6	28.5	329.7	3.9	179.1	7873.9	6293.2	36.5	0.0	191.5	425.6	179.9	2434.6	240.8	2353.4	122.6	0.3	7584.1	0.8	0.0	4660.8	5645.5	238.0	219.9	382.4	13.0	8.5	1472.8	62.1	122.2	1.2	4.2
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360569-56362823	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"liver: 114.0"	"Cell type enriched"	"Detected in some"	42	"Hepatocytes: 377.1"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 9.9"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	18000000000	4000000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.3	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.7	1.0	9.9	0.0	0.9	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.5	0.6	0.4	0.1	0.3	0.2	0.1	0.6	0.1	0.4	0.3	0.5	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.5	0.2	0.4	0.4	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.2	0.0	0.0	0.2	7.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.0	377.1	0.0	0.0	0.0	4.9	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	550	"liver: 823.7"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 7635.3"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	20	"Hep G2: 166.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	44000000000	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	823.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.7	0.9	1.3	1.0	1.3	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	166.9	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.1	0.3	0.0	0.0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1.0	0.4	0.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	46.2	0.0	0.0	0.0	0.0	206.4	1.4	1.2	0.0	0.0	0.0	3.3	0.3	0.1	0.0	0.0	163.5	2.0	0.0	0.0	0.0	0.0	7635.3	0.5	0.0	0.0	134.4	149.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.8	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253010-36267530	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 82.9;Pancreatic endocrine cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 63.8;HDLM-2: 41.2;HHSteC: 31.5;RPTEC TERT1: 24.4;RT4: 37.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	19000000000			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	22.4	7.1	2.5	16.5	3.2	0.7	11.8	1.7	2.6	16.6	13.0	1.8	11.6	9.1	19.9	15.6	15.9	11.5	25.8	11.5	3.5	2.4	22.8	66.4	23.8	9.9	3.6	2.0	21.6	7.8	1.3	6.5	39.3	4.7	26.4	7.8	13.0	9.5	24.1	6.5	3.1	22.9	17.9	4.6	23.1	17.5	6.1	2.4	9.6	21.9	10.0	9.7	25.9	46.3	2.0	3.3	12.7	7.1	17.2	10.9	4.9	5.3	1.1	0.0	0.1	12.2	11.8	3.6	0.5	2.3	3.4	10.0	0.1	8.6	1.7	63.8	5.9	7.9	1.3	0.0	4.9	0.9	41.2	0.0	1.4	0.8	10.0	31.5	0.6	5.2	2.1	0.4	10.0	0.2	0.5	6.8	0.3	6.1	21.8	0.6	0.0	2.0	0.4	0.1	0.1	0.0	3.3	0.5	0.7	24.4	37.8	0.5	0.0	2.5	1.4	0.5	0.0	0.1	1.9	6.3	7.5	3.2	0.8	0.3	1.7	0.9	0.3	4.2	3.0	1.2	9.8	4.6	3.9	10.9	5.2	8.7	2.0	6.7	9.0	3.3	1.2	4.0	5.4	12.7	17.2	7.1	0.4	4.1	4.9	2.5	3.2	1.7	2.6	3.5	2.4	3.6	2.0	4.7	2.4	53.6	33.0	11.1	14.0	1.4	0.6	3.2	17.8	34.8	22.7	17.4	2.0	9.1	0.0	33.0	0.5	36.5	7.3	0.0	17.5	4.8	20.8	22.5	10.5	82.9	8.3	0.0	7.5	40.5	15.0	0.0	25.3	6.5	0.0	22.6	15.5	0.0	64.3	23.0	22.6	1.2	0.7	6.5	7.1	0.4	0.4	1.9	5.6	15.2	2.3	48.8
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	46.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	21.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2	0.0	7.9	0.0	0.9	1.1	0.2	1.1	2.5	4.0	3.4	0.0	0.0	0.4	3.3	0.1	0.0	3.8	0.0	0.0	0.6	0.6	6.3	1.2	2.3	0.0	2.4	1.6	14.3	1.3	4.5	0.0	2.6	5.3	0.0	1.8	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.4	0.0	0.0	1.0	5.1	0.0	0.1	1.4
APOM	"ApoM, G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 94.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 596.8;Proximal tubular cells: 592.0"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	18000000000	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	1.3	1.5	1.8	1.5	1.6	6.8	1.9	1.3	2.0	1.3	1.8	2.2	1.9	2.4	2.3	3.0	1.6	1.5	1.4	1.5	1.5	1.3	15.2	94.6	1.0	3.6	1.7	1.9	3.7	3.3	1.4	1.9	0.7	1.6	1.1	0.9	2.1	3.1	1.6	2.2	2.4	2.4	1.5	2.4	1.3	1.4	6.6	1.1	3.6	2.7	1.7	3.1	1.1	1.0	3.3	1.6	5.8	2.1	1.0	2.2	1.0	2.2	1.1	2.5	4.1	2.1	2.5	0.5	1.5	2.7	1.0	2.4	1.5	3.2	3.4	0.8	2.7	2.0	3.6	1.5	1.6	2.1	2.1	2.6	2.4	1.8	3.2	3.3	4.3	1.2	3.3	1.6	1.0	3.0	2.2	0.9	3.4	4.3	2.2	2.7	3.3	3.6	4.2	2.2	1.6	0.5	2.2	1.8	3.9	2.8	3.2	2.2	1.0	2.2	0.2	1.8	1.2	4.5	3.1	0.4	1.5	0.5	2.9	0.6	4.0	3.5	4.1	1.3	6.6	0.6	5.8	1.9	1.7	1.1	0.9	1.7	3.3	1.3	1.1	1.6	1.9	1.7	1.8	1.7	1.0	2.1	1.4	2.2	1.0	1.8	1.6	1.3	1.8	1.5	1.3	1.7	1.9	1.6	1.1	0.0	6.1	14.3	4.6	5.7	1.2	1.4	10.2	2.7	2.3	14.0	3.9	1.6	64.6	3.5	42.6	1.4	9.3	0.0	6.1	0.8	4.3	3.2	4.7	596.8	4.8	0.0	4.1	6.7	11.4	29.3	8.6	3.4	5.0	0.0	2.5	13.2	5.1	3.1	6.0	592.0	2.3	0.0	2.7	19.1	5.5	5.6	1.0	8.7	3.3	3.7
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.7	13.5	22.7	15.8	3.8	8.7	3.6	7.4	9.1	15.8	16.7	8.0	7.1	12.8	9.3	6.8	20.6	12.2	28.6	14.8	17.6	13.5	20.3	6.5	13.4	12.6	9.0	16.3	7.3	9.7	8.8	17.4	13.0	8.5	11.0	16.1	9.1	14.5	14.6	13.9	16.4	17.6	20.7	19.4	21.9	12.7	11.3	30.7	30.9	7.6	15.4	11.2	16.1	15.4	15.8	23.3	26.6	7.3	2.7	10.2	6.2	36.5	11.2	11.3	19.8	11.6	16.5	8.1	14.9	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8	14.9	7.8	15.6	14.2	12.5	19.3	55.7	25.5	87.0	9.1	22.7	13.7	16.6	152.5	24.6	16.8	8.7	14.4	0.0	14.1	7.3	12.6	14.5	3.5	11.9	20.3	19.1	6.9	9.8	10.1	11.7	10.6	11.2	27.0	55.9	17.6	40.5	12.0	18.4	14.9	67.7	23.7	6.5	6.2	14.0	50.7	6.0	10.4	10.0	20.9	15.4
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 1.7;Proximal tubular cells: 4.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"									HPA000549			Uncertain	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.4	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.2"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 10.8;granulocytes: 4.6;Melanocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 9.5;HaCaT: 18.5;Hep G2: 11.4;hTEC/SVTERT24-B: 18.6;U-87 MG: 23.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: AB_2675995"	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.19e-4)"	2.0	0.5	2.1	4.3	2.0	0.9	0.5	0.7	2.0	4.9	2.1	0.6	0.3	1.0	5.0	1.2	4.2	3.6	2.2	2.4	1.7	1.1	1.4	0.8	6.2	0.4	2.5	1.0	3.3	0.8	0.0	1.8	24.2	2.0	5.5	0.8	6.9	0.8	1.5	1.4	9.2	1.0	5.6	6.6	1.2	1.6	1.1	1.0	0.8	0.6	9.2	1.6	5.2	4.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.6	0.0	0.0	0.5	0.0	4.7	7.1	9.5	6.9	0.6	1.1	0.0	1.9	6.7	0.8	18.5	0.1	3.1	3.3	0.0	0.0	0.0	0.2	11.4	0.9	0.0	0.0	0.5	2.0	18.6	0.5	6.4	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.8	0.5	0.7	6.9	0.0	0.0	0.0	0.1	6.3	0.2	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	2.0	0.7	2.0	1.7	1.1	2.5	1.0	2.0	1.0	0.0	0.0	0.0	0.0	10.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	4.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	20.3	0.0	0.0	2.0	0.5	0.0	0.4	0.8	0.2	0.0	0.8	0.0	0.7	4.1	1.1	0.0	0.0	0.0
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Basal glandular cells: 42.2;Glandular cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HUVEC TERT2: 18.4;LHCN-M2: 18.6;TIME: 23.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 15.4"	"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA			"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	3.5	2.2	2.6	2.0	2.7	0.0	2.6	10.3	3.4	7.9	4.7	0.9	4.1	1.0	4.8	2.2	9.1	4.6	6.0	5.2	1.5	1.2	9.4	3.4	6.9	3.5	1.8	3.6	4.7	2.6	13.3	1.8	6.7	4.2	7.2	5.4	1.8	9.1	3.9	0.8	1.7	1.7	10.5	2.9	0.5	5.8	0.9	2.0	0.6	1.9	3.6	1.7	7.5	18.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	2.5	0.2	0.0	4.5	9.3	0.0	20.4	15.5	12.8	5.0	0.5	1.4	0.0	2.6	9.6	4.5	2.2	0.1	5.0	16.1	0.0	0.9	0.0	2.0	0.0	13.9	0.0	0.0	5.7	5.1	8.6	17.8	9.0	18.4	0.0	0.0	0.0	18.6	0.1	0.0	0.0	0.6	0.0	3.7	0.0	2.2	0.0	16.8	0.0	0.0	0.7	1.3	0.2	0.9	3.4	0.1	0.0	23.4	14.8	4.0	2.2	9.6	0.0	0.0	0.0	7.2	0.0	4.5	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	10.3	3.4	1.5	1.2	1.8	3.6	4.2	2.0	32.8	9.8	0.0	42.2	2.6	0.1	0.9	10.2	4.0	12.5	24.4	0.0	0.3	0.0	7.3	0.0	4.0	0.9	0.0	0.7	0.1	13.6	38.6	0.0	1.3	0.4	1.6	22.5	3.7	0.0	0.0	2.3	0.7	3.3	0.0	16.4	5.2	3.6	2.9	1.4	2.9	0.1	0.0	15.1	0.0	0.2	1.0	0.3	0.5	4.3	22.3
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555074-95605064	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	8.5	10.2	6.9	4.8	7.6	4.7	7.6	14.2	12.3	8.9	8.6	4.3	9.6	5.1	8.5	9.6	6.7	7.4	6.9	8.5	7.9	7.1	11.5	9.7	7.4	5.6	8.4	9.9	12.8	11.7	29.3	14.5	11.2	7.2	10.7	5.9	7.3	6.7	11.2	5.5	8.4	5.4	6.7	8.8	5.5	9.7	4.5	7.5	10.6	15.8	2.8	4.5	9.2	14.0	6.7	2.7	10.0	1.6	3.9	9.2	2.3	3.4	2.2	4.6	4.6	23.2	12.1	6.7	10.9	6.3	4.3	8.8	2.8	5.4	4.7	5.7	3.7	7.7	3.3	4.0	6.9	9.4	5.0	5.9	3.7	5.5	4.5	6.8	2.0	3.0	8.9	6.2	6.5	4.2	9.0	6.9	6.4	3.7	5.1	9.4	1.6	5.6	3.9	6.0	1.1	10.5	3.5	7.4	7.4	9.8	0.8	3.3	3.3	6.7	2.2	6.5	6.7	6.2	2.2	12.4	6.8	5.5	10.5	6.6	4.4	7.4	5.6	6.8	5.5	25.2	10.0	1.6	2.5	5.3	1.5	6.1	5.3	6.0	6.7	0.8	6.7	9.2	6.9	1.5	3.9	1.0	2.7	4.5	2.3	6.9	7.6	14.2	12.3	7.9	7.1	8.4	9.9	7.2	7.5	3.0	2.1	2.7	7.4	3.9	8.1	3.9	2.5	5.3	2.3	7.0	11.8	9.0	3.3	3.0	6.3	5.4	2.5	0.0	2.2	43.9	10.4	4.5	23.0	12.1	3.9	9.5	2.9	3.7	3.1	1.8	10.0	5.2	5.0	6.4	1.8	13.2	1.9	3.5	11.0	4.5	9.1	0.0	8.3	2.2	7.9	6.0	4.2	9.6	3.0	1.6
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4"	"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in single"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.2	1.8	1.4	12.7	0.0	0.0	1.8	11.8	0.1	0.0	0.7	0.4	2.8	0.0	93.5	1.8	1.4	1.9	0.1	0.0	21.3	0.1	0.0	0.0	55.3	7.5	0.0	1.7	0.6	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	12.6	6.5	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"SuSa: 17.9"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	2.2	0.0	0.0	3.7	0.2	1.8	0.9	2.1	0.1	0.0	0.0	0.9	0.2	0.0	0.0	1.8	0.0	0.5	0.0	2.6	0.0	0.4	0.2	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.1	17.9	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5	0.0	2.6	0.0	1.8	0.2	0.4	1.6	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	12.7	0.3	0.0	0.0	0.2	0.4	0.7	0.6	0.0	1.7	0.1	0.0	0.0	0.0	0.3	14.5	3.1	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.1	0.3	0.7	0.0	0.2	15.9	1.7	0.3	2.4	0.0	0.0	0.1
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 18.3"	"Cell type enriched"	"Detected in some"	10	"Urothelial cells: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0"	"Region enriched"	"Detected in single"	9	"olfactory region: 4.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.0"						"Secreted in other tissues"	NA	NA						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2.0	5.1	2.0	0.6	1.6	6.2	0.4	2.1	0.5	1.0	0.1	2.4	14.4	18.3	8.0	10.4	4.8	10.0	2.5	0.7	5.3	12.4	1.0	1.2	1.1	2.0	2.0	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.8	0.7	0.5	0.4	0.1	0.1	0.1	1.2	0.2	1.2	1.2	0.1	0.7	0.3	0.1	0.4	0.3	31.5	0.0	28.0	0.2	0.1	0.9	0.4	3.0	0.0	0.0	0.1	0.6	0.0	11.8	0.5	9.0	5.4	0.0	0.4	0.3	0.9	0.1	2.1	0.1	1.7	2.6	0.0	1.1	0.5	0.0	0.4	0.1	0.5	0.6	0.2	0.1	0.0	0.6	0.5	5.0	4.5	0.3	0.5	0.2	0.2	1.2	3.0	2.2	0.3	4.0	1.4	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	4.3	1.7	0.6	1.6	1.0	0.1	4.8	0.7	0.0	0.0	0.0	2.6	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.1	5.6	0.0	0.8	0.0	0.2	0.0	0.2	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.8	4.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	56.7
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.9	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.6	0.1	2.4	0.5	0.7	0.0	0.4	0.0	0.0	0.0	0.2	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.4	0.0	0.0	0.0	0.3	0.0	1.6	1.2	2.0	0.0	0.7	0.5	3.5	0.0	0.3	1.4	0.7	0.6	3.0	0.0	0.2	0.6	0.6	0.0	0.4	3.9	1.1	0.7	0.4	0.8	1.2	1.2	0.2	0.6	0.8	0.8	4.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3	0.0	1.1	0.0	0.0	2.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.0	1.3	0.0	0.0	0.0	0.1	2.3	0.0	0.0	4.0	12.3	0.0	0.0	4.3	0.3	0.2	11.5	1.7	1.7	0.0	0.0	0.0	0.1	0.0	9.9	4.4	0.0	6.5	1.0	1.6	1.3	2.8	0.7	0.0	0.0	0.0
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		33000	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.7	0.0	2.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4	0.0	1.4	0.0	0.0	59.6	0.5	3.6	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.3	5.8	0.0	0.0	0.0	0.0	60.7	0.0	1.1	0.4	0.2	0.0	0.0	22.7	0.0	0.2	5.5	0.5	13.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	38.8	29.5	0.0	0.0	23.6	0.0	0.0	0.0	0.0
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Enzymes, Predicted secreted proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;fHDF/TERT166: 2.1;JURKAT: 2.3;RT4: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.2	0.1	0.2	0.6	0.4	8.5	0.1	1.3	0.8	0.0	0.5			0.1	0.3	0.4	0.5	0.0	0.4	0.0	0.8	0.0	0.1	0.0	0.5	1.1	0.0		0.2	0.0	0.0	0.8	0.0		0.9	0.2		0.6	2.7	0.0	2.3	1.1	0.0	0.0	2.3	0.2	0.7			0.0		0.7	3.2	0.0	0.3	0.0	0.0	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.4	3.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	1.2	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.5	1.1	0.9	0.7	0.1	0.0	0.0	0.0	0.4	0.0	3.8	0.8	0.0	0.0	0.3	0.3	0.0	1.4	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	1.2	0.3	1.8	1.8	0.0	0.0	0.3	0.6	0.0	1.9	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471040-3651122	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		39000000000	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.1	22.8	14.9	7.4	20.7	5.7	13.0	18.4	29.3	13.5	22.8	18.3	7.4	39.9	12.2	12.2	9.3	9.2	12.4	14.8	13.6	14.7	18.4	45.2	10.6	7.1	12.8	18.9	11.5	17.7	40.3	13.4	16.5	16.1	10.1	9.5	12.2	14.0	10.7	11.7	13.6	31.1	11.3	15.2	9.7	17.1	16.2	12.3	5.4	24.1	7.5	7.1	12.0	9.8	3.6	5.7	5.7	6.5	3.0	4.8	1.9	17.9	16.9	10.1	8.4	17.9	29.3	12.9	12.0	17.1	12.7	10.8	7.2	12.3	0.0	8.1	16.8	15.6	25.2	6.8	26.2	17.0	2.0	5.8	5.6	4.7	15.6	10.8	11.9	3.8	15.6	21.3	13.4	13.0	15.9	16.4	3.9	8.8	8.8	12.3	5.1	4.8	4.5	6.7	5.9	10.2	4.0	23.4	13.4	11.6	12.8	6.0	9.3	12.0	22.4	16.4	10.3	12.0	11.4	20.1	13.5	8.0	14.2	11.8	6.2	8.7	0.0	8.3	8.0	13.5	5.7	6.5	3.6	4.8	5.6	2.3	2.8	2.7	3.0	5.7	3.6	4.4	3.7	0.0	3.0	5.7	5.3	3.4	1.9	14.9	20.7	18.4	29.3	13.6	14.7	12.8	18.9	16.1	12.3	14.9	7.2	7.3	3.8	5.7	22.1	10.4	22.9	6.7	5.7	10.4	35.3	6.4	1.7	6.4	6.3	8.4	6.1	0.0	12.5	7.2	9.3	6.1	6.9	39.5	9.6	35.0	9.2	20.9	13.9	2.5	11.5	6.3	6.8	6.4	10.2	12.7	10.7	15.3	7.4	7.9	18.2	32.3	5.2	16.7	21.7	6.4	4.2	5.0	10.5	3.1
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"brain: 270.1"	"Group enriched"	"Detected in some"	5	"Late spermatids: 18.7;Proximal tubular cells: 32.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	18	"hypothalamus: 270.1"	"Cell type enriched"	"Detected in some"	6	"eosinophil: 6.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.1"	"Cell line enriched"	"Detected in single"	13	"NB-4: 7.1"	"Region enriched"	"Detected in some"	10	"hypothalamus: 273.6"	"Group enriched"	"Detected in some"	633	"basal ganglia: 1065.4;hypothalamus: 1058.2"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	NA	NA	19300				"CAB025318: , HPA071892: AB_2732190"										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.7	0.9	11.7	0.4	15.0	4.2	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	270.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.1	11.7	15.0	0.0	0.9	3.4	270.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.8	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Group enriched"	"Detected in many"	6	"Glandular cells: 2272.6;Hepatocytes: 3981.0"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	160000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.4	0.0	49.6	0.0	0.0	0.5	38.9	0.0	0.0	0.0	0.6	0.2	7.9	3.8	0.0	13.0	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.2	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7	20.8	187.7	32.0	321.8	3.8	0.0	94.8	420.4	5.3	50.0	5.2	2.0	0.0	39.7	11.0	1.3	0.4	8.5	46.7	221.1	0.0	0.2	2272.6	3.5	3981.0	0.0	0.0	11.9	58.3	79.1	3.1	0.9	0.3	59.1	3.6	5.4	22.6	173.5	5.8	0.0	512.3	0.2	0.0	1.1	4.3	0.4	8.4	0.0	15.2	6.3	497.4
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 3.3;Kupffer cells: 4.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"	"Cell line enriched"	"Detected in some"	7	"THP-1: 154.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		290000	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	3.3	0.0	0.0	0.0	4.6	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell type enhanced"	"Detected in some"	30	"Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.0	0.0	0.7	0.9	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	16.7	0.8	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2	0.0	0.0	0.0	0.0	0.0	34.2	1.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.9	0.1	22.3	1.7	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	119.7	0.0	0.0	0.4	2.3	6.3	0.0	0.0	0.2	0.1	0.0	0.1	3.2	0.0	0.1
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 144.2"	"Group enriched"	"Detected in some"	22	"Horizontal cells: 103.3;Melanocytes: 177.2"	"Group enriched"	"Detected in many"	77	"glioma: 348.5;melanoma: 75.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.7;K-562: 34.8;U-266/70: 20.9;U-266/84: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	NA	NA		98000			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	1.4	5.8	51.8	1.6	35.9	1.3	1.4	10.4	144.2	2.3	2.4	30.5	1.3	4.6	2.7	9.5	1.6	2.4	3.1	1.5	40.8	22.9	1.4	1.3	1.5	1.5	26.6	21.5	1.4	1.3	1.3	0.7	1.7	15.1	1.4	1.3	4.3	2.0	2.4	1.6	9.0	5.0	2.4	13.0	1.6	2.4	2.0	26.7	0.0	1.4	0.0	1.3	2.3	0.3	0.6	0.0	8.2	0.4	0.0	0.0	0.0	14.0	9.7	0.0	2.6	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.3	6.9	0.0	15.0	0.0	0.3	9.9	0.1	0.0	0.0	24.7	0.9	2.4	6.4	8.0	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.3	0.0	1.3	34.8	6.9	0.0	4.0	0.0	0.0	0.7	7.5	1.4	0.0	16.1	0.0	0.0	1.7	0.0	0.2	0.0	0.0	14.6	0.8	0.0	0.9	3.0	0.0	8.0	2.9	3.8	20.9	40.2	0.0	2.9	6.5	1.1	8.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	35.9	10.4	33.3	40.8	22.9	26.6	21.5	15.1	26.7	0.0	0.0	0.0	0.0	6.2	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.4	103.3	1.7	0.0	0.0	4.3	0.3	0.0	177.2	0.0	0.0	1.9	0.4	0.0	0.0	0.0	2.3	0.0	1.9	5.4	6.4	1.5	0.0	0.0	0.0	0.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 145.4"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 360.7"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 131.7"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		13000000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.0	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20.0	18.0	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1.0	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1.0	0.8	0.4	0.5	9.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	4.2	0.2	0.0	1.4	4.4	0.6	5.2	0.0	131.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.8	10.9	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	5.8	0.0	0.0	3.2	0.0	0.0	1.3	0.5	0.0	0.2	1.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1	0.0	0.0	0.0	0.3	4.8	0.9	4.3	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	1.5	0.0	0.0	0.0	0.0	2.2	0.2	0.0	360.7	0.1	1.6	0.0	6.2	5.3	5.5	2.0	0.0	18.6	0.0	0.0	34.4	0.0	0.0	0.0	2.9	1.0	0.0	4.6	0.3	0.1	3.0	0.0	0.0	0.0	0.1
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	NA	NA	16000000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.7	0.2	0.0	2.4	1.9	0.0	22.7	4.4	17.4	13.2	0.0	2.6	0.0	2.1	8.2	0.3	1.0	0.1	0.2	16.7	0.1	0.1	0.0	2.2	0.0	10.1	0.1	0.1	5.9	2.2	3.8	2.2	10.6	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.1	0.0	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	1.0	0.1	0.0	7.5	24.4	4.1	9.4	5.0	0.3	0.0	0.0	9.4	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0	35.7	0.3	0.0	0.2	0.6	4.7	9.6	0.0	0.0	0.0	1.8	3.9	0.2	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.3	4.1	0.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.5	0.0	6.6	0.4	0.7	0.0	0.6	0.0	0.0	0.0
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156241962-156243321	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in some"	13	"Melanocytes: 3.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"NK-cell: 2.2;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 4.2;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;U-87 MG: 6.4"														"Secreted to blood"	NA	NA	15500000	430000				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	1.6	0.7	6.0	6.7	6.9	2.2	1.4	5.2	11.0	1.1	9.3	6.2	0.0	3.2	4.8	1.4	0.8	2.3	1.7	0.7	4.3	2.9	1.2	1.6	1.4	2.3	6.2	6.8	3.4	0.8	1.5	1.3	3.1	9.7	2.1	3.4	0.0	3.6	2.8	2.2	6.8	6.4	3.9	8.4	2.1	2.3	0.3	4.1	0.6	1.6	0.0	1.2	0.7	1.2	0.0	4.2	0.2	0.0	2.2	0.1	0.1	0.3	0.7	1.6	0.5	0.0	0.5	1.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.4	0.0	0.7	0.6	0.0	0.4	0.0	1.8	0.9	0.0	2.0	1.1	0.5	0.0	0.4	0.0	0.6	0.6	0.6	7.5	0.6	1.5	0.5	2.2	0.0	1.9	0.0	1.4	0.8	0.1	0.3	0.9	0.1	1.4	0.6	0.0	0.2	1.8	0.6	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.4	2.7	2.5	1.4	6.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	4.2	0.0	0.1	6.0	6.9	5.2	11.0	4.3	2.9	6.2	6.8	9.7	4.1	0.0	0.0	0.0	0.9	1.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.2	1.1	0.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	1.4	0.0	3.3	0.0	0.1	0.3	0.0	0.0	0.4	1.1	0.5	6.5	0.0	0.5	0.9	1.1	0.3	0.0	0.6	0.7
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494939-153509554	"Disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Peritubular cells: 735.8;Sertoli cells: 1461.7;Smooth muscle cells: 411.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.6;BJ hTERT+: 60.2;fHDF/TERT166: 84.0;HSkMC: 44.1;hTEC/SVTERT24-B: 35.7;HUVEC TERT2: 84.3;U-138 MG: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		2500000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	41.1	39.7	8.1	23.2	14.6	0.4	20.2	5.6	14.3	76.7	12.0	18.7	16.7	6.0	63.4	31.7	21.1	23.6	86.7	133.0	8.9	5.2	67.6	78.1	77.6	29.4	8.9	16.3	39.6	16.8	5.1	26.7	131.1	15.0	33.6	7.0	48.3	20.4	38.2	17.0	31.0	8.6	56.9	5.9	101.3	10.0	28.0	15.8	3.9	45.3	29.9	14.6	34.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	4.9	11.0	0.1	46.6	60.2	8.6	2.8	5.8	0.0	0.0	8.6	84.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.0	44.1	0.3	35.7	1.6	4.4	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.1	0.0	17.8	38.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.6	5.6	14.3	8.9	5.2	8.9	16.3	15.0	15.8	3.0	9.3	0.0	1.0	92.5	0.0	6.7	5.1	2.7	4.5	8.7	0.0	13.9	1.7	2.4	1.4	48.7	0.0	0.0	0.2	33.9	142.9	2.3	3.5	1.0	4.0	3.2	0.0	198.2	3.1	4.0	137.0	6.2	33.7	3.6	0.0	0.0	1.8	0.0	735.8	0.3	0.1	1461.7	411.6	0.6	1.1	47.3	47.6	4.9	0.0	1.4
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.2	11.3	6.8	20.2	16.8	10.3	9.6	2.5	3.0	1.1	12.7	18.5	6.4	10.1	1.5	5.3	2.0	1.0	2.1	1.7	7.3	2.8	12.4	0.7	3.4	12.8	8.5	8.0	2.6	18.3	10.0	0.6	2.1	2.0	5.6	1.7	0.4	1.0	0.8	6.9	2.6	1.1	3.3	4.9	8.9	0.7	0.8	3.3	14.6	0.8	3.3	5.6	0.9	2.0	12.6	2.7	5.9	6.5	5.9	1.0	0.6	0.2	5.3	2.7	7.4	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6	6.0	61.3	0.5	5.3	5.6	1.5	3.0	2.5	1.4	2.3	5.2	0.0	2.4	0.0	21.2	0.5	10.5	18.6	0.0	7.1	8.6	24.4	2.5	15.0	15.8	4.1	1.6	2.9	14.1	4.0	0.5	9.5	3.5	10.1	0.0	5.5	3.2	11.4	11.0	10.3	3.1	1.0	25.8	18.4	0.9	3.6	4.5	20.4	1.9	9.7	6.4
BMP10		ENSG00000163217	"Bone morphogenetic protein 10"	O95393	2	68865481-68871517	"Predicted secreted proteins"	"Cell adhesion"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"heart muscle: 110.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Group enriched"	"Detected in some"	9	"JURKAT: 6.3;MOLT-4: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		120000																		"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMP15	GDF9B	ENSG00000130385	"Bone morphogenetic protein 15"	O95972	X	50910784-50916607	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 2.2;testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.1	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767664-6780280	"Cancer-related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 147.9;Basal keratinocytes: 148.5;Suprabasal keratinocytes: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.2;HeLa: 13.8;hTERT-HME1: 12.5;RT4: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	24400		Vesicles		"CAB078457: AB_2532532, HPA058610: AB_2683777"	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	11.1	1.1	1.6	10.5	3.1	0.6	5.3	1.8	7.5	3.7	13.1	2.6	1.9	4.2	3.4	6.7	3.7	3.7	15.6	3.9	2.4	1.6	3.6	3.8	12.8	1.3	2.9	1.3	3.1	9.2	4.7	2.3	7.6	2.7	8.8	9.5	18.3	2.0	1.2	2.6	9.1	13.4	3.4	1.4	8.0	13.8	1.1	2.7	0.3	13.2	6.2	3.1	14.1	9.1	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.5	2.3	0.0	0.0	21.2	0.0	0.0	0.3	0.7	0.0	7.1	4.2	1.8	0.0	0.0	3.8	0.0	13.8	0.0	1.0	0.0	0.6	0.1	6.4	0.0	12.5	2.7	4.3	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.5	2.5	0.5	4.1	0.0	0.3	1.6	16.8	0.8	1.1	5.0	0.0	0.0	4.0	0.0	4.4	1.0	1.2	1.9	0.0	0.6	0.2	0.5	0.0	2.1	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.3	2.4	1.6	2.9	1.3	2.7	2.7	74.5	147.9	4.5	34.3	148.5	0.4	4.6	53.5	0.0	13.6	1.8	0.0	0.1	0.0	19.3	0.3	9.7	64.5	0.0	8.3	0.1	15.5	30.2	8.1	2.4	2.7	0.0	10.9	46.1	3.7	0.0	5.5	1.9	8.5	1.0	18.4	4.8	23.9	17.3	0.0	0.7	0.2	19.4	38.9	0.0	0.1	104.4	0.1	0.0	15.1	24.3
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 25.1;Club cells: 20.5;Enterocytes: 20.2;Paneth cells: 23.7"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 10.6;Daudi: 16.1;RT4: 13.5;SK-BR-3: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.5	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0	3.0	25.1	0.0	0.6	0.1	2.2	1.1	0.0	9.4	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.6	0.2	0.2	23.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	5.5	3.0
BMP4	BMP2B	ENSG00000125378	"Bone morphogenetic protein 4"	P12644	14	53949736-53958761	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 24.5;Fibroblasts: 40.5;Syncytiotrophoblasts: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 1.8;intermediate monocyte: 2.9;memory CD4 T-cell: 2.5;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.1;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	12	"monocytes: 4.3;T-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;CAPAN-2: 62.6;Hep G2: 66.6;OE19: 44.9;SuSa: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006863, HPA066235"	Uncertain				"Secreted to blood"	NA	NA	162000000				"CAB006863: , HPA066235: AB_2685641"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.45e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.24e-1)"	7.9	7.8	1.2	3.6	2.0	0.0	10.3	8.1	3.1	8.6	11.7	3.6	3.5	7.8	5.9	2.7	6.0	5.4	9.9	8.3	2.1	0.8	6.1	2.8	8.2	3.4	2.4	2.6	12.0	2.1	0.0	4.1	21.4	11.9	18.0	14.5	72.4	6.4	9.4	7.3	9.4	11.0	11.0	3.7	2.7	11.9	2.4	2.6	1.6	7.3	4.5	4.0	13.0	22.5	0.0	0.3	0.0	4.3	0.0	3.3	0.9	3.1	8.3	0.4	0.3	0.1	0.0	0.1	1.6	7.1	4.3	3.3	24.9	62.6	0.0	20.8	0.0	0.4	15.2	1.8	0.2	2.3	0.8	1.2	0.0	1.7	66.6	4.2	0.0	0.2	0.0	0.6	2.0	0.1	13.1	12.4	1.4	0.0	0.0	2.0	1.4	1.0	0.0	2.9	44.9	0.7	0.0	2.2	0.0	6.0	0.2	0.0	0.0	0.0	0.2	0.2	37.5	8.2	0.3	0.6	0.1	19.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.8	0.0	0.3	2.9	0.0	0.0	2.5	0.5	0.3	0.0	3.3	1.1	0.0	0.0	4.3	0.1	0.0	0.9	1.2	2.0	8.1	3.1	2.1	0.8	2.4	2.6	11.9	2.6	8.9	8.2	0.5	3.7	24.5	0.0	4.5	10.2	6.7	2.3	5.2	0.0	24.0	3.3	4.8	1.6	7.7	0.5	0.0	0.2	15.8	40.5	1.8	1.1	1.3	3.4	0.0	0.0	23.4	0.3	0.4	9.8	0.2	3.3	0.0	3.1	0.5	23.8	0.8	1.4	1.9	1.1	0.0	7.4	1.2	2.3	15.3	29.1	0.0	0.8	1.3
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 22.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0	0.0	4.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.4	12.4	0.0	0.0	0.0	2.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 9.0;Ito cells: 19.0"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	21000	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.6	0.1	0.4	0.0	0.0	0.0	2.0	5.6	8.7	0.5	0.3	0.3	6.0	0.0	0.0	0.2	1.0	3.8	59.0	0.0	0.0	30.6	0.0	0.1	0.0	0.0	0.3	0.2	4.2	0.2	0.0	5.3	0.2	0.0	4.4	0.0	25.7	0.0	0.0	3.9	0.0	0.0	27.0	0.0	1.7	0.1	0.8	3.9	13.4	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1											0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.5	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	19.0	1.0	1.8	0.0	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168748-57266629	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.0;thyroid gland: 44.3"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000		Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	7.2	16.8	2.4	17.5	0.7	2.1	3.8	19.7	9.2	2.3	23.6	6.0	2.7	1.9	17.7	17.2	10.0	1.2	8.5	13.9	9.9	4.5	0.7	1.8	1.6	14.3	11.2	0.8	1.0	0.8	1.9	24.4	12.2	5.0	2.4	37.0	2.6	10.3	1.0	15.5	2.4	1.0	13.8	1.3	4.1	1.4	13.4	1.8	44.3	5.7	4.9	7.8	7.0	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	5.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.7	42.0	10.8	0.0	2.2	12.2	1.3	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.0	3.0	22.8	0.0	0.0	0.0	18.6	0.0	0.0	0.1	4.6	1.3	31.7	0.1	4.0	0.2	0.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.8	17.5	3.8	12.5	13.9	9.9	14.3	11.2	12.2	13.4	6.0	2.1	0.0	11.4	12.2	3.8	12.4	0.0	2.7	2.3	1.8	0.0	108.5	0.0	0.0	3.9	1.5	0.0	0.0	0.0	14.4	10.8	4.9	21.8	0.0	9.3	1.6	2.4	0.0	0.0	3.3	0.3	0.0	3.3	0.0	0.0	38.0	0.0	0.0	0.4	1.6	2.4	0.0	0.9	1.4	1.4	8.4	47.6	0.5	0.2	10.6
BMP8A		ENSG00000183682	"Bone morphogenetic protein 8a"	Q7Z5Y6	1	39491646-39525935	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"thyroid gland: 45.6"	"Group enriched"	"Detected in some"	74	"Early spermatids: 42.2;Late spermatids: 125.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 16.2;U-266/70: 7.9;U-266/84: 7.1"														"Secreted to blood"	NA	NA						"unprognostic (9.62e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.95e-9)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	0.7	1.0	1.7	1.2	2.0	0.9	0.5	0.8	3.6	3.3	1.0	8.5	0.0	1.4	3.7	1.2	0.7	2.0	2.6	1.2	1.9	1.3	0.6	0.5	0.7	5.6	4.6	1.1	8.9	3.8	0.5	0.9	1.0	4.8	1.0	0.6	0.4	1.3	1.8	1.4	1.6	2.2	1.9	8.3	1.4	1.0	4.0	2.3	1.7	45.6	0.0	0.6	0.9	0.9	0.7	0.0	0.0	0.6	0.0	0.1	0.4	0.4	0.8	0.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.4	1.9	0.0	1.7	0.3	3.9	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.2	2.9	0.0	1.7	0.0	2.1	1.1	0.2	0.1	0.5	0.3	2.4	0.1	0.1	1.5	0.4	0.1	0.2	1.2	0.3	0.7	2.9	0.1	0.0	0.7	16.2	0.0	7.9	7.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	2.0	0.8	3.6	1.9	1.3	4.6	1.1	4.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788861	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"intestine: 21.9;thyroid gland: 26.8"	"Group enriched"	"Detected in some"	15	"Early spermatids: 74.8;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 47.4;U-266/70: 14.3;U-266/84: 20.5;WM-115: 22.9"														"Secreted to blood"	NA	NA						"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	2.8	8.1	5.5	2.4	6.7	1.4	1.6	2.5	4.1	3.8	13.2	6.9	8.2	7.5	2.6	14.2	3.5	2.3	2.1	1.6	5.0	3.3	1.6	1.0	3.1	3.6	6.1	5.5	1.4	9.9	6.6	5.8	2.3	2.8	5.1	4.0	3.6	3.6	4.7	1.2	3.2	21.9	2.1	3.6	2.4	3.0	3.1	6.2	0.4	26.8	3.4	3.1	2.1	3.3	1.7	0.2	0.8	0.7	2.6	1.9	0.3	1.0	1.9	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	2.2	0.0	0.7	0.0	0.3	0.2	1.7	0.0	0.0	0.4	2.3	1.9	1.6	0.1	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	7.6	0.1	1.5	0.0	1.0	0.3	1.1	0.7	1.1	6.5	2.5	1.6	1.1	5.4	1.4	1.7	0.1	5.3	0.4	1.3	47.4	0.0	0.0	0.1	1.7	0.1	14.3	20.5	0.8	0.0	1.5	22.9	0.8	0.7	0.1	0.5	0.3	0.6	1.7	0.2	1.9	0.1	0.7	0.3	0.4	0.6	2.6	0.3	0.2	0.1	0.3	5.5	6.7	2.5	4.1	5.0	3.3	6.1	5.5	2.8	6.2	0.0	2.6	0.0	0.5	0.3	0.2	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	74.8	0.0	3.5	0.0	3.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	1.2	0.0	0.0	77.6	1.1	0.3	5.0	0.0	2.0	0.1	3.1	2.9	0.7	0.0	0.4	0.0	2.2	0.5	0.3	0.0	0.0	0.0	0.7	0.7
BMPER	"CRIM3, Cv2"	ENSG00000164619	"BMP binding endothelial regulator"	Q8N8U9	7	33904911-34155872	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"Ito cells: 97.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.8;BJ: 11.2;fHDF/TERT166: 14.5;HBF TERT88: 15.9;HSkMC: 11.9;hTEC/SVTERT24-B: 10.6;U-138 MG: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.96e-4)"	"unprognostic (5.34e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-5)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.47e-3)"	7.0	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5.0	2.4	0.6	0.0	1.3	3.4	6.7	1.6	1.6	2.0	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1.0	0.4	5.3	11.3	6.0	9.5	2.0	1.8	1.9	0.9	3.7	1.0	3.8	2.0	1.7	1.0	4.2	1.4	0.0	0.0	1.1	2.0	0.3	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	11.8	6.3	0.0	11.2	2.8	7.1	6.2	0.0	0.0	0.1	0.0	14.5	3.9	5.3	0.0	0.0	15.9	0.0	0.5	0.0	0.5	0.0	1.2	0.0	0.0	11.9	0.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	2.1	0.9	0.0	0.0	16.6	1.4	8.2	0.0	1.4	0.0	0.0	6.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	4.2	0.0	0.0	0.0	0.0	5.9	0.4	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	4.1	97.6	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.8	0.0	3.9	0.1	0.1	0.0	0.0	0.2
BPI	BPIFD1	ENSG00000101425	"Bactericidal/permeability-increasing protein"	P17213	20	38304123-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 197.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 167.9;Late spermatids: 173.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"classical monocyte: 13.6;neutrophil: 6.4"	"Group enriched"	"Detected in many"	18	"granulocytes: 6.4;monocytes: 13.6"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.2;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061284	Enhanced				"Secreted to blood"	NA	NA	7290000				"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.2	0.1	0.0	0.1	0.1	197.4	0.2	0.1	0.8	1.8	0.1	0.3	0.0	0.1	0.6	0.5	0.1	0.2	0.2	15.3	0.0	0.0	0.6	0.5	6.0	0.1	0.0	0.0	1.7	0.1	0.1	0.5	2.8	0.3	0.2	0.1	0.2	0.3	0.4	0.6	0.3	0.1	0.1	0.1	10.5	0.1	41.7	0.1	5.3	1.3	0.0	0.1	0.1	0.7	0.0	0.5	6.4	13.6	0.0	0.0	6.7	0.0	0.0	0.6	0.0	0.2	0.3	0.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	13.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.5	0.0	0.0	6.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	8.3	0.0	167.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	1.3	0.0	173.1	16.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	17.3	27.0	0.0	0.0	0.0	1.8	1.1	0.1	0.0	0.0	0.0	0.0
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell type enriched"	"Detected in some"	26	"Ciliated cells: 116.4"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"					"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	NA	NA		1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	116.4	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	265	"salivary gland: 1210.9"	"Cell type enhanced"	"Detected in some"	19	"Club cells: 1.2;Collecting duct cells: 3.5;Late spermatids: 2.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 3.7;RT4: 4.4;SK-BR-3: 1.7"					"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	1.2	0.1	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1210.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA3	"bA49G10.4, C20orf71, SPLUNC3"	ENSG00000131059	"BPI fold containing family A member 3"	Q9BQP9	20	33217310-33227758	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"testis: 86.6"	"Group enriched"	"Detected in some"	99	"Early spermatids: 659.6;Late spermatids: 2410.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062708	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA062708: AB_2684843"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	659.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2410.5	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	6.5	0.0	15.6	7.9	0.0	0.0	0.0	0.0	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 887.4;Club cells: 1261.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 6.6;RT4: 3.9;SK-BR-3: 7.9"	"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Not detected"	"Not detected"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	6.6	0.0	0.7	0.0	0.3	0.0	3.9	0.0	0.0	0.0	7.9	0.0	0.1	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	8.9	17.7	0.0	0.4	1.1	0.0	0.4	5.1	887.4	1261.4	0.0	0.0	0.2	0.0	0.1	66.1	0.2	0.0	0.0	0.2	0.1	0.9	1.9	3.5	0.0	0.2	0.0	0.0	0.0	0.0	66.3	0.3	0.3	1.7	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.4	0.4	0.1	0.0	0.0	0.7
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.0;pituitary gland: 12.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HSkMC: 5.4;U-2 OS: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA							"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0	12.2	0.0		0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1
BPIFC	"BPIL2, dJ149A16.7"	ENSG00000184459	"BPI fold containing family C"	Q8NFQ6	22	32413847-32464484	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"skin 1: 39.5;tongue: 16.4"	"Group enriched"	"Detected in some"	32	"Early spermatids: 16.4;Late spermatids: 6.5;Suprabasal keratinocytes: 4.1"	"Group enriched"	"Detected in some"	11	"head and neck cancer: 1.6;melanoma: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	56	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	56	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 3.4;hTCEpi: 1.7;SCLC-21H: 4.7;U-87 MG: 2.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA							"unprognostic (2.74e-1)"			"unprognostic (3.48e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.80e-1)"			0.0	0.0	0.4	0.0	0.5	0.0	2.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	39.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	16.4	0.8	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.1	0.0	0.0	0.0	0.0
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177171497-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 11.5;brain: 27.9"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 14.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA					"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0.0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7.0	6.0	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2.0	1.0	0.8	0.4	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	2.6	3.0	0.0	0.0	0.0	0.0	9.7	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.2	0.4	15.9	7.0	6.0	4.5	3.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
BRINP3	"DBCCR1L, DBCCR1L1, FAM5C"	ENSG00000162670	"BMP/retinoic acid inducible neural specific 3"	Q76B58	1	190097662-190478404	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;intestine: 18.6"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 35.8"	"Group enriched"	"Detected in some"	14	"breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054693	Uncertain				"Secreted in other tissues"	NA	NA					"HPA054693: AB_2682575"	"unprognostic (3.18e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.40e-1)"			"unprognostic (1.72e-1)"			"unprognostic (8.25e-2)"	"unprognostic (3.65e-1)"		"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.58e-3)"	0.7	2.4	11.3	1.0	11.9	0.3	2.0	18.4	30.4	0.5	7.2	2.1	0.0	5.3	0.6	3.7	2.2	0.9	2.0	5.6	8.9	12.2	2.8	0.4	1.6	0.3	6.0	12.7	0.4	0.3	0.4	0.4	0.3	7.4	7.8	7.6	0.0	1.6	6.3	0.4	0.4	18.6	1.0	6.8	0.3	0.7	3.7	2.7	0.0	2.4	0.0	0.5	1.1	0.3	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	11.3	11.9	18.4	19.1	8.9	12.2	6.0	12.7	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	35.8	0.0	4.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	1.9	0.0
BSPH1	"BSP1, ELSPBP2"	ENSG00000188334	"Binder of sperm protein homolog 1"	Q075Z2	19	47968046-47992170	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"epididymis: 97.1"	"Cell type enhanced"	"Detected in single"	34	"Bipolar cells: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.2;HMC-1: 1.4;NB-4: 4.6"					"Not detected"	"Not detected"			HPA048335	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048335: AB_2732546"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0			0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTBD17	"BTBD17A, LGALS3BPL, TANGO10A"	ENSG00000204347	"BTB domain containing 17"	A6NE02	17	74356416-74361946	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 18.2"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 27.0"	"Group enriched"	"Detected in some"	11	"glioma: 9.5;testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Group enriched"	"Detected in some"	20	"AF22: 3.9;NTERA-2: 5.1;SCLC-21H: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025022	Approved				"Secreted in brain"	NA	NA					"HPA025022: AB_2067352"					"unprognostic (2.63e-1)"					"unprognostic (2.77e-1)"	"unprognostic (4.82e-5)"			"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-3)"		0.4	1.5	5.4	0.4	5.1	0.4	0.4	5.6	18.2	0.4	0.4	2.7	0.0	1.2	0.4	0.4	0.4	0.4	0.4	0.4	3.7	5.7	0.4	0.4	0.4	0.4	3.8	1.8	0.4	0.4	0.4	0.2	0.4	6.1	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.5	0.4	3.7	0.6	1.4	0.5	2.2	0.0	0.6	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.1	5.6	8.2	3.7	5.7	3.8	1.8	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
BTC		ENSG00000174808	Betacellulin	P35070	4	74744759-74794686	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.5"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 45.5;Club cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;MCF7: 5.8;RPTEC TERT1: 9.9;SK-BR-3: 6.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	314000					"unprognostic (7.36e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.76e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.35e-1)"	"prognostic favorable (6.10e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.31e-3)"	3.0	1.2	1.0	5.2	2.2	0.0	3.7	0.3	2.8	2.2	23.5	1.2	3.1	3.0	2.4	5.6	9.9	6.1	10.3	2.5	1.3	1.3	3.7	0.8	3.4	0.2	0.8	1.0	3.6	2.9	5.2	4.5	0.9	2.1	3.7	5.9	7.0	6.8	3.6	0.6	12.4	11.3	8.3	0.6	0.4	6.9	0.8	0.9	0.4	5.2	1.9	2.3	5.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.2	0.0	16.4	0.0	3.5	0.0	2.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	2.7	0.1	0.0	0.0	0.1	0.4	5.8	0.1	0.0	0.1	1.7	2.5	0.0	0.0	0.0	9.9	4.7	0.2	0.0	2.4	6.6	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.3	2.8	0.3	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	2.2	0.3	2.8	1.3	1.3	0.8	1.0	2.1	0.9	8.9	6.7	0.0	3.8	0.6	1.7	0.5	0.0	45.5	17.0	10.4	2.0	0.3	0.0	3.2	1.4	0.2	3.6	0.0	5.1	0.0	0.6	3.9	0.0	0.2	0.1	0.0	11.5	3.1	0.0	0.0	0.3	0.0	0.0	0.0	9.0	10.6	3.4	6.5	0.0	1.1	5.2	0.0	3.8	0.0	0.0	2.6	0.2	0.0	6.8	6.0
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15647640	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2900000000			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	18.5	17.9	7.5	3.9	10.2	4.4	13.5	17.0	11.8	11.2	28.1	19.6	12.2	25.3	12.3	34.1	7.1	10.3	10.4	6.9	8.0	6.8	20.0	50.7	8.2	5.2	12.3	9.5	17.2	26.6	19.6	11.1	10.7	9.3	10.7	9.4	20.0	11.6	12.1	6.9	6.5	40.5	7.9	8.8	7.6	12.9	15.0	12.6	5.9	14.8	3.8	6.2	11.7	9.1	8.4	13.7	31.0	11.9	7.5	15.6	8.7	3.8	10.8	3.3	3.2	28.3	7.8	19.6	7.0	9.4	8.3	15.0	3.8	10.3	1.0	8.4	16.2	3.4	4.3	2.6	8.3	9.7	3.3	5.5	5.9	14.5	11.6	6.8	2.9	6.9	9.5	8.6	21.9	2.2	19.6	15.9	2.4	3.8	13.8	23.3	4.6	1.6	3.4	3.6	8.2	6.0	2.1	8.3	13.0	8.0	7.8	2.3	5.7	8.3	2.0	11.0	7.7	10.2	5.6	10.8	9.0	6.9	8.4	4.4	3.2	4.9	1.2	10.5	3.5	6.5	31.0	11.9	25.2	13.2	11.1	12.3	8.4	14.1	11.3	12.1	7.8	12.2	9.2	10.8	7.5	8.4	13.7	15.6	8.7	7.5	10.2	17.0	11.8	8.0	6.8	12.3	9.5	9.3	12.6	6.0	8.3	10.4	10.9	5.3	12.4	5.3	45.9	17.4	3.4	17.4	17.7	22.1	5.0	15.4	24.9	7.1	10.6	23.3	24.6	16.7	10.3	6.2	4.7	58.9	13.6	4.8	6.9	23.4	8.9	12.5	30.0	8.2	10.1	10.8	7.5	18.0	12.6	17.3	17.0	23.2	43.4	12.9	5.2	20.4	6.8	4.8	19.3	13.8	7.6	9.1
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 27.4"	"Cell type enhanced"	"Detected in single"	32	"B-cells: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.6;naive B-cell: 2.6"	"Lineage enriched"	"Detected in many"	4	"B-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 10.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011126, CAB037340"	Supported				"Secreted in female reproductive system"	NA	NA					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	27.4	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.6	0.0	1.0	1.6	0.0	1.3			0.0		0.6	0.1	0.0	5.6	0.0	0.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2											0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
BX248415.1		ENSG00000276911			1	196819745-196959210	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	938	"liver: 93.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 2.6"									"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA					"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	93.7	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf95	FLJ14280	ENSG00000120055	"Chromosome 10 open reading frame 95"		10	102449837-102451543	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.7"	"Cell type enhanced"	"Detected in many"	11	"Rod photoreceptor cells: 16.7;Syncytiotrophoblasts: 31.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;JURKAT: 11.4"	"Not detected"	"Not detected"												"Secreted - unknown location"	NA	NA						"unprognostic (2.31e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.62e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.80e-3)"	0.0	1.0	0.4	1.2	0.4	1.1	0.0	1.0	1.2	1.7	1.4	0.0	0.0	2.0	0.7	12.7	0.9	9.7	1.2	0.0	0.4		1.0	0.0	9.8	2.2	0.0	0.2	8.9	4.2	0.0	2.6	7.0	0.9	1.0	0.0	10.1	3.4	3.4	0.1	3.6	1.9	0.0	0.0	1.9	3.2	0.9	0.0	0.1	5.0	2.7	4.1	0.5	0.0	9.3	5.6	1.6	1.2	8.4	11.6	4.5	5.4	1.0	0.1	2.2	0.0	0.0	4.8	0.2	0.0	0.0	0.0	4.4	9.5	4.7	2.2	0.0	0.7	9.5	0.0	0.4	0.0	4.1	11.5	3.0	3.9	3.6	0.0	4.1	3.0	0.1	1.8	0.0	0.1	3.1	0.0	11.4	5.2	4.0	0.0	4.3	2.2	3.9	2.2	1.9	3.2	6.6	0.1	5.2	1.1	2.0	8.8	1.3	2.3	1.5	3.0	1.8	4.7	0.3	0.4	0.2	1.1	0.2	0.5	3.5	2.7	3.2	0.2	6.2	0.1	1.6	1.2	1.5	7.4	0.5	7.0	9.3	8.2	7.6	3.2	7.5	11.6	9.7	1.0	8.4	0.2	5.6	8.2	4.5											0.0	2.7	2.2	2.8	1.3	4.5	0.0	2.5	9.4	6.8	5.2	9.8	2.1	3.3	1.4	0.0	0.7	1.3	0.0	1.0	1.5	0.2	3.0	0.0	0.2	2.1	3.2	1.2	0.6	0.3	0.0	0.6	0.7	0.0	2.8	1.7	1.5	0.7	0.0	0.7	3.0	16.7	0.0	0.1	0.4	1.7	1.4	31.8	2.9	2.8	2.3
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Group enriched"	"Detected in some"	11	"Enterocytes: 485.1;Mucus-secreting cells: 220.7;Paneth cells: 599.4;Undifferentiated cells: 289.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 32.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050920	Enhanced				"Secreted in other tissues"	NA	NA					"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	485.1	0.0	0.0	0.0	0.0	0.6	4.6	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	220.7	0.0	0.0	599.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	289.2	36.8
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.4;U-937: 9.6"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.8	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.9	6.2	0.0	3.5	0.4	4.4	2.5	2.5	12.4	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.4	0.8	4.1	1.1	3.8	0.0	0.3	2.1	1.3	2.7	2.5	2.0	1.0	3.5	1.2	5.0	0.5	4.4	1.2	0.0	0.2	2.0	5.7	0.4	1.4	0.8	4.1	0.6	0.0	7.1	0.0	0.8	0.1	0.0	0.0	0.9	9.6	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6											0.0	0.3	0.0	1.0	2.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.6	1.4	0.0	0.0	0.0	0.7	2.1	0.2	0.1	1.1	0.0	8.1	0.0	0.0	0.0	4.1	5.7	0.0	2.6	0.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.6	1.0	0.0	0.0	0.7
C11orf94		ENSG00000234776	"Chromosome 11 open reading frame 94"	C9JXX5	11	45906513-45907282	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"testis: 43.4"	"Group enriched"	"Detected in some"	120	"Early spermatids: 302.2;Late spermatids: 133.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 3.9;U-266/84: 3.2"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (1.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.05e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	1.0	0.0	1.4	0.0	2.6	3.9	1.1	2.4	0.0	1.4	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.3	0.6	1.4	0.0	0.0	1.2	1.9	1.1	1.4	0.6	1.5	0.8	0.0	0.0	0.5	0.0	0.0	0.6	1.1	0.0	1.1	1.2	0.0	1.5	1.0	2.0	0.0	2.4	3.2	0.0	1.7	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	302.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.3	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0
C12orf49	FLJ21415	ENSG00000111412	"Chromosome 12 open reading frame 49"	Q9H741	12	116710185-116738070	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 41.4"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026905	Uncertain				"Secreted - unknown location"	NA	NA		260000			"HPA026905: AB_10603446"	"unprognostic (2.74e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (2.56e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.91e-11)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.73e-1)"	6.2	8.6	10.9	8.6	14.1	6.3	8.6	5.4	16.9	4.7	12.2	10.1	6.1	7.6	5.3	10.4	9.0	4.4	6.8	6.3	8.8	10.0	13.0	9.1	20.4	9.0	10.8	7.2	4.7	7.6	7.3	6.7	5.2	19.6	4.7	9.9	5.9	14.7	5.6	3.6	6.9	8.2	4.8	9.2	7.8	11.9	8.7	7.0	14.0	41.4	5.5	9.7	5.8	4.3	9.4	7.3	6.4	5.4	4.7	8.2	2.6	7.4	10.1	9.4	9.3	11.0	8.8	11.8	5.2	7.0	5.9	5.1	19.9	5.7	19.3	10.3	7.2	8.8	9.7	13.0	8.0	6.7	15.3	10.4	5.5	5.4	18.9	7.7	10.4	17.0	10.6	10.1	7.7	8.7	10.0	8.8	13.0	5.8	4.5	9.4	11.2	9.4	9.7	15.0	11.4	11.8	14.2	6.3	8.4	14.9	20.3	8.7	10.8	8.5	8.6	15.5	11.1	10.4	10.9	11.4	8.8	12.2	12.3	10.2	9.3	27.5	27.0	14.3	10.9	10.3	4.1	4.3	6.4	8.1	5.4	8.2	9.4	6.4	6.5	3.8	8.2	5.7	7.5	3.0	4.7	3.7	7.3	6.4	2.6	10.9	14.1	5.4	16.9	8.8	10.0	10.8	7.2	19.6	7.0	95.3	22.2	23.2	16.8	17.5	10.8	5.4	17.8	5.3	15.9	27.9	11.8	10.3	41.4	55.0	36.4	11.9	30.9	0.0	36.3	30.5	10.3	25.5	6.9	6.4	36.5	28.6	15.5	16.5	15.9	20.7	8.9	14.4	16.9	22.6	16.9	6.7	43.3	34.5	8.9	49.7	12.2	6.5	10.4	12.7	36.3	13.4	15.0	24.9	18.7	49.8
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"	NA	NA			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.1	16.9	10.3	4.9	6.4	11.0	6.4	3.9	7.2	5.9	11.8	5.2	7.0	8.6	3.9	6.3	9.6	10.0	8.2	5.5	10.1	20.3	10.6	16.3	14.8	7.2	15.6	9.7	5.7	9.4	3.6	6.4	17.6	6.6	20.6	13.6	4.8	6.6	6.8	17.3	23.6	8.2	5.7	19.0	10.0	6.3	6.9	9.4	8.0	27.7	9.5	6.5	11.3	14.9	7.6	19.3	8.5	3.3	8.8	4.9	6.5	6.5	13.1	20.1	14.7	10.0	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8	6.0	5.0	6.7	8.5	5.4	16.5	14.9	7.6	13.4	5.7	8.7	0.0	9.7	23.2	20.3	59.5	6.7	9.2	0.0	10.6	10.4	7.6	8.0	9.2	11.6	14.8	7.9	10.9	6.2	8.3	25.4	8.1	7.1	1.7	11.8	10.9	12.3	16.5	3.5	8.1	17.7	13.1	6.5	7.2	23.1	21.2	4.5	7.4	4.9	11.5	7.0
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985908-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	10.4	6.1	10.2	11.8	7.3	12.4	9.8	14.3	7.9	12.0	12.2	8.3	16.7	8.1	10.8	13.5	10.3	11.1	10.3	7.2	9.6	4.6	10.3	9.7	8.7	10.3	6.8	5.9	12.2	15.9	12.9	18.9	5.4	7.4	11.0	10.9	9.1	9.8	10.2	7.3	20.3	9.4	8.4	11.0	12.9	9.5	5.8	9.0	22.7	16.3	7.8	14.6	11.6	9.5	9.7	8.8	21.3	11.3	8.8	12.4	6.6	3.9	7.4	6.3	8.8	10.2	22.9	8.8	4.6	7.2	3.7	4.9	4.6	11.7	11.1	4.4	4.2	5.2	8.4	3.8	11.7	3.5	4.3	2.7	7.0	9.0	10.5	8.9	5.0	6.0	16.5	9.2	5.5	7.0	13.5	6.8	7.2	7.5	2.4	3.8	11.1	6.4	9.4	2.1	8.5	5.2	10.4	6.0	6.7	4.8	6.0	23.0	10.0	6.2	6.0	6.3	7.1	9.3	8.9	3.8	7.0	9.3	3.1	4.6	8.6	2.3	7.6	4.8	6.3	7.1	11.7	7.5	21.3	8.3	6.9	7.3	9.7	6.8	8.6	8.8	9.4	10.2	9.8	10.7	8.8	11.3	6.2	12.4	6.6	10.2	7.3	14.3	7.9	9.6	4.6	6.8	5.9	7.4	9.0	8.9	0.6	4.7	4.8	2.7	1.2	2.8	2.5	5.3	1.2	0.0	3.9	3.0	6.6	2.8	0.5	2.9	2.9	0.0	2.6	4.3	2.4	2.0	6.9	1.1	3.3	0.0	15.1	1.3	2.7	1.0	4.0	3.4	5.0	0.0	5.2	2.9	3.4	7.0	3.9	3.0	1.9	6.5	3.1	1.5	7.9	1.4	2.5	4.3	4.9	1.4
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.2	4.6	1.2	5.1	5.4	7.8	3.3	1.9	3.4	3.5	2.8	3.5	3.0	3.6	4.1	2.1	4.1	5.0	4.6	1.3	2.9	2.1	10.9	3.8	3.5	4.6	3.5	4.7	3.2	8.1	3.5	1.1	4.3	2.5	1.6	11.1	4.3	8.0	1.1	2.4	3.8	7.7	1.9	3.4	5.8	5.2	2.6	13.1	2.5	3.0	6.8	5.1	3.3	3.2	5.8	2.3	2.8	7.2	1.6	4.7	7.2	5.9	4.8	7.6	11.0	8.7	2.0	9.2	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5	20.8	9.1	25.1	28.7	59.6	71.3	69.8	20.4	6.7	7.9	15.7	35.3	35.6	68.0	21.1	136.1	26.6	30.6	0.0	25.8	25.7	33.5	30.2	33.5	33.8	26.4	12.7	26.0	17.2	20.2	22.0	38.0	16.0	35.4	7.2	47.0	62.2	24.4	38.6	24.1	54.0	68.8	32.3	28.3	136.2	21.8	53.2	17.2	31.9	43.0	15.6
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.8;thyroid gland: 79.3"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 2: 191.8;Club cells: 122.8;Distal tubular cells: 96.2"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;Hep G2: 5.9;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1200000			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	6.0	1.7	7.7	4.4	9.3	0.3	4.7	5.1	8.6	7.3	2.3	5.2	0.3	5.9	1.4	30.3	2.5	4.6	15.3	7.1	6.1	3.0	5.6	0.3	35.8	0.5	6.2	7.4	1.9	8.2	0.3	1.9	0.5	5.3	4.0	1.9	5.0	11.5	0.6	0.2	0.4	2.8	6.2	7.4	0.4	28.0	1.4	2.9	0.0	79.3	2.7	1.4	4.3	1.8	1.1	0.9	3.3	0.5	1.3	0.6	0.2	0.1	0.2	0.0	0.4	4.9	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.4	0.6	1.4	5.9	3.1	0.2	0.5	1.4	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.3	0.0	0.3	1.6	0.7	3.6	0.0	0.1	0.5	0.1	0.3	0.0	0.5	0.6	0.4	0.3	0.7	1.1	0.7	0.4	0.0	0.2	0.6	0.3	5.0	0.3	0.4	0.2	0.1	0.4	0.2	0.1	3.3	0.5	0.7	0.4	0.4	0.3	0.7	0.4	0.4	0.2	1.1	0.5	0.6	1.9	1.3	0.2	0.9	0.3	0.2	7.7	9.3	5.1	8.6	6.1	3.0	6.2	7.4	5.3	2.9	41.7	191.8	0.0	1.8	0.3	0.2	2.6	0.0	29.4	122.8	0.0	0.0	0.1	96.2	0.0	1.4	0.0	0.0	0.0	7.2	0.1	7.0	3.7	4.7	0.0	4.6	0.0	0.0	0.0	0.0	1.2	8.6	0.6	0.0	0.0	0.3	0.1	0.7	0.0	13.8	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.8
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"vagina: 24.4"	"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.0;MOLT-4: 15.3;PC-3: 10.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 3.8"	"Low region specificity"	"Detected in many"			HPA043479	Approved				"Secreted - unknown location"	NA	NA					"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	3.2	1.9	5.5	3.4	7.3	1.0	7.4	9.9	6.2	5.1	2.2	2.0	3.5	1.9	5.2	4.0	2.4	3.3	4.8	2.2	5.2	2.9	2.1	3.3	3.1	3.9	6.4	1.6	4.4	3.3	2.1	3.2	2.2	5.8	4.9	1.4	1.3	2.8	3.5	1.7	2.0	2.7	4.8	3.6	6.9	2.8	3.8	8.5	9.1	2.4	0.5	2.7	5.2	24.4	3.8	1.1	0.9	0.8	0.6	3.9	1.0	3.3	2.2	1.4	1.5	0.7	1.0	0.6	2.0	2.5	1.7	2.0	2.7	1.1	1.8	3.5	0.8	1.8	1.7	1.0	0.5	1.7	10.0	3.7	1.7	2.3	1.7	0.9	1.3	3.4	0.4	2.7	1.2	1.1	1.3	1.7	3.6	1.6	8.6	1.1	2.6	15.3	2.3	1.3	1.0	10.6	3.3	2.7	1.9	1.2	0.9	0.7	1.8	2.0	0.4	1.0	0.5	2.2	0.9	2.3	1.8	4.5	1.2	1.4	3.6	8.9	1.0	1.3	1.5	0.6	0.0	0.5	0.9	0.6	0.7	1.2	3.8	1.9	2.6	0.4	2.3	2.0	2.5	0.8	0.6	0.8	1.1	3.9	1.0	5.5	7.3	9.9	6.2	5.2	2.9	6.4	1.6	5.8	8.5	3.0	0.0	7.8	11.9	2.1	10.8	0.8	10.2	1.4	0.0	7.0	13.7	0.1	0.0	2.8	7.5	10.1	5.4	0.0	1.2	0.7	2.8	10.1	1.1	4.4	2.3	4.8	8.5	4.3	6.1	5.3	7.2	3.2	1.7	4.6	2.0	2.4	1.9	2.5	1.1	0.0	18.8	0.0	3.1	11.5	6.8	1.5	0.2	6.4	1.7	5.5
C17orf99	"GLPG464, UNQ464"	ENSG00000187997	"Chromosome 17 open reading frame 99"	Q6UX52	17	78146353-78166177	"Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 13.5"	"Cell type enriched"	"Detected in some"	53	"Erythroid cells: 93.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"HaCaT: 5.6;HMC-1: 11.6;K-562: 6.5"									HPA029655	Uncertain				"Secreted to blood"	NA	NA					"HPA029655: AB_10601691"	"unprognostic (3.55e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-4)"	"unprognostic (6.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	0.2	0.0	0.1	0.1	0.1	13.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.9	0.1	0.1	0.1	0.0	0.1	0.1	1.6	1.2	0.1	0.1	0.6	0.1	0.0	0.1	1.9	0.1	0.2	0.0	0.1	0.4	0.1	0.1	2.0	0.6	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.1	0.1	1.1	1.9	0.9	1.2	0.0	0.0	1.1	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.7	0.0	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	93.5	0.4	0.4	0.4	0.5	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.6	0.2	0.0	0.1	0.6
C18orf54	"LAS2, MGC33382"	ENSG00000166845	"Chromosome 18 open reading frame 54"	Q8IYD9	18	54357917-54385218	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 21.4;testis: 25.2"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040704			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA040704: AB_10959454"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.60e-6)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.06e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.05e-2)"	2.9	1.3	2.8	4.8	7.7	2.0	2.1	4.5	4.3	4.1	2.4	3.8	1.0	1.3	3.6	1.1	2.0	1.9	2.1	2.0	3.3	2.2	1.6	0.9	2.5	4.0	10.0	3.4	2.5	1.1	1.9	1.0	21.4	5.7	1.8	2.3	0.7	1.4	1.6	1.0	1.8	2.0	2.7	5.8	4.3	1.5	25.2	6.7	9.3	1.9	1.2	4.0	2.1	3.2	1.4	0.6	1.9	4.1	0.8	2.1	0.6	5.8	3.4	14.6	6.9	3.6	6.3	4.9	9.7	4.2	9.8	12.6	2.2	3.1	4.3	2.7	3.2	4.3	6.3	10.1	5.3	12.8	14.4	3.2	4.2	3.7	3.7	0.8	4.8	4.6	2.1	1.1	13.3	6.2	4.2	11.7	5.7	4.4	9.4	14.0	1.8	5.2	3.0	7.2	1.1	6.7	4.0	10.8	3.0	4.8	4.0	8.1	4.6	4.0	1.7	2.2	8.7	2.5	4.1	10.5	18.2	8.0	3.0	5.3	5.7	6.4	6.4	4.8	8.2	12.8	1.9	0.7	0.3	1.3	0.8	1.2	0.9	1.1	0.9	0.6	1.4	1.0	1.2	0.0	0.8	4.1	0.3	2.1	0.6	2.8	7.7	4.5	4.3	3.3	2.2	10.0	3.4	5.7	6.7	0.0	1.1	0.0	0.6	0.3	1.6	1.2	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.1	73.3	2.6	0.1	0.0	0.2	22.1	1.5	0.3	0.0	0.0	2.1	0.0	0.0	4.9	2.8	23.0	1.4	1.7	1.7	1.8	0.6	2.3	0.3	0.0	0.7	0.2	0.7	0.0	1.4	34.4	16.0	0.4	1.7	0.7	0.8	0.7
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.9	31.6	22.4	37.5	0.6	3.4	5.0	0.9	3.0	0.2	0.6	0.2	1.1	3.0	0.4	0.9	0.0	0.1	1.1	0.3	3.7	0.6	0.5	0.3	4.6	1.1	0.8	30.3	1.5	6.3	0.5	3.7	29.2	0.5	0.4	4.1	3.2	1.2	0.2	7.2	1.7	0.0	1.1	5.2	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.3	4.2	0.4	15.8	0.2	7.5	0.6	0.2	0.3	1.7	1.4	0.3	16.6	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8	3.0	5.0	2.4	2.0	5.7	0.8	6.2	2.5	0.0	2.3	21.0	0.0	1.0	64.6	0.5	7.4	64.6	2.1	0.0	2.0	0.7	22.1	1.8	1.1	0.8	45.5	0.0	1.2	49.1	98.9	15.7	88.1	71.5	11.8	20.8	1.1	11.1	1.5	0.8	97.9	2.6	1.3	32.3	69.0	16.6	1.3	4.4	3.0	2.5	1.2	5.5
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047740-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 54.8;testis: 67.7"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	NA	NA		90000000			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	3.3	6.4	2.9	2.0	3.6	0.9	3.1	3.8	3.5	3.7	2.7	5.2	5.1	2.9	3.4	5.6	3.1	4.3	4.6	5.6	3.1	2.1	4.0	6.4	2.6	2.8	3.3	2.0	4.8	7.0	3.9	6.3	3.0	3.4	4.7	1.2	4.3	6.5	6.4	4.0	3.3	2.0	3.8	2.3	2.7	3.1	67.7	3.8	0.7	7.1	1.2	1.7	3.3	3.0	16.3	7.8	54.8	15.4	15.5	28.4	1.0	4.0	8.1	2.8	1.3	4.8	4.7	2.6	2.3	3.4	1.5	1.2	3.5	5.8	0.9	3.7	2.5	3.2	5.5	1.6	0.3	0.8	5.2	1.8	1.0	6.4	4.3	3.3	1.1	0.8	3.4	1.8	2.3	0.8	2.9	2.2	1.8	2.1	2.1	1.3	15.8	1.5	2.8	4.7	3.2	4.6	1.3	2.8	2.9	1.2	2.3	3.8	7.4	7.4	3.8	5.3	5.6	7.5	3.0	2.3	2.0	3.6	5.3	2.0	5.0	3.9	12.7	3.8	0.6	2.5	54.8	7.3	13.7	27.8	15.4	20.8	14.2	24.2	24.2	5.5	16.3	20.6	28.4	20.2	15.5	12.7	7.8	13.7	1.0	2.9	3.6	3.8	3.5	3.1	2.1	3.3	2.0	3.4	3.8	6.0	8.5	68.1	31.4	57.5	18.6	7.0	48.4	6.7	10.3	40.1	19.6	38.8	33.2	18.8	336.7	30.8	8.0	46.7	12.8	26.9	47.4	29.5	39.1	34.7	28.3	17.5	14.3	63.3	73.4	44.3	26.4	65.6	84.4	83.0	12.5	13.8	26.2	17.5	24.1	24.8	24.2	25.8	37.6	148.7	13.6	72.8	74.8	126.9	12.0	45.1
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell type enhanced"	"Detected in many"	28	"Hofbauer cells: 1354.3;Kupffer cells: 3186.4;Macrophages: 679.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;NB-4: 2.3;RPMI-8226: 11.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.3	0.5	0.0	0.0	0.8	0.5	11.7	0.0	0.0	5.2	1.6	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.7	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6	32.8	68.3	87.4	1.4	16.4	0.4	9.2	53.5	28.1	33.0	0.0	0.0	7.6	0.0	0.0	1.7	7.3	0.0	0.0	0.2	8.7	13.9	1.2	19.8	15.7	1354.3	0.0	1.7	93.3	3186.4	4.5	12.0	679.3	25.3	1.0	0.0	0.0	0.0	0.0	0.4	1.0	0.3	77.6	9.0	0.5	2.0	14.6	15.2	15.8	0.0	1.0
C1QB		ENSG00000173369	"Complement C1q B chain"	P02746	1	22652762-22661538	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 262.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 1215.3;Kupffer cells: 2993.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	66	"intermediate monocyte: 41.9;non-classical monocyte: 26.9"	"Lineage enriched"	"Detected in single"	83	"monocytes: 41.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 2.8;NB-4: 2.6;SH-SY5Y: 2.9;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	NA	NA		4700000000			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	76.7	42.3	30.3	22.0	54.5	7.1	17.6	3.3	27.8	12.1	28.2	27.6	1.4	30.0	9.0	25.5	10.8	21.5	33.2	19.8	19.8	17.0	21.8	51.5	87.9	84.1	45.7	6.8	9.8	11.2	4.2	14.4	41.2	35.7	15.0	24.6	17.2	13.9	9.3	9.2	4.3	30.5	41.9	52.2	262.8	14.4	11.7	38.1	7.4	9.8	3.7	9.5	36.8	6.6	0.0	0.5	0.1	41.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.2	2.6	1.6	0.0	0.0	1.6	1.1	1.9	0.0	0.0	1.9	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.3	2.9	0.1	0.5	0.5	0.3	0.6	0.0	0.5	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	26.9	0.0	0.0	1.4	30.3	54.5	3.3	27.8	19.8	17.0	45.7	6.8	35.7	38.1	11.9	23.2	50.8	1.6	5.6	1.0	5.0	35.7	6.7	19.4	3.5	0.0	5.3	0.0	0.0	1.5	5.9	0.3	0.0	0.0	7.3	6.4	1.6	10.5	14.4	1215.3	0.0	0.0	59.5	2993.5	4.2	7.8	520.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.7	3.4	58.2	1.4	0.2	1.0	4.0	8.0	25.4	0.0	1.1
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Group enriched"	"Detected in many"	21	"Hofbauer cells: 1118.0;Kupffer cells: 1266.9;Macrophages: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;NB-4: 2.7;RPMI-8226: 6.7;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.7	0.7	0.0	0.0	1.6	0.9	6.7	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1	6.0	6.9	29.4	1.1	7.9	0.0	1.4	22.9	1.4	5.7	0.0	0.0	4.9	0.0	0.0	2.1	2.1	0.0	0.0	0.2	7.9	5.3	0.4	4.7	5.1	1118.0	0.0	0.0	29.4	1266.9	1.8	5.8	421.7	6.8	40.5	0.0	0.3	0.0	0.0	1.1	0.2	0.4	45.3	1.8	0.3	0.9	5.6	8.2	12.9	0.0	0.6
C1QL1	"C1QRF, C1QTNF14, CRF"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968071	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.5"	"Cell type enriched"	"Detected in some"	51	"Horizontal cells: 635.6"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 18.2;SH-SY5Y: 13.0;U-2 OS: 45.6;U-251 MG: 13.7;U-87 MG: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	2.5	2.3	20.2	2.0	9.7	1.3	1.5	4.9	42.5	1.6	2.9	12.7	0.0	5.2	5.0	2.0	2.5	1.8	1.8	1.8	14.4	16.3	6.4	1.4	1.3	1.3	13.3	10.4	1.3	4.3	1.2	0.7	1.3	35.2	11.6	1.8	10.3	1.4	1.4	1.2	1.6	3.9	2.5	12.8	1.3	4.4	1.6	8.5	0.0	1.4	0.0	1.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.6	0.6	9.2	0.2	0.0	0.2	0.3	0.4	0.3	0.8	0.3	0.3	0.1	1.5	0.2	2.8	0.3	1.5	0.1	0.1	5.9	3.9	0.0	4.2	0.0	1.1	0.0	1.1	0.2	0.0	0.4	0.1	3.2	0.0	1.6	0.0	0.1	0.2	0.5	1.9	0.0	1.5	0.2	5.6	3.2	0.1	0.1	0.0	0.2	18.2	13.0	7.8	0.7	0.6	0.5	2.1	0.1	0.0	0.7	45.6	0.5	13.7	0.5	0.0	0.0	14.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	9.7	4.9	13.9	14.4	16.3	13.3	10.4	35.2	8.5	0.0	0.0	0.0	0.2	0.2	6.4	0.8	5.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	635.6	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	0.1	0.0	0.0	0.0	10.6	0.0	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158889	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 15.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 2.7;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"GAMG: 1.9;NTERA-2: 2.2;SCLC-21H: 7.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 25.0"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"	NA	NA					"HPA057934: AB_2683558"	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.7	0.7	15.3	0.7	6.8	0.7	1.1	0.9	15.1	0.7	0.7	3.1	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.8	15.4	9.0	0.7	0.8	0.7	1.3	4.5	5.4	0.7	0.7	0.7	0.3	0.7	1.3	0.7	0.7	2.4	1.0	0.7	0.7	0.9	0.7	0.7	1.5	0.8	0.7	1.1	3.1	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	6.8	0.9	15.1	15.4	9.0	4.5	5.4	1.3	3.1	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	7.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
C1QL3	"C1ql, C1QTNF13, CTRP13, K100"	ENSG00000165985	"Complement C1q like 3"	Q5VWW1	10	16513743-16522005	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 33.8"	"Cell type enhanced"	"Detected in some"	28	"Cardiomyocytes: 1.2;Rod photoreceptor cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 24.9;SCLC-21H: 15.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6"						"Secreted in brain"	NA	NA						"unprognostic (7.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.19e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.29e-5)"	"unprognostic (3.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.12e-2)"	1.2	1.5	24.8	1.0	14.6	0.5	0.5	7.4	33.8	0.5	0.6	0.1	0.0	2.6	0.7	0.4	0.7	0.5	0.6	1.4	22.8	4.3	1.9	0.8	0.9	1.3	1.4	23.4	0.4	0.9	0.4	0.3	0.6	2.3	1.0	0.4	0.2	1.0	0.5	1.7	1.6	1.2	0.4	0.9	1.0	0.9	0.5	0.0	0.0	1.6	0.0	0.5	1.2	0.4	1.0	0.9	0.8	2.0	0.7	2.8	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	0.8	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.9	0.3	1.4	0.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.1	0.1	0.9	0.9	0.1	0.9	0.2	1.4	0.1	0.5	15.4	1.3	1.3	0.2	0.8	0.3	0.1	0.2	0.0	0.0	0.1	0.7	0.0	0.6	0.8	0.7	0.1	1.4	0.6	0.0	1.1	0.8	2.1	2.0	1.3	1.0	1.6	1.8	0.5	0.8	1.7	2.8	0.2	0.7	1.4	0.9	1.7	0.6	24.8	14.6	7.4	29.5	22.8	4.3	1.4	23.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QL4	"C1QTNF11, CTRP11"	ENSG00000186897	"Complement C1q like 4"	Q86Z23	12	49332411-49337188	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;testis: 7.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 21.0;Horizontal cells: 23.8;Late spermatids: 67.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.9;HAP1: 4.3;PC-3: 4.7;U-2 OS: 7.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.4"	"Group enriched"	"Detected in some"	5	"midbrain: 5.1;pons and medulla: 9.7"						"Secreted in brain"	NA	NA						"unprognostic (1.97e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.11e-3)"	"unprognostic (7.62e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (9.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.72e-2)"	0.4	0.3	2.0	0.1	1.0	0.1	0.4	0.4	2.3	0.7	0.1	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.6	2.4	0.8	0.2	0.1	0.1	1.4	0.0	0.6	0.1	0.1	0.4	0.1	9.2	0.2	0.1	0.8	0.1	0.1	0.4	1.7	0.1	0.2	2.1	0.4	0.1	7.4	0.9	0.0	3.6	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.3	27.9	0.0	0.0	0.1	0.0	0.1	0.4	1.5	0.7	0.1	0.3	1.6	0.0	1.6	0.0	4.3	0.0	0.5	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.1	4.7	0.1	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.2	1.3	0.0	0.6	0.1	0.0	0.4	7.4	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.4	2.1	0.6	2.4	1.4	0.0	9.2	0.9	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.0	0.0	67.3	0.9	0.0	3.3	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.8	0.0	0.5	1.6	1.4	0.1	0.0	0.0	0.0	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.5"	"Group enriched"	"Detected in many"	5	"Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	30000	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	62.4	18.3	1.7	7.4	4.3	0.4	60.5	1.3	5.1	14.3	10.3	5.2	30.8	2.5	11.0	14.2	10.2	14.4	19.1	77.5	2.0	4.1	9.5	19.4	9.7	16.6	4.8	2.5	25.2	7.5	10.1	4.2	34.0	7.6	13.3	3.3	19.6	13.8	51.8	11.9	8.6	6.1	6.9	2.5	14.3	6.1	8.8	2.8	1.3	26.9	13.3	5.0	14.8	27.5	0.5	0.3	1.9	0.3	1.2	0.4	0.0	0.0	8.2	0.0	0.0	84.6	7.6	0.0	4.2	19.8	1.8	3.5	0.6	4.0	0.0	0.4	1.2	5.2	0.2	0.2	0.1	1.3	0.0	0.9	0.0	3.1	0.4	32.0	0.0	0.0	17.0	0.0	3.8	0.2	2.6	2.4	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.9	8.6	0.0	5.5	0.1	0.0	0.1	0.3	1.6	2.7	0.4	7.9	0.3	0.0	0.0	0.3	9.0	0.2	1.0	1.2	0.0	0.0	0.0	20.0	0.0	0.8	1.9	0.3	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.1	0.5	0.2	0.4	0.4	1.2	0.2	0.3	0.0	0.0	1.7	4.3	1.3	4.2	2.0	4.1	4.8	2.5	7.6	2.8	0.0	1.1	0.0	0.6	5.8	0.0	9.4	10.2	0.0	0.0	1.8	0.0	17.3	0.0	13.9	0.1	10.5	1.3	0.0	5.3	1.2	14.4	1.2	0.0	1.5	2.3	0.0	4.6	145.5	10.5	0.0	9.8	0.7	3.3	19.0	6.8	0.5	3.2	2.9	3.2	0.0	0.3	103.5	105.0	0.0	0.7	4.0	39.6	0.5	4.5	0.5
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 8.3;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.6	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.3	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.1	0.9	0.6	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.0	0.6	0.1	0.0	0.0	8.2	0.1	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.2	0.0	0.0	0.0	0.0	0.7	10.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Fibroblasts: 32.3;Leydig cells: 21.6;Peritubular cells: 28.0;Smooth muscle cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.6;U-138 MG: 11.8;U-2 OS: 6.4;WM-115: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	3.0	4.0	0.7	2.5	0.1	0.7	0.0	0.1	1.0	0.5	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.6	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.2	11.8	6.4	1.1	3.2	0.1	0.0	0.0	0.4	0.0	5.2	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5	0.0	0.0	0.0	0.1	5.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	1.6	0.0	0.0	0.2	0.2	32.3	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	21.6	0.0	5.0	1.0	0.0	0.0	0.1	0.0	28.0	0.0	0.6	0.0	27.0	0.0	0.1	3.3	0.7	0.0	0.0	0.1
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34019448-34043832	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"salivary gland: 171.5"	"Group enriched"	"Detected in many"	27	"Early spermatids: 150.0;Late spermatids: 294.3;Muller glia cells: 207.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	198	"U-266/84: 132.6"									"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	44100000	27000000	"Golgi apparatus"		"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	4.4	0.3	5.7	2.7	6.4	0.2	4.5	9.6	3.4	2.4	7.9	1.8	4.8	2.1	2.5	3.9	22.5	2.0	3.6	0.9	4.2	3.1	4.0	0.5	2.6	0.5	4.3	1.4	1.1	1.0	0.3	0.7	0.8	3.7	30.2	6.6	2.4	171.5	3.2	1.3	1.4	5.5	14.4	5.6	0.5	8.4	7.9	2.6	0.6	1.0	3.6	0.7	13.1	3.2	0.4	0.1	0.4	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.1	132.6	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.4	5.7	6.4	9.6	2.8	4.2	3.1	4.3	1.4	3.7	2.6	3.0	1.3	1.5	0.6	5.0	4.5	0.4	7.6	1.4	1.2	3.5	0.0	0.8	1.7	0.7	150.0	3.1	0.7	0.0	1.2	0.4	7.4	0.6	0.0	1.5	1.1	7.9	1.7	0.6	0.6	294.3	1.7	1.3	6.8	0.0	1.4	207.9	0.5	0.0	2.5	2.0	7.8	0.0	1.9	7.5	1.7	5.1	0.3	0.7	2.1	0.4
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589664-47594659	"Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.8"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 34.8;Leydig cells: 42.6;Muller glia cells: 41.3;Peritubular cells: 36.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"REH: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041032	Approved				"Secreted in brain"	NA	NA					"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	2.5	1.5	14.2	1.4	34.2	4.1	1.6	16.8	37.8	1.6	1.5	2.0	0.0	1.7	2.1	1.4	1.3	1.5	1.6	1.4	9.7	7.1	1.4	1.4	1.4	1.5	7.9	15.5	3.3	2.2	6.3	4.7	1.4	14.5	1.8	1.4	0.0	1.3	1.7	1.8	1.5	1.6	1.8	5.2	1.6	1.5	2.0	3.7	0.0	1.5	0.0	1.4	1.3	0.3	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.0	0.7	0.0	0.0	11.2	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	14.2	34.2	16.8	37.8	9.7	7.1	7.9	15.5	14.5	3.7	0.0	0.0	0.0	6.0	2.2	14.1	0.4	0.0	0.0	0.0	3.5	15.7	1.0	3.3	0.0	9.0	2.6	0.0	0.0	0.2	2.2	11.3	3.8	0.0	0.2	2.6	4.8	0.0	2.5	0.0	34.8	42.6	0.0	10.1	0.0	0.0	41.3	0.2	0.0	36.0	0.4	22.2	25.8	3.1	11.3	26.6	1.6	3.0	0.0	0.0	1.4
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338939-119340940	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 30.5"	"Cell type enriched"	"Detected in single"	4	"Ductal cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;HHSteC: 19.0;hTERT-RPE1: 14.9;HUVEC TERT2: 28.0;TIME: 25.6"	"Low region specificity"	"Detected in all"							"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	NA	NA	219000000	1600000			"CAB025607: , HPA038604: AB_2676110"																		13.6	3.2	3.7	4.3	4.0	0.0	6.4	3.1	7.1	6.4	6.1	7.9	1.5	5.5	7.1	8.3	3.7	3.8	19.0	10.2	3.9	3.6	7.3	3.2	8.9	3.6	8.1	2.3	6.2	3.1	1.2	4.2	5.0	9.6	4.3	2.7	30.5	3.2	3.2	4.2	3.1	5.8	10.9	5.4	5.7	4.3	3.1	5.2	0.0	4.1	4.6	1.1	8.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	9.4	2.6	0.1	2.3	0.1	0.3	1.4	0.0	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	19.0	0.0	0.0	4.5	0.0	0.1	0.0	14.9	28.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.5	0.0	0.0	25.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.0	3.1	3.2	3.9	3.6	8.1	2.3	9.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180167-37199385	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 23.7;placenta: 79.5"	"Cell type enriched"	"Detected in many"	12	"Extravillous trophoblasts: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 45.0;RT4: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1.0	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4.0	3.8	1.0	6.7	8.4	4.4	1.5	0.8	8.9	13.4	1.4	2.8	1.1	0.8	1.5	9.9	0.0	5.7	2.3	0.6	14.0	0.1	3.4	0.5	1.9	1.1	1.1	3.2	1.5	3.1	0.0	0.9	12.3	1.9	0.9	0.2	3.0	10.6	0.3	0.0	3.1	0.4	45.0	0.0	0.2	2.8	1.0	0.1	0.1	0.0	1.1	10.2	20.8	0.7	5.7	0.4	8.1	1.1	2.4	2.8	0.2	3.6	0.4	2.3	0.1	0.0	6.5	0.1	0.0	0.9	0.8	1.2	1.0	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1.0	0.5	2.4	2.9	2.2	1.8	4.0	0.3	1.1	3.8	1.0	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2	0.0	0.0	3.0	1.4	1.3	0.9	1.1	2.5	4.0	2.3	1.8	0.0	4.2	1.7	1.9	1.7	1.4	2.6	0.0	1.0	349.8	8.9	0.6	1.1	5.0	8.4	0.0	0.0	11.6	1.0	6.2	0.6	0.9	5.0	1.0	2.1	4.2	2.0	3.5	0.4	1.3	0.7	0.0	3.3	7.0	4.0	0.3	28.8	2.5	3.9	1.0
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000		Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	3.2	15.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	10.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	21.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	29.7	1.0	0.9	6.5	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1090005-1096244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;HEK 293: 1.0"					"Not detected"	"Not detected"			HPA056438	Uncertain				"Secreted - unknown location"	NA	NA					"HPA056438: AB_2683134"			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	2.6	0.7	0.0	1.7	0.0	0.0	0.0	0.5	0.1	0.0			0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.8	2.1	0.1	0.0	0.3	0.0	0.4		0.0	0.0	0.0	4.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.2;skeletal muscle: 14.1"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 1.2;Collecting duct cells: 1.8;Early spermatids: 1.5;Endothelial cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.9;OE19: 1.8"									HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000				"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	5.6	0.3	0.2	2.4	0.9	0.3	4.9	0.1	0.2	0.7	2.8	0.1	0.1	1.1	1.6	1.6	4.8	0.3	1.9	15.2	0.9	0.3	0.3	0.8	0.4	0.4	0.2	0.1	0.4	1.2	0.5	0.2	4.8	0.1	2.6	0.7	0.1	0.9	1.0	14.1	0.6	1.2	1.8	0.2	0.6	1.1	1.6	0.1	0.3	0.5	5.2	0.9	1.0	7.1	0.5	0.7	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.3	0.7	0.5	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.4	0.7	0.0	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.5	0.0	0.0	0.5	0.3	1.7	0.0	1.9	0.7	1.2	0.2	1.8	1.3	0.2	0.2	0.0	0.5	0.5	0.1	0.2	0.5	0.0	0.2	0.3	0.4	0.2	0.0	0.4	0.6	1.1	0.4	0.8	0.3	0.5	0.7	0.7	1.1	0.1	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.7	0.0	0.0	0.2	0.9	0.1	0.1	0.9	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23890525-23902655	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 17.7;testis: 8.5"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 1.6;Late spermatids: 1.4"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.6;OE19: 6.5"									HPA056632	Uncertain				"Secreted - unknown location"	NA	NA					"HPA056632: AB_2683197"	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.5	0.5	0.6	0.3	0.5	0.0	0.8	0.0	0.5	0.1	0.6			0.3	0.5	0.0	1.4	0.1	0.5	3.2	4.4	1.3	0.1	0.1	0.1	0.0	0.1		0.2	0.5	0.0	1.1	0.4		4.8	0.0		1.5	0.0	3.5	17.7	0.2	0.4	0.0	1.4	0.6	8.5			0.5		0.0	0.8	0.2	2.3	3.0	1.7	1.6	1.3	1.2	0.5	1.3	3.0	1.2	1.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.2	1.9	0.3	0.0	0.1	2.4	3.1	0.0	0.0	0.0	1.9	2.5	0.7	1.6	1.6	0.3	0.3	0.7	0.1	0.0	0.0	0.0	1.5	0.0	8.6	0.7	1.6	0.0	2.0	0.4	0.1	2.0	6.5	3.0	1.2	1.5	2.4	0.0	0.2	3.7	0.1	1.8	0.1	3.0	0.9	0.9	0.4	0.2	2.9	0.8	0.2	1.8	2.6	0.4	1.3	3.6	1.1	0.6	0.0	0.8	1.7	1.2	1.1	0.4	1.0	0.2	0.1	0.6	2.3	0.4	0.6	0.0	1.3	1.6	3.0	0.0	0.5											0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	181.7	92.7	0.1	20.4	80.0	24.2	49.3	0.2	0.3	0.0	0.6	15.9	1.6	0.3	1.7	0.8	3.4	1.9	0.1	0.0	0.6	0.6	34.9	0.1	0.2	107.4	0.5	11.0	0.8	18.4	0.4	0.1	0.0	2.5	3.1	0.0	0.9	0.1	0.8	0.0	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.7	0.4	0.4	0.2	0.0	0.0	0.0	5.8	0.9	26.7	0.1	0.1	0.4	0.0	8.3	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9	20.8	84.7	28.4	53.6	48.5	0.2	14.6	168.2	6.7	34.2	17.4	2.0	2.9	3.3	164.2	3.5	51.3	0.3	23.3	39.1	4.8	462.9	14.1	9.3	1385.8	10.3	0.0	0.0	128.9	25.4	9.4	1057.9	10.1	50.6	2.8	0.6	15.1	74.1	0.6	364.9	5.0	0.9	168.1	97.8	5.7	4.1	35.0	4.3	13.1	0.7	9.8
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109273	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.1"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 133.0;Leydig cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.8;HSkMC: 35.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	20000000000			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	16.5	31.2	3.8	10.0	5.5	6.1	14.2	1.2	4.9	12.1	13.5	3.2	10.5	6.0	12.4	14.9	13.3	14.5	14.7	10.0	2.5	1.6	21.4	96.1	14.2	13.1	4.5	2.7	21.3	23.8	5.2	15.7	4.2	6.4	16.5	7.2	11.3	16.9	11.5	11.1	7.8	9.5	15.4	9.3	12.7	11.1	7.2	4.7	2.8	14.4	8.1	7.0	15.5	16.4	2.2	1.7	11.7	2.5	0.6	1.4	0.9	2.2	6.0	0.6	6.0	18.5	31.8	4.2	3.7	17.3	3.7	11.3	3.8	10.4	0.9	3.2	3.0	3.8	5.0	1.6	6.4	1.5	9.3	0.3	3.5	5.9	8.8	15.0	0.7	17.3	35.2	12.1	2.4	7.4	18.1	3.9	1.9	2.8	2.3	2.3	0.1	0.5	0.7	1.1	0.5	0.2	2.0	0.0	0.7	10.5	10.1	0.4	1.3	12.7	1.6	2.3	1.1	1.5	3.1	3.3	3.4	6.3	3.9	0.7	1.7	0.7	0.1	6.4	2.5	1.5	7.2	1.5	8.0	1.4	2.3	0.6	2.2	1.4	1.0	1.7	1.1	0.9	0.8	11.7	0.6	2.5	0.9	0.8	0.9	3.8	5.5	1.2	4.9	2.5	1.6	4.5	2.7	6.4	4.7	14.9	30.5	9.5	12.8	3.4	0.4	2.1	20.4	14.7	28.4	5.2	2.0	0.1	1.7	24.9	0.1	10.8	7.8	0.0	46.6	0.2	11.9	10.2	3.5	133.0	3.0	0.0	4.1	23.4	9.8	0.9	51.5	10.7	3.3	10.0	8.1	3.4	26.2	7.0	19.1	7.6	1.0	0.0	5.1	0.5	0.7	2.8	0.1	13.1	8.4	7.3
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell type enhanced"	"Detected in many"	21	"Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.3	99.3	132.1	0.4	17.9	42.1	9.5	17.4	0.0	0.2	0.0	2.4	22.2	2.5	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.7	29.9	0.2	0.1	70.1	0.3	7.7	0.5	11.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.9	0.2	0.2	2.1	0.0	0.0	0.0	4.4	0.3	16.9	0.0	0.0	0.0	0.1	9.5	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3	14.9	34.2	18.3	17.5	67.8	0.6	21.4	152.8	6.7	20.5	3.5	0.0	2.9	1.7	170.0	5.7	37.8	0.0	46.7	37.9	3.5	388.0	7.4	4.7	2464.3	7.1	4.8	0.0	105.6	49.3	8.8	1104.9	9.4	84.4	1.8	0.0	15.1	43.6	0.0	601.8	4.1	0.9	135.8	123.7	5.0	4.1	47.0	2.2	4.3	0.0	3.0
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 116.0;Hepatocytes: 339.0;Hofbauer cells: 221.2"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 17.3;Karpas-707: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB016775	Supported				"Secreted to blood"	NA	NA		52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	17.3	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.2	0.0	0.3	0.1	54.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	2.4	0.1	0.1	0.2	0.2	0.0	0.2	6.7	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0	23.8	116.0	3.0	1.0	3.0	1.4	0.4	10.2	9.4	6.8	1.8	0.0	1.6	0.0	0.4	0.1	0.7	2.8	23.3	2.4	1.8	15.8	5.9	3.5	339.0	221.2	1.6	2.4	25.2	60.2	0.8	6.4	8.4	3.3	10.0	4.1	0.0	7.1	15.3	1.1	30.0	0.8	0.0	2.3	0.6	0.9	2.5	3.3	3.2	3.9	2.5
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 40.8;Distal tubular cells: 19.9"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"AF22: 7.2;RPTEC TERT1: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"	NA	NA					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1	0.0	0.0	0.5	0.8	0.8	5.1	0.1	40.8	0.0	0.0	5.2	5.9	1.1	19.9	0.0	1.2	0.6	0.0	0.0	0.0	0.4	1.1	0.3	0.0	0.0	0.2	0.0	2.9	2.5	0.6	0.0	3.7	0.0	3.3	0.0	0.0	5.6	0.0	0.0	1.8	2.1	6.2	0.0	0.4	0.9	1.1	0.9	0.2	1.7	0.0	0.3
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23763021-23765861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"fallopian tube: 22.3"	"Cell type enriched"	"Detected in some"	13	"Ciliated cells: 200.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.7"					"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0"														"Secreted in female reproductive system"	NA	NA						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.1	1.0	0.0	1.7	0.4	0.1	0.0	0.0	0.8	0.1			0.0	0.2	0.0	0.0	22.3	0.2	0.0	1.4	1.9	0.0	0.0	2.7	0.2	0.0		0.5	0.0	0.0	1.5	0.2		0.1	0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.6			0.0		0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	1.8	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	4.8	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	6.5	0.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.6	1.0	0.8	0.4	0.5	1.8	0.5	0.0	0.0	0.0	2.9	0.0	0.2											0.0	2.6	0.0	0.0	0.1	0.5	0.0	0.0	200.8	15.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.3	0.0	0.0	0.0	0.0	1.3	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	12.7	3.8	0.3	0.0	0.0	0.0	0.0
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"	NA	NA			Nucleoplasm	Nucleoli	"HPA052741: AB_2681933"	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.8	4.5	11.1	6.8	8.2	8.7	10.1	7.5	8.1	6.4	8.6	4.5	5.8	5.5	5.5	6.2	6.3	4.1	5.7	5.8	7.7	19.7	5.4	6.1	9.4	3.8	4.8	4.5	12.0	6.9	7.8	10.7	7.6	4.9	1.6	8.6	9.9	8.2	5.6	14.6	3.5	5.5	4.5	13.4	3.5	5.1	9.2	6.1	5.4	6.1	2.7	4.2	8.7	7.9	11.3	8.5	9.0	5.5	4.3	8.4	14.4	4.4	3.9	17.5	17.8	5.1	5.0	5.5	11.4	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7											11.9	16.5	7.1	3.9	1.9	9.4	18.9	5.1	8.1	11.4	7.0	13.7	8.3	1.7	4.2	65.6	7.1	8.4	0.0	4.2	5.8	4.9	2.0	7.0	4.0	4.2	3.2	2.9	9.2	7.3	8.2	4.9	8.3	1.7	9.0	7.2	9.7	3.7	3.7	6.0	1.3	6.2	0.0	3.5	12.0	11.5	2.3	7.1	15.8	4.0	1.4
C2orf40	"augurin, ECRG4"	ENSG00000119147	"Chromosome 2 open reading frame 40"	Q9H1Z8	2	106063246-106078159	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ciliated cells: 481.8;Early spermatids: 894.2"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 72.8"	"Region enriched"	"Detected in all"	7	"pons and medulla: 44.8"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	77	"T-cells: 10.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HSkMC: 1.0;NB-4: 1.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1"	"Low region specificity"	"Detected in many"			HPA008546	Uncertain				"Secreted to blood"	NA	NA					"HPA008546: AB_2066524"	"prognostic favorable (4.58e-4)"	"unprognostic (3.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.30e-4)"	27.5	14.0	1.6	7.6	3.2	0.4	12.7	4.1	4.1	21.8	11.0	18.7	19.9	2.9	19.5	25.8	16.5	15.9	10.3	6.5	3.2	5.1	14.7	1.4	8.4	1.0	6.2	3.7	7.9	3.4	1.0	27.6	4.2	44.8	37.1	3.0	33.9	10.2	50.7	4.1	3.2	6.4	66.8	9.6	12.0	50.6	11.0	1.9	0.1	44.2	8.2	2.5	46.6	26.8	0.1	0.0	0.0	0.0	0.1	10.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	2.4	1.6	0.0	0.0	10.0	8.2	0.0	0.1	0.0	0.0	0.7	1.7	1.6	3.2	4.1	4.1	3.2	5.1	6.2	3.7	44.8	1.9	0.0	1.4	0.0	1.8	7.1	0.1	6.3	0.0	481.8	40.9	19.2	0.0	1.4	0.0	0.6	894.2	5.8	0.0	0.0	0.0	0.7	22.3	1.6	1.1	0.0	2.3	3.2	10.2	11.1	0.3	110.5	19.0	2.7	1.7	0.0	0.0	0.2	0.0	0.0	59.4	0.0	0.2	38.8	97.8	9.7	3.6	0.9	2.6	0.5	0.0	1.8
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 9.4;RT4: 3.5;TIME: 3.9"									HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.1	0.5	0.3	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	1.1	0.2	0.3	0.6	9.4	1.0	0.1	0.0	0.1	0.8	0.7	1.4	0.2	0.2	0.2	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	3.5	0.4	0.2	0.0	0.1	0.1	0.4	0.0	0.0	3.9	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
C2orf69	FLJ38973	ENSG00000178074	"Chromosome 2 open reading frame 69"	Q8N8R5	2	199911256-199955935	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 96.7;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045225	Approved				"Secreted - unknown location"	NA	Yes					"HPA045225: AB_10960841"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-2)"	11.6	18.4	17.7	8.9	18.5	23.6	12.1	14.3	20.0	7.9	9.9	7.3	5.1	10.4	8.3	8.7	8.8	6.0	8.0	8.2	16.2	16.3	11.3	12.3	7.6	8.4	15.9	13.4	8.8	10.2	11.4	8.5	6.7	13.3	8.5	10.4	6.4	9.0	6.6	13.5	8.2	9.0	9.7	15.8	8.3	8.8	18.6	12.7	10.2	8.6	8.9	9.0	7.4	8.5	5.2	3.6	10.8	5.4	2.9	8.6	4.3	11.5	5.3	9.9	13.4	14.0	17.7	16.7	16.6	10.0	11.3	13.5	11.8	8.4	9.6	9.8	11.7	12.0	9.4	10.4	8.8	19.1	14.2	9.5	14.7	9.2	15.0	8.2	14.7	18.3	9.1	8.0	12.9	11.3	6.1	12.6	6.5	10.5	19.0	19.0	10.0	8.1	12.9	14.5	5.1	14.2	7.9	12.9	8.6	11.1	12.0	16.2	7.1	8.0	6.1	12.3	13.3	8.9	12.8	10.9	17.7	14.5	19.7	13.2	12.6	20.3	9.5	14.1	9.5	8.8	7.1	4.2	10.8	6.0	5.4	8.6	5.2	6.7	5.6	3.6	4.8	7.1	7.4	3.5	2.9	4.0	2.1	6.1	4.3	17.7	18.5	14.3	20.0	16.2	16.3	15.9	13.4	13.3	12.7	3.0	3.2	25.1	23.0	33.8	19.4	9.8	2.5	13.4	5.7	15.7	27.5	9.4	23.2	10.8	96.7	15.0	11.7	0.0	16.1	15.1	16.4	16.8	8.1	16.3	10.6	12.7	17.9	23.9	16.4	55.3	12.4	16.2	15.1	10.0	15.8	55.2	12.3	10.5	20.5	15.7	24.7	19.4	21.7	107.2	44.6	39.3	8.2	18.5	15.3	13.9
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"liver: 611.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4080.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 1213.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.2;monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 48.5;EFO-21: 102.2;Hep G2: 105.6;HSkMC: 75.4;SiHa: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	250000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	59.7	34.1	9.3	20.0	19.6	1.0	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7.0	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3.0	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2.0	0.4	0.8	8.4	3.0	0.0	0.0	1.5	5.1	10.3	0.7	48.5	0.9	1.7	0.5	6.7	0.2	102.2	0.0	7.5	6.3	0.0	5.8	0.9	3.1	0.0	0.4	4.5	105.6	2.3	0.8	1.2	75.4	1.7	8.4	3.8	1.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	4.4	0.8	0.0	0.0	28.2	0.0	0.0	0.0	2.3	1.1	0.4	0.8	1.0	0.6	0.4	0.2	0.5	0.5	10.4	0.6	0.0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2.0	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7.0	4.1	12.3	2.2	12.8	10.7	71.5	405.7	102.4	11.5	24.5	0.0	13.3	822.9	29.4	84.2	15.7	0.0	1.2	5.0	273.3	34.0	21.5	0.3	70.0	114.7	2.1	60.9	11.5	4.7	4080.2	36.1	0.0	0.0	120.9	123.3	75.5	209.4	25.1	33.7	25.2	0.6	0.5	589.9	0.0	10.3	39.2	3.7	6.5	22.8	3.2	7.9	19.2	2.3	24.5	0.4	12.3
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	6.0	8.5	4.0	5.6	0.3	5.1	1.8	2.5	4.0	2.5	6.1	2.9	7.7	1.1	6.2	2.6	3.8	0.9	4.1	0.1	4.6	2.9	6.0	3.7	1.4	7.8	7.1	5.0	1.2	4.0	4.5	2.7	5.3	3.3	4.3	6.3	5.8	2.9	4.3	4.4	5.3	4.5	5.4	5.5	1.9	5.4	2.2	5.9	14.1	2.8	3.1	4.1	5.8	7.8	5.2	2.2	10.7	6.6	2.7	2.9	2.1	6.1	6.5	4.9	4.6	0.0	2.1	4.7	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9	3.0	7.9	0.0	5.1	1.1	7.9	9.8	2.5	5.3	7.9	0.0	5.9	3.0	5.0	3.2	5.2	2.2	1.3	0.0	2.9	2.5	4.6	4.0	6.9	3.0	2.2	6.4	3.5	1.3	0.3	4.2	5.8	1.6	1.7	0.0	3.1	15.6	1.6	3.4	7.4	5.3	7.0	0.0	3.1	11.3	17.2	1.3	3.1	2.5	4.1	2.0
C3orf58	"DIA1, HASF, MGC33365"	ENSG00000181744	"Chromosome 3 open reading frame 58"	Q8NDZ4	3	143971798-144048719	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048992	Approved				"Secreted in other tissues"	NA	NA					"HPA048992: AB_2680591"	"unprognostic (5.96e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (2.92e-7)"	"unprognostic (4.82e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.50e-2)"	9.1	6.0	12.4	7.8	15.5	21.5	13.4	27.5	15.3	11.7	9.3	21.9	5.0	5.2	11.5	4.9	12.1	10.4	11.4	9.0	13.2	10.9	5.6	15.0	10.1	9.1	16.5	10.9	16.8	7.3	11.3	5.0	29.3	10.6	9.6	7.2	5.4	7.6	10.7	4.2	19.0	6.7	12.2	14.5	7.9	8.2	6.0	18.4	10.9	10.2	4.7	8.3	11.6	12.5	6.8	11.9	16.0	9.4	7.4	5.2	4.1	9.4	3.8	9.9	58.5	9.2	8.4	5.4	6.9	6.7	6.6	7.1	2.6	3.8	5.9	5.4	2.6	4.7	5.4	14.6	5.6	10.4	2.8	5.3	8.8	3.9	3.8	4.0	8.0	4.1	6.9	3.0	4.0	6.2	6.7	10.2	2.7	1.5	17.4	8.3	2.5	2.9	3.9	6.2	3.9	2.4	4.3	5.1	6.6	4.0	11.3	6.6	0.0	4.9	2.3	2.2	2.8	6.1	4.4	4.8	5.9	2.8	9.1	7.9	7.0	2.4	8.7	9.5	3.8	7.5	16.0	9.4	15.5	3.0	6.1	5.2	6.6	3.6	3.2	11.9	6.8	3.2	3.0	2.8	7.4	7.8	7.4	3.1	4.1	12.4	15.5	27.5	15.3	13.2	10.9	16.5	10.9	10.6	18.4	86.4	8.1	22.3	12.5	31.7	3.6	13.2	28.1	14.7	15.9	5.2	23.6	1.1	0.0	5.8	2.9	24.3	8.9	23.3	4.8	1.5	32.1	15.1	18.4	16.6	18.6	9.5	32.1	16.0	26.2	3.2	16.4	18.5	21.9	3.6	8.4	30.9	3.4	13.5	18.0	2.8	6.3	19.4	23.9	2.7	17.3	26.6	2.9	10.1	9.4	6.3
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982024-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease mutation, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 36.1;Ciliated cells: 8.1;Club cells: 25.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.4;HSkMC: 36.1;U-266/70: 8.4;U-266/84: 16.0"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	98000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	2.7	17.5	1.3	4.3	1.1	0.0	3.3	0.0	0.1	0.4	3.0			2.9	1.6	5.8	0.7	3.5	0.8	2.7	0.7	0.9	12.8	49.5	6.7	1.4	0.9		8.0	2.6	0.0	2.2	0.0		1.5	1.7		1.3	0.0	0.0	0.1	1.2	0.0	0.7	2.9	4.1	0.3			8.1		1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	25.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.4	16.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											8.9	36.1	0.0	0.0	0.0	0.0	4.7	0.0	8.1	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014762-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 30.7;liver: 52.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 95.9;Cardiomyocytes: 44.1;Club cells: 42.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 53.7"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		97000000000			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	3.7	30.7	0.9	0.0	0.7	0.0	1.3	0.0	0.9	0.7	2.3			0.9	1.4	0.0	0.0	4.7	2.4	2.6	0.4	0.9	7.2	52.4	2.0	0.7	0.7		7.2	2.7	1.0	1.8	0.5		0.5	2.7		2.0	0.4	0.0	0.0	1.0	3.8	0.6	1.4	0.8	0.7			5.7		1.6	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	3.3	0.2	0.0	10.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	95.9	0.0	0.0	0.0	0.0	44.1	0.0	14.7	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.1	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104262-207144972	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 377.2"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 458.5;Alveolar cells type 2: 461.5;Hepatocytes: 752.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	153	"neutrophil: 21.6"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 21.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 28.7"									"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	34000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	377.2	26.0	0.1	0.1	0.1	0.3	1.8	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	458.5	461.5	0.0	0.0	0.0	0.0	0.1	30.6	6.7	40.9	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	23.3	16.0	0.0	0.0	0.4	3.5	752.2	0.2	0.0	0.0	23.4	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088842-207099993	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 156.5"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 556.0"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.6;T-cells: 2.5"	"Group enriched"	"Detected in some"	16	"CACO-2: 38.6;HeLa: 16.0;Hep G2: 50.1;OE19: 18.8"					"Low region specificity"	"Detected in all"			HPA051620	Approved				"Secreted to blood"	NA	NA	265000000000	1300000000			"HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	0.5	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.1	0.5	2.0	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1.0	0.6	0.1	0.0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0.0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0.0	0.0	0.0	2.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	50.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.8	0.0	0.0	0.0	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.9	1.3	1.5	0.0	0.0	0.0	0.4	45.9	2.7	4.5	0.0	0.0	0.7	1.7	11.0	3.9	0.0	3.1	0.0	76.8	0.1	0.2	0.2	0.0	556.0	1.6	0.0	1.7	9.8	9.4	1.8	0.0	0.4	0.0	1.0	3.4	0.0	52.0	11.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	2.3	0.0
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		32000	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.8	6.5	1.3	6.1	0.6	0.9	8.7	7.5	1.5	1.4	1.3	4.4	4.7	1.0	7.3	0.2	2.5	2.2	0.1	0.8	0.4	4.7	38.6	2.5	3.5	2.5	1.3	5.1	17.3	0.7	1.4	0.3	0.0	0.4	1.4	4.3	8.1	0.0	0.9	4.8	5.7	27.7	3.9	0.4	83.8	13.2	2.0	2.5	1.2	2.9	10.5	14.8	3.7	0.1	10.1	0.1	2.0	2.4	6.4	3.6	7.8	2.7	8.4	5.9	5.1	0.0	3.6	3.1	5.0	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7	0.0	3.4	61.1	5.3	19.5	14.6	6.1	17.8	6.7	3.4	190.1	0.0	7.5	59.7	304.2	76.9	29.1	185.6	23.3	194.2	111.5	25.9	12.6	109.2	8.9	199.3	17.5	225.6	114.2	260.9	247.7	17.8	117.6	310.4	64.9	97.5	43.9	199.3	378.7	26.5	6.8	11.5	12.9	12.8	61.7	167.2	8.8	11.0	64.3	73.8	9.2
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050276	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"liver: 259.9"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 458.7"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 20.5;Hep G2: 21.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	46000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.5	4.7	8.3	6.1	7.1	0.2	2.5	2.6	0.7	1.5	0.6	2.0	3.0	0.1	1.3	2.8	8.1	0.2	0.2	1.1	0.6	0.0	1.2	1.0	21.6	1.1	0.7	0.5	3.1	0.4	1.5	2.7	1.3	0.7	1.2	0.5	2.8	1.6	4.0	0.3	0.1	1.2	5.0	8.0	1.8	2.1	0.3	1.3	0.6	1.2	4.9	1.1	0.0	2.0	3.4	1.6	2.7	0.9	2.1	0.1	5.5	2.4	1.7	1.2	1.2	1.6	2.8	5.0	0.0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3	6.0	25.8	2.2	1.0	0.9	4.5	0.6	38.2	5.3	12.5	1.8	0.0	0.1	1.7	0.1	1.3	0.5	0.0	0.0	0.4	0.0	0.8	0.7	0.0	458.7	1.5	6.4	0.0	8.0	12.9	1.7	2.8	3.1	0.0	1.8	0.4	3.9	1.1	0.0	8.5	7.8	2.5	0.0	1.2	1.8	2.3	1.1	0.0	0.7	0.9	0.1
C5orf38	"CEI, IRX2NB"	ENSG00000186493	"Chromosome 5 open reading frame 38"	Q86SI9	5	2752131-2755397	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"salivary gland: 34.9"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 32.4;Distal tubular cells: 87.9;Melanocytes: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 38.2;HaCaT: 13.1;hTCEpi: 20.9;MCF7: 11.1;SiHa: 16.0;SK-BR-3: 15.0"									HPA073667			Approved	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA			"Golgi apparatus, Vesicles"		"HPA073667: AB_2686624"	"unprognostic (5.00e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-5)"	"unprognostic (4.08e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.67e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.84e-7)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.60e-2)"	8.3	0.5	4.5	0.6	7.6	0.5	16.3	10.4	3.0	0.6	1.1	1.5	9.8	0.7	0.7	6.8	4.1	0.6	0.6	2.4	6.0	7.0	6.6	0.5	19.4	1.1	10.5	2.0	0.5	3.8	5.0	2.6	4.3	14.8	5.9	0.7	3.4	34.9	3.9	0.9	10.6	0.5	0.5	12.2	0.7	11.2	1.5	4.7	0.0	5.0	1.6	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	6.9	0.0	3.0	2.1	38.2	4.9	3.9	3.3	2.9	1.9	0.0	0.0	0.0	0.9	0.0	13.1	0.7	3.8	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	20.9	0.8	2.7	0.0	0.0	0.0	0.0	0.0	0.8	11.1	0.0	0.1	1.0	4.3	0.0	0.0	1.4	0.0	4.3	0.0	1.0	0.0	16.0	15.0	0.0	2.3	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.6	10.4	0.3	6.0	7.0	10.5	2.0	14.8	4.7	11.9	8.3	0.0	13.3	21.9	0.0	0.6	0.0	1.4	6.8	12.2	0.0	32.4	87.9	0.0	0.7	0.6	0.0	0.0	0.2	12.9	3.0	11.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.5	37.1	0.0	1.3	0.0	0.5	0.0	0.4	0.7	0.6	0.0	17.8	0.4	0.9	18.7	12.2	0.0	1.2	2.4
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 262.3;Late spermatids: 107.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA			"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.1	5.1	0.0	0.0	0.0	4.6	25.5	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	8.7	25.5	0.0	0.0	1.8	0.0	0.1	0.0	12.4	262.3	0.0	0.0	0.0	2.9	0.1	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	107.1	1.7	0.0	3.3	1.0	0.0	6.7	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.8	18.1	1.1	0.0	0.0	0.1
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 132.5;Ciliated cells: 99.0;Hepatocytes: 342.0;Leydig cells: 111.4"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 5.2;ASC TERT1: 7.3;HSkMC: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA		7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	3.9	0.0	0.0	0.0	16.8	132.5	99.0	13.6	0.0	0.0	0.0	0.0	4.4	8.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	342.0	0.0	0.0	0.0	3.7	8.6	25.4	111.4	0.1	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 93.3;Late spermatids: 214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"	NA	NA					"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	22.1	23.5	18.4	14.8	20.8	7.0	16.8	12.3	25.1	15.5	18.9	16.0	8.9	17.4	15.2	13.2	14.9	14.2	14.4	21.2	15.5	11.3	21.3	29.9	13.8	16.0	16.2	17.0	20.9	20.0	12.2	11.6	23.7	15.3	14.1	16.0	14.0	15.4	14.1	17.1	11.4	23.5	14.8	13.0	20.2	16.7	16.5	16.2	17.0	12.3	10.8	16.2	16.6	11.4	7.1	9.0	9.6	10.6	4.1	9.6	4.7	5.8	4.7	11.6	17.6	32.3	27.0	13.1	12.3	17.8	10.3	12.1	6.3	5.5	5.0	10.0	15.0	17.2	9.0	7.5	11.3	17.4	8.4	18.2	7.1	4.4	13.3	22.9	11.8	11.4	33.1	9.3	12.3	14.3	18.2	12.5	11.6	18.7	14.4	17.7	10.6	6.4	8.1	9.8	10.3	5.5	4.7	6.3	13.4	12.8	6.6	4.7	10.6	10.2	6.5	8.2	13.7	10.9	15.6	13.7	4.4	8.5	23.0	8.3	18.7	28.6	7.2	14.5	11.0	11.4	8.1	10.6	9.6	4.9	10.6	6.6	4.7	7.2	8.5	9.0	7.1	9.6	7.7	5.9	4.1	8.2	3.1	4.7	4.7	18.4	20.8	12.3	25.1	15.5	11.3	16.2	17.0	15.3	16.2	14.9	4.0	8.2	8.2	8.8	12.7	7.7	2.5	8.1	9.1	14.0	23.6	23.7	8.3	9.2	93.3	7.3	18.3	23.3	13.9	27.1	15.5	11.6	9.2	15.5	14.6	7.9	13.7	9.8	16.8	214.1	16.4	9.0	18.6	11.8	9.0	25.6	10.2	11.6	11.0	11.0	22.8	0.0	8.3	5.2	14.5	8.9	24.3	7.5	10.3	10.9
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 8.3;U-2 OS: 3.7"					"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"	NA	NA					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell type enriched"	"Detected in single"	14	"Early spermatids: 8.7"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.1;RPMI-8226: 6.4;WM-115: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	NA	NA		41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.1	0.3	0.3	0.2	0.0	0.9	0.2	0.4	0.5	5.1	0.1	0.0	0.0	0.8	0.8	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.5	0.0	0.1	0.5	0.2	0.4	0.9	0.3	0.2	0.2	0.2	0.0	6.4	0.6	0.1	0.2	1.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.2
C7		ENSG00000112936	"Complement C7"	P10643	5	40909252-40982939	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 199.9"	"Group enriched"	"Detected in many"	11	"Ito cells: 387.4;Leydig cells: 980.0;Sertoli cells: 304.0"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"ASC diff: 38.5;HHSteC: 50.9;HSkMC: 70.0;SH-SY5Y: 47.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001465	Approved				"Secreted to blood"	NA	NA		67000000000			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	54.4	99.5	0.8	7.4	1.6	0.0	10.5	1.1	1.0	30.2	34.7	3.1	14.8	2.5	36.8	48.6	55.3	47.7	48.2	79.7	0.9	0.3	81.3	41.0	29.1	69.0	3.9	1.5	199.9	32.4	3.0	5.2	55.4	3.7	52.5	4.8	1.4	5.1	17.5	1.9	1.8	17.0	43.3	3.2	33.6	17.9	44.6	0.7	3.1	32.4	1.1	7.2	39.9	29.6	0.7	0.4	1.6	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.0	38.5	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.0	0.7	0.3	0.4	1.1	1.5	0.3	0.4	0.0	0.0	0.8	1.6	1.1	1.0	0.9	0.3	3.9	1.5	3.7	0.7	6.0	5.5	0.0	0.2	0.6	0.5	39.5	7.6	0.0	4.5	0.0	0.0	0.2	0.0	0.2	2.5	13.1	0.0	0.0	1.2	0.0	17.7	0.6	1.1	2.4	0.4	41.3	52.7	387.4	14.9	7.4	980.0	1.6	0.0	1.0	0.0	4.5	0.9	0.0	17.0	0.0	0.7	304.0	5.1	2.3	1.3	0.5	0.2	0.0	1.9	0.5
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 254.8"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	4.3	0.0	0.0	0.0	0.0	254.8	0.0	0.0	0.0	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929210-56966140	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"liver: 240.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 251.9"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	47	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		3600000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	240.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.3	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	251.9	0.1	0.0	0.0	6.2	5.3	8.9	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945246-136946974	"Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 165.8"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 942.4"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.5;T-cells: 3.4"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA046269	Approved				"Secreted to blood"	NA	NA		1500000000			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	6.0	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.5	0.0	0.1	0.0	3.4	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	1.1	0.6	1.1	0.7	0.0	0.2	1.0	0.0	0.1	0.0	1.1	0.1	0.4	1.7	4.6	0.0	0.1	61.0	0.0	0.2	0.2	0.0	0.2	0.2	0.4	0.1	0.6	0.2	0.8	0.1	0.5	0.0	0.1	0.2	0.1	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.7	0.3	0.1	1.5	0.4	0.7	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.2	0.5	0.2	0.0	0.1	0.0	3.4	0.0	0.4	0.0	0.7	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.3	48.4	0.0	0.0	0.0	2.0	0.3	0.0	0.2	0.8	0.4	38.4	0.0	0.7	0.8	0.2	0.1	9.2	942.4	0.2	0.0	1.7	22.7	24.1	0.9	0.0	0.0	0.0	0.0	0.7	0.8	0.6	3.5	0.7	1.4	0.5	0.0	0.0	0.7	0.7	0.4	2.9	3.8	1.7	0.1
C9		ENSG00000113600	"Complement C9"	P02748	5	39284262-39424868	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	577	"liver: 419.5"	"Cell type enriched"	"Detected in some"	39	"Hepatocytes: 1782.7"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"JURKAT: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	97000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.3	22.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.0	23.3	0.0	0.0	0.4	0.0	0.0	1782.7	0.9	0.0	0.0	46.1	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.1	1.4	0.0	0.2	1.3	0.0	0.0
C9orf47	"bA791O21.3, C9orf108, FLJ37523"	ENSG00000186354	"Chromosome 9 open reading frame 47"	Q6ZRZ4	9	88990863-88996140	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 12.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5"									CAB009902	Approved				"Secreted - unknown location"	NA	NA					"CAB009902: AB_2184764"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.94e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.19e-6)"	"unprognostic (5.61e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.77e-2)"	1.7	5.3	0.6	1.0	0.7	0.8	2.3	0.0	0.7	1.8	1.0			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1.0	1.7	0.4		0.4	1.7	0.0	3.3	1.2		1.9	0.2		0.3	0.8	0.0	0.0	0.8	1.4	0.5	1.7	1.0	0.0			0.7		0.5	0.9	1.9	0.0	0.2	0.3	2.2	0.0	0.0	0.4	0.0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.5	0.0	0.1	0.0	5.6	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.0	0.2	0.7	3.5	0.3	0.0	0.0	0.5	1.6	1.4	0.4	0.0	0.3	0.7	0.0	0.0	0.0	0.6	0.2	0.5	0.3	0.1	0.0	0.7	0.1	1.8	1.8	0.6	1.4	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4											0.0	0.0	0.0	2.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	1.2	1.0	0.0	0.0	0.2	3.2	0.0	0.6	0.0	0.0	0.3	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	12.9	1.4	0.0	0.2	0.3	0.2	0.0	0.0	0.6
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 59.5;cervix, uterine: 23.4"	"Cell type enhanced"	"Detected in some"	27	"Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.5	3.8	14.4	0.5	6.3	0.5	0.5	59.5	36.7	23.4	0.8	1.7	0.0	0.8	0.7	0.5	0.6	0.7	0.6	0.5	8.0	12.4	7.8	0.5	0.5	0.5	7.0	5.0	2.5	0.8	0.5	1.8	14.2	18.3	0.5	0.7	2.9	1.5	0.5	0.5	0.5	1.1	0.6	4.2	0.5	0.6	6.0	1.3	0.0	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.2	3.8	11.7	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	6.3	59.5	17.9	8.0	12.4	7.0	5.0	18.3	1.3	0.0	0.0	0.0	0.0	0.0	230.7	0.3	0.0	0.0	0.0	3.5	3.9	0.0	13.3	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	56.3	1.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.0	9.7	0.0	0.0	0.9	1.0	0.0	0.1	0.0	0.0	0.0
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637942-48646312	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	2.3	9.6	60.2	2.3	58.2	1.5	4.1	54.1	87.7	3.8	2.5	4.5	1.7	5.3	17.7	16.0	3.5	10.5	3.5	2.9	44.1	12.2	4.2	1.2	3.2	3.0	18.5	31.6	24.6	3.3	16.7	5.4	1.3	8.9	4.6	2.0	2.7	4.0	8.4	5.0	6.6	4.0	10.7	11.0	2.8	3.1	2.7	17.8	0.1	4.3	0.8	3.4	2.1	1.8	3.4	4.5	0.0	1.1	2.6	3.7	1.4	1.0	6.3	11.6	23.3	1.6	0.6	0.3	0.7	7.4	0.8	1.7	1.5	8.1	3.8	0.9	0.8	2.2	2.5	4.7	2.3	0.7	0.8	6.7	1.7	3.4	0.1	1.5	0.1	5.2	2.8	4.7	0.7	1.0	24.4	0.9	10.4	2.9	10.7	0.3	2.4	2.0	0.7	5.1	3.7	2.5	1.3	0.5	7.9	5.1	0.2	16.7	9.7	0.8	0.9	1.4	3.3	3.3	0.4	0.0	2.1	7.8	0.0	0.2	10.2	17.0	0.7	2.9	2.2	1.0	0.0	0.9	0.0	3.7	1.1	3.1	2.4	2.9	2.8	1.6	3.4	3.6	3.3	0.0	2.6	0.0	4.5	3.0	1.4	60.2	58.2	54.1	63.8	44.1	12.2	18.5	31.6	8.9	17.8	3.0	7.2	9.7	6.4	6.4	72.7	5.3	20.4	8.1	9.1	29.6	15.7	0.6	21.6	6.9	10.0	7.1	7.4	0.0	8.7	0.3	5.1	4.8	5.8	34.1	5.9	27.0	12.6	8.0	21.9	4.7	20.4	8.8	8.5	4.6	4.2	24.9	4.6	3.5	25.1	19.8	25.0	6.5	8.0	0.9	3.6	9.5	0.3	8.7	4.5	5.8
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell type enriched"	"Detected in single"	404	"Melanocytes: 170.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.5;U-2197: 4.8"					"Not detected"	"Not detected"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	NA	NA		34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.2	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.6	5.5	0.6	0.5	1.3	1.6	0.4	0.1	0.8	0.6	0.6	0.8	2.0	1.1	0.4	2.0	2.0	0.0	1.0	0.9	0.1	1.2	0.7	1.4	0.7	3.4	0.1	0.8	1.0	1.5	1.1	1.0	0.8	1.5	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	0.9	1.5	0.8	0.3	2.8	1.5	4.8	1.2	1.5	0.5	1.7	0.6	1.8	1.4	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 34.9"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5"	"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500				"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	34.9	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	6.5	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.5	0.0	0.0	0.0	1.3
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell type enhanced"	"Detected in some"	23	"Basal keratinocytes: 1.1;Melanocytes: 5.0;Spermatogonia: 2.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.3;Karpas-707: 11.3;SH-SY5Y: 3.9;U-266/70: 16.9"	"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"	NA	NA					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.3	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.1	0.4	0.1	0.0	11.3	0.0	0.0	0.0	0.7	3.0	0.1	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	16.9	0.6	0.4	2.3	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"		3	48223347-48225491	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 63.7;bone marrow: 201.8;epididymis: 275.0"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 14.1;Glandular cells: 10.4;Late spermatids: 6.8;Spermatogonia: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.7"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 63.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;hTCEpi: 9.5;U-698: 39.4"	"Low region specificity"	"Detected in single"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000				"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.2	0.1	0.1	0.1	0.2	201.8	0.2	0.1	0.1	0.1	0.1	0.0	14.7	0.0	0.0	275.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.2	1.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	1.1	0.1	0.1	0.1	2.6	0.0	0.1	10.1	0.1	4.0	0.0	0.4	0.4	0.1	0.2	0.4	0.1	0.5	1.5	63.7	5.2	0.5	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.4	0.0	1.5	0.0	5.5	1.1	15.8	0.0	1.7	0.0	0.5	0.0	0.0	1.5	0.3	0.0	0.0	63.7	0.5	5.2	0.8	0.0	10.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.2	0.0	0.2	10.4	0.0	0.0	3.3	0.0	0.0	0.6	0.6	6.8	0.9	0.8	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	0.0	0.0	0.0	0.0	0.4
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719163-71721048	"FDA approved drug targets, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 67.5;brain: 101.4"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 5.8;Cone photoreceptor cells: 7.9;Early spermatids: 12.3;Glandular cells: 4.8;Intestinal endocrine cells: 6.8;Rod photoreceptor cells: 7.6"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 117.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NB-4: 1.1;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 179.9"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB025515: , CAB079776: , HPA046278: AB_10961570"			"unprognostic (1.37e-1)"		"unprognostic (1.43e-1)"					"unprognostic (2.27e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (4.36e-4)"		"unprognostic (1.14e-1)"		1.6	67.5	8.0	2.8	22.3	0.5	5.8	0.1	29.0	0.5	3.4	2.1	0.0	3.5	0.6	0.9	3.5	0.7	0.6	0.5	31.1	101.4	0.5	0.5	0.5	0.5	1.0	4.5	0.5	5.3	0.5	1.7	0.5	54.1	3.3	3.1	1.6	0.5	0.5	0.5	0.5	1.4	8.1	8.6	0.5	3.4	1.9	9.7	0.0	3.4	0.0	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	22.3	0.1	29.0	31.1	101.4	1.0	4.5	54.1	9.7	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.1	0.0	7.6	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.5	0.2	1.8	0.8	0.0	4.2	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.7	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.3	0.0	0.8	0.0	0.5	0.5	0.1	0.8	0.0	1.4	0.0	4.3	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.8	2.0	0.1	0.4	0.6	0.4	0.9	0.2	0.7	0.4	0.0	0.3	0.0	1.0	0.7	0.0	0.8	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5	0.0	2.4	1.7	1.9	2.3	1.1	2.4	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.8	23.9	1.5	14.0	0.0	0.6	0.2	1.5	1.8	1.1	0.5	2.8	1.6	1.7	1.8	0.8	27.8	1.7	2.6	0.0	1.8	1.5	1.9	0.5	3.5	2.1	1.1	1.1	0.0	1.0	31.9	2.7	1.6	1.1	2.5	2.0	1.4
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281831	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 106.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 80.9;Late spermatids: 214.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in many"	12	"cerebellum: 106.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"NTERA-2: 16.7;SCLC-21H: 53.2"	"Region enriched"	"Detected in many"	9	"cerebellum: 688.3"	"Region enriched"	"Detected in all"	15	"cerebellum: 300.1"						"Secreted in brain"	NA	NA		2900000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.60e-2)"	9.9	0.8	0.9	0.1	1.0	0.0	1.2	106.6	4.9	2.0	0.4	0.4	0.4	0.6	5.9	1.4	0.8	0.9	9.0	4.2	0.7	9.2	0.2	0.7	0.1	0.9	4.5	1.0	0.5	2.4	0.0	0.9	0.4	4.6	0.3	0.4	1.1	0.7	3.0	0.5	0.3	0.5	1.5	2.3	0.1	0.5	16.0	0.4	0.2	0.6	0.6	2.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	1.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.2	1.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	106.6	1.4	0.7	9.2	4.5	1.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	3.3	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	80.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	12.7	0.0	0.0	214.3	2.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	1.5	25.8	4.4	17.6	4.5	0.1	0.0	0.0	0.0	0.0
CBLN2		ENSG00000141668	"Cerebellin 2 precursor"	Q8IUK8	18	72536680-72638521	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 33.8"	"Cell type enriched"	"Detected in some"	7	"Intestinal endocrine cells: 36.4"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA		1300000				"unprognostic (2.03e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.09e-5)"	"unprognostic (7.10e-2)"	"unprognostic (6.27e-3)"		"unprognostic (7.39e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.37e-4)"	"unprognostic (5.01e-4)"	"unprognostic (8.15e-2)"	"unprognostic (6.07e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.93e-2)"	0.6	0.7	5.4	0.8	10.4	0.4	0.6	0.8	33.8	1.0	2.9	0.9	0.0	2.5	0.5	0.4	0.5	0.5	0.4	0.4	4.5	9.5	1.5	0.9	0.4	0.5	7.0	16.4	0.6	0.4	0.4	0.3	0.4	17.8	1.8	2.6	1.9	0.4	8.2	0.4	0.9	3.8	1.5	2.6	0.4	0.6	0.6	0.0	0.0	0.4	0.0	1.3	0.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	10.4	0.8	33.8	4.5	9.5	7.0	16.4	17.8	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.0	0.0
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426532-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 105.2"	"Cell type enhanced"	"Detected in some"	8	"Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	23	"cerebellum: 105.2"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.5;naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9"	"Region enriched"	"Detected in some"	25	"cerebellum: 481.8"	"Region enriched"	"Detected in some"	47	"cerebellum: 583.0"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	2.1	7.7	1.2	4.5	1.3	0.0	1.2	105.2	1.7	1.8	1.1	1.9	1.0	0.6	1.3	4.8	1.0	1.2	3.1	1.6	1.0	1.1	1.2	1.4	1.3	7.9	1.3	1.4	3.3	1.0	1.0	1.3	1.7	4.6	1.2	0.7	1.7	1.6	1.6	1.4	1.6	1.3	1.3	2.0	7.4	1.4	1.6	1.1	1.1	1.2	1.5	5.3	1.9	1.3	2.3	0.3	0.1	0.8	0.0	0.3	0.0	1.1	1.0	0.5	1.9	5.0	10.9	0.3	4.2	8.6	1.7	2.2	0.5	2.0	1.8	0.9	2.6	1.9	0.3	0.6	2.3	1.1	12.7	0.4	0.0	3.5	0.8	2.8	0.3	0.7	18.9	1.0	2.1	1.7	7.0	1.5	0.8	0.5	14.2	2.1	0.6	0.0	0.5	0.1	1.1	1.1	0.0	0.0	1.3	1.0	0.4	0.7	0.4	0.3	0.1	0.6	0.3	0.6	0.4	6.6	6.1	1.2	2.5	0.2	9.9	2.3	2.0	0.3	0.8	1.0	0.0	0.0	0.1	0.0	0.8	0.3	1.5	0.1	0.1	0.0	2.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	1.3	105.2	1.7	1.0	1.1	1.3	1.4	4.6	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.5	0.0	1.0	0.5	2.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	3.6	0.2	0.8	0.8	0.0	1.4	0.5	0.3	0.0	1.2	0.0	0.1	0.5	0.7	0.0	0.4	0.5
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997440-56005472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5;brain: 16.8;epididymis: 11.8"	"Cell type enriched"	"Detected in some"	4	"Peritubular cells: 35.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SH-SY5Y: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"	NA	NA		10000000			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.3	23.5	11.9	0.3	8.9	0.2	1.8	0.1	16.8	2.8	0.3	0.5	0.8	0.3	1.2	11.8	0.3	5.4	0.9	0.2	5.9	14.8	1.0	1.3	1.1	0.2	1.6	5.0	2.2	1.2	0.4	0.1	0.5	2.4	0.4	0.2	0.1	0.3	0.7	0.5	0.3	0.3	0.6	0.4	0.2	0.7	2.7	0.0	0.0	1.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	8.9	0.1	16.8	5.9	14.8	1.6	5.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.6	8.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Cell line enhanced"	"Detected in many"		"BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.2	0.4	0.0	0.0	4.2	13.1	8.2	26.8	27.5	19.5	25.7	0.0	0.1	0.1	0.0	10.6	4.6	0.5	0.0	17.3	30.8	0.1	0.1	0.0	0.1	0.1	9.7	0.1	0.0	8.8	0.7	15.2	41.8	8.4	0.9	0.0	0.0	0.1	46.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	2.0	0.0	0.1	25.2	0.0	2.7	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3	3.0	2.2	0.0	1.1	4.0	7.2	0.8	2.5	1.4	3.4	0.0	7.9	0.6	0.0	0.1	0.5	0.7	0.0	0.0	0.2	0.6	3.1	1.1	1.1	0.0	0.3	14.3	0.0	12.3	1.5	0.2	8.9	0.5	6.8	0.0	0.0	1.1	0.5	0.0	0.4	0.0	42.0	0.0	4.1	0.0	0.7	3.8	0.7	0.0	0.0	0.7
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267188-115296831	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 50.4"	"Low region specificity"	"Detected in all"							"HPA045120, HPA050621"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	5.5	4.3	9.7	5.7	13.2	7.0	7.7	12.6	12.8	6.5	9.8	7.0	4.3	8.1	6.6	7.3	6.3	4.9	3.9	6.4	11.0	9.0	3.5	1.7	6.1	4.8	9.7	7.6	2.9	13.2	6.5	12.1	3.0	12.6	7.7	10.6	1.9	6.8	8.6	4.5	5.5	6.8	7.7	14.0	5.3	7.0	40.4	11.8	3.7	4.7	3.2	4.7	7.1	4.8	5.3	11.0	11.6	5.5	3.1	3.8	2.1	5.4	2.7	5.5	8.7	3.5	6.8	1.3	4.9	2.6	3.7	4.3	1.2	3.1	6.7	4.1	3.4	5.5	3.5	5.7	2.8	7.8	5.3	4.4	4.4	4.1	1.7	4.7	5.8	2.3	3.1	3.4	4.8	6.4	4.3	5.7	6.1	1.8	5.5	4.9	4.2	8.7	5.0	6.0	5.1	4.8	9.3	6.8	50.4	3.6	2.0	8.3	10.8	5.3	3.4	14.6	3.9	5.7	8.5	5.6	4.9	3.3	9.3	6.8	6.1	5.9	1.4	3.3	4.6	2.9	0.2	5.5	11.6	3.4	4.4	3.8	3.2	2.6	2.9	5.9	5.3	3.4	2.3	3.6	3.1	5.0	11.0	0.1	2.1	9.7	13.2	12.6	12.8	11.0	9.0	9.7	7.6	12.6	11.8	14.9	12.3	12.3	4.6	12.6	28.3	14.6	2.5	12.0	9.1	5.2	9.8	0.6	5.0	24.4	6.8	8.0	11.9	0.0	22.6	1.7	8.5	6.1	9.2	2.6	28.4	9.5	38.9	6.7	23.9	13.4	3.7	28.0	13.5	42.3	28.0	10.3	27.1	14.0	3.9	2.9	24.3	12.9	13.0	227.3	60.7	19.7	0.5	5.3	31.6	3.4
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 588.1;Late spermatids: 350.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		31000000	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.1	17.3	6.1	6.0	5.3	7.7	3.6	1.6	10.4	9.7	5.1	10.1	2.8	3.2	2.9	6.9	2.2	4.3	1.8	1.4	4.6	5.1	4.7	9.3	7.5	8.5	1.7	1.6	4.4	7.0	4.4	4.1	3.0	6.3	2.2	3.2	5.7	3.5	6.4	4.3	2.2	11.9	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	12.2	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.5	6.9	16.9	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1	6.0	7.2	7.1	7.0	16.9	12.6	8.3	7.6	9.4	3.4	12.2	7.9	9.0	6.6	10.1	588.1	10.5	5.8	0.0	8.0	5.6	10.4	7.1	6.9	12.7	6.2	7.9	14.5	10.4	5.1	350.6	10.6	7.9	13.5	6.4	8.6	7.2	8.1	6.2	13.4	7.2	12.6	12.9	12.2	26.8	23.8	20.7	16.9	7.5	5.6	5.9
CCDC134	FLJ22349	ENSG00000100147	"Coiled-coil domain containing 134"	Q9H6E4	22	41800679-41826299	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003936	Approved				"Secreted to blood"	NA	NA					"HPA003936: AB_1078419"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (4.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.24e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.47e-1)"	"unprognostic (6.63e-2)"	3.8	23.4	3.3	8.1	5.0	15.1	4.4	19.1	5.2	4.6	5.7	7.7	5.7	5.5	5.9	15.0	6.9	7.3	4.8	4.6	4.3	3.1	7.5	6.9	5.6	7.3	4.2	2.4	4.4	8.1	12.2	12.3	6.6	5.6	5.2	4.9	8.6	12.9	9.0	6.5	5.9	5.8	3.4	5.1	7.3	6.1	17.2	5.4	12.6	8.7	3.5	11.8	4.4	4.1	4.2	2.2	9.4	8.2	4.5	7.1	3.4	7.8	6.8	6.1	12.1	3.5	0.9	7.1	6.4	5.3	12.0	14.1	10.3	5.2	7.1	11.1	5.2	7.1	8.7	6.1	6.4	6.7	7.8	9.7	6.6	16.9	7.2	1.6	9.2	9.3	1.9	2.5	13.8	2.8	4.5	6.2	6.8	4.4	14.7	6.6	5.3	5.9	5.5	4.7	11.1	5.0	11.2	9.4	10.0	8.7	7.1	3.6	2.8	11.7	9.4	4.7	3.7	11.9	5.3	3.4	6.3	10.5	4.3	11.0	16.9	10.1	5.4	6.7	5.9	12.5	0.0	4.9	9.4	5.8	8.0	3.6	4.2	3.6	4.4	2.2	2.5	7.1	3.8	2.6	4.5	8.2	2.0	6.0	3.4	3.3	5.0	19.1	5.2	4.3	3.1	4.2	2.4	5.6	5.4	3.0	1.3	0.0	1.5	0.2	1.2	0.7	2.5	1.4	0.0	3.5	2.0	4.0	0.0	4.2	0.6	0.7	3.0	0.0	1.7	15.4	0.9	1.8	0.0	1.7	3.9	0.0	0.0	0.0	0.6	0.4	0.6	0.9	1.7	5.4	1.1	0.9	2.0	1.9	0.4	1.0	2.1	0.0	1.0	4.2	1.6	0.0	2.4	2.9	2.1	1.4
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.5	0.0	7.5	1.3	13.6	2.5	0.4	22.3	5.7	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.6	0.3	0.0	10.7	0.6	0.5	0.0	0.1	0.7	0.1	0.0	3.7	1.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	3.3	0.0	0.0	0.0	0.0	14.8	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1	0.0	0.0	0.0	6.2	44.5	1.0	4.4	0.0	0.0	1.2	0.0	0.0	0.2	1.7	0.0	0.2	8.3	0.0	0.0	0.0	0.1	9.1	1.9	0.0	0.2	0.3	0.0	0.0	8.0	0.0	1.1	20.8	1.6	13.5	0.0	0.0	0.5	0.1	0.0	57.0	0.3	1.9	32.3	95.9	0.0	3.8	32.5	0.2	0.0	0.0	1.0
CCDC70	"DKFZP434K1172, FLJ25853"	ENSG00000123171	"Coiled-coil domain containing 70"	Q6NSX1	13	51861981-51866232	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	470	"testis: 46.9"	"Group enriched"	"Detected in some"	107	"Early spermatids: 883.6;Late spermatids: 1905.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"TIME: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079644	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA079644: "					"unprognostic (5.73e-3)"									"unprognostic (1.88e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	883.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1905.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	13.0	4.7	0.0	0.0	0.0	0.0	0.0
CCDC80	"DRO1, SSG1, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596794-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 130.0;endometrium 1: 143.8"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		57000			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	49.5	3.3	1.4	16.4	3.1	0.0	39.4	3.1	3.3	130.0	14.9	3.4	54.7	1.1	143.8	94.7	34.2	17.4	39.7	87.6	2.3	2.8	10.7	2.1	17.0	10.1	3.0	1.0	53.3	6.6	2.5	2.7	6.0	7.2	28.6	12.7	8.7	8.7	21.7	4.1	19.2	8.6	81.3	14.0	19.8	12.0	14.0	3.3	4.1	20.4	29.6	10.8	57.3	33.8	2.9	3.0	2.9	1.3	1.3	2.1	0.2	2.2	0.9	11.6	0.5	48.6	38.7	0.6	32.1	9.7	10.8	15.8	0.2	0.1	0.1	1.2	113.6	1.0	3.0	0.4	0.4	11.4	2.1	0.1	0.0	2.6	0.0	10.2	0.0	0.0	38.2	1.3	15.9	1.0	221.6	2.5	0.0	0.0	0.1	31.8	0.0	0.0	0.0	2.8	0.0	0.3	0.0	1.2	0.0	0.3	0.0	0.0	0.2	4.7	0.2	0.1	2.2	0.1	0.0	12.6	31.8	5.2	6.0	13.9	0.1	0.0	0.1	9.4	0.0	5.1	2.9	1.3	0.9	1.6	0.8	1.6	1.7	1.6	1.3	0.5	2.9	2.1	1.9	1.7	1.3	0.8	3.0	1.1	0.2	1.4	3.1	3.1	1.7	2.3	2.8	3.0	1.0	7.2	3.3	6.0	12.8	0.0	3.8	54.1	0.6	19.6	0.0	33.5	9.1	5.2	0.0	40.0	1.7	22.1	452.4	12.8	0.0	0.0	1.1	85.3	524.3	1.2	1.1	0.5	8.3	0.0	0.0	56.4	2.7	232.6	71.4	5.8	136.7	3.6	0.4	119.7	10.8	0.0	32.5	0.0	1.7	19.4	127.8	6.0	3.2	45.2	23.3	0.0	0.0	1.7
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.5;skin 1: 9.9"	"Cell type enriched"	"Detected in some"	9	"Melanocytes: 585.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;THP-1: 4.0"	"Low region specificity"	"Detected in many"							HPA069716	Uncertain				"Secreted - unknown location"	NA	NA					"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.9	1.0	2.7	1.1	5.1	2.4	1.6	4.7	4.6	1.2	0.9	2.7	0.4	1.3	1.5	1.6	3.9	1.0	0.6	0.6	3.1	2.4	0.9	2.1	0.9	1.5	2.5	0.4	1.0	0.6	1.4	2.6	0.7	9.5	1.1	0.9	1.4	1.1	1.2	4.4	9.9	1.4	0.8	3.5	1.2	1.1	4.0	1.4	0.4	0.8	0.4	0.8	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.3	4.0	1.0	0.4	0.7	0.2	0.8	0.0	0.0	0.1	0.2	0.3	1.5	2.8	0.3	0.2	0.2	0.4	0.6	0.1	0.0	1.1	1.3	0.2	0.8	0.0	0.0	1.6	1.6	0.4	0.7	0.3	0.0	0.1	0.0	2.8	0.7	2.7	0.0	2.7	0.6	1.2	0.9	0.2	0.5	2.0	0.4	0.7	0.3	1.9	1.2	0.8	0.5	0.5	0.0	0.3	3.0	4.0	0.0	0.2	2.0	0.1	0.1	1.8	1.3	0.7	0.3	2.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	2.7	5.1	4.7	4.6	3.1	2.4	2.5	0.4	9.5	1.4	3.0	0.0	0.0	0.0	68.3	3.0	0.1	2.5	0.0	0.0	1.8	3.9	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.2	0.0	1.2	0.0	0.0	3.7	0.3	0.5	585.4	0.0	0.2	1.8	0.1	0.0	0.0	0.1	3.8	0.0	0.1	0.9	1.6	2.6	0.2	0.0	0.6	0.0
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	5	"Glandular cells: 57.6;Melanocytes: 38.8;Muller glia cells: 33.0"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 72.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA					"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	0.0	0.3	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5	0.0	0.0	0.0	1.0	5.0	1.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	57.6	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	38.8	0.0	0.0	33.0	0.5	0.0	0.0	0.0	3.2	0.0	2.1	0.0	0.4	1.1	8.8	0.0	0.0	3.3
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 9.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 128.7"					"Region enriched"	"Detected in single"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"	NA	NA	84400				"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285668-34288334	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 14.3"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	88500					"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favorable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	2.6	0.4	0.2	29.2	0.2	0.0	0.2	0.2	0.2	4.5	29.6	0.4	0.6	17.3	3.5	0.0	20.7	0.8	12.0	31.0	0.2	0.2	7.0	1.2	7.3	0.3	0.2	0.0	2.6	11.6	0.2	1.1	0.0	0.2	16.1	8.0	0.0	0.2	0.3	0.5	0.2	18.7	10.2	0.2	1.2	18.2	0.6	0.0	0.7	0.4	0.0	0.8	12.1	5.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	14.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL13	"CKb10, MCP-4, MGC17134, NCC-1, SCYA13, SCYL1"	ENSG00000181374	"C-C motif chemokine ligand 13"	Q99616	17	34356452-34358610	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Basal keratinocytes: 7.8;Hofbauer cells: 36.5;Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7;BJ hTERT+: 4.3;BJ hTERT+ SV40 Large T+ RasG12V: 2.9;HMC-1: 3.6;HSkMC: 4.4"														"Secreted to blood"	NA	NA	336000					"unprognostic (2.22e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.49e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.63e-8)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-2)"	12.5	4.1	0.3	3.0	0.5	0.0	9.6	0.3	0.5	3.1	17.0	0.5	2.7	10.5	1.0	16.1	5.9	4.5	3.1	20.0	0.3	0.1	3.4	0.7	14.5	1.3	0.3	0.3	1.8	2.1	0.8	0.3	7.3	0.4	3.6	13.3	0.5	2.5	0.3	4.4	3.9	17.0	4.1	0.3	0.3	1.9	2.7	0.3	5.7	5.8	5.2	1.6	11.1	2.4	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.6	4.3	0.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.5	0.3	0.1	0.3	0.3	0.4	0.3	3.0	0.0	0.0	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.1	0.2	0.0	0.0	0.0
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983291-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 80.7;lymphoid tissue: 98.4"	"Cell type enriched"	"Detected in many"	16	"Ito cells: 1401.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"HUVEC TERT2: 35.9"									"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	NA	NA	5200000	19000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	56.3	5.1	0.0	5.9	0.0	0.0	80.7	0.0	0.0	37.6	8.4	0.0	16.6	0.0	37.6	11.1	20.9	9.1	17.3	27.5	0.0		8.7	34.2	26.4	39.1	0.0	0.0	12.4	0.8	2.0	6.5	0.0	0.0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0.0	98.4	0.2	15.0	0.0	1.3	17.6	16.7	6.2	25.3	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	14.6	7.0	0.1	1.6	0.0	0.1	28.1	4.0	1.2	0.0	0.0	0.0	0.0	0.0	22.9	57.6	1.7	0.0	0.0	0.0	0.2	0.2	1.1	5.9	0.2	0.0	0.0	1401.9	89.1	43.1	1.4	0.0	0.0	0.0	1.0	0.0	0.0	3.5	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	1.3	0.6	0.1
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36002038	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 36.4;liver: 17.9"	"Cell type enhanced"	"Detected in some"	15	"Enterocytes: 260.2;Mucus-secreting cells: 154.9;Paneth cells: 333.1;Undifferentiated cells: 126.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hep G2: 25.4;OE19: 14.9"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		7900000	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.1	18.0	0.0	0.0	11.6	0.0	0.4	0.0	1.1	7.4	0.8	0.0		6.4	17.9	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	15.8	0.0	0.0	0.0	0.0	0.4	36.4	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	1.0	2.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.7	0.4	0.2	2.2	0.9	0.1	1.0	0.3	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.7	60.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.2	0.0	0.6	0.0	0.0	0.0	9.2	31.0	0.1	0.0	68.9	1.8	0.6	0.0	0.0	0.0	0.0	0.0	154.9	0.0	0.6	333.1	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.3	0.1
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981496	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 79.1"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 244.8"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"Hep G2: 15.0"					"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	2780000	20000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	244.8	0.0	0.0	0.0	17.8	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CCL17	"ABCD-2, SCYA17, TARC"	ENSG00000102970	"C-C motif chemokine ligand 17"	Q92583	16	57404767-57416062	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Cell type enriched"	"Detected in some"	685	"monocytes: 21217.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8;myeloid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	613	"HDLM-2: 231.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			CAB002583	Uncertain				"Secreted to blood"	NA	NA	248000				"CAB002583: AB_564022"	"unprognostic (4.62e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (5.83e-2)"	"unprognostic (3.52e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.14e-3)"	"prognostic favorable (5.80e-4)"	0.9	0.2	0.3	8.7	0.3	0.0	2.0	0.3	0.4	1.3	1.2	0.3	0.3	0.0	0.5	0.8	4.8	0.4	3.0	1.5	0.3	0.2	1.7	0.6	9.7	8.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.6	3.2	0.5	7.4	0.3	0.3	3.3	6.7	2.5	0.3	1.4	0.7	0.9	0.3	39.0	2.0	1.3	6.2	4.5	1.5	1.8	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	231.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.3	0.5	0.3	0.0	3.2	0.0	0.0	9.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	31.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.9	0.0	21217.8	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.4
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 197.4"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"														"Secreted to blood"	NA	NA	55500000	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	23.1	0.0	0.0	8.5	0.0	0.2	0.0	9.4	25.0	0.0	0.0	0.4	0.0	0.0	24.7	0.3	0.0	0.0	0.0	0.3	2.1	0.0	4.7	0.0	197.4	0.0	0.0	0.0	2.2	3.6	0.0	40.3	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	3.0	1.4	0.0	0.0	0.0
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689567-34691277	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 418.9"	"Cell type enhanced"	"Detected in some"	22	"Basal keratinocytes: 66.3;Melanocytes: 87.7;monocytes: 186.7;Smooth muscle cells: 46.2;Suprabasal keratinocytes: 47.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"intermediate monocyte: 2.3"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;Daudi: 2.6;HDLM-2: 7.6;HL-60: 1.9;K-562: 1.6;TIME: 3.8"					"Low region specificity"	"Detected in some"			HPA067758	Enhanced				"Secreted to blood"	NA	NA	195000				"HPA067758: AB_2685897"	"prognostic favorable (2.88e-5)"	"prognostic favorable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	22.5	0.6	1.2	82.3	1.1	0.0	10.2	0.8	1.3	5.8	4.7	1.5	1.5	1.0	1.5	5.9	16.3	3.4	10.4	16.5	0.8	0.7	11.8	12.8	13.6	418.9	2.1	1.0	3.4	1.7	0.0	2.0	0.6	1.5	7.0	11.0	7.4	23.1	1.0	0.7	8.7	40.2	4.5	2.2	8.2	9.0	2.8	0.6	73.1	14.9	9.9	90.9	13.4	2.3	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.6	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	1.1	0.8	1.3	0.8	0.7	2.1	1.0	1.5	0.6	0.0	0.0	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	87.7	186.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	46.2	0.2	0.2	47.2	0.0	0.0	0.0	0.1
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ductal cells: 3138.5;Pancreatic endocrine cells: 1040.3;Smooth muscle cells: 1844.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 10.3;eosinophil: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.9;monocytes: 10.3"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 163.0;HMC-1: 212.4"					"Low region specificity"	"Detected in many"			"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	78.1	31.2	10.3	52.3	50.6	19.1	19.0	1.5	23.3	9.7	41.9	28.6	3.0	9.4	7.2	7.6	14.4	25.8	62.0	76.9	45.1	6.7	32.5	38.4	105.2	16.9	16.0	2.0	28.6	32.8	15.2	17.3	22.8	63.6	42.0	25.3	22.3	13.5	13.4	17.8	10.5	16.7	34.6	85.4	16.1	30.2	4.6	8.6	4.8	20.8	21.6	19.1	27.2	9.0	0.0	1.1	3.9	10.3	0.0	0.1	2.3	0.0	1.3	3.5	0.0	9.8	8.4	0.0	9.9	163.0	21.2	45.5	0.6	0.0	0.0	7.9	2.3	0.3	5.5	0.3	0.0	10.8	0.0	0.0	0.0	1.2	0.0	0.3	0.0	212.4	9.4	0.0	4.4	0.2	14.2	9.6	0.0	0.5	1.7	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.2	1.7	30.3	0.0	0.0	0.7	0.0	0.5	0.2	9.9	0.4	0.2	0.5	11.3	0.5	0.3	0.0	0.1	0.0	0.0	6.6	3.1	7.2	0.0	10.3	3.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	2.3	10.3	50.6	1.5	23.3	45.1	6.7	16.0	2.0	63.6	8.6	169.7	145.0	2.7	681.4	505.1	0.0	10.8	91.7	41.5	131.9	130.9	0.0	2.4	0.0	3138.5	0.0	322.6	0.0	0.0	773.5	3.2	475.0	113.8	329.6	0.0	387.1	0.0	0.0	58.3	3.5	0.0	11.2	253.5	202.4	63.1	0.0	6.0	1040.3	0.0	1.4	11.5	0.2	129.4	1844.0	0.0	0.1	194.7	3.8	4.3	0.0	39.4
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Antibiotic, Antimicrobial, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 266.2;Glandular cells: 185.4;Paneth cells: 292.5;Urothelial cells: 548.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 36.0;Hep G2: 19.3;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	28000					"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.2	0.8	0.4	0.4	1.8	3.7	0.5	0.2	1.1	0.1	0.4	2.1	0.3	0.7	2.5	0.0	36.0	0.4	0.1	4.8	0.8	0.5	0.8	0.1	1.6	19.3	1.4	2.7	0.2	5.8	1.0	1.1	1.3	0.5	0.0	0.6	0.1	3.0	0.3	0.2	0.2	14.0	0.9	2.8	0.4	0.3	5.0	0.5	0.1	8.5	0.3	0.2	0.2	0.8	0.5	0.4	0.7	2.8	1.4	1.8	2.4	4.1	0.4	0.5	1.6	1.1	2.9	1.9	3.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4	44.7	86.3	5.0	266.2	105.6	0.2	0.8	30.6	20.1	105.8	17.4	0.0	0.1	0.0	133.7	2.4	0.2	119.7	0.0	2.5	0.3	3.3	185.4	5.7	1.0	30.6	1.6	55.7	0.0	2.2	0.0	0.0	33.0	1.7	16.2	60.3	0.0	31.3	292.5	0.0	2.4	0.1	0.0	3.8	0.0	0.9	56.7	0.7	16.0	52.5	548.3
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 129.0;Melanocytes: 136.7;Smooth muscle cells: 67.0;Suprabasal keratinocytes: 120.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.7;HL-60: 2.3;K-562: 3.9;RH-30: 2.5;U-937: 1.9"					"Low region specificity"	"Detected in many"			HPA051210	Enhanced				"Secreted to blood"	NA	NA	198000	770000			"HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	1.0	2.5	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3	20.8	38.2	0.0	0.0	129.0	0.0	7.7	0.0	18.7	23.9	1.8	0.0	0.1	0.0	8.4	4.2	47.5	0.0	0.0	3.3	0.2	3.5	0.0	10.5	0.0	0.5	0.0	0.0	49.7	0.8	2.7	0.6	7.4	136.7	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	67.0	0.0	0.2	120.3	0.2	0.0	0.0	0.1
CCL22	"A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1"	ENSG00000102962	"C-C motif chemokine ligand 22"	O00626	16	57358772-57366190	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 89.8"	"Cell type enriched"	"Detected in some"	532	"monocytes: 9361.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	18	"HDLM-2: 33.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	617000					"unprognostic (2.67e-2)"	"unprognostic (7.68e-3)"	"prognostic favorable (2.98e-4)"	"prognostic favorable (2.23e-6)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.17e-5)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.88e-2)"	10.5	0.6	0.3	27.7	0.5	0.3	1.9	0.2	0.3	1.6	1.3	0.0	0.4	1.0	0.6	0.5	4.6	0.4	2.6	0.4	0.3	0.3	0.6	0.5	4.6	11.9	0.3	0.0	0.3	0.9	0.0	0.3	0.2	0.1	0.7	5.4	0.1	5.9	0.2	0.3	7.1	7.4	0.7	0.3	5.5	1.1	0.3	0.0	89.8	0.7	5.9	31.8	3.6	1.6	3.1	2.6	3.7	0.8	1.4	0.7	0.5	0.4	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.9	0.0	0.0	0.1	33.2	0.1	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.1	1.2	0.0	1.8	0.2	0.1	0.1	1.4	0.0	0.1	0.2	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	3.6	0.8	0.6	0.6	0.4	0.4	3.1	0.5	0.4	2.6	1.6	0.6	0.7	3.7	1.4	0.4	1.0	0.4	0.5	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.0	0.1	0.0	3.0	0.6	0.0	0.2	6.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.2	0.0	0.0	17.6	0.0	0.7	0.2	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.3	9361.9	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.1	0.0	0.0	0.1
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017968	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3"	"Cell type enriched"	"Detected in some"	13	"Ito cells: 276.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	173	"eosinophil: 50.3"	"Lineage enriched"	"Detected in single"	173	"granulocytes: 50.3"	"Group enriched"	"Detected in some"	4	"HEL: 12.9;THP-1: 27.6"									HPA042015	Uncertain				"Secreted to blood"	NA	NA	937000	57000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	5.8	0.5	0.0	13.1	0.0	2.1	3.7	0.0	0.5	2.1	2.0	0.0	1.0	0.0	1.8	3.0	1.3	1.5	2.2	4.6	0.0		3.0	5.9	7.9	8.0	0.3	0.0	1.2	0.0	0.0	0.5	1.5	0.2	1.7	7.2	0.7	0.0	1.1	0.5	0.4	1.0	8.4	0.0	2.0	0.0	0.1	0.0	0.4	1.1	0.6	0.5	3.0	0.0	0.2	0.1	50.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.2	0.2	50.3	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0											3.0	2.9	0.0	0.2	1.4	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.9	9.0	0.4	0.0	0.0	0.0	0.2	0.1	9.3	1.5	6.8	0.0	0.0	276.2	21.2	0.0	0.0	1.7	1.7	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	0.2	0.8	0.4	0.1
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.7;HMC-1: 2.7;OE19: 4.1;RH-30: 3.4;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	276000					"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	4.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.4	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052767-8062650	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	23	"intestine: 136.8;lymphoid tissue: 185.2"	"Cell type enhanced"	"Detected in single"	22	"Extravillous trophoblasts: 1.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 25.4;stomach cancer: 33.5;testis cancer: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 1.8;NK-cell: 7.0"	"Group enriched"	"Detected in many"	12	"B-cells: 1.8;NK-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;HEL: 5.0;NB-4: 3.9;REH: 10.3;RPMI-8226: 3.0;SH-SY5Y: 3.4"									HPA055883	Approved				"Secreted to blood"	NA	NA	183000000				"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.2	0.1	64.9	0.0	0.0	91.9	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	136.8	0.0	0.2	0.4	0.1	0.4	0.0	185.2	0.1	0.0	0.0	0.1	0.1	1.8	0.1	0.0	0.0	7.0	0.3	0.4	0.0	0.0	0.1	0.8	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.0	3.9	0.2	0.0	0.5	10.3	0.0	3.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.3	0.2	0.0	7.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 16.6;retina: 50.2"	"Cell type enhanced"	"Detected in some"	12	"Leydig cells: 15.5;Sertoli cells: 12.9;Smooth muscle cells: 17.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	27	"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.6;PC-3: 30.2;U-2 OS: 8.6"					"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	117000					"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	1.7	2.9	0.4	0.5	0.6	0.0	1.4	0.4	0.9	2.8	0.8	0.9	1.0	0.4	0.8	2.3	1.1	1.9	1.3	3.3	0.6	0.0	1.5	0.4	1.2	4.1	1.2	0.4	16.6	0.4	5.9	13.6	0.4	3.3	1.3	8.7	50.2	1.0	0.4	0.4	1.4	0.7	1.6	0.8	0.4	0.6	1.5	0.6	0.8	0.8	0.8	0.9	1.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.7	0.9	0.0	0.4	3.1	2.8	5.9	0.3	2.0	0.0	4.7	2.6	0.2	1.3	0.1	0.0	3.9	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	10.6	0.1	1.6	0.0	0.0	5.2	0.0	2.0	0.7	0.0	0.0	6.6	0.4	30.2	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.2	5.1	8.6	2.7	1.7	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	0.9	0.6	0.0	1.2	0.4	3.3	0.6	0.0	0.0	0.0	1.0	1.0	0.4	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.4	1.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	15.5	0.0	0.0	0.0	3.3	0.3	0.3	0.0	4.6	0.0	1.6	12.9	17.5	0.0	0.0	1.6	0.0	0.0	0.5	0.4
CCL27	"ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine"	ENSG00000213927	"C-C motif chemokine ligand 27"	Q9Y4X3	9	34661880-34664048	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 96.5"	"Group enriched"	"Detected in some"	25	"Basal keratinocytes: 625.7;Suprabasal keratinocytes: 877.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 3.5;SuSa: 3.5"					"Not detected"	"Not detected"			HPA073848	Enhanced				"Secreted to blood"	NA	NA	436000				"HPA073848: AB_2732243"																		0.1	0.0	0.1	0.1	0.1	0.1	5.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	96.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	8.0	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	5.5	1.8	1.6	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.1	0.0	0.2	2.1	3.5	0.0	2.4	2.1	0.0	0.0	1.8	0.8	0.7	0.0	0.0	3.0	1.9	0.6	0.0	0.6	0.0	1.3	0.5	2.3	1.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	2.8	0.0	0.4	1.6	0.0	0.0	0.2	3.5	1.5	0.0	0.0	2.5	2.0	2.0	0.0	0.3	1.0	0.1	0.9	0.4	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	625.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	6.4	0.0	0.0	0.0	0.2	0.7	1.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	0.3	0.0	30.4	0.0	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.5	3.9	1.1	877.6	1.6	0.0	0.0	0.1
CCL28	"CCK1, MEC, SCYA28"	ENSG00000151882	"C-C motif chemokine ligand 28"	Q9NRJ3	5	43376645-43412391	"Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"salivary gland: 207.1"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 56.0;Ductal cells: 64.1;Enterocytes: 76.4;Exocrine glandular cells: 59.4;Paneth cells: 62.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.0;EFO-21: 8.6;SiHa: 19.4;SK-MEL-30: 10.6;T-47d: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077434	Supported				"Secreted to blood"	NA	NA	700000000				"HPA077434: AB_2732346"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.85e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.20e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.53e-2)"	1.2	0.6	0.8	5.3	0.6	0.6	15.7	0.4	0.8	4.0	8.2	0.2	0.2	6.2	1.4	1.0	2.0	1.1	5.2	0.9	0.6	0.7	1.9	1.0	1.5	2.5	0.6	0.6	0.9	29.8	1.2	1.5	3.1	0.7	1.3	7.6	4.1	207.1	1.1	0.4	2.7	4.9	0.3	1.1	3.0	3.9	1.1	0.5	1.1	9.0	8.4	5.4	1.1	1.4	6.7	1.3	3.8	0.4	4.3	7.7	1.9	0.5	0.0	0.1	0.1	0.6	0.1	3.2	0.4	0.3	0.0	0.0	1.3	7.0	0.0	8.6	0.2	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.5	0.8	0.0	0.5	0.1	0.1	0.7	1.8	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.8	0.2	1.1	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.1	0.9	0.2	0.1	19.4	0.7	10.6	0.2	26.3	5.1	0.1	0.1	0.8	0.1	0.1	0.5	0.0	0.1	0.0	0.1	5.8	3.8	0.4	0.4	4.8	0.3	3.7	5.5	5.3	3.9	0.8	6.7	6.4	4.6	1.2	4.3	0.2	1.3	7.7	1.9	0.8	0.6	0.4	0.8	0.6	0.7	0.6	0.6	0.7	0.5	0.0	4.8	11.5	4.7	2.4	0.0	0.3	56.0	28.1	12.5	5.2	0.0	4.7	5.0	64.1	2.2	3.3	76.4	0.0	59.4	2.7	2.8	13.2	11.5	1.6	2.2	0.0	3.5	5.5	1.2	0.4	11.5	0.2	16.9	1.0	43.5	8.5	28.2	62.6	4.6	0.0	0.6	0.0	2.2	5.1	2.3	1.1	2.3	10.1	28.3	10.1
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;lymphoid tissue: 18.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1808.9;Macrophages: 912.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 27.4;U-266/70: 46.9;U-266/84: 118.9"														"Secreted to blood"	NA	NA	138000					"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	5.3	4.3	0.0	5.7	1.6	35.7	2.4	0.5	6.0	0.9	0.9	11.6	0.0	0.8	0.7	1.4	0.4	0.4	3.5	3.4	0.0		0.5	7.9	15.1	5.8	0.0	0.0	2.0	0.4	1.8	0.0	5.7	3.7	0.5	0.9	1.7	1.0	0.2	1.2	0.0	0.8	1.1	0.0	18.0	0.2	3.7	0.0	1.8	0.8	0.5	1.8	2.3	0.0	4.5	0.2	4.0	0.8	1.1	10.2	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.1	46.9	118.9	0.0	0.2	0.0	0.0	0.1	0.8	4.0	10.2	0.5	0.3	1.4	0.3	2.8	0.2	4.5	0.0	3.0	4.0	1.1	0.5	0.0	0.0	4.6											0.0	48.5	43.9	1.0	24.7	1.5	1.6	0.0	4.0	7.9	0.0	0.0	15.8	0.0	0.4	1.2	6.7	0.0	0.0	0.2	19.5	26.9	0.9	23.1	3.2	1808.9	0.0	0.0	19.0	262.3	1.3	1.7	912.4	89.4	37.9	0.0	1.9	0.2	0.0	0.0	0.7	3.6	6.5	9.2	0.5	0.2	25.2	45.4	235.3	0.0	1.1
CCL3L1	"CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 1"	P16619	17	36194869-36196758	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.7;brain: 16.5"	"Group enriched"	"Detected in some"	18	"Hofbauer cells: 308.0;Macrophages: 77.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 7.7;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.7"	"Group enriched"	"Detected in some"	38	"U-266/70: 22.8;U-266/84: 45.4"														"Secreted to blood"	NA	NA						"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.58e-2)"	0.4	0.1	0.0	3.5	2.2	17.7	0.2	0.0	9.0	0.7	0.4	16.5	0.0	0.4	0.6	0.6	0.1	0.2	1.9	0.1	0.0		0.6	2.7	4.0	0.9	0.0	0.1	1.2	0.3	0.1	0.0	3.0	4.4	0.9	0.3	1.9	2.3	0.4	0.1	0.1	0.6	0.3	0.2	2.7	0.3	2.5	0.0	1.3	0.3	0.6	0.7	0.9	0.0	0.0	0.1	7.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	22.8	45.4	0.5	0.0	0.0	0.0	0.3	0.1	7.7	0.9	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.1											3.0	10.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	1.0	0.0	2.3	0.0	308.0	0.0	0.0	0.0	0.0	0.0	0.0	77.5	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	11.0	0.0	0.0	0.0
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 716.7;Macrophages: 396.6;T-cells: 809.7"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.2;U-266/70: 11.5;U-266/84: 5.5"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000				"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	5.5	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6											0.0	85.1	30.1	1.1	13.9	1.0	10.2	5.1	10.7	12.5	0.0	0.0	7.8	0.0	0.4	21.7	11.3	0.4	0.0	0.3	9.8	13.1	1.2	58.9	4.3	716.7	1.6	1.2	14.7	198.1	23.7	0.9	396.6	49.0	1.8	0.1	1.2	0.1	0.0	0.4	1.8	5.1	0.0	11.3	0.4	0.2	12.7	21.6	809.7	0.0	1.6
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 323.5"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"	"Group enriched"	"Detected in some"	4	"Daudi: 5.7;HMC-1: 8.2;U-266/70: 12.7"														"Secreted to blood"	NA	NA						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5											0.0	10.6	0.0	0.2	0.3	0.4	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.6	0.0	0.0	0.0	5.4	3.1	0.5	4.7	0.2	323.5	1.6	0.0	4.3	51.8	0.4	0.0	52.5	1.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.3	12.9	0.4	0.0	0.1	0.4	8.0	78.4	0.0	1.5
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 169.0"	"Cell type enriched"	"Detected in many"	5	"T-cells: 1814.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 157.7;memory CD8 T-cell: 169.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 169.0"	"Cell line enriched"	"Detected in some"	4	"NB-4: 73.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	8200000			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	3.6	2.4	0.0	28.8	0.1	17.1	2.6	0.0	0.2	6.0	14.7	1.0	0.6	7.1	5.0	7.2	5.2	1.7	20.5	7.5	0.0		2.7	4.7	29.8	33.5	2.8	0.0	5.9	2.3	0.0	0.1	4.8	1.7	7.8	4.0	8.0	5.5	6.4	2.8	0.0	38.7	2.3	2.2	38.8	6.9	1.9	0.0	12.2	1.6	5.5	27.9	11.5	0.0	1.2	1.1	9.9	0.6	40.8	169.0	106.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.4	2.9	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.1	11.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	73.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.1	0.0	17.1	0.0	0.1	0.0	0.1	0.0	2.2	0.8	0.1	0.0	15.7	0.2	9.9	0.6	0.7	157.7	0.4	103.8	1.2	36.7	169.0	1.1	0.7	8.8	99.3	4.6	40.8	0.5	0.9	0.5	106.5											92.3	350.0	25.5	1.0	6.5	1.1	2.5	0.0	52.2	76.2	1.8	0.0	1.4	1.7	0.8	0.8	18.0	2.6	46.7	0.2	0.7	6.0	1.5	74.4	4.7	28.5	0.0	1.7	48.5	34.1	0.0	0.3	29.5	11.8	2.8	0.3	0.8	1.7	3.5	0.4	5.3	0.4	0.0	7.1	1.0	0.7	5.5	13.4	1814.4	1.1	1.6
CCL7	"FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7"	ENSG00000108688	"C-C motif chemokine ligand 7"	P80098	17	34270221-34272242	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 11.5;bone marrow: 22.3"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.0;HSkMC: 4.7"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	29700					"unprognostic (7.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.53e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.54e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.99e-8)"	"unprognostic (2.83e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.79e-2)"	11.5	0.6	0.0	2.6	0.0	22.3	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.7	0.9	0.1	0.1	0.5	0.2	1.2	0.0	0.1	0.0	1.3	0.4	0.0	0.1	1.7	0.3	0.5	1.0	0.0	0.2	0.0	0.1	0.2	0.2	2.2	0.1	0.1	1.2	0.5	0.0	1.4	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	2.4	0.0	1.7	15.5	3.2	4.0	0.0	0.0	0.0	0.5	1.1	0.0	1.4	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	4.7	0.0	1.3	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.6
CCL8	"HC14, MCP-2, SCYA8"	ENSG00000108700	"C-C motif chemokine ligand 8"	P80075	17	34319036-34321402	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.7"	"Cell type enriched"	"Detected in some"	13	"Smooth muscle cells: 106.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"classical monocyte: 5.8"	"Lineage enriched"	"Detected in single"	8	"monocytes: 5.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.1;HSkMC: 6.1"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	32000					"unprognostic (7.51e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.41e-2)"	10.6	2.8	1.0	7.2	1.2	0.2	4.4	0.6	1.6	0.8	12.0	1.4	1.1	6.9	3.4	3.8	1.2	2.9	3.7	2.4	0.8	0.7	2.8	2.1	8.4	1.3	0.8	0.9	5.3	0.8	6.0	1.6	19.7	1.1	1.5	8.0	5.0	1.1	2.9	1.5	1.3	13.1	4.1	2.4	3.1	1.9	1.6	0.2	2.1	3.0	4.0	2.7	4.4	0.8	0.7	0.2	0.0	5.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.0	1.9	0.0	1.8	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.2	0.6	1.6	0.8	0.7	0.8	0.9	1.1	0.2	0.0	0.0	0.0	0.2	3.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.5	0.0	0.0	1.6	0.0	2.8	0.1	0.0	0.0	7.7	0.0	0.0	0.0	0.6	0.8	0.0	4.6	5.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	106.5	0.0	0.0	4.6	0.1	0.0	0.0	0.1
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 2162.9;Ito cells: 448.7;Kupffer cells: 633.7;Macrophages: 438.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;CACO-2: 13.9;SiHa: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	9.1	0.1	0.6	1.3	0.3	0.5	0.9	4.2	1.3	1.6	13.9	2.2	0.4	0.7	5.0	1.1	3.9	0.0	1.7	0.2	0.1	0.9	0.3	0.5	1.8	4.9	1.0	0.4	4.0	0.2	0.2	1.3	0.4	0.0	0.2	0.2	0.2	1.3	0.3	0.0	0.6	0.2	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.7	0.4	0.5	0.2	0.3	1.7	0.6	0.2	0.3	1.5	1.3	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3	8.9	44.2	23.9	3.1	4.5	9.5	2.5	28.1	6.7	6.8	1.8	0.0	15.3	1.7	3.3	1.3	13.8	7.9	0.0	1.6	12.6	12.3	2.2	8.1	323.7	2162.9	31.8	6.9	448.7	633.7	3.2	4.6	438.8	8.5	0.0	4.5	36.9	2.3	8.5	4.9	5.4	3.5	32.3	9.2	0.7	0.9	3.8	38.6	5.9	5.1	3.0
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 1509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.8	1.0	0.4	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.3	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.5	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.9	0.3	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3	3.0	8.8	9.3	0.2	1.3	0.0	3.4	10.2	2.7	9.1	0.0	2.0	1.3	0.0	0.0	2.5	1.9	0.0	0.0	0.0	1.5	1.6	0.1	4.7	5.9	221.9	0.0	0.0	28.3	1509.4	3.9	4.6	104.2	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.1	116.4	0.3	3.9	1.7	0.9	2.5	5.0	0.0	0.0
CD40	"Bp50, p50, TNFRSF5"	ENSG00000101017	"CD40 molecule"	P25942	20	46118272-46129863	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"monocytes: 413.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.1;naive B-cell: 41.3"	"Group enriched"	"Detected in many"	6	"B-cells: 41.3;monocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.3;EFO-21: 47.9;U-2 OS: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002495, HPA031567, HPA031568, CAB072868"	Enhanced				"Secreted to blood"	NA	NA	705000	16000			"CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937"	"unprognostic (6.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.28e-2)"	13.0	4.6	3.6	38.6	4.7	1.1	11.6	9.7	4.4	11.3	9.2	3.6	7.8	6.5	9.6	8.6	9.9	9.7	8.6	9.5	4.5	2.6	10.0	10.0	18.8	34.7	3.3	3.2	14.8	14.0	12.1	5.9	6.5	5.4	14.7	5.2	13.7	13.0	11.6	7.5	9.0	11.8	10.0	4.6	30.1	8.4	4.4	4.4	11.5	16.5	6.7	46.0	12.5	13.8	41.3	4.1	1.0	10.8	0.6	1.4	4.8	9.2	1.4	0.0	4.6	1.7	1.0	1.8	1.7	0.5	1.4	1.3	0.0	27.3	14.8	47.9	0.3	6.8	1.1	0.8	5.8	1.4	9.9	0.0	3.5	0.0	2.5	13.7	0.0	4.7	6.1	2.2	5.6	0.0	0.0	10.3	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.6	3.2	0.0	0.3	0.3	1.5	12.0	0.1	0.0	0.0	8.1	4.5	0.0	0.0	0.9	4.9	0.0	0.0	15.3	0.0	0.0	0.0	0.0	10.1	3.4	1.8	0.0	1.0	7.7	0.1	1.3	10.8	0.9	36.1	0.7	0.5	4.1	41.3	1.4	1.0	0.7	0.6	7.5	2.1	1.0	4.8	3.6	4.7	9.7	4.4	4.5	2.6	3.3	3.2	5.4	4.4	11.9	15.9	94.5	51.6	38.7	1.0	3.6	40.8	2.7	23.9	14.0	0.0	0.2	0.0	50.8	9.8	40.9	2.4	0.0	26.1	1.1	18.2	33.2	3.5	13.5	37.2	0.0	1.2	39.3	11.9	9.1	23.9	46.8	27.0	413.8	5.3	8.2	33.6	3.6	21.2	4.4	0.0	32.3	36.1	0.9	5.1	29.7	0.3	5.0	5.7	54.0
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell type enriched"	"Detected in some"	4	"T-cells: 24.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Cell line enriched"	"Detected in some"	14	"MOLT-4: 22.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045827, HPA072480"	Enhanced				"Secreted to blood"	NA	NA	776000				"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1	0.0	3.7	0.0	0.0	1.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.6	5.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	1.8	0.0	24.5	0.0	0.0
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321376-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 2069.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 79.2;HMC-1: 105.8;PC-3: 63.1;U-2197: 64.2"									"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	310000000			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	21.8	63.2	5.8	27.2	20.2	31.9	17.9	4.6	10.5	34.0	14.8	13.8	7.8	12.8	16.3	11.9	36.1	10.4	18.0	32.0	7.5	10.1	9.6	16.7	114.6	41.1	16.7	4.7	31.3	9.1	8.1	12.8	107.0	11.9	9.7	12.4	8.2	82.3	12.8	108.8	37.5	26.0	23.5	11.4	30.4	17.7	10.2	18.8	4.2	13.2	31.4	19.1	39.3	19.1	18.6	18.3	101.4	31.6	19.0	16.9	20.3	4.8	6.6	0.0	2.2	8.5	9.1	34.6	9.2	16.2	5.3	5.7	20.8	6.9	9.4	7.7	5.4	19.8	2.8	10.6	2.0	4.9	4.3	3.9	12.2	79.2	3.4	27.6	7.4	105.8	4.3	25.0	6.5	28.7	21.0	27.3	1.5	13.1	4.5	3.0	5.2	0.7	5.1	6.7	11.4	63.1	1.1	6.6	7.4	8.8	4.7	2.6	0.0	49.8	10.1	8.0	15.5	8.6	6.3	11.9	2.7	5.1	64.2	3.5	3.7	4.4	6.3	7.2	2.9	12.1	39.3	26.9	35.9	5.5	26.3	8.2	16.9	7.4	5.8	18.3	18.6	16.9	16.4	101.4	19.0	31.6	9.8	5.0	20.3	5.8	20.2	4.6	10.5	7.5	10.1	16.7	4.7	11.9	18.8	2069.5	358.8	93.2	172.8	626.3	1.3	63.2	2.5	389.5	704.1	22.7	0.0	192.2	3.3	54.9	311.7	62.4	158.4	0.0	162.7	371.1	199.2	136.1	142.1	6.6	62.3	1.6	16.6	41.1	161.1	60.3	30.2	161.4	151.8	53.3	67.0	5.8	238.8	150.8	8.5	3.3	2.5	6.5	60.8	7.7	4.1	669.5	708.9	76.1	69.0	491.7
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Group enriched"	"Detected in some"	28	"Hofbauer cells: 208.7;Kupffer cells: 384.3"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;Karpas-707: 2.0;REH: 2.0;RH-30: 1.2;U-266/70: 3.6"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	NA	NA	4030000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	208.7	0.0	0.0	10.4	384.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.0;lymphoid tissue: 58.1"	"Group enriched"	"Detected in some"	5	"B-cells: 10.7;T-cells: 34.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	34	"gdT-cell: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1"	"Lineage enriched"	"Detected in single"	52	"T-cells: 23.0"	"Group enriched"	"Detected in some"	12	"JURKAT: 7.8;MOLT-4: 28.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	NA	NA	5270000	110000			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.5	0.5	0.8	26.4	0.4	5.5	0.9	0.5	1.4	1.3	3.3	0.6	0.8	2.2	1.4	1.5	1.9	1.3	5.0	1.3	0.7	1.8	1.6	1.1	6.9	25.6	1.7	0.5	0.7	0.8	0.0	0.6	0.6	0.4	1.2	1.6	1.2	7.0	0.3	0.3	0.9	13.0	0.7	0.9	18.4	3.4	0.9	0.1	58.1	1.6	1.9	42.0	3.7	1.3	0.4	0.1	0.3	0.0	0.0	23.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.1	0.0	0.0	0.0	28.9	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	11.1	0.4	23.0	21.4	0.1	0.4	15.5	11.1	0.3	0.0	0.0	0.0	10.1	5.1	0.8	0.4	0.5	1.4	0.7	1.8	1.7	0.5	0.4	0.1	0.0	4.5	10.7	0.2	1.8	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.4	0.0	0.0	0.6	0.1	0.3	0.1	0.0	0.9	2.1	1.6	0.0	1.3	1.2	0.0	0.3	2.0	3.3	1.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.9	0.3	0.8	1.3	0.2	34.6	0.1	0.3
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"	NA	NA					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDNF	ARMETL1	ENSG00000185267	"Cerebral dopamine neurotrophic factor"	Q49AH0	10	14819250-14838575	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 30.8"	"Group enriched"	"Detected in many"	16	"Early spermatids: 89.1;Late spermatids: 214.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.6;U-266/70: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044587	Uncertain				"Secreted in other tissues"	NA	NA					"HPA044587: AB_10795881"	"unprognostic (2.80e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.62e-1)"	3.8	3.3	2.1	4.1	2.4	0.5	3.5	1.9	2.4	3.5	2.2	3.2	5.6	2.1	2.3	10.0	1.9	4.5	2.3	3.7	2.3	2.2	3.8	9.4	1.4	2.8	2.8	3.8	3.2	7.7	5.1	3.5	1.7	3.8	3.4	1.3	4.7	8.8	4.5	30.8	5.0	1.8	1.2	3.1	1.6	2.8	10.0	2.5	2.0	4.4	16.1	2.7	3.0	1.9	1.4	1.9	0.3	0.5	2.7	5.4	0.9	0.5	0.6	1.8	0.8	3.3	2.8	0.3	1.7	2.9	0.9	0.8	1.4	1.5	5.1	1.2	0.7	0.1	0.7	0.0	0.1	1.1	0.4	1.4	0.8	0.7	0.4	2.3	0.4	0.2	2.1	1.4	0.3	1.6	1.5	1.0	2.2	1.8	4.0	1.9	1.2	0.8	1.0	1.1	1.1	0.6	0.8	1.3	15.6	0.5	0.1	1.7	2.1	0.4	1.2	2.0	0.8	2.5	0.4	0.9	0.5	0.6	2.3	0.2	7.7	2.5	0.8	1.0	0.3	0.1	0.1	0.4	0.3	1.4	0.5	0.6	1.4	1.2	1.9	1.1	1.3	4.9	2.6	0.2	2.7	0.5	1.9	5.4	0.9	2.1	2.4	1.9	2.4	2.3	2.2	2.8	3.8	3.8	2.5	0.0	2.1	2.0	1.5	1.8	1.0	1.7	0.0	8.1	3.4	0.0	2.0	0.8	3.3	0.9	89.1	0.5	0.0	0.0	3.2	1.1	0.8	1.0	0.0	5.0	0.3	0.0	0.0	0.6	1.9	214.2	1.1	0.4	0.0	0.0	0.2	1.9	0.6	0.0	1.1	2.8	0.9	0.0	0.7	9.5	4.9	0.1	1.1	0.0	0.6	0.6
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Group enriched"	"Detected in some"	6	"granulocytes: 4.6;Suprabasal keratinocytes: 4.5"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"A-431: 5.9"	"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Not detected"	"Not detected"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.1
CEACAM16	DFNA4B	ENSG00000213892	"Carcinoembryonic antigen related cell adhesion molecule 16"	Q2WEN9	19	44699151-44710714	"Disease related genes, Predicted secreted proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9;pancreas: 7.0"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 1.1;Rod photoreceptor cells: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;RH-30: 1.5;T-47d: 2.8;U-266/70: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"	NA	NA					"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0		0.0	7.0	0.0	1.1	0.0		0.0	0.0		0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2			0.0		1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.7	0.0	0.0	0.0	0.0	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase family member 1"	Q9UNI1	12	51328443-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 6.3;blood: 12.6;pancreas: 11.8"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 15.1;Kupffer cells: 7.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in many"		"basophil: 9.0;naive CD4 T-cell: 12.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.0;T-cells: 12.6"	"Cell line enriched"	"Detected in some"	4	"BEWO: 11.0"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	6.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1		0.0	11.8	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.6			0.0		0.3	0.0	0.0	0.3	0.9	9.0	1.6	0.2	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.0	1.6	0.1	1.1	0.8	0.4	0.3	2.7	0.8	0.9	0.0	12.6	5.9	0.2	0.2	0.9	0.0	0.3	1.3											0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase family member 2A"	P08217	1	15456728-15472091	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1559	"pancreas: 2376.3"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 6761.1"	"Cancer enriched"	"Detected in single"	3819	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 5.0;K-562: 1.1;U-2 OS: 1.6"														"Secreted to digestive system"	NA	NA						"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	1.2	0.0	0.0	0.0	1.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.0	6761.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.1	0.0	0.0	361.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase family member 2B"	P08218	1	15465909-15491400	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	188	"pancreas: 697.9"	"Cell type enriched"	"Detected in some"	42	"Exocrine glandular cells: 1081.3"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	5	"U-138 MG: 9.3"														"Secreted to digestive system"	NA	NA						"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	697.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.7	1.0	1.8	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.1	0.0	0.0	0.0	0.0	0.4	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.5	0.4	0.0	0.0	9.3	0.0	0.0	0.0	0.9	0.1	0.3	0.4	0.0	0.0	3.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1081.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell type enriched"	"Detected in some"	31	"Exocrine glandular cells: 30160.2"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.6"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	29.3	0.0	0.0	0.0	30160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.3	0.0	0.0	164.1	0.0	0.0	964.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Cell type enriched"	"Detected in some"	24	"Exocrine glandular cells: 12399.8"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	5.0	1.7	1.3	2.5	1.5	2.2	1.2	1.8	1.8	1.7	5.4	2.7	5.5	2.7	1.5	2.2	1.6	1.0	0.5	0.0	2.5	4.1	2.4	4.9	4.0	1.3	1.9	3.2	2.3	2.4	1.5	0.0	2.7	2.5	3.6	2.5	5.6	0.4	2.6	2.2	1.5	1.4	0.9	3.5	3.6	0.9	4.3	0.0	3.6	3.2	1.8	3.5	0.8	0.3	3.7	2.6	2.8	3.7	2.9	1.6	2.3	1.0	4.9	4.8	2.5	1.9	4.8	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	65.6	0.0	4.9	0.0	12399.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.0	0.9	0.0	0.0	105.6	0.0	0.0	510.5	7.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 2.5;Club cells: 7.9;Cone photoreceptor cells: 5.9;Fibroblasts: 7.2;Horizontal cells: 3.2;Intestinal endocrine cells: 4.6;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 42.9;BJ hTERT+: 67.9;fHDF/TERT166: 53.9;HSkMC: 37.1;hTERT-RPE1: 40.5;U-138 MG: 19.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	42.9	67.9	1.1	0.9	0.5	0.2	0.2	0.1	53.9	0.2	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.1	0.0	8.4	0.0	40.5	0.0	0.2	0.2	0.1	1.0	0.9	0.1	0.1	0.2	14.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.6	0.2	0.0	0.2	19.6	0.1	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1	0.0	1.0	0.0	0.4	0.0	2.5	0.8	0.0	0.0	7.9	0.0	5.9	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.1	7.2	0.8	1.1	0.0	0.3	3.2	4.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.8	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.9
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 6.4;NTERA-2: 11.8;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.8"	"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	1.0	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.0	0.7	0.0	0.2	0.0	19.8	0.0	0.0	0.9	0.0	0.1	0.0	4.7	1.6	3.3	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.5	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.3	2.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.6	1.3	0.0	1.8	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9	0.0	10.7	2.7	3.8	4.7	21.1	2.7	7.6	49.5	6.8	5.2	13.7	3.5	1.7	0.9	1.4	0.4	4.0	0.0	1.4	0.4	4.1	3.9	9.2	19.7	4.5	0.0	8.6	1.3	3.8	0.8	12.7	2.9	0.0	6.4	1.7	12.1	0.9	5.8	12.0	1.0	16.1	0.0	1.0	27.7	4.8	4.5	3.8	2.9	2.6	4.8
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 43.4"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"U-266/70: 13.3"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.1	0.1	0.7	0.1	0.6	0.0	0.1	0.1	0.8	0.1	0.1	0.1	3.6	0.0	0.1	43.4	0.1	0.0	1.4	0.1	0.8	0.5	0.1	6.6	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.3	0.1	1.2	0.1	0.1	1.8	0.1	0.0	1.7	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.8	0.5	1.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Group enriched"	"Detected in some"	27	"Ito cells: 70.6;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.2;HUVEC TERT2: 8.8;TIME: 5.1"														"Secreted to blood"	NA	NA	2470000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.9	1.1	1.7	0.0	0.1	0.0	0.1	0.0	0.0	0.4	8.8	0.5	0.0	0.8	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.1	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0	0.0	2.6	2.7	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	1.0	2.4	0.0	0.0	70.6	86.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Cell type enriched"	"Detected in some"	5	"Intestinal endocrine cells: 19.8"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1"									HPA041773	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	11.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	Gastrulation	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"brain: 3.4;pancreas: 13.0;pituitary gland: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 2.2;U-2 OS: 2.1"									HPA041773	Approved				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"																		0.3	0.1	0.4	0.1	1.6	0.1	0.1	1.5	0.5	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.3	0.1	3.4	0.2	0.1	0.2	0.1	0.6	0.1	0.1	13.0	0.1	8.1	0.1	1.0	0.8	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.6	1.5	0.5	0.1	3.4	0.6	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 1885.6;Leydig cells: 4659.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Group enriched"	"Detected in some"	5	"ASC diff: 40.8;THP-1: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	732000000	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	40.8	6.4	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.6	0.2	0.0	0.0	1.1	2.9	0.0	1.8	0.6	0.6	0.3	1.0	6.4	0.0	0.0	0.0	0.1	0.0	0.7	2.3	0.1	0.0	0.9	0.0	9.2	0.1	0.7	2.9	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	1.2	57.8	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.4	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.9	35.0	13.4	57.2	697.8	3.1	53.7	12.7	21.4	23.9	17.4	2.0	31.1	10.0	6.7	18.8	25.9	9.3	0.0	0.0	35.1	1885.6	17.4	16.2	1.3	255.2	1.6	4.1	49.7	345.8	28.7	4659.7	242.8	609.0	5.4	7.5	1.2	1.9	32.5	266.2	2.5	6.3	0.0	277.1	11.8	20.4	643.3	28.7	9.2	18.5	172.1
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1052.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	13.6	0.0	0.0	21.4	12.1	0.0	5.5	13.5	0.7	2.9	0.0	2.5	0.0	2.0	0.0	0.0	0.4	0.0	5.0	0.5	0.2	0.0	4.1	16.2	0.0	26.9	0.1	0.0	26.3	0.0	4.0	1.7	81.0	16.8	0.0	15.3	0.5	19.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.6	4.3	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	16.2	0.2	0.1	0.1	0.1	0.0	0.0	2.9	0.0	1.2	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21.0	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0.0	0.0	0.0	1.9	1.5	55.0	0.0	0.0	0.7	0.0	200.9	8.6	3.5	1052.9	0.9	0.0	0.0	57.1	34.9	3.6	262.9	6.0	42.2	0.0	0.0	0.3	6.4	0.0	130.4	0.0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0.0	49.2
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 7.6;Erythroid cells: 23.3;Hepatocytes: 8.9;Ito cells: 17.2;Kupffer cells: 14.9"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HeLa: 3.2;HL-60: 4.8;U-266/70: 6.3"									"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		15000000000	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.7	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.7	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.2	0.2	4.8	0.8	0.2	0.0	0.0	0.0	1.0	0.1	1.0	0.3	2.4	0.8	0.0	1.5	0.0	0.9	0.0	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.5	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.3	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1											3.0	0.0	0.0	0.1	0.3	0.0	1.4	7.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.0	0.0	1.0	0.0	0.0	8.9	4.2	0.0	0.0	17.2	14.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.6	0.0	0.2	0.0	0.0	0.1
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943772-196959226	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1462	"liver: 146.2"	"Group enriched"	"Detected in some"	19	"Erythroid cells: 23.3;Hepatocytes: 31.8"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;TIME: 1.2"									"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		5700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774795-196795406	"Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"liver: 121.9"	"Cell type enhanced"	"Detected in some"	18	"B-cells: 5.3;Erythroid cells: 23.3;Hepatocytes: 11.3;Ito cells: 9.2;Kupffer cells: 8.5"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;SuSa: 3.1;T-47d: 6.9;U-266/70: 12.6"														"Secreted to blood"	NA	NA	582000000	3800000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.4	0.0	0.6	0.2	0.1	1.4	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	0.4	0.5	0.0	1.4	0.0	0.0	0.0	0.7	0.0	3.1	6.9	0.0	0.0	0.1	0.3	0.3	0.0	12.6	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.3	0.4	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	11.3	0.0	0.0	1.7	9.2	8.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196850241-196918972	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	188	"liver: 61.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 31.7"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.0;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 5.0;U-266/84: 2.1"														"Secreted to blood"	NA	NA		180000000									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.6	2.5	0.0	5.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009674	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"liver: 85.5"	"Cell type enriched"	"Detected in some"	24	"Hepatocytes: 88.3"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.0"									"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.3	0.0	0.0	0.0	3.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell type enhanced"	"Detected in many"	18	"Hepatocytes: 510.3;Muller glia cells: 130.7;Proximal tubular cells: 205.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.5;Hep G2: 46.8;HSkMC: 19.5;RPTEC TERT1: 52.4"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	29.5	0.0	9.4	0.1	0.2	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.1	46.8	2.0	0.0	0.0	19.5	0.0	0.0	0.0	1.3	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.4	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6	11.9	34.5	6.7	10.2	0.9	2.4	1.9	107.0	2.7	36.4	61.1	2.0	0.1	26.6	36.3	0.2	49.6	1.1	0.0	27.7	0.1	3.8	1.7	3.5	510.3	0.6	1.6	0.0	54.6	14.3	0.2	15.5	1.7	0.0	2.8	0.7	130.7	34.8	2.9	0.0	205.0	5.6	0.0	3.2	0.7	0.5	1.0	0.2	4.4	0.6	10.3
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Group enriched"	"Detected in many"	17	"Ito cells: 122.2;Kupffer cells: 303.6;Macrophages: 129.1;monocytes: 486.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 21.2;HEL: 4.6;HMC-1: 5.3;NB-4: 10.1;U-937: 7.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		8500000000	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	21.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	4.6	0.1	0.0	0.1	1.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	10.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	7.0	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0	0.0	14.5	8.5	0.1	3.5	3.2	0.8	2.5	4.0	4.5	0.0	0.0	0.3	0.0	0.2	0.1	1.0	0.0	0.0	0.6	0.4	1.6	0.2	1.1	1.7	15.7	1.6	0.0	122.2	303.6	0.0	0.9	129.1	5.0	486.9	0.0	0.2	0.4	0.0	1.1	0.4	1.7	0.0	0.9	0.0	0.2	2.6	0.3	3.3	0.6	0.0
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell type enriched"	"Detected in some"	30	"Syncytiotrophoblasts: 71349.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"BEWO: 73.5;SuSa: 141.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	1223.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2346.5	0.1	1.5	0.0	0.0	567.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	71349.9	0.0	0.0	0.3
CGB1		ENSG00000267631	"Chorionic gonadotropin beta subunit 1"	A6NKQ9	19	49035610-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 8.4"	"Cell type enriched"	"Detected in single"	125	"Syncytiotrophoblasts: 58.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.5"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	8.4	0.0	1.4	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.9	0.0	0.1	0.1	0.0	0.0	0.5	0.3	4.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin beta subunit 2"		19	49031912-49033238	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 2.1;testis: 4.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 33.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.0	0.7	0.3	0.0	0.0	1.1	1.0	0.9	0.2	0.0	0.0	0.4	0.1		0.0	0.0	0.0	1.1	1.4		0.4	0.0		0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.3	4.1			0.1		0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.1	0.0	25.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	3.0	10.2	12.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	6.5	0.0	0.5	1.1	0.0	33.4	0.0	0.0	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell type enriched"	"Detected in some"	38	"Syncytiotrophoblasts: 724.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 39.7"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	724.1	0.0	0.0	0.0
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin beta subunit 5"	P0DN86	19	49043884-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"placenta: 105.2"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 16.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"BEWO: 46.9;U-251 MG: 21.3"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	12.7	105.2	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 49.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.8	0.2	1.5	0.0	0.2	7.1	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	2.1	5.7	0.2	4.8	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.9	0.4	0.7	1.6	0.0	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.0	0.1	0.1	1.4	0.1	0.1	1.7	1.0	0.2	0.2	2.3	2.3	0.0	10.4	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	49.1	0.0	0.0	0.0
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 37.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 61.9;U-251 MG: 21.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	1.4	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.9	0.0	0.2	0.0	1.2	2.6	0.2	21.5	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119115	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 9.8;Peritubular cells: 8.1;Spermatogonia: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 18.7;SK-BR-3: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA		22000	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	5.0	3.0	15.7	1.4	28.8	2.2	7.1	14.8	31.6	2.1	3.2	2.8	0.2	4.6	5.6	2.0	3.4	5.9	4.6	2.8	16.1	13.8	3.4	10.3	0.9	0.8	8.5	15.9	11.0	3.8	0.4	1.4	0.7	10.3	5.1	4.6	0.8	13.7	1.4	3.1	2.1	6.3	6.4	2.6	1.0	13.4	4.0	3.6	0.0	0.7	1.6	2.8	4.0	0.5	1.0	0.9	0.9	1.0	0.9	1.1	0.6	3.5	3.0	0.1	3.8	9.0	3.4	0.2	4.3	0.0	0.4	0.1	0.8	2.9	0.0	1.2	8.5	1.1	0.2	0.6	0.9	0.2	0.0	1.8	0.1	5.2	7.6	8.4	2.3	0.3	2.3	8.7	1.2	1.0	5.7	0.3	0.5	0.1	0.1	0.5	11.1	1.7	3.1	1.0	18.7	8.3	0.1	0.0	0.2	0.0	0.1	8.7	13.0	8.4	38.0	4.3	0.1	12.2	6.4	0.0	0.0	3.4	0.0	0.3	1.1	0.3	0.3	0.0	0.1	4.9	0.9	1.0	0.0	0.7	0.8	0.5	1.0	1.0	0.7	0.5	0.7	0.6	1.1	0.6	0.9	0.4	0.9	0.7	0.6	15.7	28.8	14.8	20.5	16.1	13.8	8.5	15.9	10.3	3.6	0.0	0.0	0.0	0.1	0.6	9.8	0.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	1.4	0.1	1.3	2.2	0.0	3.9	0.3	0.0	0.0	3.1	0.8	1.3	4.0	0.0	0.0	0.0	4.2	0.5	1.2	0.0	8.1	3.6	2.0	0.0	0.9	2.1	13.6	0.4	0.1	0.0	0.0	0.1
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468966	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 2.5;Enterocytes: 2.0;Hepatocytes: 2.4;Mucus-secreting cells: 2.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 23.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	52	"memory B-cell: 17.9;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	83	"B-cells: 17.9"	"Cell line enhanced"	"Detected in many"		"RT4: 6.3;SCLC-21H: 13.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		15000000			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	4.5	10.0	11.3	0.8	10.9	0.4	9.5	19.2	8.5	21.0	3.2	4.2	0.1	7.7	0.7	0.9	1.8	0.4	1.5	1.0	11.6	2.7	1.5	18.4	3.7	0.7	2.2	2.9	3.0	17.9	0.1	0.8	0.6	4.9	1.0	3.7	0.3	9.0	0.4	15.4	8.1	9.1	0.2	5.0	1.2	4.7	2.0	3.5	0.6	2.5	3.4	20.6	0.8	0.5	17.9	0.1	0.0	0.0	0.0	0.2	0.5	1.5	1.1	1.1	1.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	2.3	1.2	0.1	0.4	0.0	0.3	2.3	0.0	0.0	0.0	0.9	1.2	1.8	0.9	2.1	0.0	0.6	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.2	0.4	0.0	0.7	0.0	1.1	0.1	0.2	1.2	1.4	0.2	2.4	0.0	6.3	13.1	0.5	0.2	0.5	0.0	0.5	0.6	0.3	1.4	3.5	0.7	0.2	0.0	2.5	0.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	11.3	10.9	19.2	8.5	11.6	2.7	2.2	2.9	4.9	3.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.6	0.3
CHADL	SLRR4B	ENSG00000100399	"Chondroadherin like"	Q6NUI6	22	41229510-41240934	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 45.8;salivary gland: 14.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 19.4;Melanocytes: 16.9;Muller glia cells: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.2;Hep G2: 4.4;hTCEpi: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005696, HPA024654"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA005696: AB_1079724, HPA024654: AB_1846615"	"unprognostic (6.14e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-8)"	"unprognostic (8.36e-3)"	"unprognostic (4.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.09e-2)"	3.2	6.3	8.6	0.7	20.3	1.2	2.4	2.7	22.4	2.8	4.1	45.8	0.4	2.0	1.5	2.1	4.3	3.1	3.4	6.9	12.7	9.8	1.3	1.7	2.8	1.0	18.6	10.1	2.8	4.5	0.5	1.7	0.9	17.2	4.6	0.5	7.3	14.2	5.3	2.6	7.0	1.8	1.2	39.8	1.0	3.3	2.0	20.3	0.0	4.0	0.2	0.6	1.8	1.3	0.3	4.2	1.6	1.4	0.0	1.6	1.2	0.8	0.3	0.3	0.4	0.2	0.1	16.2	0.6	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.9	0.1	0.7	0.0	0.9	0.0	0.2	0.3	0.0	0.4	4.4	0.5	0.2	0.1	1.5	4.6	0.4	0.0	0.1	0.5	0.3	0.1	0.6	0.0	0.4	0.2	0.7	0.4	0.4	0.6	0.2	0.7	0.2	0.3	0.4	1.0	0.2	1.7	0.3	0.2	0.1	0.1	1.6	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.2	2.1	0.0	0.6	1.6	0.7	1.4	0.9	0.0	0.6	1.0	0.5	0.3	1.6	0.7	0.7	0.0	0.2	4.2	0.1	1.2	8.6	20.3	2.7	15.2	12.7	9.8	18.6	10.1	17.2	20.3	6.0	2.1	0.0	7.2	3.5	1.9	2.6	2.5	5.3	1.2	3.5	0.0	2.1	6.6	1.6	19.4	1.0	0.5	0.0	1.0	5.2	2.1	4.6	0.0	2.4	4.1	0.0	2.9	1.8	0.0	6.2	3.4	0.8	16.9	0.0	0.6	37.9	1.0	0.0	2.8	4.2	1.3	0.0	0.5	0.4	1.1	3.1	1.3	0.0	1.2	4.3
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 335.7"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	14	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	230000000	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.7	90.8	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	80.6	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.4	0.0	38.1	0.2	0.0	0.0	0.2	4.8	0.0	37.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6.0	39.7	0.0	19.4	3.8	0.0	0.8	2.5	4.0	15.9	26.2	0.0	1.2	0.0	49.4	0.0	0.4	0.0	0.0	0.0	0.9	2.2	2.2	0.0	28.7	335.7	0.0	0.0	0.0	0.3	0.0	0.9	3.9	13.5	1.8	0.0	40.4	3.1	0.0	0.0	0.1	1.8	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	1.6
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.7;salivary gland: 47.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 113.5;B-cells: 47.6;Leydig cells: 69.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.0"	"Group enriched"	"Detected in many"	4	"B-cells: 16.8;T-cells: 36.0"	"Group enriched"	"Detected in some"	5	"JURKAT: 113.5;MOLT-4: 59.4"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	NA	NA		480000			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (9.10e-5)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	8.3	0.9	3.9	38.7	11.9	0.9	13.4	0.3	11.9	0.7	2.5	5.9	0.3	0.4	0.6	3.7	2.2	0.7	4.4	20.8	8.3	8.3	3.0	0.3	21.0	19.1	5.6	1.2	1.4	0.3	0.1	1.6	5.8	7.3	3.9	1.0	4.2	47.2	0.3	3.0	3.2	2.6	1.2	28.4	18.4	2.5	4.4	2.1	86.7	4.2	4.2	39.4	19.3	1.7	16.8	0.5	0.9	1.2	6.4	36.0	10.1	0.0	0.0	0.0	0.1	16.8	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.1	0.6	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.2	0.0	0.3	4.0	0.0	0.0	0.1	0.9	0.0	113.5	0.0	0.2	0.0	0.0	59.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.9	0.1	13.2	4.2	0.0	0.4	0.3	1.2	0.1	8.7	0.3	2.2	14.3	6.1	14.3	0.3	16.8	36.0	13.6	0.9	6.4	0.2	0.5	3.6	10.1	3.9	11.9	0.3	5.4	8.3	8.3	5.6	1.2	7.3	2.1	8.9	113.5	47.6	1.0	2.1	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.2	0.0	9.7	3.7	0.1	0.0	0.0	0.3	0.6	2.6	3.7	2.3	0.0	1.0	0.0	1.2	0.0	1.3	9.4	69.3	1.7	15.1	0.0	0.0	0.0	1.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.2	1.1	2.6	6.4	0.0	0.4
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell type enriched"	"Detected in single"	44	"Hofbauer cells: 42.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	42.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8;liver: 48.3"	"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 9.7;Hepatocytes: 33.8;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;Hep G2: 15.1;SuSa: 5.6;U-2 OS: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		120000			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	8.9	6.2	8.9	3.1	6.4	0.4	4.2	32.8	15.9	13.0	2.9	2.4	1.8	2.7	14.9	6.4	3.2	5.7	3.9	4.6	6.5	1.1	10.1	48.3	3.0	2.2	1.8	7.0	7.9	13.9	0.8	2.5	3.8	4.7	4.2	1.6	2.6	2.0	8.3	4.9	3.2	3.0	7.0	2.9	4.6	3.4	1.2	1.8	0.0	3.2	2.3	0.9	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.1	0.1	1.9	0.5	0.0	0.3	0.2	3.6	0.0	0.0	1.4	0.4	1.4	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.1	15.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.9	0.0	0.1	0.1	0.1	5.6	1.9	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	32.8	15.9	6.5	1.1	1.8	7.0	4.7	1.8	0.0	0.0	0.0	0.0	2.4	0.5	3.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	2.6	0.0	9.7	0.1	0.0	33.8	0.5	0.0	0.0	4.9	2.9	0.0	3.4	0.0	1.7	0.0	0.0	0.0	1.8	0.0	2.1	3.3	0.5	6.5	10.3	0.2	0.2	1.0	0.1	0.0	0.0	0.1
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	21	"Leydig cells: 38.0;Muller glia cells: 79.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 2.5"	"Group enriched"	"Detected in some"	9	"ASC diff: 93.3;ASC TERT1: 128.4;hTERT-RPE1: 58.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"	NA	NA		620000			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (2.23e-4)"	53.1	2.2	7.2	11.5	12.3	0.2	40.8	3.7	8.4	22.0	25.7	1.4	40.9	3.1	57.3	29.5	18.7	18.1	14.2	22.0	5.4	1.7	4.5	0.7	27.6	7.5	1.7	6.8	7.5	3.6	51.4	2.8	15.2	2.2	46.1	11.1	15.2	8.5	73.9	3.2	6.9	7.7	31.0	3.4	6.5	8.6	5.8	2.4	0.8	14.9	23.7	3.4	16.3	11.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	93.3	128.4	0.0	1.2	0.5	3.1	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.0	58.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.6	9.8	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	7.2	12.3	3.7	8.4	5.4	1.7	1.7	6.8	2.2	2.4	0.0	2.4	0.0	0.0	4.2	1.0	1.2	0.0	2.7	3.4	1.8	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.1	15.1	0.2	1.1	0.0	0.2	0.0	0.0	2.5	0.0	0.2	38.0	2.4	8.5	0.0	0.0	79.4	0.0	0.0	8.5	2.2	2.5	0.0	2.8	0.1	9.1	3.9	0.1	0.0	0.0	0.1
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731385	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 22.9;Hepatocytes: 76.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 6.1;PC-3: 3.2;SiHa: 6.1;TIME: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA021771, HPA076522"	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		5600000	Vesicles		"HPA021771: AB_1846689, HPA076522: "	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (6.08e-4)"	1.0	0.0	0.0	39.3	0.2	0.0	1.7	0.1	0.3	64.5	27.9	0.1	1.0	1.4	76.5	47.6	4.3	2.9	109.2	35.8	0.1	0.1	1.0	14.5	0.8	0.5	0.0	0.0	6.7	1.0	0.4	0.1	1.5	0.4	8.0	0.9	0.9	0.2	3.5	2.6	0.3	3.5	45.3	0.6	0.8	24.1	7.6	0.0	0.1	0.2	3.2	1.1	22.6	8.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	1.0	6.1	0.7	0.0	1.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	3.2	0.0	0.6	0.0	0.0	0.0	0.1	0.2	6.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.5	0.4	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.4	0.2	0.0	2.2	22.9	0.0	0.0	8.7	0.0	0.0	0.0	5.8	9.7	0.5	0.0	0.0	9.0	0.0	0.9	0.8	0.0	76.1	0.1	0.0	0.0	2.5	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.7	0.0	0.0	0.0	1.0	0.2	1.9	0.0	0.1	0.0	0.0	0.5
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.8	3.5	11.9	6.0	6.2	8.4	7.9	6.9	6.1	8.4	8.6	3.0	2.3	6.8	4.1	11.5	5.5	7.9	7.9	8.8	9.3	7.6	3.9	13.5	4.0	3.5	7.7	20.5	14.0	7.7	7.4	7.2	6.6	9.6	9.9	3.1	4.9	69.8	6.3	2.4	2.8	14.1	13.7	5.5	2.5	6.4	12.0	10.1	5.8	5.6	2.1	11.3	7.3	3.6	12.5	10.2	4.1	25.5	8.3	13.8	7.9	6.5	14.5	12.4	28.6	4.0	10.7	19.5	10.2	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5	0.0	17.8	6.2	17.2	51.4	9.0	7.1	2.5	10.7	11.4	15.7	5.9	5.6	1.7	4.4	0.7	37.9	0.9	23.3	1.9	19.4	44.1	15.0	24.4	4.9	14.0	36.5	2.9	57.7	14.0	1.3	50.9	17.6	25.3	1.0	3.4	9.1	4.6	3.4	44.2	1.9	7.3	45.3	68.0	3.9	7.2	54.6	11.6	8.7	3.1	8.5
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194758-65211488	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Leydig cells: 214.3;Peritubular cells: 54.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;ASC TERT1: 4.4;EFO-21: 1.9;HSkMC: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		11000000			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	32.0	0.4	0.0	8.1	0.1	0.0	17.0	0.4	0.0	39.9	11.1	0.1	12.7	1.2	9.2	44.7	21.4	10.5	19.6	16.5	0.0	0.0	0.5	1.0	1.8	1.4	0.2	0.0	9.6	2.4	0.1	0.4	3.0	0.1	13.3	3.9	0.6	5.6	5.1	19.7	8.4	12.5	41.6	0.3	0.3	5.4	18.4	0.0	1.4	2.0	23.4	3.1	41.4	17.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	7.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.6	0.6	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	2.4	214.3	0.0	1.7	0.0	0.0	0.3	0.0	0.0	54.1	0.0	0.0	0.0	3.8	0.6	0.2	5.4	0.0	0.0	0.0	0.0
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 9.4;testis: 10.1"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 20.5;Late spermatids: 15.9;Sertoli cells: 6.5;Spermatogonia: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.9;HEK 293: 5.2;NB-4: 3.9;THP-1: 5.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA041847	Uncertain				"Secreted to extracellular matrix"	NA	NA		11000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	2.8	0.1	0.9	1.1	1.0	3.1	3.6	0.3	1.1	3.1	0.7	0.0	0.8	0.1	0.7	1.1	0.8	0.9	5.6	1.0	0.8	1.4	0.2	0.7	0.9	2.5	0.3	0.0	9.4	0.2	1.4	0.9	2.4	0.4	1.2	0.2	3.0	2.8	0.9	4.0	0.7	0.3	0.5	0.1	0.7	0.2	10.1	0.0	0.0	7.8	0.4	1.8	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.3	0.2	8.9	0.3	1.2	1.1	0.0	0.5	0.1	2.4	0.9	0.1	2.3	0.4	0.1	1.0	0.2	0.0	0.1	0.6	5.2	0.0	0.2	0.3	0.3	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8	0.0	3.9	3.3	2.7	1.6	0.6	0.0	0.0	0.1	0.0	0.1	2.2	0.5	2.8	0.3	0.5	0.5	5.0	0.0	0.1	1.1	0.4	0.2	0.7	2.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.1	0.8	1.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.3	3.7	4.5	0.5	0.0	0.0	0.0	0.4
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 142.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	18.8	21.1	16.1	27.7	16.9	29.9	18.8	19.0	14.9	14.8	20.6	11.0	9.1	15.7	14.8	15.2	12.5	16.4	22.8	11.0	14.9	13.4	15.0	14.6	28.9	41.2	23.1	11.0	14.5	12.0	11.4	13.5	14.6	15.0	14.6	22.0	10.9	13.0	9.7	6.8	9.0	26.5	16.9	20.8	44.4	12.2	42.5	18.6	40.2	12.3	11.7	24.6	17.6	13.0	9.4	32.2	142.0	39.6	17.7	25.6	34.2	35.7	31.9	6.7	19.3	18.1	14.8	4.9	17.9	13.6	19.6	29.3	29.7	43.9	14.1	22.7	15.3	20.5	19.3	13.3	10.7	27.6	17.4	6.7	10.3	28.4	36.3	10.9	32.0	27.8	10.1	8.7	24.4	8.7	23.5	23.3	43.6	16.4	40.7	24.4	11.9	30.9	31.8	2.2	21.1	51.8	53.1	35.4	39.2	65.4	19.9	9.4	11.4	54.8	3.6	16.6	4.7	10.6	21.7	14.2	28.4	25.7	9.8	21.0	19.3	39.7	71.8	23.9	28.2	22.9	64.6	39.6	74.8	20.6	19.8	25.6	9.4	19.2	20.0	32.2	8.8	10.2	14.1	142.0	17.7	18.6	16.3	22.9	34.2	16.1	16.9	19.0	14.9	14.9	13.4	23.1	11.0	15.0	18.6	17.9	66.2	46.2	20.8	24.3	8.2	0.8	101.9	65.6	35.2	54.1	0.0	40.5	14.9	120.7	24.7	44.8	58.0	23.3	113.2	92.3	41.3	13.1	334.0	34.2	227.1	1.6	31.7	66.9	154.7	20.5	45.8	289.2	38.8	30.7	61.5	19.0	153.7	40.3	28.3	75.1	6.4	32.3	33.5	349.8	69.4	20.1	14.5	215.8	65.0	23.3
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell type enriched"	"Detected in some"	56	"Mucus-secreting cells: 1736.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;K-562: 1.7;NB-4: 5.3;RPMI-8226: 5.7;SH-SY5Y: 4.1;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1736.8	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.9	0.0
CLCF1	"BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6"	ENSG00000175505	"Cardiotrophin like cytokine factor 1"	Q9UBD9	11	67364168-67374177	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 55.6;Pancreatic endocrine cells: 36.3;Urothelial cells: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042444	Uncertain		Approved	"Nuclear bodies,Vesicles"	"Secreted to blood"	NA	NA			"Nuclear bodies, Vesicles"		"HPA042444: AB_10794527"	"unprognostic (2.68e-1)"	"unprognostic (7.87e-3)"	"unprognostic (6.21e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.47e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.37e-1)"	10.5	2.9	1.2	11.6	1.5	10.2	7.5	0.8	1.8	11.2	7.6	2.0	3.5	1.1	18.9	5.9	3.9	12.2	16.5	5.7	1.1	0.7	17.3	2.6	6.0	4.3	0.9	1.3	12.1	5.8	0.1	4.3	11.6	3.1	4.7	1.4	3.9	5.9	1.5	4.6	1.4	5.5	7.5	1.9	7.2	7.7	3.8	1.5	1.1	6.3	9.8	11.6	5.6	5.1	11.9	1.0	11.1	8.0	0.2	8.8	2.1	6.9	14.5	1.1	4.6	2.0	2.7	0.0	9.7	5.3	6.7	3.3	2.4	19.2	4.3	8.3	12.1	8.6	4.8	0.2	4.9	2.9	0.2	0.1	0.0	9.8	1.9	6.4	0.8	1.2	3.6	1.2	6.9	3.1	13.1	1.4	0.0	1.6	0.2	6.9	5.5	0.0	3.1	3.9	8.6	13.3	0.4	2.3	0.2	10.5	0.3	0.0	0.7	26.5	1.0	0.5	2.2	0.6	1.1	5.9	13.3	5.7	16.7	14.2	0.9	0.0	0.5	16.9	0.9	5.2	0.0	0.7	11.1	8.8	2.6	5.1	8.2	4.1	6.8	1.0	11.9	0.1	3.0	0.2	0.2	8.0	0.0	0.7	2.1	1.2	1.5	0.8	1.6	1.1	0.7	0.9	1.3	3.1	1.5	14.9	3.7	9.3	22.4	3.3	0.0	0.4	20.4	1.4	6.8	7.0	0.0	0.2	1.7	21.5	1.6	3.6	1.7	0.0	10.3	0.4	9.4	55.6	3.5	0.0	1.2	0.0	1.2	3.7	0.3	2.7	3.1	4.3	8.5	10.8	2.2	1.5	36.3	3.5	0.0	4.2	0.1	0.0	7.2	0.2	0.7	3.9	0.1	3.2	1.7	51.2
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 101.2;Fibroblasts: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Group enriched"	"Detected in many"	4	"HEL: 45.4;HMC-1: 84.1;NB-4: 111.7;THP-1: 90.3;U-937: 46.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		45000	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.4	6.0	10.3	17.7	4.8	2.0	2.0	0.0	0.0	0.0	0.2	8.8	0.1	0.2	0.0	0.0	1.4	0.0	2.9	45.4	0.0	0.0	2.8	0.0	84.1	4.4	0.0	0.2	0.2	0.0	2.2	2.0	0.5	0.3	3.7	0.3	0.3	111.7	0.2	0.0	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	6.8	0.0	0.1	90.3	12.7	0.1	5.5	0.0	0.1	0.2	0.2	0.0	6.4	46.9	5.8	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8	3.0	4.8	1.4	26.8	28.4	18.8	2.8	10.2	5.3	3.4	27.9	9.8	8.6	101.2	10.9	4.6	14.5	0.7	0.0	2.6	36.0	98.6	20.9	5.7	4.4	44.2	20.6	25.4	62.6	21.5	13.3	65.6	36.7	74.2	4.6	3.4	42.6	5.0	1.4	63.3	6.3	17.5	64.7	31.1	20.5	10.0	40.1	15.3	4.3	3.4	13.1
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 19.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 57.3"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"					"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;BEWO: 3.6"									HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.1	1.3	0.3	0.0	0.8	0.3	0.1	0.1	0.1	0.1	0.2			0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.5	19.6	0.1	0.1	0.1	0.3		0.1	0.3	0.0	0.1	0.0		0.1	0.1		0.7	0.1	0.0	0.1	0.5	0.0	1.0	0.7	0.5	3.4			0.1		0.1	0.4	0.0	0.9	0.3	1.6	0.0	0.5	0.1	0.0	0.3	0.3	2.8	0.2	0.0	0.8	3.6	0.0	0.0	0.6	0.2	0.6	0.1	0.5	0.3	0.0	0.5	0.0	0.0	0.4	0.3	0.6	0.9	0.0	0.0	1.5	0.0	0.7	1.8	0.0	1.4	1.4	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.4	0.0	0.0	1.0	1.6	0.1	0.8	0.0	0.1	0.5	0.7	1.6	0.0	0.7	1.9	0.2	0.0	0.7	0.8	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0											0.0	1.4	0.5	0.0	0.1	1.2	0.4	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.2	0.2	0.2	1.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.3	3.2	0.0	1.3	0.0	0.6	0.3	0.1	0.0	0.0	0.9	1.5	0.5	0.0	0.0	57.3	1.1	0.0	0.2	0.5	0.1	0.0	0.2	0.0	1.6	0.1
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 28.1"	"Cell type enriched"	"Detected in some"	11	"Proximal tubular cells: 18.2"	"Group enriched"	"Detected in some"	12	"glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7"									HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0.0	1.0	1.0	28.1	0.1	0.0	0.1	1.0		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0.0	0.2	0.0	0.2	0.1	2.0	0.1	0.1	6.1			0.1		0.1	0.0	0.6	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	1.6	2.9	1.8	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	1.1	0.5	0.5	1.0	0.9	0.0	0.1	0.3	0.2	0.4	0.3	0.1	0.7	0.0	0.3	1.7	0.4	0.1	0.1	0.7	0.0	4.1	7.3	0.0	0.3	0.0	0.0	0.0	1.2	0.3	0.8	0.4	0.0	1.6	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.2	0.9	2.7	1.6	0.3	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.3	0.6	0.4	0.0	0.0	18.2	1.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"kidney: 16.5;testis: 4.6"	"Cell type enriched"	"Detected in single"	48	"Proximal tubular cells: 18.8"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;RT4: 1.3;TIME: 3.0"									HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.6	0.3	1.3	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.6	3.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CLEC19A		ENSG00000261210	"C-type lectin domain containing 19A"	Q6UXS0	16	19285739-19322145	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 24.4"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 2.7;Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;EFO-21: 1.2;MCF7: 1.6;NTERA-2: 1.0;OE19: 2.5;RPMI-8226: 1.8;U-2 OS: 1.5"														"Secreted - unknown location"	NA	NA									"unprognostic (3.19e-1)"				"unprognostic (3.72e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.53e-1)"				0.1	0.0	2.6	0.0	0.2	0.0	0.0	0.8	7.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	4.5	1.3	0.0	0.1	0.5	0.3	0.3	0.2	0.0	0.1	0.0	0.3	0.1	1.2	0.8	0.1	24.4	0.4	0.0	0.3	1.2	0.1	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	2.5	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.6	0.2	0.8	5.0	4.5	1.3	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Cell type enhanced"	"Detected in single"	26	"Glandular cells: 1.4"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.5;T-47d: 21.4"	"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Not detected"	"Not detected"			HPA051511	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA051511: AB_2681514"	"prognostic unfavorable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell type enhanced"	"Detected in some"	15	"Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	NA	NA	6540000000	46000000000			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.53e-4)"	"prognostic favorable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	51.1	101.9	0.0	6.7	10.5	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	20.5	0.0	0.2	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5	0.0	0.0	0.0	0.0	3.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.8	10.5	0.0	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.8	0.0	0.0	43.0	1.2	15.2	27.9	0.8	3.3	1.0	0.0	0.0	0.1	0.0	6.0	0.0	0.1	0.0	4.2	0.0	0.0	3.3	0.1	0.0	0.0	0.0
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1551	"pancreas: 4260.9"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 19853.4"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1100000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	3.0	0.0	1.0	0.0	2.4	1.0	0.0	0.9	0.0	0.5	0.4	1.3	0.1	0.2	0.0	0.3	1.1	0.1	0.4	0.5	0.3	0.0	2.7	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	19853.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	228.2	0.0	0.0	2154.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781017-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"epididymis: 123.5;pancreas: 103.6"	"Group enriched"	"Detected in some"	40	"Exocrine glandular cells: 32.7;Pancreatic endocrine cells: 14.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 13.9"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.1	1.6	0.0	0.2	0.0	0.8	0.1	0.9	0.1	0.1	0.0	9.6	0.0	0.1	123.5	0.1	0.1	0.0	0.1	1.8	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	103.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	13.9	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.9	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 124.8"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 3.5;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 3.5;Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"	"Cell line enriched"	"Detected in some"	6	"T-47d: 12.6"									HPA051655	Approved				"Secreted in male reproductive system"	NA	NA					"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	124.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.0	0.4	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.3	1.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.6	0.0	0.3	12.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.4	0.2	0.0	1.1	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27615031	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 580.4;liver: 590.5"	"Group enriched"	"Detected in all"	5	"Cholangiocytes: 2112.1;Collecting duct cells: 3344.6;Hepatocytes: 3521.2;Muller glia cells: 8189.5"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 69.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 69.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 238.1;SK-BR-3: 208.2;T-47d: 151.9;U-2 OS: 135.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253"	Enhanced				"Secreted to blood"	NA	NA	169000000000	36000000000			"CAB016253: AB_673562, HPA000572: AB_1078539"	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.66e-5)"	"unprognostic (5.29e-2)"	82.5	217.4	233.5	50.2	280.3	3.4	90.4	141.2	414.7	78.3	47.9	139.5	184.6	19.9	55.4	580.4	48.3	217.2	172.7	24.6	176.2	154.7	69.8	590.5	30.5	127.3	209.0	173.1	49.6	134.8	220.4	34.3	8.5	189.0	63.4	18.0	125.4	62.2	359.2	7.7	12.8	24.0	87.9	255.2	17.2	56.6	161.5	113.5	5.3	106.6	11.8	134.8	72.2	54.7	0.1	1.3	69.2	2.1	0.9	2.7	110.6	0.7	98.0	4.3	5.1	24.3	33.5	13.7	17.4	34.3	4.6	2.4	18.8	15.5	0.3	69.8	15.5	55.6	32.9	18.6	2.8	3.0	72.3	18.0	42.5	238.1	23.1	21.2	1.0	113.5	56.1	11.2	19.8	5.7	43.1	60.4	0.6	0.5	50.1	1.6	16.4	0.3	3.2	35.8	29.0	11.6	0.3	16.4	13.5	45.4	70.8	4.0	2.5	24.1	208.2	1.0	21.9	151.9	0.6	8.9	1.4	135.9	7.8	5.8	6.4	22.9	0.8	109.3	7.0	0.6	69.2	2.1	0.9	2.3	0.6	0.8	0.0	2.7	2.5	0.7	0.1	0.3	0.8	9.6	0.9	0.1	1.3	0.7	110.6	233.5	280.3	141.2	223.1	176.2	154.7	209.0	173.1	189.0	113.5	29.8	96.4	52.8	642.1	72.2	63.1	87.3	2112.1	730.8	804.1	3344.6	72.6	73.8	34.9	312.8	239.8	477.4	8.7	46.7	557.4	25.4	414.6	130.8	770.5	3521.2	11.3	28.6	9.1	491.7	164.5	655.4	105.9	31.6	195.7	27.9	9.3	8189.5	192.6	14.0	53.7	270.7	191.3	12.9	236.7	107.2	16.3	48.3	71.6	54.8	14.0	337.2
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 335.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.6"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.6	3.9	7.5	5.1	0.0	0.0	4.5	2.9	0.2	0.0	0.0	3.1	1.5	3.1	0.7	0.0	2.7	1.1	0.0	0.4	0.0	2.5	7.0	5.2	2.1	24.6	0.0	1.7	1.0	0.2	0.0	0.0	0.0	1.3	0.3	7.7	7.3	9.1	0.0	0.8	3.1	5.6	0.5	3.2	1.8	6.3	3.5	11.0	0.8	0.8	6.6	4.6	2.9	1.8	2.2	6.3	2.4	0.8	0.6	3.0	4.4	2.1	1.4	5.2	9.1	6.5	2.4	3.4	2.6	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8	0.0	1.6	0.0	3.4	0.0	23.9	0.1	0.0	4.0	2.3	0.0	19.6	0.4	1.7	0.2	0.4	0.2	0.0	0.0	0.2	0.1	0.1	8.5	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	46.9	0.0	0.0	1.1	0.3	335.8	6.5	0.0	8.4	4.5	0.1	0.3	0.0	0.0	1.4
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"granulocytes: 52.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SuSa: 2.5;U-937: 3.1"	"Low region specificity"	"Detected in single"							"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	12.3	0.2	0.2	2.9	0.2	0.0	15.9	0.2	0.2	7.3	6.2	0.2	1.2	0.1	2.9	6.0	8.3	1.0	10.0	10.3	0.2	0.2	2.0	0.8	1.1	1.6	0.2	0.2	0.6	0.9	0.5	0.5	0.7	0.3	6.0	6.9	3.0	5.9	1.3	1.2	13.0	5.3	6.2	0.2	0.5	2.4	2.7	0.2	1.0	0.4	7.9	3.9	4.1	2.0	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.9	1.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.8	1.4	0.0	0.2	0.3	0.3	0.8	0.9	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CNBD1	FLJ35802	ENSG00000176571	"Cyclic nucleotide binding domain containing 1"	Q8NA66	8	86866442-87615219	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 16.9"	"Group enriched"	"Detected in some"	49	"Early spermatids: 118.7;Late spermatids: 73.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Karpas-707: 9.3;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025037, HPA027469, HPA027786"	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	69	"U-266/84: 42.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008933, HPA073283"	Enhanced				"Secreted in brain"	NA	NA		1900000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	26.1	0.1	0.0	0.0	0.6	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	14.6	0.6	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.0	0.2
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739812	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	33	"NTERA-2: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010510	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.3	0.3	3.1	0.3	11.1	0.3	0.4	0.9	2.5	0.3	0.5	4.3	0.0	0.3	0.3	0.3	0.6	0.4	0.3	0.4	3.0	2.6	0.3	0.3	3.9	0.3	3.7	0.9	0.4	1.1	0.3	2.5	0.5	3.1	1.6	0.5	6.1	15.1	0.4	0.5	0.5	0.4	0.3	4.4	1.0	0.4	4.2	4.1	0.0	8.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	3.1	11.1	0.9	2.3	3.0	2.6	3.7	0.9	3.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.8;Late spermatids: 18.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 5.7;SCLC-21H: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3	0.0	1.1	0.0	0.0	0.0	0.2	3.4	0.0	2.7	1.2	1.8	0.0	0.0	0.0	0.4	10.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	18.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell type enhanced"	"Detected in many"	12	"Exocrine glandular cells: 52.5;Horizontal cells: 79.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.2	1.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	5.6	6.6	0.4	0.1	0.5	0.0	0.4	0.0	7.1	0.0	3.5	0.0	30.6	5.6	2.6	20.0	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.0	0.1	12.7	39.4	1.6	0.5	0.2	2.8	32.7	3.8	0.0	1.2	8.3	0.0	0.2	0.3	1.0	36.3	9.8	0.8	0.1	0.0	4.1	0.0	15.3	0.2	0.0	0.0	0.1	0.0	1.8	4.8	3.5	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9	0.0	0.3	11.3	1.6	16.9	1.9	0.4	2.5	0.0	1.2	0.0	3.9	3.9	1.7	0.4	1.3	2.1	0.2	0.0	52.5	9.8	3.8	3.0	1.1	3.9	3.1	79.4	16.4	4.3	8.6	1.3	1.4	1.5	18.6	4.6	0.0	14.5	5.7	0.0	5.6	7.9	3.9	0.0	15.6	3.9	6.6	11.8	5.5	2.9	0.4	1.0
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 30.1"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in single"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.2	0.3	4.6	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	30.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.9	0.1	0.3	0.4	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3	0.0	1.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		270000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.5	0.0	1.5	2.1	0.0	13.5	5.2	7.8	28.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	48.5	0.0	0.3	0.0	5.9	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.2	9.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8	0.0	2.1	0.0	0.0	1.5	0.6	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.5	2.1	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.1	0.6	10.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	1.7	0.0	1.9	0.5	0.4	1.0	0.2	0.0	0.0	0.0
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pituitary gland: 28.8"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 3.9;Early spermatids: 11.3;Ito cells: 6.7;Muller glia cells: 6.7"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.4;U-698: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA		720000				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.6	0.7	0.8	0.6	1.5	0.2	0.4	6.6	2.8	1.2	0.4	2.5	0.1	1.2	0.6	1.2	0.4	0.3	0.5	1.6	1.1	0.9	0.4	0.8	0.7	0.3	2.7	0.1	0.5	1.7	0.2	28.8	0.5	1.7	0.8	0.2	2.6	2.2	0.6	2.5	1.6	1.5	0.9	2.2	0.8	3.5	4.5	1.8	1.1	2.1	0.9	0.6	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.2	0.1	2.0	0.3	1.6	1.0	0.2	0.7	0.2	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.3	2.1	0.3	0.0	0.1	0.1	0.0	0.1	1.5	0.5	0.8	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.4	0.2	1.2	0.4	0.2	0.8	1.5	0.0	0.1	2.4	1.7	2.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	6.6	1.2	1.1	0.9	2.7	0.1	1.7	1.8	0.0	0.0	0.0	0.1	1.3	1.9	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	11.3	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	6.7	1.2	1.0	0.0	0.0	1.7	0.0	0.0	6.7	0.1	0.0	0.4	0.0	1.1	0.0	1.0	0.9	1.5	1.0	0.0	0.0	0.0	0.0
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206051	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 136.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 71.5;Leydig cells: 55.8;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.5;SiHa: 97.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		4300000	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	53.1	5.6	0.9	33.1	1.3	0.0	136.8	0.4	2.0	65.0	23.0	0.5	14.8	4.2	64.6	18.1	29.2	14.9	16.3	17.1	1.1	1.1	7.6	1.5	22.2	23.5	2.0	1.5	52.0	4.1	1.5	1.9	2.6	1.6	12.3	8.7	2.4	5.9	21.4	21.6	16.8	14.1	32.4	1.4	5.0	6.9	10.6	0.4	1.0	8.2	15.0	4.4	24.8	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	35.2	19.7	3.3	32.0	26.7	22.0	30.7	3.2	0.0	0.0	3.3	164.5	0.4	7.0	0.0	3.3	20.8	0.0	0.1	0.0	11.9	0.0	13.1	0.0	0.0	29.6	0.6	4.9	6.0	21.3	3.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.8	0.0	1.8	0.0	2.7	0.0	1.1	1.6	0.0	0.0	97.7	2.5	0.0	1.9	15.5	0.0	0.0	9.5	11.8	5.0	10.6	0.0	0.0	0.0	3.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.4	2.0	1.1	1.1	2.0	1.5	1.6	0.4	71.5	6.1	0.0	0.6	18.3	0.2	2.8	0.0	2.7	7.9	3.5	0.0	0.4	0.0	0.8	19.1	3.6	0.0	0.0	3.8	0.6	25.9	1.3	1.1	0.0	0.7	0.0	0.0	5.5	0.0	9.7	55.8	1.7	20.3	0.0	0.0	0.0	4.6	0.0	12.4	0.8	0.0	45.3	24.5	0.2	0.6	11.4	0.6	0.0	0.0	0.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120372036	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 87.4"	"Cell type enhanced"	"Detected in many"	21	"Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		2000000	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	20.0	3.3	0.8	20.8	0.9	0.0	21.6	0.7	0.9	87.4	13.9	1.0	9.6	1.3	64.6	39.2	20.0	15.6	38.6	27.8	0.8	1.0	8.3	5.0	8.8	4.5	1.1	1.1	62.1	4.4	1.1	1.8	30.8	3.0	41.7	10.5	4.2	21.8	5.8	7.6	5.4	12.2	45.2	6.5	15.4	10.1	13.3	0.4	1.1	15.7	32.5	9.9	30.4	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	18.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.6	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	5.3	0.1	0.0	4.7	0.1	1.0	0.0	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	48.7	0.1	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	0.9	0.8	1.0	1.1	1.1	3.0	0.4	0.0	1.4	0.0	0.2	10.1	0.0	7.8	0.0	0.0	7.9	1.8	0.0	32.7	0.0	0.0	0.8	2.9	0.0	0.0	0.0	2.9	157.1	0.4	3.5	0.0	5.4	0.0	0.0	25.8	0.0	0.4	13.6	0.8	5.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.2	0.0	54.7	3.5	2.9	8.4	21.2	0.0	0.0	0.4
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 113.2;Leydig cells: 302.6;Peritubular cells: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.3;BJ hTERT+: 27.8;HDLM-2: 11.8;K-562: 9.0;U-2197: 23.0;U-87 MG: 10.5;WM-115: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.4	1.3	0.0	13.3	27.8	0.7	0.2	0.0	0.0	0.1	0.4	2.8	0.1	0.0	0.0	0.0	0.1	11.8	0.0	0.1	6.7	0.0	0.5	0.2	1.3	3.9	0.0	3.0	0.1	0.0	0.0	0.0	9.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.4	0.1	0.0	0.0	0.0	0.0	0.4	2.0	3.5	0.1	0.1	0.3	0.0	0.0	0.3	23.0	0.2	0.1	0.0	0.0	10.5	0.1	15.6	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4	0.0	0.0	0.0	0.1	17.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.1	5.2	71.7	0.0	0.0	0.7	3.0	113.2	0.8	0.0	0.0	7.0	0.0	0.0	0.0	0.3	11.0	302.6	1.0	16.9	1.0	0.0	0.0	0.8	0.0	454.3	0.0	0.0	12.9	16.5	1.7	1.4	14.3	6.4	0.0	0.0	0.1
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652247-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027237			Uncertain	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		530000	Cytosol	"Plasma membrane"	"HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	18.0	7.3	7.0	12.7	9.0	0.2	10.8	2.8	8.2	63.1	17.3	10.2	12.5	6.1	31.0	15.2	9.3	8.3	15.9	9.1	9.6	6.2	3.4	1.0	7.2	3.1	9.9	10.2	62.6	2.6	1.3	7.3	8.2	8.8	29.3	4.6	12.5	15.3	38.1	4.2	26.9	8.6	45.2	15.7	3.9	10.5	10.0	10.3	1.5	11.8	7.9	5.0	26.1	28.3	0.2	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	38.8	30.0	4.1	17.8	32.9	4.3	4.5	0.1	3.1	0.0	0.5	30.0	0.6	13.9	0.0	18.3	1.0	0.0	0.0	0.0	2.0	6.0	12.9	0.0	0.1	28.4	12.6	12.3	6.7	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.4	0.7	2.1	0.3	2.6	0.1	0.3	0.0	0.0	16.0	16.0	27.5	0.3	0.0	0.0	0.0	10.9	0.0	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.0	0.0	0.0	7.0	9.0	2.8	7.1	9.6	6.2	9.9	10.2	8.8	10.3	8.9	3.8	0.0	13.1	27.2	2.6	7.0	0.0	8.1	4.5	17.4	2.0	1.4	0.0	4.5	10.5	2.2	4.5	0.0	0.6	3.1	46.4	3.8	6.9	0.0	1.1	0.0	26.6	6.7	0.8	17.8	40.6	1.5	13.5	0.0	14.2	43.8	1.2	2.5	85.9	0.8	1.9	0.0	25.8	8.8	1.8	18.4	1.8	0.0	4.5	10.6
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405137-45513720	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 273.2"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 362.6;Sertoli cells: 219.9;Smooth muscle cells: 163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.8;EFO-21: 71.6;NTERA-2: 39.8;TIME: 42.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 24.8"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		250000000	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	25.5	14.4	2.2	12.7	13.0	5.6	17.7	3.4	8.5	40.4	12.7	26.0	19.6	12.6	22.2	72.5	12.0	18.8	25.3	18.5	3.5	5.3	36.2	273.2	11.9	7.6	35.5	3.5	43.3	21.8	2.6	17.8	16.5	20.8	13.9	2.3	17.3	8.8	20.2	8.1	23.1	10.6	33.4	31.9	14.5	7.1	11.0	23.6	2.3	16.0	12.0	6.7	28.7	18.2	0.4	0.4	7.3	0.4	0.0	1.2	0.2	2.5	19.5	4.8	4.4	9.1	7.6	1.0	18.7	31.8	9.0	2.4	12.1	6.9	0.5	71.6	18.5	5.2	8.8	1.0	1.1	1.7	0.2	5.4	11.2	0.3	16.5	8.8	0.4	1.1	8.8	0.7	0.8	1.0	2.1	27.6	0.2	11.3	0.1	3.2	4.5	0.4	1.1	39.8	0.8	7.2	0.5	3.1	1.1	30.2	0.4	5.5	4.2	1.8	2.0	5.9	17.9	1.8	3.0	42.1	0.2	2.8	0.1	4.4	0.1	0.2	0.3	0.1	0.9	7.7	1.0	0.4	1.5	0.1	0.4	0.2	0.4	0.4	0.0	0.1	0.1	1.2	0.6	7.3	0.0	0.3	0.4	0.0	0.2	2.2	13.0	3.4	8.5	3.5	5.3	35.5	3.5	20.8	23.6	0.0	5.5	7.0	15.2	60.1	7.9	13.7	53.5	0.0	4.5	106.4	3.9	1.4	8.3	111.6	1.1	54.0	0.0	0.0	4.9	1.1	50.8	5.3	58.6	362.6	2.2	0.0	0.0	84.7	7.3	4.5	73.9	8.3	47.2	2.8	0.0	116.0	10.0	0.0	118.5	54.9	3.8	219.9	163.2	2.6	4.5	25.0	2.1	7.5	0.0	2.2
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell type enriched"	"Detected in some"	5	"B-cells: 16.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;RH-30: 14.5;SCLC-21H: 4.1;SK-MEL-30: 12.2;WM-115: 10.2"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.5	0.0	0.0	0.0	4.1	3.0	0.0	0.0	12.2	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0	0.0	0.0	16.7	0.2	0.1	2.8	2.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.9	1.7	0.9	0.0	0.0	0.0	0.0	0.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 2038.6;Ito cells: 615.0;Leydig cells: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 91.8;BJ: 176.2;fHDF/TERT166: 266.1;HHSteC: 71.8;HSkMC: 134.8;U-138 MG: 143.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		58000000	"Endoplasmic reticulum, Vesicles"		"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	37.7	91.8	1.6	176.2	47.9	43.9	27.6	3.5	0.8	0.0	0.4	266.1	0.3	0.5	0.4	0.1	7.9	0.2	0.3	0.0	4.4	0.2	71.8	0.0	0.0	134.8	2.6	53.7	0.2	7.3	0.0	0.2	0.1	0.0	22.1	0.4	0.0	0.0	0.9	0.6	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.5	0.3	0.2	0.0	13.7	2.2	0.0	0.0	143.2	31.3	21.4	0.8	0.1	0.3	0.0	10.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7	8.9	14.4	0.5	11.0	166.9	0.0	4.8	0.0	5.3	12.5	7.0	0.0	29.5	0.0	11.2	0.9	5.1	0.0	0.0	3.7	26.1	2038.6	12.1	2.3	1.9	59.9	0.0	2.9	615.0	0.8	4.5	514.8	7.7	178.8	0.0	2.2	2.8	25.7	0.0	252.1	0.5	0.1	77.6	273.4	4.2	1.7	142.9	93.5	0.5	1.3	7.5
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	57.1	154.3	185.1	0.0	151.4	111.2	24.9	33.3	0.0	0.1	0.0	0.1	512.4	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	160.7	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.5	63.6	0.0	39.4	4.2	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1	3.0	17.5	0.0	0.5	198.1	0.1	13.3	0.0	1.4	5.7	1.8	0.0	23.0	0.0	2.8	7.1	30.1	0.0	0.0	0.2	19.3	1445.8	1.2	9.3	1.1	95.1	0.0	0.0	427.2	1.0	22.0	918.4	12.0	226.0	4.6	0.0	3.0	8.5	0.0	470.9	0.3	0.3	297.5	291.6	5.1	3.2	163.7	59.2	0.0	0.0	0.7
COL20A1	KIAA1510	ENSG00000101203	"Collagen type XX alpha 1 chain"	Q9P218	20	63293186-63334851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"brain: 21.6"	"Cell type enhanced"	"Detected in some"	18	"Horizontal cells: 3.2;Late spermatids: 1.8;Spermatocytes: 8.1;Spermatogonia: 3.6"	"Cancer enriched"	"Detected in single"	19	"glioma: 8.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.6;SK-MEL-30: 3.3;SuSa: 1.5;U-266/70: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (6.34e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.41e-7)"	"unprognostic (7.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.16e-1)"	0.6	0.9	6.9	0.6	3.9	0.6	0.5	2.2	21.6	1.0	0.6	14.0	0.0	0.5	0.5	1.2	0.5	0.6	0.5	0.6	5.6	3.0	0.6	0.6	0.5	0.5	4.7	4.5	0.7	0.5	0.5	1.1	0.6	3.5	0.6	0.5	0.7	0.8	0.6	0.5	0.5	0.6	0.5	4.3	2.0	0.5	3.0	5.0	0.0	0.5	0.2	0.5	0.5	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	1.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.1	2.5	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	6.9	3.9	2.2	6.3	5.6	3.0	4.7	4.5	3.5	5.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	1.4	0.0	0.0	8.1	3.6	0.0	0.0	0.0	0.0	0.0
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3"									HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8	0.0	1.0	0.0	2.3	5.3	0.0	36.4	0.0	58.9	12.5	0.0	0.0	17.6	0.0	0.0	3.5	3.4	0.0	0.0	0.0	52.2	33.7	0.1	0.0	0.0	5.4	0.0	0.0	4.3	0.8	1.1	14.1	1.0	5.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	6.6	0.2	0.6	3.6	19.5	0.0	0.0	1.5
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
COL24A1		ENSG00000171502	"Collagen type XXIV alpha 1 chain"	Q17RW2	1	85729233-86156943	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 59.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2"	"Low region specificity"	"Detected in some"												"Secreted to extracellular matrix"	NA	NA		12000				"unprognostic (3.00e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.44e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.48e-6)"	"unprognostic (2.79e-5)"	"unprognostic (5.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.90e-2)"	1.1	0.4	6.2	3.4	7.1	2.3	1.1	1.7	18.0	7.0	9.5	0.3	0.0	4.1	3.6	2.4	2.2	0.6	4.4	4.1	12.1	1.2	1.5	0.3	1.7	1.0	1.1	5.2	6.9	0.3	0.2	2.0	0.3	1.7	2.3	2.4	2.4	1.2	4.3	1.4	1.6	3.7	2.8	1.0	0.8	3.4	1.9	2.9	0.0	0.8	2.6	0.8	8.3	4.9	0.0	6.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.5	0.0	3.4	0.6	0.0	0.6	0.1	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.9	0.0	1.4	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	3.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	6.0	0.9	0.0	0.0	0.2	3.1	0.0	0.0	0.0	4.4	0.5	0.6	1.1	0.1	0.0	0.0	0.2	0.5	4.6	0.0	0.9	0.0	2.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	6.2	0.0	0.0	6.2	7.1	1.7	18.0	12.1	1.2	1.1	5.2	1.7	2.9	0.0	1.1	1.9	0.0	0.3	2.2	1.6	0.0	2.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.0	59.8	0.0	0.0	0.7	0.0	1.1	0.0	0.0	1.1	0.4	0.1	0.0	0.0	0.0	0.0
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362820-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.4;brain: 18.3"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"					"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in some"		"AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.1	2.5	0.3	7.0	0.3	0.2	0.4	18.3	0.1	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.2	0.3	0.1	3.3		3.1	4.8	0.6	0.9	0.0	8.1	0.2	3.1	6.7	0.0	0.5	0.6	3.7	0.0	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.3	0.4	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	20.3	1.2	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.2	0.0	0.0	0.0	7.2	0.0	0.0	0.7	0.8	0.0	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.1	13.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	2.6	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.3	0.0	0.0	0.5
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155560-114312511	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9;cervix, uterine: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 56.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.2;Hep G2: 25.5"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	23	"cerebellum: 141.7"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	4.7	4.2	6.0	4.2	4.6	0.1	4.1	56.9	5.7	41.9	4.4	2.6	5.7	2.9	25.9	17.0	3.6	6.4	6.3	3.3	4.9	1.7	11.0	16.5	4.4	2.9	5.8	1.8	13.1	12.9	0.7	2.2	9.0	8.6	9.8	1.0	9.6	4.1	11.3	4.0	11.9	3.5	8.4	7.3	3.0	9.7	2.7	5.1	2.8	6.1	5.2	3.2	5.7	17.9	0.9	0.4	2.0	0.2	0.5	0.3	0.1	2.0	4.1	9.8	3.5	0.7	1.1	30.2	4.7	3.2	3.4	2.9	4.3	0.1	0.0	1.2	2.3	2.6	4.9	3.3	4.4	1.9	0.0	0.4	0.0	3.4	25.5	1.0	0.0	10.9	2.7	1.2	4.2	1.9	1.9	5.1	4.0	0.0	1.0	1.9	0.9	0.0	1.8	3.5	8.0	1.1	13.6	9.9	1.9	8.1	2.2	0.1	0.1	0.2	0.1	0.5	3.9	0.9	3.1	4.7	3.0	6.1	0.4	7.3	0.5	0.0	0.0	2.5	0.0	4.6	0.6	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.2	2.0	0.5	0.1	0.4	0.2	0.1	6.0	4.6	56.9	5.7	4.9	1.7	5.8	1.8	8.6	5.1	3.0	16.5	1.5	4.6	24.2	0.6	24.9	73.9	0.0	6.8	8.7	5.9	0.7	3.3	9.2	1.1	3.6	0.0	0.0	4.3	60.6	14.4	5.3	0.0	35.8	5.2	1.6	4.6	6.2	1.0	0.9	17.8	0.6	21.9	0.0	1.6	6.1	5.4	0.8	4.2	5.7	1.0	25.8	35.4	0.2	1.9	19.6	1.9	0.0	2.2	1.6
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 16.0;Cone photoreceptor cells: 17.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9"	"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.3	2.0	0.2	0.3	0.0	0.9	1.2	0.5	0.0	0.1	0.0	3.3	0.1	0.2	0.0	0.1	1.0	0.0	0.5	0.1	0.9	1.0	0.0	0.7	1.8	0.0	14.2	3.8	0.0	0.2	0.8	6.9	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2	0.0	2.6	0.0	0.1	0.2	4.6	0.8	0.0	16.0	5.7	3.5	17.7	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.1	4.8	0.0	3.1	0.0	0.8	0.9	0.0	0.0	0.0	0.3	2.4	0.5	2.8	0.7	0.3	4.5	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.3	0.1
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 55.2;HAP1: 34.6;HEK 293: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	No	NA			Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	34.6	0.0	0.0	0.0	12.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.0	42.2	0.0	0.0	7.1	0.9	0.0	0.0	0.0	0.3	19.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.7	0.0	0.7	0.0	0.9	0.1
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 1855.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		16000000	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	3.1	151.5	263.7	0.0	32.9	29.3	14.4	12.9	0.4	0.0	0.0	0.0	106.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	13.9	0.0	104.2	0.1	0.0	196.1	0.0	17.5	2.8	0.0	0.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	60.2	0.0	0.0	0.0	0.1	1.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7	3.0	20.2	0.0	0.4	152.4	0.0	9.8	0.0	2.7	2.3	0.0	0.0	40.3	0.0	2.5	21.6	52.5	0.0	0.0	0.0	34.9	1855.8	0.5	5.8	0.9	81.7	0.0	5.8	358.5	0.8	11.8	299.1	3.8	163.6	0.0	0.0	0.0	6.1	0.0	221.7	0.0	0.0	446.3	215.4	1.1	1.0	136.1	105.6	0.0	0.0	0.3
COL4A1		ENSG00000187498	"Collagen type IV alpha 1 chain"	P02462	13	110148963-110307149	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 163.4"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 577.1;Ito cells: 181.7;Sertoli cells: 498.0;Smooth muscle cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.0;EFO-21: 126.5;TIME: 45.0"	"Low region specificity"	"Detected in many"							CAB001695	Approved				"Secreted to extracellular matrix"	NA	NA		55000			"CAB001695: "	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.47e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-2)"	86.0	10.0	1.6	23.5	3.0	0.2	65.2	1.5	2.0	20.5	27.7	1.6	14.3	4.4	52.3	21.8	20.6	18.8	38.8	29.2	2.5	1.5	21.1	5.7	37.3	28.9	2.6	1.0	20.0	8.5	9.1	3.9	163.4	5.0	24.6	5.9	7.6	5.9	17.3	24.6	6.9	11.6	58.1	4.1	60.5	16.0	8.7	1.1	3.1	16.5	9.0	3.8	47.0	24.5	0.0	0.4	1.1	0.1	0.0	0.0	0.0	5.1	2.0	26.7	0.0	74.0	19.9	37.6	33.7	8.0	18.6	9.2	0.5	0.0	0.0	126.5	6.2	8.1	3.5	0.0	7.6	4.2	0.1	3.9	0.0	4.0	0.0	20.8	0.0	0.0	7.2	1.1	18.4	8.4	29.2	28.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	3.7	0.0	0.4	0.0	7.9	0.0	39.8	0.0	0.1	3.6	0.0	0.0	7.4	28.5	0.0	1.7	45.0	5.5	16.6	0.1	12.8	0.0	0.1	0.2	0.0	0.0	40.1	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	3.0	1.5	2.0	2.5	1.5	2.6	1.0	5.0	1.1	38.7	12.8	3.4	7.1	12.5	0.7	31.3	7.6	4.0	1.2	22.7	0.0	40.0	1.7	11.1	0.5	125.5	0.0	0.0	0.2	577.1	125.0	3.3	1.1	0.8	24.5	0.0	0.0	181.7	6.3	0.7	35.6	3.9	28.7	1.0	0.3	2.8	0.5	0.0	102.9	11.3	0.3	498.0	250.4	1.2	5.1	13.2	37.6	0.0	0.2	0.9
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513027	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 125.7"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 145.1;WM-115: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		1900000	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	87.2	9.5	4.6	26.1	3.3	0.1	50.1	2.0	3.0	37.2	53.1	1.9	30.3	7.6	48.4	25.5	23.0	26.3	52.4	26.6	3.6	1.4	18.4	5.7	35.9	17.5	3.8	1.7	25.7	8.3	7.3	3.8	125.7	5.0	26.9	5.5	12.2	7.6	29.3	26.3	9.2	16.9	84.1	2.8	58.5	23.4	11.0	1.9	4.2	16.0	8.0	5.7	65.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	6.6	30.1	0.0	39.2	16.3	47.4	40.8	14.8	24.3	11.4	0.7	0.0	0.0	145.1	9.5	10.7	11.4	0.0	12.2	4.7	1.5	6.3	0.0	11.2	0.3	28.9	0.0	0.1	7.3	0.7	17.0	11.7	31.1	25.4	0.0	0.0	0.1	4.0	0.2	0.0	1.0	4.7	0.2	2.3	0.0	12.4	0.0	26.8	0.2	0.9	4.9	0.0	0.1	12.8	13.5	0.0	0.5	43.7	13.4	34.1	0.3	22.1	0.0	0.2	0.6	0.3	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	3.3	2.0	3.0	3.6	1.4	3.8	1.7	5.0	1.9	77.4	8.0	1.4	6.5	8.5	2.0	27.9	25.5	2.7	2.3	50.6	0.0	67.8	1.7	25.5	1.6	98.7	13.4	0.0	3.7	463.3	94.4	2.1	1.1	1.6	26.8	0.0	0.0	139.3	5.4	1.5	56.1	5.8	37.1	3.6	5.1	9.5	2.8	0.0	165.5	16.1	0.2	368.7	174.9	0.2	8.1	6.0	56.2	0.0	3.7	1.2
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	1.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	1.1	0.0	9.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	2.8	10.1	2.0	0.4	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.3	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4	157.8	24.8	4.7	0.0	0.1	58.0	1.7	0.0	0.0	17.0	40.1	375.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.8	0.0	1.7	0.0	0.0	214.6	0.9	0.0	11.3	1.0	11.5	12.9	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002711-227164453	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.7"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 68.5;Collecting duct cells: 43.6;Cone photoreceptor cells: 53.0;Muller glia cells: 117.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"memory B-cell: 8.0"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 23.1;hTERT-RPE1: 19.7;Karpas-707: 6.3;RPTEC TERT1: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.6	8.8	1.2	7.2	2.4	0.2	1.3	1.0	1.8	1.0	1.1	0.7	16.1	1.2	4.8	12.7	2.4	3.0	13.7	11.5	1.4	1.5	28.7	1.9	15.8	13.0	2.4	0.0	3.2	6.6	0.5	15.3	0.7	7.4	7.2	1.2	8.3	1.4	10.9	7.5	0.9	3.3	12.0	4.6	3.7	1.9	1.9	1.5	0.9	12.1	6.6	6.2	3.9	3.7	8.0	0.0	0.1	0.0	1.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	0.0	0.5	0.0	1.2	0.0	0.5	0.0	2.2	0.7	0.2	0.0	2.4	0.0	23.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	19.7	0.0	0.7	0.0	6.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	10.6	3.9	0.6	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.2	4.8	3.5	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	2.4	1.0	1.8	1.4	1.5	2.4	0.0	7.4	1.5	68.5	17.9	2.2	0.4	0.5	29.8	2.6	15.3	0.0	11.4	43.6	53.0	0.0	1.7	0.2	0.7	0.3	0.0	0.0	3.2	0.0	0.7	0.1	0.0	0.5	0.1	0.0	1.2	2.5	0.3	2.1	23.3	0.7	0.0	0.0	0.0	117.3	3.3	0.0	25.5	2.2	7.4	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439844-108697545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077177			Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA077177: "	"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	3.3	2.7	13.1	1.7	27.7	0.3	5.8	1.8	16.1	16.9	3.7	47.2	9.5	2.7	31.4	18.2	6.9	19.3	12.6	5.9	13.9	6.2	5.9	1.7	5.9	0.9	46.6	15.7	11.5	2.8	22.3	10.2	9.7	19.5	18.0	4.1	5.8	3.7	23.9	4.8	17.5	3.1	32.8	20.5	2.8	17.7	2.8	40.5	0.0	5.4	0.9	0.9	23.9	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.8	15.8	5.0	6.2	3.6	0.1	0.9	3.9	4.8	7.9	7.9	0.6	1.3	0.0	0.6	2.9	7.1	4.4	14.9	6.1	2.1	3.8	1.1	28.5	0.9	32.8	0.0	4.5	17.0	18.1	5.9	12.7	15.4	30.8	0.0	0.0	0.0	4.6	0.6	0.0	0.1	4.7	0.0	5.3	0.0	0.0	0.0	12.0	8.8	0.0	0.0	23.0	0.7	1.9	23.3	4.3	0.0	29.1	3.2	1.0	2.1	1.3	0.6	0.0	0.0	2.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	27.7	1.8	16.1	13.9	6.2	46.6	15.7	19.5	40.5	6.0	5.3	0.0	25.8	23.9	0.3	8.9	0.0	4.0	11.4	19.2	0.0	0.6	0.0	0.2	0.1	2.9	0.0	0.0	0.8	0.3	8.5	8.2	1.1	0.4	0.4	0.0	0.0	4.9	0.3	1.2	18.7	0.8	1.7	0.0	0.0	13.0	0.5	0.0	34.6	0.0	0.4	6.5	18.6	0.3	0.7	13.9	0.6	0.0	0.0	22.6
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 19.4;Cardiomyocytes: 9.2;Muller glia cells: 7.7;Peritubular cells: 8.5;Smooth muscle cells: 8.0;Urothelial cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.4;HeLa: 16.2;HHSteC: 24.9;hTERT-HME1: 18.2;HUVEC TERT2: 16.8;TIME: 37.6"	"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	4.0	0.0	10.1	0.7	0.0	0.0	0.7	0.1	0.1	7.1	0.0	0.0	0.0	0.0	1.6	2.3	4.1	18.4	0.3	0.1	3.5	0.3	16.2	0.1	24.9	0.0	0.0	1.0	11.4	2.6	18.2	0.0	16.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.6	0.0	1.5	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.9	0.0	0.0	7.8	0.3	0.0	37.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7	0.0	0.0	0.0	19.4	5.7	0.0	9.2	0.0	2.7	2.3	1.8	0.0	0.1	1.7	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.9	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.7	0.1	0.0	8.5	0.0	0.2	0.0	8.0	0.3	0.2	3.1	0.0	0.0	0.0	10.6
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641774-134844843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 110.7"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 127.8;Leydig cells: 56.7;Peritubular cells: 36.4;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;fHDF/TERT166: 67.3;HeLa: 48.1;HHSteC: 45.8;SiHa: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		12000000	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	11.5	4.2	1.5	13.7	1.4	0.0	9.5	3.0	1.2	110.7	20.9	1.4	11.8	3.6	42.1	24.1	12.3	20.5	31.8	12.2	1.8	0.9	4.3	3.4	13.4	7.8	3.0	1.3	19.5	3.7	3.7	2.6	53.8	2.2	23.3	4.7	9.1	5.1	9.9	5.0	6.9	8.7	26.7	1.5	6.5	12.5	9.5	1.1	2.7	4.1	10.1	4.0	21.8	22.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	2.1	3.4	32.6	35.1	1.3	72.5	14.6	12.4	13.3	0.0	0.0	0.0	16.1	67.3	6.6	0.9	0.0	0.0	3.5	0.0	0.1	0.0	48.1	0.0	45.8	0.0	0.4	34.4	0.0	11.9	0.9	0.0	14.7	0.0	0.0	0.2	6.5	0.6	0.0	0.1	1.2	0.0	1.4	2.5	8.4	0.3	0.0	0.0	0.9	0.4	47.8	0.3	0.0	30.7	0.1	0.0	25.1	26.0	10.8	31.9	15.1	0.0	0.0	0.0	20.6	0.0	4.4	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	3.0	1.2	1.8	0.9	3.0	1.3	2.2	1.1	0.0	2.6	0.0	3.4	12.9	0.3	5.6	0.0	0.0	0.0	1.8	2.0	4.0	1.7	1.3	5.2	6.8	0.0	0.0	0.0	10.7	127.8	0.4	0.0	0.0	8.0	0.0	0.0	32.5	0.3	11.4	56.7	0.5	6.8	0.0	0.0	6.9	1.9	0.0	36.4	0.1	0.6	51.8	23.2	0.5	0.6	6.8	8.7	0.0	0.0	0.3
COL5A2		ENSG00000204262	"Collagen type V alpha 2 chain"	P05997	2	189031896-189179879	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Fibroblasts: 166.6;Ito cells: 41.1;Leydig cells: 45.1;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 68.1;BJ hTERT+ SV40 Large T+ RasG12V: 58.6;fHDF/TERT166: 63.4;HSkMC: 52.3;SuSa: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		230000				"unprognostic (7.45e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.53e-10)"	"unprognostic (4.57e-3)"	"unprognostic (3.76e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.58e-4)"	31.8	2.9	1.8	14.9	4.7	0.0	18.1	0.6	8.8	51.7	25.9	0.9	5.0	3.5	42.6	19.1	11.5	13.2	30.6	11.3	5.6	1.7	3.5	4.2	15.1	9.2	1.1	4.3	13.6	3.9	2.5	4.6	40.3	1.9	13.5	9.4	4.4	4.9	5.3	3.7	7.8	12.9	35.1	2.3	8.8	13.6	10.1	0.4	1.3	6.2	18.7	5.8	19.7	18.8	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	11.0	21.5	9.7	32.7	44.3	0.0	31.7	36.1	68.1	58.6	9.0	0.0	0.0	0.3	63.4	3.4	0.2	0.4	0.2	23.3	0.0	0.1	0.1	0.1	0.0	44.1	0.0	0.0	52.3	0.8	19.4	6.8	13.9	16.1	0.0	0.0	0.0	15.9	0.2	0.0	0.0	3.1	0.0	10.7	0.0	4.7	0.0	0.0	2.7	0.1	0.1	0.4	0.3	0.7	59.2	0.2	0.0	13.4	32.5	3.5	7.6	6.4	0.0	0.0	0.0	4.8	0.0	34.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	4.7	0.6	8.8	5.6	1.7	1.1	4.3	1.9	0.4	0.0	1.0	0.0	0.1	23.2	1.7	1.6	0.0	1.4	0.0	1.8	0.0	3.6	1.7	0.7	0.5	5.8	0.0	0.0	0.6	2.9	166.6	0.4	0.0	5.5	6.0	0.0	37.1	41.1	0.8	0.5	45.1	0.7	20.3	1.0	0.2	0.6	1.6	0.0	18.4	1.0	0.5	45.3	33.5	2.6	1.6	16.4	5.1	0.0	0.0	0.4
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010471	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 63.5;Sertoli cells: 90.5;Smooth muscle cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 23.9;BJ: 13.8;BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 8.6;HSkMC: 17.2;WM-115: 15.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048256	Approved				"Secreted to extracellular matrix"	NA	NA		210000			"HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	48.9	2.6	11.6	10.8	15.9	0.4	27.0	3.2	11.9	24.5	7.8	3.2	3.1	3.6	17.5	9.8	11.3	8.1	10.7	9.5	10.1	3.0	1.9	4.1	6.4	9.2	5.2	3.5	3.4	3.8	3.2	0.9	30.2	4.5	6.8	2.2	9.7	5.1	9.1	15.4	19.0	3.9	9.6	2.5	1.3	3.4	5.3	2.6	1.6	4.5	11.5	4.7	7.3	10.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	7.6	23.9	0.0	13.8	15.5	8.6	3.4	0.0	0.0	0.0	0.1	2.5	0.2	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	17.2	0.3	3.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.1	0.0	0.0	0.0	7.0	3.2	0.3	0.0	0.0	0.0	0.0	0.9	0.0	15.4	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	15.9	3.2	11.9	10.1	3.0	5.2	3.5	4.5	2.6	0.0	0.0	0.0	0.1	3.8	63.5	3.1	0.0	1.4	0.0	0.0	5.9	0.1	0.0	0.1	5.8	3.8	0.0	0.0	0.0	0.2	13.8	0.3	0.0	17.3	0.5	3.2	0.0	6.7	0.0	0.9	16.1	0.0	13.5	0.0	0.0	1.6	0.3	0.0	7.8	0.0	22.9	90.5	30.6	0.2	0.1	6.1	0.1	0.0	0.0	0.3
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981737-46005050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 779.8;Leydig cells: 326.8;Peritubular cells: 236.2;Smooth muscle cells: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 94.0;ASC TERT1: 191.4;BJ: 71.8;HHSteC: 83.5;HSkMC: 139.9;U-138 MG: 104.8"	"Low region specificity"	"Detected in all"							"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	73.4	10.8	6.8	45.5	7.1	0.1	85.4	31.9	9.1	100.7	111.6	5.1	34.7	17.1	98.8	75.0	54.5	64.7	89.7	39.7	6.0	5.6	10.2	9.9	21.6	24.7	4.8	5.4	83.0	13.5	6.2	19.8	65.7	9.2	59.6	9.9	18.6	23.1	36.4	20.0	28.2	33.8	147.8	4.7	15.9	40.9	20.2	5.5	9.4	15.9	23.4	12.8	86.9	49.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	1.5	2.4	7.8	94.0	191.4	0.3	71.8	46.4	18.5	6.5	1.2	4.9	0.0	5.9	40.4	14.6	0.3	1.0	0.1	1.5	0.0	1.1	0.0	0.2	0.4	83.5	0.0	0.1	139.9	0.0	46.0	0.6	1.6	0.4	0.0	0.0	0.0	4.7	0.1	0.0	0.2	1.7	1.0	20.2	0.0	1.5	0.3	0.1	0.8	0.0	3.1	6.6	0.0	1.3	0.8	0.3	0.3	0.0	104.8	7.0	28.7	27.4	0.0	0.0	0.0	37.4	0.5	9.1	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.1	31.9	9.1	6.0	5.6	4.8	5.4	9.2	5.5	0.0	8.0	0.0	9.3	108.5	14.9	33.6	2.5	1.4	7.9	8.7	0.0	9.8	3.3	23.9	4.1	30.5	0.9	0.0	2.7	15.4	779.8	4.8	1.1	11.4	20.9	14.3	1.7	138.1	4.8	7.9	326.8	5.6	140.0	3.6	0.0	22.6	7.8	0.3	236.2	11.6	2.3	181.1	211.6	2.6	4.7	78.5	17.4	2.5	0.6	2.4
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098097-46132849	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 1607.7;Leydig cells: 560.6;Peritubular cells: 443.7;Smooth muscle cells: 512.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 95.7;ASC TERT1: 177.1;BJ: 85.2;BJ hTERT+: 79.3;HHSteC: 93.9;HSkMC: 126.5;U-138 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8900000	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	81.2	8.7	1.5	65.0	2.7	0.2	116.7	1.8	2.7	103.5	112.6	4.7	75.0	15.3	127.2	160.3	55.5	66.5	179.8	90.6	2.1	1.3	9.6	9.1	38.7	38.3	3.2	3.8	76.1	14.8	2.7	11.8	52.6	8.8	81.0	9.8	23.5	33.4	81.4	30.6	37.8	38.1	231.3	5.8	23.6	49.0	33.2	1.8	9.8	19.9	58.5	17.2	107.2	76.1	0.0	0.0	0.0	0.0	0.5	7.6	0.7	0.7	0.9	2.8	2.5	95.7	177.1	0.8	85.2	79.3	21.6	9.9	0.1	3.3	0.0	6.4	61.1	13.9	0.0	0.6	0.0	1.7	0.0	0.9	0.0	0.0	0.0	93.9	0.0	0.3	126.5	0.0	40.8	0.8	0.0	0.0	0.0	0.0	0.0	8.6	0.4	0.0	0.1	1.5	0.0	10.4	0.0	5.4	0.1	0.0	0.0	0.0	4.4	3.3	0.0	0.0	1.6	0.1	0.5	0.0	92.4	10.8	34.0	21.0	0.0	0.0	0.0	47.2	0.0	13.1	0.0	0.0	0.0	7.6	0.0	5.1	0.0	0.7	3.8	0.0	0.0	0.8	2.1	0.0	0.5	0.0	0.0	0.1	0.7	1.5	2.7	1.8	2.7	2.1	1.3	3.2	3.8	8.8	1.8	3.0	1.1	0.0	4.5	146.1	0.1	6.7	0.0	0.0	1.2	7.0	0.0	14.3	0.0	14.0	3.2	42.2	0.0	0.0	0.3	22.5	1607.7	10.7	0.0	0.9	32.2	0.0	0.0	166.3	6.8	7.6	560.6	4.3	172.1	3.6	0.0	3.9	6.9	0.0	443.7	0.2	0.4	291.1	512.9	2.7	10.7	122.7	33.8	8.7	0.2	2.5
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414375	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease mutation, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Fibroblasts: 396.3;Leydig cells: 291.6;Peritubular cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 206.4;ASC TERT1: 265.7;BJ hTERT+: 77.0;HSkMC: 168.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.6"	"Not detected"	"Not detected"			"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		990000000	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	95.3	2.7	0.4	22.2	1.2	0.0	48.6	0.4	0.6	104.9	29.9	1.0	27.6	3.9	101.6	70.1	31.9	33.2	47.9	33.0	0.6	0.4	6.8	3.0	24.8	32.7	0.8	0.3	61.9	12.9	2.5	1.3	35.6	1.7	47.2	9.9	1.0	17.1	16.3	31.8	10.8	17.7	73.0	0.7	17.2	16.5	25.8	0.1	4.2	18.5	22.5	8.3	74.8	39.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	206.4	265.7	3.7	48.7	77.0	10.2	11.6	0.0	0.0	0.2	0.0	48.4	4.1	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	41.9	0.0	0.0	168.7	0.0	36.3	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.1	2.7	1.6	8.3	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.8	0.3	1.7	0.1	0.0	17.5	0.0	0.5	54.3	0.8	5.8	2.5	1.4	6.8	0.0	0.0	4.8	0.0	0.9	4.6	4.7	0.0	0.0	0.0	4.6	396.3	0.8	1.1	1.5	7.1	0.0	0.0	41.7	1.0	4.0	291.6	4.3	69.2	2.8	0.0	0.5	3.9	0.0	97.2	0.0	2.5	32.3	52.3	1.2	1.0	53.8	4.8	2.9	0.0	0.8
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"lung: 9.6;skin 1: 11.1"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 3.1;Club cells: 1.2;Early spermatids: 4.1;Late spermatids: 2.4;Suprabasal keratinocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	63	"HDLM-2: 18.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"	NA	NA					"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.2	0.0	0.2	0.2	0.5	0.1	1.0	0.2	0.2	0.2	0.4	0.2	0.2	1.5	0.2	0.2	2.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	9.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	11.1	1.8	0.2	0.2	0.2	1.5	1.1	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SuSa: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		490000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	2.3	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0			0.0	0.7	0.3	1.2	0.3	0.0	5.6	0.0	0.0	0.0	0.9	11.1	0.0	0.0		0.2	0.0	0.0	5.7	0.8		0.0	0.0		2.2	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	5.5	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0											0.0	1.4	0.0	0.0	0.8	1.2	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.4	0.6	0.1	0.0	0.0	0.0
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	8.0	0.3	0.1	3.0	4.1	10.0	20.8	13.1	5.5	3.3	0.1	0.1	0.0	0.6	4.7	5.0	20.0	0.0	31.9	1.0	30.1	0.1	0.0	39.2	1.3	8.4	0.0	0.1	6.6	19.1	11.1	8.7	7.5	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.2	1.0	0.4	0.4	0.1	0.7	0.0	3.0	0.0	0.0	0.0	26.2	0.0	0.2	1.2	0.4	0.1	0.0	1.8	1.0	1.0	15.5	0.6	0.5	0.0	16.0	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7	0.0	0.0	0.5	22.7	64.5	15.5	5.3	0.0	0.0	13.6	10.4	9.8	1.0	0.0	0.6	11.6	0.8	0.2	0.0	0.6	0.8	2.6	2.0	0.0	0.4	1.5	7.9	1.7	0.0	0.3	3.8	4.6	0.7	8.5	0.0	0.2	2.3	9.3	0.0	5.3	0.0	11.7	0.0	8.5	2.8	0.9	21.1	1.0	0.0	0.0	4.6
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 229.3;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.3	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.2	0.2	0.0	0.0	11.6	23.4	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	63.4	17.4	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	64.9	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.2	0.0	32.0	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6	229.3	23.2	0.0	0.4	0.7	0.4	4.2	0.0	1.4	6.8	8.7	0.0	0.1	0.0	0.2	0.7	1.5	0.0	0.0	0.0	0.2	2.4	0.1	4.7	0.8	0.1	0.0	0.0	85.3	1.9	0.4	2.0	0.9	1.7	0.0	0.0	0.5	0.1	0.0	8.9	0.8	0.5	0.0	8.3	0.3	0.2	0.5	0.3	1.0	0.0	0.2
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.6	1.6	1.5	0.9	0.2	0.1	0.0	0.8	4.1	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.2	0.0	0.0	1.7	0.1	0.7	0.0	18.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.5	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5	0.0	2.6	0.0	1.6	1.9	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	13.4	0.7	2.3	0.0	6.5	0.0	0.0	0.6	1.9	0.0	2.8	5.1	6.8	0.0	0.0	0.3	0.4	0.0	5.6	0.0	0.0	6.5	2.3	0.0	0.1	1.1	0.7	0.0	0.0	0.4
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70215061-70303083	"Disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.6;retina: 52.6"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 18.1;Horizontal cells: 33.4;Muller glia cells: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 23.7;NTERA-2: 8.0"	"Not detected"	"Not detected"							HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.7	0.6	8.5	0.7	7.5	0.5	0.6	3.6	4.7	0.6	1.1	7.2	0.0	1.8	1.1	0.8	0.8	0.7	1.1	5.6	8.4	9.4	1.1	0.5	0.6	0.6	10.3	1.7	0.6	0.5	0.9	3.3	0.6	5.6	29.6	1.4	52.6	3.0	1.1	0.6	0.6	2.0	0.9	5.3	0.6	2.6	4.1	6.9	0.0	1.0	0.2	0.7	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.5	3.6	4.7	8.4	9.4	10.3	1.7	5.6	6.9	0.0	0.0	0.0	0.1	0.0	0.2	3.5	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	18.1	0.0	0.2	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.1	33.4	1.2	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.4	88.9	0.0	0.0	0.4	0.0	1.8	0.0	1.4	0.6	0.7	0.0	0.0	0.0	1.1	0.1
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 280.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1.0	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0.0	0.7	0.0	0.0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0.0	0.0	0.0	0.2	0.0	0.5	0.0	7.4	0.0	0.9	0.4	0.7	0.8	0.0	0.4	0.8	0.0	2.4	0.0	5.2	0.5	0.8	0.0	4.4	0.4	2.6	5.6	38.3	0.0	0.0	4.5	0.0	0.1	0.5	0.0	1.2	0.3	4.5	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0.0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0.0	2.3	0.0	6.3	0.0	0.0	3.3	0.0	0.7	0.4	1.4	7.8	26.4	0.0	3.3	0.0	12.2	1.3	0.3	0.8	2.0	6.5	1.7	30.7	5.5	280.3	3.6	7.0	0.0	0.1	7.8	0.0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3"	"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	53.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.5	21.2	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	2.4	2.9	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.6	1.8	0.1	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2	3.0	0.0	13.7	1.7	2.9	1.0	1.2	0.0	0.0	0.0	5.2	9.8	4.0	1.7	1.3	120.8	3.1	0.9	0.0	0.0	35.4	10.4	0.9	0.0	2.4	2.1	0.0	4.1	3.1	2.7	311.3	3.7	1.3	3.3	0.0	2.6	91.3	0.1	6.2	1.4	9.5	2.5	0.0	1.1	2.5	4.1	6.0	3.3	0.0	1.5	0.8
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119106582	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.4"	"Cell type enriched"	"Detected in single"	42	"Ito cells: 16.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.4;HHSteC: 3.5;SK-BR-3: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		5700000				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.1	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	8.4	0.1	0.1	0.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.9;liver: 57.4"	"Group enriched"	"Detected in many"	6	"Ito cells: 128.3;Peritubular cells: 49.1;Proximal tubular cells: 111.2;Sertoli cells: 71.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HHSteC: 53.7;SH-SY5Y: 48.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035241	Uncertain				"Secreted to blood"	NA	NA		30000000			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	3.7	13.2	0.5	0.5	1.2	0.6	1.7	0.7	1.4	0.5	1.7	1.3	0.8	1.7	0.7	1.0	1.2	1.4	61.9	14.8	0.9	0.1	7.9	57.4	0.9	1.8	0.6	0.5	15.8	6.5	0.2	2.0	2.8	3.6	1.6	0.1	1.0	0.8	0.5	1.0	0.4	3.0	1.6	0.7	1.4	0.7	2.5	0.5	0.7	5.5	0.6	0.5	1.8	1.5	1.2	0.8	4.0	0.8	1.2	1.8	0.2	0.0	0.4	0.2	0.8	0.0	0.0	4.5	0.2	0.0	0.1	0.0	0.3	0.0	0.1	1.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.4	1.5	53.7	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.2	3.8	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.6	48.5	0.5	0.3	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.2	0.1	1.0	7.8	0.4	0.1	0.4	0.2	1.9	0.8	1.2	0.6	0.2	0.5	0.6	0.3	0.3	0.3	1.2	1.8	1.0	4.0	1.2	0.4	0.8	0.3	0.2	0.5	1.2	0.7	1.4	0.9	0.1	0.6	0.5	3.6	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	14.9	0.0	0.3	1.8	0.0	0.0	0.0	0.9	12.4	0.1	0.0	6.8	2.3	0.0	0.0	128.3	3.5	0.4	6.9	0.0	3.3	0.0	0.0	0.3	0.1	0.0	49.1	111.2	0.0	71.1	4.0	0.4	11.1	0.6	1.0	0.0	0.0	0.0
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Group enriched"	"Detected in some"	5	"BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.2	1.5	1.0	17.3	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.3	0.1	0.2	0.3	0.4	0.5	5.6	1.2	0.6	0.7	0.2	0.2	0.4	1.2	0.8	0.4	0.8	0.3	0.8	0.3	1.5	0.0	0.6	0.8	0.3	0.6	1.8	0.2	0.0	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.8	0.2	0.1	0.4	1.9	1.2	0.8	0.1	0.2	1.1	1.9	0.6	1.7	1.5	0.1	0.1	8.7	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4	0.0	1.1	0.0	0.1	0.2	0.3	0.7	0.0	6.7	2.3	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.8	0.2	6.4	1.2	2.5	0.0	11.3	1.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	4.2	0.0	0.6	0.0	0.2	0.7	0.2	0.1	1.9	1.3	0.0	0.0
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 32.0;Fibroblasts: 20.3;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 138.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		1100000000	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (9.08e-5)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	138.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0	3.0	0.3	0.0	0.5	10.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.0	0.7	0.0	0.0	0.2	0.2	20.3	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	53.4	0.9	0.0	10.1	0.0	0.0	1.8	0.1	0.0	0.7	0.0	0.3	6.5	6.4	3.1	1.5	6.1	0.5	0.0	0.0	0.3
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.2	22.2	23.6	22.9	60.8	50.1	27.7	38.9	46.3	33.2	39.2	28.9	19.3	20.8	25.3	59.1	19.1	28.5	27.2	28.0	38.3	23.6	18.4	23.9	30.6	30.4	45.7	29.1	25.1	46.8	17.1	44.3	41.3	41.1	38.9	19.9	22.1	23.3	39.6	20.7	18.7	12.6	25.8	37.2	26.0	16.8	27.1	32.0	27.2	26.8	19.6	24.8	44.0	38.7	41.1	41.4	43.1	39.3	45.8	25.0	19.5	33.5	25.5	38.4	26.6	32.1	32.6	15.2	37.2	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8	71.5	41.2	52.3	29.9	25.0	49.9	41.1	48.4	53.5	42.1	38.4	76.6	33.9	11.6	44.6	11.0	42.1	70.4	0.0	43.3	55.4	50.4	56.4	43.9	64.8	46.0	42.9	53.2	53.4	85.0	4.5	65.9	62.1	25.3	31.5	79.0	38.2	46.4	45.6	53.4	38.5	48.0	38.8	52.3	37.9	23.8	27.9	57.9	41.5	60.4	44.0
CORT	MGC32686	ENSG00000241563	Cortistatin	O00230	1	10449719-10451902	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 28.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.5;Late spermatids: 3.6;Spermatocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1"	"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA						"unprognostic (1.25e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-3)"	"unprognostic (7.08e-7)"	"unprognostic (2.01e-1)"	"unprognostic (9.01e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.14e-4)"	1.0	0.7	3.3	0.9	28.8	0.9	0.6	3.2	26.6	0.7	1.0	0.1	0.0	1.3	0.8	1.0	0.5	0.7	1.0	0.6	2.3	2.5	1.2	0.8	0.7	0.7	1.0	6.2	1.0	0.9	1.0	3.2	1.7	0.0	1.1	0.8	0.0	0.7	0.8	0.8	1.1	1.2	0.7	0.7	0.8	0.9	2.1	20.3	0.0	1.1	0.0	0.5	0.8	0.5	0.2	0.4	0.0	0.1	1.2	0.3	0.3	1.2	3.7	1.8	2.3	0.2	0.2	0.8	1.1	0.2	0.4	0.4	3.2	0.5	1.2	0.9	0.0	0.3	1.0	1.1	0.0	0.0	2.1	3.2	1.7	2.8	3.0	0.4	2.4	1.1	0.0	0.3	0.5	0.0	0.2	0.0	1.6	1.1	1.0	0.3	2.5	0.5	2.3	0.3	0.2	4.5	0.9	1.6	0.5	0.2	0.9	1.6	0.8	0.9	1.1	0.7	0.9	0.7	0.0	1.7	0.3	1.8	2.2	0.6	0.9	2.8	1.1	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	3.3	28.8	3.2	21.5	2.3	2.5	1.0	6.2	0.0	20.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.4	0.3	0.0	0.0	0.0	0.1
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"EFO-21: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.9	4.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	1.8	4.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4	17.9	59.9	35.0	6.7	3.0	6.0	0.4	86.6	505.9	754.1	8.7	5.9	0.0	0.0	26.9	0.5	5.3	0.0	93.5	17.8	0.2	12.7	23.8	2.3	1101.0	0.6	4.8	0.0	42.4	37.9	0.4	0.3	3.4	0.0	2.8	0.0	606.4	111.7	0.0	0.4	0.1	13.8	0.0	2.6	0.0	0.0	2.3	0.2	4.3	0.0	44.8
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 8426.3"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	5.0	13.2	1.2	0.0	0.0	0.0	8426.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.0	77.5	0.0	2.3	847.8	0.0	0.7	0.0	0.0	0.0	0.0	0.5	2.4	0.0	1.4	0.0	0.0	0.0
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2"	"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.1	1.6	2.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.7	22.3	12.5	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	26.0
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like, alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892947-17026815	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 19.3;retina: 23.7;seminal vesicle: 30.5"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 21.4;Collecting duct cells: 26.2;Glandular cells: 18.0;Leydig cells: 29.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"BEWO: 14.7;EFO-21: 9.5;T-47d: 25.8"					"Not detected"	"Not detected"			"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	NA	NA		180000	"Focal adhesion sites"		"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	3.1	1.3	1.0	0.4	2.3	0.2	3.6	0.6	2.3	5.3	0.4	2.9	6.5	0.2	1.5	8.2	0.6	0.6	0.4	7.0	1.2	1.3	8.9	0.5	11.5	1.5	4.9	0.4	0.6	0.4	3.5	2.0	3.1	5.1	19.3	0.0	23.7	1.1	30.5	1.7	0.4	0.4	0.4	5.6	1.1	0.1	0.9	2.8	0.9	11.6	1.4	0.4	1.2	1.4	0.2	0.0	0.6	1.5	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	9.5	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.5	0.0	0.0	1.4	0.0	0.1	0.4	2.0	0.0	0.0	0.0	0.4	0.0	0.1	25.8	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	2.3	0.6	2.3	1.2	1.3	4.9	0.4	5.1	2.8	20.8	21.4	0.0	10.1	0.8	0.4	4.8	2.5	1.4	12.5	26.2	0.0	6.4	0.0	0.6	1.5	8.6	0.0	0.0	0.0	5.0	2.4	18.0	2.3	0.0	2.6	0.0	0.0	12.9	6.6	3.6	29.1	1.5	0.0	0.0	0.4	0.0	0.9	0.8	6.0	0.0	0.0	0.0	2.8	5.4	1.0	0.5	5.0	0.0	0.0	3.4
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 6332.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		6600000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.2	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	9.9	0.1	0.0	0.0	6332.0	0.0	1.4	6.8	0.0	0.0	0.8	0.0	158.6	0.0	0.0	1.9	0.6	0.0	0.0	31.5	0.0	0.0	954.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1070.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	76	"Hep G2: 62.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	24.8	0.0	0.0	0.0	0.0	0.0	127.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1070.7	0.1	0.0	0.0	16.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 24.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 56.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	0.1	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339765-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 225.5"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 157.2"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	25	"Hep G2: 37.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		42000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.2	1.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	8.5	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.3	0.2	0.6	0.0	0.1	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.3	37.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.4	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.9	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0.0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	157.2	0.2	0.0	0.0	3.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.0	42.5	0.5	11.3	17.1	4.0	8.4	1.3	0.7	1.0	9.2	17.8	5.8	0.6	0.7	0.8	3.9	10.2	1.5	9.6	1.8	5.6	8.2	2.3	12.5	22.2	2.0	4.6	1.1	34.7	1.8	0.6	9.3	30.9	9.1	0.6	0.3	4.7	1.2	0.8	1.9	2.1	0.3	0.5	8.3	4.3	1.2	0.8	4.0	0.4	8.7	10.1	4.3	9.3	8.1	17.7	2.1	0.8	4.2	3.1	0.7	0.4	11.2	7.7	11.7	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5	11.9	12.2	10.4	23.2	17.2	13.3	24.2	48.4	5.3	9.1	45.4	27.5	10.3	14.9	15.7	4.0	23.3	10.7	0.0	9.4	1.2	64.4	11.1	36.9	37.7	48.7	9.5	13.3	50.3	56.8	5.7	67.0	38.8	74.2	14.4	6.1	41.4	11.7	8.6	68.6	42.8	14.9	51.8	32.1	4.7	3.6	11.4	5.0	17.9	10.9	12.0
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794069-2800637	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.3"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 29.4;Leydig cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	26	"B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	24.0	2.4	0.5	4.6	1.1	5.6	14.9	0.9	3.7	32.2	7.4	1.3	7.6	0.2	43.6	41.4	1.4	13.6	31.1	14.4	0.5	0.2	4.3	0.6	2.7	1.9	2.1	0.6	20.7	1.7	0.6	2.7	60.3	2.4	8.5	0.2	16.2	2.7	5.3	2.2	5.8	1.4	14.5	1.4	0.5	1.0	10.1	0.3	15.2	8.8	0.7	1.5	23.0	15.2	2.3	1.4	0.0	0.0	3.9	0.0	0.7	0.0	0.0	45.9	0.0	0.0	1.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.1	0.2	2.3	6.0	0.0	0.0	0.6	0.0	0.9	25.0	0.0	2.1	0.0	0.0	0.0	8.7	2.5	0.0	0.0	0.0	0.1	40.3	9.7	0.0	0.0	41.1	0.0	1.1	0.0	0.0	0.0	30.9	0.0	0.0	0.0	7.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.0	1.1	0.0	0.7	0.5	1.1	0.9	1.1	0.5	0.2	2.1	0.6	2.4	0.3	0.0	0.3	0.5	2.6	2.4	0.0	0.5	0.0	5.3	1.2	3.5	0.0	2.4	0.0	1.9	2.1	0.5	0.0	0.0	0.0	2.1	29.4	0.8	2.3	0.0	6.0	0.0	0.0	1.3	0.0	1.8	16.1	0.3	1.7	1.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.9	0.0	1.7	1.8	2.7	0.0	0.0	0.9
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529677-167553767	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 442.0;Kupffer cells: 417.0;monocytes: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 158.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	NA	NA		550000	Microtubules	Vesicles	"HPA056390: AB_2683113"	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	50.9	52.6	15.7	21.0	17.9	29.6	56.7	11.8	15.0	23.0	32.8	21.7	21.3	16.5	22.0	46.8	41.9	25.0	40.8	48.9	15.5	13.6	39.8	81.3	68.5	83.8	16.4	9.6	43.3	41.6	19.1	36.2	46.8	14.7	41.4	23.7	28.7	39.0	22.6	33.0	37.1	30.4	40.9	21.0	98.2	22.7	27.6	15.1	12.6	53.1	32.7	23.7	50.8	40.9	1.3	26.9	21.7	36.8	3.3	5.3	13.9	12.0	5.4	2.8	5.8	44.8	12.5	7.2	5.2	2.3	4.1	5.4	8.8	13.9	13.3	15.2	5.7	7.7	19.1	3.2	11.2	2.8	18.0	11.0	5.4	4.5	4.9	15.4	12.0	40.1	13.0	33.8	4.8	5.3	5.8	1.3	4.7	27.9	54.6	5.7	5.0	2.4	12.4	3.0	27.8	8.5	4.2	7.9	158.5	7.4	8.5	1.9	3.5	13.0	17.8	14.4	9.9	23.6	32.9	2.5	1.1	5.4	17.0	3.3	10.7	21.3	8.7	18.0	12.5	2.1	15.1	36.8	21.7	1.6	21.5	2.5	1.3	2.4	2.0	26.9	0.6	5.3	2.6	13.0	3.3	19.9	1.8	1.1	13.9	15.7	17.9	11.8	15.0	15.5	13.6	16.4	9.6	14.7	15.1	32.8	78.6	17.9	43.5	39.2	16.0	45.9	63.7	22.7	31.8	52.4	84.4	79.1	19.9	26.7	18.6	34.9	20.0	116.8	34.5	36.0	45.2	30.0	29.9	79.5	442.0	14.3	28.2	43.0	417.0	20.2	40.3	100.2	23.6	450.0	40.4	25.3	26.6	24.6	26.9	45.2	30.1	12.9	41.5	32.9	43.2	44.7	106.0	14.6	47.5	37.3
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345551-101387595	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 56.0"	"Cell type enhanced"	"Detected in some"	13	"Collecting duct cells: 1.8;Early spermatids: 4.9;Late spermatids: 3.0;Pancreatic endocrine cells: 1.7;Spermatogonia: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;HaCaT: 9.5;HeLa: 3.7;OE19: 10.4;PC-3: 3.8;RT4: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"	NA	NA					"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.8	0.9	12.6	0.8	13.8	0.9	0.8	0.2	56.0	0.9	0.8	1.0	0.0	0.9	0.8	0.8	0.8	1.1	0.9	0.9	17.2	4.4	0.9	0.8	0.8	0.8	3.3	16.6	0.9	0.8	0.8	0.2	0.9	7.2	0.8	0.9	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.2	0.8	0.8	0.9	0.5	0.0	0.8	0.0	0.8	0.8	0.6	0.2	0.3	0.5	0.0	0.0	2.6	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.1	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	10.4	3.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	2.6	0.0	12.6	13.8	0.2	29.7	17.2	4.4	3.3	16.6	7.2	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.6	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	1.3
CRELD2	MGC11256	ENSG00000184164	"Cysteine rich with EGF like domains 2"	Q6UXH1	22	49918167-49927540	"Predicted secreted proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 98.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000603, CAB025604"	Approved				"Secreted to blood"	NA	NA		270000			"CAB025604: , HPA000603: AB_1078565"	"unprognostic (1.12e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (5.04e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (1.34e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.02e-1)"	10.2	10.1	8.1	14.1	11.5	8.6	17.2	7.2	7.9	11.1	12.5	7.7	18.0	15.0	10.8	26.1	8.5	10.0	13.2	11.3	7.5	9.6	10.5	39.3	15.7	24.3	9.5	6.6	9.5	98.1	4.8	23.1	8.1	10.9	10.8	9.5	6.9	24.9	17.6	7.3	5.4	10.9	10.0	8.1	13.8	17.6	12.8	7.5	7.4	31.1	7.8	10.5	11.6	7.1	15.8	29.4	13.0	8.2	18.8	13.7	6.8	12.9	9.1	10.5	35.0	11.4	13.0	14.5	26.8	16.6	15.3	13.1	15.5	16.0	7.0	21.7	23.3	15.4	13.0	13.3	13.6	6.6	3.8	20.7	3.8	13.6	19.3	47.3	15.1	15.1	11.8	12.2	13.2	11.1	10.8	15.5	7.9	5.5	29.6	11.4	41.1	5.9	16.0	7.6	25.7	18.6	14.0	18.8	16.7	7.3	11.9	7.1	20.0	23.0	27.5	10.7	7.3	11.3	18.5	11.3	13.3	21.9	12.1	8.4	23.7	5.6	6.1	19.5	11.4	20.7	13.0	6.8	8.9	10.4	8.2	10.6	15.8	8.9	13.7	7.6	11.5	7.3	6.1	3.5	18.8	4.6	29.4	5.9	6.8	8.1	11.5	7.2	7.9	7.5	9.6	9.5	6.6	10.9	7.5	6.0	17.3	30.4	27.9	29.1	34.1	14.8	20.4	20.1	23.9	8.7	23.6	26.3	6.6	36.6	77.4	28.6	31.5	23.3	54.9	90.3	53.6	71.5	35.7	52.1	67.2	23.8	38.2	45.4	27.6	20.1	40.9	33.7	91.1	24.4	37.3	35.9	49.0	25.4	38.9	14.0	28.3	12.9	36.2	131.8	131.6	26.8	46.1	46.8	32.5	34.2
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 134.3"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 1.4;SuSa: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10000									"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	134.3	0.0	0.0	0.1
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76952713-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;liver: 99.9"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 1768.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		43000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0.0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4.0	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0.0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0.0	1.9	0.9	0.4	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	5.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.1	0.0	9.7	5.4	0.0	4.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	3.5	5.4	0.0	7.8	4.0	24.9	2.7	5.4	1.8	1.2	0.0	0.0	23.4	0.0	0.3	0.0	0.6	22.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	18.4	0.0	0.0	0.2	0.3	0.4	0.0	0.0	4.9	1.6	0.0	0.0	1768.4	116.1	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.3	0.0	0.0
CRHR2	"CRF-RB, CRF2, HM-CRF"	ENSG00000106113	"Corticotropin releasing hormone receptor 2"	Q13324	7	30651943-30700129	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enriched"	"Detected in single"	13	"Horizontal cells: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.14e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.69e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (8.29e-4)"	"unprognostic (3.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.84e-1)"	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0.0	3.6	2.1	1.1	0.5	1.7	2.1	1.0	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1.0	3.9	0.9	8.0	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1.0	1.8	1.0	0.0	1.7	3.2	0.6	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.2	0.2	3.0	0.0	0.4	0.0	0.0	0.6	0.0	0.9	1.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	0.5	0.4	1.0	0.3	0.2	0.8	0.3	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 203.0"	"Group enriched"	"Detected in some"	45	"Early spermatids: 33.8;Late spermatids: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NB-4: 7.3;RPMI-8226: 2.1;SH-SY5Y: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA028445: AB_10670428, HPA030534: AB_2732459"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	48.8	0.0	0.2	203.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.4	8.8	0.2	0.2	0.6	0.0	0.2	0.2	0.2	7.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 135.5"	"Group enriched"	"Detected in some"	81	"Early spermatids: 4897.0;Late spermatids: 16112.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;U-2 OS: 1.8"					"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.0	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.1	0.3	0.0	0.1	3.2	0.0	0.0	7.0	0.7	4.4	1.7	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.1	0.0	0.1	3.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	135.5	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	38.8	7.9	0.0	0.0	0.0	0.0	0.1	4897.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16112.2	124.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	78.8	0.0	0.0	64.7	0.0	130.2	60.3	0.0	0.0	0.0	0.0	0.4
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"	"Group enriched"	"Detected in some"	20	"HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	11.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	38.2	2.7	23.9	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984515-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 22.7;Cytotrophoblasts: 18.0;Glandular cells: 13.7;Ito cells: 28.3"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	32	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	32	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 51.9;SH-SY5Y: 28.1;SuSa: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA					"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	3.2	1.0	5.3	1.7	24.7	1.0	22.4	0.7	8.2	5.4	3.8	15.9	0.0	0.5	7.1	4.0	4.0	5.9	7.8	8.4	10.2	6.4	1.6	1.6	2.2	1.8	7.8	4.7	4.7	1.8	12.1	1.9	5.7	34.4	20.0	1.2	3.1	15.1	2.2	0.7	3.2	1.7	5.4	29.6	1.4	1.7	3.2	9.3	6.0	12.9	1.6	1.1	2.4	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	51.9	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.3	0.0	0.0	7.4	0.0	0.8	0.0	4.3	0.0	0.0	0.0	1.9	0.0	1.9	0.0	1.1	0.0	0.4	2.8	0.1	0.0	0.4	6.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	5.3	0.0	1.9	0.0	7.1	0.0	0.0	0.0	0.3	28.1	0.0	0.0	2.9	11.2	3.9	2.4	0.0	1.4	7.8	0.0	0.2	0.9	0.3	0.0	1.8	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.3	24.7	0.7	8.2	10.2	6.4	7.8	4.7	34.4	9.3	3.0	0.0	0.0	7.5	0.7	1.0	0.4	0.0	22.7	9.1	1.8	0.0	18.0	0.0	0.0	10.9	0.7	0.0	0.0	0.0	1.0	4.8	13.7	3.5	0.0	1.6	0.0	0.0	28.3	2.4	1.1	3.7	0.0	6.8	0.0	0.0	9.7	0.0	0.0	1.4	0.0	0.7	0.0	1.0	1.4	4.1	0.9	10.1	0.0	0.0	0.4
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	19	"Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	15.3	5.7	23.8	11.6	10.3	9.3	6.6	1.5	0.9	0.0	1.0	10.1	2.7	0.3	0.0	0.0	9.4	0.0	0.0	0.1	0.2	0.0	56.8	0.0	0.1	23.8	0.0	2.7	0.0	3.1	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	1.5	0.6	0.0	0.1	0.1	0.1	1.8	2.3	0.1	2.7	1.2	0.2	3.4	4.7	0.3	1.3	0.1	0.6	9.7	0.3	0.1	0.0	1.9	0.0	0.2	1.4	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1	3.0	2.9	0.8	7.9	41.0	0.6	7.6	0.0	1.4	2.3	0.0	0.0	6.0	0.0	1.1	10.8	12.0	0.4	0.0	0.4	24.6	126.1	19.2	6.9	0.0	4.4	1.6	2.9	60.2	40.4	10.7	251.5	12.2	45.5	0.0	4.2	5.0	0.8	0.0	250.0	0.0	0.5	90.5	678.7	0.9	0.9	37.4	7.6	4.8	1.3	5.2
CRLF1	"CISS, CISS1, CLF, CLF-1"	ENSG00000006016	"Cytokine receptor like factor 1"	O75462	19	18572220-18607741	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 8.7;Ciliated cells: 6.7;Distal tubular cells: 5.0;Early spermatids: 6.3;Smooth muscle cells: 6.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 36.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"ASC diff: 151.1;Hep G2: 62.7"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 23.3"	"Low region specificity"	"Detected in single"			"HPA041493, HPA041793"	Approved				"Secreted in other tissues"	NA	NA					"HPA041493: AB_10795637, HPA041793: AB_10804117"	"unprognostic (1.97e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.95e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.27e-3)"	15.8	10.4	6.6	2.7	21.2	1.2	19.8	0.8	19.8	14.3	3.6	14.8	6.8	2.2	4.3	18.8	10.4	4.6	7.8	35.0	5.0	3.3	3.6	1.6	5.1	6.0	0.5	8.5	2.4	6.9	1.7	3.2	26.6	4.3	2.0	1.9	0.3	5.8	12.8	30.5	15.1	1.5	3.8	0.8	1.5	2.4	5.6	3.4	0.0	31.9	10.0	1.6	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	1.5	151.1	2.2	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.5	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.6	62.7	1.0	0.0	0.0	1.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	21.2	0.8	13.6	5.0	3.3	0.5	8.5	4.3	3.4	0.0	0.0	0.0	0.5	8.7	0.1	2.7	0.0	6.7	3.4	0.0	0.0	0.0	5.0	0.3	6.3	0.0	0.0	0.0	0.2	0.7	2.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.7	0.0	6.4	0.1	1.5	4.0	0.2	0.0	0.0	0.0
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 2991.5"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.9	0.0	13.1	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	0.0	0.0	220.4	1.2	0.0	0.0	23.3	52.3	0.0	0.0	0.0	0.0	2991.5	0.1	0.0	0.0	82.9	72.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 90.9;Club cells: 66.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.6;HMC-1: 3.3;HUVEC TERT2: 8.9;SCLC-21H: 5.9;SK-MEL-30: 9.8;TIME: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"	NA	NA		360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favorable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.8	0.0	3.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	5.9	1.3	0.7	0.0	9.8	0.4	0.1	0.0	11.9	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7	20.8	90.9	0.0	2.0	1.3	5.7	3.9	2.5	1.4	66.0	8.7	0.0	0.0	0.0	4.3	0.0	1.6	0.0	0.0	0.6	0.0	1.7	0.4	4.7	0.0	0.0	0.0	1.7	5.5	0.3	0.2	0.0	0.3	8.5	0.0	0.0	14.5	0.8	0.0	0.4	0.0	3.6	0.0	0.5	0.9	1.7	0.4	0.0	0.0	0.0	1.1
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 122.6;ASC TERT1: 80.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.1	18.1	5.7	17.8	122.6	80.3	33.0	20.0	43.7	24.3	23.2	6.1	5.2	6.4	22.4	38.0	19.6	11.8	10.1	15.3	17.6	15.8	15.7	10.0	14.2	6.3	36.7	6.4	8.2	64.0	31.4	21.9	27.9	47.3	25.5	4.0	8.5	12.3	24.5	7.8	2.3	6.6	6.8	9.8	24.7	8.5	16.7	12.3	19.0	6.1	1.2	9.2	13.5	11.9	28.8	13.8	12.8	15.9	16.6	31.9	13.6	17.3	21.1	8.9	30.1	0.9	25.0	13.0	17.4	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0	8.9	42.6	18.6	27.6	53.7	18.7	29.5	25.5	4.0	19.4	36.6	7.9	42.5	10.0	19.9	1.0	55.3	18.1	0.0	27.7	59.7	94.1	20.8	46.2	44.4	93.2	33.4	5.8	103.2	172.9	2.2	132.3	73.7	75.9	27.9	22.6	17.7	20.2	10.5	136.2	43.7	10.5	109.9	117.1	1.4	7.9	40.8	23.5	20.8	33.1	22.1
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.5	29.2	1.0	6.6	30.6	5.3	4.9	0.2	0.8	0.0	8.4	16.3	29.0	1.2	1.2	2.2	2.0	18.5	0.9	2.0	3.3	1.9	70.7	0.0	2.6	45.2	0.6	11.6	7.0	32.5	1.0	0.5	0.4	1.1	6.3	0.1	0.0	0.3	0.9	0.4	0.5	0.2	1.5	0.1	2.1	1.5	0.1	0.3	1.9	0.5	2.3	3.7	0.4	0.2	3.5	5.5	1.9	24.4	3.7	0.5	0.2	0.0	14.0	0.0	20.6	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3	8.9	47.6	2.4	5.4	6.5	0.2	2.4	22.9	0.0	5.7	3.5	0.0	0.5	0.0	23.8	0.3	19.0	0.6	0.0	2.0	0.4	28.2	4.8	111.9	2.5	9.2	0.0	7.5	54.0	3.5	0.0	23.3	11.7	10.1	2.8	0.8	1.9	8.1	0.9	8.1	1.1	0.1	58.2	25.9	0.6	0.6	4.8	0.7	8.5	0.6	1.8
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 10.7;Ductal cells: 12.3;granulocytes: 5.7;Pancreatic endocrine cells: 14.6;T-cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	23900		Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	2.6	0.0	3.6	0.0	0.7	0.0	2.7	0.1	0.0	3.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.4	7.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	10.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	4.9	0.0	1.3
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor alpha subunit"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;placenta: 79.5"	"Cell type enhanced"	"Detected in many"	26	"Cytotrophoblasts: 215.8;monocytes: 954.0;Syncytiotrophoblasts: 261.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5"	"Group enriched"	"Detected in many"	28	"dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0"	"Group enriched"	"Detected in some"	7	"BEWO: 60.4;HMC-1: 18.2;SK-MEL-30: 42.3"									CAB016148	Uncertain				"Secreted to blood"	NA	NA		9400000			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favorable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	8.7	2.3	11.8	11.1	11.1	8.9	17.7	3.4	9.6	3.1	2.2	0.6	0.6	2.2	4.4	0.6	2.1	2.2	5.7	3.7	15.0	4.7	2.4	1.7	11.2	8.3	18.8	6.5	3.5	1.0	0.2	2.1	79.5	13.2	1.5	3.3	0.6	3.1	1.0	0.6	1.8	3.3	2.9	25.5	12.6	1.7	0.6	16.3	0.6	2.5	0.6	10.4	4.2	1.5	0.3	31.9	60.2	30.0	1.4	0.2	10.1	0.1	3.5	0.2	0.0	0.0	0.0	60.4	0.0	0.1	0.1	0.0	1.2	0.3	0.0	3.9	0.0	3.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.4	0.0	0.0	1.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	5.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	42.3	5.0	2.8	5.0	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.0	5.5	0.0	2.4	30.0	36.0	0.0	17.7	0.2	0.3	0.0	0.0	31.9	0.1	0.0	0.0	60.2	1.4	8.4	30.5	0.1	10.1	11.8	11.1	3.4	9.6	15.0	4.7	18.8	6.5	13.2	16.3	0.0	8.2	11.1	1.0	6.9	0.6	1.1	5.1	4.0	5.7	1.8	0.0	215.8	0.0	0.2	0.5	1.4	0.0	0.0	1.5	101.6	5.3	0.5	9.3	0.0	66.0	0.0	0.0	1.3	66.8	0.0	0.9	146.7	8.5	954.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	6.5	2.1	0.2	0.4	4.5	261.3	0.0	0.0	2.1
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 122.0;Basal keratinocytes: 30.7;Club cells: 33.0;Melanocytes: 37.1;Suprabasal keratinocytes: 29.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.9;U-87 MG: 78.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	6170					"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	3.2	0.0	2.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2	20.8	122.0	0.0	4.6	30.7	0.0	0.1	0.0	14.7	33.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.0	8.9	8.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	37.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.7	29.4	0.0	0.0	0.1	5.4
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"placenta: 450.4"	"Group enriched"	"Detected in some"	22	"Extravillous trophoblasts: 439.3;Syncytiotrophoblasts: 913.5"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 12.0;SuSa: 18.9"									"CAB026374, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB026374: , HPA043715: AB_2678632"															"unprognostic (6.99e-2)"			2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	15.7	450.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	1.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	439.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	913.5	0.0	0.0	0.0
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"placenta: 246.2"	"Cell type enriched"	"Detected in some"	25	"Syncytiotrophoblasts: 230.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 10.2;SuSa: 15.3"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	246.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.4	0.0	0.0	0.0
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	864	"pituitary gland: 334.1;placenta: 293.7"	"Cell type enriched"	"Detected in some"	16	"Syncytiotrophoblasts: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7"									"CAB025646, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB025646: , HPA043715: AB_2678632"																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	334.1	293.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	18.1	0.0	0.0	0.0
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931081-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 184.8"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 1.6"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NK-cell: 1.6;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.5"									"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			44.7	0.0	0.0	0.0	0.1	0.0	184.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.2	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.6	0.0	3.2	0.0	0.2	0.0	0.1	0.0	0.9	0.1	1.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"breast: 82.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-266/70: 1.4"					"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	82.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	96	"breast: 91.1;salivary gland: 31.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 3.2;Late spermatids: 1.1;Spermatocytes: 1.0"	"Group enriched"	"Detected in some"	15	"breast cancer: 35.3;lung cancer: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;U-266/70: 1.6"					"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.1	0.0	0.1	0.1	0.1	0.0	91.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	31.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747553-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"salivary gland: 704.2"	"Group enriched"	"Detected in some"	118	"Cholangiocytes: 25.5;Collecting duct cells: 75.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 157.4"									"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA		6600000			"CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"prognostic favorable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.8	0.1	0.1	0.3	7.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.1	0.1	15.2	0.0	0.1	704.2	0.1	0.1	4.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	1.6	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.6	157.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2	25.5	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4
CST11	"CST8L, CTES2, dJ322G13.6"	ENSG00000125831	"Cystatin 11"	Q9H112	20	23450403-23452857	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 76.3"	"Cell type enriched"	"Detected in single"	10	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053399	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA053399: AB_2682136"						"unprognostic (9.42e-2)"				"unprognostic (2.21e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	76.3	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST2		ENSG00000170369	"Cystatin SA"	P09228	20	23823769-23826731	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	230	"salivary gland: 1538.3"	"Cell type enriched"	"Detected in single"	16	"Melanocytes: 15.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RT4: 39.1"									"CAB024963, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA		110000			"CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (1.57e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.82e-3)"	"unprognostic (6.43e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-11)"	"unprognostic (1.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	1.6	6.6	0.1	0.1	0.1	0.0	0.1	0.3	0.1	3.8	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.7	0.0	5.9	0.7	0.1	2.6	0.0	0.1	1538.3	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.8	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.0	39.1	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 3433.6;Macrophages: 4110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 163.2;ASC TERT1: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.9	29.3	6.9	15.8	163.2	111.7	12.8	22.5	31.4	15.5	12.6	55.8	20.0	0.0	21.2	30.7	20.1	43.9	6.3	45.0	4.8	0.0	21.7	13.3	5.8	94.7	58.4	0.6	22.3	86.4	37.9	20.8	22.3	32.8	24.2	1.6	12.1	0.3	21.5	20.6	0.1	14.0	9.2	41.0	64.4	0.5	8.4	17.8	63.6	29.3	7.5	8.6	16.4	4.9	28.0	10.4	13.9	48.7	60.9	14.7	10.6	20.5	8.4	13.9	0.5	0.1	12.5	29.1	16.5	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4	107.2	165.4	122.1	459.0	837.5	35.4	213.0	1645.8	65.6	135.4	608.9	27.5	429.7	351.5	407.3	34.7	720.9	2161.2	23.3	692.7	269.5	1051.9	864.5	358.3	2073.4	1660.2	46.1	847.5	528.5	3433.6	95.9	1974.8	4110.2	1482.9	256.1	1276.0	130.5	997.4	2367.2	1683.0	939.5	34.6	2160.2	727.9	82.7	461.4	718.5	392.2	90.0	866.3	802.3
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689040	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 705.3"	"Cell type enriched"	"Detected in single"	9	"Collecting duct cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 6.8;RT4: 16.7"									"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	NA	NA		2700000			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavorable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favorable (2.88e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	0.0	1.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	7.5	0.0	0.1	705.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.7	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	16.7	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875935-23879750	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 1065.3"	"Cell type enriched"	"Detected in single"	22	"Alveolar cells type 1: 8.9"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;RPTEC TERT1: 3.6;RT4: 1.9;SuSa: 2.3;U-2 OS: 1.6"									"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB024944: , HPA061449: AB_2684523"	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1065.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.9	0.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.8	0.0	0.6	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"A-431: 26.8;CAPAN-2: 74.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.8	0.0	0.0	0.1	0.0	0.0	8.0	0.2	0.0	0.0	0.0	0.1	74.8	0.0	0.4	0.9	0.0	0.9	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	7.5	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0	86.4	6.7	0.0	1.2	1.0	0.0	1.0	0.0	56.2	26.1	55.8	0.0	5.9	0.0	14.5	0.1	0.1	0.0	0.0	19.3	11.2	1.9	1.4	21.8	0.0	43.3	0.0	0.0	0.0	0.3	0.5	0.0	6.5	5.0	1.8	0.0	0.8	216.2	0.0	0.4	0.2	0.0	0.0	0.4	1.4	16.7	24.1	53.7	0.0	0.0	5.4
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Group enriched"	"Detected in many"	14	"monocytes: 1133.5;T-cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 120.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 16.1;HMC-1: 45.1;NB-4: 44.2;U-937: 79.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		12000			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	16.1	45.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.4	44.2	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	79.4	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2	8.9	22.7	14.7	0.3	20.3	0.0	0.8	2.5	4.0	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	3.0	0.0	6.1	0.1	55.7	2.1	1.4	0.0	0.0	8.6	13.8	0.0	0.0	51.5	23.6	1133.5	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	2.3	0.0	0.1	20.8	0.9	425.3	0.0	0.3
CST8	"CRES, CTES5"	ENSG00000125815	"Cystatin 8"	O60676	20	23491101-23496018	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 31.8"	"Group enriched"	"Detected in some"	122	"Early spermatids: 188.8;Late spermatids: 79.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605876	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	11	"breast: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted - unknown location"	NA	NA					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST9L	"bA218C14.1, CTES7B"	ENSG00000101435	"Cystatin 9 like"	Q9H4G1	20	23564732-23568749	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 49.8"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 2.4;Late spermatids: 7.3;Leydig cells: 2.3;Peritubular cells: 1.4;Spermatocytes: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 5.6"														"Secreted in male reproductive system"	NA	NA						"unprognostic (2.10e-2)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0
CSTL1	"CTES1, dJ322G13.4"	ENSG00000125823	"Cystatin like 1"	Q9H114	20	23439685-23444930	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	20	"testis: 7.5"	"Group enriched"	"Detected in some"	434	"Early spermatids: 55.2;Late spermatids: 53.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 4.3;OE19: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA						"unprognostic (1.14e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.04e-1)"		"unprognostic (6.58e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"		"unprognostic (5.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.97e-1)"		"unprognostic (6.87e-2)"	"unprognostic (2.35e-1)"		"unprognostic (5.36e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.1	0.0		0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	7.5			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CT55	"CXorf48, FLJ20527"	ENSG00000169551	"Cancer/testis antigen 55"	Q8WUE5	X	135156536-135171398	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 9.2"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 8.1;Spermatogonia: 23.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"K-562: 12.8"									HPA059575			Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			Vesicles		"HPA059575: "	"unprognostic (6.20e-2)"				"unprognostic (1.39e-1)"			"unprognostic (8.36e-2)"		"unprognostic (5.86e-3)"			"unprognostic (3.47e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.49e-1)"		0.1	0.2	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.2		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.2			0.2		0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.2	0.6	0.8	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.1	23.4	0.0	0.0	0.0	0.0	0.0
CTF1	"CT-1, CT1"	ENSG00000150281	"Cardiotrophin 1"	Q16619	16	30896607-30903560	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 8.3;Basal glandular cells: 16.2;Cardiomyocytes: 9.6;Collecting duct cells: 7.0;Distal tubular cells: 26.6;Muller glia cells: 19.2;Proximal tubular cells: 12.6;Urothelial cells: 6.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.8;ASC TERT1: 12.9;HHSteC: 11.3;HSkMC: 12.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB025853	Uncertain				"Secreted to blood"	NA	NA	11900				"CAB025853: "	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (7.22e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.79e-1)"	6.2	6.4	5.1	5.3	4.6	1.8	5.2	1.7	4.0	12.5	9.2	5.1	10.9	1.3	14.8	5.4	9.1	10.5	8.5	17.0	4.7	2.7	6.1	1.5	8.9	1.8	5.6	4.2	21.9	3.6	21.5	4.2	2.7	4.4	14.0	1.6	10.2	5.2	15.5	14.2	1.8	3.4	21.0	5.9	1.9	6.0	6.8	3.2	1.8	10.1	4.9	2.8	14.0	7.9	2.0	1.8	2.6	1.2	0.8	1.4	0.4	1.6	0.3	2.2	4.8	11.8	12.9	3.9	3.6	7.2	3.8	4.8	2.0	0.3	0.1	7.1	9.9	0.4	1.3	0.0	2.5	3.9	0.1	0.2	0.1	0.3	0.8	11.3	0.2	0.6	12.1	3.3	2.8	6.8	4.2	1.0	0.2	3.0	0.3	6.7	0.4	0.2	0.3	0.6	1.1	0.7	1.4	3.4	0.0	0.6	0.8	0.2	1.2	0.0	0.1	0.0	3.6	5.8	0.3	0.7	3.6	4.5	0.2	0.1	0.2	0.1	0.2	2.8	0.4	0.1	1.2	1.2	0.7	0.9	0.5	1.4	0.6	0.9	0.5	1.5	2.0	0.7	0.8	2.6	0.8	0.7	1.8	0.5	0.4	5.1	4.6	1.7	4.0	4.7	2.7	5.6	4.2	4.4	3.2	3.0	8.3	0.5	16.2	0.3	0.1	9.6	0.0	0.0	2.3	7.0	0.0	0.1	26.6	0.7	0.4	0.6	0.0	0.0	0.3	0.1	1.2	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.4	2.0	0.5	0.0	0.0	0.1	19.2	0.3	0.0	2.5	12.6	0.7	0.0	1.0	0.7	0.3	0.3	0.3	0.0	0.0	6.7
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 425.8;Ito cells: 621.2;Peritubular cells: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 131.2;HUVEC TERT2: 110.3;TIME: 227.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.2	0.3	23.2	13.2	0.1	29.6	14.3	18.4	9.8	0.0	0.9	0.0	131.2	38.0	15.1	0.4	0.3	2.1	17.3	0.1	0.2	0.0	4.2	10.6	9.1	0.0	0.0	19.2	0.4	13.3	3.3	27.8	110.3	0.0	0.0	0.0	52.2	0.2	0.0	0.0	4.9	3.2	1.7	2.5	0.4	0.0	6.7	0.0	0.0	0.0	3.0	5.0	1.4	26.2	0.5	0.2	227.6	25.5	20.0	32.1	54.7	0.9	0.1	0.2	3.4	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3	425.8	55.6	2.9	247.2	86.5	0.0	34.4	73.9	103.1	38.7	12.2	0.0	11.5	0.0	245.6	0.9	205.6	11.7	0.0	212.2	18.8	248.5	11.6	13.9	23.6	12.0	0.0	13.3	621.2	7.2	2.7	46.6	12.6	62.4	27.1	7.9	2.8	177.6	6.6	453.3	0.7	0.2	103.5	206.0	1.2	4.4	52.6	13.6	1.8	7.5	6.5
CTHRC1		ENSG00000164932	"Collagen triple helix repeat containing 1"	Q96CG8	8	103371515-103382997	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Endothelial cells: 36.6;Fibroblasts: 168.4;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.3;NK-cell: 5.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;NK-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 56.2;fHDF/TERT166: 24.7;HHSteC: 37.4;HSkMC: 77.1;WM-115: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059806, HPA061896"	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		320000	Nucleoplasm		"HPA059806: AB_2684130, HPA061896: AB_2684633"	"unprognostic (2.04e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.22e-14)"	"unprognostic (2.33e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.37e-3)"	35.1	1.4	1.1	5.2	1.1	0.0	32.3	0.8	2.3	5.3	3.8	0.5	3.0	2.0	6.9	11.2	3.5	3.0	33.0	4.2	1.1	1.6	2.0	0.7	4.5	7.6	1.6	1.3	3.7	2.1	0.3	2.1	32.2	1.9	4.0	2.1	2.6	23.0	4.2	9.2	17.4	2.1	8.4	2.6	1.4	1.8	8.4	0.8	2.2	4.8	3.7	5.4	31.3	3.6	0.2	0.7	2.3	0.0	5.2	0.4	0.3	2.1	0.1	0.6	0.1	16.9	56.2	0.0	6.3	1.7	0.6	0.9	0.2	1.5	0.2	6.7	24.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	3.4	37.4	0.1	0.1	77.1	0.1	5.7	0.0	0.2	11.0	0.4	0.0	17.0	3.4	0.3	3.0	7.3	2.0	0.0	10.6	6.4	5.7	0.2	0.5	0.0	1.0	0.8	0.0	0.0	18.9	2.4	0.0	0.0	8.9	0.8	0.3	0.9	0.0	0.5	0.1	0.1	0.4	0.0	70.8	0.0	0.0	2.3	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.2	0.3	0.1	5.2	0.0	0.7	0.0	0.3	1.1	1.1	0.8	2.3	1.1	1.6	1.6	1.3	1.9	0.8	3.0	2.9	0.0	0.1	28.4	0.3	0.6	2.5	0.0	0.0	3.5	0.0	5.6	0.0	4.4	0.3	36.6	0.0	0.0	0.6	8.9	168.4	0.6	0.0	0.0	7.0	0.0	1.2	26.4	0.3	0.2	11.5	1.7	47.2	1.0	0.0	5.5	2.4	0.0	0.4	0.3	1.0	0.0	24.7	1.6	15.6	23.8	13.8	0.0	0.0	0.4
CTRB1	CTRB	ENSG00000168925	"Chymotrypsinogen B1"	P17538	16	75219000-75226338	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	2272	"pancreas: 1908.8"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 26371.2"	"Cancer enriched"	"Detected in some"	1905	"pancreatic cancer: 962.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6"														"Secreted to digestive system"	NA	NA										"unprognostic (1.76e-1)"				"unprognostic (2.62e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (2.96e-1)"		"unprognostic (1.17e-2)"		0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	1908.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.2	1.6	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	26371.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.1	0.0	0.0	2264.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTRB2		ENSG00000168928	"Chymotrypsinogen B2"	Q6GPI1	16	75204096-75207185	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5240	"pancreas: 3761.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 45669.7"	"Cancer enriched"	"Detected in single"	1696	"pancreatic cancer: 540.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4"														"Secreted to digestive system"	NA	NA							"unprognostic (9.41e-4)"			"unprognostic (2.20e-1)"	"unprognostic (1.28e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.57e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	3761.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	9.3	0.0	1.9	0.1	2.6	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	1.0	0.0	0.0	0.0	45669.7	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.3	0.3	0.0	0.0	376.1	0.0	0.0	8606.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 5617.8"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA					"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.5	0.0	0.1	0.2	1.1	0.6	0.4	0.3	0.1	0.9	0.2	1.7	0.3	0.0	0.0	0.0	0.6	0.0	0.7	0.1	1.8	0.2	0.5	1.1	1.7	0.5	0.0	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.3	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.1	0.0	0.0	5617.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	41.5	0.0	0.0	1090.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932414	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	281	"pancreas: 639.8"	"Group enriched"	"Detected in some"	39	"Exocrine glandular cells: 185.6;Pancreatic endocrine cells: 95.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	639.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1.1	1.1	0.7	0.0	2.2	0.5	0.5	3.7	1.1	0.3	0.2	0.1	1.8	0.3	0.7	1.2	1.3	2.3	1.4	0.7	0.4	0.7	1.2	1.0	5.7	0.7	3.1	1.4	6.4	0.8	1.1	1.4	0.3	0.9	2.5	1.2	0.2	3.9	1.0	0.5	0.0	1.9	1.6	1.0	0.6	1.1	0.7	2.8	6.3	1.3	2.3	2.9	0.5	4.6	0.0	0.9	2.7	1.4	1.3	0.7	0.6	0.9	1.2	4.4	1.7	0.1	2.1	0.5	1.6	6.6	2.8	3.6	0.2	0.8	0.8	0.6	0.7	0.3	1.5	0.7	0.2	0.3	1.1	0.5	0.9	0.6	0.5	2.2	1.1	0.0	0.7	1.1	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.4	0.0	95.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell type enhanced"	"Detected in all"	11	"Hofbauer cells: 2617.6;Kupffer cells: 1392.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 239.8;fHDF/TERT166: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.5	3.8	16.2	66.6	74.9	11.8	122.8	239.8	43.0	51.0	14.0	38.4	0.1	17.8	139.3	57.7	35.8	5.2	33.9	27.2	3.2	5.0	9.5	3.4	34.5	67.8	2.1	7.1	82.1	46.2	38.9	34.8	74.9	84.1	2.8	7.9	21.7	35.7	5.2	0.8	3.5	3.2	75.8	9.9	3.4	3.8	16.6	13.1	10.2	1.6	9.6	14.2	7.7	64.0	11.7	12.5	6.4	116.4	73.1	24.8	23.4	22.8	21.6	15.7	0.6	83.9	8.2	34.2	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4	101.3	205.9	73.7	364.9	48.5	44.4	251.7	175.8	137.9	227.5	108.2	39.3	224.9	23.2	276.8	13.3	119.6	152.5	210.2	211.7	280.5	149.9	239.1	169.3	203.7	2617.6	55.6	148.7	214.9	1392.4	12.2	70.8	859.7	153.5	399.5	80.9	115.8	264.9	108.7	87.4	331.7	35.7	38.8	121.0	4.8	18.5	35.4	543.3	50.7	114.7	284.4
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Enterocytes: 1407.0;Hofbauer cells: 3678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 190.9;hTERT-RPE1: 255.7;SK-BR-3: 182.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		540000000			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	151.9	148.7	21.4	32.8	27.0	83.7	67.7	18.6	47.4	56.3	59.3	41.4	41.9	61.6	25.9	48.2	46.2	34.2	90.0	86.0	25.3	27.6	150.5	163.5	102.6	81.1	49.6	25.7	41.2	62.3	21.3	24.9	56.1	42.8	33.9	33.7	234.4	64.1	42.3	76.2	50.8	90.9	23.3	36.7	87.6	47.0	29.8	29.7	21.1	36.3	42.9	41.4	64.6	43.5	4.9	22.7	51.1	83.8	28.4	26.1	58.7	13.8	37.5	4.3	18.0	54.9	18.8	7.0	10.3	32.0	13.8	16.4	9.3	190.9	3.3	26.6	26.5	103.7	74.7	6.2	11.5	3.8	14.3	13.6	5.1	7.1	11.6	58.0	11.8	54.6	30.2	50.5	7.4	13.7	255.7	10.1	4.4	6.1	20.6	24.4	51.1	3.0	6.6	10.2	56.8	15.1	4.3	5.3	12.5	48.7	43.4	6.0	5.9	12.2	182.5	34.6	6.5	71.4	16.3	12.7	42.1	6.4	5.8	16.4	28.3	35.5	2.1	61.3	31.9	35.2	29.0	83.8	25.2	26.1	47.6	15.1	4.9	12.2	18.3	22.7	3.2	14.3	18.3	51.1	28.4	38.5	19.2	13.5	58.7	21.4	27.0	18.6	47.4	25.3	27.6	49.6	25.7	42.8	29.7	104.2	261.1	102.1	219.0	64.0	155.9	226.4	366.9	115.1	126.3	519.9	104.1	198.5	92.9	592.1	2.7	92.6	1407.0	70.0	321.5	138.5	112.5	108.8	466.1	497.1	3678.7	249.5	153.3	833.5	1087.5	9.0	100.4	573.5	215.9	205.6	341.0	186.6	426.0	610.2	120.6	259.1	69.6	109.9	103.0	22.4	56.8	71.8	394.2	188.4	260.3	345.7
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.2;bone marrow: 41.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 70.4;T-cells: 273.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2"	"Group enriched"	"Detected in many"	48	"NK-cells: 157.2;T-cells: 106.6"	"Group enriched"	"Detected in some"	23	"HEL: 38.8;NB-4: 88.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			CAB016345	Enhanced				"Secreted to blood"	NA	NA		340000			"CAB016345: AB_626813"	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.2	1.2	0.9	4.9	1.0	41.4	2.3	0.6	0.7	3.9	4.9	0.8	0.5	2.4	8.4	4.0	2.1	2.1	2.5	9.0	0.9	1.0	2.5	6.8	12.7	36.0	1.1	0.6	3.0	1.1	0.0	1.4	10.7	1.4	7.4	2.5	6.3	10.9	1.5	1.9	1.5	5.9	1.7	2.1	33.1	3.3	3.4	0.4	11.1	3.1	1.3	18.2	4.5	2.6	0.4	2.7	2.3	0.3	157.2	106.6	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	38.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.4	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	2.4	0.0	2.3	0.2	0.3	106.6	0.2	67.7	0.4	11.7	68.3	2.7	0.3	7.0	51.4	2.0	157.2	0.3	1.7	1.6	45.7	0.9	1.0	0.6	0.7	0.9	1.0	1.1	0.6	1.4	0.4	0.0	6.2	3.7	0.4	4.0	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.2	1.8	0.6	0.0	0.0	0.0	0.1	3.2	0.3	70.4	1.7	1.9	0.0	0.0	5.5	5.3	8.8	0.0	7.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.8	0.2	0.9	5.5	0.2	273.8	0.0	0.3
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		35000000	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	26.6	65.6	47.9	28.3	60.1	33.5	47.6	37.7	73.7	47.7	37.9	36.8	53.9	42.1	40.1	78.5	30.5	46.0	48.8	49.6	45.2	44.9	46.3	61.6	39.0	77.4	46.5	37.8	57.7	66.6	43.8	86.1	45.7	39.8	38.8	28.9	34.2	74.3	69.7	34.6	32.7	37.2	32.4	47.0	36.0	38.7	27.3	31.6	52.2	69.7	30.3	31.3	42.6	28.9	56.5	31.4	27.1	32.0	49.9	69.8	60.8	43.8	26.3	42.1	53.3	31.7	31.2	20.4	40.1	75.1	77.6	82.7	26.2	27.4	31.0	31.2	45.9	56.4	26.8	27.3	40.8	43.8	26.2	60.5	32.3	43.6	68.6	41.3	25.1	24.6	41.3	34.5	37.3	31.5	54.0	20.8	32.9	39.6	63.1	56.7	34.1	38.0	53.5	37.7	38.0	34.7	41.8	25.1	81.9	53.4	19.1	82.4	42.0	24.0	41.8	72.8	25.2	30.7	52.8	22.9	42.0	35.7	29.8	41.8	62.0	61.6	33.9	36.3	55.6	34.1	27.1	32.0	16.5	45.7	22.9	63.2	56.5	67.6	52.7	31.4	44.2	68.5	53.2	4.6	49.9	16.8	27.1	69.8	60.8	47.9	60.1	37.7	73.7	45.2	44.9	46.5	37.8	39.8	31.6	122.1	105.5	178.5	242.5	204.8	84.5	113.4	239.5	131.2	121.7	300.1	64.8	309.8	240.4	162.1	64.8	93.9	157.7	23.3	122.9	203.5	204.8	237.5	167.3	299.7	277.3	73.1	280.4	131.3	162.9	285.6	185.2	150.2	300.3	80.2	266.0	150.8	114.3	196.4	180.0	440.5	69.0	90.5	220.1	100.6	65.6	201.4	203.1	245.2	291.8	203.9
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372458-57385048	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 39.3;Endothelial cells: 39.1;Glandular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 13.7;HDLM-2: 37.3;Hep G2: 27.8;RPTEC TERT1: 16.6;SK-BR-3: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	1870000		"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	24.3	3.6	13.4	4.7	26.6	0.7	42.5	3.8	45.1	12.4	5.9	6.9	8.7	4.2	12.1	7.0	10.7	11.7	14.9	12.0	16.4	13.8	14.5	11.2	35.3	6.0	9.2	18.0	5.2	9.6	3.8	4.5	3.4	11.7	22.3	4.5	12.2	39.9	34.4	9.2	9.9	5.0	21.7	6.6	1.5	5.0	3.8	3.9	0.8	12.0	5.7	4.9	19.7	6.7	1.0	0.8	2.1	0.7	0.8	0.6	0.2	0.0	0.3	3.6	3.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	13.7	0.0	1.9	0.1	0.0	0.0	0.0	37.3	0.2	0.0	0.0	27.8	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.0	16.6	0.1	0.1	3.2	0.0	9.7	0.8	2.4	0.0	0.1	0.0	0.1	2.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.7	0.5	0.6	0.4	0.3	0.6	0.4	0.3	0.2	1.0	0.4	0.6	2.1	0.8	0.4	0.8	0.2	0.2	13.4	26.6	3.8	37.3	16.4	13.8	9.2	18.0	11.7	3.9	3.0	5.8	0.0	39.3	3.9	5.4	7.0	25.5	10.7	25.0	3.5	3.9	0.0	0.0	25.9	0.3	39.1	0.2	0.0	1.6	0.0	3.3	28.6	1.1	10.0	0.0	4.8	1.7	3.1	0.6	0.0	4.4	0.0	0.0	1.0	0.0	0.8	6.6	0.0	26.2	10.2	1.7	12.9	14.4	0.1	0.1	2.3	0.2	0.0	0.7	24.6
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 990.8;Club cells: 598.3;Ductal cells: 654.4;Glandular cells: 1080.1;Intestinal endocrine cells: 612.7;Urothelial cells: 1138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 80.8;EFO-21: 206.4;RPTEC TERT1: 74.5"														"Secreted to blood"	NA	NA	384000					"prognostic favorable (7.83e-4)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.2	80.8	1.9	2.0	0.0	1.4	0.0	206.4	0.1	7.9	4.1	0.0	0.3	10.5	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.0	0.1	14.5	1.1	0.1	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	74.5	1.7	0.0	0.0	0.1	0.0	4.0	0.2	0.0	0.1	18.6	0.0	0.7	4.0	0.1	0.0	0.1	0.3	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7	41.7	227.2	0.5	990.8	112.5	0.0	3.2	298.1	463.1	598.3	5.2	0.0	0.2	0.0	654.4	0.0	47.2	8.0	0.0	37.1	0.6	117.2	1080.1	15.1	1.3	22.0	0.0	612.7	4.3	11.7	0.0	0.0	126.7	118.1	99.2	4.2	0.0	202.8	8.2	0.0	0.8	0.0	0.0	77.8	0.2	0.1	92.0	0.3	6.9	15.1	1138.8
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	253000					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.2	3.4	3.4	0.3	0.1	3.0	0.3	0.0	7.9	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	6.3	0.1	3.6	0.0	0.0	0.0	0.7	2.0	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9	0.0	2.1	0.5	9.7	0.8	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.8	10.1	1.1	0.0	18.2	0.0	0.0	0.0	5.6	3.5	0.3	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3"					"Not detected"	"Not detected"			CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000				"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.3	8.3	8.8	0.0	0.2	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5	3.0	0.0	0.0	2.5	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	3.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.6	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 145.9;Fibroblasts: 106.4;Kupffer cells: 133.6;Melanocytes: 128.2;Smooth muscle cells: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	9	"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 62.6;BJ hTERT+: 36.1;BJ hTERT+ SV40 Large T+: 35.5;BJ hTERT+ SV40 Large T+ RasG12V: 53.7;fHDF/TERT166: 58.6;HSkMC: 159.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"	NA	NA	1030000				"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	83.4	14.6	4.1	38.2	5.6	3.8	65.7	1.8	6.0	94.2	39.4	6.9	21.1	7.6	84.2	45.5	50.0	35.8	74.7	59.5	4.7	3.6	35.9	61.9	15.4	55.6	4.6	7.0	45.6	76.3	20.7	6.8	2.1	5.8	47.1	17.8	35.2	44.6	25.8	31.4	29.1	25.8	54.5	5.9	95.6	14.5	17.6	3.0	34.8	32.5	63.7	57.7	55.1	63.6	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.6	9.7	0.0	22.1	36.1	35.5	53.7	0.0	0.0	0.0	0.2	58.6	0.0	0.0	0.0	0.0	11.8	21.4	0.2	0.0	0.0	0.0	21.3	0.0	0.1	159.2	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	32.4	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	5.6	1.8	6.0	4.7	3.6	4.6	7.0	5.8	3.0	0.0	0.6	0.0	0.4	67.9	0.1	21.4	10.2	0.0	1.2	5.2	0.0	0.1	145.9	0.8	1.7	71.6	0.0	0.0	18.1	0.3	106.4	0.7	0.0	0.8	2.3	0.0	0.0	79.8	133.6	1.3	65.0	18.9	128.2	0.0	2.8	1.7	4.5	0.0	8.1	17.4	0.6	84.1	103.9	0.5	4.5	54.7	0.6	1.9	0.1	0.1
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell type enriched"	"Detected in some"	6	"monocytes: 67.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.4"									HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700				"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.3	0.0	10.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	2.8	1.1	8.6	10.5	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	2.8
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 140.1"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 3051.6;Fibroblasts: 4090.0;Proximal tubular cells: 2046.8;Suprabasal keratinocytes: 1848.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;granulocytes: 1.1"	"Group enriched"	"Detected in some"	12	"HAP1: 17.2;hTCEpi: 22.8;RPTEC TERT1: 61.9;SuSa: 34.3;U-2 OS: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000				"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	59.5	0.9	19.4	25.8	14.9	0.2	44.1	0.6	20.7	40.7	30.0	1.5	4.5	38.8	6.8	26.1	16.7	5.2	3.8	11.2	10.8	4.6	79.2	10.3	1.7	13.9	6.3	9.3	2.1	2.8	0.3	25.4	30.5	7.6	7.0	34.3	14.3	44.2	3.7	17.2	140.1	59.2	8.6	1.0	15.1	18.7	5.1	2.4	1.5	10.0	30.2	22.9	12.7	17.0	0.2	3.2	1.1	0.3	0.3	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.8	0.0	1.1	0.0	17.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3	61.9	0.0	0.3	0.2	0.1	0.0	0.0	34.3	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.3	0.2	0.2	0.1	0.3	0.1	0.2	0.1	3.2	0.2	0.3	0.2	1.1	0.3	0.2	0.2	0.2	0.1	19.4	14.9	0.6	20.7	10.8	4.6	6.3	9.3	7.6	2.4	0.0	0.6	0.9	12.3	3051.6	249.2	2.0	0.0	0.0	0.0	268.7	0.0	28.7	477.5	0.0	0.6	4.8	0.0	0.0	0.0	24.5	4090.0	8.5	0.0	0.0	56.4	6.4	0.0	74.3	0.0	1.1	19.2	3.2	416.7	0.0	0.0	3.7	0.1	0.0	0.4	2046.8	14.0	0.0	20.0	0.5	4.1	1848.7	64.5	0.0	0.0	8.1
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733526-4739922	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7"	"Cell line enhanced"	"Detected in many"		"A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9"									"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	4000000	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	32.5	9.5	8.2	18.7	9.7	16.3	9.7	2.0	6.6	8.0	17.2	15.8	3.4	19.1	4.8	10.5	13.1	9.5	23.0	5.2	9.9	6.9	12.5	34.8	41.9	28.8	13.3	5.1	10.6	11.0	34.6	8.6	9.7	10.0	9.8	8.3	12.7	26.6	5.9	3.3	11.3	29.5	5.2	16.5	34.1	18.7	51.9	10.0	4.5	8.1	8.5	10.1	9.7	7.4	3.4	10.7	25.9	37.7	0.0	0.3	6.9	35.0	4.8	0.0	11.3	0.1	0.9	4.5	0.4	3.4	3.4	4.6	24.1	19.0	0.0	4.2	0.2	2.1	39.2	5.6	4.0	1.2	3.6	6.4	0.0	0.5	10.6	2.4	0.0	5.2	0.2	6.7	1.8	0.2	1.3	0.9	0.1	0.0	0.2	0.3	7.4	0.1	0.6	0.0	10.1	3.0	0.4	0.0	5.2	7.2	5.8	0.0	0.4	7.1	2.9	1.8	0.4	18.9	0.4	0.1	0.5	2.5	0.8	2.0	1.2	1.6	0.0	0.1	0.1	0.9	0.0	18.3	4.0	0.1	29.3	0.1	2.9	0.3	0.2	10.7	3.4	0.1	0.3	25.9	0.0	37.7	4.6	0.0	6.9	8.2	9.7	2.0	6.6	9.9	6.9	13.3	5.1	10.0	10.0	68.5	50.1	21.2	107.8	62.3	2.0	0.7	40.8	14.7	37.5	38.4	2.0	2.4	3.3	146.2	715.4	13.4	32.3	0.0	129.6	1.8	13.6	179.9	71.7	5.9	190.7	3.2	29.6	160.8	160.8	3190.9	22.7	246.0	25.3	938.6	23.4	6.8	134.1	45.6	28.3	6.8	0.8	19.4	18.9	20.7	11.8	66.9	2.4	10.0	19.3	257.2
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428288-42443048	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.0;lung: 83.0;stomach 1: 79.9"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 380.6;Ciliated cells: 365.4;Club cells: 424.2;Pancreatic endocrine cells: 272.5;Urothelial cells: 1358.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Group enriched"	"Detected in some"	7	"OE19: 13.0;RT4: 3.9"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.7	0.1	0.1	17.4	0.1	0.4	0.1	0.0	1.0	5.1	68.0	6.3	1.3	0.1	0.1	0.0	0.7	0.4	83.0	0.1	0.1	0.1	2.8	11.4	0.0	2.3	0.1	0.3	6.8	0.0	0.3	39.2	0.5	0.1	0.0	0.1	0.3	0.1	0.1	79.9	0.3	0.1	0.5	1.2	8.8	40.1	5.5	10.0	0.0	0.0	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.3	13.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	32.8	380.6	0.0	160.7	0.0	0.2	0.0	2.5	365.4	424.2	5.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	159.6	0.0	0.0	167.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.6	0.0	0.0	272.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1358.9
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097035-74099293	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 1610.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.0;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	25	"granulocytes: 1.4;monocytes: 3.5"	"Cell line enriched"	"Detected in some"	8	"GAMG: 95.1"														"Secreted to blood"	NA	NA						"prognostic favorable (5.93e-5)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	22.8	3.8	2.4	19.9	4.3	20.7	10.9	0.8	1.7	20.4	5.7	2.3	0.9	0.9	4.4	3.8	6.2	5.8	15.2	14.2	1.7	2.0	3.2	113.1	22.4	35.0	2.8	0.5	5.8	24.9	0.6	2.3	1.4	4.3	5.1	6.4	5.1	4.8	3.6	30.9	1.3	3.8	4.1	4.6	3.7	7.5	3.1	1.6	0.0	2.1	18.5	1.8	11.7	4.1	0.0	0.0	1.4	3.5	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.2	0.9	0.0	0.9	11.3	0.4	1.3	0.0	1.7	0.0	1.5	0.0	95.1	0.0	0.0	2.4	1.8	0.0	0.0	0.7	0.9	0.0	7.9	0.3	0.0	0.9	8.3	6.0	8.1	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.5	0.4	0.1	1.7	0.8	0.0	0.0	0.0	6.9	1.8	0.0	1.4	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.5	0.0	0.0	0.1	2.4	4.3	0.8	1.7	1.7	2.0	2.8	0.5	4.3	1.6	443.7	1610.2	15.2	162.7	369.1	0.0	20.4	257.4	125.8	325.3	8.7	0.0	1.9	0.0	632.5	1.0	297.5	87.8	0.0	520.6	3.2	166.5	200.8	79.0	270.4	117.3	0.0	126.9	134.4	220.1	0.6	14.7	392.1	263.2	87.4	36.2	0.5	376.8	15.8	0.0	0.5	0.0	71.1	657.8	1.2	3.4	199.1	1.8	7.9	38.9	91.4
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Cell type enhanced"	"Detected in many"	12	"Macrophages: 757.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.2;hTEC/SVTERT24-B: 36.5;RPTEC TERT1: 21.0"														"Secreted to blood"	NA	NA	28700					"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.7	0.0	2.5	23.2	0.6	1.4	0.0	2.8	0.0	2.5	0.0	8.6	0.1	0.1	0.8	5.1	0.0	0.0	1.9	0.2	0.0	2.8	0.2	0.0	0.5	0.6	36.5	3.6	0.6	0.5	0.4	0.4	0.0	1.0	0.0	0.5	0.1	0.3	3.3	0.7	0.0	0.8	0.0	21.0	0.6	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.0	0.9	5.2	0.2	2.6	6.4	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6	92.3	203.1	5.1	105.8	203.0	0.0	6.1	33.1	87.0	40.9	5.2	0.0	0.5	0.0	138.2	0.4	32.1	49.7	0.0	85.9	1.0	32.9	154.6	26.5	1.1	74.4	0.0	50.8	10.4	119.3	0.9	13.0	757.6	178.8	48.7	41.4	0.0	148.4	28.8	0.4	0.0	0.0	38.8	169.7	0.7	3.1	129.9	6.8	2.5	59.8	50.3
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 71.4;Pancreatic endocrine cells: 163.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 34.5;EFO-21: 29.1;HSkMC: 20.9;hTEC/SVTERT24-B: 15.0;RPTEC TERT1: 111.3"									HPA065474	Approved				"Secreted to blood"	NA	NA	1110000				"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	34.5	0.1	0.0	0.0	1.3	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	29.1	0.0	6.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.9	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2	3.0	0.0	0.0	0.8	0.8	0.0	1.3	15.3	1.4	3.4	0.0	0.0	0.0	0.0	71.4	0.2	0.7	0.0	0.0	1.2	0.0	0.5	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	9.3	0.0	2.8	0.0	0.0	163.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.3	0.0	0.0	0.0	0.3
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 280.2;Ductal cells: 403.7;Glandular cells: 173.8;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.2;EFO-21: 41.4;HUVEC TERT2: 27.0;RPTEC TERT1: 32.1"														"Secreted to blood"	NA	NA	108000					"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.5	0.0	0.9	17.2	0.1	0.2	0.0	0.0	0.0	41.4	0.0	1.3	3.4	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.1	8.7	0.0	0.1	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	32.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0	3.0	1.3	0.0	76.4	0.3	0.0	0.2	280.2	68.3	72.8	0.0	0.0	0.0	0.0	403.7	0.0	0.0	0.0	0.0	3.2	0.0	2.3	173.8	0.0	0.0	0.2	0.0	75.3	0.0	0.8	0.0	0.0	1.1	0.0	13.6	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	356.0
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 9866.5;Glandular cells: 5032.8;Urothelial cells: 12569.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 291.3;GAMG: 80.6"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"	NA	NA	7260				"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	291.3	2.6	8.6	0.0	0.9	0.0	39.9	0.0	80.6	3.4	0.0	0.0	41.6	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.7	0.2	0.9	9.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.0	1.4	0.0	0.0	0.0	23.1	1.2	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.3	22.4	4.2	0.3	1.1	3.8	0.0	0.0	0.1	18.8	2.1	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1	47.6	287.8	4.2	9866.5	0.0	0.2	22.2	150.3	327.9	783.7	0.0	0.0	3.4	0.0	1020.3	1.4	16.9	1.6	0.0	220.3	4.9	10.8	5032.8	48.7	2.5	332.1	0.0	18.3	23.9	507.0	0.5	0.6	391.0	0.0	2049.7	1.0	0.4	645.9	0.0	0.4	0.4	1.1	38.8	17.7	0.0	1.2	0.0	17.8	4.3	1.6	12569.9
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell type enhanced"	"Detected in some"	15	"Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	902000					"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	6.6	0.0	0.0	0.0	11.9	1.4	0.6	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.7	0.3	0.1	0.0	0.0	0.1
CXorf36	"DIA1R, FLJ14103"	ENSG00000147113	"Chromosome X open reading frame 36"	Q9H7Y0	X	45148374-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Endothelial cells: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Cell line enriched"	"Detected in single"	59	"HUVEC TERT2: 43.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8.0	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12.0	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5.0	4.2	5.6	2.0	0.3	12.3	12.0	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0.0	0.5	0.4	0.3	2.4	0.1	0.0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2.0	3.0	2.2	0.0	0.4	3.9	0.0	4.5	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.2	94.9	0.0	0.0	0.2	0.1	1.0	0.1	1.1	0.0	0.2	0.0	0.0	13.5	1.2	1.5	0.9	1.3	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.1	4.1	0.2	0.0	0.0	0.5
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.9	10.7	6.2	6.5	40.1	11.8	2.6	7.7	16.7	5.7	5.8	3.1	5.3	2.6	7.0	8.9	4.8	11.3	2.6	3.6	2.3	8.5	12.9	2.4	6.7	5.3	7.3	1.0	4.9	15.4	8.6	3.1	6.2	11.9	10.2	5.8	2.5	15.8	4.3	9.8	3.7	1.6	2.2	6.8	5.8	4.5	5.5	6.3	13.1	4.2	5.0	4.2	8.7	5.1	11.4	7.2	13.5	1.6	13.7	8.3	2.1	7.6	4.0	3.0	2.3	2.0	10.2	2.2	3.2	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1	11.9	9.3	19.5	18.9	47.7	26.3	8.5	56.0	45.5	11.4	29.6	55.0	44.7	44.7	26.6	19.7	31.6	18.6	0.0	23.9	24.3	20.3	8.4	10.5	31.1	17.8	38.1	13.3	29.4	21.3	23.3	26.7	17.5	13.5	14.4	13.8	34.2	24.3	17.3	26.9	34.9	30.0	0.0	21.2	83.1	23.6	37.5	32.3	15.2	15.8	7.8
CYR61	"CCN1, GIG1, IGFBP10"	ENSG00000142871	"Cysteine rich angiogenic inducer 61"	O00622	1	85580761-85583962	"Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 678.9;Basal glandular cells: 1529.5;Basal keratinocytes: 745.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 99.0;U-138 MG: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029853	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA029853: AB_10611822"	"unprognostic (6.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-3)"	79.6	23.6	3.5	106.4	6.4	0.0	47.8	0.8	4.8	110.6	27.4	13.1	20.3	3.0	73.4	64.4	26.3	76.5	108.4	60.1	4.7	4.0	30.8	41.7	98.8	59.9	2.9	4.4	66.8	17.2	5.1	8.8	64.7	7.2	60.8	16.5	23.6	14.6	49.3	55.3	28.2	15.6	102.4	6.1	58.9	35.0	26.6	3.7	1.9	56.4	23.6	16.3	101.6	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	2.2	6.3	1.3	41.6	38.6	9.5	68.1	51.1	99.0	75.9	16.4	2.4	0.0	43.6	67.0	66.5	4.5	6.4	16.2	82.3	0.1	0.8	0.0	10.3	2.3	64.0	0.4	0.0	20.9	10.7	44.6	30.2	69.8	73.6	0.0	0.1	0.0	51.4	2.0	0.0	0.1	4.1	0.6	4.3	0.0	18.8	0.0	75.5	2.8	0.0	0.4	76.3	15.5	10.3	23.7	5.0	0.3	79.3	99.2	31.0	14.2	95.9	0.0	0.1	0.1	1.2	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.4	0.8	4.8	4.7	4.0	2.9	4.4	7.2	3.7	678.9	102.9	2.4	1529.5	745.3	1.5	85.3	73.9	29.4	76.2	36.6	2.0	128.7	1.7	489.8	1.5	159.3	2.6	0.0	263.1	474.2	526.6	216.8	12.8	32.1	36.5	0.0	0.0	244.9	3.2	1.1	103.6	25.2	99.5	4.6	4.4	75.3	290.4	34.5	86.7	11.3	6.0	291.1	529.9	0.7	0.8	212.2	109.8	9.6	10.4	81.8
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell type enhanced"	"Detected in some"	12	"Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Cell line enhanced"	"Detected in some"		"HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	34.2	0.0	0.0	1.7	0.0	0.0	0.0	83.4	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	5.2	0.0	0.0	0.0	11.7	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	20.2	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4	0.0	0.3	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.3	0.0	0.0	0.0	0.1	15.8	0.5	9.2	0.0	12.7	0.0	0.0	1.3	0.0	0.0	0.0	5.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.5	0.0	0.0	0.6
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell type enriched"	"Detected in single"	29	"Cardiomyocytes: 13.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.2	0.1	1.1	21.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3	0.0	0.0	0.0	0.2	0.1	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell type enriched"	"Detected in some"	386	"Melanocytes: 7747.1"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		370000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.6	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.8	0.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.4	0.7	0.4	0.0	0.0	0.2	0.4	0.2	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.0	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	1.3	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7747.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	20.1	0.0	0.0	0.0	0.0
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183123	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Fibroblasts: 3854.4;Leydig cells: 5816.6;Peritubular cells: 1745.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"basophil: 18.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 18.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 232.6;ASC TERT1: 179.3;BJ hTERT+: 179.9;HSkMC: 163.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1300000			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	152.8	64.6	4.8	52.8	8.3	0.0	137.1	4.5	5.8	177.7	60.6	5.1	105.8	7.8	124.0	266.8	142.9	113.6	94.3	190.2	5.2	4.0	35.4	35.1	107.0	27.5	16.7	9.1	265.5	25.7	1.5	12.7	192.0	12.4	130.7	28.3	40.7	32.7	51.8	77.2	76.0	34.9	222.4	24.9	1.8	47.5	116.5	6.0	3.3	74.2	99.4	29.3	187.8	113.8	0.8	0.6	18.7	0.3	0.5	0.4	0.0	0.0	0.0	0.3	0.0	232.6	179.3	0.3	41.2	179.9	1.9	2.1	0.0	0.0	0.0	0.0	35.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	1.3	0.0	49.7	0.0	0.0	163.1	0.4	5.2	2.5	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.0	33.1	0.0	0.1	0.1	0.1	0.5	0.1	0.0	18.7	0.3	0.6	0.4	0.2	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.7	0.5	0.2	0.6	0.3	0.0	4.8	8.3	4.5	5.8	5.2	4.0	16.7	9.1	12.4	6.0	38.7	48.6	0.0	2.9	541.1	1.7	148.1	0.0	10.7	21.6	19.2	0.0	35.4	1.7	0.9	19.7	45.0	0.0	0.0	0.0	24.9	3854.4	4.6	19.8	2.0	52.9	0.0	0.0	357.3	3.4	36.2	5816.6	40.7	575.3	0.0	0.0	2.3	4.2	0.0	1745.6	0.3	0.6	207.0	499.8	12.6	6.3	421.7	53.4	6.9	0.0	8.9
DEFA4	"DEF4, HP-4"	ENSG00000164821	"Defensin alpha 4"	P12838	8	6935822-6938338	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 245.5"	"Cell type enhanced"	"Detected in single"	23	"Hepatocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 9.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 9.8"	"Cell line enriched"	"Detected in some"	8	"THP-1: 11.9"									HPA051266	Enhanced				"Secreted to blood"	NA	NA					"HPA051266: AB_2681414"																		0.3	0.0	0.1	0.1	0.2	245.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.0	0.1	0.1	0.1	1.5	8.9	0.5	0.1	0.0	0.4	0.0	0.0	0.4	3.5	0.4	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.0	26.5	0.0	0.0	0.0	8.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.3	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	16.8	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	4	"Enterocytes: 16.2;granulocytes: 4.6;Intestinal endocrine cells: 13.6;Mucus-secreting cells: 13.7;Paneth cells: 11.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 19.9;NB-4: 16.4;RPMI-8226: 17.2;SH-SY5Y: 14.0;U-2197: 6.0"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	NA	NA			Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	1.8	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.8	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924693-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"intestine: 316.3"	"Cell type enriched"	"Detected in some"	5	"Mucus-secreting cells: 29.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Group enriched"	"Detected in some"	12	"BEWO: 12.8;NB-4: 13.4;RPMI-8226: 15.7;SH-SY5Y: 10.8;U-2197: 5.0"									HPA019462	Enhanced				"Secreted to digestive system"	NA	NA					"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	262.3	0.0	0.0	181.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	316.3	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell type enriched"	"Detected in many"	5	"Distal tubular cells: 11270.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.8"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.2	0.0	1.3	0.6	27.8	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3	3.0	5.0	2.9	372.3	80.0	0.3	0.0	2435.7	5.3	4.5	931.7	0.0	6.7	11270.5	1231.2	0.0	0.6	52.3	0.0	250.8	0.3	5.0	291.3	0.0	169.8	3.4	0.0	15.1	4.9	6.0	0.0	16.1	5.3	6.8	26.2	10.3	0.5	226.2	20.7	0.0	94.9	0.6	0.0	4.1	0.0	0.0	470.0	3.1	3.8	11.3	236.2
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2"														"Secreted in other tissues"	NA	NA																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 4.1;lymphoid tissue: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2"														"Secreted in other tissues"	NA	NA																							0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.1	0.0			0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB104A	"DEFB-4, DEFB104, DEFB4"	ENSG00000176782	"Defensin beta 104A"	Q8WTQ1	8	7836471-7841242	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	45	"epididymis: 110.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"GAMG: 1.9;SH-SY5Y: 1.1"									HPA045292	Supported				"Secreted in male reproductive system"	NA	NA					"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	110.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB104B		ENSG00000177023	"Defensin beta 104B"	Q8WTQ1	8	7470308-7475082	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	46	"epididymis: 108.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"GAMG: 1.9;SH-SY5Y: 1.1"									HPA045292	Supported				"Secreted in male reproductive system"	NA	NA					"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	108.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB105A	"DEFB-5, DEFB105"	ENSG00000186562	"Defensin beta 105A"	Q8NG35	8	7821966-7823889	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	438	"epididymis: 227.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;GAMG: 1.3;NB-4: 12.8;SH-SY5Y: 2.6"														"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	227.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2		0.4	0.0	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB105B		ENSG00000186599	"Defensin beta 105B"	Q8NG35	8	7487669-7489593	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	396	"epididymis: 150.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NB-4: 2.2"														"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	150.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB106A	"DEFB-6, DEFB106"	ENSG00000186579	"Defensin beta 106A"	Q8N104	8	7825172-7829053	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	17	"epididymis: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"BEWO: 3.0;RPMI-8226: 1.9;SH-SY5Y: 4.6"									HPA045592	Supported				"Secreted in male reproductive system"	NA	NA					"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	22.0	0.1	1.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB106B		ENSG00000187082	"Defensin beta 106B"	Q8N104	8	7482504-7486400	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	362	"epididymis: 164.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"NB-4: 5.6"									HPA045592	Supported				"Secreted in male reproductive system"	NA	NA					"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	164.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB107A	"DEFB-7, DEFB107"	ENSG00000186572	"Defensin beta 107A"	Q8IZN7	8	7811720-7815716	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	100	"epididymis: 77.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;NB-4: 1.8"									HPA045626	Approved				"Secreted in male reproductive system"	NA	NA					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.1			0.0	0.3	77.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB107B	HsT21816	ENSG00000198129	"Defensin beta 107B"	Q8IZN7	8	7495846-7509311	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	95	"epididymis: 78.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;NB-4: 1.8"									HPA045626	Approved				"Secreted in male reproductive system"	NA	NA					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.3	78.7	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB108B		ENSG00000184276	"Defensin beta 108B"	Q8NET1	11	71833200-71837710	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"HaCaT: 2.8"									HPA042588	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042588: AB_10959523"																		0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB110	"DEFB-10, DEFB-11, DEFB111"	ENSG00000203970	"Defensin beta 110"	Q30KQ9	6	50009138-50021981	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	158	"epididymis: 149.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NB-4: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.9	0.0	0.1	149.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB112	DEFB-12	ENSG00000180872	"Defensin beta 112"	Q30KQ8	6	50043575-50048651	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	54	"epididymis: 58.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"NB-4: 2.9"														"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB113	DEFB-13	ENSG00000214642	"Defensin beta 113"	Q30KQ7	6	49968677-49969625	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	139	"epididymis: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1			0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB114	DEFB-14	ENSG00000177684	"Defensin beta 114"	Q30KQ6	6	49960249-49964105	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	67	"epididymis: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB115	DEFB-15	ENSG00000215547	"Defensin beta 115"	Q30KQ5	20	31257664-31259632	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	22	"epididymis: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"U-2 OS: 6.0"									HPA053160	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA053160: AB_2682062"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB116	DEFB-16	ENSG00000215545	"Defensin beta 116"	Q30KQ4	20	31303212-31308585	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"epididymis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA047430	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA047430: AB_10964749"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0			0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB118	"C20orf63, DEFB-18, dJ1018D12.3, ESC42"	ENSG00000131068	"Defensin beta 118"	Q96PH6	20	31368618-31373923	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"epididymis: 167.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.9;NB-4: 4.5;RPMI-8226: 1.6"									HPA042634	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA042634: AB_10797505"														"unprognostic (3.24e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	167.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390603	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"epididymis: 218.6;testis: 126.7"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 32.4;Cone photoreceptor cells: 37.3;Early spermatids: 56.5;Late spermatids: 59.1;Rod photoreceptor cells: 148.5"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 5.1;RPMI-8226: 3.2;SCLC-21H: 1.2;SH-SY5Y: 2.4"									HPA043059	Supported				"Secreted in male reproductive system"	NA	NA					"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	218.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	126.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	59.1	11.5	0.0	0.0	0.0	0.0	16.4	0.0	0.0	6.0	0.0	148.5	12.9	0.0	7.7	7.7	0.0	0.0	0.0	0.0	0.0
DEFB121	DEFB-21	ENSG00000204548	"Defensin beta 121"	Q5J5C9	20	31404845-31412838	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	133	"epididymis: 201.9"	"Group enriched"	"Detected in some"	13	"Early spermatids: 9.2;Late spermatids: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	81	"NB-4: 8.0"														"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	201.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
DEFB123	DEFB-23	ENSG00000180424	"Defensin beta 123"	Q8N688	20	31440519-31450257	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	403	"epididymis: 39.9;testis: 75.3"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 12.5;Late spermatids: 37.8;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;U-2197: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA																				"unprognostic (9.16e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	3.6	3.9	0.0	0.0	0.0	0.0	0.0
DEFB124	DEFB-24	ENSG00000180383	"Defensin beta 124"	Q8NES8	20	31465506-31476757	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.1;testis: 7.7"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 6.7;Club cells: 2.3;Smooth muscle cells: 1.4;Spermatocytes: 1.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.9;HMC-1: 2.8;U-2 OS: 2.1;WM-115: 10.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 1.6;thalamus: 3.4"						"Secreted in other tissues"	NA	NA						"unprognostic (1.24e-2)"	"unprognostic (9.76e-3)"		"unprognostic (1.27e-1)"	"unprognostic (3.23e-3)"	"unprognostic (6.92e-3)"		"unprognostic (3.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.43e-1)"	"unprognostic (3.32e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.28e-1)"	3.5	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.7	1.9			0.0	5.3	4.6	0.4	9.1	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.6	0.0		0.4	0.0	1.3	0.9	0.0		1.0	0.9		0.5	5.0	0.9	0.2	0.9	0.6	0.0	0.6	0.9	7.7			0.8		0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0
DEFB125	DEFB-25	ENSG00000178591	"Defensin beta 125"	Q8N687	20	87250-97094	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	13.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0
DEFB126	"bA530N10.1, C20orf8, DEFB-26"	ENSG00000125788	"Defensin beta 126"	Q9BYW3	20	142369-145751	"Disease related genes, Predicted secreted proteins"	Fertilization	"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 255.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;OE19: 5.9;RPMI-8226: 1.1;SH-SY5Y: 1.0;SK-BR-3: 1.2"														"Secreted in male reproductive system"	NA	NA											"unprognostic (1.16e-1)"		"unprognostic (1.21e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.41e-2)"			"unprognostic (2.32e-1)"		"unprognostic (1.47e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	18.2	0.0	0.1	255.5	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	5.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	1.2	0.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1
DEFB127	"bA530N10.2, C20orf73, DEF-27"	ENSG00000088782	"Defensin beta 127"	Q9H1M4	20	157470-159163	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	56	"epididymis: 170.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BEWO: 3.1;NB-4: 3.0;SH-SY5Y: 2.0"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	3.0	0.0	0.1	170.3	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB128	DEFB-28	ENSG00000185982	"Defensin beta 128"	Q7Z7B8	20	187853-189681	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	239	"epididymis: 186.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BEWO: 2.9;NB-4: 3.2;RPMI-8226: 1.8"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	186.7	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB129	"bA530N10.3, C20orf87, DEFB-29"	ENSG00000125903	"Defensin beta 129"	Q9H1M3	20	227258-229886	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 223.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 3.5"					"Not detected"	"Not detected"			HPA014581	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA014581: AB_2732410"																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	14.0	0.0	0.2	223.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB130A	"DEFB-30, DEFB130, DEFB30"	ENSG00000232948	"Defensin beta 130A"	P0DP74	8	12310962-12318316	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB130B		ENSG00000233050	"Defensin beta 130B"	P0DP73	8	12064389-12071747	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"ductus deferens: 31.3;epididymis: 65.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"TIME: 6.8"														"Secreted in other tissues"	NA	NA																					"unprognostic (2.11e-1)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	9.0	0.0	31.3	5.5	0.1	65.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	10.9	0.1	0.1	10.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	8.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB131B		ENSG00000225805	"Defensin beta 131B"	A0A096LNP1	11	71878453-71884561	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 36.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 17.5"														"Secreted in male reproductive system"	NA	NA						"unprognostic (5.87e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.78e-2)"		"unprognostic (7.44e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.62e-1)"	0.0	0.0		0.2		0.0	0.0		0.1	0.0	0.0			0.5	0.0	36.6	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.7			0.4	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.8	0.1	0.0		0.0	0.0	0.1			1.5		0.0	0.9		0.3	3.0	0.8	0.7	1.4	1.2	0.0	0.6	0.0	3.6	1.4	0.0	0.0	0.4	3.7	0.0	0.0	0.0	4.4	4.1	3.5	1.3	0.0	1.6	3.8	0.0	0.0	0.0	2.8	2.9	3.7	2.2	2.5	0.0	4.7	1.7	0.0	0.0	0.0	0.0	1.7	0.0	8.0	8.5	6.1	0.0	3.3	2.0	1.2	1.1	4.0	5.7	3.9	17.5	1.1	0.0	1.1	4.1	1.6	3.5	2.0	3.4	3.2	3.5	0.4	2.1	1.3	3.6	2.5	0.3	3.0	1.0	4.7	2.1	4.1	0.8	0.8	0.7	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.6	0.0	1.4	0.5	3.0	0.9	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257736-261096	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 37.1;epididymis: 119.7"	"Cell type enriched"	"Detected in some"	10	"Collecting duct cells: 10.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.1;NB-4: 3.3;RPMI-8226: 1.8;SH-SY5Y: 1.7"									HPA046399	Approved				"Secreted in male reproductive system"	NA	NA					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						17.2	0.1	0.1	0.0	0.1	0.0	4.4	0.1	0.1	0.1	0.1	0.0	37.1	0.0	0.1	119.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	6.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.3	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DEFB133		ENSG00000214643	"Defensin beta 133"	Q30KQ1	6	49946021-49950265	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	30	"epididymis: 18.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"K-562: 4.2"														"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB134		ENSG00000205882	"Defensin beta 134"	Q4QY38	8	11993174-11996312	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"epididymis: 24.4"	"Group enriched"	"Detected in some"	43	"Early spermatids: 38.2;Late spermatids: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;NTERA-2: 1.3;U-87 MG: 1.2;WM-115: 1.3"														"Secreted in male reproductive system"	NA	NA																				"unprognostic (3.80e-2)"	"unprognostic (2.20e-1)"		0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.6	0.3	0.0	24.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
DEFB135		ENSG00000205883	"Defensin beta 135"	Q30KP9	8	11982321-11984590	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"epididymis: 30.8"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 1.8;MCF7: 7.0"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB136	DEFB137	ENSG00000205884	"Defensin beta 136"	Q30KP8	8	11973937-11974599	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"epididymis: 5.8;prostate: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HAP1: 2.8;WM-115: 1.4"	"Not detected"	"Not detected"							HPA068255	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA068255: AB_2732780"																		0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0			0.0	0.3	5.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.3	0.0		1.5	0.0		0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	32	"Exocrine glandular cells: 31.8;Pancreatic endocrine cells: 27.9"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"EFO-21: 6.9;NTERA-2: 2.6"														"Secreted in other tissues"	NA	NA							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414860-7416863	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 14.3;lymphoid tissue: 8.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CAPAN-2: 1.4;JURKAT: 1.2"														"Secreted in other tissues"	NA	NA											"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0			0.0		8.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog"	O43323	12	49089421-49094819	"Disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Cell type enhanced"	"Detected in single"	17	"Endothelial cells: 1.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"midbrain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;EFO-21: 7.3;HUVEC TERT2: 2.9;K-562: 12.2;TIME: 6.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"midbrain: 2.1"						"Secreted in male reproductive system"	NA	NA						"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.9	0.4	0.2	1.2	0.6	0.1	1.4	0.3	0.6	0.6	0.5	0.2	0.3	0.3	1.0	0.9	0.5	0.6	1.7	0.9	0.2	0.2	0.6	0.2	0.9	0.2	5.2	0.0	0.4	0.2	0.2	0.8	1.5	1.2	0.7	0.2	1.3	0.7	0.8	0.6	0.3	0.5	1.0	1.2	0.3	0.3	35.7	0.0	0.0	0.4	1.3	0.2	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.6	0.2	0.2	5.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DHRS13	"MGC23280, SDR7C5"	ENSG00000167536	"Dehydrogenase/reductase 13"	Q6UX07	17	28897781-28903071	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022991	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA022991: AB_1853865"	"unprognostic (8.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.55e-1)"	2.3	6.0	5.9	5.1	7.9	31.7	5.9	24.9	5.7	6.4	4.5	6.4	9.0	4.1	2.6	6.5	6.7	4.0	3.0	2.7	5.3	10.9	6.9	27.0	4.1	8.6	6.7	5.4	3.6	9.5	8.5	5.3	9.5	9.9	14.9	3.5	5.0	11.8	10.9	1.1	6.8	3.0	3.2	5.6	8.0	5.5	2.8	3.6	4.4	5.5	1.2	8.1	9.2	5.1	4.0	3.1	29.7	3.5	4.6	6.3	3.1	5.6	3.6	8.5	10.8	1.3	1.9	8.3	3.1	4.0	5.7	8.8	11.2	3.4	15.6	5.3	0.6	6.6	5.1	12.0	3.4	2.4	15.7	11.6	8.8	6.7	6.1	3.2	4.4	1.0	1.4	3.1	3.6	3.8	4.0	1.7	11.0	19.7	5.4	1.1	10.2	9.7	7.4	5.2	14.9	0.5	15.5	8.1	12.0	10.5	9.6	12.3	10.3	4.9	34.0	6.6	4.7	22.6	7.2	0.5	1.8	5.6	4.4	4.2	12.6	11.8	9.7	5.4	5.6	4.5	0.4	2.3	1.6	4.8	3.5	5.9	3.6	6.1	6.0	3.1	4.0	6.3	4.6	29.7	4.6	3.3	1.7	5.7	3.1	5.9	7.9	24.9	5.7	5.3	10.9	6.7	5.4	9.9	3.6	3.0	3.4	3.0	11.5	1.3	5.4	0.4	2.5	0.0	3.4	7.0	2.0	21.6	8.3	7.8	10.7	2.9	2.4	46.7	2.4	18.2	1.9	9.4	1.1	3.8	5.2	4.8	2.9	6.7	0.8	3.8	1.1	2.7	5.0	24.4	2.7	6.9	3.2	2.9	0.4	2.9	5.0	6.5	1.4	1.5	12.6	1.5	11.3	5.3	5.7	4.3
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 186.0;Proximal tubular cells: 502.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.9	2.2	11.0	21.4	22.4	0.2	7.7	15.3	11.3	8.4	3.7	10.1	5.6	5.3	15.5	7.3	9.3	9.9	12.9	9.4	18.2	6.0	1.3	11.2	23.0	15.8	7.1	22.2	23.1	16.4	7.3	10.8	7.8	13.2	17.3	4.3	19.9	12.1	26.9	17.7	7.4	4.4	20.1	14.3	28.0	9.1	17.4	16.2	11.3	12.0	7.2	10.6	9.8	6.4	4.9	11.8	10.7	9.3	6.0	6.2	7.0	3.9	11.6	9.2	1.6	5.2	10.3	8.5	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5	14.9	23.5	21.4	38.6	24.6	9.7	15.1	17.8	32.1	23.9	24.4	2.0	16.3	107.8	33.6	16.0	33.7	49.1	23.3	48.9	6.2	41.2	29.1	17.3	186.0	120.7	11.1	35.8	45.4	59.2	31.0	40.6	42.6	49.0	45.9	56.0	58.7	33.6	63.1	35.0	502.2	6.9	32.3	38.1	8.9	1.4	35.1	10.9	27.3	69.8	32.0
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791297	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 62.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BJ hTERT+: 4.5;HeLa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA										"unprognostic (6.83e-2)"													0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.7	0.0	87.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219516-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	NA	NA			Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	7.3	9.5	21.5	3.1	26.7	2.9	55.7	21.5	25.3	32.1	7.3	1.2	1.2	4.6	25.1	6.4	3.2	7.5	6.7	37.8	23.7	3.4	34.6	18.9	5.8	3.2	21.8	16.9	25.0	15.2	5.5	24.2	32.7	28.3	7.7	6.5	1.2	10.8	5.7	6.3	4.9	6.5	5.3	26.5	5.9	8.6	3.4	23.6	1.2	8.1	1.2	2.7	6.1	27.4	12.2	18.3	30.0	21.1	8.7	9.1	10.0	4.5	20.9	14.1	6.5	17.6	11.1	10.6	10.4	17.7	8.0	10.8	15.6	9.9	7.3	13.4	12.3	18.7	2.2	9.7	8.4	5.7	13.4	15.1	7.0	11.0	11.6	20.3	3.8	5.7	13.6	10.4	6.9	6.9	13.6	6.3	8.1	7.7	3.6	12.8	5.2	13.9	5.3	3.4	6.1	5.8	5.4	7.4	2.0	8.6	11.2	13.4	13.4	9.9	11.8	7.7	9.0	5.1	6.0	8.5	8.8	2.1	4.9	6.1	4.2	0.0	18.8	5.8	5.0	3.9	6.5	21.1	17.1	8.4	15.7	8.9	12.2	7.6	7.0	18.3	10.6	7.2	6.0	30.0	8.7	9.5	14.8	9.1	10.0	21.5	26.7	21.5	25.3	23.7	3.4	21.8	16.9	28.3	23.6	17.9	9.4	13.4	20.7	9.4	8.8	20.9	25.5	6.7	5.7	24.4	9.8	36.6	11.6	44.5	0.4	12.8	31.3	0.0	70.9	36.4	20.8	43.3	18.4	46.5	34.3	3.2	18.5	11.6	15.9	1.8	22.5	27.2	11.8	47.7	19.0	8.0	61.5	28.1	23.7	35.4	5.9	19.4	14.4	9.7	17.2	5.6	89.7	13.4	22.6	17.1
DKK1	"DKK-1, SK"	ENSG00000107984	"Dickkopf WNT signaling pathway inhibitor 1"	O94907	10	52314296-52318042	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 153.6"	"Cell type enhanced"	"Detected in many"	19	"Basal glandular cells: 400.3;Glandular cells: 95.5;Pancreatic endocrine cells: 113.3;Urothelial cells: 308.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 113.4;BJ hTERT+: 62.2;CACO-2: 99.0;fHDF/TERT166: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in female reproductive system"	NA	NA						"unprognostic (5.65e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.35e-8)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (1.54e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-2)"	15.6	0.1	0.5	0.3	0.4	0.0	4.0	0.4	0.6	26.2	0.3	0.6	1.8	0.1	2.1	0.5	5.3	0.1	2.8	0.6	0.8	1.7	0.5	0.2	0.6	0.3	0.7	0.3	0.9	0.1	0.1	0.2	153.6	15.2	4.2	0.1	0.7	1.6	1.3	0.6	11.7	0.2	1.2	0.2	0.4	0.8	1.6	0.4	0.1	0.2	0.1	0.5	10.6	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.3	21.3	0.0	3.2	15.5	3.1	0.0	113.4	62.2	39.0	20.8	99.0	6.4	0.0	0.1	156.8	9.5	24.3	0.0	12.9	37.1	0.0	0.0	0.0	0.4	2.5	3.3	0.0	0.0	3.1	1.6	8.4	50.0	2.0	3.5	0.0	0.0	0.0	25.6	13.1	0.0	0.0	0.0	1.3	54.5	0.0	3.5	0.0	14.9	2.5	0.0	34.8	10.2	0.1	1.6	0.0	0.1	0.0	7.8	0.0	0.0	34.2	20.6	0.0	0.0	0.0	0.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.8	1.7	0.7	0.3	15.2	0.4	23.8	0.0	0.0	400.3	4.7	0.1	0.4	0.0	1.4	1.2	0.0	0.0	3.4	0.0	3.5	1.1	0.3	0.4	0.0	3.6	4.7	77.0	95.5	4.6	0.0	8.5	0.0	0.0	1.8	0.0	0.4	0.0	0.8	0.0	0.0	0.3	5.8	113.3	0.0	0.0	0.0	0.3	0.0	1.4	0.2	0.9	2.8	7.0	0.0	0.4	308.8
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 21.7"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 6.8;Fibroblasts: 6.3;Hofbauer cells: 12.7;Ito cells: 4.9;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 3.0"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	6.6	1.2	3.0	1.5	2.5	0.0	4.8	1.8	3.6	21.7	3.6	0.2	0.0	0.1	1.4	2.4	2.0	0.9	1.6	3.1	2.9	2.2	0.4	0.3	7.9	0.9	2.0	1.5	6.3	0.3	0.9	3.4	3.4	2.5	2.9	0.7	6.8	2.7	2.4	2.4	6.1	0.5	0.9	2.3	1.7	0.4	0.5	0.2	0.1	1.3	4.4	3.7	1.1	2.6	0.0	0.2	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.7	0.0	0.7	0.4	0.0	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.5	1.8	3.6	2.9	2.2	2.0	1.5	2.5	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	6.3	0.0	0.0	0.0	12.7	0.0	0.0	4.9	0.3	0.0	3.7	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	6.5	0.0	0.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 489.8;Muller glia cells: 1823.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.1	93.0	26.6	30.3	1.3	0.4	0.0	6.6	87.0	14.2	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	17.0	0.0	0.0	6.7	8.7	9.0	22.3	54.3	28.2	0.0	0.0	0.0	36.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	7.8	0.2	0.0	0.0	7.3	0.0	0.0	49.9	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5	3.0	4.8	0.0	55.5	40.5	22.0	489.8	0.0	4.0	20.5	0.0	11.8	0.4	0.0	0.6	98.7	37.6	0.0	0.0	0.2	0.6	30.9	9.6	1.1	0.0	15.3	12.7	1.7	47.3	1.0	66.1	19.0	2.3	60.8	0.0	0.0	1823.0	1.0	0.0	54.1	0.0	52.9	187.5	74.5	0.5	1.3	12.9	0.7	4.9	0.1	2.6
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374068-42377232	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.6;gallbladder: 9.9"	"Group enriched"	"Detected in some"	10	"Basal glandular cells: 3.4;Early spermatids: 1.1;Glandular cells: 1.4;Pancreatic endocrine cells: 2.5;Spermatocytes: 1.2;Urothelial cells: 4.3"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052916	Uncertain				"Secreted in other tissues"	NA	NA					"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.1	0.1	0.1	0.2	1.6	2.8	0.1	2.3	0.1	0.1	0.1	5.1	1.6	2.3	10.6	0.7	9.9	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.5	1.4	0.0	0.1	1.7	1.9	0.2	0.2	0.9	0.5	0.1	0.1	2.2	2.9	0.1	1.8	0.1	5.9	1.6	2.5	4.3	0.7	0.7	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.1	2.8	0.1	0.1	1.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.3
DKKL1	"CT34, SGY-1"	ENSG00000104901	"Dickkopf like acrosomal protein 1"	Q9UK85	19	49361783-49375116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 91.5"	"Group enriched"	"Detected in some"	39	"Early spermatids: 1802.9;Late spermatids: 1817.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.1"	"Lineage enriched"	"Detected in single"	42	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"AF22: 7.3;AN3-CA: 13.8"	"Group enriched"	"Detected in many"	17	"amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8"	"Low region specificity"	"Detected in all"			"CAB025410, HPA047194"	Enhanced		Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			Vesicles		"CAB025410: , HPA047194: AB_2679979"	"unprognostic (1.64e-1)"	"unprognostic (5.30e-1)"	"unprognostic (5.39e-4)"	"unprognostic (1.85e-4)"	"unprognostic (3.79e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.52e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.57e-2)"	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.4	0.5	0.3	0.4	0.2	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	91.5	0.0	0.0	0.0	0.2	0.1	0.3	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.3	13.8	0.1	0.5	0.6	1.4	0.0	0.2	0.4	0.0	0.6	0.0	1.0	0.3	0.5	0.1	0.2	0.0	0.0	0.0	2.6	0.0	3.5	0.3	0.0	0.0	1.2	1.0	0.4	0.2	0.5	1.3	1.2	0.0	1.4	0.6	0.1	0.6	0.0	0.1	2.9	0.7	1.5	0.1	0.1	0.1	0.0	0.0	0.0	3.0	1.2	0.0	0.7	1.5	1.4	2.7	1.7	1.6	0.9	1.0	0.0	0.6	0.8	0.3	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	1802.9	1.0	0.0	0.0	0.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1817.6	15.5	0.0	1.7	0.0	0.1	2.2	0.4	0.0	11.3	0.0	0.1	6.5	0.3	46.8	10.9	0.0	0.0	0.0	0.0	0.1
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 122.3;salivary gland: 130.0"	"Group enriched"	"Detected in many"	12	"Alveolar cells type 2: 221.3;Paneth cells: 136.4"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.6;LHCN-M2: 9.2;RH-30: 21.4"									HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	NA	NA		7500000	"Centriolar satellite"		"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.1	0.1	0.2	2.4	0.2	0.0	0.1	0.1	0.2	1.1	34.8	0.1	0.1	122.3	0.2	0.1	0.3	0.3	2.7	0.1	0.3	0.2	0.1	0.1	13.1	0.1	0.6	0.1	0.2	1.2	0.0	0.1	0.1	0.1	0.5	1.5	0.1	130.0	0.1	0.2	0.2	68.3	0.9	1.1	0.1	0.2	0.3	0.1	0.1	0.1	19.7	14.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.3	0.2	4.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	21.4	2.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.6	2.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.1	0.1	0.1	6.0	221.3	0.0	3.3	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.4	2.3	0.0	14.7	0.0	13.8	0.0	0.0	0.8	9.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.4	0.0	1.0	136.4	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	4.5	12.8
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 7442.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	32.0	5.2	0.0	0.0	1.3	2.0	9.0	0.1	4.3	0.2	0.3	39.6	34.0	0.0	13.0	0.3	1.6	18.0	9.8	51.9	0.4	0.1	9.5	0.0	0.0	8.8	1.5	0.0	0.1	17.8	14.0	0.9	30.2	3.0	0.0	0.0	0.1	0.0	0.1	28.0	0.0	0.0	28.8	23.3	2.1	0.0	0.0	1.3	51.3	21.2	0.1	0.0	7.8	0.0	3.1	8.6	13.0	0.0	0.0	5.0	15.2	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3	98.3	94.2	3.7	121.7	1442.2	1.4	15.2	94.3	261.0	92.1	193.7	0.0	0.7	195.6	125.9	15.0	6.0	1.3	0.0	120.1	1.1	57.3	55.5	7.0	2.0	1.0	0.0	47.4	5.5	0.8	67.8	12.0	5.1	290.1	4.6	4.2	9.3	137.6	5.8	14.9	4.4	0.7	0.0	14.2	7.1	16.4	7442.2	1.9	5.3	11.0	72.7
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650307-87664361	"Disease related genes, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.9;testis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.4;SuSa: 1.1;U-266/70: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.5	5.8	10.2	5.3	3.0	2.6	4.8	4.0	0.7	3.3	4.8	6.9	6.1	10.7	3.3	0.6	7.0	4.2	3.6	1.1	3.5	4.6	5.6	3.7	8.6	4.5	1.5	2.6	8.7	2.1	4.3	4.4	1.1	5.2	2.2	9.0	9.3	4.7	2.8	10.4	5.3	11.5	6.2	7.4	3.1	12.6	4.6	5.2	2.8	2.2	7.2	6.7	3.0	9.2	1.7	5.3	9.1	6.6	3.0	6.1	4.5	3.8	2.3	4.3	6.1	18.5	1.7	4.9	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5	8.9	10.1	2.4	8.5	2.4	27.4	4.8	5.1	9.4	11.4	15.7	21.6	6.6	48.0	4.5	16.1	4.5	12.7	0.0	9.7	3.3	5.1	9.8	2.3	1.5	3.2	23.8	13.7	4.9	2.7	34.9	7.8	3.8	1.7	11.8	11.3	12.8	4.3	11.2	7.4	1.4	18.3	0.0	4.2	15.1	17.5	3.3	5.1	10.5	15.3	5.3
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7;skin 1: 20.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Horizontal cells: 1.6;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044714			Uncertain	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.6	1.3	1.3	0.6	2.1	0.8	2.1	8.8	2.8	0.6	0.6	0.6	0.6	0.8	1.2	3.5	0.6	0.4	0.6	0.6	1.6	2.1	0.9	1.6	0.6	0.6	1.5	0.6	0.7	1.9	0.2	2.1	1.3	1.3	0.8	0.2	0.6	11.7	0.6	0.7	20.6	0.8	0.6	1.3	1.0	0.9	1.9	0.6	2.4	2.7	7.1	3.4	0.6	0.6	0.0	0.0	1.6	0.0	0.0	0.2	0.0	1.9	4.0	1.7	1.8	1.4	0.8	6.9	0.6	0.5	1.6	0.8	4.4	4.1	2.6	2.1	0.2	0.5	0.6	0.6	0.2	0.2	5.1	3.8	1.1	6.2	1.0	0.2	1.2	4.2	0.9	1.4	1.2	0.3	1.6	0.3	3.0	3.5	3.9	0.6	4.5	3.6	7.5	1.7	0.5	2.7	6.7	2.0	3.5	0.9	0.9	3.5	1.8	0.9	1.5	2.8	0.4	6.1	2.7	0.2	3.4	4.4	1.9	1.4	9.5	4.5	2.4	1.1	2.5	1.7	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	2.1	8.8	2.8	1.6	2.1	1.5	0.6	1.3	0.6	0.0	1.1	0.0	0.0	0.1	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Necrosis"	"Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.1;liver: 72.3;lymphoid tissue: 46.9"	"Cell type enriched"	"Detected in many"	11	"Ito cells: 2006.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"plasmacytoid DC: 78.1"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 78.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;Karpas-707: 3.2;RPMI-8226: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"	NA	NA					"HPA019955: AB_1847805"	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0.0	6.0	2.0	0.4	1.4	9.2	12.0	3.3	1.2	0.9	1.8	14.0	0.4	1.3	46.9	0.8	1.5	0.0	11.0	3.9	20.1	17.0	3.6	3.2	3.8	78.1	0.1	0.0	0.1	0.0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.4	0.3	0.2	0.3	0.1	1.0	0.3	0.5	0.4	0.0	1.3	1.6	0.2	0.0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	0.2	1.1	0.1	0.5	3.2	0.0	0.7	0.3	1.3	0.5	0.1	0.4	0.6	0.7	5.6	0.2	0.3	0.8	0.5	0.4	0.4	0.6	0.5	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.9	0.5	0.8	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.1	3.8	0.0	0.0	0.1	0.1	0.0	78.1	0.0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0.0	0.0	15.6	31.8	0.3	8.1	0.0	0.6	48.4	0.0	2.3	0.0	0.0	0.1	3.3	0.0	1.3	29.5	0.0	46.7	0.3	0.7	3.1	0.4	1.1	21.7	0.4	1.6	0.0	2006.5	176.2	3.1	3.7	12.8	3.3	55.1	0.0	0.0	0.0	0.0	24.1	1.8	0.1	0.0	1.3	0.1	0.0	14.3	0.2	13.8	0.0	0.9
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 134.1;Proximal tubular cells: 80.1;Syncytiotrophoblasts: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 43.4;BJ hTERT+: 39.8;RPTEC TERT1: 58.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted in other tissues"	NA	NA		170000000			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	42.8	43.4	0.1	7.9	39.8	2.2	7.7	8.0	0.2	0.0	3.0	13.7	7.4	0.2	0.1	0.0	1.3	2.5	0.1	0.0	0.0	11.9	17.4	0.0	0.0	4.9	0.0	13.4	0.1	2.0	1.3	0.1	0.0	0.0	0.7	0.0	0.7	0.1	0.4	0.3	16.4	0.0	0.0	0.1	58.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	7.1	4.6	0.2	0.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1	6.0	17.5	0.0	0.3	3.7	1.7	4.0	12.7	4.0	4.5	14.0	9.8	134.1	1.7	3.1	13.0	3.9	21.3	0.0	0.0	52.7	45.7	38.3	12.8	39.9	12.7	0.0	53.0	12.3	1.6	6.2	0.0	4.6	5.0	1.0	11.0	0.0	0.9	11.4	0.0	80.1	0.0	0.0	1.0	2.1	0.8	3.6	143.8	11.4	12.8	0.3
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 55.3;fHDF/TERT166: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		25000	Vesicles		"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.2	0.0	0.0	2.4	2.7	2.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8	3.0	1.7	0.0	0.1	28.3	0.0	5.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.3	155.7	0.2	0.0	0.0	0.6	0.0	0.0	12.9	0.0	0.7	214.6	0.0	37.1	0.0	0.0	0.0	0.3	0.0	116.3	0.0	0.0	0.0	15.0	0.3	0.3	28.0	0.3	0.0	0.0	0.5
DRAXIN	"C1orf187, Draxin, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691729-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 5.6;brain: 9.5"	"Cell type enhanced"	"Detected in some"	6	"Basal glandular cells: 2.5;T-cells: 3.5"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 25.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA014302	Uncertain				"Secreted in brain"	NA	NA					"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.7	0.4	9.5	1.0	4.4	2.8	1.4	4.1	4.7	0.3	0.4	4.9	0.0	0.6	1.0	0.8	0.6	0.7	0.6	0.4	8.9	0.9	0.5	0.2	1.2	1.0	2.7	3.0	0.5	0.7	0.4	0.2	0.4	2.4	0.4	0.5	0.0	3.6	0.7	0.6	1.3	0.7	0.3	1.9	0.9	0.4	1.5	2.5	0.0	0.7	0.8	0.5	0.4	0.2	1.2	0.6	5.6	1.1	0.9	1.9	0.5	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.9	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	0.3	25.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	4.3	0.0	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	5.6	1.1	0.7	1.9	0.6	0.7	0.6	0.5	1.1	0.3	1.2	0.8	1.0	2.9	0.9	0.7	0.6	0.8	0.5	9.5	4.4	4.1	4.2	8.9	0.9	2.7	3.0	2.4	2.5	0.0	0.3	0.9	2.5	0.5	0.8	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.9	0.0	0.0	0.2	0.1	0.7	1.6	1.1	0.0	0.4	0.0	0.0	0.0	0.3	1.8	0.6	1.5	1.7	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.9	0.6	1.9	0.3	0.0	3.5	0.0	2.0
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616910	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease mutation"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036230	Uncertain				"Secreted in other tissues"	NA	NA					"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229498-4237531	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"placenta: 411.9"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 389.3;monocytes: 881.9;Syncytiotrophoblasts: 281.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 15.5;naive B-cell: 8.5"	"Group enriched"	"Detected in many"	15	"B-cells: 15.5;monocytes: 4.5"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 68.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046635	Enhanced				"Secreted to blood"	NA	NA		1200000			"HPA046635: AB_2679729"	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	2.1	2.5	1.9	5.7	1.5	0.4	1.4	0.3	1.0	0.8	1.3	1.1	0.3	1.7	0.6	0.8	0.5	1.7	2.3	0.7	1.7	1.4	2.1	1.9	1.8	18.5	2.5	0.7	0.6	1.0	0.1	1.1	411.9	1.1	1.0	0.7	0.7	1.1	0.6	0.4	0.2	5.1	0.8	3.8	24.6	1.5	0.9	1.3	4.9	0.5	0.3	2.9	2.0	0.5	15.5	0.6	0.1	4.5	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.4	0.2	1.3	0.1	0.0	0.4	0.3	1.3	5.4	0.0	0.6	0.0	0.0	0.0	0.0	68.8	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.7	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	3.7	0.0	15.5	0.0	0.0	0.6	8.5	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.4	1.9	1.5	0.3	1.0	1.7	1.4	2.5	0.7	1.1	1.3	0.0	0.3	0.9	0.0	0.3	0.0	0.1	2.5	0.0	1.2	0.0	0.0	2.4	0.0	2.3	0.0	0.3	0.0	0.0	0.8	389.3	0.0	0.1	11.5	0.0	9.0	0.0	0.0	1.3	69.8	0.0	0.0	8.1	0.0	881.9	0.0	0.0	0.8	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	281.4	0.0	0.0	0.0
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.2	0.6	2.3	0.0	14.0	77.4	2.1	22.7	53.9	14.2	18.6	0.3	3.5	0.1	0.2	50.8	1.6	13.1	0.0	2.7	14.9	0.1	0.1	0.9	0.8	0.1	3.9	0.0	23.5	6.8	0.1	36.5	1.3	20.9	3.9	0.1	4.8	0.1	39.5	0.0	0.0	0.7	0.2	26.5	0.7	0.3	17.0	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.4	1.1	0.0	6.0	1.0	30.1	4.5	3.4	4.9	0.1	0.2	0.2	15.8	2.1	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0	0.0	0.6	1.4	1.8	13.1	0.7	1.1	12.7	0.0	2.3	3.5	0.0	1.3	0.0	4.8	0.2	4.4	0.2	0.0	3.7	26.0	80.6	1.0	10.3	0.6	16.0	1.6	0.0	56.4	2.1	0.0	9.2	4.8	70.9	0.0	0.3	0.8	42.0	0.0	20.8	0.0	1.1	12.9	16.1	0.5	0.4	16.7	9.2	0.0	0.2	5.8
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 43.8;Hepatocytes: 36.8;Leydig cells: 113.1;Peritubular cells: 65.4;Smooth muscle cells: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.4;ASC TERT1: 20.8;HSkMC: 21.9;hTCEpi: 24.9;hTERT-HME1: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"	NA	NA		5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.4	20.8	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.2	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.9	24.9	0.5	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4	0.0	2.9	0.0	0.1	10.2	2.5	4.5	0.0	5.3	3.4	0.0	2.0	0.0	0.0	0.0	3.8	2.9	0.7	0.0	0.0	9.4	43.8	0.1	0.0	36.8	0.4	0.0	0.0	3.7	1.9	5.5	113.1	1.1	5.0	0.0	0.0	0.0	0.0	0.0	65.4	6.7	2.8	25.8	33.0	0.7	0.6	8.0	0.7	0.0	0.0	0.1
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745892-20748380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ductus deferens: 61.8;epididymis: 129.9"	"Cell type enriched"	"Detected in some"	22	"Collecting duct cells: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NB-4: 3.4;SH-SY5Y: 1.5"									HPA049952	Approved				"Secreted in male reproductive system"	NA	NA					"HPA049952: AB_2680970"	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	61.8	0.0	0.1	129.9	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.2	14.7	0.1	0.1	0.1	0.0	0.1	0.4	0.4	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0
EDDM3B	"FAM12B, HE3-BETA"	ENSG00000181552	"Epididymal protein 3B"	P56851	14	20768427-20770948	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"epididymis: 261.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 7.2;RPMI-8226: 1.7;SH-SY5Y: 2.1"									HPA001323	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA001323: AB_1848377"	"unprognostic (2.40e-2)"																	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.1	0.1	0.2	0.1	0.0	12.9	0.0	0.2	261.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.2	0.4	0.1	0.0	0.2	0.1	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384793	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enriched"	"Detected in many"	6	"Bipolar cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 105.9;LHCN-M2: 32.2;TIME: 38.1;U-2 OS: 32.4;U-87 MG: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"	NA	NA					"HPA020415: AB_2670434"	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	7.9	12.6	29.3	7.2	45.3	0.2	3.6	5.5	46.2	10.9	20.1	77.0	0.3	9.3	15.6	26.2	9.9	4.9	19.2	10.8	42.6	24.7	6.5	1.1	11.7	0.5	67.3	22.5	6.1	2.0	0.9	2.1	2.6	37.1	8.1	21.8	5.0	2.5	13.5	1.2	5.5	14.3	14.4	85.3	1.8	10.6	1.4	61.6	0.0	2.4	0.1	2.1	7.7	5.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.9	0.0	2.4	3.2	0.0	4.0	0.0	0.0	0.0	1.7	3.7	0.0	0.1	1.8	0.0	1.7	0.0	11.5	0.0	19.7	0.1	0.0	5.0	0.5	11.7	1.6	105.9	4.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	1.6	0.0	7.5	0.0	7.9	0.0	5.4	0.0	0.8	0.1	0.0	0.0	0.0	5.2	0.0	0.0	38.1	11.8	32.4	0.4	10.5	0.3	0.0	0.0	21.8	0.0	3.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	29.3	45.3	5.5	30.1	42.6	24.7	67.3	22.5	37.1	61.6	8.9	5.9	0.0	1.5	10.8	147.4	10.0	0.0	1.4	2.3	3.5	2.0	0.2	0.0	0.1	25.1	3.5	0.0	0.0	0.0	0.0	17.5	0.7	5.7	0.0	0.2	4.8	22.0	2.5	0.0	12.5	2.3	0.0	3.3	0.0	8.3	4.1	0.7	5.8	3.5	0.7	9.6	6.5	24.5	1.1	0.6	14.1	0.3	0.0	9.7	0.4
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 804.7;Ductal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.6	9.2	0.1	0.0	0.0	0.0	0.0	2.9	2.6	2.4	2.0	11.9	1.4	0.0	109.7	1.1	1.5	0.8	0.0	1.7	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	0.7	72.7	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.1	1.6	0.1	0.0	0.8	0.0	5.8	1.5	0.1	0.0	0.3	8.7	0.0	20.3	22.4	0.1	53.8	6.2	4.9	0.1	3.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6	160.8	31.6	0.8	804.7	168.7	0.0	2.0	5.1	0.0	46.6	36.6	0.0	1.4	3.3	273.4	11.4	170.8	145.3	0.0	195.7	0.6	8.2	167.4	1.1	0.8	1.7	1.6	15.0	109.2	6.3	10.0	5.2	3.6	8.5	19.0	12.9	0.2	217.0	147.3	0.4	5.7	0.0	6.5	6.2	1.1	0.4	56.3	0.7	5.7	34.9	116.8
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.6	0.0	21.7	0.0	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.8	5.1	5.8	0.4	10.4	0.0	0.2	25.8	0.0	0.5	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1	6.0	1.0	0.0	145.6	27.0	0.0	0.4	5.1	1.4	0.0	66.3	0.0	0.0	0.0	6.2	0.0	0.0	10.9	0.0	0.9	0.0	0.5	63.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	6.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.5	0.0	0.0	3.3	23.3
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Deafness, Disease mutation, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Group enriched"	"Detected in some"	4	"Enterocytes: 53.9;Paneth cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 4.0"	"Low region specificity"	"Detected in all"												"Secreted to blood"	NA	NA	30900					"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4	8.9	0.3	0.0	3.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	53.9	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.3	70.2	1.8	0.0	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	14.4	0.1
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.4	0.0	20.0	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	1.3	20.9	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.0	0.0	0.0	64.6	6.9	1.5	17.2	129.3	263.2	0.0	0.0	0.0	5.6	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.3	6.5	0.0	0.4	20.2	0.0	233.1	0.1	7.0	25.8	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5	232.3	83.7	0.0	78.5	70.5	1.6	12.3	10.2	99.0	89.9	26.2	0.0	1167.9	8.3	27.4	0.3	12.2	0.0	0.0	23.4	127.3	186.9	9.1	2.3	0.4	83.0	0.0	0.0	68.7	0.6	0.8	39.4	4.3	16.9	1.0	0.0	149.0	2.2	0.0	0.0	6.9	3.9	0.0	22.5	0.0	0.2	27.7	744.0	0.0	0.0	3.9
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 114.5;Leydig cells: 86.6;Peritubular cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.5;gdT-cell: 4.4;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.5;NK-cells: 2.3;T-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.8;BJ: 27.4;BJ hTERT+: 34.2;fHDF/TERT166: 49.4;HSkMC: 33.2;hTERT-RPE1: 34.7;LHCN-M2: 29.8;U-138 MG: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	NA	NA		1100000			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	22.1	10.5	9.4	10.1	9.9	1.6	13.4	6.2	7.3	38.9	16.4	7.7	19.8	4.8	29.3	28.4	13.0	16.3	29.7	29.4	7.0	6.0	14.7	5.4	14.5	15.1	8.4	5.7	39.7	12.2	14.1	7.6	21.9	6.5	26.5	4.0	24.5	9.6	22.1	11.9	6.9	6.9	23.6	7.6	8.4	10.4	19.9	4.8	2.8	25.3	11.3	4.8	23.1	15.2	0.1	0.3	1.5	0.2	2.3	4.4	0.5	0.1	0.0	0.5	9.1	11.8	23.8	0.2	27.4	34.2	10.8	9.7	0.0	0.8	0.1	2.3	49.4	0.1	0.2	0.0	0.3	2.7	1.4	0.0	0.2	0.7	1.8	18.7	0.0	0.0	33.2	0.0	4.2	0.2	34.7	6.1	0.2	0.0	1.7	29.8	0.1	0.0	4.2	0.3	0.0	0.1	0.1	0.1	0.7	0.3	0.1	0.1	2.9	0.0	0.3	0.3	1.3	0.3	2.2	13.7	23.8	5.8	11.4	0.1	3.0	0.1	0.0	9.1	0.2	4.2	0.0	0.2	1.5	4.4	0.1	0.1	0.1	0.5	0.0	0.3	0.0	0.1	0.5	0.6	2.3	0.2	0.0	0.0	0.5	9.4	9.9	6.2	7.3	7.0	6.0	8.4	5.7	6.5	4.8	32.8	9.0	1.9	33.1	11.9	4.1	37.6	10.2	12.0	15.9	17.4	0.0	2.4	6.6	23.0	12.3	21.2	0.0	0.0	0.2	3.2	114.5	14.2	0.0	1.6	8.0	6.4	0.0	50.3	4.6	22.0	86.6	2.5	23.6	1.0	0.0	54.8	3.5	0.0	100.8	17.0	4.4	38.8	45.0	27.4	3.1	8.8	4.9	1.8	0.1	10.4
EFNA1	"ECKLG, EPLG1, LERK1, TNFAIP4"	ENSG00000169242	"Ephrin A1"	P20827	1	155127460-155134857	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 123.2"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 660.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 12.1;naive CD8 T-cell: 6.0"	"Lineage enriched"	"Detected in single"	26	"T-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 58.2;HaCaT: 20.4;SiHa: 33.5;SK-BR-3: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069549	Approved				"Secreted to blood"	NA	NA		2100000			"HPA069549: "	"unprognostic (5.14e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	16.2	6.1	6.8	2.9	14.5	0.4	29.5	4.4	10.9	7.1	27.6	11.8	10.7	21.7	7.2	11.7	12.6	8.0	8.7	13.3	6.4	4.6	16.1	123.2	27.0	2.7	15.7	4.3	5.7	14.0	4.9	5.3	38.2	13.8	18.6	20.2	5.0	17.7	17.2	10.4	27.5	27.5	5.1	9.6	2.3	13.1	3.3	14.8	3.7	30.2	7.8	4.1	10.7	12.7	0.3	0.0	0.4	0.0	0.3	12.1	2.0	3.1	1.3	0.1	2.5	0.4	0.0	58.2	0.0	0.0	0.0	0.0	3.2	7.1	0.0	5.9	0.0	1.9	20.4	1.3	7.1	0.0	2.0	0.4	0.0	4.5	17.6	0.1	0.0	0.3	0.9	17.3	0.0	6.0	1.5	10.9	0.2	0.5	0.1	0.0	11.6	0.0	0.2	0.4	10.9	4.2	1.2	0.3	2.0	13.7	5.0	2.0	3.1	33.5	51.5	1.2	11.3	10.8	0.0	1.3	0.0	2.0	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.7	0.0	0.3	12.1	6.0	0.4	0.3	0.0	0.0	0.0	2.0	6.8	14.5	4.4	10.9	6.4	4.6	15.7	4.3	13.8	14.8	184.6	95.0	4.2	57.3	113.4	3.4	35.5	84.1	53.5	91.0	17.4	0.0	130.6	11.6	117.4	0.2	123.9	167.8	0.0	55.8	660.1	20.2	202.8	5.8	108.3	24.7	4.8	17.9	76.1	6.4	0.0	4.4	7.0	59.1	1.0	105.2	4.9	63.4	143.2	0.4	26.7	0.9	0.0	30.9	0.2	0.1	190.3	212.6	5.0	70.3	74.6
EFNA4	"EPLG4, LERK4"	ENSG00000243364	"Ephrin A4"	P52798	1	155063731-155069553	"Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 72.2;Paneth cells: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB021350	Uncertain				"Secreted to blood"	NA	NA					"CAB021350: "	"unprognostic (4.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.97e-3)"	"prognostic unfavorable (3.14e-4)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.29e-2)"	5.5	10.8	3.5	6.1	1.9	0.9	16.8	2.0	2.1	12.0	18.9	1.9	13.2	9.7	9.4	12.3	20.0	4.9	9.6	6.5	3.0	1.3	8.4	12.8	5.3	10.8	2.4	2.5	16.1	6.3	4.2	2.7	9.7	2.6	11.5	11.5	7.5	20.1	9.5	2.2	25.3	27.0	4.0	1.9	7.0	5.0	5.1	2.2	6.4	12.0	13.5	16.3	6.6	11.5	17.1	18.2	7.8	9.2	2.6	9.5	4.7	6.1	4.6	11.5	16.9	6.8	4.4	9.5	2.7	5.3	5.5	5.1	6.8	10.3	7.9	15.9	2.8	4.3	14.6	6.8	4.2	2.2	3.6	2.0	0.7	4.2	9.5	2.4	1.7	12.5	2.6	13.0	2.7	3.3	4.8	10.9	6.6	3.2	5.3	3.0	13.6	4.0	4.4	21.0	23.5	9.7	14.0	4.5	7.7	8.5	5.3	2.8	12.6	5.5	20.9	2.4	8.7	13.6	5.5	5.6	3.2	9.7	6.5	4.1	5.4	5.6	7.7	3.1	4.2	3.3	0.0	7.4	5.0	5.9	6.6	6.1	17.1	6.5	6.7	6.0	14.1	9.5	6.3	7.8	2.6	9.2	18.2	6.2	4.7	3.5	1.9	2.0	2.1	3.0	1.3	2.4	2.5	2.6	2.2	0.0	4.6	5.4	6.7	22.2	0.2	1.2	7.6	5.3	4.5	15.7	0.0	7.9	1.7	23.3	0.0	5.8	20.0	0.0	12.2	72.2	10.5	12.9	1.1	1.8	10.8	0.0	2.9	4.9	5.1	0.0	7.2	5.4	16.9	7.2	17.5	5.2	17.8	37.9	5.3	3.8	0.0	0.0	5.1	0.4	2.7	28.5	8.2	7.4	25.2	8.4
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Cell type enhanced"	"Detected in some"	10	"Ciliated cells: 17.4;Cytotrophoblasts: 12.5;Fibroblasts: 9.4;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.6;NTERA-2: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA001838: AB_2666457"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0	0.0	1.3	0.0	1.3	0.9	4.9	0.3	0.0	17.4	6.8	0.0	0.0	12.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	8.1	9.4	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	7.3	0.0	0.2	0.4	22.1	0.0	0.0	3.8
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 112.4"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 251.2;Hofbauer cells: 218.0;Ito cells: 521.1;Spermatogonia: 179.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.9;HUVEC TERT2: 70.6;RPMI-8226: 27.7;TIME: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA050716: AB_2732562"	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	54.8	11.2	17.7	9.0	23.7	8.7	34.2	8.5	23.6	19.7	10.3	7.2	17.4	9.3	28.9	19.7	9.5	14.6	17.5	31.0	18.0	12.7	24.3	10.6	46.9	12.0	21.5	8.1	7.5	9.7	5.7	10.5	112.4	27.5	13.7	3.5	19.9	21.3	16.1	29.3	14.1	9.9	10.9	10.4	41.1	7.4	11.4	17.6	0.2	20.7	16.2	4.9	10.7	55.3	0.1	7.1	4.2	7.7	0.2	0.3	3.4	0.0	9.6	3.1	11.2	0.2	0.2	7.2	2.7	0.5	1.6	0.5	3.3	9.0	0.0	39.9	0.9	2.5	1.3	0.8	1.7	0.0	15.9	3.0	5.9	0.7	0.2	2.5	0.0	8.7	0.3	0.7	0.8	0.0	0.5	70.6	0.4	21.3	0.0	0.5	17.2	0.1	0.1	4.5	13.3	0.5	18.9	1.2	27.7	1.0	0.2	2.0	6.7	1.3	1.2	2.5	0.9	3.3	9.1	65.9	0.4	8.2	0.9	0.5	0.0	0.0	0.1	0.0	0.0	8.1	0.0	2.6	4.2	0.1	7.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	1.1	0.2	6.2	7.1	0.0	3.4	17.7	23.7	8.5	23.6	18.0	12.7	21.5	8.1	27.5	17.6	0.0	40.6	8.9	4.8	10.5	1.1	15.4	5.1	0.0	2.3	3.5	0.0	2.9	6.6	21.4	2.1	251.2	1.7	0.0	1.6	13.3	17.6	15.2	19.7	15.3	218.0	3.2	1.2	521.1	30.4	6.8	8.1	8.2	18.6	0.0	2.8	1.3	8.5	1.1	5.6	16.8	1.6	12.9	13.3	3.6	179.3	8.3	5.0	2.5	0.0	3.1
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465021	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 113.9;Leydig cells: 143.8;Sertoli cells: 84.1;Smooth muscle cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.2;HBEC3-KT: 8.7;hTERT-HME1: 11.6;HUVEC TERT2: 11.1;LHCN-M2: 25.6;U-2 OS: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA					"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	18.6	10.4	0.8	3.1	2.6	0.0	25.9	1.5	0.7	7.8	4.0	1.5	5.1	0.8	9.3	9.2	6.3	3.9	4.0	7.8	0.6	1.1	4.8	3.5	1.5	11.0	1.3	0.6	16.6	1.4	2.1	3.0	25.7	3.5	9.9	1.5	19.8	6.6	11.1	54.7	2.9	2.3	3.5	2.2	8.1	1.8	9.1	1.3	4.9	4.6	19.4	4.2	6.0	6.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	4.6	0.1	0.5	0.1	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.1	7.2	0.0	0.1	0.0	0.0	8.7	0.0	0.0	1.1	0.0	4.1	0.0	2.0	0.0	0.0	3.9	0.0	0.0	11.6	0.0	11.1	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	2.7	0.0	2.6	0.1	1.0	0.0	0.1	0.0	0.1	11.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.6	1.5	0.7	0.6	1.1	1.3	0.6	3.5	1.3	0.0	0.0	0.0	0.2	2.4	1.0	2.0	0.0	0.0	0.0	0.0	113.9	0.4	3.3	0.4	41.7	3.3	0.0	0.0	0.9	0.4	12.7	0.2	0.0	0.0	0.6	0.0	0.0	1.3	0.0	39.1	143.8	0.6	5.0	0.0	0.0	1.5	0.9	0.0	29.0	2.9	30.1	84.1	78.8	8.1	3.1	1.8	0.5	0.0	0.0	0.3
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 244.3"	"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 7.7;Fibroblasts: 5.7;Kupffer cells: 5.6;Leydig cells: 5.8;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 3.2;neutrophil: 6.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 3.2"	"Cell line enriched"	"Detected in some"	65	"THP-1: 197.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015409, HPA066836"	Enhanced				"Secreted to blood"	NA	NA		59000			"CAB015409: AB_831596, HPA066836: AB_2685733"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	1.5	0.3	0.1	0.3	0.1	244.3	1.6	0.2	0.6	0.3	0.6	0.7	0.0	0.3	0.3	0.7	0.5	0.6	0.8	31.2	0.0	0.0	0.3	1.5	17.8	1.6	0.0	0.0	0.3	1.8	0.3	0.4	4.7	0.5	1.4	0.3	1.0	0.7	0.3	1.1	2.1	0.5	0.5	0.0	22.5	0.5	0.3	0.0	23.0	2.3	0.9	0.3	1.0	0.2	0.0	0.0	6.9	3.2	0.0	0.5	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	11.2	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	5.6	0.0	5.8	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.7	0.2	0.0	6.5	0.0	0.0	0.0	0.0
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.9	0.1	0.1	23.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.0	9.0	0.1	0.0	0.0	4.6	11.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	133.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4	0.0	8.3	0.0	13.2	9.7	0.9	8.9	2.5	4.0	5.7	7.0	2.0	0.1	0.0	0.2	2.5	26.4	0.0	0.0	3.5	0.2	53.4	1.2	0.0	2.1	0.4	6.4	1.7	49.1	0.3	4.2	102.4	1.0	13.5	0.0	1.3	17.8	1.5	0.0	139.3	0.0	0.7	0.0	31.5	0.9	1.1	9.5	0.1	0.0	0.0	0.8
ELSPBP1	"E12, EDDM12, HE12"	ENSG00000169393	"Epididymal sperm binding protein 1"	Q96BH3	19	47994651-48025153	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"epididymis: 279.8"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 15.7;Early spermatids: 23.3;Horizontal cells: 17.5;Late spermatids: 14.5;Muller glia cells: 16.0;Rod photoreceptor cells: 68.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.9"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 14.6;NB-4: 7.9"					"Not detected"	"Not detected"			"HPA044256, HPA050341"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA044256: AB_2678879, HPA050341: AB_2681097"					"unprognostic (1.51e-1)"				"unprognostic (1.11e-1)"						"unprognostic (1.87e-1)"			0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	279.8	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	17.5	0.0	0.0	0.0	14.5	0.6	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.4	0.0	68.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490870	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 52.1;PC-3: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053905	Uncertain				"Secreted to blood"	NA	NA					"HPA053905: AB_2682303"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	17.8	24.4	21.9	12.4	21.2	17.2	11.1	10.8	32.1	14.5	22.4	41.1	23.1	23.4	17.4	24.9	14.4	22.7	24.9	21.9	21.8	19.2	33.8	43.2	15.3	19.8	23.0	20.0	22.4	25.6	32.5	48.2	21.1	22.2	20.5	8.7	29.8	29.4	19.0	147.8	13.9	28.7	8.5	31.4	14.6	33.1	24.3	19.1	15.4	34.0	13.7	16.4	12.6	11.7	12.2	10.8	11.2	10.5	4.7	10.3	6.8	17.2	21.4	0.8	8.3	2.4	3.0	0.2	16.8	3.1	1.5	1.6	0.2	11.9	5.7	0.2	3.0	2.7	14.5	1.0	2.7	0.5	22.0	52.1	1.2	9.5	0.0	4.1	4.9	33.5	3.7	3.1	1.5	1.2	1.4	3.6	5.0	11.0	12.2	3.0	12.1	7.8	0.1	0.0	6.8	37.2	13.5	2.6	18.4	6.8	15.8	13.3	29.6	24.8	8.0	8.8	1.0	8.4	9.1	6.9	1.0	23.0	6.3	9.1	13.6	33.8	4.7	6.8	3.5	8.3	7.8	10.5	11.2	8.1	8.0	6.9	9.4	8.6	8.6	7.7	12.2	10.3	10.0	4.5	4.7	5.9	10.8	6.8	6.8	21.9	21.2	10.8	32.1	21.8	19.2	23.0	20.0	22.2	19.1	59.6	135.5	78.7	47.6	26.4	78.3	8.1	86.6	29.4	64.8	66.3	76.6	114.1	19.9	150.7	157.7	33.8	118.0	0.0	98.3	126.3	46.9	69.4	51.9	61.8	121.6	35.0	203.6	53.4	97.1	29.5	63.9	74.5	79.2	85.6	93.3	93.2	107.1	129.8	108.2	56.1	61.3	6.5	41.2	14.0	52.6	27.4	126.3	73.4	108.6	54.5
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205851-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 23.3;granulocytes: 11.5;Ito cells: 14.7"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 23.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 2.3"	"Group enriched"	"Detected in some"	4	"HEL: 13.2;NB-4: 45.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"	NA	NA					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	19.3	17.8	3.6	12.7	11.7	2.4	3.5	17.9	2.9	5.4	14.2	2.2	4.8	10.5	2.5	0.9	10.4	4.8	1.3	12.6	6.1	7.7	2.1	7.0	13.3	5.6	14.7	4.8	12.7	4.5	1.2	4.7	3.8	5.2	3.4	2.9	4.7	4.2	0.7	3.6	7.4	2.3	2.6	31.0	7.0	2.1	6.9	4.6	8.4	0.5	2.2	5.0	1.4	0.1	0.0	0.0	0.0	2.3	0.3	0.1	0.0	0.1	2.3	4.9	0.0	0.0	0.3	0.0	0.0	0.2	0.1	2.6	0.3	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	5.2	4.1	13.2	0.0	0.5	0.3	1.8	1.0	0.1	0.1	0.1	0.0	0.0	0.0	3.0	1.1	0.0	0.0	3.6	0.1	45.9	0.5	0.0	0.2	0.0	0.1	5.0	0.0	0.0	6.3	3.0	0.2	0.0	0.0	0.4	1.9	2.4	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	17.8	12.7	3.5	17.9	12.6	6.1	5.6	14.7	3.8	6.9	0.0	4.5	0.0	0.8	2.5	0.1	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.1	2.2	0.0	23.3	1.2	0.1	3.1	2.4	11.5	0.2	0.3	0.0	0.0	14.7	0.8	0.2	2.8	0.0	0.0	1.0	0.0	1.2	0.7	0.0	1.8	1.4	0.5	0.0	2.8	0.0	1.5	1.8	0.2	0.5	0.0	0.4
EMILIN1	"DKFZp586M121, gp115"	ENSG00000138080	"Elastin microfibril interfacer 1"	Q9Y6C2	2	27078567-27086408	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 43.4;Ito cells: 52.2;Leydig cells: 78.9;Peritubular cells: 157.3;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 29.8;BJ hTERT+: 20.1;HHSteC: 31.6;HSkMC: 34.9;SH-SY5Y: 40.3;U-138 MG: 20.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA002822	Supported				"Secreted to extracellular matrix"	NA	NA		20000000			"HPA002822: AB_1078738"	"unprognostic (3.14e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (8.13e-9)"	"unprognostic (8.96e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.70e-3)"	13.8	12.7	2.8	25.2	4.2	1.0	17.9	0.6	2.7	56.7	45.2	2.8	35.5	14.1	56.2	34.2	22.5	29.2	66.8	16.9	2.3	1.1	14.6	9.4	21.2	18.4	3.1	2.2	75.0	4.8	0.6	6.4	9.2	3.8	42.9	4.8	13.6	4.1	34.5	6.5	4.2	18.3	80.2	7.2	26.2	21.4	14.1	3.0	1.3	6.8	5.0	4.5	58.2	37.3	0.6	2.5	1.8	0.3	0.0	1.1	0.1	0.2	0.2	1.8	0.2	11.3	15.7	0.3	29.8	20.1	6.4	9.3	0.1	0.2	0.2	0.2	17.1	0.0	0.3	0.0	0.0	1.2	0.9	0.4	0.5	0.1	13.1	31.6	0.4	8.5	34.9	0.0	4.4	0.0	0.0	0.0	0.4	0.2	0.2	1.3	0.3	0.2	8.6	1.0	0.1	0.2	4.6	0.4	0.3	0.0	0.1	0.5	40.3	0.0	0.1	0.3	0.1	0.1	0.7	3.6	20.0	0.6	2.3	0.1	0.5	0.5	0.3	0.2	0.4	5.3	0.0	0.3	1.8	0.4	0.3	0.5	0.2	0.2	0.5	0.2	0.6	0.8	0.1	0.0	0.0	0.0	2.5	1.1	0.1	2.8	4.2	0.6	2.7	2.3	1.1	3.1	2.2	3.8	3.0	0.0	0.3	0.0	0.1	3.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.4	4.0	0.0	23.3	0.3	1.1	43.4	0.2	4.6	0.9	5.7	0.0	0.0	52.2	2.4	4.2	78.9	1.9	10.1	0.0	0.3	3.8	0.9	0.0	157.3	1.1	0.9	71.1	23.9	0.6	0.2	2.8	2.4	0.0	0.0	0.1
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847030-2915993	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 83.7"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 45.1;Hofbauer cells: 53.4;Kupffer cells: 51.7;Macrophages: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.6;BEWO: 17.4;HL-60: 16.4;HMC-1: 27.9;HSkMC: 12.3;SuSa: 12.3;THP-1: 16.3;U-2197: 21.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		600000			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	32.3	1.4	0.9	8.4	0.7	4.9	14.5	0.3	0.8	5.8	3.9	1.1	2.2	1.1	6.8	6.7	3.9	5.2	4.3	9.6	1.0	1.1	2.0	1.3	10.9	24.4	3.1	0.0	11.0	1.8	83.7	0.6	34.9	3.7	4.6	2.0	2.4	2.9	1.0	3.9	3.0	2.4	5.7	16.4	6.9	1.9	2.8	0.3	2.8	3.0	4.1	1.8	7.9	6.6	0.5	2.1	8.0	2.3	3.1	0.9	0.6	0.1	0.1	1.3	0.0	22.6	9.4	17.4	3.5	0.0	0.6	1.1	2.5	0.0	0.0	0.2	8.6	0.2	0.0	0.4	0.0	1.2	0.0	1.2	0.2	0.1	0.1	0.8	16.4	27.9	12.3	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	12.3	0.0	16.3	0.2	0.0	2.4	21.4	0.2	0.0	0.0	0.0	1.4	4.1	0.4	8.0	2.3	0.6	0.9	1.6	0.7	0.4	0.9	0.6	2.1	0.5	0.5	0.9	2.3	3.1	1.4	1.4	0.6	0.6	0.9	0.7	0.3	0.8	1.0	1.1	3.1	0.0	3.7	0.3	3.0	7.9	13.7	4.1	5.0	0.0	14.9	2.5	6.7	9.1	3.5	0.0	3.6	1.7	2.4	1.6	8.0	1.1	0.0	1.0	8.1	19.7	2.5	45.1	0.0	53.4	0.0	2.9	3.1	51.7	2.1	14.1	73.7	5.0	24.4	3.9	0.0	1.8	8.0	1.1	1.1	0.3	0.0	8.5	4.7	3.5	3.4	2.4	4.9	4.5	1.7
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359966-41366827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 49.9"	"Cell type enhanced"	"Detected in some"	25	"Leydig cells: 1.7;Peritubular cells: 4.6"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;HAP1: 12.1;NTERA-2: 7.7;SCLC-21H: 14.4"	"Region enriched"	"Detected in single"	29	"cerebellum: 3.7"	"Low region specificity"	"Detected in single"			"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	NA	NA		650000	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.9	1.9	2.9	1.6	2.0	0.5	3.5	0.7	8.2	7.1	4.1	1.9	8.5	1.1	2.7	49.9	1.1	3.2	0.9	6.0	3.0	2.9	0.8	0.6	0.7	0.6	3.8	0.7	9.2	0.6	0.5	1.6	0.6	2.7	8.1	0.8	5.8	1.5	10.0	1.3	3.4	1.4	1.6	2.2	0.6	1.9	4.3	2.3	0.3	0.7	2.9	0.8	2.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	12.1	0.0	0.3	0.0	1.4	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.4	1.4	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	2.0	0.7	8.2	3.0	2.9	3.8	0.7	2.7	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell type enriched"	"Detected in some"	7	"Melanocytes: 32.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Group enriched"	"Detected in some"	4	"Daudi: 2.4;RPTEC TERT1: 1.5;U-266/70: 2.5;U-266/84: 3.4;U-698: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	3.4	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.0	0.0	3.5	0.0	0.0	3.3	0.7	4.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	32.1	0.0	0.0	0.0	0.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 42.1;placenta: 86.0;tongue: 28.8"	"Group enriched"	"Detected in some"	6	"Suprabasal keratinocytes: 8.0;Syncytiotrophoblasts: 28.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.9;SK-BR-3: 8.7;SuSa: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	0.6	0.1	1.3	0.2	1.4	0.2	1.2	0.2	1.1	7.5	0.2	0.2	0.2	0.1	0.3	0.8	42.1	0.6	0.4	0.4	0.7	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.9	0.2	0.1	0.2	86.0	0.5	0.2	0.1	0.2	9.3	0.2	0.2	13.5	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.5	0.4	28.8	21.6	0.2	10.9	0.2	0.2	0.8	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.5	2.1	1.4	0.3	1.7	1.4	1.2	0.2	0.1	3.9	0.9	0.1	0.0	0.2	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	8.7	0.1	8.7	0.2	0.0	0.2	0.4	0.1	1.1	0.2	2.2	2.1	0.8	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.3	1.4	0.2	0.7	0.7	0.1	0.4	0.3	0.5	0.2	0.0	0.0	0.0	0.2	1.4	0.0	1.4	0.0	0.0	1.2	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	8.0	28.7	0.0	0.0	0.1
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521040-34523041	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 79.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 53.5"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"myeloid DC: 19.4"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 19.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted to blood"	NA	NA	4240000				"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	1.9	58.0	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0.0	3.0	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12.0	2.0	1.4	52.0	27.1	1.5	2.6	1.2	1.0	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0.0	1.4	0.0	1.4	1.5	0.0	0.0	19.4	0.0	2.5	2.7	0.0	0.4	0.1	1.0	5.3	13.4	0.1	0.0	0.3	0.0	0.0	2.1	2.2	0.5	0.2	2.2	3.7	0.0	4.3	0.2	6.1	0.4	0.4	0.3	5.9	0.0	0.1	1.2	0.2	0.0	3.0	0.0	0.1	0.0	0.2	0.0	0.0	4.3	0.0	1.9	0.5	0.3	0.0	0.0	18.5	1.0	3.7	0.1	0.0	0.3	0.5	0.0	9.4	8.9	0.7	4.1	0.4	0.7	0.3	1.7	0.0	0.4	2.1	0.1	0.1	1.1	1.3	0.1	0.5	0.0	3.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	2.7	0.7	1.0	0.0	0.4	58.0	59.3	15.5	37.0	36.3	37.5	52.0	27.1	13.7	13.4	0.0	0.3	0.0	2.5	2.5	4.3	0.4	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.2	1.0	10.2	0.0	2.6	2.6	4.8	1.7	1.3	0.3	2.7	0.3	3.2	1.7	1.0	0.0	53.5	0.0	0.0	0.4	0.3	2.8	0.0	0.1	0.5	5.9	2.8	0.0	0.0	0.0	0.5
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in all"		"RT4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5000000			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.4	4.4	5.0	9.3	10.0	9.5	5.8	5.7	4.7	3.8	4.4	3.3	6.6	6.2	2.9	7.8	3.7	6.5	5.0	8.3	4.3	5.2	2.4	4.6	3.2	18.1	9.7	2.7	5.4	7.7	8.4	5.4	11.2	5.4	7.6	10.2	5.1	9.4	5.6	7.7	3.1	3.3	1.5	4.9	9.6	3.5	4.8	3.0	6.7	34.5	3.6	3.7	9.7	7.7	5.5	4.0	11.1	2.5	6.4	7.7	8.0	4.6	4.2	6.1	9.5	5.0	4.9	5.1	6.9	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5	14.9	7.9	6.7	4.8	3.3	6.1	4.8	12.7	5.3	10.3	7.0	3.9	6.4	21.6	5.1	13.9	5.4	99.9	0.0	11.3	5.7	4.9	39.5	1.1	120.9	5.5	9.5	15.5	11.6	7.0	8.7	2.6	5.1	5.0	6.4	67.4	4.8	7.4	54.7	5.3	50.1	12.0	12.9	4.1	20.1	18.3	3.0	2.7	4.9	41.0	12.3
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		18000	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.7	32.9	9.0	17.3	11.4	14.3	19.4	17.1	12.4	14.8	13.7	17.6	16.1	12.6	25.8	16.4	29.0	27.2	11.0	26.0	9.9	7.7	9.8	10.2	5.0	39.7	17.1	13.6	15.8	13.4	14.5	18.7	14.2	10.9	11.9	12.3	13.3	22.0	11.0	19.9	12.7	8.4	5.7	17.3	25.8	7.2	28.2	28.8	18.6	13.0	14.4	7.5	4.7	28.9	76.8	8.7	21.1	11.5	12.8	17.3	18.0	14.2	20.1	13.8	11.1	5.5	12.4	9.0	32.5	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5	17.9	31.6	13.4	14.5	8.8	16.7	4.3	28.1	8.1	7.9	17.4	9.8	53.2	8.3	33.5	18.1	5.8	66.6	0.0	35.1	18.5	10.3	22.0	3.5	13.0	22.9	23.8	32.6	17.2	15.4	46.1	19.0	16.9	10.1	17.2	55.2	3.9	28.8	57.5	39.6	11.0	7.9	6.5	5.9	3.2	9.1	5.3	50.0	8.4	60.2	10.1
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"hTCEpi: 62.6;U-2197: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.1	0.0	62.6	1.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	2.2
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Cell type enhanced"	"Detected in some"	16	"Exocrine glandular cells: 3.6;Extravillous trophoblasts: 12.2;Hepatocytes: 8.5;Pancreatic endocrine cells: 6.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Group enriched"	"Detected in some"	7	"BEWO: 3.6;Hep G2: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300				"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.2	0.0	0.0	13.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	12.2	0.0	0.1	0.0	8.5	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	2.4	0.0	0.0	0.0
EPPIN	"CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7"	ENSG00000101448	"Epididymal peptidase inhibitor"	O95925	20	45540626-45547752	"Predicted intracellular proteins, Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"epididymis: 89.0;testis: 72.2"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 41.5;Late spermatids: 17.4;Sertoli cells: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.5;U-87 MG: 6.8"									HPA067335	Supported				"Secreted in male reproductive system"	NA	NA					"HPA067335: "	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"		"unprognostic (3.08e-3)"				"unprognostic (1.06e-2)"		"unprognostic (3.75e-2)"				"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.00e-2)"		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.5	89.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	72.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.5	0.4	3.1	0.7	0.5	0.8	0.1	1.9	0.2	1.0	1.0	1.0	1.7	1.4	2.3	0.1	0.3	0.1	1.4	0.7	1.6	1.0	0.2	2.1	0.8	0.3	0.0	0.1	1.5	0.4	1.1	1.3	1.1	0.3	0.6	2.2	0.5	0.5	0.4	0.3	0.4	0.2	1.3	1.6	5.5	0.5	1.2	0.6	2.1	2.2	0.5	0.5	1.8	0.6	1.3	0.2	0.7	1.1	1.4	0.7	0.4	1.1	1.2	1.2	1.5	1.8	2.0	1.7	2.4	1.3	1.8	2.0	0.9	6.8	0.7	2.2	3.1	0.7	0.4	0.8	0.1	0.5	0.5	0.3	0.4	0.2	1.5	0.5	0.4	1.4	0.5	0.4	0.4	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	41.5	2.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	3.5	2.4	0.0	0.0	0.0	0.0	0.0
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	"EPPIN-WFDC6 readthrough"	O95925	20	45536986-45547426	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"epididymis: 25.8;testis: 68.0"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 2.7"									HPA067335	Supported				"Secreted in male reproductive system"	NA	NA					"HPA067335: "										"unprognostic (1.46e-3)"					"unprognostic (6.38e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.9	25.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	68.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTERT-RPE1: 8.2;U-266/70: 2.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.4	4.7	6.4	6.0	35.4	34.7	18.6	5.5	17.7	13.3	23.3	5.9	27.0	22.3	11.5	10.6	18.7	7.6	5.3	11.2	8.3	40.2	2.2	7.2	3.2	4.0	40.6	3.4	13.4	14.4	4.9	15.2	4.7	19.6	18.2	14.5	3.7	21.6	7.9	3.5	32.0	3.6	3.2	0.9	3.1	23.8	8.7	11.1	9.9	11.5	2.4	1.6	8.7	5.9	8.5	4.6	5.1	16.6	14.5	11.4	3.9	1.9	9.0	8.1	15.1	17.3	12.2	11.8	6.7	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8	8.9	12.3	13.7	12.1	22.1	11.6	8.5	10.2	22.7	14.8	8.7	2.0	8.0	0.0	10.8	20.0	11.3	25.8	0.0	13.4	9.1	16.1	9.2	14.0	27.0	16.2	3.2	9.9	18.4	31.2	5.2	9.2	18.5	6.8	21.6	25.9	9.7	11.2	17.5	15.2	5.0	7.2	0.0	9.5	1.2	0.7	9.7	7.7	20.0	19.1	12.2
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875939-96919716	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 63.4;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.1;GAMG: 30.0;hTEC/SVTERT24-B: 23.7;MOLT-4: 26.2;TIME: 51.5"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		7400000	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	9.0	6.0	3.1	21.6	3.8	3.5	7.4	2.2	3.5	9.6	37.0	3.1	6.2	17.0	8.3	10.3	12.4	5.7	5.6	5.8	3.3	2.6	8.6	10.8	16.8	30.8	4.2	0.5	18.2	5.9	1.4	11.1	13.6	3.6	9.4	3.1	7.0	9.3	3.5	4.1	4.9	22.4	5.1	8.7	37.6	9.2	2.6	3.1	32.5	11.3	9.6	24.4	11.8	8.7	16.4	10.7	10.9	15.3	24.0	22.4	14.1	0.5	0.6	0.4	0.2	0.5	1.0	0.1	2.1	3.7	2.0	3.3	2.1	49.1	2.9	9.7	3.1	30.0	0.7	0.2	17.8	1.6	1.0	2.1	0.1	0.7	2.0	0.7	10.8	5.2	7.3	3.3	23.7	0.1	0.3	1.3	7.3	0.0	7.3	5.6	0.3	26.2	5.4	0.0	0.0	1.0	11.7	4.2	7.7	14.2	4.1	0.9	0.0	0.3	0.2	4.1	0.1	1.7	0.4	51.5	1.0	0.3	2.7	6.3	7.1	6.1	1.0	14.3	1.4	0.2	10.9	6.5	7.8	14.2	15.3	18.1	16.4	20.2	17.6	10.7	9.6	22.4	17.0	2.2	24.0	14.4	3.5	18.2	14.1	3.1	3.8	2.2	3.5	3.3	2.6	4.2	0.5	3.6	3.1	29.8	18.3	63.4	8.3	5.0	1.4	3.5	7.6	9.4	15.9	41.8	0.0	10.0	0.0	5.0	0.2	29.2	40.8	0.0	21.9	14.9	15.1	3.1	6.9	14.3	12.0	0.0	1.7	20.3	17.4	0.0	9.8	22.3	6.8	7.2	21.5	7.5	14.1	24.6	7.4	5.7	2.0	0.0	8.2	0.9	0.7	2.6	5.6	53.6	20.6	8.1
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
ERFE	"C1QTNF15, CTRP15, FAM132B, FLJ37034"	ENSG00000178752	Erythroferrone	Q4G0M1	2	238158982-238168900	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 7.5;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 3.3;granulocytes: 4.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.2"	"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 14.1;hTEC/SVTERT24-B: 13.7;REH: 14.0;RH-30: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	277000					"unprognostic (1.66e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.64e-4)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.84e-1)"	"unprognostic (9.61e-4)"	"unprognostic (4.68e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.31e-4)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (4.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.33e-2)"	1.6	0.0	2.4	2.5	1.0	3.5	0.1	9.2	2.5	2.1	0.5	0.4	0.1	0.6	0.9	3.0	0.8	0.1	0.3	3.2	1.9	0.1	3.3	0.3	0.5	0.1	0.1	0.7	0.4	0.3	0.2	0.1	3.5	0.5	0.4	0.3	0.4	1.5	1.6	12.4	0.0	1.1	0.5	0.1	0.5	0.7	13.8	0.1	0.4	25.6	4.8	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.1	0.6	0.9	1.9	0.1	3.4	0.2	1.4	2.0	3.5	5.8	0.1	5.2	0.0	4.0	0.3	6.9	0.2	9.3	0.4	3.1	0.0	14.1	0.0	0.2	0.1	1.2	0.0	1.0	7.3	1.0	13.7	9.8	0.4	0.1	4.5	3.0	0.0	9.0	2.8	0.0	5.8	1.5	0.6	0.9	14.0	17.9	0.6	7.3	0.0	0.3	5.4	2.1	0.4	7.9	1.8	0.3	10.5	0.8	5.5	5.1	2.1	7.2	0.0	0.0	0.6	9.3	2.9	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	1.0	9.2	2.5	1.9	0.1	0.1	0.7	0.5	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	1.8	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		5000000	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.5	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	28.2	6.0	0.0	0.6	0.1	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	20.3	0.0	3.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	1.9	1.8	0.8	0.0	0.0	0.0	15.1	0.4	1.2	0.3	1.9	0.8	0.0	3.0	2.5	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3	0.0	0.0	0.0	1.1	0.5	0.0	2.4	0.0	0.0	0.0	7.0	0.0	66.3	0.0	2.3	3.2	0.1	0.0	0.0	0.7	80.6	1.3	1.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.3	0.2	0.4	0.1	14.5	0.0	0.4	1.1
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977864-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.4;thyroid gland: 14.8"	"Cell type enhanced"	"Detected in some"	21	"Ductal cells: 8.7;Endothelial cells: 4.9;Ito cells: 1.8;Pancreatic endocrine cells: 1.9"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	32	"NK-cells: 3.7;T-cells: 2.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 55.5;TIME: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB047364	Approved				"Secreted to blood"	NA	NA	1540000	400000			"CAB047364: "	"unprognostic (4.70e-2)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.5	3.5	0.3	0.4	0.6	0.2	0.6	0.2	0.7	1.5	1.1	0.8	4.2	0.3	3.0	1.1	0.3	0.2	0.9	2.4	0.9	3.7	31.4	2.2	12.9	0.9	0.5	0.3	2.3	1.8	1.7	9.0	0.5	1.3	4.8	0.0	1.5	5.6	3.2	0.7	0.3	2.4	0.4	1.1	4.0	0.5	0.6	0.5	0.6	14.8	0.8	0.4	1.4	1.0	0.0	0.0	0.0	0.0	3.7	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	1.7	0.7	0.1	0.0	0.0	0.0	1.3	1.0	0.4	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	55.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.7	0.9	2.5	7.2	3.8	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.6	0.0	2.7	1.7	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.6	0.2	0.7	0.9	3.7	0.5	0.3	1.3	0.5	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	4.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
EYS	"bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM"	ENSG00000188107	"Eyes shut homolog (Drosophila)"	Q5T1H1	6	63719980-65707225	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 40.7"	"Cell type enhanced"	"Detected in some"	26	"Cone photoreceptor cells: 298.4;Early spermatids: 59.0;Rod photoreceptor cells: 144.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;SCLC-21H: 3.9"														"Secreted in other tissues"	NA	NA						"unprognostic (2.92e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.11e-1)"	2.8	0.4	0.4	0.6	0.2	1.1	1.1	1.2	0.8	0.2	0.7	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.4	0.4	0.4	0.2	0.2	1.7	0.3	0.6	0.2	0.5	0.4	0.6	0.0	2.2	0.3	0.5	0.6	2.6	40.7	0.5	0.2	0.6	1.3	0.6	0.2	0.3	0.3	0.3	2.9	0.2	0.6	0.5	0.2	0.2	0.4	0.3	0.3	0.3	3.7	0.8	0.3	0.4	0.9	0.5	0.3	0.7	0.5	0.0	0.6	0.2	0.4	0.3	0.0	0.0	0.4	0.3	0.8	0.5	0.1	0.2	0.2	0.9	0.4	0.0	0.5	0.7	0.5	1.3	1.1	0.1	0.8	0.3	0.3	0.9	0.3	0.1	1.0	0.0	0.4	0.6	5.5	0.5	0.0	0.3	0.3	0.2	1.2	0.6	0.3	0.1	0.4	1.2	0.2	3.9	0.3	0.2	0.1	0.2	0.8	0.0	0.8	0.3	0.5	0.6	0.3	0.5	1.6	0.8	0.4	0.6	1.1	0.2	3.7	0.8	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.3	0.3	0.4	3.2	0.3	0.3	0.2	0.1	0.9	0.4	0.2	1.2	0.7	0.4	0.2	0.2	0.5	0.5	0.2	0.0	2.6	0.0	0.5	0.2	7.4	1.5	0.0	0.0	1.2	1.8	298.4	0.6	0.0	0.2	59.0	0.3	0.0	0.0	0.4	0.2	0.2	0.2	2.3	0.0	0.1	9.5	19.4	0.0	0.0	34.1	0.9	0.2	0.0	0.0	0.1	4.0	0.4	0.0	0.7	0.1	144.8	0.0	0.3	1.8	0.7	0.1	0.9	0.0	0.2	0.1
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 174.9;Leydig cells: 199.9;Peritubular cells: 222.0"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 8.5;BJ hTERT+: 6.8;CACO-2: 7.2;fHDF/TERT166: 7.6;Hep G2: 33.5;HHSteC: 7.0;SH-SY5Y: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.5	0.2	4.9	5.0	0.0	8.5	6.8	0.5	0.2	7.2	0.0	0.0	0.3	7.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	33.5	7.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6	0.0	0.0	0.0	0.0	14.0	1.0	4.8	7.6	0.0	0.0	1.8	0.0	0.6	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.6	66.0	0.1	1.1	174.9	1.2	6.4	17.1	9.8	4.5	5.6	199.9	0.3	18.6	1.0	1.4	3.8	0.5	2.9	222.0	5.6	1.1	51.8	54.2	2.1	1.1	13.4	0.9	2.5	0.9	0.2
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 14.0"	"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.3	2.5	0.0	4.5	1.8	0.0	0.0	10.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402140-177409576	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 180.1"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 391.6"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.5;eosinophil: 6.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.9;monocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.7;MCF7: 11.1;PC-3: 8.2;SH-SY5Y: 5.6;U-937: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	6600000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.0	6.9	2.5	0.7	0.3	1.0	0.8	2.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	1.4	0.0	0.4	0.0	0.3	1.4	0.7	0.4	0.0	8.7	1.9	1.4	0.3	0.9	0.2	0.7	3.1	0.2	1.3	0.1	0.4	0.1	0.2	2.1	0.4	3.3	0.0	11.1	0.1	2.6	0.0	2.6	8.2	0.6	0.2	1.9	1.1	0.0	2.6	5.6	0.3	1.0	0.7	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.3	0.5	0.0	0.1	0.1	5.8	0.6	0.0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.9	0.7	0.9	1.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	8.5	7.4	29.5	0.4	0.8	17.8	0.0	0.0	1.8	3.9	0.0	0.0	6.1	19.4	0.7	34.8	0.0	3.5	0.2	0.9	2.0	0.0	391.6	0.5	0.0	9.9	17.8	13.2	32.7	0.6	1.8	8.5	1.0	5.5	0.2	9.4	20.1	0.0	9.1	0.5	0.0	0.7	13.0	12.8	47.4	0.1	0.7	30.8	5.8
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell type enriched"	"Detected in many"	6	"Hofbauer cells: 646.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.5	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5	0.0	3.4	0.8	0.0	16.7	0.0	7.5	10.2	4.0	0.0	0.0	0.0	4.0	0.0	0.0	3.8	4.7	0.0	0.0	0.0	3.4	16.5	0.0	1.1	0.8	646.4	0.0	0.0	4.3	113.2	4.2	4.0	57.6	18.6	1.0	0.0	0.7	0.1	0.0	0.7	3.1	4.1	58.2	9.2	1.4	1.0	13.2	8.5	0.0	0.0	0.0
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 49.0"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		3400000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719180-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	593	"liver: 324.8"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 904.6"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 78.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	43000000000			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	324.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.6	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	904.6	0.0	0.0	0.0	24.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	117.4	0.2	0.2	0.0	12.8	6.3	6.6	16.7	10.0	18.1	19.7	2.1	25.2	0.0	8.6	20.7	3.9	55.6	1.5	144.4	29.9	0.1	0.1	0.0	3.6	0.3	4.2	0.0	0.0	10.9	3.2	8.5	41.9	34.4	0.1	0.1	0.1	0.1	12.6	0.2	0.1	2.4	1.1	0.7	0.2	0.1	1.2	0.0	2.2	0.3	0.1	0.3	13.3	5.5	0.4	3.6	0.1	1.6	0.0	11.0	0.3	54.8	5.0	0.1	0.1	0.1	8.4	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0	122.1	188.9	0.5	636.0	14.4	1.5	21.1	7.6	72.3	238.8	14.0	0.0	13.6	0.0	120.9	5.6	10.5	10.3	0.0	410.4	4.8	48.3	85.3	2.3	0.6	5.4	3.2	12.6	12.3	4.0	9.8	260.4	4.9	3.3	3.6	40.9	389.7	1078.7	11.0	498.9	0.3	13.3	6.5	7.2	1.1	3.4	6.6	6.4	0.8	9.5	358.5
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell type enhanced"	"Detected in many"	22	"Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in some"	23	"Hep G2: 13.8;OE19: 52.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1	3.0	1.1	0.0	4.4	0.1	0.1	8.6	79.0	5.3	3.4	0.0	2.0	65.0	0.0	1.6	0.7	1.0	0.0	0.0	0.2	1.6	7.7	0.3	0.0	221.3	4.7	0.0	24.2	3.1	18.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	49.8	1.3	0.0	9.0
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 131.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.6;Hep G2: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.5	0.0	0.0	131.2	0.1	0.0	0.0	3.7	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.5	0.0	0.0
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"Ito cells: 376.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"	NA	NA		6400000			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	48.9	9.4	6.8	3.1	7.2	1.5	32.2	1.5	8.6	11.9	10.3	2.2	6.1	2.3	11.1	8.5	18.4	5.4	4.4	38.0	4.9	4.4	17.1	31.3	24.4	25.6	5.6	1.2	18.8	7.2	6.0	14.0	2.8	5.1	20.5	3.5	8.8	4.0	7.1	30.3	2.0	4.3	12.8	3.3	39.0	3.2	17.2	1.8	1.1	15.8	15.0	3.0	17.5	20.2	2.3	3.0	5.2	3.3	4.0	12.9	2.7	4.8	3.9	0.8	1.8	6.1	9.6	0.2	2.6	1.7	1.9	3.1	0.1	5.8	10.4	7.3	2.7	4.2	0.5	0.9	0.9	1.7	4.2	1.5	2.2	2.0	0.0	2.9	1.7	5.0	6.8	0.5	1.6	2.2	3.3	1.1	5.1	0.8	8.0	9.1	2.3	1.4	1.6	1.2	1.5	4.0	1.2	1.3	1.4	1.7	1.1	3.2	2.4	6.3	0.6	3.3	1.0	1.4	4.3	1.1	9.5	4.8	15.0	2.8	4.7	3.9	5.0	8.7	10.8	5.0	3.7	3.3	0.5	6.5	2.8	12.9	2.3	3.9	6.8	3.0	1.6	2.0	5.1	5.2	4.0	2.6	0.4	5.2	2.7	6.8	7.2	1.5	8.6	4.9	4.4	5.6	1.2	5.1	1.8	0.0	4.6	2.2	1.5	1.5	7.9	14.6	12.7	2.7	2.3	3.5	2.0	0.9	6.6	2.3	0.9	33.2	0.5	0.0	0.6	0.7	2.8	1.7	1.1	9.2	2.9	6.4	0.0	376.3	25.4	1.9	10.6	3.2	0.0	1.8	0.7	6.5	6.9	0.0	4.9	8.4	3.3	6.5	3.3	1.6	2.5	1.0	0.1	4.9	0.4	0.9
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 475.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;RH-30: 2.0;SiHa: 1.6;U-698: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000000										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.2	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	475.1	0.0	0.0	0.0	15.4	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.2	3.4	5.5	9.7	7.5	6.2	5.2	3.7	8.4	5.9	4.6	2.6	2.9	1.2	15.5	3.6	12.6	7.8	0.0	6.7	3.8	8.8	9.3	0.0	5.2	5.6	7.6	0.1	6.5	4.6	1.1	5.0	11.6	5.5	11.8	5.7	1.8	1.3	2.2	6.4	3.2	0.2	9.4	5.1	6.9	5.8	2.2	7.9	5.9	0.2	16.9	17.6	2.3	6.5	8.6	3.7	19.1	2.1	11.9	7.2	5.6	5.8	11.6	14.0	8.4	0.8	23.2	1.2	5.1	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0	6.0	5.3	6.7	16.9	9.8	21.2	5.1	10.2	16.0	1.2	14.0	13.7	8.2	1.7	5.6	3.9	8.8	13.1	23.3	2.9	2.7	5.4	12.7	6.9	1.5	6.8	22.3	9.2	15.4	5.4	0.7	17.3	8.3	1.7	9.0	6.4	14.1	7.4	8.6	19.4	3.0	16.3	6.5	10.3	11.6	6.8	12.8	27.8	4.4	8.1	13.1
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.6	5.4	13.3	14.9	16.0	19.4	6.9	9.9	7.7	4.3	4.3	3.7	6.5	6.7	7.5	11.6	7.7	4.1	4.0	14.0	10.1	4.5	4.8	8.9	11.3	2.5	6.8	6.8	10.3	16.9	8.0	3.9	7.6	15.6	9.8	6.3	1.8	2.0	17.7	5.1	5.7	5.2	2.0	8.6	4.4	6.4	14.0	6.3	6.8	9.0	11.9	21.2	8.0	3.4	7.3	8.7	8.2	8.3	9.7	10.3	9.3	6.7	11.7	8.6	12.5	7.6	16.2	7.6	18.8	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6	50.6	23.7	24.4	21.0	10.9	48.1	20.2	28.1	62.9	25.0	10.4	29.5	11.1	51.4	16.4	38.4	23.3	15.8	0.0	18.6	10.7	16.0	19.5	24.3	12.4	10.1	39.7	16.3	17.8	18.0	23.9	35.6	17.5	20.3	22.6	11.5	34.6	17.2	13.9	34.3	27.9	51.6	12.9	17.9	19.0	23.5	8.8	9.2	23.5	16.4	20.4
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		180000	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	20.8	25.6	29.5	17.5	29.2	24.9	20.6	14.1	25.9	27.2	45.8	29.2	19.6	32.6	16.3	17.9	22.2	12.7	22.0	44.2	31.6	35.3	35.5	49.1	36.0	10.4	41.1	24.2	14.4	21.5	14.2	43.8	17.7	39.6	37.9	41.6	13.6	19.5	22.3	33.8	17.4	34.0	25.5	45.4	15.7	24.1	42.6	22.2	13.3	31.0	19.0	12.8	27.6	18.2	14.1	16.8	56.7	15.1	9.4	18.5	9.7	20.3	16.5	12.6	10.1	21.8	21.9	17.0	33.3	18.1	17.3	19.0	16.8	27.0	8.5	23.8	31.6	23.6	21.4	15.2	18.8	22.2	23.8	11.6	6.5	20.9	56.8	26.9	9.9	15.1	19.6	24.8	20.9	16.5	25.5	19.8	15.4	15.4	26.2	33.3	29.2	12.2	9.2	10.3	32.1	23.5	7.0	17.8	11.8	31.3	22.1	17.6	15.8	39.3	30.9	25.6	26.0	28.6	7.6	23.2	22.7	20.1	25.2	17.0	20.4	24.4	10.0	14.0	6.6	22.1	20.9	15.1	24.9	10.7	11.4	12.6	14.1	14.2	12.2	10.9	11.3	11.3	11.0	56.7	9.4	9.7	16.8	18.5	9.7	29.5	29.2	14.1	25.9	31.6	35.3	41.1	24.2	39.6	22.2	223.4	156.1	82.9	157.1	142.8	34.3	125.5	66.2	148.5	129.7	99.5	25.5	63.2	101.2	106.7	472.3	134.1	241.2	46.7	217.0	95.5	80.8	234.3	79.8	184.5	67.0	22.3	128.5	82.9	53.3	400.3	50.0	70.6	141.7	179.5	172.8	36.1	275.5	227.7	49.8	271.4	43.2	45.3	134.8	116.8	87.3	149.8	103.1	90.6	196.2	201.3
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"U-2197: 74.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	8.1	8.4	0.0	4.2	16.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.3	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	16.7	0.0	74.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.6	0.0	6.8	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	2.8	0.0	0.0	4.3	0.6	0.0	0.0	0.0
FAM198A	"C3orf41, DKFZP434B172"	ENSG00000144649	"Family with sequence similarity 198 member A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		440000	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	8.9	3.5	6.2	3.7	8.3	0.1	5.4	4.1	6.8	10.8	3.5	6.1	2.4	1.3	11.7	9.4	4.0	13.8	13.0	2.0	7.2	2.6	1.3	12.1	3.8	1.1	5.1	5.5	9.4	3.0	0.3	2.6	3.2	11.2	2.7	1.8	4.0	4.1	3.8	1.4	1.8	2.5	9.2	5.2	1.2	4.3	3.1	6.8	0.0	2.0	1.1	0.6	3.8	4.2	0.0	1.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	1.7	0.3	0.6	0.0	0.0	0.2	1.8	0.0	1.8	0.0	2.8	0.0	0.7	0.0	0.0	0.0	2.5	0.9	0.0	0.0	1.3	0.5	2.1	1.2	0.0	0.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.1	0.4	0.0	4.2	0.0	0.3	11.9	1.4	0.0	0.8	1.2	2.4	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	0.0	6.2	8.3	4.1	6.8	7.2	2.6	5.1	5.5	11.2	6.8	0.0	0.0	0.0	0.1	0.1	1.2	0.6	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.6	0.3	0.0	0.0	0.2	1.9	3.1	0.2	0.0	11.9	3.1	3.2	0.0	1.8	0.3	0.0	9.2	0.0	0.0	1.0	0.0	17.2	0.3	0.0	18.7	0.3	1.6	6.5	1.4	0.9	0.9	0.5	2.3	0.0	0.0	0.0
FAM19A1	"TAFA-1, TAFA1"	ENSG00000183662	"Family with sequence similarity 19 member A1, C-C motif chemokine like"	Q7Z5A9	3	68004216-68545625	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.9;brain: 28.0"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 14.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.9"	"Cell line enriched"	"Detected in single"	9	"REH: 6.1"	"Low region specificity"	"Detected in many"							HPA013407	Approved				"Secreted in brain"	NA	NA					"HPA013407: AB_1848386"	"unprognostic (5.19e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-4)"	"unprognostic (5.77e-2)"	0.7	2.0	10.6	0.8	9.0	0.4	0.5	0.4	28.0	0.5	0.7	0.1	0.3	2.3	0.8	2.0	0.5	0.5	1.4	0.5	18.4	4.8	0.8	0.8	0.5	1.2	4.4	10.4	0.4	0.4	0.4	0.6	0.4	25.2	2.6	0.6	0.0	0.6	6.2	0.6	0.4	0.5	0.9	1.3	0.9	0.5	0.7	0.2	0.0	0.6	0.0	0.7	0.7	0.3	0.0	0.0	0.2	0.1	2.1	13.9	2.6	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.9	0.0	10.7	0.0	11.5	7.5	0.0	0.0	8.2	11.5	0.2	2.1	0.0	0.0	5.0	2.6	10.6	9.0	0.4	24.4	18.4	4.8	4.4	10.4	25.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
FAM19A3	"TAFA-3, TAFA3"	ENSG00000184599	"Family with sequence similarity 19 member A3, C-C motif chemokine like"	Q7Z5A8	1	112720419-112727235	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"adrenal gland: 19.6;brain: 5.2;testis: 8.8"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8"									HPA055927	Approved				"Secreted in other tissues"	NA	NA					"HPA055927: AB_2682972"	"unprognostic (9.96e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.63e-4)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.14e-6)"	"unprognostic (2.10e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	0.1	19.6	0.4	0.1	0.0	0.0	0.3	5.2	0.4	0.1	0.0			0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.4	3.9		0.6	0.0	0.0	0.2	0.1		0.3	0.0		0.1	0.2	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.8			0.2		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.2	0.0	0.0	0.6	0.8	0.2	9.5	0.7	0.6	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.1	0.5	0.4	1.6	0.3	3.7	0.0	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.5	0.0	0.2	0.0	0.4	0.4	0.4	0.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.6	0.1	0.0	1.1	0.0	1.4	1.3	0.2	0.5	0.1	0.0	0.0	3.8	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	44.6	0.4	0.0	0.0	0.0	0.0	64.8	0.0	0.0	0.3	8.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.6	0.9	0.0	0.1	0.0	0.0	0.0
FAM19A4	TAFA-4	ENSG00000163377	"Family with sequence similarity 19 member A4, C-C motif chemokine like"	Q96LR4	3	68731766-68953297	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.0;brain: 10.9"	"Cell type enriched"	"Detected in some"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1"	"Region enriched"	"Detected in some"	5	"thalamus: 14.7"	"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (1.92e-1)"			"unprognostic (9.97e-3)"	"unprognostic (2.28e-1)"			"unprognostic (8.19e-3)"		"unprognostic (8.78e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.50e-1)"		0.5	26.0	2.3	0.9	7.3	0.5	0.6	0.4	7.5	0.5	0.7	10.8	0.0	0.6	0.5	0.5	1.1	0.6	2.7	0.5	2.9	4.2	0.7	0.5	0.6	0.6	10.9	1.8	1.0	0.5	0.5	1.8	1.8	8.7	2.2	0.6	5.0	0.7	1.1	0.5	0.5	0.5	1.0	10.4	0.6	8.3	2.1	8.2	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.3	0.4	7.5	2.9	4.2	10.9	1.8	8.7	8.2	0.0	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
FAM19A5	TAFA-5	ENSG00000219438	"Family with sequence similarity 19 member A5, C-C motif chemokine like"	Q7Z5A7	22	48489460-48850912	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 15.0;Muller glia cells: 37.6;Peritubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 13.8;HEK 293: 9.3;Hep G2: 21.3;NTERA-2: 12.0;SCLC-21H: 6.1;U-2 OS: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025629	Approved				"Secreted in brain"	NA	NA					"CAB025629: "	"unprognostic (2.86e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.94e-2)"	1.9	2.5	22.7	1.7	18.7	0.7	2.7	19.1	40.2	12.2	1.8	8.5	0.1	2.0	8.1	6.9	1.1	3.4	3.4	1.4	23.6	22.8	1.9	3.0	2.2	1.2	18.1	12.9	8.3	2.4	0.8	1.9	0.8	8.7	4.0	1.0	0.7	7.3	5.7	1.5	1.9	2.6	1.8	9.9	1.1	3.7	2.5	7.3	1.3	1.1	0.0	1.0	2.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.1	0.0	0.9	0.0	0.0	0.0	9.3	0.0	0.1	21.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	12.0	0.4	0.0	0.5	0.0	5.1	0.0	0.0	6.1	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	16.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	18.7	19.1	21.9	23.6	22.8	18.1	12.9	8.7	7.3	3.0	2.9	0.0	0.0	1.6	15.0	1.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.6	0.0	0.0	0.3	0.0	5.6	1.0	0.0	0.0	0.2	3.2	0.0	0.6	0.0	0.0	6.4	0.2	5.0	0.0	0.0	37.6	0.7	0.0	8.9	1.8	1.5	0.0	0.9	0.5	3.4	1.4	0.0	0.0	0.0	0.0
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A, golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601389	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.2;salivary gland: 50.4"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 68.0;Early spermatids: 61.3;Hepatocytes: 58.2;Hofbauer cells: 72.2;Late spermatids: 140.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.8"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.8;BJ hTERT+: 27.3;HSkMC: 22.8;U-2197: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048964	Approved				"Secreted in other tissues"	NA	NA		10000000			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	4.9	1.1	0.2	4.7	0.4	1.0	3.7	0.2	1.5	12.1	3.2	0.7	0.7	1.4	7.6	9.9	2.2	4.1	2.3	6.5	0.3	0.4	19.6	59.2	17.6	14.7	0.3	0.8	6.8	1.0	0.6	4.8	4.2	3.8	3.5	1.0	8.7	50.4	1.7	2.8	1.5	1.2	4.7	2.4	7.3	9.5	9.1	0.2	0.9	8.2	4.0	2.5	3.7	3.4	0.2	1.0	1.8	2.1	0.1	0.3	0.0	0.0	0.1	0.0	0.1	1.3	11.8	0.0	0.5	27.3	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.9	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.1	1.8	0.1	2.1	1.0	0.0	0.0	0.2	0.4	0.2	1.5	0.3	0.4	0.3	0.8	3.8	0.2	14.9	68.0	0.0	0.1	2.1	3.1	4.8	7.6	1.4	37.5	41.8	0.0	0.5	0.0	0.3	61.3	1.3	0.0	0.0	0.4	2.0	5.8	0.0	1.1	58.2	72.2	39.7	0.0	7.4	20.3	140.0	10.3	11.6	1.7	1.8	0.0	0.2	0.6	0.0	13.8	13.0	2.9	6.5	0.7	1.2	0.2	1.6	2.3	0.0	0.0	0.0
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM24A	AC073585.4	ENSG00000203795	"Family with sequence similarity 24 member A"	A6NFZ4	10	122910701-122913111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 20.9"	"Cell type enriched"	"Detected in some"	17	"Early spermatids: 125.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.9;LHCN-M2: 1.2"									HPA052490	Supported				"Secreted in male reproductive system"	NA	NA					"HPA052490: AB_2681851"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.2	0.0	0.0	0.5	0.6	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.0	0.0
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.6	16.0	4.0	13.5	12.2	6.2	11.4	8.5	5.9	5.9	7.0	7.3	10.1	10.8	43.4	14.2	11.5	12.1	6.3	7.5	1.4	8.8	8.6	4.2	14.0	5.1	19.1	2.8	6.8	7.7	6.8	12.1	8.5	7.0	4.1	7.0	8.0	8.0	6.7	17.4	5.2	12.3	1.7	18.1	20.1	6.5	4.0	29.7	6.4	6.9	8.0	6.1	3.9	9.5	14.0	3.1	7.2	4.4	4.5	7.9	4.8	21.4	11.5	30.8	16.8	13.2	14.6	7.4	8.1	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8	11.9	14.7	8.0	19.3	14.4	23.0	20.5	25.5	8.1	6.8	21.0	13.7	39.7	23.2	22.8	0.6	17.7	66.7	23.3	37.0	40.6	24.2	23.6	5.7	27.2	26.3	20.6	16.8	20.3	14.9	1.6	31.1	13.9	32.1	19.0	45.1	25.5	24.3	49.1	27.6	26.2	15.2	6.5	16.0	3.7	8.6	18.4	59.6	19.3	33.2	20.3
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777, CAB034131"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2080000	57000	Vesicles		"CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	13.2	0.0	0.0	0.0	42.4	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2	20.8	18.8	0.0	11.2	1.1	0.0	0.1	81.5	22.7	50.0	62.8	0.0	242.6	21.6	113.7	19.2	1.0	0.0	0.0	349.6	6.2	5.7	99.4	1.1	0.0	23.0	0.0	0.0	0.0	2.5	7.0	0.6	8.1	5.0	3.6	0.9	0.0	184.9	0.0	0.4	0.4	0.0	0.0	0.9	26.7	7.2	1.1	134.9	0.0	0.0	104.8
FAM3C	"GS3876, ILEI"	ENSG00000196937	"Family with sequence similarity 3 member C"	Q92520	7	121348851-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 13.9;naive B-cell: 11.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 13.9"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	18.1	18.0	38.0	13.7	29.8	3.2	16.3	26.5	46.6	38.6	27.1	8.2	12.8	65.6	20.9	23.0	15.5	14.3	13.7	24.6	23.4	20.0	24.3	20.7	15.9	15.3	20.6	42.0	15.7	35.5	20.6	15.8	21.7	30.6	12.3	21.2	11.1	20.4	13.2	9.0	14.5	60.8	16.9	14.1	16.8	21.9	9.0	12.7	6.4	42.8	11.4	16.2	17.3	15.9	13.9	1.1	0.6	0.9	2.3	1.8	0.7	16.8	4.3	8.0	8.5	13.6	22.6	7.3	18.2	8.1	5.5	7.0	3.4	167.0	16.0	8.6	9.4	15.6	11.2	4.6	10.1	11.8	1.9	9.1	4.4	2.6	3.4	9.9	7.4	8.4	22.6	6.9	7.8	7.7	14.8	9.8	3.2	2.9	20.3	43.1	2.8	2.8	5.8	14.4	5.8	6.0	4.4	8.2	6.5	34.3	9.8	5.2	5.1	5.4	22.3	9.9	17.6	3.1	4.1	23.5	14.4	4.7	31.3	12.4	19.4	8.6	6.3	15.5	7.7	25.7	0.0	0.9	0.6	1.8	0.9	1.7	13.9	0.8	1.4	0.8	11.9	1.0	0.8	0.2	2.3	0.7	1.1	0.4	0.7	38.0	29.8	26.5	46.6	23.4	20.0	20.6	42.0	30.6	12.7	8.9	32.3	73.0	174.8	63.7	109.7	59.0	40.8	38.8	47.8	52.4	21.6	74.8	51.4	169.6	2.5	40.5	66.5	23.3	169.6	170.2	99.2	134.9	19.6	32.1	40.3	42.9	50.3	46.1	27.3	4.5	88.9	38.7	94.5	40.5	46.7	50.7	269.6	77.2	90.2	60.6	51.8	71.1	82.5	23.9	18.5	58.1	100.7	42.4	72.4	398.1
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Cell line enriched"	"Detected in single"	72	"OE19: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	NA	NA		8200			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	38.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.0	0.6	0.0	7.9	0.0	0.0	0.2	56.0	28.1	9.1	14.0	0.0	0.0	0.0	0.6	0.4	0.6	558.6	0.0	0.0	0.0	0.0	70.7	9.2	0.0	0.3	0.0	146.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1112.4	0.0	1.9	854.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.0	821.7	144.0
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 59.6;Basal keratinocytes: 91.9;Suprabasal keratinocytes: 129.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 32.4;hTERT-HME1: 16.7;NTERA-2: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	4.0	1.2	0.5	0.6	1.0	2.8	0.9	11.3	4.5	7.7	2.6	0.0	4.8	1.5	2.5	6.3	0.7	10.3	3.0	0.0	0.6	0.1	1.5	1.3	5.7	0.0	0.2	2.6	32.4	3.4	16.7	0.0	0.1	0.0	0.2	0.0	1.4	1.5	0.0	0.6	17.0	1.4	0.8	0.2	0.0	0.1	11.0	0.0	0.4	0.3	5.4	12.2	7.1	8.7	9.6	0.1	0.2	2.7	9.4	0.3	0.6	0.1	0.4	0.0	0.5	0.0	1.7	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1	59.6	1.9	0.0	24.5	91.9	0.1	0.0	0.0	2.7	0.0	0.0	0.0	1.7	0.0	0.0	1.4	0.5	1.1	0.0	0.0	2.6	2.4	12.8	0.0	0.0	0.5	0.0	7.0	1.8	0.0	1.4	4.6	0.8	6.8	0.0	1.2	5.0	0.0	0.0	1.8	0.0	0.6	0.0	17.8	5.8	3.9	129.2	4.5	0.0	0.9	10.6
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 30.0"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 25.9;Muller glia cells: 68.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 45.4;ASC TERT1: 48.2;BJ hTERT+: 38.0;hTERT-RPE1: 48.7;U-138 MG: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA059739	Uncertain				"Secreted to blood"	NA	NA		34000000			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	19.8	0.7	2.6	3.2	1.2	0.0	7.5	0.6	3.7	17.6	4.5	0.4	4.0	0.1	30.0	13.7	4.1	5.1	14.9	5.2	3.1	0.9	2.0	0.9	4.7	0.8	2.6	1.2	4.1	2.3	0.5	1.0	17.0	1.9	4.1	1.5	2.4	5.3	3.9	8.1	2.9	1.4	17.9	2.2	0.9	1.7	9.8	3.4	0.0	3.5	9.0	0.8	12.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	48.2	0.0	18.5	38.0	3.9	5.9	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	15.5	0.2	6.4	1.2	48.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	1.9	0.0	0.0	0.0	19.0	38.7	0.7	9.4	0.0	0.0	0.0	0.0	8.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.6	3.7	3.1	0.9	2.6	1.2	1.9	3.4	0.0	0.0	0.0	0.1	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	2.9	0.0	0.0	0.2	1.6	25.9	0.1	0.0	0.0	0.8	1.6	4.7	2.5	0.0	2.3	7.8	0.3	3.3	0.0	0.0	68.0	1.6	0.0	0.0	0.6	1.5	0.0	1.4	0.2	0.0	3.8	1.5	0.0	0.0	0.0
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 44.7"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.7	3.4	1.8	5.6	14.5	21.4	0.0	19.2	19.5	0.7	3.8	0.0	9.5	1.7	7.4	18.0	3.2	1.4	0.3	16.2	1.3	28.0	2.8	0.1	1.8	5.7	13.9	0.9	0.4	26.5	14.5	12.0	26.0	9.4	1.7	6.4	0.0	44.7	19.6	0.8	2.8	1.4	0.2	0.0	0.9	0.2	0.1	1.8	27.1	2.8	0.1	0.1	2.8	0.0	0.3	2.8	6.1	0.3	4.2	6.2	3.4	5.7	4.4	17.5	1.8	0.1	5.1	3.5	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1	53.6	14.4	3.7	100.3	40.8	0.0	1.2	15.3	21.4	21.6	8.7	0.0	0.4	0.0	6.7	5.4	8.4	12.0	0.0	3.8	0.2	34.9	22.7	3.5	15.3	5.0	1.6	8.1	2.5	6.9	3.5	17.5	12.7	11.8	20.8	15.0	17.1	4.3	0.0	13.1	11.5	0.7	6.5	33.4	4.8	1.3	38.3	0.3	37.9	23.2	22.7
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659018-172666874	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.6;lymphoid tissue: 13.4"	"Cell type enriched"	"Detected in some"	7	"T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 25.6"	"Group enriched"	"Detected in many"	12	"NK-cells: 16.0;T-cells: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;LHCN-M2: 2.5;NB-4: 1.2;RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600				"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.9	1.1	0.5	1.9	0.7	3.6	1.8	0.5	0.8	0.7	2.6	0.6	0.0	3.0	3.9	1.2	1.0	0.8	1.6	1.2	0.5	0.5	1.2	2.2	6.8	7.7	1.4	0.0	1.5	0.6	0.0	0.7	2.4	0.6	4.7	1.2	2.8	1.9	0.3	0.4	0.5	3.8	1.9	1.7	13.4	2.1	0.4	0.0	1.2	1.1	0.0	10.1	1.4	0.9	0.0	0.0	1.6	0.0	16.0	25.6	5.5	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.7	0.1	0.0	0.1	0.3	0.6	2.5	0.0	0.0	1.2	0.4	0.2	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.8	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	25.6	0.0	15.8	0.0	5.4	13.7	0.0	0.0	1.1	11.7	0.8	16.0	0.0	0.0	0.1	5.5	0.5	0.7	0.5	0.8	0.5	0.5	1.4	0.0	0.6	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	30.5	0.0	0.0
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.4	3.4	10.2	21.4	157.8	70.0	46.9	84.6	134.5	7.5	2.8	14.5	0.4	0.0	3.6	3.1	0.2	7.4	6.4	0.2	0.9	0.0	1.7	0.0	18.4	9.7	20.9	0.0	0.0	115.4	1.3	7.5	2.7	0.1	0.0	0.1	0.0	0.1	5.2	0.2	0.0	0.2	14.4	0.3	1.2	0.1	0.0	0.1	3.4	121.1	0.7	13.6	10.4	49.3	0.0	30.3	0.3	0.4	0.6	1.4	9.4	38.9	0.0	0.1	0.0	0.1	0.1	0.0	3.6	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8	6.0	2.2	0.0	92.6	151.8	0.0	8.6	12.7	1.4	13.6	1.8	0.0	571.3	0.0	0.5	8.4	22.5	0.0	0.0	0.2	448.0	795.3	17.7	1.1	0.4	73.2	0.0	0.0	36.2	0.0	18.3	85.4	3.3	161.9	0.0	0.0	0.0	0.7	0.0	28.7	0.3	0.5	116.4	93.7	18.7	76.7	113.9	1016.7	0.0	0.2	69.1
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7"	"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.8	0.0	75.4	10.2	4.5	23.5	18.8	23.6	15.6	1.5	0.0	0.0	1.1	49.5	0.0	0.0	0.0	0.1	4.4	0.0	0.0	18.6	0.4	0.0	5.1	0.0	60.2	43.7	0.3	3.7	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	0.9	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	17.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5	0.0	1.0	0.0	0.7	27.4	0.0	7.3	0.0	0.0	3.4	7.0	2.0	6.6	0.0	0.0	3.4	29.2	0.0	0.0	0.2	4.5	266.2	1.0	24.1	0.2	3.2	0.0	0.0	25.8	0.3	6.5	158.2	2.1	37.1	0.0	0.0	1.3	0.2	0.0	213.6	0.0	0.2	12.9	19.6	2.6	8.8	25.2	5.1	0.0	0.0	0.9
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869412-91947987	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leydig cells: 580.2;Peritubular cells: 747.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Group enriched"	"Detected in many"	19	"granulocytes: 8.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 87.8;ASC TERT1: 45.9;BJ: 41.1;BJ hTERT+: 38.5;fHDF/TERT166: 73.5;HSkMC: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4500000	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	48.3	23.5	3.4	11.5	9.5	1.8	49.5	2.2	5.6	52.4	26.6	5.3	20.3	6.0	51.7	36.0	22.6	32.2	97.4	54.5	2.5	2.6	38.9	12.1	50.5	8.6	7.0	4.1	36.5	14.6	7.6	3.9	21.0	9.4	41.2	6.4	40.6	18.3	23.8	24.7	17.5	12.8	51.8	6.8	48.2	18.8	43.9	2.1	1.2	30.3	15.1	9.4	56.4	51.1	0.2	0.1	8.5	0.3	0.0	2.8	0.6	0.0	0.2	0.0	0.0	87.8	45.9	4.6	41.1	38.5	1.1	0.8	0.7	0.0	0.0	0.8	73.5	0.1	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.8	0.0	14.6	0.0	0.0	42.1	0.0	0.7	2.7	0.5	1.9	0.0	0.0	0.0	4.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	5.8	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.5	1.3	0.5	0.0	0.3	0.6	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	3.5	1.2	0.2	0.7	0.1	0.5	0.1	0.0	0.2	1.7	2.8	4.1	0.0	0.3	0.1	0.1	0.6	3.4	9.5	2.2	5.6	2.5	2.6	7.0	4.1	9.4	2.1	77.4	13.3	0.0	2.5	8.1	0.0	4.5	0.0	17.4	12.5	5.2	0.0	1.9	5.0	3.7	4.7	9.2	0.0	0.0	4.3	1.4	129.7	1.2	2.3	0.5	7.7	0.0	0.0	46.6	1.9	12.1	580.2	2.5	20.3	1.0	0.0	0.0	2.7	0.0	747.1	24.2	0.0	6.5	15.0	2.1	2.0	7.5	3.1	6.9	0.0	0.7
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.5	0.0	1.9	1.4	0.0	3.8	12.5	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	9.2	1.0	0.2	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	4.4	0.2	0.0	11.3	9.0	0.0	0.0	0.5	0.1	0.5	0.1	3.6	0.6	0.5	18.1	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1	3.0	0.3	0.0	0.7	3.9	3.7	0.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	1.9	2.1	0.0	0.0	0.2	5.9	4.7	0.4	1.1	1.0	0.4	3.2	0.0	0.6	0.0	1.7	0.3	0.0	16.9	0.0	0.0	2.2	0.4	0.0	4.9	0.5	7.2	6.5	4.7	0.1	0.2	3.3	1.3	4.4	0.0	0.3
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		540000000	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.9	79.9	0.0	28.8	10.4	8.6	5.5	0.0	0.0	0.0	1.3	68.5	0.0	0.1	0.6	0.1	7.8	3.3	0.2	0.3	14.7	0.0	20.8	0.1	0.0	43.2	0.0	22.7	2.6	35.7	9.2	0.2	0.0	0.0	9.2	0.0	0.2	0.0	0.6	0.0	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	2.7	0.0	0.2	17.4	35.1	1.0	51.0	6.0	0.2	0.1	0.0	23.5	0.0	2.3	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6	0.0	2.2	0.0	1.1	22.8	4.5	9.3	0.0	5.3	10.3	12.2	0.0	91.8	0.0	0.2	6.3	21.7	0.0	0.0	0.5	16.3	78.5	0.5	1.1	0.6	13.5	0.0	0.0	38.1	1.0	15.7	218.7	4.4	40.5	3.6	0.0	0.5	2.0	0.0	213.6	0.6	0.1	25.8	44.7	3.0	2.1	18.1	55.0	0.0	0.0	0.1
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.5	16.4	0.0	2.7	4.7	3.4	17.9	0.0	15.9	11.9	0.0	0.0	0.0	0.0	23.9	0.0	2.7	10.6	2.7	14.9	0.0	4.2	0.0	7.5	0.0	38.0	2.3	0.0	27.1	1.4	6.7	59.9	5.1	33.7	0.0	0.0	0.0	9.8	0.0	0.0	0.9	7.1	0.0	5.4	5.1	5.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	14.0	0.0	5.0	0.0	6.4	12.2	18.3	0.0	0.0	0.0	0.0	1.9	0.0	6.7	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2	0.0	0.3	0.0	0.1	0.0	0.0	11.3	0.0	0.0	2.3	0.0	0.0	251.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	27.7	3.3	1.5	0.0	0.0	29.6	0.0	0.0	0.0	12.9	5.3	1.1	1.8	1.7	0.0	0.0	3.1	0.1	0.0	2.1	0.0	0.0	6.5	0.2	12.7	3.8	0.4	136.7	0.0	0.0	0.1
FBN3		ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149846	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 5.2;salivary gland: 7.5"	"Cell type enhanced"	"Detected in some"	30	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.4;Cardiomyocytes: 2.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 3.7;NTERA-2: 12.6;REH: 18.2;SuSa: 4.9"					"Low region specificity"	"Detected in many"			HPA049482	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	1.0	0.2	1.2	0.0	0.5	0.2	2.4	0.2	0.2	2.8	0.2	0.0	0.7	0.2	0.5	1.8	0.2	0.2	1.0	1.1	3.6	0.5	5.2	0.2	2.4	0.2	0.8	0.2	0.0	1.9	0.2	2.1	1.7	0.3	0.2	7.5	0.2	0.9	0.6	0.3	0.3	2.0	0.2	0.1	1.1	1.7	0.8	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.6	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.2	2.4	1.0	1.1	2.4	0.2	2.1	1.7	6.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 87.2;lymphoid tissue: 38.4"	"Cell type enriched"	"Detected in some"	57	"B-cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"memory B-cell: 28.2;naive B-cell: 87.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 87.2"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 99.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"	NA	NA		59000			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	2.4	0.3	0.5	17.1	0.5	2.3	1.2	0.3	1.1	0.3	1.0	0.1	0.4	1.3	0.3	2.3	1.0	0.4	0.5	0.8	0.3	0.3	0.6	0.6	0.8	21.1	0.3	0.0	0.4	0.3	0.0	0.3	0.3	0.1	0.3	0.8	0.0	7.5	0.7	0.4	0.6	7.7	0.4	0.3	38.4	0.8	0.5	0.0	6.3	0.7	0.0	33.8	2.0	0.5	87.2	0.7	0.2	2.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.5	0.0	0.0	2.5	0.0	28.2	0.0	0.0	0.7	87.2	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.0	0.5	0.5	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0	0.0	1.1	110.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.6	0.0	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"	22	"Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA		2500000000			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0	20.8	30.6	13.0	0.0	0.5	0.1	0.4	7.6	10.7	19.4	3.5	2.0	1.1	0.0	0.0	0.9	0.8	0.0	0.0	0.0	1.1	0.3	0.0	17.4	3.4	191.4	0.0	0.0	9.2	556.1	1.5	0.3	266.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	19.4	0.0	0.0	0.5	0.0	1.7	99.7	0.0	0.1
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.1;Ciliated cells: 4.0;Club cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.5"														"Secreted to blood"	NA	NA						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9	3.0	11.1	0.0	0.0	0.0	0.0	0.3	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in many"	11	"B-cells: 125.3;T-cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 53.0;U-266/70: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		2400000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	2.7	0.0	7.4	0.0	0.1	1.0	0.1	0.0	0.0	0.0	1.7	0.2	53.0	0.0	0.1	0.0	0.0	1.0	0.2	5.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.7	1.9	7.4	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0	0.0	4.6	125.3	3.9	0.0	0.0	3.0	7.6	1.4	2.3	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	2.6	0.1	0.6	2.6	0.0	1.1	3.8	0.0	0.0	5.5	5.1	0.0	0.3	1.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.1	1.0	0.0	0.0	41.7	1.2	7.1
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134905890-134917963	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 318.5;bone marrow: 135.4"	"Cell type enriched"	"Detected in many"	9	"Kupffer cells: 627.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 318.5;intermediate monocyte: 218.1"	"Lineage enhanced"	"Detected in many"		"monocytes: 318.5"	"Group enriched"	"Detected in some"	7	"NB-4: 15.7;U-937: 23.4"									"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	63000000			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1.0	1.8	2.0	0.4	0.0	0.1	1.6	7.8	1.0	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0.0	0.7	9.2	0.9	1.6	1.0	3.0	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1.0	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.2	0.0	23.4	0.0	1.2	318.5	3.0	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99.0	2.5	0.3	273.0	0.6	0.7	0.4	1.0	0.5	0.6	2.3	0.1	0.9	0.5	6.0	27.5	10.5	0.2	1.6	0.0	2.4	0.0	1.4	9.1	1.8	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.1	0.2	11.6	1.3	71.4	0.0	0.0	3.1	627.5	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.5	0.0	0.1
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880812-134887520	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 77.4"	"Cell type enriched"	"Detected in some"	16	"Ito cells: 1725.4"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.0;intermediate monocyte: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2"														"Secreted to blood"	NA	NA	8100000000	1800000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		2.0	11.4	0.2	0.2	0.2	0.0	4.0	0.2	0.3	0.2	0.3	0.3	0.5	0.0	0.3	0.6	0.2	0.0	0.2	0.5	0.2	0.0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0.0	0.2	1.4	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0.0	3.3	1.3	6.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.9	0.0	0.0	6.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	7.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	1725.4	106.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell type enriched"	"Detected in many"	14	"Ito cells: 3886.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2"									CAB025945	Approved				"Secreted to blood"	NA	NA	22800000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	1.1	0.0	0.4	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2	0.0	15.2	66.2	0.3	0.7	0.0	2.0	81.5	4.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	99.1	0.0	93.5	0.0	0.0	0.2	0.4	3.5	6.8	0.3	0.0	0.0	3886.1	270.1	2.2	3.1	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.4	0.6	1.0	0.0	8.6	0.0	0.3
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	7	"B-cells: 61.9;Early spermatids: 51.2;Melanocytes: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.8;U-698: 12.3"														"Secreted to blood"	NA	NA	169000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	4.5	61.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.6	0.3	4.4	0.3	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	1.1	0.0	0.0	0.6	0.5	0.0	0.0
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226071-70235252	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 176.5;salivary gland: 452.5"	"Cell type enriched"	"Detected in single"	38	"Ductal cells: 37.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0"									"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favorable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	0.4	0.4	0.4	95.4	0.4	0.0	9.7	0.4	0.4	0.4	1.0	0.0	0.0	0.0	0.4	0.0	1.9	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	452.5	0.0	0.5	0.4	3.7	0.0	0.4	12.1	0.4	0.4	0.0	0.4	0.5	35.9	176.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.2	8.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	4500000000	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	2.6	11.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.5	0.0	1.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.7	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	1.3	2.4	4.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 15347.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 77.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	77.7	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	153.8	0.0	0.0	0.0	0.4	257.4	0.0	0.0	3.5	0.0	0.0	1.7	3.0	0.4	0.0	0.0	467.2	3.2	0.1	0.0	0.0	0.0	15347.2	0.3	0.0	1.7	349.9	342.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 65.0;heart muscle: 35.5;kidney: 41.5"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 49.6;Collecting duct cells: 19.2;Cone photoreceptor cells: 15.7;Muller glia cells: 68.6"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 19.8;BJ hTERT+: 14.8;BJ hTERT+ SV40 Large T+: 16.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.6;HBF TERT88: 29.5;hTEC/SVTERT24-B: 20.6;LHCN-M2: 13.7;U-2 OS: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	7.3	3.5	44.2	2.0	43.1	1.5	9.7	10.5	59.9	1.8	1.7	65.0	0.0	1.6	3.1	8.7	2.3	2.1	2.7	35.5	47.4	33.0	41.5	2.0	2.9	1.4	62.6	13.8	1.5	1.4	3.4	1.6	2.3	36.3	2.2	1.8	0.8	5.8	2.6	2.3	2.0	1.7	2.6	57.7	5.5	1.1	2.2	48.6	0.0	4.9	0.8	2.2	1.7	0.4	1.2	1.0	1.8	0.6	0.1	2.3	0.2	2.4	0.1	0.1	0.7	0.5	1.5	0.8	19.8	14.8	16.3	20.6	0.1	0.1	0.5	1.4	6.8	0.9	0.3	0.0	1.5	29.5	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.2	0.7	0.5	20.6	1.2	4.4	0.0	0.1	0.0	0.7	13.7	0.3	0.0	0.4	0.6	0.0	0.6	0.1	0.7	0.2	0.6	0.1	0.5	1.0	0.0	0.4	0.2	3.9	0.0	0.1	0.4	2.6	14.7	0.3	9.3	0.3	0.1	0.1	3.7	0.1	0.7	0.3	0.3	1.8	2.3	0.1	1.8	0.4	0.8	0.9	0.2	1.2	0.9	1.9	1.7	0.1	0.6	1.0	0.5	0.2	44.2	43.1	10.5	22.6	47.4	33.0	62.6	13.8	36.3	48.6	0.0	0.0	0.0	3.4	0.3	1.6	49.6	0.0	0.0	3.4	19.2	15.7	0.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.4	1.8	1.4	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	3.3	0.0	0.0	68.6	0.7	0.0	0.4	0.0	9.6	6.5	4.7	0.0	0.1	0.0	0.7	0.0	0.0	0.3
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44303544-44389706	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease mutation, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 26.4"	"Group enriched"	"Detected in some"	8	"Leydig cells: 7.8;Muller glia cells: 5.2;Peritubular cells: 9.9"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AF22: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010315	Uncertain				"Secreted in other tissues"	NA	NA					"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	10.5	1.8	0.2	3.4	1.2	0.0	13.1	0.6	1.9	15.5	6.1	0.4	2.1	0.2	3.1	17.2	3.8	5.4	5.0	4.2	0.2	0.5	0.9	0.1	2.5	1.8	1.0	0.3	26.4	5.4	0.0	5.4	7.7	1.4	11.7	2.0	3.2	6.8	4.2	0.7	0.9	2.5	11.0	1.7	0.1	4.4	6.2	0.4	0.2	5.0	8.6	0.8	9.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.6	1.9	0.2	0.5	1.0	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	5.2	0.5	0.0	9.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447405-77457278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.2;seminal vesicle: 4.2"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 22.7"	"Group enriched"	"Detected in some"	6	"basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		3.2	0.0	0.2	0.1	0.2	0.0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0.0	1.2	0.6	0.5	0.4	0.7	1.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 31.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.6;Cone photoreceptor cells: 13.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.2;Hep G2: 2.4;MOLT-4: 2.3;RPMI-8226: 4.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.2"	"Low region specificity"	"Detected in some"			HPA052600	Uncertain				"Secreted in brain"	NA	NA					"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.4	4.9	2.5	0.4	3.2	0.2	0.4	31.3	7.7	0.5	0.4	0.4	0.4	0.2	2.2	0.6	0.4	0.7	0.6	0.4	2.2	4.7	0.4	0.4	0.5	0.4	1.3	2.9	0.5	2.6	3.6	2.1	0.4	3.3	1.2	0.2	0.4	2.4	0.5	0.4	0.9	0.4	1.0	0.9	3.0	0.8	0.6	0.4	1.6	2.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.6	0.6	1.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.9	0.7	0.0	2.4	0.1	0.0	1.5	0.0	0.3	0.0	0.1	1.4	0.0	1.2	0.1	0.1	0.0	0.7	2.3	0.8	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.0	1.6	0.0	0.0	0.2	0.3	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.2	31.3	7.7	2.2	4.7	1.3	2.9	3.3	0.4	0.0	0.0	0.0	0.2	0.0	8.6	0.8	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.1	0.1	0.0	1.1	0.0	1.1	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.0	0.1
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419656-171457623	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 23.0"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 6.0;Cardiomyocytes: 14.9;Smooth muscle cells: 6.2"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"EFO-21: 66.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA018795	Uncertain				"Secreted in other tissues"	NA	NA					"HPA018795: AB_1848523"	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	4.4	0.6	0.6	2.8	0.6	0.1	2.0	0.4	1.2	1.3	0.8	0.5	0.0	1.1	1.6	1.5	0.9	2.0	1.4	23.0	0.5	0.4	1.3	0.4	2.9	0.5	0.4	0.0	1.6	0.9	0.1	1.8	0.9	1.6	2.2	0.3	0.3	1.0	0.7	5.4	1.8	2.2	1.2	0.9	1.1	0.7	1.0	0.3	0.2	2.2	2.5	0.8	2.2	0.5	0.9	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	66.7	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.6	0.4	1.2	0.5	0.4	0.4	0.0	1.6	0.3	6.0	0.0	0.0	0.7	2.2	0.0	14.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	4.1	3.5	0.4	0.0	0.0	0.2	2.7	3.0	0.0	0.0	0.1	0.0	1.7	4.9	0.0	0.4	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	6.2	0.5	1.0	2.8	0.0	0.0	1.2	0.9
FGF19		ENSG00000162344	"Fibroblast growth factor 19"	O95750	11	69698232-69704642	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"gallbladder: 62.4"	"Cell type enriched"	"Detected in some"	5	"Cholangiocytes: 38.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CAPAN-2: 47.6"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.8"	"Region enriched"	"Detected in single"	19	"basal ganglia: 0.9"	HPA036082	Approved				"Secreted to blood"	NA	NA	133000				"HPA036082: AB_10669665"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.22e-1)"		"unprognostic (4.68e-3)"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-3)"		"unprognostic (2.26e-1)"	"unprognostic (6.39e-3)"			"unprognostic (1.66e-2)"	"unprognostic (8.82e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0		0.0	0.1	0.4	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.5	0.0	0.4	38.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	1.1	0.0	0.0	0.1	1.6
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 12.4;Smooth muscle cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500		"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.8	6.9	4.4	7.4	0.0	57.4	33.7	24.1	14.0	0.0	0.1	0.0	6.7	62.3	19.0	0.2	1.8	0.1	24.3	4.5	0.8	0.0	6.5	0.0	13.0	0.3	0.0	3.9	0.4	23.8	34.4	12.1	2.6	0.0	1.7	1.9	6.2	0.0	0.0	0.0	5.2	0.0	1.4	0.0	0.9	0.0	7.6	0.0	1.0	0.9	11.1	0.0	0.4	10.8	0.0	0.1	2.4	20.0	3.9	7.4	4.9	3.4	3.6	0.0	5.7	0.0	2.1	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3	6.0	0.0	0.0	1.5	1.4	3.5	3.9	0.0	0.0	2.3	7.0	0.0	1.8	3.3	6.9	8.7	5.8	0.0	0.0	0.8	0.0	12.4	5.2	0.0	0.4	0.4	0.0	1.7	7.4	0.0	2.5	9.2	0.9	5.0	1.0	0.0	8.4	6.7	0.0	7.8	0.4	1.8	0.0	15.5	3.1	0.2	1.1	4.0	0.0	0.0	0.3
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992169-17002181	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;CAPAN-2: 10.5;OE19: 2.5"	"Region enhanced"	"Detected in some"		"midbrain: 0.7"	"Region enriched"	"Detected in some"	5	"cerebellum: 3.4"						"Secreted in other tissues"	NA	NA						"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.2	2.0	1.9	0.2	1.6	0.0	1.1	9.0	3.7	3.9	0.1	4.0	0.1	0.4	0.1	2.5	0.1	0.8	1.2	0.3	2.3	2.1	0.1	0.1	0.1	0.5	2.9	2.4	2.5	0.2	0.0	0.9	0.5	2.7	0.6	0.2	0.8	3.8	0.6	0.1	0.0	0.2	0.1	4.2	3.6	2.2	0.8	1.1	0.1	0.5	0.1	1.6	0.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.4	0.0	1.2	3.3	0.5	1.6	0.0	10.5	0.0	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	9.0	3.7	2.3	2.1	2.9	2.4	2.7	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755559-48758333	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	113	"liver: 37.8"	"Cell type enriched"	"Detected in some"	12	"Cardiomyocytes: 67.7"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 3.1;U-2 OS: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061286	Supported				"Secreted to blood"	NA	NA	254000				"HPA061286: AB_2684466"				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF22		ENSG00000070388	"Fibroblast growth factor 22"	Q9HCT0	19	639879-644371	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 7.5;Horizontal cells: 12.7;Rod photoreceptor cells: 5.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.25e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.66e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.36e-2)"	0.5	0.7	2.2	0.0	2.6	0.1	0.4	0.9	3.5	0.1	0.1			0.4	0.4	0.0	0.1	0.2	0.0	0.1	1.8	2.3	0.2	0.1	0.2	0.1	2.0		2.7	0.0	0.0	0.0	0.2		0.6	0.1		1.2	0.4	1.3	14.1	0.2	0.1	0.8	0.2	0.1	0.6			0.1		0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	1.0	0.3	5.9	0.4	0.0	1.4	0.4	0.0	0.2	0.0	1.4	0.2	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.9	2.5	0.3	1.7	0.7	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	1.7	0.3	0.0	2.1	0.0	0.0	1.1	0.4	0.6	1.2	2.2	1.5	0.0	0.3	0.2	1.0	0.5	0.7	0.5	0.0	0.6	0.0	0.4	0.1	1.7	0.3	0.5	0.6	0.4	0.2	0.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.0	0.0	1.7	0.7	7.5	1.4	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.3	1.0	2.2	0.0	0.2	0.2	12.7	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.3	3.2	0.2	0.0	0.0	0.1	5.6	0.0	2.1	0.7	1.4	0.9	2.9	0.7	0.3	0.5
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 9.8;Early spermatids: 3.8;Ito cells: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 5.5;HBEC3-KT: 4.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	56800								"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.5	1.8	2.9	0.6	0.8	0.1	0.1	0.0	0.2	1.0	2.0	0.3	0.2	0.9	0.3	1.2	0.8	4.0	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.2	0.5	1.6	0.2	2.5	3.3	0.3	0.4	0.2	0.5	2.3	0.1	0.0	0.7	1.4	1.4	0.3	0.2	0.9	0.1	0.9	0.7	1.1	1.2	1.1	0.0	1.8	0.2	1.0	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	1.6	0.0	14.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809969-69819024	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 16.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	38	"cerebellum: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 4.8"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"	NA	NA					"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell type enhanced"	"Detected in single"	28	"Early spermatids: 2.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	64	"NTERA-2: 18.6;SuSa: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	7.2	0.0	20.2	38.1	5.3	3.9	0.0	0.0	0.0	0.0	27.5	0.4	0.0	0.0	7.0	28.7	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	15.6	7.5	9.0	1.8	0.0	0.0	0.1	25.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.5	35.6	1.4	1.7	17.0	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF6		ENSG00000111241	"Fibroblast growth factor 6"	P10767	12	4428155-4445614	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 24.6;tongue: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NB-4: 1.7;NTERA-2: 6.2;REH: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA																				"unprognostic (4.29e-2)"			0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	6.2	0.0	0.0	6.6	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	24.2	22.3	0.0	7.3	4.5	0.0	0.0	0.0	0.1	0.0	0.1	10.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.1	0.0	22.6	0.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	12.2	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0	11.9	13.4	0.9	13.5	12.8	7.9	40.0	5.1	0.0	0.0	8.7	2.0	4.7	101.2	1.1	2.8	5.3	0.0	0.0	0.6	3.8	91.0	9.0	1.1	2.5	1.8	3.2	0.0	0.0	1.0	3.1	77.1	3.1	6.8	0.0	0.0	7.3	0.6	0.0	4.6	24.5	6.0	6.5	82.4	0.3	0.1	11.0	2.4	1.0	0.0	7.1
FGF8	AIGF	ENSG00000107831	"Fibroblast growth factor 8"	P55075	10	101770130-101780369	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 30.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"endometrial cancer: 2.1;testis cancer: 3.3;urothelial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	20	"RH-30: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (1.56e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.09e-2)"		"unprognostic (8.75e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.35e-9)"	"unprognostic (6.17e-3)"	"unprognostic (9.01e-2)"		"unprognostic (1.97e-1)"	0.3	0.0	0.6	0.1	0.6	0.0	0.2	0.1	2.2	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	1.9	1.9	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	30.5	0.0	0.1	0.1	0.2	0.3	0.0	3.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	2.1	1.6	4.8	3.0	2.6	2.5	1.3	0.4	0.1	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.8	0.7	0.2	0.1	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.6	0.0	0.3	0.4	1.6	0.1	0.0	0.0	0.4	31.3	0.6	0.0	0.2	0.6	0.7	0.0	0.4	0.3	0.0	0.5	0.0	0.4	0.5	0.9	0.6	0.1	0.1	0.5	0.9	0.6	0.5	0.6	4.8	1.5	1.8	1.2	1.9	2.5	1.6	1.9	1.5	1.4	2.1	2.4	2.3	4.2	2.6	3.0	1.6	1.7	1.3	0.6	0.6	0.1	2.2	1.9	1.9	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671383-21704498	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.7;kidney: 21.7"	"Cell type enhanced"	"Detected in many"	23	"Distal tubular cells: 33.2;Horizontal cells: 38.1;Muller glia cells: 152.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.4;HEK 293: 2.4;JURKAT: 3.8;RPMI-8226: 3.6;RPTEC TERT1: 5.5;SCLC-21H: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced	Approved			"Secreted in other tissues"	NA	NA					"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	3.1	7.3	2.1	1.0	4.4	0.8	0.7	17.7	7.3	3.8	2.1	0.3	0.5	1.8	3.7	0.9	0.9	1.0	1.2	5.5	3.7	2.6	21.7	0.5	2.6	0.6	2.6	2.5	2.3	1.8	0.5	12.0	0.7	12.6	1.1	3.1	2.4	1.2	1.6	1.4	0.5	4.0	4.0	2.5	0.6	2.2	1.5	0.3	0.0	0.6	0.0	0.5	3.0	1.4	1.0	0.0	0.0	0.2	0.0	1.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.4	0.0	1.7	0.9	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	1.1	3.6	5.5	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.7	1.4	1.7	0.0	1.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	2.1	4.4	17.7	7.3	3.7	2.6	2.6	2.5	12.6	0.3	8.9	3.5	0.0	0.2	1.4	13.4	21.0	0.0	0.0	2.3	3.5	0.0	0.0	33.2	0.2	3.4	0.5	3.5	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	38.1	17.9	0.0	0.0	3.0	0.6	0.0	1.7	2.8	0.9	152.2	0.2	0.0	0.0	0.5	4.6	0.0	0.5	1.4	1.9	1.3	0.2	0.0	6.2	0.1
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 927.5;Suprabasal keratinocytes: 687.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 79.0;HBEC3-KT: 136.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	1.5	0.0	0.0	79.0	0.0	136.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.7	0.0	0.0	0.0	13.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	5.9	0.0	92.0	927.5	0.0	0.0	0.0	37.5	51.2	0.0	0.0	0.1	0.0	10.2	0.0	0.0	32.6	0.0	6.6	0.0	6.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	70.9	1.0	12.3	0.0	81.1	20.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	687.3	1.9	0.0	8.4	179.5
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Group enriched"	"Detected in many"	8	"Melanocytes: 43.9;T-cells: 86.3"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 11.2;T-47d: 5.5;WM-115: 2.2"														"Secreted to blood"	NA	NA	346000000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.2	0.3	5.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0	0.0	7.7	0.9	0.0	8.5	0.0	1.4	0.0	0.0	2.3	5.2	7.9	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	3.5	0.2	0.0	0.0	0.0	4.9	0.3	1.7	0.0	2.2	43.9	0.0	0.0	1.0	0.2	0.0	0.4	0.8	0.3	0.0	0.8	0.3	0.1	6.8	0.8	86.3	0.0	0.0
FGFBP3	"C10orf13, MGC39320"	ENSG00000174721	"Fibroblast growth factor binding protein 3"	Q8TAT2	10	91906589-91909483	"Predicted secreted proteins"		"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 20.6"	"Cell type enhanced"	"Detected in many"	10	"Intestinal endocrine cells: 44.4;Muller glia cells: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"AF22: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053943	Uncertain				"Secreted in brain"	NA	NA					"HPA053943: AB_2682318"	"unprognostic (8.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.76e-3)"	1.4	2.1	6.4	1.4	4.6	1.0	2.0	3.4	20.6	1.3	1.6	4.1	0.3	1.1	1.8	2.8	1.0	1.1	0.6	2.1	6.9	5.9	1.4	0.8	1.1	2.2	4.0	5.6	2.5	1.9	2.0	2.3	0.9	6.7	2.3	1.9	0.5	1.9	1.4	3.3	1.8	1.1	1.0	3.9	1.7	2.2	1.1	4.4	0.9	2.7	0.3	1.2	1.0	0.8	3.7	0.6	2.0	0.5	0.9	1.9	0.2	0.0	0.6	85.8	1.2	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.3	0.5	0.0	0.2	0.3	0.9	1.7	0.7	1.0	0.2	9.1	0.2	0.2	0.1	0.4	0.4	0.2	0.0	1.1	0.8	0.3	0.0	0.7	1.0	3.7	6.3	0.3	0.3	2.7	0.5	0.1	0.1	0.2	0.9	1.1	0.2	0.0	1.4	0.5	0.3	0.1	0.1	0.1	0.6	0.1	0.2	0.2	0.5	0.3	0.0	1.0	0.1	2.0	0.5	0.0	1.7	0.1	0.6	2.1	1.1	0.9	0.6	3.7	1.9	1.4	0.0	0.9	0.0	0.3	0.1	0.2	6.4	4.6	3.4	6.4	6.9	5.9	4.0	5.6	6.7	4.4	0.0	1.3	0.0	4.3	1.1	11.6	3.6	5.1	8.1	4.5	5.2	2.0	2.4	16.6	1.6	0.3	1.6	0.9	0.0	3.0	0.9	2.6	4.6	0.0	1.5	1.2	6.4	44.4	0.6	4.3	0.0	5.5	2.2	3.3	0.0	5.4	21.5	0.7	3.1	3.5	2.5	14.1	0.0	1.7	0.3	1.0	2.4	0.8	6.9	4.0	3.9
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell type enriched"	"Detected in many"	15	"Hepatocytes: 7797.1"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"Hep G2: 128.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	128.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.9	218.6	146.9	0.0	0.0	0.0	0.2	507.0	2.7	4.5	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	327.1	40.0	0.1	0.0	0.0	10.5	7797.1	0.2	0.0	0.0	232.7	240.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	266.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.3	20.1	0.0	0.0
FGL1	HFREP-1	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 450.7"	"Cell type enriched"	"Detected in many"	23	"Hepatocytes: 6738.7"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 22.2;Hep G2: 52.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		1800000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	22.2	0.0	2.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.2	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	3.4	104.9	0.1	0.0	0.0	1.0	298.1	0.0	0.0	0.0	0.0	0.2	0.0	4.2	35.8	0.0	0.0	140.2	59.6	0.4	0.0	8.5	0.0	6738.7	15.3	0.0	0.0	190.3	185.3	19.0	0.6	0.0	0.0	2.8	0.0	0.0	121.6	0.0	0.4	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.8	0.0	0.0	0.1
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193371-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 431.4;Macrophages: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	50	"classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5"	"Group enriched"	"Detected in many"	56	"dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.1;Karpas-707: 3.8;LHCN-M2: 4.2;NB-4: 4.6;RPTEC TERT1: 8.0;U-937: 8.4;WM-115: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	6400000			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	30.0	8.7	6.0	28.7	10.7	1.5	18.0	5.7	4.7	8.0	29.5	5.0	7.7	14.2	7.6	18.4	41.4	13.8	16.2	17.8	5.1	5.5	23.3	14.3	17.0	28.1	10.3	4.1	6.4	3.0	1.8	8.0	7.0	11.4	17.9	20.3	6.8	11.7	4.4	6.2	8.6	40.9	73.7	18.4	63.4	16.9	3.4	8.6	12.0	19.2	18.3	9.1	55.8	7.7	1.0	38.1	68.4	82.0	0.7	1.1	34.6	0.0	0.0	0.0	0.0	4.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	3.8	4.2	0.1	0.0	4.6	0.3	0.0	0.2	0.2	0.5	0.4	8.0	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	8.4	9.0	0.6	59.3	52.6	1.1	82.0	0.5	1.0	0.7	1.0	38.1	0.5	0.4	0.8	68.4	0.7	73.5	1.2	1.1	34.6	6.0	10.7	5.7	4.7	5.1	5.5	10.3	4.1	11.4	8.6	6.0	18.4	34.2	1.0	33.9	1.1	3.2	0.0	4.0	9.1	83.7	9.8	1.1	5.0	0.2	7.0	45.8	11.9	0.0	0.0	1.0	69.5	0.8	9.3	4.2	36.4	1.6	0.0	56.4	431.4	7.1	25.6	384.4	47.2	1.0	0.3	11.3	0.1	2.8	18.4	5.4	7.7	0.0	9.5	0.5	0.3	27.4	3.1	19.2	0.3	1.4
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	54000	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.4	13.8	6.3	3.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	11.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.2	0.0	15.6	1.4	0.4	0.0	0.0	0.0	1.0	0.8	9.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.0	31.0	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2	0.0	8.9	2.2	0.5	3.7	5.9	12.6	5.1	2.7	1.2	0.0	3.9	155.4	1.7	0.0	116.6	192.1	0.0	0.0	0.0	778.4	17.5	1.1	1.1	2.1	28.1	1.6	0.0	284.2	16.1	130.7	17.3	5.3	0.0	0.0	0.0	172.0	0.0	0.0	45.6	0.0	7.3	90.5	6.6	12.9	2.8	4.3	942.6	2.9	0.0	0.5
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351489	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 50.6;Leydig cells: 25.9;Mucus-secreting cells: 57.0;Peritubular cells: 26.9;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;CACO-2: 21.3;HHSteC: 6.9;HSkMC: 12.8;OE19: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		2400000				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (2.67e-4)"	35.9	6.0	1.0	12.6	2.0	0.0	32.2	1.2	2.0	62.5	14.2	2.0	12.0	12.1	69.6	43.6	16.9	31.2	87.1	58.3	1.1	1.2	10.8	6.1	22.8	27.4	3.0	2.5	86.7	39.4	5.0	12.1	21.0	5.0	37.5	16.0	44.3	25.0	16.2	20.1	10.5	8.4	27.4	7.5	18.3	36.5	14.2	0.6	2.7	57.6	20.4	37.6	32.0	42.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.4	0.1	4.0	4.5	0.0	0.6	21.3	0.0	0.0	0.5	4.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.0	6.9	0.0	0.0	12.8	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.1	1.1	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	1.2	2.0	1.1	1.2	3.0	2.5	5.0	0.6	0.0	7.5	0.0	5.1	6.2	0.0	0.8	0.0	1.4	3.4	7.0	0.0	0.7	0.0	1.2	0.0	5.4	0.8	0.0	0.6	0.6	50.6	13.8	0.0	0.0	1.1	0.0	5.8	13.5	0.0	0.0	25.9	0.6	11.8	1.0	57.0	7.8	2.1	0.0	26.9	0.0	0.8	6.5	33.2	0.0	0.0	3.8	2.6	0.0	6.8	1.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436172	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 235.4;placenta: 433.0"	"Cell type enhanced"	"Detected in many"	19	"Extravillous trophoblasts: 2156.8;Fibroblasts: 526.4;Hepatocytes: 963.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 845.3;HSkMC: 395.4;hTERT-HME1: 232.5;hTERT-RPE1: 257.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	20.2	4.5	3.1	13.0	5.2	0.2	13.1	2.2	4.3	21.9	57.1	4.4	235.4	3.5	25.1	27.5	37.4	26.5	20.9	57.3	3.9	2.9	5.8	166.3	81.5	7.9	4.6	5.0	16.9	3.3	1.7	3.5	433.0	6.1	17.1	25.1	5.1	10.4	141.2	9.8	7.0	13.5	114.9	4.6	1.9	21.8	9.0	2.7	9.4	5.4	17.4	2.6	64.7	16.9	0.2	0.8	0.0	0.6	0.0	0.3	0.0	0.2	1.9	2.6	0.5	107.3	845.3	0.1	43.6	29.1	44.2	31.4	26.4	1.0	0.0	0.2	144.9	1.2	4.5	0.4	99.3	23.8	0.0	0.1	0.0	0.6	82.3	77.6	0.0	0.1	395.4	0.6	104.4	232.5	257.3	51.2	0.0	0.1	0.1	88.0	0.3	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.1	1.1	0.3	0.1	0.6	5.2	2.7	28.3	119.4	0.4	0.0	98.1	63.9	6.8	70.0	8.0	0.1	0.0	0.0	76.0	0.0	16.6	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	3.1	5.2	2.2	4.3	3.9	2.9	4.6	5.0	6.1	2.7	62.5	83.1	7.8	3.5	48.9	5.1	27.2	35.7	24.1	28.4	15.7	0.0	51.6	0.0	4.9	1.5	166.7	0.0	0.0	8.1	2156.8	526.4	18.4	17.4	963.3	368.5	1.6	20.2	165.1	27.1	2.6	172.6	39.4	104.6	1.8	4.3	1.4	19.0	0.0	83.1	0.6	9.7	71.1	163.2	1.1	4.5	32.6	172.1	0.9	3.7	1.6
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enriched"	"Detected in some"	5	"Fibroblasts: 15.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.4	6.6	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	7.4	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	2.9	0.0	1.4	0.0	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	15.5	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.4	0.3	1.3	0.1	0.0	0.0	0.0
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712657-108742740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 5.2"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 1.1;Early spermatids: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8"	"Not detected"	"Not detected"							"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.1	0.1	0.6	0.1	0.8	0.6	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.5	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.9	0.5	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.3	0.1	0.0	1.1	0.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.5	0.3	0.3	0.1	0.4	0.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	1.1	1.7	0.7	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FOLR2		ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 838.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 27.8;intermediate monocyte: 20.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.8;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	5	"U-698: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		12000000				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	59.4	17.7	5.4	7.4	4.5	2.0	16.3	1.0	4.7	8.3	17.3	6.3	2.0	5.0	9.1	32.3	10.3	12.3	22.4	28.8	4.3	3.0	11.9	19.9	15.4	21.3	5.0	2.9	7.9	4.9	2.6	4.3	57.8	5.4	14.9	13.1	12.2	9.3	4.6	17.4	6.5	11.9	12.4	4.8	21.3	8.6	11.2	2.0	9.5	7.3	9.7	9.6	20.9	4.7	4.2	7.8	0.4	27.8	0.6	0.1	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.2	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.3	0.0	20.1	0.5	0.9	0.0	0.0	27.8	0.0	0.1	20.3	0.0	4.2	0.0	0.0	7.8	1.2	0.0	0.0	0.4	0.6	5.1	0.1	0.0	7.8	5.4	4.5	1.0	4.7	4.3	3.0	5.0	2.9	5.4	2.0	0.0	1.1	3.2	0.0	7.0	0.0	1.9	2.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.8	1.6	0.0	0.0	0.0	4.2	5.3	0.2	2.3	0.8	838.4	0.0	0.0	3.1	177.7	1.6	1.4	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.6	0.2	4.4	13.4	0.7	0.0	0.1
FOLR3	FR-G	ENSG00000110203	"Folate receptor 3"	P41439	11	72114869-72139892	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 344.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"classical monocyte: 52.9;neutrophil: 73.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 73.4;monocytes: 52.9"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 35.6;U-2197: 31.5"														"Secreted to blood"	NA	NA		9600000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.4	1.0	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0.0	0.1	1.7	0.0	0.1	4.5	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0.0	5.1	73.4	52.9	0.0	0.2	29.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.0	6.2	1.8	4.5	0.0	0.0	0.0	0.6	0.9	0.1	0.4	0.0	3.3	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	2.6	35.6	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.1	31.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	52.9	4.3	0.0	3.5	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	73.4	0.0	0.1	0.9	0.0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0.0	0.2	0.2	0.0	12.2	0.0	0.0	0.2	0.0	0.0	0.0	2.7	3.4	22.7	0.0	0.0	344.8	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	1.6	0.0	0.0	0.6	8.7	8.6	0.0	11.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14734666-14910995	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.3;epididymis: 30.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 69.1;Late spermatids: 99.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEL: 63.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	4.4	2.5	1.5	3.2	1.4	0.2	4.0	22.2	2.5	10.9	7.5	5.0	22.9	1.8	33.3	30.8	0.9	4.5	3.1	7.3	1.8	2.0	10.4	0.8	2.6	0.1	1.1	1.0	2.3	14.2	6.0	1.2	4.6	4.0	3.1	1.5	5.0	1.0	11.4	0.7	2.6	9.3	12.8	2.7	0.4	1.3	3.5	0.6	1.7	0.8	3.4	1.1	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	22.2	2.5	1.8	2.0	1.1	1.0	4.0	0.6	0.0	1.1	0.0	0.2	1.1	0.7	2.0	5.1	0.0	0.0	1.8	0.0	0.4	0.0	0.2	69.1	0.0	0.7	0.0	0.0	0.2	11.3	0.1	4.7	0.0	0.4	0.0	0.0	6.2	1.2	99.8	0.6	0.0	0.0	1.0	0.1	4.0	0.3	0.0	1.4	1.0	0.0	0.0	1.0	0.7	0.6	1.0	0.2	0.0	0.2	0.0
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"brain: 5.0;lung: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"TIME: 3.2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8"	"Low region specificity"	"Detected in some"			HPA041641	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA041641: AB_2677592"	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	1.8	0.0	0.2		0.0	0.0	0.1	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182867162	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 265.8"	"Cell type enriched"	"Detected in many"	12	"Muller glia cells: 3160.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 21.7"	"Group enriched"	"Detected in some"	9	"memory B-cell: 3.0;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;ASC diff: 8.6;NTERA-2: 7.2;SH-SY5Y: 6.1"	"Region enhanced"	"Detected in many"		"olfactory region: 69.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		27000				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	4.4	1.4	2.8	4.8	5.4	0.0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4.0	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12.0	4.2	2.3	3.1	5.0	3.1	3.4	3.5	6.2	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.7	0.2	8.6	0.2	0.1	0.0	0.8	3.1	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	7.2	0.0	0.0	0.6	0.7	0.0	0.0	0.0	1.1	6.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3	0.0	0.3	0.0	0.4	7.2	34.0	2.2	0.0	0.0	2.3	0.0	31.4	4.3	0.0	0.1	0.3	2.1	1.0	0.0	7.5	3.0	28.8	1.7	0.0	0.9	6.8	25.4	1.2	4.3	1.5	1.9	3.4	0.8	232.8	0.0	99.8	3160.2	0.1	0.0	13.8	0.0	101.0	271.7	137.0	0.2	0.0	2.8	10.4	0.0	3.3	0.4
FSHB		ENSG00000131808	"Follicle stimulating hormone beta subunit"	P01225	11	30231016-30235261	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"pituitary gland: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB023410, HPA069703"	Enhanced				"Secreted to blood"	NA	NA		47000			"CAB023410: AB_324983, HPA069703: AB_2686176"												"unprognostic (1.04e-1)"						0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	70.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480409-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	5	"monocytes: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	12.4	3.2	2.0	3.1	0.8	0.1	7.1	0.2	0.7	3.5	5.2	0.3	1.1	0.9	2.3	9.5	3.6	4.9	4.1	5.6	1.0	1.0	1.7	42.7	4.3	0.8	0.4	0.6	20.7	19.4	0.0	2.9	13.5	1.0	9.3	1.7	5.7	5.5	6.5	12.6	9.0	4.3	3.7	0.4	0.2	4.8	4.9	0.5	1.2	2.0	6.7	7.1	6.2	13.8	0.1	0.2	0.0	1.0	0.0	2.0	0.1	3.3	0.3	5.9	0.0	6.7	2.3	9.8	13.0	59.4	8.0	7.8	0.0	0.0	0.0	0.1	3.4	0.4	50.3	0.0	32.1	5.7	0.1	0.0	0.6	0.2	5.3	3.6	0.0	36.1	5.5	0.0	14.7	9.6	5.5	6.8	0.0	0.0	0.1	5.0	0.0	0.0	0.2	9.0	0.0	97.2	0.6	7.5	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.3	15.8	0.0	0.0	0.0	22.0	6.3	2.2	1.9	0.0	0.0	0.0	2.5	0.7	20.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.8	0.2	0.7	1.0	1.0	0.4	0.6	1.0	0.5	0.0	1.4	0.0	12.8	17.7	0.0	7.3	0.0	0.0	12.5	0.0	0.0	0.6	0.0	0.6	0.3	1.6	0.0	0.0	3.8	7.6	85.9	5.3	0.0	22.9	1.6	0.0	0.0	1.3	0.3	0.9	2.8	0.4	5.0	0.0	0.0	0.0	10.0	0.0	10.6	0.0	0.0	12.9	12.5	0.3	0.7	4.1	5.0	0.0	0.0	26.0
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120451253	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 309.5;Fibroblasts: 318.9;Leydig cells: 303.2;Peritubular cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 129.7;BJ: 150.5;fHDF/TERT166: 185.7;HBF TERT88: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		32000000	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	72.3	28.6	4.8	23.1	5.8	0.0	104.0	2.5	6.7	52.1	39.1	7.3	28.7	5.8	41.6	58.1	39.2	42.6	45.6	69.4	5.9	3.2	15.1	5.5	33.6	44.4	4.3	4.3	26.9	8.7	5.5	7.9	110.0	13.2	36.3	15.4	26.2	17.5	32.5	23.6	18.4	18.6	90.2	9.4	16.7	22.1	19.8	4.9	4.7	23.8	29.1	11.1	67.1	65.8	0.1	1.2	10.2	0.1	0.0	0.0	3.6	5.4	1.4	15.7	6.5	94.2	129.7	0.0	150.5	84.5	97.5	86.5	0.0	12.5	0.0	12.8	185.7	7.9	1.4	4.8	18.7	124.2	0.0	2.2	0.0	11.9	0.0	20.7	0.0	0.0	98.5	0.6	62.9	13.7	43.5	56.4	0.7	0.0	0.0	15.8	0.0	1.5	0.1	12.9	0.0	12.6	0.0	6.5	0.0	10.4	0.1	2.8	6.6	53.4	0.9	5.4	34.2	1.6	0.4	68.9	36.7	35.2	19.1	22.3	0.0	0.0	0.1	12.8	0.0	4.7	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	3.6	4.8	5.8	2.5	6.7	5.9	3.2	4.3	4.3	13.2	4.9	59.6	13.1	0.0	32.3	56.9	1.8	102.1	7.6	37.5	35.2	22.7	0.0	90.3	0.0	52.7	1.9	103.4	0.0	0.0	5.1	309.5	318.9	79.3	1.1	12.2	18.0	1.6	2.9	169.4	14.3	3.6	303.2	5.6	104.6	17.2	0.0	128.4	76.1	0.0	254.5	2.4	2.8	58.2	135.9	0.9	1.3	42.0	45.8	0.5	0.6	31.6
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676365-683399	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 201.0"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 2939.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		6800000	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	19.9	29.1	4.0	10.7	6.2	5.6	24.7	1.3	4.2	13.1	14.9	3.8	8.1	3.8	12.8	15.6	12.7	14.1	13.1	27.0	5.0	2.0	13.7	5.1	26.9	8.7	7.3	4.5	16.8	11.7	1.4	5.3	201.0	6.0	14.3	3.1	12.0	4.5	11.0	4.1	6.2	6.5	20.6	10.4	3.9	9.1	34.5	4.9	0.7	7.2	5.5	1.4	16.7	18.3	0.9	2.2	0.1	4.4	0.6	2.6	2.0	1.9	15.9	1.1	0.8	5.0	12.8	36.2	27.0	4.0	6.8	2.5	5.8	3.1	0.8	10.9	18.2	3.9	13.9	0.9	23.0	2.2	1.6	1.9	0.7	22.2	4.7	21.6	1.4	2.6	16.0	40.0	7.5	31.3	17.6	1.2	0.8	1.7	1.1	10.2	7.0	0.5	0.8	1.3	13.1	5.5	1.5	0.7	1.8	9.4	0.3	0.7	1.2	73.8	1.5	0.8	1.4	1.3	0.7	16.2	6.8	23.5	38.1	9.9	1.8	0.8	0.4	1.0	4.2	3.1	0.0	4.4	0.0	1.0	4.4	0.2	0.3	1.4	1.1	2.2	0.9	2.6	1.6	0.1	0.6	3.2	0.9	0.2	2.0	4.0	6.2	1.3	4.2	5.0	2.0	7.3	4.5	6.0	4.9	17.9	3.4	2.2	19.6	12.9	1.6	12.8	30.6	2.7	1.2	8.7	0.0	22.7	6.6	69.7	5.6	4.5	0.9	0.0	56.0	2939.6	52.2	21.7	0.0	0.9	68.4	3.2	1.2	22.1	3.8	6.5	56.7	4.0	5.0	11.8	0.9	7.8	198.1	0.0	25.1	5.6	0.5	45.3	32.5	2.3	7.7	6.8	662.4	2.9	1.7	20.7
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612564	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.5"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Approved	"Nuclear membrane,Mitochondria"	"Secreted to blood"	NA	NA			Mitochondria	"Nuclear membrane"	"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.7	2.2	8.4	1.0	14.6	3.0	1.1	18.5	18.0	1.0	1.6	1.7	0.0	1.1	0.5	2.8	3.1	1.6	0.7	0.6	1.5	3.2	4.8	0.5	2.0	0.4	1.9	10.1	0.8	2.9	7.1	4.0	6.4	2.6	2.9	1.9	1.4	1.4	0.1	1.5	5.3	1.2	0.3	1.0	0.5	2.3	2.8	4.7	0.0	1.3	0.0	1.7	10.2	1.6	2.8	1.2	3.4	1.1	0.8	2.3	1.2	4.4	7.6	0.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	6.8	0.9	0.3	6.2	0.0	0.8	0.1	0.9	0.2	0.0	0.4	0.3	0.3	7.4	0.6	0.0	0.0	0.4	0.1	1.1	0.0	0.0	0.2	0.0	0.3	3.4	4.0	0.0	7.2	0.8	0.3	8.2	7.8	0.8	0.3	0.7	7.7	0.0	8.4	33.1	0.7	1.7	1.4	0.1	7.8	2.8	0.3	0.2	0.3	1.4	0.4	0.2	11.9	11.8	0.3	0.1	0.0	0.2	3.4	1.1	0.6	1.2	0.4	2.3	2.8	1.7	1.2	0.6	2.6	2.1	1.3	2.4	0.8	0.7	1.2	1.6	1.2	8.4	14.6	18.5	18.0	1.5	3.2	1.9	10.1	2.6	4.7	0.0	1.9	0.0	1.7	1.4	10.3	7.3	0.0	6.7	7.9	0.0	13.7	0.3	0.0	0.2	31.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	8.6	0.0	0.0	13.9	0.3	0.0	10.1	0.0	0.0	3.3	0.8	0.0	0.7	2.3	2.4	6.5	0.0	0.4	0.6	1.4	0.0	0.0	0.0	2.6
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 106.9"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA							"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.5	12.1	3.5	0.6	6.9	0.5	0.5	106.9	19.9	0.5	0.6	0.6	0.0	0.5	0.5	1.7	0.5	0.6	0.5	0.5	3.2	5.9	0.6	0.5	0.5	0.5	3.0	3.0	0.5	1.0	0.5	1.1	0.7	18.2	0.5	0.8	7.1	0.5	0.6	0.5	0.8	0.6	0.6	3.1	0.5	0.5	1.5	2.9	0.0	0.6	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	5.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.9	106.9	6.9	3.2	5.9	3.0	3.0	18.2	2.9	0.0	0.0	0.0	0.0	0.2	248.5	0.1	0.0	0.0	0.0	0.0	435.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	27.0	0.0	0.0	0.0	1.7	0.6	0.0	1.7	0.0	0.0	18.6	0.1	0.0	0.4	0.0	131.6	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851173	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA065748			Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.21e-2)"	4.5	9.4	5.5	1.8	19.0	4.0	4.2	1.6	12.0	1.7	2.3	9.7	2.6	2.1	1.2	3.9	2.9	3.9	2.0	5.3	5.8	4.8	8.0	17.9	2.8	3.5	7.6	7.5	2.4	4.3	1.9	2.0	1.5	7.9	2.8	2.5	2.7	4.8	1.7	13.1	2.4	1.8	3.4	9.1	8.0	2.1	2.8	4.0	0.1	11.0	2.4	1.8	1.6	1.9	3.8	10.6	2.0	6.2	1.2	2.4	1.9	0.7	2.4	0.1	0.1	2.5	1.5	1.8	0.9	0.9	1.2	0.5	0.0	4.3	2.4	0.3	1.0	7.2	0.0	1.1	6.4	1.5	2.9	0.8	1.8	1.0	2.0	0.9	6.4	8.1	1.1	0.2	0.5	0.1	0.9	0.0	6.1	3.4	0.1	0.9	7.4	2.4	2.6	2.0	0.6	5.1	0.4	0.2	0.1	0.5	0.0	2.9	0.0	4.2	3.9	4.0	1.8	6.0	8.5	0.7	3.5	0.0	2.2	1.5	6.5	3.5	1.4	6.5	3.3	1.7	0.0	5.3	2.0	0.6	6.2	2.3	3.8	2.2	0.8	6.9	2.1	1.5	2.4	0.0	1.2	5.6	10.6	0.0	1.9	5.5	19.0	1.6	12.0	5.8	4.8	7.6	7.5	7.9	4.0	0.0	0.0	0.5	2.3	2.4	3.3	4.5	5.1	0.0	2.3	3.5	3.9	1.1	1.7	0.2	1.6	1.1	0.0	0.0	0.6	1.2	1.4	1.8	0.0	5.8	7.0	1.6	0.0	2.5	6.2	0.8	0.3	4.3	6.8	1.0	0.6	0.9	0.5	0.0	0.4	8.7	5.4	0.0	3.6	0.5	0.7	1.9	0.2	0.0	0.9	0.7
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494811-143511690	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		53000000			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	22.6	32.6	10.3	14.2	16.2	11.6	24.1	6.2	11.4	18.5	21.2	17.6	23.1	22.0	17.9	24.8	11.9	17.2	25.0	25.6	11.6	11.8	34.1	45.7	21.7	30.0	20.4	8.7	21.9	32.6	52.3	14.4	40.7	16.9	12.0	28.4	21.4	18.9	24.5	6.7	9.3	29.5	14.6	18.5	20.3	20.4	11.0	16.1	3.6	17.9	8.7	10.3	16.7	15.0	4.1	22.9	9.3	29.3	9.7	6.7	14.9	23.3	13.7	11.9	21.7	17.8	35.0	22.7	22.1	23.7	27.3	46.5	26.1	23.5	0.0	16.6	29.6	8.6	0.1	6.0	2.9	38.0	20.9	23.0	7.8	25.6	39.3	25.7	0.0	4.0	18.6	17.5	24.4	10.6	23.3	27.7	0.0	27.8	12.3	30.7	27.6	0.0	18.2	15.5	10.7	18.9	0.0	25.1	17.3	32.4	14.6	9.0	5.9	24.3	16.3	19.8	9.6	8.0	19.3	16.2	16.3	13.8	40.6	42.5	4.5	4.9	0.1	18.8	14.4	5.6	9.3	29.3	8.7	4.9	28.8	5.6	4.1	3.6	4.1	22.9	2.5	1.6	3.0	2.0	9.7	20.0	3.5	6.7	14.9	10.3	16.2	6.2	11.4	11.6	11.8	20.4	8.7	16.9	16.1	38.7	28.1	11.5	10.0	10.0	2.5	22.9	30.6	22.7	15.9	24.4	0.0	45.1	10.0	64.9	1.4	23.4	39.4	23.3	109.4	92.6	60.3	14.4	36.9	31.6	98.2	1.6	9.2	25.8	46.4	0.9	61.9	43.0	40.5	41.5	35.4	11.3	60.3	28.1	42.8	36.9	0.8	6.5	23.7	3.7	3.6	6.9	38.8	12.9	49.1	15.7
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in many"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	4.5	6.8	0.0	0.1	0.0	48.0	1.8	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	1.1	14.4	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	0.0	1.1	0.0	24.8	0.0	0.0	13.6	0.0	88.7	11.4	0.5	4.3	0.0	0.0	9.1	0.1	0.0	9.4	35.8	4.7	0.2	0.0	5.3	0.2	10.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4	0.0	0.0	0.0	15.3	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.1	0.0	0.2	0.0	0.0	43.2	33.3	2.4	54.2	4.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	13.7	0.4	11.4	3.0	1.6	0.0	0.6	11.9
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176020-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 4.4;liver: 4.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;EFO-21: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 29.0"	HPA053938	Uncertain				"Secreted in brain"	NA	NA					"HPA053938: AB_2682315"				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.2	1.2	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.1	1.1	0.7	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864067	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 328.9;Sertoli cells: 316.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"BJ: 56.3;BJ hTERT+: 81.4;HSkMC: 47.7;RPMI-8226: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	NA	NA	8900000	920000	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: AB_2683032"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (8.93e-6)"	25.6	12.6	10.6	6.8	10.7	1.0	35.3	8.0	13.2	52.9	17.1	7.9	35.7	17.9	48.6	20.1	27.0	45.8	24.3	45.9	10.6	8.3	14.7	13.9	27.9	14.4	9.2	9.5	33.0	18.4	7.3	15.8	19.1	13.9	34.2	9.5	20.3	26.8	35.9	27.1	27.9	17.0	53.4	8.8	7.7	16.5	25.2	9.5	10.0	29.2	13.1	6.5	31.8	44.7	0.0	31.7	0.0	0.6	0.0	0.1	0.5	23.8	1.0	0.7	0.6	28.7	16.0	3.0	56.3	81.4	23.5	28.2	1.5	11.5	0.2	1.8	25.3	4.1	22.5	0.3	12.6	6.0	0.0	3.2	0.1	1.7	0.1	20.5	0.1	0.2	47.7	7.4	6.5	6.5	40.6	0.8	0.3	0.4	13.1	37.9	1.1	0.1	0.2	1.5	3.8	1.6	0.7	0.0	77.2	8.5	0.3	3.9	3.5	6.2	0.2	0.0	4.1	7.5	19.1	13.2	6.1	7.6	0.7	15.9	0.0	1.2	0.2	7.0	0.5	0.9	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	31.7	0.0	0.5	10.6	10.7	8.0	13.2	10.6	8.3	9.2	9.5	13.9	9.5	184.6	30.0	11.5	77.9	75.0	18.8	75.9	35.7	10.7	31.8	29.6	0.0	2.0	23.2	27.3	4.3	59.4	72.1	0.0	6.0	1.3	59.2	12.7	8.1	19.5	77.3	328.9	9.9	109.2	19.1	6.6	85.4	18.7	116.4	11.8	57.5	28.3	16.4	31.6	55.9	0.3	8.5	316.9	124.6	3.9	17.6	62.9	2.4	3.8	132.1	33.9
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712326-41715969	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	61	"stomach 1: 529.2"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 7.3"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 27.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		43000			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	0.1	1.7	6.9	0.0	2.4	7.3	0.0	0.0	0.0	2.6	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	529.2	0.1	0.0	8.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.1
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 41.7;Alveolar cells type 2: 23.2;Collecting duct cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	16.7	36.5	26.6	16.3	24.9	10.6	19.1	30.9	29.8	15.1	15.0	20.7	19.8	23.3	17.7	22.4	16.6	18.8	20.0	16.7	27.0	26.2	19.8	18.6	15.3	15.6	25.8	19.4	21.9	16.6	15.5	22.9	16.4	22.0	18.6	10.5	15.8	20.0	23.8	19.2	27.2	21.5	12.6	21.7	17.2	19.1	17.5	21.5	12.8	17.0	13.0	11.5	11.9	14.3	4.0	9.5	1.3	8.7	1.7	4.7	2.8	16.8	9.8	9.4	10.1	4.4	6.8	9.1	10.0	4.4	9.3	8.3	7.0	26.4	9.2	3.7	6.6	10.1	18.1	7.0	8.9	4.7	11.7	50.6	5.6	14.7	14.8	7.6	10.5	12.0	9.7	9.9	4.0	6.1	8.6	7.1	10.7	13.7	8.4	5.2	4.9	11.8	11.3	9.0	5.5	18.0	13.0	6.4	11.5	8.2	3.8	24.4	9.6	9.7	13.9	6.8	2.6	12.0	6.9	13.0	10.1	7.6	5.4	7.7	10.1	5.1	11.7	15.3	14.0	8.2	1.3	7.0	1.3	4.7	8.7	3.4	4.0	4.5	4.4	9.5	3.5	3.9	2.6	0.7	1.7	3.5	5.5	2.1	2.8	26.6	24.9	30.9	27.7	27.0	26.2	25.8	19.4	22.0	21.5	41.7	23.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.6	21.0	0.0	11.0	5.0	9.7	0.0	0.0	0.0	0.0	6.5	6.9	0.0	0.0	5.8	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	8.2	0.0	0.0	11.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC, vitamin D binding protein"	P02774	4	71741693-71804041	"Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 552.1"	"Group enriched"	"Detected in some"	30	"Cholangiocytes: 1228.0;Hepatocytes: 2290.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.2;K-562: 1.8;RH-30: 6.5;SiHa: 3.2;U-2 OS: 1.8;U-698: 2.3;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	69000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.0	0.0	2.6	0.1	0.2	0.1	0.1	43.7	0.1	0.1	0.1	2.0	552.1	0.1	0.0	0.1	0.0	0.1	6.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.4	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	1.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.8	0.0	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1228.0	0.0	0.0	0.0	0.0	0.0	5.0	18.0	0.2	0.0	0.0	46.7	14.8	0.1	0.0	0.0	0.0	2290.1	0.1	0.0	0.0	57.1	59.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	19.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Cell type enriched"	"Detected in some"	14	"Intestinal endocrine cells: 5260.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 38.0;U-2 OS: 54.1"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000		"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	2.9	0.0	1.4	9.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5260.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	8.5	0.0	378.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0
GDF1		ENSG00000130283	"Growth differentiation factor 1"	P27539	19	18868545-18896096	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 36.4;skeletal muscle: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;EFO-21: 5.3;HEK 293: 6.4;NB-4: 8.3;NTERA-2: 4.3;SCLC-21H: 3.6"														"Secreted to blood"	NA	NA																							2.2	2.1	25.6	2.2	28.6	1.9	1.9	11.7	32.1	2.0	2.0	36.4	0.0	1.9	2.0	1.9	2.0	2.0	2.0	2.1	24.6	18.0	2.0	1.9	1.9	1.9	26.2	18.3	2.4	2.0	2.0	1.1	1.9	30.4	2.2	1.9	1.4	2.1	2.0	15.5	1.9	2.0	2.0	33.7	1.9	2.0	4.9	19.8	0.0	2.0	0.0	1.9	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	3.4	0.0	0.0	0.3	0.2	0.0	0.3	0.3	0.8	0.0	0.0	5.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.0	8.3	4.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.6	2.3	0.0	0.0	1.5	0.1	0.6	2.6	0.0	0.0	1.0	0.8	0.5	0.3	0.0	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	28.6	11.7	32.1	24.6	18.0	26.2	18.3	30.4	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1											0.0	1.1	0.0	0.0	0.3	17.8	0.6	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	4.7	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.2	0.9	0.0	1.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	34.3	0.0	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0
GDF11	BMP-11	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743280-55757278	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 35.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 71.9;Cone photoreceptor cells: 72.6;Horizontal cells: 54.0;Rod photoreceptor cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	270000	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	4.6	4.9	15.9	5.6	13.9	2.6	1.9	10.7	13.3	10.3	4.5	9.2	6.6	2.7	10.0	3.5	4.0	6.9	7.4	11.4	13.3	12.9	3.2	1.6	3.1	4.1	13.9	7.3	7.5	4.7	4.6	4.6	3.3	9.3	7.7	2.8	35.4	7.0	16.0	1.9	2.1	3.6	7.3	13.1	5.7	3.5	1.7	9.5	5.7	4.6	1.6	2.9	7.5	2.9	2.4	2.3	1.4	1.2	0.8	3.9	0.5	1.9	3.1	13.8	7.7	10.5	7.7	3.5	4.1	3.9	5.3	4.5	10.6	0.9	3.8	5.5	4.3	2.5	1.9	10.4	7.4	1.8	7.3	9.4	4.7	5.2	1.6	2.1	3.9	54.1	7.4	0.4	7.7	2.2	5.9	6.8	5.2	5.2	12.6	6.7	3.7	6.3	3.4	11.1	0.1	7.8	10.1	3.8	2.4	3.2	2.7	9.4	5.7	2.5	1.2	1.1	5.9	4.4	4.3	4.1	6.4	9.9	5.0	3.0	3.4	1.0	1.9	3.4	3.9	4.4	0.7	0.7	1.4	3.9	0.5	3.6	2.3	2.4	2.5	0.6	2.4	2.2	3.0	1.2	0.8	1.2	2.3	1.7	0.5	15.9	13.9	10.7	10.0	13.3	12.9	13.9	7.3	9.3	9.5	0.0	0.6	5.4	8.5	0.5	71.9	23.4	0.0	0.0	1.2	0.0	72.6	2.9	0.0	4.3	0.4	4.5	1.3	0.0	1.2	3.9	5.8	4.5	5.7	0.0	1.4	54.0	10.3	3.7	0.6	0.4	8.3	0.3	3.3	2.8	1.3	28.4	3.1	2.9	5.3	0.4	49.9	12.9	5.7	1.2	3.5	0.6	3.9	17.3	2.0	5.3
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell type enhanced"	"Detected in many"	18	"Glandular cells: 1046.1;Syncytiotrophoblasts: 3600.0;Urothelial cells: 2603.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 72.3;Hep G2: 37.2;HHSteC: 100.5;TIME: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	890000	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	16.2	1.6	0.6	3.9	3.3	72.3	5.6	3.0	0.2	3.3	0.7	5.0	0.0	10.2	0.5	16.9	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	37.2	100.5	0.0	6.2	8.6	24.3	15.7	10.2	0.1	17.1	0.0	24.8	0.1	3.9	3.9	0.0	0.1	0.9	5.7	9.0	0.0	0.6	0.0	11.9	15.9	0.1	0.1	0.0	0.9	20.2	6.4	0.4	0.0	36.0	0.0	1.3	0.3	0.2	0.2	0.6	0.0	9.0	0.0	4.7	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4	32.8	67.9	2.2	222.2	1.1	0.0	0.4	45.9	80.3	68.2	246.0	0.0	48.7	28.2	235.7	0.0	5.8	50.0	0.0	324.0	161.2	17.1	1046.1	28.8	5.0	31.5	0.0	81.4	3.7	1.8	0.0	0.9	5.9	3.3	17.2	220.9	0.2	679.3	95.1	1.4	74.0	0.5	0.0	14.6	0.0	0.6	1.5	3600.0	0.5	186.1	2603.9
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322490-47326270	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Angiogenesis	"Cytokine, Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	273	"liver: 27.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	NA	NA	2210000	300000			"CAB023357: AB_2111086"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689782-7695776	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 6.4;lymphoid tissue: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 101.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	1.3	1.1	0.0	1.1	0.7	0.0	6.4	0.0	0.0	0.5	0.2	0.0	0.0	0.4	0.5	1.5	0.4	1.4	0.9	2.2	0.0	0.0	4.7	0.5	0.5	0.9	0.0	0.0	1.7	0.0	0.1	2.0	0.0	0.0	0.7	0.1	0.6	0.2	1.9	0.2	0.3	1.4	0.7	0.0	6.6	0.2	1.8	0.0	0.0	1.2	1.0	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	101.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 16.4"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 2.1;granulocytes: 1.1;Spermatocytes: 1.0"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.9;BJ hTERT+: 5.0;GAMG: 8.7;HHSteC: 5.5;HSkMC: 13.7;U-87 MG: 6.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA015648	Uncertain				"Secreted to blood"	NA	NA					"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	1.3	0.2	0.6	0.2	1.9	0.2	0.9	0.2	1.3	0.7	2.3	0.1	1.0	0.1	0.9	0.2	0.2	0.2	0.5	0.9	0.3	0.1	0.8	0.1	3.3	0.1	0.7	0.0	0.4	0.1	0.1	4.1	0.2	0.6	1.6	0.2	0.5	16.4	2.4	0.2	0.2	0.1	1.1	1.0	0.1	0.3	0.7	0.0	1.0	0.5	1.1	0.1	0.5	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	16.9	0.1	2.6	5.0	0.4	0.9	0.0	0.0	0.0	0.0	4.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	13.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.2	0.0	0.1	0.6	1.9	0.2	1.3	0.3	0.1	0.7	0.0	0.6	0.0	0.0	2.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.1
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.4	2.9	1.9	0.0	1.7	1.5	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	15.4	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20666664-20679245	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 13.3;seminal vesicle: 22.0"	"Cell type enhanced"	"Detected in some"	7	"Alveolar cells type 1: 6.0;Cardiomyocytes: 6.2;Club cells: 5.7;Collecting duct cells: 5.2;Hepatocytes: 6.2;Horizontal cells: 4.8;Proximal tubular cells: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	8	"B-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.6;Hep G2: 6.3;RT4: 12.2;SH-SY5Y: 5.0"	"Region enhanced"	"Detected in single"		"amygdala: 0.3"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.3	0.3	0.4	1.5	0.5	0.0	0.2	0.5	1.3	13.3	0.4	0.2	4.7	0.0	6.8	3.1	0.9	0.6	1.8	2.4	0.2	0.2	3.3	7.2	0.5	3.1	2.9	0.9	0.4	0.8	0.0	0.6	2.3	0.4	3.6	0.0	2.4	1.1	22.0	0.6	1.5	1.5	1.0	0.2	3.2	0.7	0.7	1.2	0.2	0.2	0.0	1.5	1.6	6.0	2.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	1.9	12.2	0.0	5.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.5	0.5	1.3	0.2	0.2	2.9	0.9	0.4	1.2	6.0	0.0	0.5	0.5	0.0	0.2	6.2	0.0	1.4	5.7	5.2	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	6.2	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.2
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 6.6;testis: 11.1"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 3.9;Early spermatids: 10.3;Late spermatids: 4.0;Spermatocytes: 13.6"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069146	Supported				"Secreted in female reproductive system"	NA	NA					"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.1	0.7	1.3	0.1	1.9	0.1	1.1	0.4	1.1	0.4	0.2			0.4	0.3	6.6	0.1	1.1	0.1	0.1	1.0	1.4	1.5	0.7	0.1	0.5	1.1		0.6	1.0	1.4	2.0	0.1		0.7	0.3		1.0	0.6	0.6	1.4	0.3	0.1	0.8	0.4	0.8	11.1			1.4		0.4	0.7	0.1	0.1	0.8	1.2	0.6	0.0	1.1	0.3	0.4	0.4	1.1	2.3	1.7	0.7	0.4	0.0	0.2	0.4	0.3	0.8	1.8	0.6	1.5	0.2	2.1	0.5	0.9	1.0	0.4	0.8	1.7	1.1	0.9	0.3	0.4	0.2	0.1	0.8	1.3	0.1	0.8	0.2	0.0	8.8	0.2	2.8	0.6	0.6	1.5	1.7	0.4	0.2	0.2	1.4	0.1	0.4	0.7	0.5	2.1	2.0	0.4	0.3	1.1	1.7	1.1	0.3	0.2	2.1	0.9	0.4	0.3	3.0	3.6	0.2	0.5	0.4	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.8	0.1	0.8	0.1	1.2	0.0	0.6	0.0	0.0	0.3											0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.4	3.3	0.0	10.3	0.0	0.4	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.6	0.3	4.0	0.6	0.0	0.0	0.0	0.5	1.2	0.1	0.0	0.4	0.2	0.9	0.0	0.0	13.6	1.1	0.1	0.6	0.0	0.5	0.1
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37839686	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in single"	9	"Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Low region specificity"	"Detected in many"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	1.9	0.3	0.6	1.9	2.3	0.0	0.4	14.1	1.3	0.8	9.4	0.4	0.4	1.6	1.7	3.4	1.0	0.9	0.9	0.9	0.6	0.4	1.0	0.7	0.4	0.4	0.6	1.2	4.5	0.4	0.0	0.4	6.3	1.4	1.6	3.1	1.1	0.4	6.3	12.4	1.4	2.5	2.5	0.5	0.4	1.9	3.9	2.4	0.4	0.4	1.5	0.4	0.6	1.1	0.8	0.4	1.2	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	3.4	2.1	0.6	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.0	1.0	0.1	25.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.7	7.8	0.0	0.0	0.0	3.4	0.0	0.8	3.9	2.3	0.0	0.0	7.6	0.0	27.5	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.8	0.2	0.4	1.2	0.9	0.2	0.4	0.1	0.0	0.6	2.3	14.1	1.3	0.6	0.4	0.6	1.2	1.4	2.4	0.0	0.0	0.0	0.0	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.6	0.0	0.8	0.3	0.1	0.0	0.0	0.5
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HEL: 18.8;HMC-1: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.4	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	10.2	10.6	0.7	0.6	6.6	2.0	3.2	0.4	0.7	3.8	18.8	3.9	3.9	1.5	5.4	29.1	0.6	2.5	1.0	2.8	1.6	5.7	2.7	0.6	0.9	0.8	2.4	1.2	3.3	1.0	2.5	2.2	4.1	1.4	5.2	0.3	1.4	3.5	0.6	2.5	0.4	2.4	1.4	0.6	0.5	7.7	0.9	2.0	2.2	3.3	8.5	4.8	12.2	0.8	3.2	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1	0.0	2.6	12.7	4.9	18.0	38.9	87.7	12.7	12.0	0.0	0.0	0.0	0.4	0.0	4.3	0.0	36.2	13.5	46.7	2.7	27.6	5.8	2.3	4.6	16.8	2.4	1.6	8.1	33.2	15.8	0.0	2.3	10.4	11.8	0.0	11.8	2.0	18.1	31.7	1.1	0.5	3.0	12.9	20.8	0.0	1.7	19.6	0.6	34.8	3.3	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.2	9.3	19.2	9.5	7.1	11.0	7.8	10.1	14.6	15.0	12.9	8.6	15.8	7.3	9.0	7.8	11.8	9.6	9.0	12.4	9.4	11.8	4.0	8.1	18.3	7.2	6.5	7.8	5.9	10.4	19.3	5.8	7.2	21.0	16.2	8.2	3.1	8.1	19.9	10.6	7.8	12.6	5.6	8.3	17.0	5.5	12.2	8.9	13.3	19.1	11.2	19.3	6.5	5.9	5.7	9.9	4.3	16.1	11.4	11.4	10.1	7.7	8.0	11.3	17.2	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1	0.0	5.9	5.4	11.8	20.4	12.7	3.7	20.4	20.1	10.3	10.4	13.7	8.1	5.0	17.9	77.4	35.6	18.8	0.0	10.2	17.9	10.3	10.3	4.6	39.5	5.8	20.6	41.5	26.4	6.3	21.4	8.1	4.7	8.5	3.6	15.0	11.3	13.3	18.2	10.6	10.1	9.9	6.5	12.3	14.2	17.9	23.8	18.5	10.2	15.6	15.5
GH1	"GH, GH-N, GHN, hGH-N"	ENSG00000259384	"Growth hormone 1"	P01241	17	63917200-63918838	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 994.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1;T-reg: 2.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.1;T-cells: 2.2"	"Cell line enriched"	"Detected in some"	5	"U-698: 7.6"									HPA043715	Supported				"Secreted to blood"	NA	NA	2690000	180000			"HPA043715: AB_2678632"	"unprognostic (1.91e-2)"							"unprognostic (3.51e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.45e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.03e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.33e-1)"		0.3	0.0	0.0	0.5	0.0	1.1	0.2	0.1	0.1	0.4	0.4	0.0	0.0	3.3	1.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.0	0.3	994.5	217.7	0.1	0.2	0.5	0.0	0.1	0.2	0.8	0.9	0.4	0.1	0.0	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.6	7.6	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881935	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	309	"pituitary gland: 47.3;placenta: 138.4"	"Group enriched"	"Detected in some"	22	"Extravillous trophoblasts: 7.9;Syncytiotrophoblasts: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BEWO: 13.7"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"															"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	138.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	19.8	0.0	0.0	0.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HSkMC: 13.6;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.1	2.1	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.6	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.6	4.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.4	34.7	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.6	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2	0.0	0.3	0.0	2.8	4.1	0.6	13.6	2.5	0.0	0.0	1.8	0.0	8.6	1.7	0.0	3.3	2.9	0.0	0.0	0.2	0.9	9.3	3.5	0.0	103.6	1.6	0.0	2.9	4.9	1.9	1.8	17.3	0.3	1.7	0.0	2.0	0.8	0.2	0.0	11.3	8.8	0.2	12.9	4.4	0.0	0.3	3.1	33.6	0.0	1.5	0.9
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251082-37261835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.3"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 1.1"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	15	"hypothalamus: 37.3"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.6;U-266/84: 12.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 38.7"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.1	2.7	0.3	0.1	2.4	0.0	0.6	0.1	1.0	0.1	4.0	0.1	0.1	8.1	0.1	0.1	0.7	0.0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0.0	0.7	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	1.0	0.1	37.3	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285675-10292947	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;stomach 1: 64.9"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 8.2;Bipolar cells: 7.7;Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.2;classical monocyte: 6.0;eosinophil: 6.0;myeloid DC: 21.8;neutrophil: 13.5;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 21.8;granulocytes: 13.5;monocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	69000			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	1.2	0.6	1.8	4.2	1.7	1.5	0.6	0.7	1.5	0.6	1.2	1.8	2.2	7.4	0.9	2.3	1.1	1.0	1.7	1.3	1.6	0.7	0.8	0.8	1.8	14.5	0.9	0.4	1.0	1.7	0.2	0.8	0.2	1.1	1.2	0.2	0.7	3.2	0.1	0.7	0.8	1.4	0.3	0.9	4.9	64.9	0.7	1.3	1.7	1.2	0.0	4.3	0.7	0.5	0.8	21.8	13.5	6.0	2.1	0.1	2.0	0.7	0.3	3.0	2.3	2.2	0.0	5.5	2.8	0.0	0.8	0.2	3.2	0.6	1.6	1.0	0.1	2.4	0.4	0.0	0.7	0.0	0.5	3.3	3.4	1.8	6.8	0.0	3.5	6.1	0.4	0.0	0.1	0.1	0.2	0.6	2.1	1.4	16.6	0.0	0.7	1.3	4.8	1.5	0.5	6.0	0.9	0.3	0.9	0.0	3.6	2.1	0.3	1.8	1.2	0.1	2.1	1.7	4.2	2.9	1.4	0.9	1.3	1.8	2.0	2.8	3.5	0.5	3.9	0.6	6.2	6.0	6.0	0.1	2.8	0.0	0.8	0.1	0.0	21.8	0.5	0.1	0.0	13.5	2.1	0.2	15.0	0.1	2.0	1.8	1.7	0.7	1.5	1.6	0.7	0.9	0.4	1.1	1.3	0.0	1.4	8.2	3.3	1.1	7.7	0.0	0.0	0.0	0.0	1.8	9.8	1.3	0.0	1.0	0.2	1.1	0.0	0.0	1.2	1.0	1.0	2.1	0.0	0.0	1.5	3.2	0.0	0.6	2.8	0.4	0.3	7.1	1.7	4.6	0.0	2.9	0.6	0.0	0.4	0.0	5.4	6.5	1.2	1.2	0.8	0.5	0.2	5.2	0.6	1.7
GIF	"IF, IFMH, INF, TCN3"	ENSG00000134812	"Gastric intrinsic factor"	P27352	11	59829268-59845501	"Disease related genes, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"stomach 1: 185.6"	"Cell type enriched"	"Detected in single"	108	"Exocrine glandular cells: 10.8"	"Cancer enriched"	"Detected in some"	11	"stomach cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039908, HPA040774"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA039908: AB_10796335, HPA040774: AB_10795626"			"unprognostic (2.78e-4)"								"unprognostic (1.04e-1)"		"unprognostic (2.45e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	7.1	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	185.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"intestine: 87.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 8.8;BEWO: 8.0;Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900				"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	87.5	0.0	0.0	75.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	61.7	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.4	0.7	8.0	0.4	0.0	0.1	0.0	2.2	0.9	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	1.3	0.0	1.5	12.6	0.1	0.0	0.1	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980974	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"stomach 1: 918.9"	"Cell type enriched"	"Detected in some"	61	"Pancreatic endocrine cells: 201.5"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		26000000			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.4	0.0	2.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	918.9	0.0	0.0	1.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.0	13.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GKN2	"blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465"	ENSG00000183607	"Gastrokine 2"	Q86XP6	2	68945232-68952970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"stomach 1: 311.1"	"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 107.2;Alveolar cells type 2: 78.7;Club cells: 30.7;Pancreatic endocrine cells: 70.5"	"Cancer enriched"	"Detected in some"	8	"stomach cancer: 43.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;HaCaT: 2.0;HMC-1: 3.7;MOLT-4: 2.8;NTERA-2: 4.2;PC-3: 7.9;U-2 OS: 3.1;U-266/70: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057765	Enhanced				"Secreted to digestive system"	NA	NA					"HPA057765: AB_2683520"								"unprognostic (1.81e-1)"			"unprognostic (1.44e-4)"			"unprognostic (2.22e-1)"				0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.0	0.1	0.1	0.2	0.0	1.4	0.1	0.1	0.0	0.1	0.1	38.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	311.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.2	0.0	7.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.1	0.3	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	107.2	78.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	70.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 158.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	6.0	0.6	3.3	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.1	19.6	0.0	6.5	0.0	2.7	20.7	9.9	0.1	0.0	0.0	9.4	0.0	2.6	0.2	0.9	0.0	11.4	0.1	0.3	0.0	0.0	0.0	0.0	3.0	9.9	0.0	0.0	5.8	1.6	1.1	1.8	47.6	7.2	0.0	0.0	0.5	5.6	4.3	14.0	5.2	4.4	5.6	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0.0	2.6	0.0	4.2	1.9	6.1	1.0	2.5	8.1	3.4	0.0	39.3	0.2	0.0	2.0	1.7	0.6	9.7	0.0	2.1	0.9	1.5	7.6	0.0	0.0	0.2	4.8	8.6	0.0	0.0	4.9	1.1	0.0	5.0	0.0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0.0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6
GLDN	"CLOM, COLM, colmedin, CRG-L2, UNC-112"	ENSG00000186417	Gliomedin	Q6ZMI3	15	51341629-51408013	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3"	"Group enriched"	"Detected in many"	4	"Paneth cells: 30.0;Syncytiotrophoblasts: 84.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 5.7;SuSa: 3.9;U-266/70: 6.8;U-266/84: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059441	Uncertain				"Secreted to extracellular matrix"	NA	NA		190000			"HPA059441: AB_2684018"	"unprognostic (5.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.15e-5)"	"unprognostic (3.21e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.07e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.37e-1)"	16.6	3.3	8.1	2.9	22.8	1.5	5.2	1.8	22.7	2.3	5.7	42.8	0.0	0.9	0.9	1.4	1.2	1.5	5.5	7.7	14.2	8.3	0.9	0.7	10.4	0.7	43.3	10.1	0.7	1.1	1.1	0.6	16.0	20.1	1.6	10.3	1.3	1.1	1.6	1.0	4.5	1.0	1.4	26.8	2.6	3.8	0.7	25.4	0.0	0.8	0.8	0.8	2.4	1.0	0.1	1.9	1.0	0.8	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.3	0.1	1.4	0.0	0.0	0.1	0.6	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	5.7	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.6	0.3	0.0	0.2	1.0	1.7	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.0	2.1	0.0	3.9	0.0	1.1	0.0	0.0	0.0	0.3	0.0	6.8	5.5	0.0	0.8	0.0	0.0	1.0	0.2	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.4	0.1	0.8	1.9	0.1	0.0	8.1	22.8	1.8	12.4	14.2	8.3	43.3	10.1	20.1	25.4	0.0	1.6	0.0	0.0	5.6	1.2	3.0	0.0	1.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.5	2.3	0.1	0.0	0.0	5.1	0.0	1.2	0.0	13.7	0.0	0.3	8.1	3.3	0.0	1.6	0.3	0.1	30.0	0.0	0.0	0.8	0.0	4.4	0.0	0.0	3.4	84.0	0.0	3.1	0.5
GLIPR1L1	MGC26856	ENSG00000173401	"GLIPR1 like 1"	Q6UWM5	12	75334639-75370560	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 45.6"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 154.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 50.2"					"Low region specificity"	"Detected in all"			HPA042095	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA042095: AB_10796898"	"unprognostic (2.45e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.11e-2)"	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.4	0.8	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.5	0.1	0.5	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.4	0.1	0.2	0.8	0.1	0.1	0.1	0.2	0.2	45.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.4	1.5	0.4	1.7	0.5	1.5	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	50.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	7.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.4	1.5	0.4	0.8	1.3	1.1	0.3	0.2	2.4	0.5	0.9	0.0	0.5	1.7	1.5	0.6	0.4	0.1	0.1	0.4	0.8	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.3	4.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.1	0.3	6.5	0.0	12.1	1.8	0.0	0.0	0.0	0.0	0.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Group enriched"	"Detected in some"	6	"MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.3	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3	0.0	0.0	0.5	0.0	0.8	0.4	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.5	0.0	0.0	1.8	11.4	34.0	0.3	1.7	1.7	0.0	0.0	9.8	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.6	0.2	0.3	0.1	0.0	0.0	0.0
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 65.2;Proximal tubular cells: 128.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	11.8	0.9	1.2	1.3	0.0	0.4	2.3	0.0	0.1	0.0	2.2	1.8	0.1	1.0	15.5	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.7	0.6	0.0	5.4	0.2	0.2	0.3	0.6	1.0	0.9	0.6	0.3	0.0	0.9	1.6	1.0	2.2	0.4	0.6	0.1	1.4	0.1	2.5	0.8	1.0	0.5	0.4	0.2	0.6	0.1	0.3	0.7	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.3	0.0	65.2	0.1	0.0	0.0	1.8	1.3	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	128.9	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.5
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698854	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 444.6"	"Cell type enhanced"	"Detected in many"	26	"Alveolar cells type 2: 120.7;Melanocytes: 75.9;T-cells: 467.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 226.1;NK-cell: 444.6"	"Group enriched"	"Detected in many"	55	"NK-cells: 444.6;T-cells: 226.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;JURKAT: 1.5;NB-4: 3.4;SuSa: 1.4;U-2197: 2.0;U-87 MG: 2.5"									"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000				"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	7.1	1.0	2.1	3.5	2.3	72.0	3.3	1.2	2.0	1.7	2.4	5.8	0.0	1.2	31.5	2.2	4.4	2.0	2.1	4.0	2.3	3.2	1.8	5.7	20.8	10.7	3.8	0.8	1.0	0.6	0.1	1.4	45.2	3.6	3.2	2.1	4.9	2.6	1.9	5.7	0.8	12.4	1.4	4.2	34.3	1.5	0.7	1.8	2.0	2.4	3.9	5.9	2.3	1.6	0.8	1.5	6.1	0.8	444.6	226.1	175.3	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.5	0.7	0.0	1.5	0.3	0.8	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	2.0	0.0	0.3	0.1	0.0	2.5	0.6	0.0	4.0	0.7	0.4	226.1	0.6	61.2	0.8	26.0	96.4	0.6	0.5	7.4	89.8	6.1	444.6	0.8	1.5	1.0	175.3	2.1	2.3	1.2	2.0	2.3	3.2	3.8	0.8	3.6	1.8	11.9	120.7	9.9	0.3	6.3	0.0	1.6	0.0	6.7	11.4	0.0	2.0	1.0	1.7	0.0	0.0	9.8	1.3	70.0	0.0	1.3	3.2	0.1	48.8	1.5	5.5	0.0	1.7	14.7	5.7	0.0	0.3	5.7	75.9	0.0	0.3	0.0	0.0	0.0	0.0	7.2	0.1	0.0	3.1	0.2	0.2	6.8	0.9	467.7	0.2	0.5
GNRH1	"GNRH, GRH, LHRH"	ENSG00000147437	"Gonadotropin releasing hormone 1"	P01148	8	25419260-25424654	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 9.2;Peritubular cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.5;cerebellum: 6.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 20.8;hypothalamus: 14.2;olfactory region: 8.3"	"Group enriched"	"Detected in some"	30	"basal ganglia: 21.7;hypothalamus: 66.0"	HPA027532	Supported				"Secreted to blood"	NA	NA					"HPA027532: AB_10612111"	"unprognostic (6.49e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.53e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.08e-9)"	"unprognostic (7.98e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.68e-2)"	2.0	1.3	1.7	1.7	23.5	3.6	5.0	6.9	2.3	2.4	2.6	2.1	1.7	2.6	2.5	6.7	2.3	1.9	2.8	2.3	1.7	3.7	2.3	1.7	2.7	2.8	1.7	1.7	4.3	2.8	0.8	2.0	1.9	1.7	3.6	2.5	1.7	3.3	2.4	4.0	12.6	2.9	1.7	1.7	3.1	1.5	1.7	3.2	1.7	1.8	1.7	2.3	1.7	3.9	0.9	1.1	1.7	0.3	0.2	1.9	0.1	1.0	1.7	4.6	2.5	1.6	5.4	2.0	4.0	1.6	1.3	1.9	1.7	1.2	1.3	0.9	2.4	2.9	4.1	1.4	0.3	3.0	1.8	2.4	1.5	6.1	1.8	1.3	0.3	1.5	3.1	2.4	0.9	0.8	4.1	1.0	1.4	1.7	1.3	2.1	0.7	1.5	3.1	1.6	1.4	0.5	1.0	0.6	0.6	1.2	0.7	21.5	0.8	1.1	0.8	1.4	1.8	0.9	1.9	3.8	3.6	1.7	4.1	1.5	0.2	0.3	2.0	1.7	1.1	1.6	0.0	0.0	0.0	1.9	0.1	0.8	0.3	0.2	0.6	0.1	0.9	0.4	0.3	1.7	0.2	0.3	1.1	1.6	0.1	1.7	23.5	6.9	2.3	1.7	3.7	1.7	1.7	1.7	3.2	0.0	0.3	0.0	1.7	4.4	2.8	1.8	0.0	0.0	1.2	3.5	3.9	0.1	0.0	0.2	0.3	1.1	1.6	0.0	0.6	0.2	3.1	3.3	0.0	0.2	0.4	0.0	1.7	1.8	0.3	0.0	9.2	0.2	3.3	0.0	0.6	0.5	0.5	0.0	9.2	0.0	4.5	0.0	1.0	1.9	1.1	2.0	0.1	1.0	1.4	1.3
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 10.2"	"Cell type enriched"	"Detected in single"	7	"Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 7.5"									HPA004338	Uncertain				"Secreted to blood"	NA	NA					"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2.0	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1.0	1.6	2.0	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	3.2	4.0	2.0	0.5	0.6	0.8	0.0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	1.2	3.3	1.3	1.1	0.9	1.2	3.6	1.3	1.1	2.5	0.0	0.2	2.2	2.5	2.6	2.5	0.0	0.4	0.8	2.6	1.5	0.5	1.3	1.1	0.8	2.5	1.4	0.0	0.0	0.9	0.4	0.8	0.5	2.8	4.5	2.1	0.2	2.7	1.5	1.5	2.9	1.4	0.0	1.9	0.9	1.6	1.8	1.1	7.5	1.0	1.7	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone alpha 2"	Q96T91	11	64934471-64935888	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 98.0"	"Cell type enhanced"	"Detected in some"	28	"Exocrine glandular cells: 15.7;Pancreatic endocrine cells: 3.7;Spermatocytes: 4.7;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067068			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.7	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.7	98.0	0.0	15.1	0.1	0.2	0.7	0.0	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	4.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	21.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.4	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.1
GPHB5	"GPB5, ZLUT1"	ENSG00000179600	"Glycoprotein hormone beta 5"	Q86YW7	14	63312835-63318879	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	4	"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 17.5;Cone photoreceptor cells: 64.8;Hepatocytes: 55.7"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;U-698: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.9	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.4	0.1	10.5	1.2	0.2	0.3	0.0	1.7	0.3	0.2	1.3	3.5	1.5	1.4	4.4	0.0	1.8	0.2	0.1	0.2	0.1	0.0	1.2	0.0	2.6	0.7	0.5	0.3	0.7	1.0	0.6	4.0	0.7	0.5	2.0	0.3	0.1	0.4	5.2	3.3	3.5	1.1	0.1	0.5	0.9	0.5	0.5	0.1	1.3	1.3	0.1	1.4	3.1	4.8	10.7	0.2	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6	0.0	3.0	0.0	0.4	0.0	17.5	10.1	0.0	1.4	2.3	1.8	64.8	0.2	0.0	0.3	3.0	1.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	55.7	0.1	14.3	1.7	0.6	1.3	2.3	2.8	0.0	0.0	0.0	0.3	4.3	0.1	0.0	3.2	0.3	10.5	0.0	0.5	0.5	5.3	0.5	0.0	0.0	0.4	2.2
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 3198.5;Proximal tubular cells: 9534.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 427.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	427.5	0.3	0.4	0.1	0.0	0.4	0.1	9.1	0.2	0.0	11.7	0.2	0.1	0.1	2.1	23.0	0.3	0.3	0.1	0.0	0.2	9.9	16.4	0.0	0.2	36.1	2.2	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	4.0	0.2	0.6	0.6	0.0	1.7	0.1	1.9	2.3	0.1	0.1	0.1	1.0	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2	8.9	50.9	26.2	69.3	16.5	21.7	621.6	15.3	28.1	26.1	615.9	41.2	663.5	1502.1	3.9	2.4	100.8	0.7	0.0	42.8	818.8	102.8	81.4	10.5	137.7	137.1	15.9	43.8	697.9	65.5	7.5	413.6	35.5	21.9	1.0	5.6	3198.5	11.1	7.0	38.5	9534.8	68.9	672.6	191.9	3.8	10.7	18.9	1478.3	13.8	0.6	29.7
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	32	"Early spermatids: 10.4;Late spermatids: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.5;Late spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.6"	"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.8;HEL: 21.0;REH: 25.0;RPMI-8226: 42.2;THP-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.2	11.5	2.3	6.7	0.0	4.2	0.2	5.1	5.3	4.0	0.0	0.0	3.4	22.8	0.0	0.0	9.8	0.0	2.8	0.0	0.0	21.0	1.2	3.7	8.4	0.0	0.0	15.5	0.0	0.8	0.0	0.0	7.7	0.1	0.0	0.0	9.5	0.0	1.0	10.9	10.7	0.0	0.0	25.0	0.0	42.2	0.4	0.0	4.7	9.3	11.1	0.0	7.2	1.0	0.0	33.4	0.4	0.0	1.3	1.3	0.0	0.0	0.0	15.6	0.0	0.0	3.8	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2	3.0	5.6	19.2	9.6	1.9	0.9	3.7	10.2	10.7	9.1	3.5	0.0	18.6	5.0	11.2	5.0	4.4	0.0	0.0	13.7	18.3	24.5	4.9	1.1	3.4	10.3	4.8	1.2	20.9	1.8	4.9	14.1	5.2	6.8	4.6	0.7	7.7	6.1	0.0	12.7	2.6	0.5	12.9	4.1	10.0	8.1	2.9	13.0	7.9	0.0	3.3
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32717974-32745107	"Disease related genes, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 66.8;smooth muscle: 42.5"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 62.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 32.8;BJ hTERT+: 50.3;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 100.9;hTEC/SVTERT24-B: 31.6"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.6;olfactory region: 13.4"	"Low region specificity"	"Detected in single"			HPA007526	Uncertain				"Secreted to blood"	NA	NA	242000000				"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	14.9	1.2	3.1	23.1	10.2	1.1	11.7	0.8	5.6	31.3	15.2	6.6	1.1	2.6	5.1	1.0	15.4	1.0	66.8	1.1	4.4	2.0	1.2	1.5	1.2	8.0	6.6	6.4	1.0	1.5	1.0	0.2	1.1	5.5	6.4	15.2	0.0	1.0	5.1	2.4	4.1	24.4	42.5	4.8	1.3	23.7	1.1	9.3	0.0	1.4	2.2	2.3	27.3	32.2	0.4	0.5	1.4	0.4	0.7	0.3	0.0	0.0	0.5	0.0	0.0	1.3	1.7	0.0	32.8	50.3	12.4	31.6	0.0	0.0	0.0	0.0	100.9	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	31.6	0.0	7.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.7	0.4	0.5	0.2	0.0	3.1	10.2	0.8	5.6	4.4	2.0	6.6	6.4	5.5	9.3	0.0	0.0	0.0	6.2	6.0	1.9	2.6	0.0	0.0	0.0	62.8	2.0	0.1	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	2.8	8.5	0.0	1.0	1.0	1.6	0.0	0.6	0.3	0.0	0.0	0.0	3.3	4.6	0.1	0.2	0.2	0.0	0.4	0.3	0.5	0.0	4.7	0.0	0.2	4.0	0.2	1.0	0.0	6.3
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612149	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 90.3;parathyroid gland: 31.4"	"Cell type enriched"	"Detected in many"	14	"Syncytiotrophoblasts: 249.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2;memory CD4 T-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 26.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"	NA	NA					"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.6	0.9	3.0	9.5	4.5	0.0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3.0	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0.0	0.7	3.0	4.1	2.2	0.7	0.0	0.0	0.5	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	1.6	2.1	0.0	5.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	2.5	1.1	0.0	0.0	3.3	0.4	0.7	0.3	0.9	0.0	0.0	2.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	2.5	1.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.2	3.0	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3.0	0.9	0.0	0.0	0.0	0.0	4.1	17.3	0.3	0.0	1.4	0.0	0.0	11.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.0	10.5	1.5	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.1	0.0	4.2	0.0	6.1	0.0	2.2	0.4	0.4	3.1	249.2	0.0	0.0	0.1
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345086-44353102	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 1368.6;Kupffer cells: 737.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 138.4;intermediate monocyte: 80.4;myeloid DC: 109.8;neutrophil: 61.8;non-classical monocyte: 36.4;plasmacytoid DC: 95.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 109.8;granulocytes: 61.8;monocytes: 138.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA		91000000	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	66.8	27.1	8.2	31.2	10.2	76.4	30.1	5.2	13.9	29.1	45.0	16.6	46.2	23.2	29.8	76.5	104.7	18.8	51.4	46.9	7.8	9.5	39.3	43.2	74.9	81.1	10.5	9.3	20.7	21.6	11.6	18.0	116.4	11.4	28.7	25.1	23.8	54.5	42.1	15.2	37.3	42.9	21.1	13.4	76.3	25.6	21.0	9.7	23.5	31.4	46.3	52.1	34.8	38.5	13.0	109.8	61.8	138.4	2.1	3.8	83.8	17.2	28.1	8.6	23.1	70.2	37.0	26.3	21.1	67.3	34.8	46.3	12.2	42.4	50.8	45.3	34.1	49.1	26.8	12.3	49.3	15.8	8.3	26.4	5.4	14.8	25.6	35.6	8.8	71.7	48.9	65.5	29.0	19.1	68.3	39.6	9.4	10.3	7.6	23.6	25.5	5.0	25.3	6.5	16.8	47.5	14.2	26.8	59.8	38.9	20.5	8.2	10.9	28.3	13.4	52.0	30.9	30.4	33.2	47.5	65.3	15.7	44.6	14.5	17.0	46.2	17.3	39.4	20.8	18.0	12.5	138.4	11.9	2.7	80.4	2.1	13.0	2.9	2.4	109.8	8.2	2.2	2.1	61.8	2.1	36.4	95.5	3.8	83.8	8.2	10.2	5.2	13.9	7.8	9.5	10.5	9.3	11.4	9.7	80.4	76.5	96.8	125.1	100.1	22.2	74.9	117.2	30.8	66.0	207.6	17.7	350.9	8.3	337.2	1.7	134.9	311.0	0.0	271.0	268.0	137.7	79.7	74.9	71.0	1368.6	44.5	119.5	213.0	737.0	3.4	56.4	553.1	197.4	402.2	200.3	69.2	249.3	496.5	53.7	96.2	10.8	84.1	74.3	9.6	45.1	84.3	535.3	32.4	196.1	159.2
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220168-59230774	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.6;pituitary gland: 13.2;retina: 22.5"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 8.5;Glandular cells: 6.6;Late spermatids: 9.9;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BJ hTERT+: 8.6;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8"						"Secreted to blood"	NA	NA	340000					"unprognostic (3.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.01e-3)"		"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.86e-4)"	"unprognostic (2.65e-4)"	"unprognostic (9.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.16e-2)"	0.7	0.7	3.6	0.5	0.7	0.2	5.2	0.5	3.7	0.5	2.3	1.3	0.0	0.4	0.9	0.9	0.6	0.3	1.3	0.2	11.7	5.6	0.3	0.2	15.6	0.2	4.9	0.7	0.2	4.7	4.7	13.2	0.2	10.5	1.9	0.4	22.5	0.2	0.5	0.2	0.4	0.7	2.3	1.6	0.3	12.7	3.0	0.1	0.1	11.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	0.7	0.0	10.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.5	3.7	11.7	5.6	4.9	0.7	10.5	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 1444.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 171.2;HaCaT: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	510000000000	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	187.8	23.1	14.1	23.7	21.4	26.6	186.2	7.3	20.0	81.9	69.6	53.7	48.0	22.3	88.1	64.7	99.6	57.8	59.6	235.1	17.6	11.9	14.8	3.9	30.6	12.9	42.8	16.5	40.8	20.4	7.4	25.7	17.5	33.4	74.0	29.0	83.0	44.8	63.2	48.1	55.6	32.7	154.8	33.4	12.4	45.0	32.5	29.9	5.6	67.7	46.4	20.9	113.5	109.0	2.2	43.3	133.9	15.2	24.4	0.4	11.8	6.0	8.2	6.0	17.3	171.2	56.3	3.9	20.0	44.1	4.8	9.8	8.3	17.9	0.4	5.4	26.3	7.4	68.0	0.4	13.7	2.8	1.1	1.1	4.8	7.6	18.8	4.7	1.1	23.4	21.0	13.1	8.0	5.1	13.1	17.4	0.8	1.4	0.6	21.5	10.7	0.0	35.1	2.0	11.0	6.4	1.1	2.0	0.5	22.7	9.2	0.9	1.5	9.0	9.8	26.2	12.7	38.6	21.3	31.6	14.0	4.9	1.3	1.9	0.2	0.2	0.4	15.5	2.3	38.5	30.2	15.2	133.9	0.2	10.2	0.1	2.2	0.1	0.1	43.3	0.6	0.0	0.0	37.0	24.4	2.6	28.7	0.4	11.8	14.1	21.4	7.3	20.0	17.6	11.9	42.8	16.5	33.4	29.9	137.0	60.9	14.2	278.6	303.1	7.0	213.2	89.2	178.0	84.2	115.1	72.6	38.7	89.5	187.0	7.8	643.0	116.7	0.0	181.3	83.9	1444.1	71.1	102.6	18.7	489.5	1.6	60.6	248.6	117.0	8.4	545.1	370.4	509.5	819.7	545.7	186.0	216.7	466.4	631.5	19.2	78.1	601.5	596.4	7.0	11.7	261.3	70.3	27.7	39.3	112.7
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Group enriched"	"Detected in some"	16	"Enterocytes: 4125.7;Paneth cells: 4082.4"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 34.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018215	Enhanced				"Secreted to blood"	NA	NA		26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	4125.7	0.0	1.0	2.7	0.0	0.0	23.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	263.8	0.0	0.1	4082.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	76.4	0.1
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	27	"Enterocytes: 716.3;Paneth cells: 2864.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	9.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	716.3	0.0	43.1	0.1	0.0	0.0	23.0	2.6	0.1	0.0	21.9	0.6	0.0	1.1	0.0	0.0	0.0	0.0	67.1	0.0	3.8	2864.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	33.2	0.0
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102648-55110252	"Enzymes, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9"	"Cell type enriched"	"Detected in many"	28	"T-cells: 796.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"gdT-cell: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9"	"Group enriched"	"Detected in many"	38	"NK-cells: 61.9;T-cells: 92.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.4;JURKAT: 6.3;REH: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA					"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	4.3	1.8	1.1	16.3	1.2	10.0	2.5	0.7	0.8	3.9	12.5	0.9	1.3	10.3	5.2	2.9	2.9	2.9	9.6	4.5	1.1	1.1	4.6	5.2	11.8	20.3	1.7	0.9	3.0	5.8	0.0	1.9	5.8	1.5	3.4	6.3	4.5	5.1	1.3	2.6	1.2	31.0	2.5	2.6	40.9	3.9	1.1	0.6	1.9	3.1	4.2	11.1	6.6	2.9	0.2	0.2	2.0	0.3	61.9	92.3	52.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	92.3	0.2	90.8	0.2	25.4	89.3	0.2	0.1	5.2	50.5	2.0	61.9	0.3	0.2	2.9	52.0	1.1	1.2	0.7	0.8	1.1	1.1	1.7	0.9	1.5	0.6	3.0	28.1	9.2	0.0	0.3	0.0	0.7	2.5	5.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.1	0.8	0.1	7.0	2.4	0.2	0.0	0.0	12.3	16.8	0.0	0.0	1.3	3.3	0.0	0.6	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	1.3	0.6	796.9	0.5	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"blood: 298.5"	"Cell type enriched"	"Detected in many"	4	"T-cells: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 298.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 298.5"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 21.2"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA					"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	6.4	0.7	0.8	8.0	1.1	26.4	3.2	0.7	0.7	1.6	3.0	0.5	1.3	0.8	3.9	1.5	4.0	1.0	3.1	4.8	0.7	2.4	2.1	5.7	21.7	16.7	1.1	0.0	1.4	0.7	0.0	1.0	7.5	0.8	2.6	0.9	4.0	2.7	2.3	3.5	0.6	2.9	1.8	1.5	33.0	3.5	0.9	0.4	6.1	4.4	5.3	16.8	6.0	1.5	0.2	298.5	2.0	0.2	19.9	60.5	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.9	0.3	0.1	0.2	60.5	0.1	0.7	0.2	4.6	28.4	0.2	0.1	1.4	28.7	2.0	19.9	0.2	298.5	0.1	53.6	0.8	1.1	0.7	0.7	0.7	2.4	1.1	0.0	0.8	0.4	6.0	57.5	21.4	0.2	2.5	0.0	0.4	0.0	8.1	13.6	0.0	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.2	16.3	1.1	0.2	0.0	0.0	3.1	2.1	0.0	0.0	5.5	40.5	0.0	0.0	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.5	0.0	0.0	3.6	0.2	243.7	0.2	0.1
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 134.9"	"Cell type enriched"	"Detected in some"	9	"T-cells: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 134.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;JURKAT: 1.8;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5"					"Low region specificity"	"Detected in many"			HPA029200	Enhanced				"Secreted to blood"	NA	NA					"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.6	3.1	1.1	5.0	1.2	16.5	3.6	0.5	1.0	1.9	3.1	0.4	0.2	0.9	1.0	2.7	2.6	1.8	8.1	4.8	1.0	1.1	1.7	3.6	16.4	11.5	2.6	1.3	3.0	1.1	0.0	3.7	1.6	1.2	4.5	1.1	5.1	5.4	4.2	4.5	0.8	2.2	2.0	3.1	22.6	2.5	2.5	0.7	0.2	2.5	3.4	6.4	5.1	1.9	0.4	3.2	1.8	0.3	17.6	134.9	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.4	0.9	1.8	0.2	0.1	134.9	0.2	2.4	0.4	41.8	109.7	0.2	0.2	13.9	102.7	1.5	17.6	0.3	3.2	0.3	82.9	1.1	1.2	0.5	1.0	1.0	1.1	2.6	1.3	1.2	0.7	0.0	5.8	3.0	0.0	1.0	0.0	0.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.8	0.1	0.0	0.0	9.2	2.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	1.6	0.0	79.8	0.0	0.0
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024253-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.8;lymphoid tissue: 37.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 95.8;memory CD8 T-cell: 59.0"	"Group enriched"	"Detected in many"	191	"NK-cells: 56.9;T-cells: 95.8"	"Cell line enriched"	"Detected in single"	10	"JURKAT: 5.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA					"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.5	1.6	0.6	10.5	0.6	3.6	3.1	0.5	0.5	4.1	3.7	0.2	1.7	0.4	3.2	2.6	2.8	1.8	7.4	1.6	0.6	0.7	4.3	4.1	10.2	37.3	0.7	0.2	2.1	1.5	0.0	1.0	0.9	0.5	6.6	1.9	2.9	5.7	2.1	0.8	0.8	7.4	0.8	1.6	36.4	2.4	2.1	0.3	3.3	3.1	2.7	28.2	4.9	2.6	0.0	0.1	0.4	0.1	56.9	95.8	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	21.1	0.1	95.8	0.0	13.2	59.0	0.0	0.0	0.6	10.5	0.4	56.9	0.1	0.1	0.8	9.9	0.6	0.6	0.5	0.5	0.6	0.7	0.7	0.2	0.5	0.3	3.0	12.4	0.0	0.0	1.3	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.0	0.2	0.0	0.0	8.0	8.7	0.2	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.2	137.0	0.0	0.0
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.2;lymphoid tissue: 28.6"	"Cell type enriched"	"Detected in some"	8	"T-cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.2"	"Group enriched"	"Detected in many"	31	"NK-cells: 22.7;T-cells: 79.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 3.7;HMC-1: 4.6;JURKAT: 7.5;MOLT-4: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015624	Enhanced				"Secreted to blood"	NA	NA					"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	1.8	1.0	0.7	13.6	0.9	15.6	1.0	4.3	1.4	1.0	3.5	0.2	0.1	1.8	1.0	2.9	2.0	1.1	4.7	1.6	0.7	0.6	1.1	2.6	4.8	15.1	0.7	0.4	0.8	0.4	0.0	0.9	1.6	0.5	1.7	0.1	1.5	12.0	0.3	0.8	0.7	5.1	0.5	1.1	21.1	3.0	1.5	0.4	28.6	1.4	1.1	10.9	1.1	1.2	0.4	0.4	1.6	0.2	22.7	79.2	27.0	0.1	0.6	0.1	0.3	0.2	0.0	0.6	0.0	0.1	0.1	0.0	0.5	0.2	0.1	4.6	0.0	0.1	0.1	0.0	0.0	0.0	3.7	0.4	0.0	0.6	0.2	0.5	0.4	4.6	0.2	0.0	0.1	0.0	0.0	0.1	7.5	1.4	0.3	0.0	1.0	3.0	1.3	0.8	0.2	0.7	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.7	0.8	0.0	0.9	0.3	1.0	0.3	0.7	0.3	0.8	0.1	0.1	79.2	0.2	49.8	0.1	26.4	63.6	0.1	0.4	25.8	53.1	1.6	22.7	0.2	0.4	12.2	27.0	0.7	0.9	4.3	1.4	0.7	0.6	0.7	0.4	0.5	0.4	0.0	0.0	0.8	0.0	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.4	0.0	23.3	0.3	0.3	1.9	0.0	0.0	0.8	0.2	0.0	0.0	2.5	2.8	0.8	0.0	1.6	1.7	0.0	0.1	1.5	0.2	0.0	0.0	0.7	1.4	0.0	0.2	0.1	0.7	1.3	0.5	184.9	0.0	0.1
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 135.4"	"Group enriched"	"Detected in some"	13	"Cholangiocytes: 122.3;Hepatocytes: 184.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 33.5;RPTEC TERT1: 27.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	3200000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.6	0.3	0.0	0.4	26.4	0.4	0.0	0.0	20.9	135.4	0.2	0.0	0.0	0.0	0.8	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.5	0.0	0.0	0.0	0.2	122.3	0.0	0.0	1.8	0.0	0.0	3.3	10.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	184.9	0.7	0.0	0.0	6.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.7	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 716.5"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 1549.8"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.5;plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 7.6"	"Cell line enriched"	"Detected in single"	229	"Hep G2: 69.9"					"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	3900000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10.0	1.8	0.3	716.5	0.4	1.0	4.2	0.0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0.0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4.0	0.0	0.3	0.0	1.0	0.4	0.0	0.5	7.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	1.8	10.8	0.2	4.4	10.0	1.8	4.2	0.0	6.7	4.0	0.0	0.0	9.3	0.9	0.5	0.0	1.1	30.6	0.0	1.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	23.3	82.0	0.9	0.5	5.2	69.8	1549.8	198.8	0.0	0.0	28.3	41.3	0.0	0.0	3.4	0.0	0.0	1.0	0.5	36.6	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	16.3	0.6	1.5	0.2	1.7
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.1	0.0	0.0	28.3	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	4.4	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619294-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"brain: 108.1"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 32.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"	NA	NA					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.5	11.0	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0.0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0.0	1.3	43.1	1.9	1.3	0.0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0.0	1.3	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	4.6	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5	0.0	0.0	0.0	0.0	0.1	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	32.3	7.6	0.7	1.9	0.0	0.0	0.0	0.0	0.1
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 899.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.0;U-2 OS: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.4	0.9	9.8	2.8	3.0	3.1	2.7	0.6	1.0	1.3	2.8	4.1	0.0	7.8	3.4	1.6	1.0	9.3	1.2	0.0	21.0	8.2	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	2.0	0.1	0.1	4.6	0.4	0.0	6.0	0.4	0.1	0.0	0.0	7.3	0.0	0.1	0.0	0.4	7.3	1.8	0.1	0.1	2.7	0.5	0.5	3.7	1.2	0.0	0.4	0.8	7.1	21.0	5.3	0.4	0.9	0.0	0.0	2.5	0.0	6.1	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8	0.0	4.3	0.9	6.0	28.4	2.6	7.7	0.0	1.4	5.7	1.8	9.8	5.6	0.0	5.7	0.0	18.6	0.0	0.0	1.8	899.6	9.3	3.9	1.1	0.0	17.6	0.0	0.0	3.1	0.0	0.0	0.9	2.9	16.9	16.2	0.2	2.4	8.7	0.0	0.7	0.1	108.4	12.9	38.9	0.5	1.7	21.1	17.0	3.2	0.2	6.8
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19255641-19262796	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 38.5;intestine: 24.3"	"Cell type enriched"	"Detected in single"	6	"Hepatocytes: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"	NA	NA					"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.5	1.9	3.0	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0.0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	5.7	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.5	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
HBEGF	"DTR, DTS, HEGFL"	ENSG00000113070	"Heparin binding EGF like growth factor"	Q99075	5	140332843-140346631	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Urothelial cells: 590.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.9;myeloid DC: 3.5;non-classical monocyte: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 23.2;JURKAT: 30.2;TIME: 25.2;U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053243	Uncertain				"Secreted to blood"	NA	NA	118000				"HPA053243: AB_2682086"	"unprognostic (3.64e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.44e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	31.1	7.0	5.5	18.0	7.5	17.0	22.4	6.8	5.8	8.1	11.1	13.0	5.7	2.6	12.1	13.8	25.3	6.3	32.8	24.3	7.7	6.2	6.9	5.6	36.0	2.7	10.5	4.2	6.5	4.1	4.6	7.3	8.9	8.1	7.8	9.1	6.7	7.0	6.4	14.3	9.8	8.2	20.6	14.1	3.4	13.7	6.4	8.4	1.2	8.5	27.6	13.4	18.2	10.3	0.7	3.5	0.1	4.9	0.0	0.3	0.4	8.2	0.6	1.2	3.0	0.6	0.2	1.0	8.0	3.1	15.2	12.6	4.7	9.0	0.1	6.4	1.9	5.3	2.6	1.5	13.6	23.2	0.4	1.4	0.1	1.7	0.6	0.4	0.5	0.4	0.3	17.2	16.7	6.7	4.5	7.6	30.2	0.0	1.3	3.2	0.5	0.7	3.8	1.1	3.3	2.2	1.4	4.9	0.2	9.4	1.1	0.4	0.4	2.3	0.3	2.7	9.0	0.5	2.1	25.2	8.7	7.3	2.7	17.9	0.1	0.6	33.9	11.0	4.0	11.2	0.0	0.8	0.0	0.0	4.9	0.0	0.7	0.1	0.0	3.5	0.0	0.3	0.1	0.1	0.0	3.4	0.6	0.0	0.4	5.5	7.5	6.8	5.8	7.7	6.2	10.5	4.2	8.1	8.4	205.4	73.7	0.9	536.0	190.6	1.8	73.4	12.7	17.4	61.4	10.4	0.0	2.2	0.0	42.2	0.5	52.6	189.4	0.0	9.6	1.6	18.8	102.7	20.8	1.9	65.1	4.8	84.7	16.0	33.7	0.0	0.3	85.3	30.4	1.8	54.7	6.0	53.3	73.7	0.7	0.4	0.3	0.0	21.2	1.6	5.3	109.4	2.2	0.7	56.1	590.9
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	31	"brain: 84.3"	"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 1.8;Intestinal endocrine cells: 2.9;Kupffer cells: 1.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;Karpas-707: 1.0;RPMI-8226: 3.7"	"Region enriched"	"Detected in some"	5	"hypothalamus: 110.5"	"Region enriched"	"Detected in some"	57	"hypothalamus: 152.0"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.9	0.0	0.0	1.1	0.2	0.9	0.0	0.0	0.7	0.0	0.5			1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.4	0.0	0.0	0.4	0.1		0.3	0.0	0.0	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.3			0.0		0.0	0.0	0.0	2.7	0.4	2.3	0.5	0.4	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.0	0.0	0.0	0.8	0.8	0.4	0.9	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.7	0.8	0.2	0.0	0.1	0.0	2.3	0.5	0.0	1.2	0.4	2.2	1.5	0.9	1.6	0.4	2.7	1.4	1.3	0.1	0.4	0.2	0.3	0.5	0.1											0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.9	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.7	0.1
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000				"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.7	45.8	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.8	20.1	0.1	10.8	0.0	22.5	0.0	0.0	0.5	0.0	0.0	62.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.4	4.2	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9	0.0	5.5	0.0	0.3	0.9	0.1	0.8	2.5	0.0	1.2	0.0	0.0	4.6	0.0	0.0	11.8	6.3	0.0	0.0	0.0	3.2	19.8	0.2	1.1	0.5	17.6	0.0	0.0	40.5	14.3	1.7	17.0	5.5	1.7	3.6	0.0	30.6	0.0	0.0	10.3	0.0	0.3	12.9	13.8	0.0	0.1	0.1	10.1	0.0	0.0	0.1
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Group enriched"	"Detected in some"	14	"Early spermatids: 70.8;Hepatocytes: 52.3;Late spermatids: 115.2"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.0	1.3	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.5	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	0.0	3.2	0.0	2.5	3.5	115.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.3	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646021-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;lung: 29.7"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 69.8;TIME: 80.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	4.0	5.2	9.9	1.7	22.2	2.3	1.1	2.3	16.0	3.4	6.5	31.5	0.0	5.5	4.1	8.1	1.0	1.2	3.0	1.1	16.0	6.3	2.4	12.7	29.7	1.0	21.6	9.9	2.2	4.8	1.0	1.1	1.0	17.5	9.8	6.8	4.4	1.3	6.2	1.3	1.1	8.2	1.3	12.3	1.0	11.2	3.7	26.5	2.3	1.6	0.0	1.0	7.1	1.0	0.1	2.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	3.8	69.8	6.2	0.0	0.0	1.0	0.0	9.8	0.0	0.9	0.0	0.6	0.1	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.0	0.8	0.0	0.5	0.4	0.0	2.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.0	9.9	22.2	2.3	16.0	16.0	6.3	21.6	9.9	17.5	26.5	11.9	177.0	0.0	0.0	0.0	1.4	1.1	0.0	8.1	6.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.4	0.0	16.1	0.0	0.1	0.0	0.0	16.0	0.0	1.8	126.0	1.0	1.7	0.0	0.0	0.2	0.1	0.0	41.4	0.0	3.5	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645110-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 14.1"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 11.2;Melanocytes: 3.3;Muller glia cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.3;fHDF/TERT166: 9.1;SiHa: 6.1;THP-1: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		59000				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	3.8	1.6	9.8	4.0	12.7	1.1	2.1	5.1	14.1	3.2	2.7	2.5	2.9	2.2	4.8	2.6	3.3	2.7	6.2	3.6	7.3	4.9	1.3	1.6	2.0	4.5	4.8	6.8	2.4	1.2	1.1	1.6	2.5	5.4	4.4	1.7	4.4	2.4	3.8	2.5	1.9	2.2	6.3	3.2	3.3	2.1	1.7	2.7	0.0	1.1	1.6	2.4	2.5	1.8	0.1	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.4	0.7	0.2	0.2	0.0	2.9	2.6	0.7	0.6	0.2	0.2	0.8	0.3	5.3	9.1	0.1	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.0	2.9	0.0	0.1	1.6	0.3	2.1	0.3	0.3	2.5	0.1	0.1	0.2	1.6	0.4	0.1	0.4	2.1	0.0	0.1	0.8	0.0	0.3	0.1	0.2	0.3	1.1	6.1	0.1	0.0	1.1	0.1	6.4	1.6	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	9.8	12.7	5.1	10.8	7.3	4.9	4.8	6.8	5.4	2.7	0.0	0.0	0.0	0.0	0.0	11.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.5	0.0	0.0	1.3	1.6	0.0	0.3	0.0	3.3	0.0	0.0	12.4	0.0	0.6	1.8	0.0	1.4	0.0	0.8	0.3	0.2	0.0	0.1	0.0	0.0	0.1
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA			Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.0	18.4	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.0	9.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"placenta: 1.3"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"NTERA-2: 4.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6		0.0	0.0	0.0	0.1	1.3		0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	13.7	0.0	0.0	0.0	0.0	0.6	0.0	2.7	4.5	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 66.0"	"Cell type enriched"	"Detected in many"	15	"Extravillous trophoblasts: 586.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 1.2;SuSa: 3.9"									CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000				"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.2	0.1	0.0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0.0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0.0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66.0	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	1.1	1.4	6.4	20.3	0.0	0.8	5.1	0.0	0.0	0.0	0.0	7.8	0.0	2.8	16.1	5.2	2.6	0.0	4.7	586.1	11.7	5.5	0.0	1.1	21.9	0.0	16.8	8.0	11.0	5.3	2.3	3.3	11.8	0.0	39.2	0.0	15.5	20.1	2.5	0.2	0.0	0.0	3.3	4.7	3.0	30.7	33.9	6.9	9.7	6.7
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734551-186190949	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 8.2;Fibroblasts: 12.4;Horizontal cells: 25.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;hTERT-RPE1: 9.8;MCF7: 35.5;SK-MEL-30: 23.4;WM-115: 21.0"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"olfactory region: 22.1"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		2000000	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	14.9	1.3	1.0	4.8	2.5	0.0	10.9	0.4	1.7	9.8	8.4	0.8	0.5	0.8	5.9	3.0	12.0	1.9	6.8	13.4	0.9	0.9	2.2	7.9	23.9	2.6	1.3	0.2	4.4	1.1	0.1	6.2	7.7	2.0	8.4	2.9	8.1	7.8	1.3	4.4	4.0	3.7	4.5	1.8	13.1	1.9	2.4	0.4	0.5	3.3	15.8	6.1	3.0	4.3	0.0	0.0	0.3	0.0	0.0	3.0	0.0	0.1	0.0	0.7	0.0	2.3	2.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.9	0.1	10.5	0.8	2.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.7	0.2	9.8	1.3	0.0	0.0	0.0	0.0	35.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	23.4	2.2	0.0	0.0	0.0	6.7	0.6	0.0	2.4	0.1	0.0	0.1	1.3	0.0	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.0	2.5	0.4	1.7	0.9	0.9	1.3	0.2	2.0	0.4	3.0	6.5	0.0	0.2	2.9	0.7	2.3	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.6	12.4	0.1	0.0	1.5	0.1	25.4	0.0	5.5	0.8	1.5	3.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 15.6;Enterocytes: 21.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;RH-30: 19.2;SCLC-21H: 2.8;SH-SY5Y: 4.5;U-138 MG: 3.2;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		7700000	Vesicles		"HPA053903: AB_2682301, HPA070647: AB_2686290"	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	7.4	1.7	0.2	10.2	0.2	0.1	3.8	0.1	0.4	18.3	25.0	0.0	1.0	5.9	21.9	25.1	4.9	5.1	5.0	8.7	0.4	0.4	1.4	0.4	2.7	2.3	0.0	0.0	8.9	0.8	0.2	0.1	0.3	0.8	5.1	2.3	0.1	1.7	3.4	24.3	2.8	11.2	20.8	0.5	0.3	2.3	6.3	0.0	1.8	2.6	10.9	1.5	12.1	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	19.2	0.1	0.0	0.1	2.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.4	0.0	0.0	0.8	0.0	3.0	6.9	0.5	0.2	0.8	0.5	3.6	0.0	6.7	6.8	0.0	0.0	0.0	1.7	0.0	15.6	1.3	21.5	0.0	0.0	0.1	2.4	0.7	7.0	1.1	0.3	1.6	0.0	0.6	0.3	8.0	0.0	0.9	1.7	0.0	1.9	0.0	0.1	7.0	0.0	1.1	0.6	0.0	3.8	0.2	0.7	0.5	0.2	0.0	2.9	3.3
HMSD	"ACC-6, ACC6, C18orf53"	ENSG00000221887	"Histocompatibility minor serpin domain containing"	"A8MTL9, P0C7T4"	18	63949301-63981774	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"brain: 26.1"	"Cell type enriched"	"Detected in some"	5	"monocytes: 49.5"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.7;GAMG: 8.7;HDLM-2: 18.0;Karpas-707: 7.1"														"Secreted to blood"	NA	NA						"unprognostic (5.83e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.19e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.14e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.55e-1)"	1.7	1.9	3.9	3.4	8.4	0.5	1.5	0.6	4.8	0.4	0.8	11.3	0.0	0.7	0.3	0.2	1.3	0.8	0.4	1.0	5.8	4.2	0.3	1.9	3.0	5.9	15.1	1.0	1.2	0.9	0.2	0.3	0.3	12.1	0.3	2.1	0.0	0.6	0.5	0.5	2.9	1.0	0.4	26.1	2.1	1.5	2.1	11.2	1.4	0.8	0.2	4.9	0.5	1.3	0.2	5.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	3.3	7.7	0.0	0.6	2.1	0.3	4.0	0.0	0.8	0.0	0.0	0.9	8.7	3.3	1.3	0.2	2.6	18.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	2.8	0.1	1.0	0.0	0.0	0.0	7.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	0.0	0.2	1.3	0.0	0.0	3.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	3.9	8.4	0.6	3.7	5.8	4.2	15.1	1.0	12.1	11.2	3.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	49.5	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.4	0.1	0.1	0.0	0.5	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Cell type enriched"	"Detected in many"	51	"Hepatocytes: 52541.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 66.2;HSkMC: 37.9"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	140000000000	Vesicles		"CAB003787: , HPA047750: AB_2680146"	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	66.2	0.1	9.5	1.8	37.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.1	0.8	0.0	0.0	0.3	7.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.5	0.0	3.7	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	17.9	220.1	295.8	0.8	0.1	0.2	72.5	853.5	10.7	10.3	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	864.3	9.6	0.0	0.2	0.2	3.5	52541.7	2.4	0.0	0.0	971.0	1021.7	0.0	9.5	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	0.3	0.1	23.0	0.0	0.0
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 430.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 33.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	77000000000	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3											0.0	9.8	0.0	0.0	0.1	0.0	14.9	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	23.3	0.2	0.0	0.2	0.0	0.0	430.8	0.0	0.0	0.0	9.8	7.3	2.1	9.2	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.9	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 31.0;smooth muscle: 22.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 23.2;Late spermatids: 41.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Group enriched"	"Detected in some"	19	"BJ hTERT+: 12.3;HEL: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044603	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	1.6	0.1	2.0	4.1	9.7	0.1	5.5	2.7	4.2	31.0	3.1	5.4	0.9	3.4	8.0	0.2	17.2	2.3	2.1	0.1	1.7	8.3	1.4	0.1	2.4	0.1	12.2	1.4	0.2	0.1	0.1	0.2	1.7	12.4	12.1	3.2	0.4	1.0	4.9	0.2	1.4	5.1	22.2	11.9	0.1	2.5	2.2	7.6	0.0	0.2	0.2	0.4	12.4	12.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	12.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	23.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.0	9.7	2.7	3.1	1.7	8.3	12.2	1.4	12.4	7.6	0.0	0.0	0.0	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.1	1.8	0.1	0.0	0.0	0.0	0.7
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	949	"liver: 528.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 5619.6"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	230000000000			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	528.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.3	1.4	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.7	0.1	21.3	0.0	2.9	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.4	0.2	0.0	0.1	0.2	0.0	1.0	3.1	0.2	0.3	1.1	0.0	0.4	0.3	0.2	1.1	0.1	0.3	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.3	49.0	0.1	0.6	0.9	0.4	73.9	0.0	0.0	0.0	2.0	0.0	0.0	0.1	2.5	0.3	0.3	116.8	0.5	0.1	0.2	1.8	0.0	5619.6	0.2	0.0	0.0	121.5	102.4	2.8	0.3	0.3	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.2	0.3
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678240	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease mutation, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"liver: 425.4"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 394.5"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.8;HL-60: 5.9;RH-30: 6.9;RPTEC TERT1: 1.7;SiHa: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	30000000000			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	425.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	6.9	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	394.5	0.0	0.0	0.0	13.5	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell type enriched"	"Detected in many"	7	"Ito cells: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	7.0	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7.0	5.7	4.7	0.0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0.0	3.1	0.9	4.2	1.9	0.0	3.2	1.9	3.2	2.9	1.0	9.2	0.9	6.0	0.9	0.2	0.6	8.1	3.4	4.7	2.0	1.3	1.2	82.5	6.1	8.0	4.7	0.3	0.0	1.0	0.4	1.6	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0.0	9.4	0.0	63.1	1.0	75.0	34.2	0.0	21.9	85.1	58.4	6.6	22.0	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65.0	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050402-70058845	"Predicted secreted proteins"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	1306	"salivary gland: 1826.6"	"Cell type enhanced"	"Detected in single"	33	"Club cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;hTCEpi: 1.0;SK-MEL-30: 3.6"									HPA077315	Approved				"Secreted to digestive system"	NA	NA					"HPA077315: "									"unprognostic (2.22e-1)"									0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1826.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.3	1.1	0.1	0.1	0.2	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028413-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	535	"salivary gland: 3346.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.5;HL-60: 4.9"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA					"CAB073541: "																		0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	1.4	0.0	6.2	0.0	0.0	0.2	0.0	0.0	3346.6	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	3.3	0.3	0.1	0.1	1.2	0.6	2.2	1.2	0.5	1.0	0.4	1.1	1.4	0.5	0.5	0.0	0.3	0.4	0.2	0.0	0.6	0.6	0.2	1.6	1.7	0.8	0.2	2.0	0.9	0.0	0.3	0.1	4.5	0.7	0.3	0.9	0.6	0.0	4.9	3.5	0.4	0.8	0.1	0.0	0.5	0.7	0.8	0.6	3.0	0.5	0.6	1.3	2.4	1.2	0.6	1.4	3.0	0.8	0.6	0.3	0.6	2.0	1.2	1.1	0.8	0.9	1.0	2.2	1.3	0.0	1.2	1.8	1.2	0.9	2.0	2.3	0.7	1.1	1.5	2.5	2.2	0.7	0.5	0.5	1.1	0.3	1.0	0.8	0.4	0.4	1.2	1.0	0.6	2.0	0.5	1.2	0.6	0.5	0.4	0.1	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Horizontal cells: 591.1;Muller glia cells: 269.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 203.0;ASC TERT1: 75.4;fHDF/TERT166: 68.7;HSkMC: 132.4;LHCN-M2: 100.6;U-87 MG: 83.1"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.5	1.6	0.4	203.0	75.4	0.0	8.7	15.9	3.6	1.9	0.0	0.0	0.0	2.4	68.7	5.6	1.0	0.6	9.9	0.5	0.0	0.4	0.0	5.8	0.0	10.3	0.0	0.0	132.4	36.4	2.1	17.0	41.7	16.7	0.0	0.0	0.1	100.6	1.7	0.0	0.0	1.7	0.0	5.5	0.0	0.1	0.0	23.0	0.1	0.1	0.3	21.9	0.0	9.4	7.8	0.7	0.0	10.9	25.6	0.3	11.5	7.4	0.0	0.0	0.0	83.1	0.0	12.0	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5	20.8	8.6	0.0	31.0	39.2	55.4	23.4	10.2	14.7	0.0	61.1	51.1	15.8	0.0	2.1	2.5	64.7	0.0	0.0	3.9	127.5	77.4	8.5	1.1	85.6	53.0	591.1	0.0	54.6	17.2	3.1	29.4	7.2	43.9	12.6	0.1	269.0	4.2	0.2	72.9	18.8	110.5	6.5	59.8	0.1	0.2	26.7	73.3	4.5	0.2	12.7
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-2197: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.1	3.9	0.1	0.8	0.0	1.0	0.2	0.0	0.0	0.0	4.8	2.1	0.5	0.0	0.4	0.0	0.3	0.0	0.8	0.4	5.0	0.0	2.2	0.0	0.2	0.4	0.0	1.4	0.0	0.6	3.4	0.0	0.1	0.0	3.5	0.0	0.0	12.2	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.1	9.1	0.1	0.0	10.6	0.0	0.4	2.7	0.5	1.7	64.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6	0.0	0.0	0.0	0.3	4.6	0.0	14.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.6	3.1	0.0	0.0	0.0	3.7	45.9	0.1	0.0	0.0	1.1	0.0	0.0	4.3	0.0	0.5	40.3	0.9	0.0	0.0	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.0	5.1	0.2	0.9	4.5	1.1	0.0	0.0	0.1
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974164-38988662	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"placenta: 55.2"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 319.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	23	"BEWO: 72.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in some"			HPA045402	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA045402: AB_2679316"	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0.0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0.0	0.2	0.2	4.3	1.0	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1.0	1.0	1.7	0.0	0.1	0.1	0.1	0.2	0.3	0.2	72.8	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	3.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1.0	1.0	2.2	1.4	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	1.1	0.1	0.5	0.4	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	319.8	0.2	1.2	0.0	0.0	10.7	1.6	0.0	2.5	0.3	0.0	0.0	1.5	1.7	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	33.8	0.0	0.2	0.7
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 116.0;Proximal tubular cells: 50.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 45.8;SK-BR-3: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.2	1.4	0.0	0.4	0.2	0.3	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.9	45.8	2.1	0.3	0.3	1.9	6.6	0.0	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.3	3.3	0.2	0.0	0.1	0.1	2.7	0.1	0.1	1.0	0.0	13.3	0.1	1.2	1.0	0.1	0.9	0.3	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8	17.9	14.4	0.0	0.2	2.6	1.1	19.5	17.8	1.4	0.0	10.4	3.9	0.0	19.9	13.8	7.3	16.5	0.7	0.0	13.2	0.0	1.0	0.2	0.0	116.0	0.1	0.0	1.7	30.1	4.0	6.7	2.0	0.9	0.0	0.0	0.8	0.2	7.9	0.0	1.1	50.7	0.5	6.5	2.3	0.0	1.0	2.8	0.6	0.0	0.2	1.6
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronoglucosaminidase 3"	O43820	3	50292831-50299468	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1"	"Group enriched"	"Detected in many"	16	"Early spermatids: 73.0;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.1;eosinophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Cell line enhanced"	"Detected in many"		"HEL: 22.4;HMC-1: 40.2;THP-1: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049402	Uncertain				"Secreted to blood"	NA	NA					"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	3.5	4.2	6.3	3.1	8.8	48.8	3.3	11.4	12.5	4.2	3.6	3.8	6.1	3.8	2.7	5.1	5.6	3.7	5.4	3.4	6.4	5.6	2.9	7.0	3.2	4.2	5.3	5.6	4.3	3.7	2.6	3.1	3.6	11.1	4.9	2.9	3.7	6.7	5.6	3.9	3.0	4.1	4.6	3.4	2.8	6.6	31.1	2.7	3.0	3.3	5.1	3.7	4.8	3.8	1.1	4.2	26.9	2.1	1.0	2.2	1.2	2.2	2.6	1.5	1.7	3.1	1.6	0.9	2.5	2.2	3.2	2.4	3.5	2.4	2.0	1.2	2.9	4.9	2.5	2.7	5.9	1.2	4.6	1.4	22.4	6.8	2.8	2.2	2.4	40.2	3.3	4.5	3.2	2.1	2.3	3.2	2.2	1.7	2.5	1.5	1.3	0.9	14.2	1.1	2.6	6.6	1.0	2.0	3.6	3.8	1.0	1.8	2.1	3.6	2.9	2.0	1.8	1.9	41.3	4.3	2.7	1.9	8.6	1.4	1.2	2.5	1.5	2.4	8.6	2.2	12.1	2.1	26.9	0.7	1.1	1.2	0.9	2.2	1.0	4.2	1.1	0.6	0.8	0.7	1.0	0.7	1.1	1.3	1.2	6.3	8.8	11.4	12.5	6.4	5.6	5.3	5.6	11.1	2.7	3.0	1.4	0.0	2.2	2.7	1.5	0.3	0.0	1.4	4.5	3.5	3.9	2.5	8.3	4.5	73.0	3.4	0.3	0.0	0.6	4.1	1.8	2.3	6.9	1.0	2.0	4.8	4.1	7.4	1.8	206.1	1.7	2.8	3.3	9.0	1.2	1.5	3.1	0.0	2.5	1.9	0.4	6.5	3.1	4.3	3.8	3.1	2.5	1.3	1.6	3.0
IAPP	"AMYLIN, DAP, IAP"	ENSG00000121351	"Islet amyloid polypeptide"	P10997	12	21354959-21379978	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"pancreas: 63.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 21.2;Pancreatic endocrine cells: 24.8"	"Cancer enriched"	"Detected in single"	76	"pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;NTERA-2: 1.6;U-2 OS: 4.9;U-698: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000352, HPA053194"	Enhanced				"Secreted to blood"	NA	NA	11900				"CAB000352: AB_2121635, HPA053194: AB_2682076"							"unprognostic (5.52e-3)"				"unprognostic (1.00e-1)"	"unprognostic (4.16e-1)"		"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	63.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	1.3	1.8	0.6	0.7	0.7	0.1	0.1	0.0	0.9	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.2	0.3	0.0	0.2	0.1	0.5	0.4	0.2	1.1	0.0	0.1	0.7	0.0	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.5	0.9	0.1	0.3	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.3	0.3	4.9	0.1	0.8	0.5	1.2	1.7	0.2	0.2	0.1	1.8	0.6	0.1	0.4	0.2	0.1	0.4	0.5	0.2	0.3	0.7	0.4	0.7	1.5	0.7	0.2	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	1.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.0	0.9
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799581-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2"	"Cell type enriched"	"Detected in single"	46	"Hofbauer cells: 6.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-138 MG: 13.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.2	0.0	1.9	0.6	0.4	1.0	0.1	2.0	4.5	4.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.8	1.3	1.0	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.8	6.2	1.1	2.6	0.4	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	2.0	1.5	1.0	0.1	0.9	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 5.7;hTERT-RPE1: 5.9;NB-4: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA10	IFN-alphaC	ENSG00000186803	"Interferon alpha 10"	P01566	9	21206181-21207143	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;hTERT-RPE1: 1.2;NB-4: 3.5;TIME: 1.5"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21239991	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;kidney: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"HMC-1: 1.0"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA16	IFN-alphaO	ENSG00000147885	"Interferon alpha 16"	P05015	9	21216373-21217311	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA17	"IFN-alphaI, LEIF2C1"	ENSG00000234829	"Interferon alpha 17"	P01571	9	21227243-21228222	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell type enriched"	"Detected in single"	20	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in single"		"SuSa: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	253000				"HPA047557: AB_2680087"																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA21	IFN-alphaI	ENSG00000137080	"Interferon alpha 21"	P01568	9	21165637-21166660	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.2;brain: 2.1;lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.4	0.3	0.3	0.9	0.0	0.0	2.1	0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.3	1.3	0.0	0.0	0.1	1.4	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.3	0.0	0.2	0.2	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA4	"IFN-alpha4a, MGC142200"	ENSG00000236637	"Interferon alpha 4"	P05014	9	21186694-21187671	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA5	IFN-alphaG	ENSG00000147873	"Interferon alpha 5"	P01569	9	21304326-21305312	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ: 1.5"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.3	0.3	0.0	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.5			0.6	0.4	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0		0.0	0.1	0.0	0.3	0.2		0.2	0.1		0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.3	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA6	IFN-alphaK	ENSG00000120235	"Interferon alpha 6"	P05013	9	21349835-21351378	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	1.2	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA7	"IFN-alphaJ, IFNA-J"	ENSG00000214042	"Interferon alpha 7"	P01567	9	21201469-21202205	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA8	IFN-alphaB	ENSG00000120242	"Interferon alpha 8"	P32881	9	21409147-21410185	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"HeLa: 3.2"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNAR2	IFNABR	ENSG00000159110	"Interferon alpha and beta receptor subunit 2"	P48551	21	33229901-33265675	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 52.3;U-266/70: 66.4;U-266/84: 34.4"														"Secreted to blood"	NA	NA		610000				"unprognostic (2.00e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-3)"	"unprognostic (8.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.42e-1)"	"prognostic unfavorable (7.54e-7)"	"unprognostic (9.70e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.85e-2)"	16.9	8.7	9.9	28.1	11.3	19.1	18.3	10.7	13.0	10.2	12.2	10.6	9.6	12.8	12.0	10.1	8.1	11.1	15.5	13.6	10.3	9.7	13.4	20.5	21.6	41.7	13.3	8.3	11.9	10.2	11.2	10.9	15.7	10.2	9.9	13.2	7.9	14.4	11.6	6.6	6.6	14.1	13.0	13.2	40.9	9.9	4.6	12.1	34.7	11.3	6.6	25.3	24.2	10.7	9.9	37.6	37.1	25.3	12.2	23.7	14.2	4.1	4.7	2.5	5.7	3.0	7.1	4.1	4.2	11.2	3.6	3.8	6.3	4.7	6.5	3.1	6.5	5.5	2.6	3.5	2.3	3.5	4.1	5.3	23.8	5.2	5.8	4.4	4.0	8.9	5.0	2.2	4.0	4.9	6.4	11.4	10.2	7.5	52.3	3.5	2.4	10.3	4.9	4.5	5.5	3.1	3.5	12.9	12.8	7.6	8.3	6.5	3.7	7.2	6.4	6.1	2.7	1.1	7.6	7.5	3.7	2.2	2.9	2.3	66.4	34.4	16.1	5.3	14.4	8.6	13.7	14.5	22.7	12.2	23.7	12.8	9.9	15.2	11.5	13.6	6.7	11.2	12.3	37.1	12.2	25.3	37.6	23.7	14.2	9.9	11.3	10.7	13.0	10.3	9.7	13.3	8.3	10.2	12.1	56.6	17.3	28.9	40.1	6.1	5.2	2.5	25.5	28.1	20.5	10.4	5.9	24.6	3.3	61.4	2.4	32.2	8.1	0.0	54.3	61.5	11.8	37.0	31.1	17.4	40.5	19.1	2.9	38.6	68.7	2.4	6.9	46.3	18.6	33.3	3.7	5.7	58.2	3.6	8.5	8.4	5.4	0.0	13.3	2.9	22.4	5.0	19.7	40.3	3.8	62.9
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077105-21077963	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 1.8;bone marrow: 3.7;breast: 5.9"	"Cell type enriched"	"Detected in single"	21	"Hofbauer cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;GAMG: 1.2;NB-4: 1.2"					"Low region specificity"	"Detected in many"			HPA073843	Supported				"Secreted to blood"	NA	NA	3750				"HPA073843: "	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.1	0.3	0.0	0.0	0.0	3.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.8	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	2.5	0.0	0.0	1.2	1.2	0.2	4.1	0.2	0.2	0.3	0.1	2.7	0.0	0.8	0.8	0.4	1.4	0.0	2.6	0.4	0.0	0.0	0.0	10.6	0.0	0.7	0.0	0.0	1.1	0.5	1.6	2.3	13.1	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159747	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.4;lung: 14.5"	"Cell type enriched"	"Detected in some"	14	"T-cells: 93.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"gdT-cell: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;U-266/70: 2.3;U-698: 1.2"					"Low region specificity"	"Detected in some"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470				"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	2.4	0.9	0.3	4.5	0.3	14.4	0.5	0.1	1.0	1.4	0.9	0.5	0.0	0.2	0.6	1.4	1.3	0.2	0.6	1.0	0.3	0.3	0.7	4.1	14.5	8.5	1.5	0.4	0.4	0.2	0.0	0.5	0.8	0.6	1.2	0.4	1.1	1.4	0.2	1.7	0.3	0.7	0.7	1.3	4.1	0.8	0.2	0.0	0.8	1.3	3.1	4.7	2.2	0.6	0.5	0.0	0.2	0.0	1.2	8.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.3	8.6	0.0	0.5	0.8	5.2	0.2	1.2	0.0	0.0	0.2	1.1	0.3	0.3	0.1	1.0	0.3	0.3	1.5	0.4	0.6	0.0	0.0	0.0	0.5	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.1	0.0	0.0	1.3	3.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	93.0	0.1	0.1
IFNK		ENSG00000147896	"Interferon kappa"	Q9P0W0	9	27524314-27526498	"Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;skin 1: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.8"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA							"unprognostic (5.58e-3)"				"unprognostic (4.64e-3)"								"unprognostic (1.06e-1)"				0.1	0.0	0.1	0.1	0.5	0.7	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.1	0.1	1.7	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNL1	"IL-29, IL29"	ENSG00000182393	"Interferon lambda 1"	Q8IU54	19	39296325-39298673	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.1"	"Cell type enriched"	"Detected in single"	24	"T-cells: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 4.4;MAIT T-cell: 4.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 4.1;myeloid DC: 3.3;naive CD8 T-cell: 2.3;NK-cell: 6.1"	"Group enriched"	"Detected in many"	46	"dendritic cells: 3.3;NK-cells: 6.1;T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.1;GAMG: 2.5;SK-MEL-30: 1.0;U-266/84: 1.9"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	97000					"unprognostic (3.08e-2)"	"unprognostic (8.74e-2)"		"unprognostic (2.46e-4)"		"unprognostic (5.76e-2)"		"unprognostic (6.91e-3)"	"unprognostic (5.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.80e-2)"		"unprognostic (2.96e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	0.1	0.0	0.1	0.9	0.1	0.6	0.1	0.1	0.1	0.3	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.2	0.3	0.9	0.4	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.5	0.3	0.1	0.1	1.6	0.1	0.6	0.1	1.8	1.6	0.1	0.1	0.1	0.1	0.0	3.3	0.0	0.0	6.1	4.4	0.9	0.0	0.9	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.4	0.0	2.1	4.1	3.3	0.0	0.2	2.3	0.0	6.1	0.0	0.0	0.3	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.0
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268514-39270092	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 4.1;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HDLM-2: 16.7"									CAB025489	Uncertain				"Secreted to blood"	NA	NA					"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNL3	"IL-28B, IL28B, IL28C"	ENSG00000197110	"Interferon lambda 3"	Q8IZI9	19	39243553-39245129	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 1.1;CACO-2: 3.3;GAMG: 2.2;HDLM-2: 1.8"														"Secreted to blood"	NA	NA	1700					"unprognostic (2.67e-1)"	"unprognostic (9.19e-2)"				"unprognostic (4.17e-1)"				"unprognostic (6.86e-2)"				"unprognostic (1.89e-2)"	"unprognostic (1.66e-1)"			0.1	0.0	0.5	0.0	0.3	0.2	0.0	1.1	0.7	0.1	0.0			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.2		0.0	0.0		1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	1.5			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNW1		ENSG00000177047	"Interferon omega 1"	P05000	9	21140214-21142145	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.2;NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.0;U-266/70: 1.1;U-937: 1.1"														"Secreted to blood"	NA	NA																							0.1	0.4	0.5	0.1	0.6	1.3	0.1	0.6	1.0	0.1	0.0			0.3	0.0	0.1	0.3	0.2	0.2	0.1	0.5	0.9	0.0	0.2	0.1	0.8	0.6		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.7	1.4	0.5	0.1	0.3	0.4	0.2	0.8			0.4		0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.0	0.5	0.5	0.2	0.0	0.3	0.5	0.9	0.0	1.1	0.3	0.0	0.1	1.1	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGF1	"IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Leydig cells: 1021.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 21.8;HDLM-2: 28.4;K-562: 12.7;Karpas-707: 6.8;U-266/70: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048946	Approved				"Secreted to blood"	NA	NA	103000000	410000000			"HPA048946: AB_2680566"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	33.4	3.6	0.8	10.7	1.4	0.3	23.0	0.6	2.1	46.6	6.7	0.6	20.6	2.2	35.0	58.3	16.1	8.1	8.8	17.4	1.5	1.0	3.9	32.8	7.6	13.3	0.9	0.4	17.6	3.2	1.2	1.2	13.5	1.9	57.2	2.8	3.7	5.4	32.0	11.9	3.2	3.5	29.4	1.0	4.9	5.9	19.0	0.2	1.5	29.3	11.6	2.2	21.2	15.3	4.5	0.2	0.5	0.1	0.2	0.1	0.8	0.2	0.0	0.0	0.0	21.8	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	2.4	0.1	0.1	0.0	4.5	0.1	0.1	0.5	0.2	0.1	0.2	0.0	0.8	0.8	1.4	0.6	2.1	1.5	1.0	0.9	0.4	1.9	0.2	3.0	2.1	0.0	0.5	2.3	186.6	0.3	5.1	0.0	1.2	0.0	0.0	0.8	0.0	0.0	10.2	5.2	0.0	0.0	0.5	2.2	63.7	1.2	0.0	167.4	91.5	0.0	0.0	4.3	14.4	22.9	1021.5	9.8	13.5	6.4	0.0	2.1	0.1	0.0	181.8	1.0	7.0	0.0	3.3	1.6	1.0	2.4	1.0	2.9	0.0	0.1
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8"	"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	15.2	0.1	0.4	0.0	115.4	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	79.2	20.3	0.0	0.0	24.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	45.5	0.3	0.0	0.1	0.1	0.0	0.2	0.0	56.5	0.1	0.0	0.1	4.5	68.8	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	871.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2792.3	0.0	0.0	0.0	0.0	192.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1348.9	0.0	0.0	0.0
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 107.6"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 12.7;Hepatocytes: 39.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.3;T-47d: 2.1;U-266/70: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	44000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.8	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.2	7.4	0.1	0.1	0.2	0.2	107.6	0.4	0.1	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.4	0.1	0.0	1.4	0.6	0.1	0.2	0.2	0.1	0.1	0.3	0.1	5.0	0.5	0.1	1.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.9	5.3	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.0	0.0	1.3	0.2	0.5	0.2	0.1	0.0	1.3	0.5	1.6	0.0	0.0	0.4	0.3	0.3	0.0	0.7	0.1	2.1	0.2	0.2	0.4	1.5	0.2	0.2	5.2	1.8	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.2	1.6	12.7	0.0	0.0	0.0	5.9	0.0	0.0	1.4	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	1.7	0.0	5.0	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 863.0"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	18.0	0.1	0.3	0.0	0.0	0.2	3.9	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.5	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	38.2	0.0	1.2	0.0	0.0	0.7	0.0	6.7	0.1	0.0	0.0	23.3	0.0	2.0	1.0	0.0	0.0	863.0	1.6	0.0	3.4	9.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Collecting duct cells: 251.2;Hepatocytes: 556.2;Intestinal endocrine cells: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 141.7;HMC-1: 330.5;NB-4: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	1000000000	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.9	25.2	141.7	43.3	0.5	7.8	3.9	0.3	0.0	0.0	0.0	0.0	11.1	0.0	0.9	0.7	9.3	9.9	0.0	0.0	5.3	5.6	0.0	1.6	3.5	2.3	330.5	14.4	1.0	0.1	0.4	0.8	0.0	11.7	0.2	0.7	0.1	6.3	9.8	68.2	27.9	6.1	0.3	8.5	0.5	0.1	0.1	7.3	5.4	28.6	0.0	0.2	0.1	24.6	21.2	4.1	0.0	0.1	0.1	0.1	0.3	0.4	0.0	0.5	0.3	10.8	30.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0	3.0	1.1	8.3	536.0	12.2	0.0	11.2	10.2	13.4	3.4	251.2	2.0	1.6	24.9	2.4	0.6	38.2	7.3	0.0	111.9	2.0	21.3	92.5	4.6	556.2	4.8	0.0	307.8	26.4	24.0	2.6	5.2	2.5	3.3	1.8	53.3	3.8	95.4	31.9	74.6	1.0	1.6	103.5	14.6	2.8	44.3	4.8	1.8	13.8	47.1	201.7
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell type enhanced"	"Detected in many"	19	"Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.6	2.9	5.7	0.0	4.3	1.8	0.0	42.1	7.6	3.6	1.9	0.0	7.8	0.0	13.4	422.0	1.8	23.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.8	0.6	0.7	2.7	5.7	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	3.9	2.6	20.8	0.6	1.6	14.6	0.5	0.7	13.3	0.0	0.0	0.0	41.7	0.0	175.0	2.3	0.6	0.0	0.0	90.6	0.0	14.0	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1	3.0	4.6	0.0	95.2	406.6	0.6	9.7	7.6	33.5	117.2	216.3	0.0	45.9	10.0	71.8	0.8	62.6	0.4	0.0	1.7	1874.7	137.7	80.4	1.1	1.7	72.5	0.0	263.4	181.7	8.2	1.9	266.9	3.0	15.1	12.6	1.6	0.4	19.7	2.9	6.3	0.7	0.6	0.0	28.8	0.4	0.4	213.8	129.0	8.2	0.6	581.2
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443461-40457731	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 370.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 472.5;Ito cells: 497.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.6;NK-cell: 20.5"	"Group enriched"	"Detected in many"	5	"NK-cells: 20.5;T-cells: 12.6"	"Cell line enhanced"	"Detected in many"		"A549: 111.6;ASC diff: 84.3;ASC TERT1: 82.6;BJ: 89.6;BJ hTERT+: 92.2;HSkMC: 175.6;U-2197: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	NA	NA	227000000	500000000			"HPA066240: AB_2685643"	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	79.7	23.3	2.5	36.8	5.2	0.0	198.7	1.8	3.1	115.0	57.1	3.2	41.1	9.9	88.8	126.5	67.7	67.4	117.5	119.1	2.2	1.8	72.3	255.6	88.2	101.4	3.7	2.3	370.8	21.5	6.5	19.4	99.8	5.1	66.7	17.0	46.2	24.4	38.6	36.3	22.3	36.8	80.4	6.4	68.1	38.7	53.2	2.3	4.2	81.0	50.4	22.5	89.9	123.9	3.6	0.1	0.0	0.0	20.5	12.6	0.9	0.0	111.6	5.7	0.0	84.3	82.6	0.1	89.6	92.2	17.1	13.4	4.9	1.4	0.0	48.6	42.6	2.3	0.9	1.9	0.5	7.8	0.3	0.1	0.3	8.1	7.3	52.9	0.2	0.0	175.6	0.4	22.9	3.2	2.0	29.7	0.0	1.7	0.0	24.6	3.3	0.0	20.6	3.1	4.8	15.1	5.5	0.1	0.1	0.7	3.5	1.5	4.5	40.4	0.1	1.3	5.7	41.3	2.0	44.7	23.9	1.2	75.4	0.0	0.0	0.0	0.1	14.2	0.8	6.1	0.0	0.0	0.0	1.8	0.0	12.6	0.4	3.3	4.4	0.0	3.6	0.2	0.4	0.0	20.5	0.0	0.1	0.0	0.9	2.5	5.2	1.8	3.1	2.2	1.8	3.7	2.3	5.1	2.3	8.9	44.4	38.9	76.3	50.0	1.2	15.1	99.3	8.1	12.5	7.0	0.0	4.9	14.9	3.0	5.5	236.2	69.3	0.0	2.2	4.7	103.0	15.8	2.3	472.5	206.0	1.6	8.1	497.8	43.5	7.0	228.1	14.8	69.2	5.4	77.9	3.8	23.2	69.1	111.4	154.4	1.0	187.5	232.9	2.3	6.4	41.8	6.3	14.4	110.8	67.4
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695525	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 245.3"	"Cell type enhanced"	"Detected in many"	13	"Leydig cells: 1692.8;Muller glia cells: 665.4;Peritubular cells: 922.8;Sertoli cells: 1254.7;Smooth muscle cells: 840.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 211.9;T-47d: 51.5;U-138 MG: 70.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	110000000	330000000	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	47.3	23.4	6.2	19.2	6.3	0.1	41.3	3.6	6.5	191.7	23.1	19.7	15.8	3.9	94.6	91.0	30.0	96.9	21.4	16.9	8.2	2.4	34.8	7.8	9.3	14.5	12.1	7.4	245.3	3.5	6.5	37.7	32.7	7.0	31.4	7.9	188.5	12.0	15.1	47.0	13.5	14.2	71.8	7.4	7.6	36.9	51.7	12.0	1.5	130.1	34.5	17.6	28.8	45.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.5	0.0	23.7	0.7	0.0	79.7	211.9	10.6	1.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	2.5	0.0	0.5	0.0	0.7	20.5	0.4	0.0	10.3	0.0	0.1	3.3	0.0	1.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	6.9	23.7	1.4	0.8	1.4	9.8	0.0	1.3	51.5	0.0	7.6	70.3	4.3	10.6	3.8	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.2	6.3	3.6	6.5	8.2	2.4	12.1	7.4	7.0	12.0	3.0	4.1	2.4	13.8	91.0	5.3	81.7	0.0	100.4	23.9	106.4	5.9	4.0	5.0	13.3	6.4	89.9	0.0	0.0	0.0	5.9	302.8	15.2	2.3	0.9	7.6	3.2	0.0	62.6	0.8	10.9	1692.8	25.6	96.2	1.0	0.0	665.4	3.2	0.0	922.8	1.1	10.8	1254.7	840.1	1.9	2.1	59.5	4.7	1.0	0.0	13.1
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leydig cells: 954.4;Peritubular cells: 1406.1;Sertoli cells: 1151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.3;BJ: 76.0;fHDF/TERT166: 27.1;HaCaT: 45.1;U-87 MG: 31.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008005	Uncertain				"Secreted to blood"	NA	NA	199000000	320000000			"HPA008005: AB_1851499"	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	60.2	15.9	0.9	6.7	1.4	1.2	61.0	0.3	4.7	70.2	15.2	0.8	34.9	5.2	20.7	78.5	47.0	37.6	14.7	27.5	0.7	0.8	6.4	2.6	12.5	3.3	5.9	2.9	37.5	3.9	1.7	19.6	12.5	6.1	29.4	3.6	41.5	6.1	23.5	18.3	6.5	8.9	52.6	26.1	8.0	12.6	36.0	0.0	0.2	15.1	55.8	7.6	58.0	90.5	0.0	0.7	12.5	7.1	0.0	1.7	0.4	15.8	10.0	0.0	6.3	8.6	28.3	0.0	76.0	17.7	3.0	2.0	0.9	13.2	0.0	7.9	27.1	2.0	45.1	0.0	1.7	0.5	0.0	0.2	0.1	1.7	1.6	4.3	0.0	0.0	11.4	0.0	1.9	0.2	9.3	0.8	0.2	0.0	0.2	0.8	0.0	0.5	0.1	0.4	0.0	21.7	0.1	0.5	0.2	0.1	0.0	0.0	0.8	23.4	0.0	0.6	0.0	0.3	0.0	18.0	3.7	4.7	6.6	1.3	0.4	0.3	0.0	31.6	0.2	1.9	0.0	0.0	12.5	0.1	2.1	0.8	0.0	0.3	1.0	0.7	0.0	0.1	1.7	0.0	0.0	7.1	0.0	0.0	0.4	0.9	1.4	0.3	1.7	0.7	0.8	5.9	2.9	6.1	0.0	6.0	3.4	1.9	38.3	100.9	0.8	17.1	2.5	5.3	15.9	19.2	0.0	1.8	10.0	77.1	7.3	95.5	0.0	0.0	6.8	5.0	243.8	14.8	0.0	0.6	7.2	0.0	0.0	124.0	1.3	18.8	954.4	10.0	136.7	2.8	0.1	21.1	50.2	0.0	1406.1	11.3	2.9	1151.2	137.9	3.5	4.3	76.8	2.9	5.1	0.0	18.5
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 10593.1;Peritubular cells: 11028.0;Sertoli cells: 8052.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 72.1;BJ hTERT+: 67.4;hTERT-RPE1: 157.3;RPTEC TERT1: 72.4;TIME: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.4	0.1	0.0	14.6	5.5	0.5	72.1	67.4	6.3	2.0	0.2	0.0	0.0	46.2	3.4	3.7	7.2	0.0	11.5	1.6	0.1	0.5	0.2	8.4	0.0	22.6	1.7	1.8	25.4	5.9	10.2	2.8	157.3	14.5	0.0	0.0	0.0	14.9	0.0	0.0	7.5	0.6	0.0	0.1	1.3	0.0	0.2	72.4	0.0	0.1	0.1	13.5	1.0	0.0	30.7	0.1	6.6	104.5	6.4	4.9	0.8	11.7	4.3	0.0	0.1	17.0	6.0	0.1	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7	104.2	26.5	28.2	113.1	211.8	3.7	148.5	22.9	163.3	72.8	1980.3	21.6	4.6	437.7	2492.0	58.3	2171.1	0.0	0.0	12.7	4.7	511.0	37.3	15.1	7.2	25.9	0.0	1.2	2456.5	118.7	133.2	10593.1	113.8	895.8	35.1	0.0	9.3	120.5	0.0	11028.0	461.5	9.2	8052.1	3278.8	32.0	37.3	156.6	4.8	78.4	1.5	34.4
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0"	"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	67.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.1	0.0	19.5	0.1	0.0	0.0	69.8	67.7	1.1	0.0	0.0	43.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229752-46231243	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 51.5;tongue: 29.7"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 1.4;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 6.3;RT4: 23.4;SK-BR-3: 8.0"									HPA014001	Uncertain				"Secreted in other tissues"	NA	NA					"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.1	14.7	0.1	0.0	0.0	0.1	0.3	0.1	51.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	11.0	0.1	0.1	1.8	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.9	0.1	29.7	14.4	0.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	6.3	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.2	8.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.0	0.0	0.0	0.0	0.0
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Group enriched"	"Detected in some"	64	"CACO-2: 28.9;OE19: 58.1"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.9	1.9	0.4	0.0	0.0	1.2	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.5	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.4	8.0	7.0	4.1	2.2	0.0	1.3	0.0
IGFL3	UNQ483	ENSG00000188624	"IGF like family member 3"	Q6UXB1	19	46120071-46124674	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 22.4"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 2.7;Exocrine glandular cells: 5.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.3;CACO-2: 2.2;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.6"									HPA062776	Uncertain				"Secreted in other tissues"	NA	NA					"HPA062776: AB_2684866"	"unprognostic (8.61e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.69e-1)"		"unprognostic (4.78e-2)"	"unprognostic (7.45e-3)"		"unprognostic (2.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-4)"			"unprognostic (2.86e-2)"	"unprognostic (1.90e-1)"		"unprognostic (3.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	22.4	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.9	0.1	2.7	0.1	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.3	0.6	0.5	2.2	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.1	1.2	0.5	2.8	0.3	1.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.0	0.0	0.1	0.7	0.0	0.2	5.6	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.6	0.6	0.1	0.2	0.2	1.5	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;HaCaT: 5.9;OE19: 10.3"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	6.6	0.2	0.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	1.4	0.3	0.9	0.1	0.1	0.9	5.9	0.0	0.0	0.0	0.7	1.1	0.0	0.8	1.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.7	0.0	0.7	0.1	0.5	0.3	10.3	0.3	0.1	2.9	1.4	0.0	0.3	0.4	0.4	0.0	0.1	1.7	0.8	0.4	1.2	0.6	0.8	1.4	0.4	0.4	0.8	0.4	0.2	0.1	0.9	1.8	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5	0.0	0.0	0.0	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.4	1.3	1.0	0.0	0.0	0.0	0.0
IGIP	"C5orf53, LOC492311"	ENSG00000182700	"IgA inducing protein"	A6NJ69	5	140125935-140129392	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 13.9"	"Low region specificity"	"Detected in all"							"HPA041877, HPA048615"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA041877: AB_2677721, HPA048615: AB_2680462"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.94e-1)"	"prognostic favorable (6.25e-6)"	"unprognostic (2.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.98e-2)"	"unprognostic (7.77e-2)"	5.1	7.6	13.9	2.0	13.1	0.0	5.3	16.0	13.7	7.3	3.8	3.4	1.6	2.8	3.8	8.0	2.5	3.5	3.8	4.6	13.4	13.7	7.6	6.2	3.8	3.1	17.8	3.3	5.3	3.6	16.2	6.1	3.7	9.8	5.8	3.1	3.7	4.3	7.3	7.7	7.5	3.7	8.2	14.4	3.8	3.4	1.9	9.4	2.0	7.1	2.8	3.0	3.7	3.4	0.6	0.1	1.0	0.5	0.5	2.2	0.1	2.0	0.6	1.0	2.9	14.4	13.9	1.3	5.1	5.1	1.2	1.5	2.0	1.6	3.8	5.5	6.9	0.7	2.1	1.1	3.1	2.3	3.3	1.9	0.8	2.8	1.5	3.4	1.0	1.4	4.7	7.9	2.3	4.4	8.9	1.5	2.8	0.6	1.5	4.4	1.7	1.1	2.5	0.2	1.6	1.6	1.2	2.4	1.7	6.8	1.8	1.0	1.5	2.8	1.8	2.9	1.1	1.4	3.0	8.9	3.6	0.3	1.2	2.8	3.7	2.4	1.3	3.8	2.6	2.6	0.0	0.2	1.0	0.7	0.1	1.9	0.6	1.0	0.8	0.1	0.5	2.2	1.8	0.0	0.5	0.5	0.1	1.1	0.1	13.9	13.1	16.0	12.9	13.4	13.7	17.8	3.3	9.8	9.4	11.9	3.2	0.5	1.7	1.8	19.0	13.8	10.2	2.7	5.7	3.5	13.7	1.9	0.0	2.5	1.5	3.7	3.9	0.0	1.6	1.1	2.9	3.5	8.1	4.7	0.9	27.0	8.6	4.3	2.6	0.5	6.1	2.2	6.8	1.8	4.4	5.6	2.5	5.1	15.9	2.2	9.4	0.0	5.0	2.3	0.9	3.4	1.5	0.8	3.4	1.7
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"	"Cell line enriched"	"Detected in some"	34	"REH: 129.9"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	129.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	60.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	104.2	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.4	4.4	0.0	0.0	0.0	9.7	0.5	0.3	0.0	0.0	0.0	0.1
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896107	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 87.9;lymphoid tissue: 102.9"	"Cell type enriched"	"Detected in some"	923	"Melanocytes: 89092.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	230	"memory B-cell: 87.9;naive B-cell: 72.8"	"Lineage enriched"	"Detected in single"	252	"B-cells: 87.9"	"Group enriched"	"Detected in some"	7	"Daudi: 103.5;U-266/70: 74.1;U-698: 70.4"														"Secreted to blood"	NA	NA		120000000000				"prognostic favorable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	3.5	1.8	1.3	82.6	1.5	6.5	12.3	1.3	1.5	3.3	37.7	1.4	1.3	39.0	1.5	1.7	7.5	4.3	5.8	1.3	1.3	0.3	4.6	3.6	10.8	22.8	1.5	1.3	2.1	1.3	0.0	1.3	1.5	1.7	2.1	23.3	3.3	42.9	2.8	1.5	0.6	25.2	1.3	1.3	102.9	27.7	3.1	1.3	5.8	5.8	2.9	69.8	38.2	2.6	87.9	0.3	0.1	0.0	0.0	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	103.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	74.1	12.0	70.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	72.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	10.7	1.3	1.5	1.3	1.5	1.3	0.3	1.5	1.3	1.7	1.3	3.0	54.3	41.7	0.0	96.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	23.3	0.0	0.0	1.0	0.0	10.5	0.0	0.0	0.0	1.2	1.3	0.3	2.7	0.0	1.6	89092.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.9	0.0	0.0
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 33.6;testis: 11.5"	"Group enriched"	"Detected in some"	15	"Bipolar cells: 30.6;Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 25.2;NTERA-2: 11.4;SH-SY5Y: 16.4;SuSa: 7.4;U-2 OS: 4.8"	"Low region specificity"	"Detected in all"							HPA041994	Approved				"Secreted in brain"	NA	NA					"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	2.0	4.6	9.6	1.1	6.0	1.9	0.7	33.6	16.5	0.6	0.8	0.8	0.0	0.9	0.8	2.2	2.8	0.7	1.0	1.2	9.5	13.7	0.6	2.3	0.6	0.6	11.1	8.4	1.5	1.1	0.5	0.5	1.3	29.3	1.1	0.7	3.0	1.1	2.4	0.6	1.5	1.1	0.8	10.9	0.7	0.7	11.5	2.6	0.0	0.6	0.0	0.6	1.1	0.4	0.0	0.9	1.4	0.3	0.2	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	2.4	0.0	0.1	0.1	16.4	0.0	0.0	0.0	7.4	0.1	1.5	0.0	0.0	4.8	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.9	0.0	0.0	9.6	6.0	33.6	10.7	9.5	13.7	11.1	8.4	29.3	2.6	0.0	0.0	0.0	0.0	0.0	30.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.7	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	3.5	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.0	0.0
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.8"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 118.2;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		280000	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	2.5	2.9	0.6	0.1	0.4	0.0	4.5	0.0	0.2	0.3	0.5			0.0	0.7	0.8	2.0	3.4	7.3	4.1	0.7	0.8	0.0	0.0	6.7	0.5	0.3		17.8	0.1	0.7	1.5	0.0		0.0	0.6		3.7	0.0	0.0	1.2	0.7	0.7	0.3	0.2	0.4	0.3			1.3		1.6	1.5	0.1	0.2	1.5	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.2	4.0	25.6	0.0	0.9	12.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	29.6	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	3.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.3	0.5	1.2	2.2	14.0	1.1	2.5	13.4	10.3	1.8	3.9	18.9	0.0	0.2	118.2	0.7	0.0	0.0	1.2	2.6	5.4	0.9	0.0	0.0	1.2	57.2	5.8	0.0	0.3	22.0	6.4	1.6	3.3	1.0	0.4	23.5	0.3	0.0	1.1	0.3	2.2	0.0	0.9	6.7	2.4	2.0	25.9	0.0	0.0	0.0
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog"	Q14623	2	219054420-219060467	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2"	"Cell type enhanced"	"Detected in some"	16	"Enterocytes: 15.4;Intestinal endocrine cells: 47.3;Mucus-secreting cells: 35.7;Undifferentiated cells: 20.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.4;OE19: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		13000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.1	0.1	20.2	0.1	0.0	0.1	0.3	0.2	4.5	33.1	0.1	0.7	10.7	14.3	10.3	0.7	0.7	19.1	0.1	0.1	0.2	3.7	3.4	3.3	0.1	0.1	0.1	0.7	0.1	0.0	0.6	0.2	0.1	2.3	11.4	8.2	0.1	1.1	0.1	0.1	42.8	0.5	0.1	0.1	11.6	0.3	0.1	0.1	1.1	0.1	0.1	0.9	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	2.5	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	3.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.4	11.5	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.3	0.3
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206772494	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.3"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 25.9;Kupffer cells: 36.4;Macrophages: 43.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;intermediate monocyte: 4.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.4"	"Group enriched"	"Detected in some"	8	"HMC-1: 18.6;U-266/70: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670				"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	10.9	3.1	1.1	10.7	1.2	4.1	2.1	0.3	1.3	1.6	1.8	2.1	0.5	0.8	1.0	1.9	1.7	4.0	5.2	3.9	0.8	0.9	1.3	3.1	4.3	9.2	1.8	0.9	1.5	1.2	0.4	2.3	3.6	2.3	1.7	1.8	2.1	1.6	0.8	0.9	0.7	2.1	4.6	2.2	28.3	2.0	1.6	1.4	2.2	2.4	0.9	3.5	4.1	1.0	0.2	0.5	0.5	5.4	0.1	1.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	9.6	0.3	0.3	0.0	0.1	0.0	0.5	5.4	0.1	0.2	4.0	0.0	0.1	0.2	1.0	0.5	0.2	0.1	0.1	0.3	0.1	1.4	0.1	0.9	1.0	1.1	1.2	0.3	1.3	0.8	0.9	1.8	0.9	2.3	1.4	0.0	3.4	1.4	0.3	0.9	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	6.9	0.3	0.0	0.0	0.0	0.1	0.6	0.3	1.1	0.0	25.9	0.0	0.0	0.6	36.4	2.2	0.0	43.8	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	1.0	0.1	1.3	0.0	0.4
IL11	"AGIF, IL-11"	ENSG00000095752	"Interleukin 11"	P20809	19	55364389-55370463	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 10.9;Pancreatic endocrine cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 9.2;hypothalamus: 3.7;pons and medulla: 2.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 18.3;BJ hTERT+: 20.8;hTEC/SVTERT24-B: 17.0;U-251 MG: 65.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	34800					"unprognostic (6.60e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.32e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.84e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (4.83e-2)"	"unprognostic (4.07e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.08e-2)"	1.1	0.1	0.6	7.7	0.9	1.5	0.6	9.2	1.0	0.6	0.6	1.8	0.6	0.3	6.1	0.6	2.3	0.0	5.9	0.6	0.6	3.7	3.4	0.6	0.9	0.6	1.2	0.6	0.6	0.6	0.0	5.3	2.3	2.7	3.7	0.2	0.6	0.6	1.1	0.6	2.5	0.6	0.6	0.6	0.6	2.8	1.4	0.6	0.6	0.6	0.6	0.6	2.3	0.6	0.7	0.3	2.8	0.3	0.8	0.4	0.0	0.7	0.4	0.1	0.3	0.0	0.0	0.1	18.3	20.8	9.7	12.8	0.3	0.4	0.2	0.8	1.6	5.0	0.9	0.1	0.4	13.0	0.7	0.5	0.0	1.1	1.2	1.0	0.0	0.1	0.1	0.4	17.0	0.1	4.1	0.0	0.0	0.1	0.5	1.1	0.5	0.0	0.1	0.3	0.6	1.5	0.0	6.1	0.0	0.1	0.1	0.9	0.6	2.3	0.3	0.4	2.3	0.2	0.1	0.2	5.8	7.0	0.0	65.9	0.3	0.7	0.1	12.5	0.1	2.9	1.4	0.3	0.5	0.3	0.2	0.2	0.7	0.3	0.1	0.1	0.7	0.3	0.4	2.8	0.8	0.1	0.3	0.2	0.0	0.6	0.9	9.2	0.8	0.6	3.7	1.2	0.6	2.7	0.6	0.0	0.3	0.0	0.3	2.9	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.8	0.2	0.0	0.0	2.3	0.8	1.9	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	0.0	0.2	37.7	0.2	1.4	0.0	0.2	0.0	0.4	0.3	0.9	0.5	0.2	0.0	0.2	0.3
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988750-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.1"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 8.1;Sertoli cells: 6.5;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	7	"B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 7.5;HDLM-2: 11.4;SK-BR-3: 17.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.7"	"Low region specificity"	"Detected in some"			HPA001886	Uncertain				"Secreted to blood"	NA	NA					"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.7	1.4	3.4	1.6	6.2	3.3	2.0	2.6	5.6	0.5	1.6	1.0	0.0	1.5	1.2	0.8	10.1	5.7	0.6	1.4	3.1	2.2	1.2	0.6	5.2	2.9	3.2	1.7	1.6	1.1	0.1	1.0	0.4	5.4	0.9	1.3	0.2	2.1	1.1	0.4	0.2	1.5	0.8	2.7	2.8	1.2	0.9	4.1	0.0	0.5	0.5	2.1	0.9	1.1	5.1	0.1	1.3	0.3	0.0	1.6	0.3	2.8	0.3	0.4	2.4	0.0	0.1	0.2	3.1	1.9	3.6	7.5	1.2	0.1	0.0	0.2	0.5	4.2	0.3	0.8	0.5	3.4	11.4	3.9	0.1	0.1	0.8	2.6	0.6	5.3	0.6	0.9	6.4	2.5	2.5	1.2	0.3	0.0	2.0	2.2	0.0	0.1	0.0	0.4	0.1	1.7	2.2	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.1	0.4	0.6	0.8	1.2	0.8	0.9	0.8	2.1	5.8	1.2	0.0	0.0	1.4	5.2	0.7	0.0	0.1	1.3	0.9	0.3	1.4	1.3	0.4	1.6	0.1	5.1	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.3	3.4	6.2	2.6	5.6	3.1	2.2	3.2	1.7	5.4	4.1	0.0	1.1	1.9	1.1	0.1	0.0	0.2	0.0	8.1	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.5	0.1	0.0	0.0	0.5	1.6
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314783-159330887	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 10.8"	"Cell type enriched"	"Detected in single"	60	"monocytes: 11.8"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.0;NB-4: 2.7;SCLC-21H: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	NA	NA	140000				"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.2	0.2	0.2	0.7	0.2	1.4	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	0.4	0.2	0.7	0.2	0.2	0.2	0.6	0.3	0.9	1.8	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	0.2	0.6	0.2	0.7	0.2	0.2	1.3	0.5	0.2	0.2	1.8	0.9	0.5	0.2	10.8	0.4	0.2	0.9	0.3	0.2	1.1	0.3	2.9	0.5	1.0	0.2	0.0	0.3	0.4	0.6	0.7	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.6	0.9	0.5	0.1	0.1	0.2	0.4	0.1	0.1	0.0	0.5	0.9	0.1	1.5	0.2	0.1	0.4	1.1	0.3	0.3	0.1	0.0	0.7	0.1	0.4	0.2	3.0	0.0	0.2	0.5	2.7	0.6	0.1	0.4	0.6	0.8	1.8	0.0	0.2	3.7	0.2	0.3	0.3	0.0	0.8	0.4	0.4	0.4	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.5	0.2	1.7	0.5	0.2	0.2	0.1	0.1	1.1	0.2	0.1	0.1	0.3	0.2	0.2	2.9	1.0	0.1	0.3	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 74.4;Late spermatids: 141.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	177	"HDLM-2: 30.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	40000		"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	141.6	2.6	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.2	1.2	0.5	0.0	0.0	0.0	0.0
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636599-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"monocytes: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.5;Karpas-707: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.7	1.1	21.3	1.5	2.9	9.2	1.8	2.2	6.0	8.8	0.8	2.2	6.3	11.3	7.4	5.6	4.6	9.9	9.3	1.1	1.5	6.9	3.7	14.4	18.8	2.3	1.6	3.2	3.1	0.5	4.5	9.9	2.1	7.7	5.7	5.9	6.9	3.6	9.1	3.2	14.2	7.1	2.6	17.0	5.3	2.6	2.0	9.8	18.1	5.9	11.0	9.8	16.9	3.7	4.6	8.1	14.0	2.6	4.5	4.4	2.4	5.2	0.2	0.5	0.8	4.7	1.3	5.6	5.2	5.8	4.7	2.8	6.8	2.3	7.3	4.8	5.0	3.6	0.1	3.0	3.2	15.5	1.4	0.4	13.7	0.4	3.9	1.6	1.1	1.7	1.2	3.8	0.4	11.9	3.7	1.8	3.8	15.2	3.7	0.8	3.4	0.3	2.6	1.8	1.6	0.9	13.4	0.3	7.6	0.6	0.5	1.3	2.4	3.7	2.7	0.6	0.9	0.2	5.5	5.9	3.8	1.7	3.4	10.7	1.3	0.7	6.3	0.6	2.1	8.1	14.0	0.8	2.5	12.4	4.5	3.7	2.9	2.2	4.6	3.4	1.2	1.3	1.0	2.6	12.5	0.1	1.5	4.4	1.1	1.5	1.8	2.2	1.1	1.5	2.3	1.6	2.1	2.0	0.0	3.2	10.4	2.8	5.5	0.3	2.4	0.0	4.0	7.9	5.2	0.0	1.0	0.0	8.1	4.0	11.3	3.9	0.0	12.2	1.8	7.2	4.3	0.0	1.7	4.9	0.0	0.0	11.6	18.3	1.5	2.6	19.3	8.5	96.4	4.7	15.1	14.3	3.5	1.1	8.4	0.5	6.5	3.1	0.5	0.7	3.0	0.2	6.4	2.3	2.1
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 48.0;monocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.0;EFO-21: 18.2;HDLM-2: 32.7;HHSteC: 18.7"									CAB026215	Approved				"Secreted to blood"	NA	NA					"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	20.5	5.6	2.2	13.0	4.1	6.4	33.9	1.4	2.6	12.7	15.6	1.6	7.7	10.1	10.9	9.4	14.3	10.6	18.7	19.2	2.6	1.9	7.8	17.5	35.7	15.2	4.0	2.0	8.7	9.6	0.9	3.9	15.5	3.6	13.2	7.4	6.4	8.9	9.4	9.2	7.6	18.8	10.8	2.7	18.8	10.3	5.0	2.7	3.5	13.9	7.5	9.8	12.9	17.3	7.0	4.2	6.3	19.5	6.8	18.7	6.7	7.0	1.0	0.0	0.3	9.3	2.2	1.9	3.6	7.8	4.8	5.0	0.1	30.0	0.8	18.2	6.8	2.6	6.7	0.8	5.3	1.0	32.7	1.4	0.8	1.8	0.5	18.7	0.4	0.2	1.9	1.8	2.5	0.1	1.8	11.7	0.6	8.7	10.0	0.1	3.7	1.4	3.4	0.2	2.5	3.3	4.2	0.0	5.7	1.1	0.5	0.0	0.0	5.5	0.5	0.2	0.0	2.6	3.2	4.5	0.1	0.5	13.0	4.8	9.0	2.4	0.1	2.2	5.3	0.3	6.3	16.0	3.9	12.3	19.5	18.7	7.0	9.5	12.5	4.2	3.3	4.1	7.1	4.7	6.8	11.7	0.0	10.2	6.7	2.2	4.1	1.4	2.6	2.6	1.9	4.0	2.0	3.6	2.7	6.0	5.3	7.5	4.2	5.0	0.0	5.3	25.5	2.7	0.0	0.0	0.0	0.6	0.0	30.4	1.5	20.4	6.9	23.3	48.0	1.6	12.7	6.8	3.5	6.4	6.3	0.0	5.2	34.4	12.7	1.5	4.6	6.2	3.3	89.2	7.1	0.0	29.3	13.5	0.7	0.0	0.0	0.0	5.1	0.2	0.2	5.6	0.1	5.7	7.5	6.5
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8"	"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	37	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	Yes	NA	208000	14000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	13.2	0.0	0.0	0.4	9.3	23.8	0.4	0.0	0.0	0.2	0.0	0.2	1.6	1.4	5.0	0.0	0.0	0.7	9.9	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	2.1	0.1	0.1	0.1	0.4	0.0	28.3	2.4	11.7	0.8	15.8	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5	3.0	10.0	169.7	0.1	7.2	0.0	1.2	10.2	8.1	3.4	1.8	0.0	0.2	0.0	0.1	1.3	4.9	0.0	70.0	0.2	0.2	6.6	0.1	25.5	2.4	16.6	0.0	0.0	36.2	59.0	0.7	10.0	30.8	27.0	0.0	0.3	0.4	0.0	0.3	17.0	0.3	0.6	6.5	3.7	2.1	4.7	3.1	0.3	92.0	0.0	0.0
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	37	"Karpas-707: 7.3;U-266/84: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920				"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Peritubular cells: 12.4;Sertoli cells: 25.8;Smooth muscle cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"midbrain: 8.9"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;Hep G2: 2.1;K-562: 1.7;Karpas-707: 3.7;NB-4: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000				"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	2.1	3.3	0.1	2.2	0.1	0.6	7.5	0.1	0.8	4.7	4.2	0.1	2.8	0.7	6.8	3.6	4.1	1.6	1.1	5.1	0.1	0.0	0.8	0.1	0.9	0.1	8.9	1.2	0.7	0.1	0.0	0.1	0.4	1.4	3.6	0.4	2.4	7.1	5.6	1.5	1.3	1.7	5.3	5.4	1.1	1.3	5.9	0.4	0.4	0.6	1.6	0.3	1.8	1.3	0.0	0.2	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	4.5	0.0	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	3.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.5	0.0	0.5	0.2	0.1	0.0	0.0	1.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.1	0.0	8.9	1.2	1.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	25.8	8.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638591-88640473	"Predicted secreted proteins"	"Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.6"	"Cell type enriched"	"Detected in single"	6	"Exocrine glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065051	Supported				"Secreted to blood"	NA	NA	30500				"HPA065051: AB_2685413"	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.1	0.0	0.1	0.1	0.6	0.8	0.1	1.2	0.1	1.0	0.1	0.1	0.1	0.0	7.6	0.1	0.8	0.2	1.4	2.3	0.1	0.0	0.1	0.1	3.6	0.2	0.1	0.1	0.1	0.1	0.2	0.3	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.9	0.5	0.1	0.1	1.3	0.9	2.0	0.1	0.1	0.1	2.5	0.1	1.2	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3
IL17D	"FLJ30846, IL-17D, IL-22, IL-27, IL27"	ENSG00000172458	"Interleukin 17D"	Q8TAD2	13	20702127-20723098	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 36.1;skeletal muscle: 65.7"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 15.7;Late spermatids: 24.2;Leydig cells: 10.6;Melanocytes: 8.5;Muller glia cells: 18.6"	"Group enriched"	"Detected in many"	9	"glioma: 10.8;melanoma: 3.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"TIME: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	25000					"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.97e-2)"	2.5	3.2	22.4	1.3	24.6	0.6	2.1	9.5	36.1	3.6	1.9	16.1	0.2	5.6	2.9	1.1	5.5	1.4	3.2	3.9	16.5	13.9	0.8	0.5	3.5	1.0	16.7	9.4	5.3	3.7	0.7	0.6	1.4	11.0	3.1	0.7	2.2	1.8	1.4	65.7	2.0	3.5	1.2	14.6	0.7	1.4	1.9	10.9	0.0	2.5	1.1	0.6	2.6	1.6	0.3	0.0	0.1	0.1	1.9	1.0	0.1	10.7	1.5	2.4	5.2	5.7	3.2	12.5	3.0	0.8	0.3	0.6	5.0	5.9	7.3	0.6	0.3	3.7	5.7	1.0	0.1	0.1	2.6	8.3	0.5	0.5	6.0	0.7	7.9	1.6	4.4	0.1	0.4	0.0	4.7	3.4	10.3	2.9	0.0	2.0	10.4	8.7	6.5	7.3	12.7	1.8	11.6	5.9	0.8	0.1	9.4	14.2	4.6	1.7	2.6	11.8	4.4	6.5	6.8	18.2	1.2	2.1	0.9	3.7	1.3	1.1	1.9	2.8	3.8	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.2	1.0	0.0	0.2	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.1	22.4	24.6	9.5	15.2	16.5	13.9	16.7	9.4	11.0	10.9	0.0	0.0	0.0	0.2	2.2	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	15.7	0.4	0.2	0.0	0.2	6.2	2.0	0.1	0.0	0.0	0.3	0.0	0.0	1.8	0.0	24.2	10.6	0.0	8.5	0.0	0.0	18.6	0.3	0.0	1.1	0.0	4.3	0.0	1.4	0.5	0.7	1.8	0.9	0.0	0.2	0.1
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	30000						"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 160.8;Kupffer cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000		"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.5	9.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.1	42.1	0.0	6.1	0.0	0.7	38.5	0.0	29.0	0.0	0.0	0.2	4.0	9.5	2.1	0.9	2.1	7.7	0.0	44.4	0.0	10.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	7.3	25.8	0.0	0.0	0.0	19.0	5.7	0.0	0.0	18.3	12.2	0.1	0.2	7.3	5.8	0.0	0.1	50.0	0.3	8.2	0.1	0.0	0.1	0.0	15.4	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5	160.8	35.5	7.5	33.3	109.2	1.7	0.7	22.9	73.6	43.3	8.7	0.0	2.1	68.0	27.4	1.8	2.4	69.7	0.0	126.1	2.6	5.4	10.6	97.2	2.0	69.6	0.0	13.9	6.2	163.5	0.9	0.0	66.1	3.3	30.7	23.3	1.7	111.9	97.0	4.2	13.2	37.2	6.5	2.2	0.6	0.5	97.2	1.5	27.7	45.4	67.4
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell type enriched"	"Detected in single"	4	"Exocrine glandular cells: 1.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	172000					"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.8	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Early spermatids: 6.2;Late spermatids: 3.2;Macrophages: 4.8;Pancreatic endocrine cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 86.6;hTCEpi: 42.9;hTERT-HME1: 56.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	10800					"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.1	0.0	10.4	0.0	13.1	0.7	0.0	86.6	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	42.9	0.7	56.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2	6.0	1.4	0.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	6.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	4.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.3
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell type enriched"	"Detected in many"	7	"Macrophages: 764.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 93.2;HBEC3-KT: 42.4;HMC-1: 34.6;hTEC/SVTERT24-B: 46.6;hTERT-RPE1: 40.3;U-87 MG: 85.2"	"Low region specificity"	"Detected in some"												"Secreted to blood"	NA	NA	2330					"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	93.2	0.4	1.0	0.0	0.0	0.0	2.6	0.0	1.6	2.1	0.0	42.4	5.8	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.6	0.1	1.3	46.6	15.7	40.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	3.5	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	85.2	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8	8.9	45.3	1.4	4.6	27.4	0.0	4.3	0.0	13.4	7.9	1.8	0.0	1.2	0.0	12.2	0.1	2.2	0.3	0.0	0.5	2.1	9.9	2.3	39.4	0.0	109.6	0.0	0.0	1.3	54.0	0.0	0.0	764.6	21.9	0.0	2.2	0.0	3.6	6.2	0.0	0.5	0.2	0.0	4.3	0.0	0.2	17.8	3.7	2.2	0.0	4.6
IL1F10	"FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833"	ENSG00000136697	"Interleukin 1 family member 10"	Q8WWZ1	2	113067970-113075850	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 5.9;skin 1: 14.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;GAMG: 2.0"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	222000						"unprognostic (3.89e-1)"				"unprognostic (6.25e-2)"		"unprognostic (1.48e-1)"	"unprognostic (1.18e-1)"			"unprognostic (2.42e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Club cells: 93.3;Ito cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	95.6	42.7	0.6	4.0	18.2	2.8	4.3	0.8	0.5	0.0	2.9	8.0	5.0	0.8	0.0	0.3	2.4	7.9	0.0	0.1	0.4	4.4	30.0	0.0	0.0	117.7	0.3	3.2	0.7	1.2	1.2	0.0	0.5	0.1	4.1	0.8	0.0	0.1	0.1	0.8	0.1	0.0	0.3	0.0	2.7	1.9	0.0	0.0	1.8	1.1	0.0	0.5	1.6	0.1	0.0	8.2	0.5	13.7	0.3	0.0	0.0	0.0	3.2	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8	23.8	55.6	3.7	27.6	27.6	0.0	3.9	28.1	40.2	93.3	5.2	0.0	5.3	3.3	21.6	6.4	58.3	0.0	0.0	18.7	76.6	77.2	84.5	1.1	43.2	5.1	0.0	1.2	139.3	12.4	9.4	25.9	21.6	18.6	9.0	0.7	7.3	15.4	0.0	1.4	6.2	1.0	6.5	23.1	0.7	0.9	33.8	20.0	2.6	0.9	19.6
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 102.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.1	0.0	102.2	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1	6.0	0.6	5.4	8.6	131.3	0.0	0.4	17.8	4.0	0.0	1.8	0.0	0.4	5.0	8.0	2.6	1.9	8.6	0.0	7.3	28.9	9.3	2.5	2.3	14.4	5.9	0.0	6.4	4.3	197.6	1.5	0.3	236.7	30.4	1.0	105.1	0.0	123.7	31.7	0.0	0.4	0.0	6.5	8.9	0.0	1.4	73.4	23.2	1.0	20.4	7.1
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 100.2;Hepatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.9	1.0	1.6	0.2	2.9	2.4	3.1	1.7	3.5	4.1	4.0	1.7	8.8	0.7	18.3	4.8	9.5	10.2	0.9	17.1	5.7	0.7	1.0	0.8	1.7	4.2	6.1	5.8	2.8	3.2	7.0	5.9	18.9	8.6	1.8	1.8	0.1	0.0	1.9	1.8	0.5	2.6	2.6	1.7	1.8	2.8	2.5	1.4	1.5	4.2	0.3	0.0	8.0	4.4	72.7	1.6	2.9	4.2	2.4	3.2	3.2	9.7	7.9	1.5	0.0	0.1	5.4	5.3	18.6	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9	0.0	14.3	1.4	14.3	39.8	5.4	4.0	43.3	2.7	20.5	3.5	7.9	3.1	0.0	6.5	2.3	7.1	1.3	0.0	6.4	100.2	7.0	5.6	7.0	172.7	6.9	0.0	5.2	8.0	33.0	0.0	4.0	18.3	8.5	1.0	1.3	0.9	14.8	0.0	2.5	0.8	0.6	0.0	3.1	0.0	0.6	32.5	20.3	2.5	1.2	12.8
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Cell type enriched"	"Detected in many"	11	"granulocytes: 477.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	3.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.7	0.1	0.1	55.4	0.4	82.4	1.1	0.3	1.3	8.9	0.1	40.2	0.0	0.2	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3	8.9	22.8	0.0	15.1	7.6	0.0	1.8	0.0	12.0	13.6	1.8	0.0	0.0	0.0	0.0	0.2	29.2	0.0	0.0	0.4	0.1	4.2	8.9	477.2	0.0	0.0	0.0	0.0	44.2	0.3	0.9	0.9	11.2	3.3	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.2	38.8	5.2	0.0	0.0	4.4	0.0	4.3	0.0	11.1
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Cell line enhanced"	"Detected in some"		"A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.4	41.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	7.0	0.0	0.1	7.9	0.0	5.4	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.6	0.0	4.7	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.1	4.0	4.7	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2	6.0	10.6	0.5	50.9	163.8	0.0	0.3	12.7	18.7	17.0	3.5	0.0	1.3	0.0	17.2	35.3	2.2	6.5	0.0	25.2	2.5	6.6	30.8	9.3	38.4	319.3	0.0	0.0	3.1	35.8	72.7	0.6	100.5	23.6	1.0	0.6	0.0	89.0	0.0	0.4	0.0	0.0	0.0	6.6	0.7	0.1	294.2	3.8	0.9	2.2	333.6
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Group enriched"	"Detected in some"	6	"Melanocytes: 3.3;T-cells: 3.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Group enriched"	"Detected in some"	19	"JURKAT: 1.7;MOLT-4: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300				"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865354-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"seminal vesicle: 19.5"	"Cell type enriched"	"Detected in some"	7	"Basal keratinocytes: 61.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.9;GAMG: 1.6;hTCEpi: 1.0;SiHa: 5.9;SK-MEL-30: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000				"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	4.6	2.2	0.2	0.2	0.2	0.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.8	0.2	0.4	0.7	1.3	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.2	0.6	19.5	0.2	3.8	0.2	3.2	0.2	0.2	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.0	2.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	5.3	61.8	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	8.7	0.0	0.0	0.0	5.8
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 11.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Group enriched"	"Detected in some"	4	"HeLa: 4.3;Karpas-707: 1.1;SiHa: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	55700												"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL22	"IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18"	ENSG00000127318	"Interleukin 22"	Q9GZX6	12	68248242-68253607	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.8;urinary bladder: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-HME1: 1.6"					"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	86900							"unprognostic (2.57e-1)"											"unprognostic (4.24e-2)"				0.2	0.0	0.0	2.8	0.0	0.1	0.0	1.0	0.0	0.0	0.2			0.5	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.0	1.5	0.8	0.0	0.1	0.0	0.7			0.0		0.6	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Cell type enriched"	"Detected in single"	6	"Syncytiotrophoblasts: 1.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	NA	NA	40500000				"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.0;lymphoid tissue: 15.2;testis: 12.1"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 26.3;monocytes: 58.7;Pancreatic endocrine cells: 46.8;Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4"	"Group enriched"	"Detected in many"	14	"B-cells: 10.6;T-cells: 17.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.4;CAPAN-2: 16.5;U-266/70: 27.6;U-266/84: 12.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	11000		Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.7	0.5	0.4	3.9	0.5	3.6	0.4	0.3	0.3	0.5	0.6	0.3	0.3	0.0	1.3	0.8	6.0	0.5	2.0	0.3	0.4	0.5	1.3	1.4	1.2	7.5	0.4	0.3	0.3	1.1	0.0	1.1	0.6	0.3	1.0	0.2	0.3	1.8	0.3	0.3	0.8	2.5	1.0	0.4	2.8	0.7	12.1	0.3	12.9	0.6	10.4	15.2	7.4	0.6	10.6	0.5	0.1	0.2	1.0	17.0	5.9	9.4	0.2	0.3	0.3	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	16.5	0.5	4.9	0.0	0.5	0.9	0.0	1.6	0.0	0.6	0.3	0.3	0.1	0.7	0.0	0.2	0.6	0.1	0.0	0.0	0.4	2.1	0.0	2.2	0.4	4.1	0.0	0.4	0.3	0.5	1.4	0.2	0.3	0.2	0.1	0.4	5.7	4.7	0.3	0.4	0.2	0.2	0.8	1.4	0.1	4.4	0.3	0.3	0.3	0.3	1.1	27.6	12.4	1.2	0.3	2.4	0.2	0.0	0.2	0.0	1.7	0.0	8.4	10.6	15.5	7.4	0.5	10.6	17.0	10.6	0.1	1.0	0.0	0.0	8.4	5.9	0.4	0.5	0.3	0.3	0.4	0.5	0.4	0.3	0.3	0.3	3.0	2.1	14.5	10.2	3.2	0.0	0.3	0.0	2.7	5.7	1.8	0.0	0.3	1.7	26.3	4.7	0.6	0.3	0.0	6.4	0.3	1.4	5.0	0.0	0.6	2.4	0.0	0.0	0.0	0.0	3.2	0.3	8.1	8.5	58.7	0.0	0.1	46.8	0.0	0.7	0.5	0.1	0.0	1.9	41.1	5.3	3.4	0.0	10.2	0.0	13.9
IL24	"C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16"	ENSG00000162892	"Interleukin 24"	Q13007	1	206897443-206904139	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 22.5"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 2.2;Basal keratinocytes: 6.1;Smooth muscle cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.7;T-cells: 12.0"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 63.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.9"	CAB025972	Uncertain				"Secreted to blood"	NA	NA	140000				"CAB025972: "	"prognostic favorable (5.09e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.43e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.33e-2)"	5.3	0.0	0.2	9.2	0.2	1.6	0.2	0.2	0.4	0.2	1.3	0.2	0.2	0.3	0.9	0.7	0.9	1.4	1.7	0.8	0.2	0.0	0.6	2.4	2.5	22.5	0.2	0.2	0.9	0.2	0.0	0.2	1.1	1.3	1.3	0.0	0.2	0.2	0.2	3.9	0.2	1.3	0.2	0.2	19.6	0.9	0.5	0.2	0.4	0.2	0.9	2.7	3.3	0.3	18.7	0.4	0.7	0.0	3.4	12.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.8	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.9	7.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	5.1	0.2	0.0	0.0	0.0	0.9	0.4	2.8	0.1	3.3	0.2	0.5	0.5	0.0	0.1	0.4	0.0	0.0	4.3	0.0	6.2	18.7	6.8	6.4	0.0	18.6	11.8	6.5	0.7	3.4	0.0	0.4	12.0	3.6	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	1.3	0.2	0.0	2.2	0.8	1.3	6.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.5
IL25	"IL-17E, IL-25, IL17E"	ENSG00000166090	"Interleukin 25"	Q9H293	14	23372809-23376403	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.2;testis: 2.3"	"Cell type enriched"	"Detected in single"	40	"Cardiomyocytes: 13.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB024864	Uncertain				"Secreted to blood"	NA	NA	4230000				"CAB024864: "	"unprognostic (1.49e-1)"				"unprognostic (6.82e-2)"													0.5	0.2	0.4	0.3	0.6	0.0	0.6	0.1	0.7	0.4	0.0			0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.5	0.3	0.0	0.0	0.0	1.4	0.3		0.1	0.0	0.5	0.0	0.0		0.8	0.0		0.3	0.5	0.8	1.0	0.2	0.7	0.5	0.5	0.0	2.3			0.1		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 17.1"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	35700						"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0
IL27	"IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28"	ENSG00000197272	"Interleukin 27"	Q8NEV9	16	28499362-28512051	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antiviral protein, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;brain: 6.5;liver: 21.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 17.1;Syncytiotrophoblasts: 19.3"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 4.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 6.5"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.2;intermediate monocyte: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"BEWO: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB024722	Approved				"Secreted to blood"	NA	NA	521000				"CAB024722: "	"unprognostic (4.79e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (1.30e-4)"	"unprognostic (3.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (6.07e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.41e-7)"	"unprognostic (6.44e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	0.8	0.2	0.1	1.4	0.9	0.9	0.1	0.1	1.0	0.2	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.1	6.5	0.1	0.1	21.2	0.6	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.8	2.2	0.2	0.0	0.4	0.1	0.0	0.6	0.1	0.1	0.2	1.4	2.9	0.1	0.5	1.2	1.9	0.4	0.0	0.0	0.2	0.0	0.3	1.1	3.5	6.3	2.7	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	6.2	1.3	0.1	6.3	0.2	0.3	0.0	0.1	1.1	0.0	0.0	0.0	3.5	2.7	0.2	0.0	0.4	1.5	0.1	0.9	0.1	1.0	6.5	0.1	0.2	0.0	2.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	17.1	0.8	0.0	0.0	0.0	3.7	0.0	0.0	1.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0
IL3	"IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF"	ENSG00000164399	"Interleukin 3"	P08700	5	132060529-132063204	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;lymphoid tissue: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"HMC-1: 7.6"														"Secreted to blood"	NA	NA	17800																			"unprognostic (9.74e-2)"			0.1	0.1	0.0	0.3	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	2.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL31	IL-31	ENSG00000204671	"Interleukin 31"	Q6EBC2	12	122172030-122174199	"Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"HDLM-2: 1.3;Karpas-707: 2.5"									CAB025657	Uncertain				"Secreted to blood"	NA	NA	37800				"CAB025657: "														"unprognostic (1.70e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 216.2;liver: 316.2;pancreas: 196.4"	"Cell type enhanced"	"Detected in many"	12	"Ductal cells: 1462.7;Enterocytes: 1496.0;Exocrine glandular cells: 1263.1;Pancreatic endocrine cells: 3369.3;Proximal tubular cells: 2476.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 216.2"	"Lineage enriched"	"Detected in many"	9	"T-cells: 216.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 67.9;CAPAN-2: 46.0;HDLM-2: 96.7;Hep G2: 65.8;Karpas-707: 57.9;MOLT-4: 43.0;RH-30: 49.4;U-937: 42.8"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"	NA	NA	46100				"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	18.8	6.1	2.7	45.3	3.3	3.9	16.7	1.4	1.9	4.5	46.5	2.2	4.7	36.3	6.3	10.9	7.7	3.1	18.3	21.5	2.4	2.5	78.1	316.2	42.8	43.3	3.5	1.9	6.7	196.4	0.0	3.3	8.3	3.1	9.5	15.6	4.0	23.5	4.1	51.4	3.5	149.0	8.7	3.9	73.8	8.1	4.6	1.5	48.8	21.3	113.6	40.3	10.5	11.2	0.4	0.6	2.3	0.5	24.7	216.2	88.7	34.5	1.5	0.1	0.0	0.0	4.0	2.8	1.6	4.3	2.1	3.5	67.9	46.0	0.0	8.5	1.0	13.1	1.5	0.1	4.1	2.6	96.7	0.3	0.1	6.9	65.8	7.9	0.1	2.9	4.8	0.5	1.8	7.7	1.7	8.2	1.1	0.0	57.9	2.7	0.2	43.0	1.0	1.0	0.4	1.0	0.1	49.4	4.5	32.8	2.2	0.1	0.5	15.3	1.0	0.2	7.5	0.9	0.5	22.3	8.1	9.5	0.4	4.9	0.6	1.4	0.2	0.1	42.8	4.2	1.1	0.5	0.5	134.0	0.4	132.1	0.4	122.1	126.9	0.4	0.4	47.6	89.8	2.3	24.7	0.4	0.6	216.2	88.7	2.7	3.3	1.4	1.9	2.4	2.5	3.5	1.9	3.1	1.5	184.6	95.2	38.9	79.1	52.9	0.0	2.4	257.4	12.0	22.7	113.4	0.0	1.4	213.9	1462.7	0.2	120.5	1496.0	23.3	1263.1	8.0	41.1	84.6	51.9	80.5	3.7	0.0	129.8	68.2	41.3	1.1	32.5	49.5	62.4	345.4	194.0	0.0	3369.3	645.3	43.2	2476.2	0.5	19.4	101.0	0.7	0.8	45.0	5.5	783.6	79.7	80.6
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 19.9;U-2197: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	19.7	8.6	13.7	17.7	13.2	0.0	14.8	7.4	6.7	33.0	16.7	4.6	9.1	3.4	29.2	14.8	32.3	13.5	13.8	29.6	12.7	5.6	3.9	22.3	22.0	57.7	5.8	7.9	18.6	2.5	1.9	6.0	25.2	5.9	39.8	8.3	16.6	9.5	13.9	6.6	18.1	9.6	42.0	6.3	7.9	21.6	9.2	6.0	1.3	13.9	11.6	17.4	53.2	15.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.1	0.1	19.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	13.2	7.4	6.7	12.7	5.6	5.8	7.9	5.9	6.0	6.0	11.1	0.0	10.2	21.5	0.0	5.6	7.6	112.4	135.4	0.0	0.0	0.0	0.0	2.2	0.6	153.6	0.0	23.3	6.7	0.0	9.7	1.7	1.1	2.6	0.1	0.0	10.3	400.8	26.5	0.7	19.0	1.5	1.7	0.0	0.0	9.6	7.1	0.0	11.7	0.0	0.0	0.0	12.4	0.0	0.4	42.3	0.1	1.5	0.1	1.7
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.1;skin 1: 31.9"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 17.0;Muller glia cells: 14.3;Peritubular cells: 38.2;Sertoli cells: 19.4;Suprabasal keratinocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.8;BJ hTERT+: 3.3;Hep G2: 4.5;HSkMC: 4.3;NTERA-2: 9.5;U-138 MG: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	57100					"unprognostic (3.76e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	3.3	10.8	13.4	3.3	13.1	0.6	5.3	5.4	17.7	3.8	2.7	2.7	2.7	4.6	2.2	1.8	10.1	2.8	4.9	3.4	8.6	6.6	2.6	1.6	7.6	5.6	3.9	9.5	1.6	1.5	1.5	5.5	0.9	4.8	2.6	2.2	9.8	6.7	3.4	3.4	31.9	5.1	2.3	1.7	65.1	1.9	2.7	3.0	0.3	2.3	5.0	4.3	3.7	6.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.4	3.8	0.4	0.3	3.3	0.4	0.3	0.7	0.1	0.0	0.5	0.5	0.2	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.0	4.5	1.6	0.0	2.8	4.3	0.2	0.4	0.0	0.4	0.9	0.1	0.0	0.0	1.1	0.0	0.1	0.1	9.5	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.3	0.8	0.2	0.3	0.1	0.5	0.0	0.0	0.0	6.3	0.3	0.3	0.4	0.4	0.0	0.0	0.8	1.9	0.1	1.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.1	5.4	17.7	8.6	6.6	3.9	9.5	4.8	3.0	0.0	2.6	0.0	1.7	7.3	0.8	0.4	2.5	0.0	0.0	0.0	3.9	0.1	0.0	5.9	0.1	1.2	0.0	0.0	1.9	0.7	5.7	1.7	0.0	0.0	2.9	4.8	0.0	4.9	0.0	0.0	17.0	0.3	11.8	0.0	0.0	14.3	0.6	0.0	38.2	0.3	0.5	19.4	2.3	0.0	0.4	17.9	0.7	0.0	0.2	1.8
IL36A	"FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553"	ENSG00000136694	"Interleukin 36 alpha"	Q9UHA7	2	113005461-113008044	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"esophagus: 106.0;lymphoid tissue: 87.9;tongue: 90.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 8.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Group enriched"	"Detected in some"	5	"JURKAT: 4.0;MOLT-4: 3.9;REH: 1.5;U-266/70: 4.2"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	327000						"unprognostic (1.37e-1)"				"unprognostic (9.66e-3)"		"unprognostic (5.46e-1)"										0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	106.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	87.9	0.0	4.8	0.0	0.0	0.0	0.0	0.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.2	0.3	0.6	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022091-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"GAMG: 34.4;U-87 MG: 35.3"									HPA035664	Uncertain				"Secreted to blood"	NA	NA	15300				"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985665	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1"	"Group enriched"	"Detected in some"	6	"Suprabasal keratinocytes: 11.5;Urothelial cells: 6.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;GAMG: 3.7;HaCaT: 3.1;HMC-1: 3.2;hTERT-RPE1: 2.9"														"Secreted to blood"	NA	NA						"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	10.9	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	2.8	0.1	0.1	22.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	94.1	31.5	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	2.3	0.0	0.0	0.0	0.7	0.0	1.7	0.1	1.2	0.0	0.0	0.0	0.7	0.0	3.7	3.1	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.5	0.4	0.0	1.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.5	0.0	0.0	0.0	6.7
IL36RN	"FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840"	ENSG00000136695	"Interleukin 36 receptor antagonist"	Q9UBH0	2	113058638-113065382	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 26.7;skin 1: 31.9;tongue: 68.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.8;Syncytiotrophoblasts: 3.2"	"Cancer enriched"	"Detected in some"	7	"head and neck cancer: 25.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"BEWO: 21.5;GAMG: 9.1;U-87 MG: 16.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	107000					"unprognostic (3.88e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"		"unprognostic (4.29e-1)"	"unprognostic (8.68e-3)"		"unprognostic (9.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"		"unprognostic (3.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.23e-3)"	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	68.9	26.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	9.1	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	3.2	0.0	0.0	0.1
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 55.0"	"Cell type enhanced"	"Detected in single"	22	"Suprabasal keratinocytes: 2.5"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"					"Cell type enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.9;PC-3: 10.6;RT4: 5.7"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.8	0.1	0.0	0.0	0.2	0.4	4.9	0.3	0.5	0.5	0.6	0.0	0.5	0.3	0.5	0.1	0.2	0.8	1.5	0.3	0.0	1.8	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.4	0.0	0.1	0.0	0.1	1.1	0.0	0.0	1.4	0.5	0.4	10.6	0.1	0.0	0.0	0.0	5.7	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.0	0.0	0.0	0.0
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.4"					"Low region specificity"	"Detected in many"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	NA	NA	13600				"CAB078477: AB_417057, HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell type enriched"	"Detected in many"	12	"monocytes: 1188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.8	1.1	0.3	1.0	1.8	18.0	0.2	1.5	0.3	0.2	0.0	0.1	31.2	0.1	0.8	0.0	0.2	0.1	0.6	6.4	0.5	0.2	0.3	0.0	0.2	1.4	0.2	0.1	25.3	0.0	0.2	0.4	1.0	0.2	0.4	0.1	0.5	0.5	1.7	1.2	1.6	0.4	0.4	0.2	0.5	0.3	0.1	0.2	1.4	1.5	3.8	0.5	0.0	0.5	2.2	4.7	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4	0.0	0.0	0.0	0.5	8.7	0.0	0.6	0.0	0.0	1.2	3.5	0.0	0.3	0.0	1.9	52.0	3.1	0.0	0.0	3.4	0.6	1.4	1.0	1.1	0.0	102.3	0.0	0.0	1.8	1.8	11.1	0.3	40.3	3.3	1188.5	0.0	0.1	0.5	0.0	0.4	1.6	0.2	0.0	2.1	11.9	2.5	7.2	0.7	5.0	0.1	1.4
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 107.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 34.4"	"Group enriched"	"Detected in all"	6	"B-cells: 34.4;granulocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA		49000	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	20.7	14.8	8.7	31.6	10.6	36.9	12.0	4.4	7.7	20.8	30.3	5.9	11.5	10.9	18.0	12.8	24.7	13.6	25.1	12.3	6.7	4.4	13.3	39.1	40.9	44.8	10.8	1.7	14.7	11.3	3.8	5.5	16.1	10.1	18.8	15.1	12.3	7.7	11.5	7.2	9.9	18.6	39.6	13.6	31.8	21.1	10.4	9.8	9.1	8.6	13.7	38.4	31.6	15.4	34.4	1.6	11.9	2.6	3.3	4.0	1.8	11.5	3.0	2.0	3.9	1.0	4.6	4.2	7.3	8.5	2.9	2.4	6.2	32.0	36.5	9.1	11.5	5.7	12.3	2.1	35.1	2.5	31.6	1.0	6.8	1.8	9.5	13.2	1.8	19.4	7.0	14.2	13.5	8.0	15.5	15.7	2.1	2.9	3.1	4.7	5.1	0.1	5.5	2.4	10.4	2.7	0.1	15.2	2.9	13.6	13.2	0.6	0.3	1.0	7.0	1.6	5.3	2.7	7.0	23.5	6.7	3.0	5.9	5.1	1.8	0.5	34.0	0.7	6.1	0.0	0.5	2.6	4.7	1.7	1.1	1.3	7.7	2.6	1.7	1.6	34.4	4.0	1.9	11.9	3.3	0.6	1.6	1.8	1.8	8.7	10.6	4.4	7.7	6.7	4.4	10.8	1.7	10.1	9.8	26.8	51.7	49.6	35.5	11.7	0.0	2.2	20.4	17.4	30.7	1.8	0.0	15.0	0.0	31.7	0.1	31.5	27.6	0.0	28.2	3.5	13.9	27.2	107.5	47.4	22.9	0.0	22.4	54.6	31.1	0.2	0.3	21.3	13.5	40.5	32.8	0.0	35.6	22.1	0.0	1.1	0.0	38.8	27.4	0.5	1.9	13.0	20.8	20.3	15.0	38.2
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541444-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.8;testis: 10.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"memory B-cell: 3.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HEK 293: 2.2;Hep G2: 7.2;TIME: 3.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB010304	Approved				"Secreted to blood"	NA	NA	4130				"CAB010304: AB_2296159"	"unprognostic (1.66e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.30e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-2)"		"unprognostic (7.98e-2)"	"unprognostic (2.03e-2)"		"unprognostic (3.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	0.1	0.1	0.3	0.3	1.0	0.0	0.1	0.3	1.3	0.2	0.1	0.0	0.0	1.0	0.5	0.0	0.1	0.7	1.1	0.4	1.0	0.3	0.1	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	2.0	0.0	0.9	0.1	0.3	0.0	0.1	0.0	0.1	0.1	1.8	0.1	0.3	0.1	0.3	10.6	0.0	0.4	0.7	0.0	0.2	0.2	0.2	3.8	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.8	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.4	0.9	0.4	0.8	0.0	0.2	0.8	0.0	0.0	0.0	0.5	0.0	0.0	3.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.0	0.3	1.3	1.0	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.7	0.1	0.0	0.0	0.0	0.0
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in many"	9	"Smooth muscle cells: 589.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 208.4;GAMG: 141.1"					"Low region specificity"	"Detected in single"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.8	208.4	3.9	13.4	0.0	0.0	0.0	6.8	1.3	141.1	0.1	0.0	0.0	5.3	8.2	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.5	0.0	39.8	5.7	3.8	1.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.5	0.0	0.0	0.7	0.0	0.0	1.2	1.3	0.1	2.4	0.4	0.0	2.3	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2	6.0	27.2	7.2	1.9	39.6	0.0	0.9	0.0	13.4	20.5	3.5	0.0	0.5	0.0	5.8	0.3	40.7	0.0	0.0	2.4	3.1	63.9	7.3	5.8	0.0	4.2	0.0	0.0	3.1	6.1	0.0	0.0	46.2	38.8	7.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	589.1	0.0	0.0	29.2	1.1	0.0	0.0	9.0
IL6ST	"CD130, GP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55994993	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Ito cells: 851.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 21.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.7;BJ hTERT+: 58.7;HHSteC: 65.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		100000000	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	44.8	34.2	24.7	25.5	23.4	8.8	76.9	15.9	22.9	38.1	23.9	15.0	29.0	8.7	26.1	24.9	22.7	23.1	31.1	31.9	21.9	19.7	37.2	71.2	36.3	70.0	25.8	14.7	42.1	16.4	35.8	36.2	97.0	22.5	31.9	17.1	20.0	26.3	33.0	27.1	12.5	20.6	36.6	33.8	35.5	19.7	13.7	20.3	19.4	37.6	12.5	18.7	33.7	51.1	0.7	2.1	0.9	3.8	0.8	21.0	4.0	9.5	11.9	3.9	9.2	27.6	57.7	15.9	28.5	58.7	15.4	22.9	16.7	9.2	0.3	21.4	17.6	35.0	4.1	3.0	8.5	31.6	0.8	3.1	2.2	9.8	13.7	65.6	0.2	4.6	50.5	4.6	33.4	16.3	22.9	35.1	0.8	1.6	40.2	17.7	1.6	0.4	0.4	0.6	1.2	3.9	0.5	10.8	5.5	8.4	5.6	2.1	3.4	11.5	3.8	11.7	10.7	19.2	1.5	56.4	5.9	6.7	24.1	15.0	9.9	4.2	0.3	15.9	0.4	15.5	0.2	3.8	0.1	0.8	3.5	0.4	0.7	4.9	0.8	2.1	0.6	21.0	5.9	0.9	0.8	0.6	1.8	3.4	4.0	24.7	23.4	15.9	22.9	21.9	19.7	25.8	14.7	22.5	20.3	125.0	112.6	23.8	82.7	92.3	54.8	67.9	140.1	99.0	149.0	64.6	33.4	63.8	6.6	64.2	9.5	210.0	31.1	23.3	53.6	60.1	240.2	110.2	31.3	186.2	46.3	15.9	19.0	851.3	103.7	11.5	98.1	51.0	75.9	21.6	29.0	179.7	66.2	30.6	122.7	46.2	33.9	97.0	142.0	37.1	34.3	73.0	85.1	35.0	13.3	89.2
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.5;lymphoid tissue: 26.3"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 40.2;Early spermatids: 81.1;Late spermatids: 98.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 13.2;HEL: 14.0;HMC-1: 20.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA019590	Approved				"Secreted to blood"	NA	NA	60700				"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	6.8	1.9	1.3	13.4	1.8	1.8	2.2	1.7	1.7	2.6	9.5	0.4	1.3	7.0	1.9	5.0	5.0	5.2	8.2	1.5	1.0	0.9	5.6	8.9	6.5	26.3	0.8	0.1	2.4	2.6	0.0	1.3	1.0	1.0	5.0	4.8	1.1	7.9	2.0	0.9	9.6	20.5	2.4	1.2	8.6	4.4	3.0	0.9	2.0	4.1	4.4	10.4	3.9	3.3	10.9	2.4	5.4	0.8	0.5	7.5	0.6	0.2	0.0	0.1	0.0	0.4	0.3	0.0	1.2	1.1	1.0	1.5	0.0	6.0	0.1	0.0	3.4	3.6	3.4	0.1	0.0	0.0	13.2	0.0	14.0	0.3	1.7	0.0	0.1	20.7	1.0	0.0	0.1	0.5	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	4.3	2.4	0.0	2.0	2.0	0.2	0.2	0.0	0.1	0.0	0.2	0.7	0.8	0.0	1.6	0.2	0.0	0.0	2.7	0.0	1.5	5.4	0.3	0.0	0.4	0.2	0.0	10.9	1.1	1.1	2.4	8.2	0.3	0.3	0.0	0.5	0.8	0.3	7.5	0.6	1.3	1.8	1.7	1.7	1.0	0.9	0.8	0.1	1.0	0.9	0.0	2.2	9.0	3.2	5.4	0.0	0.4	5.1	40.2	3.4	1.8	0.0	0.0	8.3	1.2	81.1	1.9	7.0	0.0	4.6	0.0	1.1	1.1	0.0	2.4	1.0	0.0	2.9	1.3	1.0	98.2	0.6	2.6	0.0	5.4	5.5	1.8	2.1	11.5	1.1	6.8	0.3	0.0	0.6	1.0	0.7	5.6	0.0	1.5	3.4	0.7
IL9	"HP40, IL-9, P40"	ENSG00000145839	"Interleukin 9"	P15248	5	135892246-135895827	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.0;skin 1: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	267	"HDLM-2: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	11000																						0.1	0.2	0.3	0.0	2.2	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	2.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.2	0.3	1.1	0.7	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921115-76072678	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 110.5"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 634.2;Rod photoreceptor cells: 409.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;AF22: 3.0;HaCaT: 4.1;TIME: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.6	0.0	0.4	0.4	10.3	0.0	0.4	1.0	2.8	0.4	0.4	0.4	0.4	2.8	0.4	0.4	0.4	0.1	1.1	0.5	0.5	0.4	0.8	0.4	0.5	0.4	0.5	0.4	0.4	5.4	0.0	0.4	0.6	0.4	0.7	0.0	110.5	0.6	0.4	0.6	4.0	2.3	0.4	0.4	0.5	0.7	0.9	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	3.0	0.0	0.0	0.6	1.6	0.8	0.0	0.0	0.0	1.8	0.6	0.0	0.3	0.0	0.1	4.1	0.0	0.0	0.0	0.1	1.5	0.7	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.2	0.6	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.7	1.2	0.0	1.8	0.4	0.6	0.0	0.3	2.4	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.3	1.0	1.9	0.5	0.4	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	44.9	0.2	0.0	0.0	0.0	0.0	634.2	0.1	3.3	0.0	1.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.2	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	409.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 276.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.5	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	0.7	2.6	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	0.9	1.3	0.0	0.7	2.5	0.0	0.0	3.3	0.0	0.1	3.0	0.0	0.2	1.7	0.2	1.1	0.1	0.2	0.0	0.7	0.3	0.4	1.0	1.6	12.8	0.4	6.6	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5	0.0	0.0	0.0	0.1	0.0	3.4	1.4	0.0	0.0	0.0	7.0	2.0	6.0	0.0	1.5	0.7	0.0	0.0	0.0	7.9	29.6	0.2	0.0	0.0	0.0	2.3	6.4	0.0	1.3	0.3	4.1	3.7	0.0	0.0	0.0	0.0	3.3	3.3	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.4	0.0	276.8	0.0	0.0	0.0
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell type enhanced"	"Detected in many"	17	"Leydig cells: 127.4;Smooth muscle cells: 270.9;Syncytiotrophoblasts: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.2;hTEC/SVTERT24-B: 58.9;hTERT-HME1: 24.3;hTERT-RPE1: 36.3;TIME: 30.4;U-138 MG: 45.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		290000				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.6	0.5	2.5	0.8	0.0	0.1	0.0	0.3	1.7	3.0	3.8	0.0	19.2	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	58.9	24.3	36.3	2.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	1.7	0.0	0.0	30.4	45.9	13.3	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3	3.0	17.8	0.5	7.8	15.3	0.0	4.8	0.0	4.0	5.7	0.0	0.0	0.4	0.0	4.5	0.5	3.1	0.0	0.0	1.6	2.6	14.6	5.6	7.0	11.4	1.4	0.0	0.0	1.3	2.7	1.9	127.4	45.7	13.5	46.9	0.0	12.6	10.6	0.0	21.9	0.0	0.9	0.0	270.9	0.5	0.1	7.9	149.2	0.0	0.0	2.3
INHBB		ENSG00000163083	"Inhibin beta B subunit"	P09529	2	120346143-120351808	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 15.3;Ciliated cells: 41.5;Cone photoreceptor cells: 23.6;Ito cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;ASC diff: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 13.0;MCF7: 18.6;PC-3: 30.2;SK-BR-3: 54.1;T-47d: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.57e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.76e-2)"	23.3	3.6	6.0	1.2	3.5	0.2	19.2	0.9	3.8	7.0	0.8	3.1	2.6	1.3	3.9	2.6	1.5	3.3	2.4	3.5	4.7	1.4	1.2	19.2	2.7	1.0	2.2	3.1	1.6	3.5	4.5	3.8	1.2	4.7	7.7	0.3	0.5	7.8	0.9	4.9	7.6	0.9	2.1	1.9	0.4	1.8	14.4	2.2	0.4	19.1	1.6	1.3	4.4	7.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.8	15.5	0.0	0.0	21.5	1.7	0.0	1.0	1.2	6.9	13.0	0.3	0.0	0.0	2.8	0.4	0.0	0.0	1.2	0.0	9.7	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.8	1.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	1.5	30.2	0.0	0.0	0.3	1.8	0.0	1.8	0.0	0.0	54.1	0.0	0.0	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	3.5	0.9	3.7	4.7	1.4	2.2	3.1	4.7	2.2	3.0	2.1	0.0	2.0	3.5	0.0	0.6	15.3	41.5	7.9	1.8	23.6	0.0	0.0	0.3	0.6	8.4	0.0	0.0	0.0	0.2	2.1	9.5	0.0	9.6	0.1	0.0	0.0	15.4	1.6	1.9	10.9	0.2	1.7	0.0	0.0	0.3	0.1	0.0	6.3	0.0	0.3	0.0	2.5	0.0	7.1	2.6	0.1	0.0	0.0	1.8
INHBC		ENSG00000175189	"Inhibin beta C subunit"	P55103	12	57434760-57450828	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	256	"liver: 121.3"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 5.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 9.7;Karpas-707: 10.0;RH-30: 5.0;U-266/70: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000				"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0.0	9.7	0.0	0.4	0.1	0.4	0.0	0.0	0.7	0.0	0.0	2.7	0.1	10.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	5.0	0.7	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.1	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin beta E subunit"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 127.6"	"Cell type enriched"	"Detected in single"	51	"Hepatocytes: 32.6"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		1400000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	127.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.0	0.9	3.1	0.6	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.8	2.2	0.0	2.7	0.1	0.0	1.1	0.5	0.2	0.0	0.1	0.5	0.0	0.3	5.1	0.0	0.0	0.0	3.3	15.2	0.6	0.7	1.4	1.5	0.3	3.3	0.1	0.0	0.5	1.3	22.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	2.3	0.0	0.0	5.7	0.2	0.0	0.0	2.1	0.1	0.1	2.4	0.0	0.0	1.2	0.0	0.1	76.9	2.4	1.0	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1.0	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161341	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"pancreas: 514.0"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 2404.6"	"Cancer enriched"	"Detected in single"	7166	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 53.7;U-2 OS: 70.4;U-698: 22.2"					"Region enriched"	"Detected in single"	13	"midbrain: 1.7"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000				"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.4	0.0	5.4	0.0	2.4	22.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.2	0.0	0.0	2404.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	148	"pancreas: 467.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.2;SH-SY5Y: 5.8"									CAB019430	Enhanced				"Secreted to digestive system"	NA	NA					"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.3	0.0	0.4	467.6	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 234.1"	"Group enriched"	"Detected in some"	68	"Leydig cells: 1148.3;Peritubular cells: 938.7"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.9;PC-3: 4.1;SCLC-21H: 8.2;SH-SY5Y: 7.4"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000				"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.1	0.4	0.1	1.1	0.2	0.3	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.3	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	9.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	1.1	0.1	234.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.3	5.7	1.2	1.3	2.9	1.1	0.4	1.0	0.2	0.8	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1.7	0.2	2.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.3	0.0	0.1	2.0	1.3	0.9	0.0	0.0	0.0	0.0	0.2	0.1	8.9	0.0	1.6	0.3	1.6	0.0	1.7	4.1	1.3	0.0	0.2	0.2	0.5	8.2	7.4	0.1	2.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.7	3.1	0.2	0.1	2.0	0.0	0.8	0.5	0.0	1.8	1.2	1.8	0.3	2.4	2.3	0.3	2.4	2.1	2.9	5.7	1.3	0.3	0.3	2.0	1.1	0.1	0.2	0.2	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	15.4	1148.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	938.7	0.0	0.0	0.0	0.0	2.6	4.7	0.0	0.5	0.0	0.0	0.0
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"placenta: 88.0"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 2990.3"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"A549: 23.6"									HPA065145			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA065145: "		"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	88.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	23.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	269.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2990.3	0.0	0.0	0.0
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"intestine: 52.9"	"Cell type enriched"	"Detected in some"	577	"Intestinal endocrine cells: 8520.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;hTCEpi: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030100, CAB033849"	Enhanced				"Secreted to blood"	NA	NA	38500000				"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.1	1.0	0.0	30.8			0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	1.8	0.4	0.0	0.0	0.0	0.5		0.0	0.0	0.0	0.5	0.0		0.2	52.9		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8520.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5131979-5185668	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 22.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 106.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;HL-60: 1.6"					"Low region specificity"	"Detected in single"			HPA021364	Enhanced				"Secreted to blood"	NA	NA					"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	20.6	9.0	0.0	0.2	0.0	0.0	0.0
ISG15	"G1P2, IFI15, UCRP"	ENSG00000187608	"ISG15 ubiquitin-like modifier"	P05161	1	1001138-1014541	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.3;salivary gland: 116.2"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 427.6;Smooth muscle cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 140.4;BJ hTERT+ SV40 Large T+ RasG12V: 141.7;HeLa: 45.8;SK-MEL-30: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004627	Approved				"Secreted to blood"	NA	NA	5000000				"HPA004627: AB_1079152"	"unprognostic (3.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.11e-10)"	"unprognostic (4.55e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.46e-2)"	25.0	5.5	22.6	14.5	14.8	48.5	8.5	2.3	22.7	15.2	11.3	6.2	5.5	17.4	12.8	20.4	7.9	4.3	12.7	12.0	13.2	16.4	29.8	28.9	18.3	13.0	12.0	8.6	6.5	8.2	2.6	10.7	50.1	13.4	9.9	3.5	7.6	116.2	9.0	7.1	3.4	16.8	7.8	17.8	26.9	11.2	4.9	6.4	28.7	16.7	6.2	9.4	9.3	9.1	30.4	22.0	103.3	50.6	31.4	61.3	27.7	5.4	0.8	0.4	3.7	0.5	1.1	3.3	3.8	9.1	140.4	141.7	8.8	8.8	4.8	27.7	3.1	24.5	3.4	0.4	1.6	2.1	5.4	2.4	2.2	45.8	5.9	5.3	1.4	9.3	2.4	0.5	8.9	0.1	0.4	4.3	6.5	1.3	2.6	1.1	25.9	4.6	23.5	0.4	3.4	29.9	8.0	1.1	2.4	1.8	1.6	0.1	0.1	7.4	1.2	44.5	0.2	0.2	2.8	2.4	2.8	2.7	1.2	0.8	3.5	1.8	3.5	2.7	5.5	0.2	55.8	35.9	103.3	30.3	50.6	39.3	30.4	35.1	33.5	22.0	23.5	22.7	26.2	83.7	31.4	42.9	7.3	61.3	27.7	22.6	14.8	2.3	22.7	13.2	16.4	12.0	8.6	13.4	6.4	35.7	20.3	41.2	41.4	39.6	1.5	18.2	35.7	24.1	26.1	43.6	0.0	12.7	5.0	129.5	3.0	180.0	253.7	0.0	242.3	427.6	85.6	41.8	60.0	52.1	238.9	0.0	33.7	74.9	63.0	9.3	30.5	163.4	84.4	57.7	87.1	19.4	135.8	228.0	38.9	17.0	1.4	97.0	303.7	1.7	1.1	32.2	27.0	93.5	15.6	46.9
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3"	"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.9	18.2	0.1	5.2	0.0	0.0	0.0	0.0	2.1	0.0	0.3	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	4.0	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6	0.0	2.2	0.0	0.1	10.4	0.0	3.1	0.0	2.7	1.2	0.0	0.0	1.1	0.0	0.2	1.7	8.7	0.0	0.0	0.2	1.6	63.6	0.1	0.0	0.0	3.5	0.0	0.0	7.4	0.0	3.2	199.0	0.8	11.8	0.0	0.0	0.1	1.3	0.0	150.3	0.0	0.3	25.8	21.7	0.9	0.5	7.8	0.8	0.0	0.0	0.2
ISM1	"bA149I18.1, C20orf82"	ENSG00000101230	"Isthmin 1"	B1AKI9	20	13221771-13300651	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 4.0;Fibroblasts: 8.1;Proximal tubular cells: 3.1;Suprabasal keratinocytes: 2.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Group enriched"	"Detected in some"	5	"ASC diff: 36.3;Hep G2: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.13e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.27e-3)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.32e-6)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.81e-2)"	7.8	2.4	0.8	0.5	1.1	0.0	17.0	0.7	1.5	2.4	2.1	0.8	2.0	0.3	1.8	2.3	4.5	2.3	4.4	2.2	1.0	1.7	2.4	4.5	3.2	1.0	0.7	0.9	1.1	5.7	0.1	1.0	12.7	1.3	1.9	0.2	0.8	8.9	0.7	2.3	9.2	1.1	1.7	0.6	4.8	1.9	1.2	0.8	1.4	33.8	5.5	1.1	3.8	6.1	0.0	0.0	0.0	0.0	0.0	4.0	1.5	0.0	0.3	0.2	0.5	36.3	5.1	0.2	0.3	3.0	0.0	0.0	2.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	13.9	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.2	0.0	0.3	0.3	0.0	0.2	1.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	1.0	0.1	0.7	0.0	0.0	0.0	2.1	0.3	0.1	0.2	0.0	3.4	0.6	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.8	1.1	0.7	1.5	1.0	1.7	0.7	0.9	1.3	0.8	0.0	0.3	0.0	0.5	4.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	2.3	0.0	0.0	0.0	0.2	8.1	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.8	0.0	0.2	2.5	0.6	0.5	0.0	0.1
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 91.4"	"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	240.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	440.1	0.3	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	148.4	0.0	0.0	0.0
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Fibroblasts: 24.6;Ito cells: 14.7;Peritubular cells: 7.8;Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2;ASC TERT1: 30.3;fHDF/TERT166: 71.2;LHCN-M2: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.7	6.3	1.2	1.1	1.7	0.0	24.0	8.3	1.6	17.6	1.4	2.7	2.0	0.3	3.4	1.7	19.5	3.5	25.5	13.6	2.7	2.2	2.0	4.9	17.9	0.7	4.0	4.0	3.6	5.2	3.4	18.8	21.6	5.9	8.4	1.7	15.8	18.1	3.0	6.5	9.9	0.4	19.5	7.7	2.4	5.8	3.8	1.6	0.4	6.2	14.3	2.7	11.9	17.4	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	45.2	30.3	0.0	13.6	14.1	6.2	4.0	0.0	0.5	0.0	0.0	71.2	2.9	14.7	0.0	5.0	9.8	0.0	0.0	4.3	0.1	0.0	4.7	0.0	0.0	12.8	0.3	3.5	10.0	11.8	16.0	0.0	0.3	0.1	65.3	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.1	7.1	5.7	0.0	1.7	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.2	1.7	8.3	1.6	2.7	2.2	4.0	4.0	5.9	1.6	3.0	0.3	0.0	0.0	3.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	3.0	0.1	0.0	0.0	0.2	0.4	24.6	0.0	0.0	0.4	0.5	4.8	0.0	14.7	0.0	1.1	0.0	0.3	5.0	0.0	0.0	0.3	0.7	0.0	7.8	0.0	0.4	0.0	6.6	8.6	7.2	2.0	0.7	0.0	0.0	0.1
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777592-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"liver: 321.2"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 864.9"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	31000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	321.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	864.9	0.1	0.0	0.0	18.4	14.8	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.5	0.0	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703269-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"liver: 249.0"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 455.1"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	445	"Hep G2: 155.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		22000000000	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	249.0	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0.0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.3	94.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	455.1	0.1	0.0	0.0	11.1	9.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	233	"liver: 326.9"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 931.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 19.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		4500000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	0.9	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0.0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	35.0	0.0	0.1	0.5	0.4	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.5	0.0	23.3	0.0	0.0	0.1	0.0	0.0	931.8	0.0	0.0	0.0	69.3	71.7	90.2	1.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.0	6.7	0.2	0.1	0.1	0.2	0.5	0.0	0.0
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain family member 4"	Q14624	3	52812975-52831479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 461.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 104.1;Hepatocytes: 95.7;Late spermatids: 94.2"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;JURKAT: 4.5;U-266/70: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	53000000000	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	0.5	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	1.3	0.2	0.1	0.1	0.6	0.1	0.0	0.2	461.4	0.2	0.1	0.1	0.2	0.2	22.8	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	4.1	0.1	0.1	0.2	0.1	0.5	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.3	0.3	0.6	0.6	2.6	0.8	0.0	0.0	0.4	1.0	2.1	1.1	0.0	0.4	0.1	0.0	0.0	0.2	0.3	0.2	1.3	0.0	0.5	0.2	1.1	0.0	0.0	0.5	5.3	0.2	2.2	0.0	2.8	0.9	2.4	0.2	0.3	0.3	0.0	0.1	0.0	0.0	4.5	0.6	1.8	0.0	0.2	0.5	0.7	1.0	0.2	0.0	1.8	1.0	0.0	0.8	0.7	0.1	1.0	0.7	0.0	0.4	1.1	1.1	0.7	0.2	0.0	0.9	1.0	0.0	6.5	3.0	0.5	0.1	0.7	1.2	0.0	0.6	0.0	0.1	0.1	0.1	0.3	0.7	0.0	0.0	0.2	0.0	0.8	0.6	2.6	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.6	1.9	0.2	0.7	10.2	0.4	5.1	0.0	1.2	0.0	11.8	0.0	0.0	0.3	104.1	0.6	0.0	23.3	2.3	0.0	0.4	0.3	0.0	95.7	0.4	4.8	0.0	3.1	2.6	94.2	1.1	1.6	0.0	1.0	0.0	1.7	3.5	0.0	1.8	0.0	5.6	6.5	2.1	0.9	1.4	0.3	0.2	1.3	0.0	0.1
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain family member 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"placenta: 58.6"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 223.5;Sertoli cells: 77.6;Smooth muscle cells: 89.6;Syncytiotrophoblasts: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"WM-115: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	42.6	2.4	3.7	15.2	5.0	0.0	33.7	2.9	5.1	8.1	9.4	3.6	4.4	4.1	12.0	8.6	6.9	3.4	18.8	4.8	4.4	4.0	5.3	2.3	6.9	3.2	4.4	4.3	7.2	4.4	1.4	3.1	58.6	4.6	11.0	5.3	12.7	3.4	16.2	4.7	4.1	5.7	37.5	3.9	2.2	5.6	4.0	2.2	0.0	6.4	5.2	5.5	24.0	11.7	0.8	0.4	1.4	0.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	7.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	1.4	0.3	0.3	0.4	0.4	0.5	0.4	0.6	0.4	0.2	0.8	0.6	0.5	1.0	0.5	0.5	0.4	0.5	0.1	3.7	5.0	2.9	5.1	4.4	4.0	4.4	4.3	4.6	2.2	3.0	2.4	0.0	2.3	10.1	1.3	4.0	5.1	1.4	6.8	0.0	2.0	223.5	0.0	15.3	1.6	30.5	0.0	0.0	0.3	45.7	53.7	1.2	2.3	0.0	18.1	0.0	0.0	1.8	0.0	1.6	4.9	3.3	13.5	1.0	0.0	25.4	0.5	0.0	14.5	1.0	2.1	77.6	89.6	1.9	7.5	7.8	185.6	0.0	0.0	1.4
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"WM-115: 34.1"									HPA000506	Uncertain				"Secreted to blood"	NA	NA					"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell type enriched"	"Detected in many"	16	"Mucus-secreting cells: 1345.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Group enriched"	"Detected in some"	4	"HEL: 3.8;HL-60: 2.8;OE19: 10.5;U-937: 10.6"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.5	0.0	0.0	0.0	1.5	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	10.6	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2	0.0	6.7	0.9	0.1	0.0	0.0	6.1	2.5	1.4	3.4	3.5	0.0	0.0	0.0	0.0	0.5	0.0	20.4	0.0	3.3	0.7	0.0	0.3	1.1	0.0	0.8	0.0	17.2	81.0	86.0	0.4	13.6	0.0	0.0	0.0	1345.2	0.0	4.3	11.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	43.2	0.1
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 71.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4"									"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	5.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	71.5	7.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	8.0	0.0	0.0	1.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 108.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1393.1;Late spermatids: 1780.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.1;RPMI-8226: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	1.6	1.1	4.4	0.9	5.6	0.6	0.9	1.3	4.4	1.0	0.8	2.9	1.2	0.6	0.9	1.6	1.0	1.4	1.3	1.6	4.4	2.1	1.1	2.0	0.9	1.1	10.5	3.3	3.0	8.3	0.8	2.7	0.6	4.2	1.9	0.8	0.6	1.4	1.6	0.9	1.4	0.7	0.7	3.6	0.8	1.0	108.2	6.6	0.4	1.3	0.8	1.4	0.9	0.6	5.3	2.8	3.4	3.1	1.0	5.1	2.6	0.8	0.7	0.4	3.4	1.5	1.6	0.5	0.5	0.8	0.6	0.1	0.3	0.7	0.6	0.8	0.8	0.0	0.7	0.1	3.8	0.2	1.6	0.3	0.0	1.3	1.0	4.3	0.0	0.6	0.6	1.4	1.0	1.1	1.2	0.0	2.0	0.0	11.1	1.4	0.2	1.0	0.3	0.3	1.4	0.9	0.8	0.0	13.4	1.7	0.4	0.6	0.9	0.5	1.2	0.5	0.2	0.6	1.3	0.5	0.5	0.2	0.1	0.3	1.2	1.4	1.0	1.8	1.2	0.3	0.0	1.6	1.4	1.6	2.2	3.5	5.3	5.1	3.7	2.2	1.8	4.1	1.7	3.4	1.0	3.1	2.8	4.7	2.6	4.4	5.6	1.3	4.4	4.4	2.1	10.5	3.3	4.2	6.6	0.0	0.0	0.9	3.8	2.2	3.7	1.2	2.5	0.0	0.0	8.7	7.9	0.4	5.0	2.0	1393.1	0.6	1.6	0.0	5.1	3.3	0.9	6.1	0.0	8.9	0.8	0.0	7.5	0.6	2.1	1780.5	26.4	1.6	11.8	16.2	1.9	6.0	2.5	0.0	18.7	7.2	8.7	6.5	1.3	339.6	12.2	1.5	1.4	5.1	2.6	3.7
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134068925-134152001	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.0"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 60.5;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.2"	"Group enriched"	"Detected in many"	7	"B-cells: 8.2;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		570000	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	14.0	14.9	17.6	7.9	34.1	2.2	9.9	7.0	28.7	15.5	23.4	77.0	6.9	5.9	25.0	12.9	16.3	11.9	17.8	21.4	26.1	16.9	6.7	3.0	13.7	6.2	40.3	17.4	32.0	4.4	14.5	19.5	68.8	29.6	26.2	9.7	17.5	9.4	32.5	4.1	9.1	11.7	29.7	34.8	8.7	12.0	24.8	34.1	5.1	7.6	4.6	5.6	22.7	22.6	8.2	0.2	0.8	0.1	0.1	4.0	2.9	0.2	0.4	28.4	14.6	26.5	19.7	23.8	12.1	14.3	4.5	4.5	0.4	0.2	0.3	12.5	15.7	18.3	0.4	20.4	0.2	8.6	0.2	10.2	0.8	0.1	1.8	7.9	0.5	12.6	13.4	0.0	3.2	2.9	11.4	29.5	13.2	0.3	0.2	19.5	0.3	8.7	1.0	6.7	0.3	1.2	0.2	38.8	0.2	0.2	0.1	19.1	10.7	0.2	0.3	0.4	12.6	0.3	0.3	0.2	8.5	6.2	13.3	8.2	0.1	0.1	0.2	9.4	1.2	16.2	0.4	0.1	0.3	2.2	0.0	2.6	8.2	2.8	1.6	0.2	4.8	4.0	2.6	0.8	0.1	0.0	0.2	0.1	2.9	17.6	34.1	7.0	28.7	26.1	16.9	40.3	17.4	29.6	34.1	0.0	8.9	6.9	5.7	4.5	16.1	14.9	0.0	2.7	1.2	5.2	7.9	4.8	1.7	0.4	1.9	26.3	0.0	0.0	0.2	40.4	29.1	1.6	1.1	0.0	6.8	7.9	0.0	16.0	0.8	3.6	39.7	0.9	16.9	0.0	0.0	18.1	0.3	0.0	60.5	0.0	71.5	25.8	29.8	12.5	19.0	3.3	5.1	0.7	0.0	0.7
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 2: 174.1;B-cells: 379.6;Erythroid cells: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 162.4;Karpas-707: 86.7;RPMI-8226: 172.1;U-266/70: 366.4;U-266/84: 142.2;U-698: 211.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		4200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	162.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	86.7	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.1	172.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.5	0.2	0.2	366.4	142.2	211.2	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7	20.8	174.1	379.6	2.5	0.0	0.0	0.3	10.2	6.7	14.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	864.3	0.0	0.1	0.0	0.5	73.2	1.5	0.3	0.0	7.0	91.4	24.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.9	0.2	0.0	0.2	10.2	0.0	0.3
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061841-101068131	"Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 34.5;Erythroid cells: 23.3;Mucus-secreting cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.7;T-47d: 29.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011800	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.11e-1)"	2.6	0.6	0.8	3.2	0.5	0.1	2.6	0.3	1.0	10.3	2.3	0.4	2.9	3.3	5.2	10.6	1.6	2.0	3.0	7.7	1.0	0.4	1.9	0.4	2.4	2.8	0.6	0.3	1.9	1.1	1.6	3.6	1.1	1.5	24.0	2.0	22.5	8.3	3.0	4.8	1.7	3.7	5.6	0.5	20.6	8.7	1.8	0.3	0.6	2.5	5.7	2.3	3.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	1.8	22.7	1.9	6.9	1.7	4.2	4.8	1.1	1.0	4.9	1.8	0.2	2.4	4.2	0.4	0.4	1.5	0.0	0.2	2.7	0.8	0.4	5.0	4.8	0.4	0.3	2.1	0.9	0.3	0.1	0.8	0.3	0.1	0.8	0.6	2.5	0.7	3.8	0.1	1.5	0.5	5.8	9.2	9.7	8.5	0.3	0.5	1.2	0.3	1.0	0.5	0.7	1.3	0.5	29.0	0.6	0.1	0.6	1.9	0.3	1.1	0.8	2.1	2.0	1.1	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	1.0	1.0	0.4	0.6	0.3	1.5	0.3	0.0	1.0	0.0	0.8	1.8	1.2	0.8	2.5	0.0	0.0	0.0	2.0	0.3	1.7	0.6	0.0	3.6	34.5	23.3	1.8	0.5	12.7	7.7	0.0	0.0	0.8	0.0	2.4	2.5	3.7	0.0	9.2	0.3	1.7	0.0	45.7	0.8	1.3	10.4	0.4	0.3	1.6	0.0	3.9	3.5	1.1	2.5	0.5	0.0	6.3	0.3
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 50.6;Early spermatids: 18.3;Late spermatids: 21.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.7;HMC-1: 7.7;U-87 MG: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	13.7	0.2	2.1	0.0	0.3	1.0	0.0	0.0	0.0	1.9	0.1	1.0	0.0	1.2	0.2	0.0	7.7	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.9	0.4	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											11.9	4.3	0.8	1.1	0.0	2.5	0.8	0.0	0.0	6.8	50.6	2.0	0.2	0.0	0.2	18.3	0.3	5.9	0.0	0.2	1.0	1.1	0.3	2.3	0.2	1.0	3.2	2.4	2.5	2.2	21.8	1.1	2.3	0.0	0.0	3.1	0.2	2.5	1.9	0.4	2.9	1.0	0.0	0.0	5.1	2.4	0.0	1.1	1.9	6.4	3.6
KERA	"CNA2, SLRR2B"	ENSG00000139330	Keratocan	O60938	12	91050491-91057983	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 10.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 10.7;basal ganglia: 8.1;cerebral cortex: 16.0;hippocampal formation: 13.1"	HPA039321	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA039321: AB_10795248"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.65e-1)"		"unprognostic (6.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.96e-2)"		"unprognostic (4.93e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.53e-1)"	0.8	0.0	0.2	1.9	0.2	0.0	2.9	0.0	0.2	1.9	2.5	0.0	0.0	0.0	1.0	2.5	1.5	2.2	4.3	0.4	0.1	0.0	0.0	0.0	0.6	0.2	0.5	0.0	0.6	0.0	0.0	0.0	1.5	0.2	0.5	0.3	0.0	2.8	0.2	4.7	0.2	0.9	0.4	0.0	0.0	1.3	0.2	0.0	0.3	0.1	10.9	0.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614440-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	No	No			"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	27.7	31.2	22.3	21.3	34.7	21.9	26.3	28.1	40.1	20.0	24.0	28.2	20.9	15.5	24.7	21.6	25.4	24.0	20.1	21.4	22.0	22.4	38.1	30.7	24.1	26.3	23.1	19.6	25.6	24.6	48.0	27.0	32.7	35.6	22.7	28.5	22.1	27.0	23.3	40.7	25.0	27.9	28.4	21.4	26.4	22.8	24.8	18.6	26.3	28.6	20.2	26.6	22.7	18.8	2.9	7.2	3.5	3.0	2.0	3.3	1.3	19.6	37.6	19.1	18.1	34.8	20.8	13.9	18.4	24.6	22.6	21.3	25.8	9.0	27.4	22.2	33.6	23.6	26.3	28.0	27.3	27.4	30.3	26.2	21.8	29.8	14.1	15.0	38.0	37.9	21.2	21.2	30.5	23.3	17.6	32.2	19.6	20.5	8.9	20.5	28.2	27.7	18.1	8.3	35.7	13.9	21.3	21.4	17.9	13.6	35.4	18.8	14.5	23.2	63.6	15.5	24.8	38.0	26.6	29.7	17.3	19.1	23.1	34.7	8.4	9.7	17.7	19.7	24.7	20.1	0.8	3.0	3.5	3.0	2.5	3.3	2.9	1.5	2.7	3.3	1.7	1.8	1.8	1.8	2.0	2.7	7.2	1.7	1.3	22.3	34.7	28.1	40.1	22.0	22.4	23.1	19.6	35.6	18.6	14.9	19.1	3.9	6.3	9.2	31.3	27.1	15.3	12.0	12.5	12.2	27.5	10.4	5.0	8.4	12.4	10.5	22.7	23.3	9.4	8.0	8.9	11.1	8.1	28.0	9.4	27.0	11.6	21.5	29.7	18.3	8.6	15.0	10.1	14.4	15.6	12.6	9.2	8.6	6.0	13.8	22.8	0.0	7.8	16.9	20.9	9.7	38.1	8.6	16.1	11.2
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 57.8;Late spermatids: 47.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	4.3	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	1.9	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.2	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.4	0.8	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3	3.0	0.3	0.0	0.0	0.0	1.8	1.2	0.0	10.7	2.3	0.0	0.0	0.0	0.0	0.2	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	47.2	0.6	0.0	0.0	1.0	0.7	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.6	0.0	0.3	0.2
KIR3DX1	"FLJ00060, LENG12"	ENSG00000104970	"Killer cell immunoglobulin like receptor, three Ig domains X1"		19	54532692-54545771	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 13.1;Ciliated cells: 2.7;Club cells: 4.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"U-266/84: 10.0"									HPA052110	Uncertain				"Secreted - unknown location"	NA	NA					"HPA052110: AB_2681731"	"unprognostic (5.85e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.47e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.22e-4)"	"unprognostic (1.36e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.73e-9)"	"unprognostic (1.09e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.20e-3)"	1.9	0.0	0.0	1.3	0.6	2.2	0.3	0.0	1.2	0.6	0.2	3.9	0.0	0.0	1.0	0.0	0.5	0.1	0.4	3.6	0.1		0.1	0.2	2.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.5	0.6	4.6	0.0	0.5	0.1	0.0	0.2	0.0	2.7	0.0	0.0	0.4	0.3	1.7	0.2	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.0	0.0	0.0	0.8	0.0	1.7	0.2	0.0	1.1	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.1	0.2	0.6	1.2	0.0	0.3	0.3	0.0											0.0	13.1	0.9	0.5	0.6	0.0	0.2	0.0	2.7	4.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.3
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Cell type enriched"	"Detected in many"	41	"Syncytiotrophoblasts: 1117.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BJ: 55.9;U-2 OS: 22.8"					"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	55.9	0.7	1.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	3.3	27.0	0.3	5.1	0.0	4.0	4.1	0.4	1.8	0.0	2.9	14.5	0.0	0.0	1.3	0.0	3.1	0.3	0.0	0.0	0.0	0.6	0.0	2.9	0.8	0.0	1.2	0.0	0.0	0.1	0.1	0.4	0.0	1117.8	0.0	1.9	2.2
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell type enhanced"	"Detected in many"	19	"Exocrine glandular cells: 663.7;Mucus-secreting cells: 890.7;Pancreatic endocrine cells: 205.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 29.2"														"Secreted to digestive system"	NA	NA		4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	17.9	1.4	17.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	38.1	2.8	0.4	0.1	46.5	0.0	663.7	0.0	1.6	15.7	9.2	0.0	0.6	0.0	112.7	0.0	0.8	0.0	5.8	2.9	5.0	9.0	890.7	0.0	205.3	113.2	0.0	0.2	0.0	0.0	0.1	0.3	0.7	47.2	0.0	0.0	128.7	3.4
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		670000				"prognostic favorable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.7	0.0	2.8	0.0	0.0	76.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	49.9	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2	29.8	1.6	0.0	13.6	6.6	0.6	0.4	7.6	10.7	77.3	0.0	0.0	0.0	0.0	3.4	0.2	0.3	0.0	0.0	14.1	0.0	0.5	41.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	10.6	1.1	0.0	1.0	0.0	0.2	43.5	0.0	5.6	0.0	0.4	0.0	0.9	0.9	1.2	3.8	0.0	0.0	0.0	18.7
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HaCaT: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	9.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2	80.4	7.2	0.0	141.1	94.9	0.0	0.4	63.7	26.8	108.1	0.0	0.0	0.0	0.0	2.9	105.3	2.2	0.0	0.0	118.6	0.0	8.9	237.5	1.1	0.0	0.3	0.0	19.4	0.0	0.0	257.5	2.6	2.6	8.5	0.0	2.8	0.0	49.0	0.0	0.4	0.0	1.4	0.0	0.3	2.1	2.5	189.7	0.0	0.0	0.3	143.9
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 22.9;Intestinal endocrine cells: 38.5;Late spermatids: 21.2;Mucus-secreting cells: 8.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0;U-698: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"	NA	NA					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favorable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	38.5	0.0	0.0	21.2	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	1.8
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51056206-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 100.5"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 184.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HaCaT: 20.8"	"Not detected"	"Not detected"							HPA062136	Enhanced				"Secreted in other tissues"	NA	NA					"HPA062136: AB_2684694"	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0.0	0.5	0.1	0.2	0.1	0.0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	20.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.6	1.8	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	184.3	0.3	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.7	1.1	0.0	0.0	0.0	2.0
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.2"	"Group enriched"	"Detected in some"	29	"Ciliated cells: 1.4;Club cells: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;HEK 293: 4.0;U-266/84: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026228	Uncertain				"Secreted in other tissues"	NA	NA					"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.2	0.0	0.4	0.2	1.2	0.1	2.7	2.1	0.9	3.8	0.6			1.8	0.4	0.9	1.2	0.8	0.3	1.1	0.6	0.5	0.1	0.1	0.5	0.4	0.3		0.9	0.4	0.0	0.3	0.0		0.7	0.4		1.1	0.7	0.3	14.2	1.0	0.0	0.3	0.4	0.8	0.7			0.1		0.6	0.2	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.8	0.1	1.0	0.7	0.6	0.8	0.2	0.0	0.0	0.2	1.7	2.1	0.8	0.6	0.3	0.4	14.0	0.2	0.3	0.0	0.5	4.0	0.3	1.0	0.0	0.2	0.3	0.3	0.4	0.4	0.5	0.6	0.2	0.2	0.6	0.3	0.5	0.0	1.2	0.2	0.8	0.8	1.6	1.5	0.2	0.1	0.8	0.0	0.7	0.1	0.0	0.3	1.3	0.4	0.4	0.6	0.0	0.0	0.2	0.6	0.9	0.2	3.7	7.3	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 5.7;salivary gland: 9.7"	"Cell type enhanced"	"Detected in some"	19	"Late spermatids: 6.7;Mucus-secreting cells: 21.9;Spermatocytes: 14.7;Spermatogonia: 7.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 7.3"	"Not detected"	"Not detected"							HPA019802	Uncertain				"Secreted to blood"	NA	NA					"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		1.4	2.1		9.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	2.1			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	6.7	0.9	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	7.0	0.0	0.0	0.0	0.6	0.0
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"prostate: 163.5"	"Cell type enriched"	"Detected in some"	36	"Glandular cells: 729.8"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.0;NB-4: 10.2"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.0	0.1	0.0	0.1	0.0	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.5	0.0	0.1	2.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.2	0.0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0.0	0.9	5.0	0.5	0.3	0.2	0.2	0.6	0.8	1.8	0.2	0.0	0.8	2.0	0.2	0.0	0.3	1.7	1.1	0.0	1.3	0.4	0.0	0.3	3.1	0.5	0.3	0.3	0.4	0.5	0.0	1.1	1.5	2.0	0.3	1.8	1.2	10.2	1.1	1.7	0.0	0.9	0.0	2.9	0.0	1.7	0.9	1.6	0.3	1.4	1.3	0.2	1.3	0.4	0.8	1.3	1.9	4.9	1.7	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1.0	1.0	1.0	0.8	1.0	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	13.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	729.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	5.0	0.6	0.0	0.0	0.0	9.2
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Cell type enriched"	"Detected in some"	62	"Glandular cells: 3142.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	138	"BEWO: 22.4;NB-4: 18.9;RPMI-8226: 12.5;SH-SY5Y: 7.4;U-2197: 7.6"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3142.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"prostate: 79.3"	"Cell type enriched"	"Detected in some"	23	"Glandular cells: 120.1"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.0;HaCaT: 9.8;OE19: 8.8;SK-BR-3: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051839	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.2	0.8	0.1	0.3	0.1	0.1	0.7	0.2	0.5	2.0	1.2	0.0	3.8	1.8	1.5	7.7	0.4	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.5	79.3	0.8	0.2	3.2	2.1	0.7	2.4	1.2	0.6	0.1	0.1	0.3	0.6	0.1	0.0	8.7	0.0	0.0	0.2	0.2	0.1	0.4	0.6	0.1	0.0	0.3	0.0	4.9	2.0	0.2	0.3	0.0	0.0	4.4	0.1	0.0	0.0	0.0	4.5	8.0	0.5	0.4	0.1	0.2	9.8	0.0	5.3	0.0	1.3	1.3	1.5	3.6	1.7	0.0	1.6	2.2	0.0	2.5	0.0	0.0	0.3	0.0	0.4	0.9	4.1	0.0	1.2	0.1	2.4	0.1	8.8	0.4	0.3	0.5	1.1	0.0	3.2	0.0	0.6	0.3	6.3	0.0	0.2	5.1	0.4	1.1	0.3	0.3	1.3	0.3	2.6	1.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.5	0.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	2.9	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	120.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	1.7
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 69.2;tongue: 67.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 88.7;Late spermatids: 144.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"A-431: 87.4;HaCaT: 85.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014343, CAB025503, CAB026341"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB025503: , CAB026341: , HPA014343: AB_1852603"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavorable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavorable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (3.85e-6)"	1.1	0.0	0.7	0.4	0.2	0.0	12.1	0.2	0.5	3.8	0.3	0.2	0.2	0.1	1.4	0.9	6.5	0.2	0.3	0.2	0.2	0.1	0.6	0.2	2.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	7.0	0.2	0.4	69.2	0.2	0.2	0.2	0.2	0.0	3.3	0.2	0.4	0.3	67.3	4.4	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	85.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.2	14.9	0.0	0.0	1.9	23.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	144.1	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.5	9.5	0.0	0.0	0.0	0.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 70.0;CAPAN-2: 167.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	167.5	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	15.4	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.2	0.0	0.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	2.7
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.7;HaCaT: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.7	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.7	0.0	1.0	0.0	0.1	26.6	0.0	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0	6.0	0.6	0.0	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	1.8
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	13	"Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		950000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	42.3	0.0	0.8	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.7	0.0	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	157.5	0.0	0.0	0.0	0.1
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51003111-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 37.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"HaCaT: 1.2;HBEC3-KT: 4.2"									CAB025049	Enhanced				"Secreted to digestive system"	NA	NA					"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	37.6	3.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 102.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 203.0"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	28900000000	4900000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.3	0.3	0.8	0.3	1.2	0.0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1.0	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0.0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	7.3	0.1	0.0	0.1	0.0	0.2	1.3	0.0	5.0	0.4	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	17.8	1.4	0.0	1.8	15.7	0.0	0.0	1.1	2.2	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	203.0	0.2	0.0	2.9	5.5	3.2	0.8	0.6	0.0	0.0	0.0	0.3	14.6	0.7	0.3	0.0	0.9	3.6	0.0	0.2	1.4	0.9	0.0	0.0	0.0	0.4	0.0
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717276-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 323.8"	"Group enriched"	"Detected in some"	22	"Distal tubular cells: 555.4;Hepatocytes: 1509.4"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 4.5;HL-60: 2.4;RH-30: 4.0;SiHa: 2.7"					"Low region specificity"	"Detected in some"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	64000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	41.9	323.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.4	2.3	0.2	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	1.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.5	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.7	0.1	0.0	0.1	4.0	0.0	0.2	0.0	0.5	0.1	2.7	0.4	0.0	1.5	0.1	0.0	0.9	0.0	0.2	0.0	0.0	1.0	0.0	1.9	0.0	2.0	0.0	2.3	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	1.6	0.7	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.4	38.2	0.0	0.0	31.4	0.0	0.0	555.4	0.0	0.3	0.0	0.5	46.7	0.0	0.0	0.0	0.0	0.0	1509.4	0.1	0.0	0.0	25.2	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 4612.7"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"hTCEpi: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	NA	NA		62000000			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.2	309.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.3	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.9	0.0	40.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	38.6	16.1	4612.7	0.0	0.0	0.0	0.3
LACRT	LACRITIN	ENSG00000135413	Lacritin	Q9GZZ8	12	54630811-54634895	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"salivary gland: 67.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	304	"breast cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	NA	NA		460000																					0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 171.5;monocytes: 433.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	36.7	0.3	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.0	23.8	32.6	0.0	2.1	0.0	0.0	47.4	0.0	36.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	35.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	40.2	0.0	0.1	0.9	50.5	0.4	0.0	1.6	0.4	24.4	34.6	1.9	0.0	0.0	56.7	0.6	1.5	8.5	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3	3.0	27.8	1.5	72.1	78.6	0.0	1.8	89.2	4.0	28.4	29.6	0.0	2.9	38.1	140.9	1.0	0.2	171.5	0.0	107.2	4.6	4.1	25.8	0.0	8.5	0.4	0.0	17.4	0.0	0.3	2.4	0.0	2.5	10.1	433.8	49.1	0.0	149.1	89.0	0.4	54.9	0.0	0.0	5.2	0.0	0.0	133.5	8.7	0.0	93.8	117.6
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"	NA	NA					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1	0.0	3.5	0.9	0.8	4.5	4.0	1.2	0.0	0.0	5.7	0.0	9.8	0.2	0.0	0.1	0.3	1.9	1.1	0.0	0.0	0.2	2.1	1.9	0.0	2.5	8.7	0.0	20.8	5.5	3.5	1.1	36.2	0.3	1.7	4.6	4.5	1.3	0.3	0.0	65.0	0.2	6.2	6.5	2.5	0.3	2.0	2.6	0.1	29.6	2.5	0.3
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 233.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"	"Group enriched"	"Detected in some"	5	"BEWO: 6.9;Hep G2: 3.3"														"Secreted - unknown location"	NA	NA						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	233.4	0.5	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	26.9	24.5	0.0	0.0
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"breast: 217.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;MCF7: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	217.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
LAMA1	LAMA	ENSG00000101680	"Laminin subunit alpha 1"	P25391	18	6941744-7117814	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.9"	"Group enriched"	"Detected in many"	5	"Enterocytes: 39.1;Mucus-secreting cells: 37.7;Paneth cells: 37.4;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.2;ASC diff: 13.6;BEWO: 65.1;hTEC/SVTERT24-B: 13.5;SK-MEL-30: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010179	Enhanced				"Secreted to extracellular matrix"	NA	NA					"CAB010179: AB_2133741"	"unprognostic (2.75e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.85e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.34e-3)"	3.2	0.4	2.2	0.9	4.4	0.4	4.2	0.7	3.3	2.7	0.5	7.3	0.6	0.4	2.8	4.0	0.5	0.7	0.6	0.6	5.2	1.7	5.5	0.5	0.9	0.4	3.6	1.9	4.4	1.4	0.4	3.4	0.8	5.4	0.7	0.6	0.2	3.6	2.0	0.4	0.7	0.4	1.3	5.7	0.7	0.4	20.9	4.7	0.0	6.7	0.0	0.4	1.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	13.6	12.2	65.1	0.6	3.1	3.2	7.0	7.7	0.0	0.0	0.1	1.1	2.6	0.0	0.0	2.3	1.3	0.0	1.0	0.0	3.6	0.0	1.6	0.0	0.0	10.3	0.3	13.5	7.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.0	0.0	12.7	4.0	0.0	0.0	0.0	2.4	6.8	1.3	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.4	0.7	2.4	5.2	1.7	3.6	1.9	5.4	4.7	6.0	0.0	0.0	0.6	0.0	0.0	1.7	5.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.1	0.0	39.1	0.0	0.4	2.2	0.4	0.7	0.0	0.0	0.7	0.0	1.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	37.7	2.5	0.0	37.4	0.0	1.1	0.3	0.0	0.0	0.5	1.7	0.0	4.0	0.0	12.1	0.3
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883141-129516569	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.7;placenta: 71.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 76.7;Leydig cells: 170.6;Peritubular cells: 210.7;Sertoli cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 2.2;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 66.7;ASC TERT1: 48.6;HHSteC: 14.5;HSkMC: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	NA	NA		38000000			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (3.65e-5)"	35.3	7.4	1.7	3.5	8.1	0.9	38.9	6.4	3.8	22.0	10.4	1.7	6.3	2.0	13.3	12.8	17.1	17.7	13.6	65.7	2.1	1.5	3.6	3.8	17.1	8.8	4.7	3.3	33.0	5.4	2.1	7.0	71.2	6.2	8.2	4.2	3.5	9.4	7.5	26.1	8.2	7.2	26.8	6.9	7.3	10.2	16.7	5.4	0.0	9.6	9.2	1.4	18.5	22.1	0.1	0.1	0.0	0.0	2.2	2.2	0.1	0.0	0.0	0.7	0.0	66.7	48.6	0.0	6.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	40.8	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.2	11.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.0	2.2	0.0	0.0	0.5	0.1	1.7	8.1	6.4	3.8	2.1	1.5	4.7	3.3	6.2	5.4	0.0	0.3	0.0	2.3	3.3	0.8	76.7	0.0	5.3	1.2	0.0	0.0	1.9	0.0	1.4	6.0	5.7	0.0	0.0	0.2	1.5	36.3	0.1	0.0	0.0	2.7	0.0	0.0	5.5	0.0	4.7	170.6	1.3	1.7	0.0	0.0	14.2	0.6	0.0	210.7	0.4	1.0	116.4	8.2	1.4	0.7	2.5	3.2	1.3	0.0	0.7
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	17.3	2.2	0.0	0.0	0.9	0.2	0.0	0.3	0.2	0.1	0.2	0.7	20.1	0.0	2.3	0.2	0.0	31.7	0.0	154.2	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.2	17.3	0.1	18.3	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.4	2.0	0.3	0.0	0.0	6.8	2.0	0.0	0.3	0.7	0.3	0.0	0.0	0.6	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5	107.2	23.7	0.5	53.6	27.8	3.8	2.0	5.1	13.4	23.9	1.8	0.0	0.1	0.0	30.0	3.7	2.8	50.4	0.0	30.6	0.2	2.0	16.7	5.7	0.8	0.2	0.0	7.9	1.8	0.0	2.8	5.5	1.1	1.7	1.0	11.0	0.0	340.7	31.6	3.2	0.0	1.9	6.5	19.6	3.1	1.9	8.7	0.1	0.7	6.6	15.4
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		350000	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	51.9	79.0	0.0	13.0	7.8	1.3	0.2	0.0	4.9	0.0	8.6	22.4	3.0	0.0	0.5	0.0	0.2	0.0	6.7	0.0	6.5	0.0	10.6	0.0	0.0	61.5	0.0	9.4	0.0	38.0	64.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.2	0.3	0.0	0.3	2.0	0.0	10.0	0.2	0.0	0.0	59.2	21.4	1.1	23.8	4.3	0.0	0.0	0.0	5.3	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5	3.0	5.0	0.0	1.2	20.1	1.0	47.4	0.0	0.0	3.4	3.5	0.0	0.9	3.3	0.4	76.6	56.3	0.0	0.0	0.6	71.2	77.1	1.1	1.1	28.2	2.7	0.0	0.0	19.6	2.2	34.0	154.2	1.7	54.0	1.0	0.0	0.0	0.6	0.0	76.4	0.0	0.2	64.7	100.7	0.7	0.5	16.3	2.5	0.0	0.0	5.2
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 71.5;Cytotrophoblasts: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 30.9;CACO-2: 42.6;EFO-21: 31.8;HaCaT: 29.0;HeLa: 27.8;TIME: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054609, CAB078157"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		1200000	Vesicles	Nucleoplasm	"CAB078157: AB_2665809, HPA054609: AB_2682540"	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	22.6	5.9	5.6	8.1	5.9	2.5	16.8	24.0	6.6	16.7	28.0	3.1	18.6	7.6	23.2	13.8	18.0	14.2	27.4	13.7	4.7	2.9	17.0	7.3	19.7	4.4	3.7	2.3	6.9	13.9	8.3	6.0	33.3	5.5	17.4	2.6	18.6	12.7	25.0	9.4	45.2	9.0	25.0	4.5	8.8	13.3	4.4	3.4	2.0	18.4	11.8	10.4	19.4	24.9	0.9	1.2	0.2	0.0	0.0	0.0	0.0	3.9	30.9	0.6	4.0	0.7	8.8	23.8	1.1	0.6	0.9	0.1	42.6	16.0	0.3	31.8	0.0	0.9	29.0	0.8	12.4	0.0	0.1	1.7	1.0	27.8	12.1	2.8	0.0	4.6	0.4	8.2	2.1	2.2	1.5	4.1	0.0	1.8	0.4	0.0	5.9	0.0	0.1	2.0	5.1	18.0	0.0	0.3	3.3	8.0	18.9	0.3	12.3	17.1	17.1	0.3	3.3	17.0	0.2	37.3	0.4	11.8	0.2	5.0	0.2	0.0	0.1	8.8	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	5.6	5.9	24.0	6.6	4.7	2.9	3.7	2.3	5.5	3.4	71.5	26.6	8.3	15.9	15.1	1.3	15.3	22.9	13.4	35.2	36.6	7.9	73.3	0.0	28.3	4.3	36.5	0.0	0.0	3.8	24.9	7.8	13.3	2.3	9.4	11.6	3.2	2.4	17.8	0.0	1.1	9.2	2.5	1.7	1.8	0.0	8.2	10.9	0.0	18.4	10.2	1.7	25.8	31.9	0.7	1.9	11.0	47.9	1.0	0.2	24.5
LAMB1	CLM	ENSG00000091136	"Laminin subunit beta 1"	P07942	7	107923799-108003255	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 66.5;Leydig cells: 65.9;Peritubular cells: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.8;ASC TERT1: 108.0;HSkMC: 105.6;TIME: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004056, HPA004132, CAB004256"	Enhanced				"Secreted to extracellular matrix"	NA	NA		140000000			"CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.01e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-1)"	47.3	9.9	5.4	11.8	9.9	0.0	36.4	7.0	5.7	20.3	29.4	1.9	9.3	13.2	31.8	16.8	20.5	18.5	21.2	36.2	2.5	1.4	36.9	6.8	39.4	18.2	3.1	3.9	16.5	20.1	3.3	10.9	57.5	6.9	25.1	17.8	20.4	10.4	13.4	15.8	13.8	24.2	27.0	4.6	28.5	20.3	13.3	2.6	6.7	31.8	7.8	5.5	28.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	17.9	10.8	0.5	81.8	108.0	42.6	15.0	22.7	8.3	9.1	37.5	21.9	0.0	21.6	24.5	11.4	5.5	3.0	18.1	6.7	0.0	3.2	0.7	7.4	15.7	55.2	0.0	0.8	105.6	6.8	21.5	24.9	58.5	57.0	0.5	2.3	0.0	17.9	4.4	0.0	0.0	6.4	7.5	12.9	0.1	7.6	0.0	44.6	12.7	3.8	21.8	10.5	14.8	10.1	27.3	5.0	0.1	78.1	24.1	7.0	8.2	17.8	0.0	0.0	0.0	12.3	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.9	7.0	5.7	2.5	1.4	3.1	3.9	6.9	2.6	0.0	6.4	1.4	5.8	7.9	9.7	14.5	10.2	4.0	10.3	26.2	3.9	66.5	3.3	16.3	1.1	20.3	9.3	0.0	9.9	22.3	57.5	0.9	2.3	1.6	8.8	7.9	18.4	21.5	1.8	1.1	65.9	2.4	8.5	1.0	5.8	2.0	17.2	14.4	133.3	11.9	9.6	51.8	8.6	5.9	3.7	5.8	27.2	1.8	16.4	0.9
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 142.0;Leydig cells: 135.4;Peritubular cells: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;myeloid DC: 2.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.0;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		18000000	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	46.1	35.3	7.4	13.0	7.7	0.9	29.0	5.1	8.3	55.0	25.9	10.5	41.3	9.3	43.4	38.6	34.3	27.1	37.7	62.5	9.7	4.1	30.6	29.6	28.2	5.7	8.2	6.1	56.0	12.9	51.7	8.0	41.3	9.9	37.7	7.3	45.1	17.4	39.2	22.7	17.0	23.0	31.5	6.9	16.7	22.7	24.1	8.1	2.1	36.5	21.8	11.4	45.3	38.4	0.0	2.0	0.2	2.4	0.0	0.0	0.4	3.2	8.0	7.4	26.4	43.4	45.0	6.7	28.0	34.7	16.7	16.8	3.8	11.1	0.0	9.7	63.2	8.4	10.5	6.4	10.0	11.5	0.0	2.0	1.4	12.6	6.6	29.3	0.0	0.0	39.1	15.0	13.3	13.6	40.5	16.3	0.0	0.8	0.0	13.5	6.2	0.0	0.0	3.2	4.2	6.7	0.0	3.6	0.1	11.7	4.1	0.0	4.4	16.0	9.3	14.6	13.1	20.2	0.2	27.0	18.1	7.9	6.4	7.3	0.0	0.0	0.0	8.6	0.0	12.2	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	7.4	7.7	5.1	8.3	9.7	4.1	8.2	6.1	9.9	8.1	110.2	52.2	0.0	12.0	27.7	1.3	142.0	43.3	2.7	38.7	52.4	5.9	8.5	5.0	25.4	2.6	76.6	5.9	0.0	8.0	4.8	81.7	11.7	1.1	44.7	9.0	7.9	0.0	93.9	11.6	7.1	135.4	9.2	40.5	3.6	2.2	44.2	14.8	8.6	132.2	36.6	2.1	116.4	74.5	3.5	7.3	21.3	7.9	2.2	4.7	7.1
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652466	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 205.4;Basal glandular cells: 278.5;Pancreatic endocrine cells: 523.1;Urothelial cells: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.9;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.5;HaCaT: 66.0;HBEC3-KT: 161.1;hTCEpi: 51.6;hTERT-HME1: 32.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		15000	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	24.5	8.4	1.2	5.5	1.7	3.3	11.7	0.8	4.1	10.2	9.9	0.9	3.2	12.1	7.0	3.1	22.1	6.3	8.4	8.9	1.1	0.8	4.7	4.7	11.0	1.6	1.2	2.2	1.4	2.1	0.0	1.1	16.1	1.1	11.9	6.3	0.8	19.1	10.3	1.9	17.9	22.8	2.7	1.4	2.1	28.7	1.7	0.8	4.9	1.1	35.8	30.2	16.2	13.3	0.1	1.9	3.4	0.5	0.4	0.4	0.1	21.1	3.1	0.0	0.0	2.3	1.5	0.1	0.6	1.9	0.7	1.1	8.3	43.5	0.0	1.8	0.4	1.1	66.0	0.0	161.1	1.1	1.5	0.1	0.1	11.2	0.1	0.3	0.1	0.1	0.3	51.6	2.4	32.1	1.4	0.7	0.0	0.3	0.8	0.2	0.0	0.0	0.1	0.0	9.7	9.1	0.0	2.1	19.3	8.9	13.2	0.0	0.0	9.0	1.0	1.8	0.1	0.2	1.1	16.8	3.6	7.8	0.1	12.6	0.2	0.4	0.0	5.3	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.9	0.1	0.4	0.0	3.4	0.4	0.0	0.0	0.0	0.1	1.2	1.7	0.8	4.1	1.1	0.8	1.2	2.2	1.1	0.8	205.4	75.6	2.2	278.5	97.4	0.2	6.9	2.5	44.2	151.2	45.4	0.0	0.1	0.0	174.0	4.1	1.1	142.2	0.0	132.9	1.1	4.3	108.8	18.4	3.9	2.1	3.2	7.5	0.0	0.0	7.4	1.7	10.1	8.5	3.6	43.8	0.8	523.1	80.7	0.7	1.9	0.3	0.0	4.2	0.3	0.7	22.7	0.5	0.0	20.5	285.9
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Cell type enhanced"	"Detected in some"	22	"Basal keratinocytes: 31.0;Early spermatids: 8.6;Late spermatids: 7.6;Suprabasal keratinocytes: 12.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 6.1;HMC-1: 3.6"					"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.3	0.1	0.6	0.5	6.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.6	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	5.0	0.0	8.6	0.1	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	2.2	0.3	12.0	1.1	0.0	0.0	0.0
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.2	8.5	28.2	8.0	170.5	93.8	42.7	38.6	38.8	15.6	9.2	25.3	6.0	1.9	17.8	18.5	9.2	13.1	5.3	10.2	11.9	0.0	5.4	0.0	7.7	9.2	26.8	1.6	0.9	105.6	5.5	18.6	14.7	27.9	27.1	0.0	0.0	5.7	18.9	2.3	0.0	1.7	11.4	9.7	1.6	1.3	23.8	0.9	25.2	14.0	1.8	5.3	10.1	0.0	9.9	50.7	2.2	4.4	50.0	19.1	7.5	17.6	9.6	2.2	0.0	1.2	15.8	1.2	18.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7	32.8	16.3	4.5	38.6	27.8	1.9	48.8	25.5	10.7	17.0	34.9	3.9	80.1	1.7	50.0	5.4	59.4	0.7	0.0	19.8	53.9	99.3	48.3	2.3	17.8	16.1	1.6	1.2	26.4	10.8	3.8	111.9	5.3	32.1	10.0	1.7	2.0	39.3	3.5	58.7	10.2	0.6	71.1	83.0	7.0	39.9	14.8	60.3	0.5	2.6	21.6
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Pancreatic endocrine cells: 902.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	No	No			Cytosol		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0.0	0.0	0.4	1.1	3.6	0.3	0.4	0.1	0.0	3.6	44.7	0.0	19.0	0.1	1.4	22.3	0.0	221.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	17.2	0.5	137.0	0.2	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	18.1	3.1	0.0	0.1	0.0	53.2	12.9	2.7	0.0	1.3	0.0	0.0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0.0	163.7	76.6	0.0	1.1	15.3	66.9	51.2	22.7	0.0	26.6	0.0	197.8	16.4	0.5	28.1	0.0	81.6	9.8	7.8	209.4	0.0	0.0	2.2	0.0	8.6	0.0	0.0	8.3	3.1	2.9	8.5	4.6	13.0	0.0	902.6	26.0	0.4	0.0	0.0	0.0	2.3	3.7	1.0	26.0	69.7	0.7	7.1	119.2
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009082-131094473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.8;testis: 32.5"	"Group enriched"	"Detected in some"	5	"Leydig cells: 109.6;Peritubular cells: 342.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;EFO-21: 20.5;Hep G2: 7.4;SiHa: 7.6;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022814	Enhanced				"Secreted to extracellular matrix"	NA	NA		240000			"HPA022814: AB_2670960"	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.3	9.5	1.0	0.9	2.0	0.6	1.6	0.8	3.0	23.5	1.3	2.4	2.2	1.0	6.0	5.1	1.2	1.2	9.1	0.9	1.4	1.0	8.8	3.7	15.6	0.6	1.7	2.1	1.3	3.3	0.9	8.8	50.8	3.6	7.0	0.7	7.5	1.8	4.9	0.7	6.2	0.6	10.7	1.9	17.0	1.0	32.5	0.8	0.0	1.1	2.4	0.5	13.8	12.4	0.7	0.2	1.7	0.3	0.3	0.8	0.1	0.0	0.7	5.2	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.8	7.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.5	0.1	7.6	0.0	3.3	0.6	0.0	0.6	0.0	0.0	6.4	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	1.2	0.3	0.3	0.2	0.0	0.2	0.7	0.5	0.1	0.2	0.4	0.8	0.5	1.7	0.3	0.1	0.2	0.5	0.1	1.0	2.0	0.8	3.0	1.4	1.0	1.7	2.1	3.6	0.8	0.0	0.0	0.0	0.0	6.1	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.8	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.6	36.3	0.0	0.0	0.0	1.3	0.0	0.0	3.7	0.0	3.4	109.6	0.0	10.1	0.0	0.0	0.0	0.1	0.0	342.3	0.0	0.0	45.3	6.6	0.6	3.2	3.9	0.8	0.0	0.0	0.0
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 356.7"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"ASC diff: 12.4;HSkMC: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.7	0.0	0.0	0.0	0.0	0.1	6.6	0.3	0.6	0.0	0.0	23.3	9.1	0.1	0.0	0.0	0.0	356.7	0.3	0.0	0.0	11.1	8.6	0.0	0.6	0.0	0.0	1.0	0.0	0.0	8.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 204.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 35.6;Hep G2: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.5	4.0	6.0	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4.0	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15.0	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0.0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2.0	6.0	0.0	1.6	0.0	4.3	0.0	0.0	0.9	2.7	7.1	2.9	1.1	204.0	2.1	0.0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0.0	7.5	1.4	0.0	8.1	0.0	0.5	12.9	7.1	1.0	1.5	2.3	10.2	0.0	0.0	1.4
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-2 OS: 1.0;U-87 MG: 2.0"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"memory B-cell: 5.5;naive B-cell: 6.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 1.3;REH: 2.1;RPMI-8226: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA					"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	2.8	0.0	0.5	1.4	0.5	0.2	2.2	0.5	1.0	6.2	0.9	0.7	3.2	0.2	7.2	21.8	0.8	7.8	1.2	4.5	0.5	0.0	0.5	0.5	0.5	0.8	0.5	0.5	1.8	1.5	0.0	0.5	0.5	0.5	2.1	0.6	0.5	1.2	0.8	0.6	0.2	2.0	2.5	0.5	1.4	1.5	2.1	0.5	0.5	4.3	0.5	0.9	2.1	2.6	6.2	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.7	0.6	0.0	0.0	2.1	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	6.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.5	0.5	1.0	0.5	0.0	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN12	MGC48935	ENSG00000184925	"Lipocalin 12"	Q6JVE5	9	136949551-136955497	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 131.5"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 47.1;Distal tubular cells: 16.6;Intestinal endocrine cells: 15.7;Muller glia cells: 26.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	21	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.8;BEWO: 1.4;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.1"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (7.27e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.33e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.06e-1)"	"unprognostic (5.00e-2)"	"unprognostic (7.91e-4)"	0.3	0.4	0.9	0.3	1.8	0.3	0.3	0.2	0.9	0.9	0.3	0.4	24.4	0.4	0.5	131.5	0.3	2.4	0.3	0.3	0.8	0.8	2.3	1.2	0.3	0.3	1.0	0.7	0.6	0.7	0.3	1.9	0.3	1.2	0.3	0.3	1.6	0.3	10.9	0.3	0.3	0.4	0.3	0.9	0.6	0.4	1.1	0.9	0.0	8.6	0.0	0.3	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.9	1.8	0.2	0.9	0.8	0.8	1.0	0.7	1.2	0.9	0.0	2.1	0.5	0.3	0.0	0.2	6.9	0.0	1.4	2.3	47.1	2.0	0.1	16.6	1.0	0.6	0.0	2.9	0.0	1.1	0.0	0.2	0.9	0.0	10.2	0.2	0.0	15.7	0.0	0.3	0.8	13.8	0.0	0.0	0.0	2.6	26.1	0.7	0.0	10.3	5.9	0.9	0.0	0.0	1.4	0.2	0.0	0.2	0.0	4.7	0.2
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell type enriched"	"Detected in some"	54	"Intestinal endocrine cells: 377.4"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	377.4	0.0	0.8	1.7	0.0	0.0	1.7	0.0	0.7	0.0	0.0	7.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Cell type enhanced"	"Detected in many"	16	"Ductal cells: 4866.3;Exocrine glandular cells: 1633.7;Pancreatic endocrine cells: 4295.8;Urothelial cells: 1384.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 277.6;EFO-21: 113.7"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.7	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.6	0.0	113.7	0.0	0.2	18.1	0.0	0.5	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	5.1	0.0	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1	0.0	17.3	2.4	352.2	0.2	0.0	0.2	932.5	180.7	184.2	130.9	0.0	0.3	0.0	4866.3	1.9	0.1	78.8	23.3	1633.7	0.3	0.2	349.2	13.8	18.3	0.5	0.0	55.6	2.5	0.6	10.5	3.1	0.6	0.0	103.6	135.4	0.0	4295.8	131.2	0.0	0.7	0.0	0.0	3.1	0.0	0.2	0.0	0.2	0.7	262.6	1384.7
LCN6		ENSG00000267206	"Lipocalin 6"	P62502	9	136744011-136748528	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	19	"epididymis: 261.0"	"Cell type enhanced"	"Detected in some"	21	"Endothelial cells: 16.9;Ito cells: 3.7;Leydig cells: 5.2;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in some"	10	"thyroid cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 4.7;REH: 14.9"														"Secreted in male reproductive system"	NA	NA						"unprognostic (4.05e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.83e-4)"	"unprognostic (3.41e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-1)"	4.5	0.5	0.4	1.3	0.6	1.1	4.4	0.4	0.6	5.1	1.6	0.4	13.9	0.5	10.1	261.0	1.5	6.5	1.8	8.3	0.4	0.0	0.8	0.5	1.1	0.6	0.6	0.5	2.6	1.0	0.6	0.3	0.5	0.6	3.4	0.6	0.6	2.0	1.2	1.5	0.5	3.1	1.4	0.7	1.0	3.1	3.2	0.4	0.3	2.2	0.4	0.5	2.9	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	14.9	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.4	0.6	0.4	0.0	0.6	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 72.1"	"Cell type enriched"	"Detected in single"	8	"B-cells: 2.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 5.3"	"Group enriched"	"Detected in some"	57	"memory B-cell: 5.3;naive B-cell: 9.3"	"Lineage enriched"	"Detected in single"	72	"B-cells: 9.3"	"Cell line enriched"	"Detected in some"	6	"REH: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA									"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.7	0.1	0.0	0.0	2.5	0.0	0.2	72.1	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.5	0.0	0.0	0.9	0.0	0.6	0.0	0.0	1.9	0.0	0.2	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	7.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	5.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825221	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 2: 1.1;Ciliated cells: 1.4;Collecting duct cells: 1.8;Early spermatids: 1.0;Ito cells: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.9;TIME: 6.3"									HPA030478	Approved				"Secreted - unknown location"	NA	NA					"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	5.4	1.9	0.2	2.2	0.2	2.7	2.2	0.0	0.1	1.7	3.2			4.7	3.1	0.0	1.3	2.2	1.6	3.6	0.5	1.1	1.5	0.1	1.0	1.8	0.0		0.5	1.1	0.0	0.9	0.2		3.1	0.3		5.7	0.1	2.7	1.3	1.7	0.2	0.0	2.3	3.2	0.8			1.6		0.9	2.2	1.8	0.6	2.5	1.9	0.0	0.7	0.0	0.0	0.5	0.7	0.4	0.6	0.2	0.0	1.3	0.9	0.0	0.0	0.0	0.4	1.5	0.0	2.4	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.1	0.3	0.0	0.0	0.2	0.0	1.4	2.5	0.3	0.4	3.4	0.5	0.0	0.0	0.4	0.0	0.3	0.5	0.1	0.1	0.7	0.2	2.9	6.3	0.6	0.6	0.8	0.0	0.0	0.1	0.4	0.1	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0											0.0	1.1	0.0	0.0	0.5	0.0	0.5	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.4	0.2	0.0	0.0	0.0
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132872322-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 52.4"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 1416.7"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		1300000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.68e-4)"	0.1	0.1	0.0	0.2	0.1	0.0	0.2	1.5	0.0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0.0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0.0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0.0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2.0	0.3	0.5	2.3	2.4	4.8	2.7	1.3	1.8	1.0	0.2	0.7	1.6	2.4	2.8	2.0	0.4	0.3	0.8	4.2	3.8	1.1	0.5	3.6	1.7	1.7	5.7	1.7	0.7	0.9	1.3	1.1	1.9	0.7	1.3	2.0	0.7	3.5	1.4	4.9	0.7	1.2	1.6	3.9	1.4	1.9	1.1	1.4	1.6	1.5	1.0	2.0	1.6	1.1	1.0	1.0	0.8	1.1	1.5	1.2	0.4	2.7	1.6	1.2	0.6	5.8	4.3	1.7	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2.0	0.3											0.0	1.6	16.9	9.6	9.0	15.8	1.2	76.5	1.4	1.2	0.0	31.4	2.7	8.3	2.3	3.7	3.8	75.4	0.0	8.7	4.9	6.7	7.2	6.9	1416.7	1.2	12.7	4.6	21.5	19.4	0.2	1.4	3.4	5.0	0.0	3.4	4.6	2.5	34.5	1.8	36.3	23.1	0.0	6.2	4.1	1.9	6.8	6.1	10.0	4.4	7.8
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135955034	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 100.7"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 116.8;Erythroid cells: 23.3;Hepatocytes: 93.6;Late spermatids: 39.1"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	820000	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	100.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.5	2.5	1.2	0.1	0.8	0.3	1.0	1.2	1.5	2.5	0.6	2.2	2.3	0.5	0.2	0.0	0.0	0.9	1.4	2.4	1.9	1.0	1.1	1.5	0.2	0.7	0.2	0.9	3.2	2.4	3.3	4.1	1.0	3.0	0.5	0.8	0.7	1.1	1.1	2.0	1.1	2.6	0.9	2.0	2.0	1.5	1.2	1.3	1.7	0.8	1.9	1.6	1.4	0.7	1.6	2.7	1.0	1.9	0.0	0.6	0.1	3.3	0.3	1.6	2.5	0.9	1.5	1.3	0.4	3.6	1.7	1.0	1.1	2.8	2.4	2.4	1.2	0.4	0.7	0.8	0.5	1.3	0.8	0.8	0.2	1.0	0.7	0.5	2.5	0.1	0.6	0.5	0.7	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	3.7	2.2	39.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	6.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell type enriched"	"Detected in many"	4	"Undifferentiated cells: 330.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 34.0"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	3.6	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	14.5	1.5	0.0	6.7	0.0	27.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	2.1	1.4	0.0	0.0	0.0	45.3	0.8	0.5	73.7	1.8	4.8	1.3	0.0	0.3	1.6	1.5	0.0	0.0	0.0	330.1	1.3
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 16.3;Late spermatids: 27.4;Leydig cells: 16.7;Peritubular cells: 11.3"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 24.3;RPMI-8226: 26.2;SuSa: 15.6"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.3	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.3	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	27.4	16.7	0.0	1.7	0.0	0.1	0.3	0.0	0.0	11.3	0.0	0.1	0.0	1.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 361.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	11	"BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.3	0.1	7.1	0.2	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.3	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.2	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	361.5	0.0	0.0	0.1
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell type enhanced"	"Detected in many"	18	"Endothelial cells: 59.1;Hepatocytes: 196.4"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Secreted to blood"	NA	NA	8240000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.7	3.9	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.5	0.5	1.1	0.9	5.2	5.5	7.0	1.5	7.7	3.6	0.1	3.0	0.5	0.6	13.2	3.0	1.2	4.7	15.7	5.9	0.6	46.5	0.9	9.5	0.3	0.6	0.1	1.8	0.8	0.1	0.1	0.9	0.3	22.5	0.6	0.7	11.4	1.4	0.6	1.6	6.7	2.1	2.1	2.2	2.1	4.4	0.4	3.2	1.3	0.9	0.2	4.5	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1	0.0	16.5	3.0	1.9	31.4	4.9	3.5	10.2	2.7	4.5	8.7	0.0	1.2	3.3	1.5	1.0	59.1	0.4	0.0	0.9	2.3	20.2	3.3	1.1	196.4	1.9	1.6	0.0	27.6	6.5	1.5	31.9	5.8	33.7	2.8	0.9	0.0	1.6	1.7	7.1	6.8	0.9	0.0	17.7	1.1	0.6	25.7	2.2	0.5	0.8	1.4
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675608-37679806	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 4031.4;Hofbauer cells: 3788.4;monocytes: 10290.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	No		19000000	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	167.5	49.3	23.0	56.0	22.9	29.8	213.7	7.6	30.9	158.6	94.5	20.1	44.2	22.0	150.9	80.3	74.0	66.8	78.8	108.6	18.9	29.3	24.0	20.8	55.8	45.4	41.4	28.9	105.1	18.2	5.1	17.5	80.1	53.6	85.9	23.4	35.7	34.9	89.6	117.1	29.2	29.2	145.8	88.3	40.3	40.0	42.4	20.5	16.7	19.6	59.1	20.4	99.8	81.7	29.0	185.2	44.0	149.1	19.6	73.1	180.2	94.5	55.8	1.2	49.5	116.0	227.9	1.1	219.9	258.2	162.9	162.4	6.2	12.5	0.1	22.6	222.0	56.2	10.1	1.9	144.6	57.0	97.1	1.0	8.3	58.6	25.6	75.7	4.8	110.9	141.1	9.9	129.9	55.6	149.1	178.8	0.0	6.0	40.1	126.0	42.2	0.1	67.3	0.4	21.0	132.4	0.1	83.0	25.9	67.0	0.2	0.1	29.4	43.9	7.7	54.9	2.4	40.9	56.9	241.8	217.7	108.9	96.6	112.2	24.6	16.4	0.4	255.8	25.1	86.6	44.0	149.1	5.3	40.8	114.2	6.1	29.0	38.0	39.8	185.2	10.8	6.6	26.8	6.3	19.6	120.0	45.7	73.1	180.2	23.0	22.9	7.6	30.9	18.9	29.3	41.4	28.9	53.6	20.5	154.9	138.0	222.9	146.3	648.8	7.2	914.1	63.7	54.9	94.4	155.3	5.9	84.3	14.9	558.2	21.5	662.6	6.4	23.3	75.7	807.6	4031.4	43.7	528.7	472.3	3788.4	7.9	2.9	939.1	2674.9	59.6	903.3	2724.8	2709.5	10290.5	1.7	156.0	264.8	1.7	1222.7	15.1	31.2	1623.4	2845.4	14.7	12.1	513.9	126.7	373.6	0.9	48.4
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 3145.4;Paneth cells: 2942.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	21.7	6.9	0.2	0.1	45.3	90.9	26.5	17.4	36.7	4.8	8.6	15.0	72.2	0.0	9.2	20.3	8.8	21.8	0.4	18.2	2.7	25.7	0.3	0.0	7.7	6.9	34.4	0.0	0.0	28.3	27.8	5.6	11.7	11.0	7.5	0.0	0.0	21.0	10.9	14.7	0.0	5.3	0.3	119.2	19.6	0.0	0.9	1.5	45.3	29.1	0.6	1.7	40.7	0.0	169.5	1.2	17.9	2.4	13.7	23.0	3.2	8.5	0.3	11.7	37.1	0.1	33.0	1.4	2.4	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7	670.0	300.6	39.7	543.1	560.7	2.0	183.5	254.8	1263.4	586.9	113.4	0.0	565.8	570.3	541.1	17.4	423.0	3145.4	116.8	951.7	754.6	506.8	590.1	552.4	0.9	1164.5	1.6	166.8	50.3	236.1	23.5	514.6	722.3	804.8	642.0	1587.7	215.8	859.9	2942.3	361.0	42.5	11.3	142.3	241.1	7.7	3.6	697.2	404.6	52.2	1480.8	936.7
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78980109	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 677.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 30.2"	"Group enriched"	"Detected in all"	6	"monocytes: 10.6;T-cells: 30.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 77.5;SK-BR-3: 176.5;SK-MEL-30: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	NA	NA		11000000000			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	34.8	60.8	10.0	18.7	16.2	9.0	28.4	3.7	21.4	36.4	40.9	49.8	32.9	61.9	31.9	43.8	34.2	32.2	85.0	73.4	12.9	16.5	27.9	23.6	33.7	11.2	28.7	10.1	45.9	17.2	18.6	36.7	43.1	31.6	39.9	16.2	35.0	100.6	39.8	5.0	9.3	56.5	20.0	43.6	17.3	62.1	29.7	20.8	25.3	37.1	21.3	21.3	30.4	30.8	2.0	3.1	2.0	10.6	3.3	30.2	10.0	42.6	26.8	0.6	0.9	13.4	15.8	13.1	5.8	3.9	31.1	61.7	10.8	77.5	0.2	37.1	2.7	28.7	18.0	4.5	16.7	0.9	0.1	32.1	3.2	23.1	43.5	32.1	0.0	2.8	26.5	9.5	16.5	1.1	6.4	0.8	6.9	0.3	0.1	6.8	6.1	12.1	0.5	1.2	12.3	17.1	8.6	18.7	0.4	11.6	37.0	21.7	24.7	5.2	176.5	69.3	1.1	5.1	1.4	1.5	24.0	16.4	0.6	19.6	0.0	0.2	0.2	30.5	8.4	22.9	0.3	7.5	2.0	5.2	10.6	10.8	2.0	18.6	7.6	3.1	1.1	30.2	14.0	0.6	3.3	4.9	0.2	10.0	10.0	10.0	16.2	3.7	21.4	12.9	16.5	28.7	10.1	31.6	20.8	175.7	113.6	6.9	113.2	27.6	39.6	127.8	145.2	77.6	150.2	132.6	5.9	159.0	14.9	221.8	6.8	16.4	677.9	0.0	124.0	273.7	163.4	80.0	12.7	40.4	82.0	69.9	161.4	64.4	28.9	23.9	261.8	24.7	77.6	39.7	255.4	98.6	98.1	413.8	250.3	37.4	18.1	174.6	100.1	2.8	2.0	23.8	91.1	10.8	293.5	106.4
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.9"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 273.5;Kupffer cells: 189.6;Paneth cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 11.4;HMC-1: 29.7;MOLT-4: 14.7;REH: 10.4;THP-1: 26.6;U-937: 22.8"									"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	448000		Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favorable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	25.7	3.9	6.4	15.6	11.2	22.2	6.1	2.0	5.3	5.7	26.9	12.6	0.2	8.6	4.3	6.1	6.0	8.5	13.9	4.6	5.6	3.4	5.0	9.0	14.7	29.6	9.7	2.7	5.9	6.0	0.5	2.9	8.5	8.7	4.2	26.0	10.9	5.7	2.1	2.5	3.7	15.0	5.1	13.2	48.9	20.2	2.2	7.9	22.1	3.8	2.0	17.1	14.8	3.6	6.6	28.7	12.0	35.2	4.2	7.0	10.9	0.4	0.3	0.2	0.1	0.0	0.1	0.5	0.2	0.4	3.4	11.4	0.0	2.3	0.4	2.5	0.5	0.3	1.2	0.1	0.0	0.2	3.4	0.4	3.6	0.4	0.0	0.1	7.5	29.7	0.1	0.0	0.2	0.0	0.1	4.0	2.1	0.2	0.2	0.0	0.0	14.7	3.6	0.1	5.3	0.0	10.4	0.0	0.3	1.6	0.3	0.1	0.3	0.0	1.0	0.0	0.2	0.1	26.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.8	0.1	5.6	16.4	12.0	1.0	35.2	0.6	4.5	2.6	1.3	28.7	6.6	1.5	0.7	7.2	4.2	31.2	4.5	7.0	10.9	6.4	11.2	2.0	5.3	5.6	3.4	9.7	2.7	8.7	7.9	8.9	7.5	29.3	6.0	2.9	0.1	0.8	25.5	10.7	12.5	7.0	0.0	2.0	3.3	99.7	1.1	23.3	125.2	0.0	111.9	2.5	6.8	2.9	31.1	0.8	273.5	0.0	38.8	18.4	189.6	1.5	4.0	133.7	1.7	127.2	146.3	0.4	119.4	182.0	2.8	0.4	0.5	19.4	3.1	0.1	0.7	1.5	3.1	24.5	106.1	25.8
LGI1	"EPITEMPIN, EPT, ETL1, IB1099"	ENSG00000108231	"Leucine rich glioma inactivated 1"	O95970	10	93757809-93806272	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 45.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.9;Hepatocytes: 5.9"	"Group enriched"	"Detected in some"	7	"glioma: 1.8;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.3;CACO-2: 2.4;NTERA-2: 8.9;SuSa: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (1.26e-1)"			"unprognostic (4.68e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.65e-1)"	1.4	4.5	15.3	1.4	30.6	1.1	1.5	18.1	45.1	1.4	4.4	7.3	0.0	1.3	1.3	1.2	7.2	1.2	2.6	1.5	16.3	10.1	1.2	5.4	1.2	1.2	9.6	17.3	1.3	1.5	1.1	6.5	1.1	35.6	2.2	5.2	10.9	1.1	1.9	9.2	1.2	2.3	2.1	7.3	1.1	2.4	1.5	10.4	0.0	1.2	0.0	1.3	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	30.6	18.1	20.7	16.3	10.1	9.6	17.3	35.6	10.4	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	5.9	0.0	0.0	0.0	0.6	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.2	0.0	4.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.8	0.0	0.9	10.4	0.4	0.0	14.7	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9	0.0	0.0	0.0	0.1	0.1	0.4	2.6	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.8	1.6	0.0	1.3	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 20.3;Melanocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	2.1	1.1	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.3	0.0	4.6	0.6	0.0	0.0	4.6	0.0	0.5	0.0	0.0	0.0	2.6	0.4	0.0	0.0	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8	0.0	20.3	0.0	0.0	2.1	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	38.8	0.0	0.0	1.0	0.1	0.0	6.7	0.0	2.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.3;skeletal muscle: 59.4"	"Group enriched"	"Detected in many"	7	"Muller glia cells: 88.9;Sertoli cells: 77.6;Smooth muscle cells: 120.2"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in single"	30	"WM-115: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA			"Golgi apparatus"		"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	35.6	10.7	31.7	7.9	18.5	2.0	9.9	16.3	36.5	22.3	26.9	17.1	6.3	7.4	13.2	8.9	9.0	12.2	9.4	12.2	23.3	7.9	3.4	4.7	5.3	4.5	15.4	31.5	5.8	4.5	4.4	1.0	7.6	26.0	10.4	8.1	8.7	8.7	24.7	59.4	5.9	11.7	9.6	50.3	3.5	8.5	3.1	15.1	0.0	5.6	4.8	2.4	9.6	24.4	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	26.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	31.7	18.5	16.3	36.5	23.3	7.9	15.4	31.5	26.0	15.1	0.0	0.0	0.0	0.4	2.3	0.8	10.4	0.0	1.4	1.2	1.8	2.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.2	8.0	0.6	0.0	1.7	0.1	0.0	1.7	12.9	0.0	0.0	13.6	1.1	10.1	0.0	0.1	88.9	0.1	2.5	6.7	0.0	2.8	77.6	120.2	0.6	0.9	2.0	0.0	0.0	0.2	0.7
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 6.6;U-266/84: 7.1"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.6	0.3	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.4	1.9	1.8	0.1	0.0	0.3	0.5	0.0	0.4	0.0	1.7	5.2	0.3	1.7	2.5	0.3	0.4	1.8	0.0	0.0	0.3	0.0	0.0	0.3	1.1	4.8	2.9	0.3	0.4	0.1	0.6	0.7	0.3	0.5	2.8	1.2	1.3	0.0	1.4	3.0	1.2	2.0	0.4	2.2	0.0	2.0	0.0	0.0	2.7	2.8	0.3	3.3	2.5	7.1	1.8	1.4	3.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.7	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.5	0.0	8.6	0.0	0.0	0.1
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.4	14.2	0.4	3.1	0.0	1.2	5.2	1.2	5.1	1.5	3.7	2.3	13.8	0.0	3.1	0.0	27.0	2.1	0.3	3.8	2.1	2.0	0.6	1.0	4.8	3.1	1.4	0.0	11.1	1.3	0.7	34.3	1.0	31.7	0.0	0.0	0.2	0.0	6.6	6.3	0.1	0.0	0.5	7.7	8.8	0.2	4.8	0.0	12.2	3.2	0.0	0.1	1.4	0.1	2.5	1.6	0.3	0.1	0.1	38.2	14.1	14.4	27.6	0.0	0.0	0.0	30.2	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8	20.8	58.9	0.0	12.0	3.1	0.0	0.2	17.8	4.0	13.6	5.2	0.0	0.1	0.0	27.7	0.1	0.5	3.5	0.0	3.0	0.4	11.3	13.8	63.7	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	2.9	1.2	24.9	0.0	0.0	0.6	0.1	0.0	39.8	0.0	0.2	2.5	0.2	0.5	5.5	18.0
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 21.6;Kupffer cells: 82.8;Macrophages: 28.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 3.0;THP-1: 6.1;U-937: 13.6"														"Secreted to blood"	NA	NA		130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.1	0.0	3.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	6.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.6	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3	3.0	4.8	0.0	0.7	0.2	0.4	0.4	2.5	2.7	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.9	5.8	0.0	21.6	0.0	0.0	0.6	82.8	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4
LILRA5	"CD85, CD85f, ILT11, LILRB7, LIR9"	ENSG00000187116	"Leukocyte immunoglobulin like receptor A5"	A6NI73	19	54307070-54313139	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.2;lymphoid tissue: 67.3"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 84.9;Macrophages: 23.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 10.6;intermediate monocyte: 27.0;neutrophil: 14.5;non-classical monocyte: 30.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;monocytes: 30.2"	"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 4.1"														"Secreted to blood"	NA	NA		370000				"unprognostic (8.52e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.51e-3)"	"unprognostic (4.68e-2)"	"unprognostic (6.21e-2)"	3.4	0.6	0.3	9.9	0.3	19.1	0.7	0.1	0.3	0.4	0.6	0.1	0.0	0.8	0.4	2.0	0.6	2.0	0.9	7.0	0.2	0.2	1.7	10.8	14.4	24.2	0.5	0.0	1.5	0.4	0.1	0.4	1.3	0.6	0.6	0.7	0.6	0.5	0.3	0.9	0.1	1.8	1.3	0.7	67.3	1.0	0.6	0.0	0.1	1.4	0.4	0.4	2.7	2.8	0.0	2.6	14.5	30.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	27.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	14.5	0.0	30.2	2.1	0.0	5.1	0.3	0.3	0.1	0.3	0.2	0.2	0.5	0.0	0.6	0.0	0.0	13.3	1.4	0.1	0.1	0.0	0.0	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	10.5	0.2	6.5	0.0	0.0	0.6	84.9	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 125.3"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	7.0	0.0	0.0	5.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	20.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	4.5	0.6	0.0	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.8	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0.0	0.0	5.1	0.0	0.2	0.0	0.8	12.7	0.0	1.2	3.5	0.0	0.0	5.0	3.7	0.0	0.0	0.0	0.0	3.3	0.0	1.2	0.2	0.0	125.3	0.1	0.0	0.0	5.5	4.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.3	0.0	0.0	9.6	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.8	31.4	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.6	4.9	0.0	7.6	0.0	9.6	48.1	2.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	11.1	4.9	9.6	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.7	32.0	3.7	0.2	0.0	0.2	0.3	0.0	1.8	0.0	0.0	62.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4	0.0	1.4	0.0	4.8	1.5	0.8	1.7	25.5	0.0	3.4	14.0	56.9	4.7	0.0	3.2	8.0	1.4	9.5	0.0	1.2	60.0	1.0	8.4	0.0	66.8	1.6	0.0	13.3	4.9	1.9	6.0	0.3	0.0	1.7	1.0	3.4	1.0	7.7	2.9	0.0	1.0	2.4	0.0	0.7	1.0	0.8	2.3	16.2	0.7	6.2	9.9
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552613	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.8;lung: 28.5;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 134.0;Enterocytes: 247.9;Mucus-secreting cells: 115.8;Urothelial cells: 130.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 37.9;OE19: 8.6;RPTEC TERT1: 19.2;T-47d: 9.1;U-266/84: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA049079	Approved				"Secreted to blood"	NA	NA					"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favorable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.5	0.5	5.1	1.2	0.0	2.1	0.3	1.4	2.5	20.4	0.6	3.1	6.2	0.2	5.1	12.9	0.5	16.5	0.6	0.4	0.7	8.5	0.5	28.5	0.0	0.3	0.0	0.7	13.6	0.0	2.1	0.9	1.8	10.7	21.9	2.1	15.7	3.0	0.3	6.1	28.8	1.6	0.3	0.5	27.0	6.2	0.0	0.2	0.4	4.1	14.9	8.8	5.0	0.9	0.4	2.4	0.9	0.6	0.7	1.7	5.1	6.8	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.1	0.1	0.6	37.9	0.0	3.9	0.1	1.5	1.8	2.8	0.0	0.2	0.0	0.8	0.9	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	0.3	8.6	0.5	0.0	0.0	0.5	19.2	4.6	0.0	0.0	0.5	6.3	0.1	0.3	9.1	0.1	0.0	0.0	0.5	0.0	0.1	0.6	9.0	0.0	0.0	0.0	0.0	2.2	0.9	0.4	0.5	0.2	0.3	0.4	0.5	0.4	0.2	0.9	0.7	0.6	2.4	0.6	0.4	0.4	0.3	1.7	0.5	1.2	0.3	1.4	0.4	0.7	0.3	0.0	1.8	0.0	134.0	29.7	0.0	12.6	0.7	0.4	0.4	68.8	45.5	54.6	64.6	0.0	0.2	1.7	42.3	0.0	0.2	247.9	0.0	22.4	0.1	0.4	71.5	6.9	0.0	0.0	0.0	21.4	1.3	0.0	0.0	0.0	0.1	15.1	1.0	115.8	0.3	39.8	89.6	0.0	1.6	0.7	0.0	0.2	0.5	0.0	1.8	0.2	0.0	61.8	130.6
LIPI	"CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5"	ENSG00000188992	"Lipase I"	Q6XZB0	21	14108813-14210891	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"epididymis: 113.2"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 1.1"	"Cancer enriched"	"Detected in single"	6	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.1;REH: 2.0;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA						"unprognostic (2.60e-2)"	"unprognostic (3.49e-1)"		"unprognostic (1.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.64e-13)"	"unprognostic (2.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.0	0.0	0.6	0.0	1.2	113.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	1.4	0.0	0.0	4.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.7	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.5	3.1	1.4	0.0	0.4	2.0	0.5	1.0	0.0	0.0	0.3	1.9	0.7	0.1	0.1	1.8	0.1	0.1	0.0	0.5	0.3	0.8	0.2	0.3	0.0	0.3	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LIPK	"bA186O14.2, LIPL2"	ENSG00000204021	"Lipase family member K"	Q5VXJ0	10	88724544-88752786	"Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 27.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.65e-2)"	"unprognostic (8.64e-2)"				"unprognostic (3.57e-2)"		"unprognostic (3.19e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.13e-1)"						"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.1		0.0	0.0		0.1	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0
LIPM	"bA304I5.1, LIPL3"	ENSG00000173239	"Lipase family member M"	Q5VYY2	10	88802730-88820546	"Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"skin 1: 30.1"	"Cell type enriched"	"Detected in single"	9	"Suprabasal keratinocytes: 1.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 6.9;HL-60: 3.9;NB-4: 3.3;OE19: 6.1;RT4: 2.9;T-47d: 3.3;U-937: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.72e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.23e-4)"	"unprognostic (6.70e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.75e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.05e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.02e-2)"	"unprognostic (9.70e-6)"	0.0	0.0	0.0	0.8	0.0	0.2	1.9	0.0	0.0	0.0	0.1			0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	30.1	0.0	0.0	0.0	0.1	2.2	0.0			0.0		0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	0.1	0.1	2.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	6.1	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.3	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
LIPN	"bA186O14.3, LIPL4"	ENSG00000204020	"Lipase family member N"	Q5VXI9	10	88761406-88778242	"Disease related genes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	Ichthyosis	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 12.5;skin 1: 25.5"	"Cell type enhanced"	"Detected in single"	23	"Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"					"Group enriched"	"Detected in many"	5	"classical monocyte: 4.8;eosinophil: 12.5;intermediate monocyte: 10.7;neutrophil: 7.7;non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 11.3"	"Group enriched"	"Detected in some"	7	"Daudi: 3.3;HL-60: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.13e-1)"		"unprognostic (2.99e-1)"	"unprognostic (1.08e-1)"		"unprognostic (3.27e-1)"	"unprognostic (1.07e-1)"		"unprognostic (2.03e-2)"		"unprognostic (9.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.65e-1)"	1.5	0.1	0.0	2.8	0.0	3.7	1.3	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.1	0.0	0.0	25.5	0.0	0.3	0.1	1.2	0.0	0.0			0.0		0.0	0.4	1.1	0.0	1.8	12.5	11.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	1.1	4.8	12.5	0.0	10.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	11.3	0.0	0.0	1.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 84.0;Extravillous trophoblasts: 135.9;Fibroblasts: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"BJ: 23.4;BJ hTERT+: 26.8;hTERT-RPE1: 26.7;U-87 MG: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.7	20.3	0.7	23.4	26.8	9.9	17.6	0.4	0.6	0.0	4.3	17.2	2.5	6.9	0.1	0.0	2.4	0.0	1.5	0.0	0.7	0.1	2.3	0.0	0.0	16.5	0.0	7.4	0.0	26.7	0.3	0.4	0.0	0.1	11.8	0.8	0.1	0.4	2.2	1.5	16.0	0.0	13.8	0.2	0.9	4.1	1.9	0.0	0.7	0.1	0.0	2.4	0.1	0.0	1.7	19.5	17.3	15.3	8.9	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3	0.0	1.1	0.0	5.2	5.3	0.4	84.0	0.0	0.0	0.0	8.7	0.0	1.8	3.3	2.5	1.2	2.9	0.0	0.0	1.2	135.9	59.0	2.9	1.1	0.0	5.6	0.0	3.4	19.0	0.0	1.0	9.2	0.0	10.1	0.0	0.1	5.2	8.2	0.0	19.8	1.4	0.2	0.0	20.5	2.6	1.9	3.0	4.2	0.0	0.9	3.1
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532414-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Hofbauer cells: 15.6;Kupffer cells: 10.8;Muller glia cells: 13.0;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 11.1;non-classical monocyte: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 27.3;HDLM-2: 20.2;U-138 MG: 48.1;WM-115: 103.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		15000			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	7.9	7.1	6.3	8.5	5.0	15.9	9.7	2.9	6.5	6.6	8.4	13.1	2.2	5.1	10.2	7.5	4.1	5.8	8.0	10.8	4.5	5.0	3.2	2.0	6.8	8.0	5.7	6.7	4.2	3.3	2.3	3.9	18.8	7.4	4.4	4.8	7.8	3.6	5.5	1.6	2.1	4.9	10.2	9.7	12.3	3.7	3.5	4.8	0.6	3.0	3.4	2.9	6.1	6.0	0.1	3.4	2.7	11.1	0.0	0.0	2.5	0.2	0.0	3.9	0.7	3.2	4.2	0.7	13.4	27.3	6.5	6.3	4.5	0.2	0.0	0.1	13.7	0.3	0.1	0.5	0.3	3.8	20.2	0.0	3.1	0.2	0.0	1.0	0.1	3.2	4.3	0.0	17.3	0.7	2.2	0.1	0.1	0.1	0.3	1.1	0.6	0.0	1.1	2.2	0.1	0.1	0.3	0.4	0.0	0.0	0.2	1.8	2.4	0.0	0.1	2.8	0.5	0.3	0.2	0.0	48.1	1.6	0.2	0.1	0.1	0.1	0.0	18.1	1.2	103.3	0.1	5.6	0.3	0.0	11.1	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	2.7	0.0	8.7	0.3	0.0	2.5	6.3	5.0	2.9	6.5	4.5	5.0	5.7	6.7	7.4	4.8	0.0	0.3	0.0	0.1	0.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.1	3.7	0.2	1.1	0.0	15.6	1.6	0.0	0.6	10.8	0.4	4.6	6.8	0.0	3.6	0.0	13.0	0.2	0.0	4.2	0.0	0.9	19.4	2.1	0.5	0.9	0.1	0.7	0.0	0.0	0.1
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268250	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.1"	"Cell type enhanced"	"Detected in many"	15	"Club cells: 9.1;Collecting duct cells: 29.6;Ductal cells: 8.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 60.1;CAPAN-2: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.3	1.8	1.1	1.1	4.2	0.1	10.7	1.0	1.7	20.7	7.3	4.6	1.4	1.4	8.0	4.6	2.3	7.4	4.6	1.8	1.6	0.3	4.4	29.1	3.1	0.6	1.1	1.2	6.1	14.5	1.7	1.4	5.1	8.2	5.1	1.5	3.2	15.7	10.7	14.7	3.1	2.5	7.1	3.0	1.8	2.3	10.8	1.0	1.4	5.7	1.9	1.7	3.1	6.0	0.8	1.2	0.1	0.2	2.3	0.0	0.0	0.0	0.4	0.0	0.0	1.7	7.4	0.2	7.6	60.1	0.6	6.5	1.2	72.2	0.0	6.9	5.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	3.1	1.6	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.1	0.0	13.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.3	0.0	1.2	0.0	0.0	1.1	4.2	1.0	1.7	1.6	0.3	1.1	1.2	8.2	1.0	6.0	1.0	0.0	1.9	0.8	0.2	1.1	5.1	4.0	9.1	29.6	0.0	0.2	0.0	8.6	0.2	0.6	0.0	0.0	0.5	0.3	5.1	2.0	1.1	0.2	0.2	0.0	0.0	3.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	4.9	3.3	0.0	1.4	0.5	0.0	0.0	1.6	0.0	0.2	0.6	0.3	0.0	0.0	1.6
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"liver: 43.4"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 79.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 4.7"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	2900000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	1.3	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.2
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
LPO	SPO	ENSG00000167419	Lactoperoxidase	P22079	17	58218548-58268518	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Antimicrobial, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	262	"salivary gland: 345.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.0;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"THP-1: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028688	Enhanced	Supported			"Secreted to digestive system"	NA	NA					"HPA028688: AB_10601909"	"unprognostic (2.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.8	1.3	0.7	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.0	1.5	0.0	0.9	0.7	0.4	0.6	0.3	0.5	0.9	0.7	0.6	0.2	1.2	0.6	0.9	1.3	0.8	0.3	0.8	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	1.1	0.0	0.2	1.6	0.0	0.6	0.0	10.6	0.3	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.4
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.1	6.5	17.5	10.8	21.2	24.1	6.8	13.2	16.0	16.1	18.9	15.3	9.6	9.9	20.7	16.2	22.9	11.9	14.6	12.8	21.7	7.9	9.1	16.5	9.7	13.0	14.5	12.6	13.0	16.5	7.8	15.3	19.6	15.6	19.0	8.8	10.4	16.5	15.2	15.4	9.5	5.5	12.0	9.3	13.6	10.0	10.9	7.1	8.5	10.7	8.7	9.4	16.0	12.1	12.7	16.8	21.2	11.1	18.5	13.4	7.7	16.2	13.2	15.3	13.7	9.0	12.7	18.0	12.6	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4	29.8	24.8	15.9	14.0	9.4	55.4	14.2	17.8	16.0	19.4	8.7	53.0	7.0	1.7	10.1	9.5	20.2	6.8	0.0	8.4	5.5	19.9	12.7	10.5	13.0	7.6	36.5	5.8	41.7	13.0	7.1	23.3	15.3	16.9	28.9	8.2	26.6	11.3	7.0	26.9	4.2	44.4	19.4	17.0	16.3	16.6	9.3	5.0	14.0	9.2	13.1
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610543	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"epididymis: 54.8"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 39.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0"														"Secreted in male reproductive system"	NA	NA						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.4	0.1	0.0	54.8	0.0	0.2	0.4	0.0	0.2		0.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.5	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	3.1	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536409-4540474	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 636.5"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 728.6"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 58.9"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 58.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	74000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3.0	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0.0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3.0	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0.0	0.2	0.4	5.9	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	4.3	2.1	7.7	0.0	0.3	0.8	0.0	1.0	0.0	7.7	0.2	0.1	0.1	8.2	0.0	0.2	8.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.3	0.0	6.0	0.1	4.7	0.0	0.0	0.1	6.2	0.6	1.1	0.0	0.0	0.0	8.8	0.1	0.8	2.6	14.8	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	27.4	0.0	0.5	1.4	3.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	58.9	0.0	0.2	0.0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3	11.9	51.2	16.5	26.9	7.1	0.0	0.4	58.6	78.9	39.8	14.0	0.0	0.5	1.7	54.6	0.0	8.3	25.4	0.0	54.4	10.6	1.4	2.9	11.5	728.6	5.4	1.6	4.7	42.4	17.4	0.0	0.0	7.6	1.7	10.0	20.0	0.0	55.9	7.0	0.0	3.6	0.0	0.0	2.1	0.0	0.2	5.1	1.1	2.9	16.7	29.6
LRP8	"APOER2, HSZ75190, LRP-8, MCI1"	ENSG00000157193	"LDL receptor related protein 8"	Q14114	1	53242364-53328070	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;thyroid gland: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 39.8;Ciliated cells: 14.7;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;T-cells: 1.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073031	Enhanced				"Secreted in other tissues"	NA	NA		240000			"HPA073031: AB_2732217"	"unprognostic (3.83e-2)"	"unprognostic (6.06e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (3.46e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.03e-3)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.88e-16)"	"unprognostic (7.73e-3)"	"unprognostic (5.47e-2)"	"unprognostic (6.98e-2)"	"unprognostic (3.00e-2)"	2.6	1.9	7.0	5.5	7.1	5.8	1.9	13.0	15.1	1.8	1.8	2.7	0.3	1.4	2.0	2.8	6.1	3.6	2.3	1.9	7.6	8.0	1.4	0.8	3.2	5.6	5.8	7.9	1.3	0.9	0.8	4.2	5.0	6.6	1.5	2.4	11.9	1.4	1.6	0.8	1.5	1.5	2.9	3.8	2.3	1.3	22.5	3.4	1.7	48.7	2.4	4.9	1.7	2.0	0.3	3.2	0.0	0.4	0.0	1.6	0.2	10.0	21.4	8.4	12.1	5.8	5.6	10.8	12.4	10.3	18.8	13.1	5.8	12.0	16.4	14.4	8.3	27.9	17.1	6.6	14.2	8.9	12.0	6.5	9.2	24.4	10.2	6.0	16.6	16.6	1.6	1.6	20.5	11.2	2.9	14.7	12.7	3.6	7.2	2.7	12.5	10.2	7.8	15.6	9.8	15.6	18.2	12.3	14.2	7.3	8.5	19.2	7.3	5.9	33.5	7.9	5.3	4.0	11.3	11.8	4.9	7.9	10.7	24.7	11.5	17.8	6.8	24.5	23.1	28.1	0.0	0.4	0.0	1.0	0.0	1.6	0.3	0.6	0.4	0.5	0.2	0.2	0.2	0.0	0.0	0.0	3.2	1.4	0.2	7.0	7.1	13.0	12.7	7.6	8.0	5.8	7.9	6.6	3.4	0.0	6.7	3.0	1.7	1.3	39.8	2.3	0.0	14.7	6.8	0.0	0.0	2.0	0.0	2.3	2.1	1.9	0.0	0.0	2.1	1.6	0.9	5.1	1.1	0.0	1.7	25.4	2.4	0.0	6.2	3.8	0.6	2.0	0.0	10.0	1.2	1.4	2.9	0.0	2.5	0.0	1.8	0.0	2.7	3.2	0.9	1.3	8.1	2.5	0.5	4.6
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Group enriched"	"Detected in some"	4	"Leydig cells: 94.3;Peritubular cells: 29.7;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	NA	NA			Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.8	4.3	0.0	0.2	2.5	0.0	0.4	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	4.0	0.1	3.0	0.0	20.0	19.6	0.0	0.0	0.0	172.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2	0.0	0.6	0.0	0.1	0.8	3.7	0.8	0.0	0.0	0.0	1.8	2.0	0.2	0.0	1.5	2.4	3.6	0.0	0.0	0.3	0.1	11.8	0.2	1.1	0.6	0.3	0.0	0.0	9.2	0.0	0.7	94.3	0.0	5.0	1.0	0.0	0.2	0.2	0.0	29.7	0.0	1.9	64.7	14.3	0.6	0.3	0.5	0.0	0.0	0.1	0.1
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;MOLT-4: 3.6;U-266/84: 1.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150				"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.6	13.7	0.0	0.1	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	2.1	0.5	0.4	0.0	7.5	0.0	0.0
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946972-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 79.5;Fibroblasts: 97.9;Leydig cells: 83.7;Peritubular cells: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 106.2;HSkMC: 34.2;HUVEC TERT2: 34.7;U-87 MG: 46.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005707, CAB025428"	Approved		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		200000000	Cytosol		"CAB025428: , HPA005707: AB_1853394"	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	10.4	4.9	4.5	16.3	5.4	3.4	9.2	1.3	3.9	66.7	15.6	9.5	10.2	3.6	28.5	22.9	22.9	21.7	64.9	45.6	5.7	2.9	10.6	6.5	15.5	3.4	3.5	4.9	23.4	3.1	0.6	7.0	28.7	11.7	29.6	6.1	10.0	10.6	27.6	8.0	6.6	8.6	38.9	10.9	3.7	22.7	16.2	4.7	2.1	4.4	16.4	10.0	37.4	18.1	0.1	0.3	4.3	0.1	0.0	0.1	8.1	0.0	2.2	5.7	0.0	4.8	106.2	2.4	8.2	17.1	1.1	1.7	4.4	0.8	7.2	0.1	1.0	1.6	0.4	0.1	0.2	4.0	0.1	2.7	23.7	2.8	0.7	22.0	0.0	2.8	34.2	0.8	25.5	1.2	11.2	34.7	1.1	1.5	0.0	9.1	3.4	0.9	0.0	4.0	0.1	7.0	0.8	11.9	0.1	0.0	3.9	1.1	0.6	1.6	13.0	0.1	9.3	5.0	0.0	22.2	1.1	4.8	32.6	6.5	13.6	13.6	10.4	46.7	0.9	1.9	4.3	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	8.1	4.5	5.4	1.3	3.9	5.7	2.9	3.5	4.9	11.7	4.7	0.0	1.1	0.0	4.2	11.9	0.0	79.5	5.1	5.3	1.2	1.8	0.0	38.5	0.0	5.5	5.3	26.2	5.3	23.3	5.7	19.4	97.9	11.5	0.0	9.5	6.8	0.0	1.2	26.4	0.3	4.5	83.7	0.9	18.6	0.0	2.1	0.0	18.1	3.1	151.4	0.0	0.1	58.2	59.0	0.5	7.2	8.5	36.4	0.0	3.4	18.7
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498170-74612378	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease mutation, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 19.4;Peritubular cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 44.9;HUVEC TERT2: 24.5;LHCN-M2: 24.4;TIME: 107.9"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.9;olfactory region: 3.0"	"Region enriched"	"Detected in some"	5	"olfactory region: 31.6"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		13000000	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	25.0	1.7	0.8	8.0	1.3	0.0	21.5	1.0	1.0	50.3	5.0	1.2	4.8	1.2	18.0	11.8	16.2	6.2	20.1	20.3	0.8	0.8	2.4	1.4	29.5	4.8	1.6	1.9	32.1	3.9	0.4	4.2	19.0	3.1	15.7	0.9	51.8	13.6	9.7	20.5	6.0	3.2	8.6	2.6	2.5	4.3	12.2	0.4	2.2	44.8	14.4	6.0	14.7	11.6	0.4	1.7	0.3	0.2	0.0	1.2	0.2	0.5	0.9	0.2	0.0	7.2	13.3	0.0	9.0	3.1	1.7	1.1	0.0	3.3	0.0	2.7	44.9	0.8	0.9	0.0	3.3	0.7	0.0	0.1	0.1	0.4	0.3	1.7	0.0	0.1	13.7	1.4	9.6	5.6	13.3	24.5	0.0	0.0	0.0	24.4	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	2.1	1.2	0.2	0.6	6.4	0.0	0.2	0.6	0.2	0.0	107.9	0.6	10.8	3.3	3.3	0.1	0.1	0.0	2.4	0.0	0.3	0.1	0.1	0.1	1.2	0.1	1.0	0.2	0.6	0.2	0.2	0.4	0.7	0.6	0.3	0.0	0.2	1.7	0.0	0.2	0.8	1.3	1.0	1.0	0.8	0.8	1.6	1.9	3.1	0.4	0.0	2.1	0.0	14.7	4.9	2.3	5.0	0.0	0.0	10.3	0.0	0.0	0.3	5.0	1.2	1.2	3.5	0.0	0.0	0.3	0.4	19.4	1.6	1.1	0.2	4.1	3.2	0.0	12.9	0.0	4.5	15.3	1.5	0.0	0.0	0.0	0.4	2.8	0.0	77.4	0.0	0.6	6.5	6.2	0.7	2.7	0.9	1.0	0.0	0.0	1.7
LTBP3	LTBP2	ENSG00000168056	"Latent transforming growth factor beta binding protein 3"	Q9NS15	11	65538805-65558930	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Amelogenesis imperfecta, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.2;U-87 MG: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		760000				"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.50e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	35.3	31.6	25.2	14.9	21.5	7.3	33.4	24.3	27.2	41.8	29.4	28.7	37.5	12.2	43.5	42.7	17.1	36.0	45.0	38.7	24.6	12.7	22.9	25.7	36.7	16.1	22.1	22.7	55.1	35.7	48.1	37.1	18.2	23.4	40.2	6.8	36.1	34.4	43.5	33.9	13.9	16.9	30.3	34.4	24.4	19.8	16.8	23.7	12.5	40.6	17.2	11.8	30.7	29.6	28.6	8.0	1.3	5.4	4.6	6.7	3.6	3.9	16.1	2.1	10.7	15.5	25.1	2.1	15.8	10.8	2.0	1.3	6.1	21.0	0.4	13.6	15.6	5.1	17.7	2.9	2.9	0.9	2.2	6.5	3.8	5.8	6.2	10.3	0.5	3.3	28.2	1.2	3.0	0.3	74.2	7.9	1.2	1.1	3.1	1.4	9.3	2.5	1.4	1.9	3.5	20.1	7.1	0.2	7.6	1.7	1.3	0.7	10.5	4.2	6.2	8.1	0.9	11.4	1.4	26.1	6.3	8.4	10.6	4.2	3.4	6.2	0.3	39.9	0.6	12.9	0.0	3.3	1.2	4.3	4.9	6.7	28.6	6.1	5.0	4.0	22.7	5.2	5.4	1.3	4.6	5.4	8.0	6.2	3.6	25.2	21.5	24.3	22.9	24.6	12.7	22.1	22.7	23.4	23.7	11.9	13.2	21.5	23.8	65.6	52.7	11.0	38.2	4.0	13.6	38.4	2.0	17.2	18.3	24.9	0.9	26.0	20.9	0.0	10.2	7.9	35.2	30.8	24.2	45.0	19.0	27.0	29.4	38.1	8.3	2.2	80.3	18.2	28.7	10.8	9.3	76.6	17.0	14.4	116.3	14.6	13.3	38.8	37.1	4.6	40.3	69.4	13.6	20.2	14.5	24.3
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leydig cells: 900.3;Peritubular cells: 587.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		7300000			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	16.9	10.0	2.7	22.8	4.0	1.0	16.2	1.3	2.8	86.1	30.3	4.3	29.2	12.3	54.8	41.7	43.7	28.3	51.1	52.1	2.6	3.4	9.9	7.9	51.2	14.1	7.8	2.5	47.6	6.6	3.1	11.0	7.4	6.9	78.0	8.1	31.1	12.1	36.8	14.6	9.8	28.9	62.0	13.5	15.1	15.7	37.1	5.3	6.1	25.2	44.5	20.0	46.4	50.6	4.0	5.5	0.4	2.7	2.9	10.2	2.2	6.7	7.6	15.3	20.6	5.6	6.0	2.4	2.7	9.1	2.8	2.3	2.2	15.6	7.2	12.8	4.6	4.6	9.4	3.8	9.6	0.9	20.8	1.3	2.5	17.6	0.8	18.1	0.9	8.5	7.4	7.9	5.7	10.3	15.2	1.7	7.7	15.3	43.3	0.6	6.9	1.0	0.5	1.8	19.6	9.3	17.9	0.4	13.4	1.4	0.6	0.6	6.3	10.0	7.8	2.7	2.4	4.0	4.0	6.8	0.5	30.9	1.0	5.7	9.7	8.1	2.3	13.0	9.8	7.1	0.0	1.6	0.4	10.2	2.7	6.6	4.0	9.4	7.7	3.0	2.6	3.9	4.1	0.4	2.9	1.4	5.5	6.1	2.2	2.7	4.0	1.3	2.8	2.6	3.4	7.8	2.5	6.9	5.3	6.0	16.8	2.9	25.1	51.2	46.1	11.9	7.6	1.4	11.4	21.0	0.0	1.4	1.7	5.3	9.2	20.7	58.4	0.0	4.1	2.2	141.6	8.7	10.3	2.9	6.8	38.1	4.1	68.7	6.0	14.3	900.3	12.0	55.6	11.8	29.8	3.5	5.1	15.0	587.0	0.2	2.7	58.2	44.8	15.3	8.9	25.5	2.2	20.8	32.1	20.1
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in many"	4	"Club cells: 55.7;Collecting duct cells: 68.0;Glandular cells: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.8;TIME: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"	NA	NA		600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.5	29.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.2	0.9	0.1	0.5	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1	0.0	3.2	0.0	7.7	1.0	0.0	1.2	5.1	12.0	55.7	68.0	0.0	0.0	0.0	0.3	0.7	2.3	0.0	0.0	0.8	0.1	0.5	88.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.7	4.6	0.9	0.0	0.0	0.0	0.0	5.0	0.0	0.0	10.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	16.6
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111831	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 344.8"	"Group enriched"	"Detected in many"	8	"Fibroblasts: 1406.2;Leydig cells: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		59000000000			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	44.8	25.3	0.8	15.1	0.7	0.0	19.7	0.7	0.7	56.7	26.9	0.7	28.1	5.1	64.8	77.8	28.1	12.2	76.6	48.8	0.8	0.7	26.9	6.4	77.1	32.0	0.9	0.6	73.0	9.1	0.7	2.7	344.8	2.8	77.4	13.3	1.4	5.6	9.9	9.1	8.3	24.0	48.7	4.0	1.3	8.2	30.9	0.3	1.7	18.1	32.3	11.5	65.3	20.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.0	11.3	0.0	37.8	186.6	1.5	2.3	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	18.0	0.0	0.0	15.6	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.0	1.6	0.0	0.0	0.0	1.6	0.4	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.7	0.7	0.8	0.7	0.9	0.6	2.8	0.3	11.9	51.4	0.0	1.2	86.7	0.0	10.1	0.0	1.4	9.1	0.0	2.0	47.4	0.0	0.8	2.4	11.6	0.0	0.0	0.0	27.5	1406.2	2.2	17.4	0.4	58.5	0.0	0.0	93.9	0.8	2.9	371.9	3.6	111.3	1.8	0.0	75.5	3.0	0.0	42.1	0.2	2.8	0.0	68.4	0.2	0.9	87.6	70.3	0.0	0.0	4.2
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 18.8;Paneth cells: 21.8"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1"	"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5	0.0	0.0	0.0	0.1	0.6	2.3	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.6	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	1.8	0.2	0.1	21.8	0.0	0.6	0.6	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.9	0.7
LY6G5B	"C6orf19, G5b"	ENSG00000240053	"Lymphocyte antigen 6 family member G5B"	Q8NDX9	6	31670167-31673776	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Rod photoreceptor cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA048307	Approved				"Secreted - unknown location"	NA	NA					"HPA048307: AB_2680348"	"unprognostic (2.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (8.34e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-4)"	"unprognostic (7.27e-3)"	"unprognostic (1.98e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.98e-4)"	7.2	2.4	3.7	4.8	3.7	14.7	6.1	17.5	5.5	4.8	5.3	3.7	14.9	3.4	7.8	6.6	3.7	5.8	3.7	3.7	3.7	1.5	3.7	3.7	6.5	6.2	3.7	3.7	8.9	3.7	1.0	5.0	4.3	7.2	5.2	6.6	5.6	4.3	4.1	5.2	13.3	6.5	5.3	3.7	7.7	4.2	10.3	3.7	6.0	6.2	3.7	7.2	3.9	4.7	0.4	0.5	0.0	0.4	0.6	1.4	0.0	4.2	4.7	9.4	12.8	2.2	4.7	12.0	8.4	2.6	6.0	6.0	5.7	5.5	10.3	2.3	10.4	3.9	6.9	2.2	11.0	9.7	4.1	14.6	9.8	5.0	4.4	1.8	12.1	8.1	10.0	6.6	8.8	4.2	8.5	3.2	7.8	5.9	6.2	4.1	3.8	6.6	9.4	5.2	1.2	2.1	9.3	2.9	4.5	2.8	11.8	6.6	10.7	3.8	1.5	2.8	12.1	3.8	8.2	6.1	12.0	6.3	5.4	2.0	11.2	7.8	9.6	4.2	11.7	3.6	0.0	0.4	0.0	1.4	0.2	0.1	0.0	0.3	1.1	0.5	0.4	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	3.7	3.7	17.5	5.5	3.7	1.5	3.7	3.7	7.2	3.7	3.0	0.0	1.5	1.0	0.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.8	0.6	0.0	0.2	0.4	0.0	1.2	0.6	0.0	0.0	0.6	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	1.1	0.5	0.0	0.8	0.9
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.3"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 5.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2"									"HPA017770, CAB075742, CAB075743"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	6.6	0.4	1.4	0.3	1.8	0.4	7.6	0.9	3.8	1.8	1.6	0.1	9.8	0.5	0.7	0.8	10.9	0.8	1.2	1.2	1.5	1.9	2.0	0.2	0.6	1.9	1.7	0.0	0.7	0.4	0.0	0.3	6.3	1.0	1.1	0.1	0.1	1.4	7.0	6.3	4.3	0.2	0.6	1.1	0.3	0.4	39.3	0.2	0.2	1.1	4.5	6.8	1.0	3.2	0.1	0.1	5.3	0.2	0.4	0.2	0.0	28.8	0.5	0.0	1.5	0.6	1.9	0.3	31.3	3.7	9.7	5.9	0.0	0.2	0.0	2.6	3.5	3.4	2.6	0.0	1.7	8.2	0.3	0.0	0.0	34.1	0.0	0.4	0.0	0.0	2.9	5.1	7.2	9.3	0.0	0.8	0.0	0.0	0.1	18.2	0.2	0.0	0.0	1.0	0.9	0.5	0.0	0.1	0.0	1.6	0.4	0.9	0.1	49.0	0.6	9.5	1.7	0.1	0.0	1.2	0.4	2.8	66.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.3	0.4	0.1	0.1	0.0	0.0	1.4	1.8	0.9	1.7	1.5	1.9	1.7	0.0	1.0	0.2	3.0	0.3	0.0	65.7	34.6	0.3	0.1	10.2	1.4	7.9	24.4	0.0	11.3	0.0	0.5	5.0	3.3	0.0	0.0	0.0	132.9	2.9	88.0	0.0	0.0	5.3	0.0	0.0	1.3	0.0	10.1	3.7	2.8	11.8	0.0	0.0	0.5	3.9	0.0	2.8	0.0	0.7	0.0	13.3	359.5	76.0	39.3	21.2	0.0	0.0	76.5
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 44.6"	"Group enriched"	"Detected in many"	8	"B-cells: 109.7;Hofbauer cells: 173.4;Kupffer cells: 183.5;Macrophages: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 58.2;myeloid DC: 58.7"	"Group enriched"	"Detected in many"	43	"B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.9;NB-4: 11.3;RPMI-8226: 67.8;THP-1: 27.2;U-698: 9.4;U-937: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		83000			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	10.2	5.0	9.9	18.2	12.9	11.5	2.9	1.6	5.3	3.9	3.2	15.4	0.0	1.5	1.8	1.5	2.0	2.8	7.4	2.5	8.9	7.0	2.8	5.2	13.3	31.2	16.5	4.1	2.1	2.0	0.8	2.8	6.3	9.3	2.5	4.3	2.3	4.5	3.0	0.9	1.5	13.0	4.6	19.9	44.6	2.5	1.1	12.7	2.9	1.7	0.3	32.7	8.4	1.7	47.7	58.7	1.2	58.2	0.7	0.7	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	2.4	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	12.7	0.0	0.5	58.2	0.4	0.1	32.1	0.1	47.7	0.1	0.1	58.7	35.6	0.7	0.4	1.2	0.7	11.6	2.3	0.2	25.7	9.9	12.9	1.6	5.3	8.9	7.0	16.5	4.1	9.3	12.7	0.0	19.6	109.7	0.0	1.8	0.0	0.5	2.5	1.4	2.3	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	1.6	2.8	0.0	1.1	0.8	173.4	0.0	0.0	5.5	183.5	12.8	0.3	157.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.3	0.9	0.0	2.0	1.6	1.3	0.0	0.1
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 473.5;Kupffer cells: 449.9;Macrophages: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.0;GAMG: 21.8;Karpas-707: 52.3;RPMI-8226: 25.2;U-87 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	NA	NA		95000	Vesicles		"HPA053060: AB_2682029"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.1	21.0	0.0	14.0	17.0	3.7	8.8	0.0	0.1	4.3	4.8	8.9	21.8	0.1	0.0	0.2	9.8	4.6	0.1	0.1	0.0	0.5	5.0	0.7	0.2	6.1	0.1	6.1	1.2	0.6	18.6	2.7	0.0	52.3	13.4	0.0	1.7	0.6	0.0	0.0	0.3	1.7	0.0	25.2	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.9	14.4	9.7	0.7	5.1	3.3	13.8	6.4	2.6	27.0	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6	14.9	15.4	42.6	1.0	12.2	0.1	0.7	0.0	4.0	13.6	3.5	0.0	2.4	0.0	3.2	22.0	45.8	0.0	0.0	6.3	2.6	16.0	0.6	3.5	2.0	473.5	0.0	0.0	102.5	449.9	2.0	13.3	173.5	72.6	46.9	0.0	0.0	13.2	0.0	6.3	0.6	0.1	6.5	14.7	0.5	0.1	10.2	5.4	15.9	0.0	1.0
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"kidney: 22.5"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 18.3;Proximal tubular cells: 70.3"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"	NA	NA						"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.0	0.4	1.0	1.1	1.0	0.7	2.1	2.3	1.0	1.1	1.0	1.0	1.0	1.2	1.4	1.9	1.0	0.7	1.0	1.0	1.0	0.4	22.5	3.1	1.0	1.5	1.0	1.0	1.1	1.0	0.0	1.0	1.0	1.0	1.6	1.1	1.0	1.0	1.0	2.0	1.5	1.2	1.0	1.0	2.6	0.6	2.9	1.0	1.0	1.2	1.0	1.2	1.0	1.0	1.0	0.4	1.2	0.9	0.0	2.4	0.5	0.5	3.9	3.0	4.9	6.9	4.1	3.4	1.5	1.7	1.6	2.7	0.8	3.5	0.8	2.7	0.7	0.4	1.7	4.0	0.6	1.9	2.7	2.4	2.2	2.9	1.3	1.4	0.8	5.4	3.2	4.3	2.6	1.0	3.6	0.8	5.2	1.2	2.6	1.8	0.8	2.0	6.7	0.7	2.0	3.8	4.9	1.7	1.3	6.9	1.5	1.7	1.0	0.6	1.2	1.1	3.8	0.5	0.7	2.2	2.0	2.5	3.6	1.7	3.0	1.8	0.6	0.6	4.0	1.0	0.0	0.9	1.2	1.5	0.1	1.4	0.2	0.2	0.6	0.4	1.0	1.2	0.7	0.0	0.0	0.0	0.0	2.4	0.5	1.0	1.0	2.3	1.0	1.0	0.4	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.2	0.0	1.0	0.3	0.0	0.0	2.3	1.8	2.0	0.2	18.3	0.5	7.8	0.3	0.3	0.0	0.2	0.1	0.4	0.5	4.6	0.0	0.3	0.0	0.0	1.3	0.3	3.6	0.3	0.4	0.0	1.0	0.3	0.3	0.6	0.0	0.4	70.3	0.5	0.0	0.4	1.8	0.2	0.0	0.5	0.5	0.2	0.1
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 4.0;skin 1: 13.0;testis: 4.8"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 12.8;Cone photoreceptor cells: 13.7;Horizontal cells: 14.3;Rod photoreceptor cells: 24.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;dendritic cells: 2.9;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.3;U-937: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039179	Uncertain				"Secreted in other tissues"	NA	NA					"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.5	0.5	0.1	0.4	0.7	1.7	0.0	0.7	0.7	0.0	0.1			1.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.1		0.0	0.0	0.0	0.4	0.0		0.1	0.0		1.1	0.0	0.9	13.0	0.2	0.0	0.0	0.5	0.5	4.8			0.3		0.0	0.0	0.0	4.0	2.9	0.3	0.7	0.5	2.5	0.0	0.8	1.1	1.0	1.2	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.9	0.7	2.2	0.5	0.0	2.7	0.5	0.0	0.0	0.3	1.1	0.2	0.5	1.2	0.3	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.6	0.2	0.0	2.6	0.5	1.6	0.8	0.0	3.2	0.6	1.5	1.2	2.9	0.8	1.2	0.3	0.2	0.2	0.0	1.0	0.9	4.3	1.6	1.8	1.2	0.2	1.0	0.6	2.1	0.3	0.8	6.1	1.2	0.0	0.7	0.3	1.2	0.2	0.6	1.9	2.5	1.4	0.2	4.0	1.0	0.9	0.3	0.5	0.0	2.9	0.4	0.0											0.0	0.0	0.0	0.2	0.6	12.8	0.3	2.5	0.0	0.0	0.0	13.7	0.7	0.0	0.2	5.9	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.2	14.3	0.0	1.3	0.8	1.3	0.0	0.0	1.7	0.0	0.0	6.8	0.1	0.0	0.7	0.0	24.2	0.0	0.6	1.4	1.3	0.4	0.2	0.0	0.2	0.1
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Group enriched"	"Detected in many"	33	"Early spermatids: 54.3;Late spermatids: 174.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	18.6	0.0	0.0	0.2	7.6	3.3	9.6	6.1	0.1	1.5	0.0	0.4	23.9	4.7	1.9	2.7	0.0	13.1	0.0	0.9	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.8	0.1	0.1	0.0	0.0	0.0	23.7	3.0	0.0	1.7	2.7	1.6	2.2	0.0	10.3	0.0	1.2	19.5	0.7	3.4	5.1	5.8	0.6	6.3	0.7	0.3	0.0	0.2	3.0	0.2	4.1	0.0	0.0	0.0	1.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6	0.0	0.0	0.0	0.5	0.1	1.9	0.3	2.5	1.4	3.4	0.0	0.0	0.0	3.3	2.2	54.3	0.2	1.0	0.0	0.7	0.2	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	174.5	2.8	0.0	0.0	0.0	2.5	3.5	3.3	0.0	0.4	0.0	3.2	0.0	0.1	0.7	1.1	0.0	0.2	0.0	1.9	1.1
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248718649-248755739	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 60.0;lymphoid tissue: 40.9"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 701.4"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"					"Group enriched"	"Detected in some"	6	"classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;THP-1: 2.5"					"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA						"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.1	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.8	0.0	0.0	0.0	0.0	0.0	8.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.1	2.3	1.1	0.0	1.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	3.4	0.0	57.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	30.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	104.6	0.0	0.0	701.4	0.0	1.7	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	16.3	0.0
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"	"Cell line enriched"	"Detected in some"	13	"OE19: 521.4"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	39.8	0.0	4.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.5	0.1	521.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	22.3	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5	80.4	424.7	79.8	2.3	50.8	0.1	0.0	815.3	52.2	87.6	26.2	0.0	4.1	0.0	46.7	1.4	10.8	19.6	0.0	484.8	7.4	19.7	4.1	113.9	7.3	924.7	0.0	12.0	37.4	3040.5	3.7	3.7	4386.3	50.6	757.4	61.5	0.0	1930.3	401.2	2.1	5.0	1.1	38.8	3.9	0.6	2.3	33.4	7.1	13.8	38.3	2.2
LYZL1	"LYC2, MGC33408"	ENSG00000120563	"Lysozyme like 1"	Q6UWQ5	10	29289061-29318328	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	371	"testis: 39.5"	"Group enriched"	"Detected in some"	48	"Early spermatids: 474.4;Late spermatids: 148.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;SuSa: 2.9"														"Secreted in male reproductive system"	NA	NA												"unprognostic (1.88e-1)"						"unprognostic (8.40e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	474.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	4.2	1.9	0.0	0.0	0.0	0.0	0.0
LYZL2		ENSG00000151033	"Lysozyme like 2"	Q7Z4W2	10	30611779-30629762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"testis: 34.2"	"Group enriched"	"Detected in some"	53	"Early spermatids: 605.6;Late spermatids: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 8.2"														"Secreted in male reproductive system"	NA	NA						"unprognostic (2.83e-4)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	1.6	0.0	0.0	0.0	0.0	0.0
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397078-42410600	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 29.0"	"Group enriched"	"Detected in some"	72	"Early spermatids: 297.8;Late spermatids: 112.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"OE19: 9.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"	NA	NA					"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	297.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.4	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.3	0.0	0.0	1.9	2.1	0.0	0.0	0.0	0.0	0.0
LYZL6	"LYC1, PRO1485, TKAL754"	ENSG00000275722	"Lysozyme like 6"	O75951	17	35934518-35943699	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 33.2"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 287.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"NB-4: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025734, HPA053073"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA025734: AB_1853444, HPA053073: AB_2682034"																		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	287.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	23.0	7.8	0.7	4.5	2.0	1.0	1.9	0.0	0.5	0.0	0.3	0.8	0.6	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.4	0.0	24.0	0.0	0.0	1.4	0.2	0.6	0.4	8.2	1.9	0.0	0.0	0.2	29.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.6	2.8	10.1	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	28.7	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.4	5.5	0.4	3.1	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.0	37.9	2.9	0.0	0.0	0.2	5.7	21.0	0.1	1.1	0.0	2.6	0.0	0.0	0.0	0.0	9.1	89.5	0.7	10.1	0.0	0.0	15.4	0.3	0.0	77.1	0.3	0.2	38.8	25.0	0.3	0.4	4.3	0.2	0.0	0.0	0.0
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.6	10.1	22.3	15.5	9.6	16.8	19.6	8.2	11.3	4.3	15.5	4.1	8.1	18.1	19.3	8.3	0.5	5.3	4.5	4.8	4.2	5.4	5.4	4.8	9.8	10.2	25.4	20.4	5.3	6.5	1.8	14.9	9.5	5.3	2.3	10.6	10.6	5.0	5.0	6.5	1.8	10.3	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.2	6.7	4.3	5.2	13.4	13.8	17.3	15.0	4.6	18.6	10.5	4.4	3.8	2.2	17.5	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4	14.9	20.5	11.5	3.9	4.4	9.1	14.7	22.9	10.7	13.6	10.4	5.9	9.9	1.7	8.9	0.4	7.3	11.9	0.0	9.3	7.5	10.1	7.8	10.4	36.3	17.8	9.5	7.5	12.3	27.8	0.0	18.1	10.4	3.3	3.6	8.7	12.1	9.5	7.0	23.0	3.7	6.8	12.9	7.3	0.9	0.7	3.3	7.1	10.9	6.6	3.7
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 383.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	18.5	9.3	24.9	30.7	17.2	22.4	26.6	29.9	24.7	30.5	29.3	14.4	43.5	40.7	25.0	18.5	70.4	11.1	30.9	30.8	29.8	18.7	15.6	32.7	14.0	33.1	56.3	15.6	21.0	9.6	26.0	31.6	42.5	29.4	39.3	16.9	7.0	44.6	28.2	11.3	25.9	31.2	21.6	44.2	40.4	11.2	16.0	41.8	25.6	12.4	9.4	30.4	25.1	15.1	18.1	28.6	12.1	21.0	18.4	17.3	17.0	21.0	32.8	36.2	14.7	26.3	30.3	31.2	33.5	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5	29.8	19.2	79.0	180.0	144.9	12.1	43.7	68.8	24.1	18.2	52.4	5.9	166.0	36.5	141.5	75.3	67.4	57.1	0.0	109.7	259.3	107.8	169.1	63.3	130.9	163.5	11.1	111.7	81.0	38.0	80.4	55.5	75.0	172.1	98.2	64.3	32.2	172.7	66.6	48.4	54.7	15.7	64.7	82.0	145.8	74.5	140.4	383.9	60.7	57.1	181.4
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 27.1;BJ hTERT+: 103.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	27.1	103.4	0.4	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7	0.0	2.6	0.0	0.1	2.6	0.0	32.5	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.2	11.0	0.0	0.0	57.1	0.4	0.0	0.0	30.7	2.4	3.8	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	5.9	0.0	0.0	1.5	0.1	0.5	0.0	0.1
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell type enriched"	"Detected in some"	68	"Hepatocytes: 541.9"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.5	0.8	0.0	0.0	0.0	1.3	1.1	2.4	0.7	0.0	0.6	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.6	20.5	0.0	2.2	1.7	0.0	0.0	0.1	0.0	2.0	0.0	1.9	0.8	0.5	0.0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1.0	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	3.4	0.2	0.8	0.0	0.4	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	541.9	0.1	0.0	0.0	8.0	7.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1, cartilage matrix protein"	P21941	1	30711277-30723587	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 6.6"	"Cell type enhanced"	"Detected in some"	14	"B-cells: 2.7;Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;Karpas-707: 3.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA028580	Supported				"Secreted to extracellular matrix"	NA	NA					"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.4	0.4	1.1	1.0	0.7	2.6	0.4	0.4	1.7	2.0	0.4	0.4	0.4	0.3	1.7	0.6	0.4	0.9	0.7	0.4	1.2	1.1	0.4	0.4	6.6	2.0	1.1	0.4	2.9	0.6	0.0	1.1	1.1	0.4	0.5	0.0	0.4	1.4	0.4	0.4	0.9	0.5	0.4	1.4	1.4	0.5	1.0	0.4	0.4	1.4	0.4	0.4	0.5	1.2	3.0	0.1	0.2	0.1	0.0	2.3	0.6	0.9	0.5	0.2	1.0	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.1	1.5	0.7	3.5	0.1	0.7	1.3	0.2	0.1	0.2	1.5	0.4	1.3	1.0	0.1	0.0	0.4	1.0	0.0	0.0	0.0	0.9	0.6	0.0	0.4	2.0	3.5	0.0	1.4	0.1	0.2	0.2	0.3	1.0	0.5	1.4	0.5	0.0	0.4	0.4	0.6	0.5	0.4	0.8	0.6	0.4	1.2	0.6	0.3	0.8	0.2	0.8	0.9	0.1	0.3	0.0	0.6	2.1	0.0	0.1	0.0	0.5	0.0	0.9	0.9	0.6	0.5	0.0	3.0	2.3	1.2	0.2	0.0	0.0	0.1	0.8	0.6	1.1	0.7	0.4	1.7	1.2	1.1	1.1	0.4	0.4	0.4	0.0	0.3	2.7	0.5	0.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.1	0.2	0.0	0.0	0.1
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036716	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ito cells: 119.7;Leydig cells: 95.8;Peritubular cells: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 20.4;BJ: 23.3;BJ hTERT+ SV40 Large T+: 25.9;BJ hTERT+ SV40 Large T+ RasG12V: 35.5;HaCaT: 36.9;HBF TERT88: 33.5;SuSa: 23.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		600000			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	11.9	11.8	20.7	15.4	12.3	0.0	12.1	5.4	9.0	56.4	21.7	11.4	30.2	12.9	49.7	24.2	9.1	14.2	23.0	36.1	10.4	4.9	10.7	6.3	4.3	6.1	15.5	4.0	39.8	3.2	1.2	3.8	39.5	11.7	43.0	13.2	5.8	11.9	41.6	1.6	13.8	36.9	40.4	9.0	1.4	8.3	10.6	13.0	0.6	63.3	9.2	3.6	27.9	47.8	0.4	1.2	0.1	0.8	0.2	9.0	0.2	7.5	3.4	7.6	0.8	20.4	1.2	4.9	23.3	5.7	25.9	35.5	4.0	2.7	0.0	2.3	9.3	1.1	36.9	0.7	1.4	33.5	0.0	0.9	0.2	2.0	0.2	4.7	0.0	0.0	4.5	3.1	5.3	0.2	7.3	0.1	0.4	0.0	0.0	1.3	3.5	0.0	0.2	2.3	0.0	1.2	0.0	0.8	3.5	1.8	1.7	5.2	0.5	3.7	0.0	6.0	23.2	3.5	0.4	0.2	1.7	10.8	5.2	3.5	0.3	0.0	0.0	6.2	0.1	1.9	0.0	0.2	0.1	0.3	0.8	9.0	0.1	1.2	1.6	1.2	0.4	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.2	20.7	12.3	5.4	9.0	10.4	4.9	15.5	4.0	11.7	13.0	3.0	2.2	0.0	10.9	33.2	5.8	24.8	20.4	1.4	3.4	15.7	51.1	1.2	0.0	8.0	77.0	22.7	18.7	0.0	0.0	0.9	57.2	5.6	0.0	7.8	1.3	0.0	22.5	119.7	5.7	77.1	95.8	1.2	27.0	2.8	22.4	5.6	1.9	18.7	243.3	3.8	43.8	12.9	8.2	1.9	1.4	7.4	2.1	2.5	23.0	1.5
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	1.9	6.5	0.0	1.9	4.1	0.4	0.8	0.4	2.6	3.4	1.8	1.1	0.0	0.3	0.6	2.5	0.4	0.1	5.0	3.8	0.0	0.1	0.0	0.4	56.1	0.4	0.0	0.0	8.8	0.3	2.9	0.7	1.8	3.5	0.0	0.0	0.0	5.5	0.9	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	7.9	1.7	0.0	0.8	4.2	0.7	2.4	11.6	7.7	0.0	1.9	3.9	4.8	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0	35.7	2.1	0.0	0.3	0.2	0.0	0.2	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.2	1.6	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.7	0.0	4.2	0.3	0.0	25.8	11.4	0.0	1.5	0.1	0.1	0.0	0.0	0.1
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 5.7;Exocrine glandular cells: 2.3;Spermatogonia: 3.8;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 7.0;SK-MEL-30: 2.3;U-937: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.4	0.1	0.3	0.3	0.0	0.0	0.0	1.0	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.4	0.0	7.0	0.3	0.0	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.3	0.0	0.1	0.6	0.0	0.2	1.0	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	5.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	2.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.4	3.8	3.8	0.2	0.0	0.0	0.9
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52771700	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"liver: 82.5"	"Cell type enriched"	"Detected in some"	62	"Hepatocytes: 190.6"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 7.0"	"Region enriched"	"Detected in single"	5	"pons and medulla: 0.5"	"Not detected"	"Not detected"			"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1700000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.6	0.0	0.0	0.0	3.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MDK	"FLJ27379, MK, NEGF2"	ENSG00000110492	Midkine	P21741	11	46380756-46383837	"Cancer-related genes, Predicted secreted proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 115.9"	"Cell type enhanced"	"Detected in many"	11	"Intestinal endocrine cells: 971.2;Paneth cells: 1226.4;Urothelial cells: 439.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6;neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 89.4;REH: 130.0;SH-SY5Y: 111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010055, HPA057126"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	158000	1200000	Vesicles		"CAB010055: AB_627949, HPA057126: AB_2683344"	"unprognostic (8.87e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (8.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	8.0	16.2	4.7	11.9	5.6	1.7	13.5	5.3	5.9	62.5	36.3	5.3	13.9	50.6	41.0	33.9	6.5	34.6	35.0	6.4	4.0	5.9	6.1	2.0	8.0	3.6	4.9	4.4	115.9	13.1	8.9	64.8	11.5	5.5	47.7	7.4	59.0	22.2	24.5	4.7	4.1	58.4	16.6	4.0	13.9	21.0	9.3	2.1	22.5	5.2	5.5	12.4	15.3	23.0	3.6	0.2	4.9	0.6	0.2	2.0	1.5	4.9	6.5	76.3	0.2	0.5	6.4	1.8	3.8	7.7	14.7	13.1	49.5	21.8	0.3	53.8	5.6	0.6	42.5	43.0	0.0	1.3	15.1	9.0	2.1	0.6	67.8	34.8	0.1	0.3	10.3	1.3	8.9	0.0	3.1	21.4	2.9	36.6	0.3	8.2	33.8	1.8	0.9	89.4	26.7	38.8	130.0	2.9	0.4	0.1	0.1	42.4	111.0	12.7	1.1	1.0	70.5	34.8	34.3	5.8	22.6	54.3	0.3	2.6	0.2	1.0	0.4	0.6	1.3	19.6	0.0	0.1	0.0	0.3	0.5	0.0	3.6	0.2	0.5	0.1	1.1	0.2	0.0	4.9	0.2	0.6	0.2	2.0	1.5	4.7	5.6	5.3	5.9	4.0	5.9	4.9	4.4	5.5	2.1	0.0	4.8	2.4	142.7	9.8	0.1	5.8	40.8	41.5	46.6	45.4	0.0	140.1	1.7	217.8	16.4	56.2	413.9	0.0	92.4	97.9	99.4	135.8	4.6	5.9	43.2	0.0	971.2	77.3	4.0	90.5	101.5	7.1	35.4	16.2	245.7	23.8	203.6	1226.4	17.7	13.5	0.7	84.1	56.5	14.9	29.0	7.0	128.0	3.2	126.6	439.7
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	Yes	No		580000	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.5	7.2	1.6	3.1	0.1	0.1	0.5	22.5	6.3	1.9	0.6	1.5	5.3	0.0	7.2	7.7	1.3	2.8	0.0	0.2	0.2	0.0	0.1	0.0	20.3	1.3	0.0	0.1	0.4	0.0	0.2	0.1	0.2	26.6	2.4	0.0	0.0	0.0	0.0	2.5	0.0	4.1	1.0	1.0	0.4	0.9	0.9	2.7	0.4	1.4	1.6	1.5	8.1	0.5	2.8	2.3	2.2	0.4	1.0	8.2	0.8	20.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4	20.8	19.4	0.0	7.5	16.4	0.8	3.0	5.1	0.0	6.8	1.8	0.0	0.1	0.0	3.0	0.2	8.7	0.3	0.0	1.2	1.0	6.4	3.4	1.1	0.9	1.0	0.0	0.0	16.5	0.8	0.0	10.6	2.8	18.6	0.0	1.3	9.5	3.6	0.0	3.2	1.7	1.0	0.0	2.1	0.5	0.6	9.9	0.3	0.0	0.7	3.0
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699499-41799456	"Predicted intracellular proteins, Predicted secreted proteins"	Meiosis		"Disease mutation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 26.8;lymphoid tissue: 20.3;testis: 34.7"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 50.5;Late spermatids: 37.4;monocytes: 22.6;T-cells: 22.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.9;HMC-1: 6.4;Karpas-707: 21.4;U-266/70: 22.7"	"Group enriched"	"Detected in many"	17	"amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9"	"Region enriched"	"Detected in single"	4	"olfactory region: 4.2"	HPA049240	Approved				"Secreted in male reproductive system"	NA	NA					"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favorable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	2.1	0.9	1.4	7.7	1.4	12.4	3.1	1.7	3.3	1.6	6.3	0.5	0.9	2.6	0.8	3.6	1.6	1.2	1.9	1.5	1.2	1.8	2.2	1.3	3.5	20.3	1.1	0.4	0.9	1.0	0.0	1.0	1.6	1.6	1.2	3.3	3.3	6.0	1.0	0.7	1.1	6.5	0.6	1.1	15.5	4.5	34.7	0.3	3.8	1.9	1.8	17.1	4.0	1.3	11.0	3.2	7.3	3.7	7.8	26.8	8.8	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	1.7	0.0	0.2	0.4	0.1	0.4	0.4	0.1	0.2	0.1	0.0	0.0	0.0	5.0	0.0	1.4	7.9	0.9	1.3	1.0	6.4	0.1	0.1	0.0	0.0	0.3	0.3	0.6	0.2	21.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	0.7	0.4	0.0	0.0	0.0	22.7	3.6	0.9	0.3	2.1	0.1	6.2	3.7	7.3	15.8	2.7	15.2	11.0	15.8	13.3	3.2	7.3	11.7	12.8	0.7	7.8	1.1	1.2	26.8	8.8	1.4	1.4	1.7	3.3	1.2	1.8	1.1	0.4	1.6	0.3	0.0	5.6	14.9	0.2	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	50.5	1.0	0.0	0.0	0.0	0.1	1.4	0.2	13.9	0.8	7.4	0.0	0.0	1.8	1.9	37.4	0.6	6.3	16.9	22.6	0.3	0.0	3.2	0.0	1.1	0.3	0.6	0.0	2.5	19.7	19.0	0.9	0.0	22.5	0.0	0.2
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.1;Enterocytes: 6.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.1	1.0	0.3	0.3	0.1	0.6	1.4	1.7	0.5	0.0	0.8	0.2	0.0	0.0	0.0	0.8	1.0	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.7	0.5	1.6	1.1	0.2	0.0	1.9	1.3	4.1	1.3	0.5	0.0	1.8	1.8	2.9	0.0	0.7	10.6	2.4	0.8	0.2	0.3	0.3	0.4	3.1	0.9	1.4	0.8	3.4	0.0	0.6	2.3	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 34.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 34.2;cerebral cortex: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.0"					"Group enriched"	"Detected in some"	4	"amygdala: 1.3;basal ganglia: 0.7"	"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		24000000			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.2	0.2	34.2	0.2	5.2	0.3	0.5	0.0	10.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	2.4	1.7	0.3	0.2	0.3	0.2	0.5	5.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	5.2	0.0	10.0	2.4	1.7	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell type enriched"	"Detected in many"	8	"Muller glia cells: 554.6"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.4;PC-3: 41.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in all"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.5	4.4	22.5	7.9	4.4	7.2	5.3	2.7	2.1	1.4	3.3	6.6	0.4	12.5	3.7	8.2	9.9	0.6	5.2	0.3	1.4	9.9	0.9	4.1	17.0	4.8	1.9	2.9	10.7	5.7	0.6	1.3	6.7	0.7	6.3	1.5	0.5	1.6	53.4	0.7	6.5	1.6	2.9	41.3	7.3	5.1	7.3	5.5	0.7	7.0	8.9	2.1	5.9	27.4	0.5	8.9	3.8	2.4	6.1	11.7	7.1	4.6	3.4	0.9	0.4	9.6	1.4	14.4	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0	0.0	2.1	4.2	14.7	3.4	38.6	14.0	50.9	2.7	0.0	15.7	13.7	0.6	43.1	6.3	6.5	12.6	15.0	0.0	4.2	1.8	8.7	28.3	0.0	27.2	5.2	66.7	26.2	19.0	5.1	14.5	10.3	4.8	10.1	0.0	8.1	554.6	5.4	14.7	8.9	43.5	29.1	25.8	15.3	3.9	11.3	2.6	0.3	6.4	8.6	14.2
METRNL		ENSG00000176845	"Meteorin like, glial cell differentiation regulator"	Q641Q3	17	83079691-83095119	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.7;U-2197: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023792	Uncertain				"Secreted to blood"	NA	NA	445000				"HPA023792: AB_2144182"	"unprognostic (7.99e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.41e-3)"	"unprognostic (7.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-2)"	21.8	4.0	3.7	13.3	4.0	16.9	19.9	3.4	4.8	20.4	18.8	4.2	8.8	25.9	7.5	12.7	37.0	8.5	13.3	29.4	3.7	2.9	15.6	4.4	19.4	9.7	3.1	2.8	11.4	17.7	16.0	8.2	27.9	8.0	10.1	4.6	15.6	15.3	8.5	10.3	52.3	21.8	13.3	4.1	13.9	13.5	8.8	3.3	2.5	25.3	23.3	18.0	20.5	26.3	1.2	4.8	10.8	7.8	3.2	2.1	1.4	3.9	0.1	2.0	2.4	2.1	7.9	9.0	4.2	1.9	3.0	3.4	0.4	2.8	0.2	1.6	3.1	2.1	9.8	0.6	0.2	1.9	2.7	1.5	8.6	10.9	1.0	5.2	2.6	16.7	3.8	0.8	12.1	0.8	1.9	1.5	0.0	5.4	0.0	2.5	6.1	0.2	8.1	0.4	5.7	5.3	2.6	3.8	1.2	0.4	1.5	0.1	1.2	5.8	10.3	4.5	2.0	9.1	2.9	3.6	40.7	4.6	54.7	1.2	0.0	0.0	0.1	9.5	1.1	2.5	6.5	3.6	10.8	2.1	6.2	0.1	1.2	0.4	1.4	4.8	0.2	0.0	0.6	6.1	3.2	7.8	1.8	1.8	1.4	3.7	4.0	3.4	4.8	3.7	2.9	3.1	2.8	8.0	3.3	23.8	42.7	4.8	15.0	20.4	3.3	30.3	12.7	1.4	9.1	47.1	5.9	9.8	3.3	11.0	7.6	13.9	56.8	23.3	12.2	4.6	31.9	16.1	31.3	0.5	44.3	1.6	5.8	15.4	48.0	0.0	7.2	49.5	15.1	4.6	28.5	87.9	15.3	27.7	3.2	6.4	22.5	0.0	14.9	1.1	3.8	43.0	16.0	17.3	22.7	48.9
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 4.3;Horizontal cells: 1.6;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	34	"T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 2.6;HHSteC: 3.1;SCLC-21H: 4.6;SH-SY5Y: 2.8;SuSa: 4.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	2.1	1.9	2.4	3.7	2.8	0.0	1.8	2.8	2.1	11.9	10.8	2.9	4.8	1.5	16.2	5.0	5.6	7.0	9.6	3.2	2.1	1.9	5.2	1.1	2.4	0.6	2.1	2.7	9.2	2.3	5.8	4.6	0.3	2.2	8.6	5.0	10.2	1.1	8.6	0.4	1.1	4.0	16.1	2.8	0.6	6.0	2.8	1.5	0.6	2.1	3.0	1.5	13.3	5.1	0.0	0.1	0.0	0.0	0.2	7.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.4	2.8	2.8	2.1	2.1	1.9	2.1	2.7	2.2	1.5	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	24.0	45.5	29.6	18.8	34.9	50.0	45.1	12.2	31.9	34.2	19.1	18.7	15.5	14.9	23.4	35.6	30.2	23.8	19.4	32.0	22.2	20.0	61.0	8.7	24.0	38.8	26.8	8.4	22.8	28.8	37.2	25.0	25.4	17.7	23.8	20.3	32.5	22.1	19.3	30.6	21.5	20.6	21.1	25.0	29.6	18.8	10.8	18.1	39.8	37.8	20.0	25.9	24.9	24.6	4.9	14.1	30.5	24.5	5.6	7.3	7.6	13.6	10.4	26.4	22.8	27.3	49.5	9.5	21.9	31.4	17.3	21.0	7.5	24.9	24.0	18.7	38.3	16.7	8.6	17.5	19.6	23.7	18.2	14.3	10.4	10.5	27.9	19.6	8.1	21.6	29.1	20.9	17.9	23.4	32.6	33.1	26.9	15.3	19.8	34.2	15.1	21.1	13.6	23.7	17.0	10.8	30.8	20.5	21.8	28.5	13.4	15.3	27.6	18.6	12.9	46.7	20.7	13.1	4.2	18.7	28.8	12.6	17.6	13.4	16.8	27.0	19.3	28.3	20.2	20.3	30.5	24.5	10.7	4.0	4.5	4.8	4.6	6.8	7.3	14.1	4.9	7.3	5.4	12.5	5.6	3.9	4.4	5.4	7.6	29.6	34.9	12.2	31.9	22.2	20.0	26.8	8.4	17.7	18.1	17.9	25.0	67.7	73.4	63.7	38.7	50.8	28.1	17.4	25.0	82.0	43.2	62.9	238.8	101.7	6.4	91.1	45.1	0.0	107.0	99.3	82.6	115.4	48.3	10.4	80.8	42.9	81.5	80.4	211.5	4.5	58.7	86.5	99.5	101.8	76.5	49.9	98.9	45.6	61.2	326.8	37.5	64.7	68.4	13.2	20.0	67.2	116.4	146.0	75.0	107.4
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.7"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	13.1	1.6	0.2	6.0	0.4	0.0	20.8	0.4	0.8	24.8	5.0	0.5	6.7	1.6	28.7	14.0	5.7	6.6	29.7	29.6	0.6	0.3	3.4	0.8	12.5	1.2	0.3	1.0	23.6	33.9	0.0	4.7	51.7	1.8	16.9	1.7	15.4	6.9	5.0	4.6	10.9	4.3	18.3	2.9	1.3	3.5	10.4	0.3	0.7	3.8	7.4	3.3	10.3	13.2	0.3	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.0	19.0	0.0	48.7	50.2	1.2	4.8	20.0	7.5	14.7	4.3	0.2	0.0	16.6	16.7	0.0	0.0	1.3	1.5	3.0	0.0	14.8	0.0	7.0	0.4	4.6	0.0	0.0	20.5	3.7	21.1	8.4	23.3	51.4	0.0	0.0	3.1	3.7	2.3	0.0	0.0	22.1	0.1	0.1	0.2	0.0	0.6	0.2	0.0	1.0	43.1	1.6	7.2	1.8	15.6	2.4	2.5	14.2	13.1	27.4	10.6	0.5	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.8	0.6	0.3	0.3	1.0	1.8	0.3	0.0	1.7	0.0	5.7	6.0	0.0	0.4	2.5	1.4	7.9	3.5	0.0	3.9	0.0	0.9	13.1	0.6	0.0	0.0	0.7	148.9	84.5	1.0	0.0	0.0	6.7	0.0	9.7	1.8	0.0	4.5	49.8	0.9	16.9	0.0	0.3	26.5	3.2	0.0	60.1	0.0	0.8	0.0	4.1	1.1	8.1	5.5	24.3	0.0	0.0	0.8
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 593.8;Peritubular cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 60.2;ASC TERT1: 91.9;fHDF/TERT166: 41.1;HHSteC: 42.1;HSkMC: 63.7;MOLT-4: 52.6;SH-SY5Y: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		140000000	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.2	91.9	0.1	6.5	23.5	0.6	0.4	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	42.1	2.0	0.0	63.7	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	52.6	4.8	1.0	0.0	0.0	3.7	3.7	0.0	0.0	0.0	5.3	52.5	0.0	0.0	0.0	0.3	0.0	11.8	0.0	7.6	0.5	0.3	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3	3.0	15.5	0.0	0.5	42.2	0.7	9.5	0.0	5.3	5.7	1.8	0.0	5.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	3.1	593.8	1.2	1.1	0.0	8.2	0.0	0.0	19.0	0.0	2.0	72.5	2.4	64.1	0.0	0.0	71.0	0.1	0.0	225.6	0.0	2.9	19.4	95.8	0.2	0.5	35.9	16.2	0.0	0.0	0.4
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.1"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 937.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010553	Enhanced				"Secreted to extracellular matrix"	NA	NA		3800000			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.81e-4)"	44.3	3.2	0.6	3.3	0.7	0.3	21.8	0.5	0.5	71.5	11.2	0.5	18.2	1.4	78.4	34.0	31.3	9.0	6.8	16.5	0.7	0.6	1.9	3.0	3.3	3.3	0.6	0.4	4.7	1.4	0.2	1.7	128.1	0.7	7.6	11.0	0.9	6.0	13.5	19.6	13.0	9.0	37.0	3.4	1.0	7.9	12.3	0.3	1.0	13.1	35.0	4.5	46.3	21.1	1.1	1.2	5.3	2.4	0.6	1.2	0.8	0.4	1.6	0.4	0.7	8.7	3.7	50.0	18.1	0.3	0.2	0.3	0.6	0.3	0.1	43.9	5.6	0.4	2.5	0.1	3.7	0.0	0.1	0.1	0.4	16.6	0.5	0.1	0.3	0.2	2.5	1.3	2.1	0.0	0.9	0.0	0.5	0.7	1.0	15.1	0.2	0.5	0.2	0.9	0.2	0.8	0.3	0.4	1.8	1.8	0.7	0.2	0.2	0.5	0.2	0.3	42.1	6.9	0.2	0.6	3.2	6.3	13.2	0.8	0.6	0.5	0.5	1.7	0.2	0.0	5.3	2.4	2.0	0.7	1.9	1.2	0.4	0.4	0.4	1.2	1.1	1.2	0.5	3.1	0.6	1.4	1.0	0.1	0.8	0.6	0.7	0.5	0.5	0.7	0.6	0.6	0.4	0.7	0.3	11.9	4.3	0.0	0.4	20.5	0.2	5.2	0.0	2.7	3.4	0.0	0.0	70.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	937.0	96.1	0.0	0.0	0.0	24.9	0.0	0.0	7.4	1.9	0.2	56.7	3.6	11.8	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	20.2	0.0	0.0	15.7	210.9	0.0	0.0	0.1
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule-EGF factor 8 protein"	Q08431	15	88898683-88913411	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 363.2;Rod photoreceptor cells: 972.8;Sertoli cells: 1067.2;Smooth muscle cells: 475.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.9;ASC TERT1: 94.5;fHDF/TERT166: 64.0;HSkMC: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000	1100000	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	34.2	23.2	5.4	14.5	11.2	0.9	73.4	5.7	14.8	43.4	15.8	9.6	11.3	5.2	73.2	38.6	32.8	56.2	30.2	115.4	5.6	4.1	12.4	3.9	20.8	14.9	6.0	8.3	49.8	6.6	2.9	8.1	23.1	10.8	29.5	7.3	59.5	15.6	50.7	57.8	18.3	15.4	39.6	8.8	6.5	22.2	23.6	4.4	8.5	21.7	21.1	12.6	32.8	68.3	1.2	0.0	3.6	0.2	6.3	13.3	2.0	1.8	7.1	7.8	9.5	181.9	94.5	0.6	46.9	14.0	9.4	11.2	6.2	2.2	0.0	14.5	64.0	14.1	0.9	2.7	9.3	3.1	7.5	4.7	13.6	0.4	0.6	47.9	0.0	4.8	95.7	25.0	7.4	12.4	20.5	3.6	3.4	2.1	4.1	18.2	0.1	2.1	0.3	39.9	0.7	2.5	2.1	7.4	2.4	3.3	0.6	0.8	4.1	2.5	0.2	21.2	17.1	0.2	1.0	3.9	23.4	12.6	6.0	3.4	14.4	2.8	1.4	3.1	1.1	9.0	3.6	0.2	0.4	1.2	0.0	4.2	1.2	4.2	3.0	0.0	0.8	4.4	3.1	0.0	6.3	0.1	0.0	13.3	2.0	5.4	11.2	5.7	14.8	5.6	4.1	6.0	8.3	10.8	4.4	11.9	4.8	1.9	27.2	43.3	16.8	80.8	12.7	0.0	2.3	3.5	363.2	4.3	0.0	12.8	9.7	36.0	0.8	0.0	3.6	16.7	111.8	11.6	4.7	7.4	7.1	15.9	42.9	28.3	35.4	22.8	173.2	16.6	113.1	2.8	5.4	69.0	18.8	0.0	102.6	0.0	972.8	1067.2	475.7	2.7	8.6	31.5	4.5	12.2	1.2	7.4
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A"	Q9UM21	2	98619106-98731126	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	8.1	5.1	11.3	11.9	15.6	49.2	8.2	28.5	14.3	6.1	14.6	8.3	6.8	17.6	5.2	4.1	4.1	6.2	8.0	5.1	11.3	10.4	17.1	6.0	13.7	16.7	9.9	8.3	2.9	26.7	33.3	14.1	11.9	10.4	6.6	15.8	5.6	14.5	4.4	3.3	3.4	38.5	7.2	16.1	7.0	8.4	3.9	14.3	20.3	6.4	3.1	11.6	8.3	5.0	2.0	9.3	7.6	2.9	7.7	19.7	7.4	3.0	0.6	1.2	2.6	0.0	0.0	46.0	0.0	0.0	0.3	0.0	7.3	3.7	0.0	6.9	0.0	0.9	0.1	2.5	0.3	0.0	3.6	2.8	0.1	0.0	12.7	0.0	6.1	2.3	0.0	1.7	0.0	0.2	0.1	17.2	30.7	0.5	3.3	0.0	5.9	13.3	10.7	0.4	2.6	0.5	3.3	0.0	3.6	8.9	6.2	3.7	1.2	0.8	11.5	1.6	3.4	2.7	8.3	27.8	0.0	1.4	0.0	0.9	1.1	2.5	0.7	0.0	9.2	0.2	3.3	2.9	6.6	12.3	0.5	15.9	2.0	14.9	13.7	2.0	1.1	19.7	16.1	7.6	7.7	1.1	9.3	8.4	7.4	11.3	15.6	28.5	14.3	11.3	10.4	9.9	8.3	10.4	14.3	50.6	31.3	18.2	18.4	8.9	20.9	11.7	10.2	5.3	13.6	21.0	3.9	3.9	18.3	15.5	10.0	32.8	84.5	0.0	25.8	66.5	5.4	17.8	12.7	8.5	53.2	46.1	50.8	20.3	30.7	13.9	2.3	33.8	10.1	10.0	34.5	13.6	22.1	48.9	2.1	25.6	4.8	6.5	5.1	2.8	3.4	9.3	12.5	74.0	30.1	20.1
MGP		ENSG00000111341	"Matrix Gla protein"	P08493	12	14881181-14885926	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Fibroblasts: 1780.1;Ito cells: 1289.1;Leydig cells: 1866.9;Peritubular cells: 1223.8;Sertoli cells: 827.9"	"Cancer enhanced"	"Detected in all"		"breast cancer: 845.3"	"Group enriched"	"Detected in many"	4	"olfactory region: 7.9;pons and medulla: 22.5"	"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.8"	"Cell line enriched"	"Detected in some"	5	"AN3-CA: 471.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013949	Approved				"Secreted to blood"	NA	NA		15000000			"HPA013949: AB_1853599"	"unprognostic (5.71e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.97e-3)"	97.0	82.5	0.7	53.2	2.2	0.0	303.5	1.6	3.2	190.5	93.5	5.7	145.0	5.1	149.5	404.0	94.1	118.3	82.0	156.2	1.9	1.1	120.8	6.8	109.2	24.7	3.5	7.9	86.5	22.9	4.8	54.4	18.8	22.5	189.7	21.3	195.1	245.8	96.5	33.3	20.1	45.2	160.5	13.0	11.0	55.8	143.0	0.8	2.1	203.9	58.8	16.0	183.7	135.7	0.0	4.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	471.2	79.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.6	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	1.4	0.0	0.4	0.0	0.1	86.3	0.0	1.0	0.5	0.0	0.1	1.3	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.7	2.2	1.6	3.2	1.9	1.1	3.5	7.9	22.5	0.8	17.9	88.3	12.5	172.0	132.6	0.6	41.2	0.0	45.5	342.4	109.9	3.9	17.9	1.7	1.6	12.8	555.1	0.0	0.0	72.4	10.5	1780.1	99.4	12.8	2.6	28.3	0.0	0.0	1289.1	5.4	23.5	1866.9	34.3	214.2	4.6	0.0	27.6	1.3	0.0	1223.8	0.6	5.5	827.9	564.2	6.8	5.6	103.5	33.1	3.2	0.0	53.8
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	10	"Melanocytes: 97.8;monocytes: 52.3;Pancreatic endocrine cells: 38.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"	"Group enriched"	"Detected in some"	31	"AN3-CA: 21.8;CAPAN-2: 18.3;SK-MEL-30: 63.5;WM-115: 60.2"									HPA042369	Approved				"Secreted to blood"	NA	NA	8270000				"HPA042369: AB_10794420"	"prognostic favorable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.8	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	18.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	63.5	0.8	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	60.2	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4	0.0	0.3	0.0	0.1	4.6	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.6	0.7	0.0	2.7	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.6	0.0	97.8	52.3	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.6	0.0	0.5	0.4
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 1397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 129.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	49.8	11.0	2.4	11.2	0.9	2.3	18.7	18.8	3.1	6.1	7.8	8.3	8.2	23.7	14.9	1.3	2.8	22.2	2.6	11.4	0.7	19.9	129.4	8.9	10.1	17.2	4.9	34.6	21.1	4.7	6.8	3.6	1.7	4.5	4.8	17.8	13.8	12.1	2.0	25.1	23.5	64.2	14.3	9.8	60.3	30.2	4.1	66.5	4.7	3.4	32.5	37.8	12.0	12.7	31.0	0.6	16.4	10.4	13.7	5.3	35.6	3.2	0.4	52.3	18.4	24.4	21.5	12.9	10.8	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2	145.9	147.8	297.7	257.6	597.1	25.5	0.3	433.1	384.1	354.8	657.8	2.0	427.6	1397.6	643.7	166.1	220.2	275.4	0.0	324.9	742.0	370.2	224.8	172.4	900.8	252.9	20.6	335.5	293.4	221.5	97.3	311.3	223.0	733.9	288.6	378.1	30.6	687.0	340.1	284.6	1307.4	25.0	135.8	432.6	7.9	117.5	663.2	573.7	251.6	418.6	198.5
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	175	"intestine: 76.0"	"Cell type enriched"	"Detected in single"	34	"Intestinal endocrine cells: 3.4"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4"					"Not detected"	"Not detected"			HPA069392	Enhanced				"Secreted to blood"	NA	NA	450000				"HPA069392: AB_2686136"					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	58.4	0.0	0.0	76.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	30.6	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	3.1	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell type enriched"	"Detected in some"	7	"Pancreatic endocrine cells: 1303.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7"									HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	430000	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	90.2	36.9	9.6	0.7	0.0	0.0	0.4	21.6	14.2	0.3	0.0	12.6	89.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.9	3.2	0.0	234.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.1	30.6	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	115.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3.0	1.6	0.0	14.4	2.1	0.0	0.0	35.7	0.0	23.9	3.5	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	184.0	0.0	0.2	5.4	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	7.2	0.0	0.0	1303.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	25.0
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2"	"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.6	0.7	0.1	0.1	0.3	0.0	0.0	3.7	1.9	0.2	2.9	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	16.2	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.0	0.5	1.7	0.0	0.0	0.0	0.0	0.7	5.2	0.0	2.5	0.0	0.0	0.9	0.0	0.0	2.0	3.9	1.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	38.9	0.7	0.0	0.0	0.0	5.3	70.5	27.9	0.0	0.0	0.0	9.8	5.0	0.0	0.0	0.0	12.9	0.0	0.2	5.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.8	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	7.4
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB002593: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.7	2.8	4.2	0.0	0.2	5.0	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.9	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	9.7	2.9	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.6	0.5	0.1	7.8	0.0	0.2	0.3	0.0	2.9	5.0	1.9	0.3	0.0	3.0	1.7	0.0	1.3	0.3	0.0	0.7	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2	0.0	4.5	0.8	0.8	0.9	0.4	4.3	2.5	1.4	0.0	0.0	0.0	0.3	1.7	5.9	6.6	0.2	0.0	0.0	0.6	34.6	5.7	0.4	1.1	0.0	0.7	0.0	1.7	1.3	0.0	8.0	0.6	0.0	1.7	0.0	0.8	0.5	1.6	0.0	0.4	2.2	0.6	0.0	2.0	1.1	2.7	0.5	15.6	0.0	0.8	0.3
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.6	0.1	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	17.0	80.4	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	1.4
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	8	"Club cells: 30.7;Urothelial cells: 14.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HaCaT: 19.5;PC-3: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	2.7	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	20.4	0.7	1.4	0.0	7.5	1.1	2.1	1.3	0.0	0.0	0.0	0.0	3.3	1.2	0.0	4.0	0.0	2.6	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.1	0.9	3.8	8.8	0.0	0.0	0.7	1.1	0.0	0.0	0.0	1.2	0.0	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.4	0.0	0.0	0.1	1.6	0.8	0.0	4.9	9.7	5.5	0.1	2.8	0.0	0.0	0.0	3.9	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5	0.0	0.0	0.0	0.0	1.0	3.9	0.6	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	4.9	2.9	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	1.6	0.0	0.6	0.0	4.7	0.9	0.6	1.7	0.0	0.0	3.2	0.2	0.0	1.1	0.0	0.3	0.0	1.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0
MMP17	MT4-MMP	ENSG00000198598	"Matrix metallopeptidase 17"	Q9ULZ9	12	131828393-131851783	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enriched"	"Detected in some"	7	"Melanocytes: 27.0"	"Cancer enriched"	"Detected in many"	10	"melanoma: 29.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7"	"Group enriched"	"Detected in many"	4	"REH: 17.3;SK-MEL-30: 42.1;WM-115: 62.3"	"Group enriched"	"Detected in many"	5	"amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (9.11e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.66e-4)"	"unprognostic (7.68e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.26e-10)"	"unprognostic (1.15e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.81e-2)"	4.6	2.0	12.6	3.0	23.3	6.2	2.5	1.4	21.5	5.6	3.0	3.1	0.0	1.4	4.2	0.9	2.1	2.1	7.0	1.1	22.5	10.1	0.5	0.5	1.8	5.5	3.7	7.6	9.0	5.0	3.1	0.7	1.1	2.2	1.6	0.8	1.6	8.5	2.5	1.6	9.7	1.9	1.7	1.6	4.8	1.4	2.9	3.5	0.0	0.8	1.5	1.6	2.8	2.8	1.7	1.2	0.2	2.7	0.1	0.0	1.1	0.1	5.3	0.2	0.5	4.3	1.7	0.1	2.7	6.7	2.6	2.7	0.0	1.5	0.0	2.2	4.2	1.6	2.3	2.2	2.5	0.5	0.0	0.3	0.9	1.9	0.0	5.3	0.0	3.8	2.6	0.7	3.7	0.9	1.0	3.5	0.0	1.0	0.1	3.3	4.7	0.1	4.0	2.4	1.6	3.2	17.3	0.0	2.0	0.0	0.0	2.3	0.7	0.3	0.9	42.1	0.7	4.9	10.0	2.7	0.7	0.7	3.8	0.3	0.0	0.0	0.0	1.4	0.5	62.3	0.1	2.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	1.2	1.7	0.0	0.0	0.2	0.1	2.7	0.0	0.0	1.1	12.6	23.3	1.4	17.9	22.5	10.1	3.7	7.6	2.2	3.5	0.0	0.0	0.0	0.1	2.3	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	1.0	0.2	0.0	0.0	0.6	3.2	0.0	1.3	4.0	0.0	0.9	0.4	27.0	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	0.0	1.0	0.5	0.4	1.0	0.0	0.0	0.0	0.1
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.1	9.7	0.1	292.5	85.2	15.9	25.0	57.5	5.0	4.0	0.0	0.1	0.0	20.1	44.1	1.9	2.7	0.0	0.2	2.9	0.0	0.0	0.0	0.6	0.1	27.7	0.0	0.7	72.6	0.0	26.0	0.2	329.2	32.7	0.0	0.0	0.1	16.8	0.0	0.0	0.3	7.7	0.0	0.0	0.0	2.3	0.0	0.8	0.3	0.1	17.6	4.6	0.0	0.1	45.4	0.0	1.7	45.9	79.6	7.6	15.2	3.2	0.0	0.0	0.0	93.1	1.3	14.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1	0.0	0.3	0.0	13.0	108.4	5.2	3.1	0.0	0.0	3.4	10.4	0.0	5.4	0.0	1.7	11.5	11.9	0.0	0.0	0.3	217.4	249.9	2.7	0.0	0.0	25.6	1.6	27.1	15.4	0.0	26.9	315.0	5.3	121.4	0.0	0.0	5.0	6.9	0.0	393.8	0.0	1.8	12.9	70.0	1.2	2.1	89.5	14.4	0.0	0.0	3.8
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576835-102625332	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.0;testis: 3.5"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 66.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.5
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125766453-125775821	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets, Heterotaxy"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 37.6"	"Cell type enhanced"	"Detected in single"	32	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.8"	"Not detected"	"Not detected"												"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.1	0.2			0.1	0.1	37.6	0.1	0.4	0.2	0.9	0.0	0.4	0.1	1.0	0.1	0.1	0.0		2.8	0.8	0.0	0.3	0.0		0.6	0.1		0.5	0.1	0.0	0.1	0.5	0.1	0.0	0.7	0.2	0.1			0.6		0.1	0.2	0.0	1.1	0.0	0.0	0.1	0.5	0.6	0.0	0.1	0.0	0.0	0.8	0.3	0.0	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	0.0	2.1	1.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 50.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.7	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.3	0.6	0.3	0.0	0.0	4.0	0.8	0.1	0.1	0.0	0.0	0.1	50.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.5	0.2	3.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	3.6	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	1.0	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5	3.0	10.7	0.0	0.2	0.3	0.6	0.4	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.5	1.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.0	0.0	23.4	0.0	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	3.1	0.1	0.1
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"endometrium 1: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"endometrial cancer: 8.8;prostate cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"	NA	NA									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3"					"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	275.6	1.8	0.5	0.0	0.0	0.0	0.0	119.3	6.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	11.5	7.4	0.0	0.2	5.1	0.0	11.4	0.0	0.0	0.1	0.0	0.7	14.6	0.0	0.0	0.0	1.2	2.2	1.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	3.0	0.2	0.0	0.1	5.2
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell type enriched"	"Detected in single"	32	"Hofbauer cells: 4.3"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Cell line enriched"	"Detected in some"	8	"WM-115: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"	NA	NA		83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Cell line enriched"	"Detected in some"	12	"NB-4: 89.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	57000000	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	89.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.3	0.0	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0	0.0	8.5	0.0	0.0	30.5	1.6	0.4	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.8	0.6	0.5	0.0	0.0	1.5	2.0	1.7	0.1	1.1	0.0	273.8	3.2	0.0	0.0	1.9	0.0	0.0	115.1	54.0	3.6	0.0	0.5	1.6	0.0	0.0	0.3	4.3	0.0	12.3	5.4	5.5	24.6	1.6	0.0	0.0	0.0
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 46.9;Ito cells: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 168.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1	0.0	11.8	6.1	0.1	3.8	0.0	2.0	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	11.8	46.9	0.0	0.0	0.0	0.0	1.5	0.1	2.3	0.8	0.4	0.0	0.0	114.2	6.3	3.2	0.3	2.5	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.7	0.0	4.0	0.0	0.0	0.0	0.1
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"Endothelial cells: 80.1;Ito cells: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 24.6;HUVEC TERT2: 51.7;TIME: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		86000000	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	61.0	8.0	5.4	5.7	6.5	0.4	63.6	4.1	6.8	17.2	10.1	3.5	9.5	5.0	19.0	12.0	12.5	12.5	10.2	51.0	8.2	4.9	11.1	11.1	26.1	7.5	5.9	2.5	12.2	5.4	6.7	5.2	41.9	7.4	13.1	4.4	13.8	12.8	15.2	20.2	19.5	8.1	13.9	6.3	30.8	7.5	10.5	6.0	2.0	16.2	17.6	6.2	23.4	42.2	0.5	0.1	0.1	0.3	0.0	3.1	0.1	3.0	0.8	0.1	0.0	0.3	1.8	2.0	1.1	3.0	1.3	1.9	1.7	24.6	0.0	10.6	2.0	3.3	6.0	0.0	1.4	1.8	2.2	0.0	0.6	2.4	0.0	0.2	0.0	1.3	0.4	7.4	1.6	10.9	3.7	51.7	0.6	0.5	9.8	0.5	1.9	0.1	1.1	0.5	0.1	1.3	0.0	0.0	0.0	0.5	4.7	1.3	0.0	0.8	1.0	0.3	0.2	4.1	0.3	61.7	0.5	3.2	0.5	0.0	0.7	1.0	0.0	1.6	0.0	0.7	0.1	0.3	0.0	0.3	0.0	3.1	0.5	0.9	0.7	0.1	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.9	0.1	5.4	6.5	4.1	6.8	8.2	4.9	5.9	2.5	7.4	6.0	0.0	8.0	0.0	0.9	8.4	0.0	8.3	5.1	0.0	1.2	1.8	0.0	0.6	0.0	0.0	0.9	80.1	0.0	0.0	0.0	0.1	3.6	0.5	0.0	3.4	1.3	0.0	0.0	127.1	8.1	1.5	2.3	0.5	3.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.5	6.5	4.7	1.5	1.8	6.8	0.2	0.0	0.0	0.9
MSMB	"IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94"	ENSG00000263639	"Microseminoprotein beta"	P08118	10	46033307-46046269	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"prostate: 437.8"	"Cell type enriched"	"Detected in some"	25	"Glandular cells: 8376.6"	"Cancer enriched"	"Detected in many"	42	"prostate cancer: 3435.3"					"Cell type enriched"	"Detected in single"	5	"eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.5;NB-4: 16.5;RPMI-8226: 8.6;SH-SY5Y: 4.7;SK-BR-3: 4.8;U-2197: 9.7"									"CAB026357, HPA051257"	Enhanced				"Secreted in male reproductive system"	NA	NA		3700000			"CAB026357: , HPA051257: AB_2681410"	"unprognostic (6.47e-2)"	"unprognostic (7.21e-3)"		"unprognostic (1.37e-2)"		"unprognostic (8.18e-3)"	"unprognostic (4.28e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"		"unprognostic (2.01e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.19e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.8	0.0	0.1	0.1	0.0	1.8	0.1	0.0	7.2	0.0	0.0		0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	437.8	0.0	0.0	14.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	26.8	0.6	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.3	16.5	0.2	0.1	0.0	0.0	0.0	8.6	0.0	1.2	0.9	4.7	0.0	4.8	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	3.2	0.0	273.5	0.0	0.0	0.0	7.6	333.3	236.6	0.0	0.0	1.9	0.0	0.0	43.1	0.0	0.0	0.0	0.2	0.2	0.0	8376.6	1.1	1.0	0.2	0.0	0.0	0.0	0.0	49.8	0.3	0.0	3.3	0.0	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	1.3	0.0	0.0	190.4
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	67	"Early spermatids: 95.5;Late spermatids: 142.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 35.1;PC-3: 44.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"	No	No			Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0	0.0	0.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	95.5	0.3	0.0	0.0	1.8	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	142.6	0.3	0.0	1.7	0.0	0.0	0.8	1.3	0.0	0.7	0.2	0.6	0.0	0.0	0.7	0.4	0.1	0.2	0.0	0.0	1.1
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	8	"liver: 117.0"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 361.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;memory B-cell: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.7	3.5	4.0	0.3	4.8	1.4	1.0	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117.0	1.6	0.7	2.0	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4.0	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5.0	0.3	1.1	0.8	0.7	1.2	0.9	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.6	1.0	1.9	4.1	1.9	0.5	0.7	0.3	0.4	2.0	0.6	0.1	1.3	0.6	0.3	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	42.3	3.1	0.0	0.8	5.5	1.3	0.3	1.1	7.5	0.7	1.8	0.3	5.2	1.0	0.3	0.2	8.6	0.1	0.5	0.5	0.2	0.2	1.1	2.3	0.3	0.1	1.5	0.0	0.9	0.2	1.3	0.7	2.8	0.5	1.0	0.3	0.0	0.1	11.5	1.4	0.2	1.1	1.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	4.0	4.8	4.9	5.4	6.5	1.1	2.0	2.9	4.8	2.3	6.0	3.8	6.0	4.8	2.6	7.2	1.7	38.2	5.3	4.5	26.2	7.9	3.6	53.0	5.4	4.2	2.1	4.6	46.7	3.3	13.8	3.3	1.1	1.1	361.8	1.2	1.6	7.9	11.6	9.5	0.5	2.8	1.4	3.3	0.0	7.3	7.7	2.3	7.0	1.8	54.1	6.9	0.0	2.0	18.7	4.4	4.1	4.2	2.1	12.1	2.7
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055697-190062729	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.2;tongue: 15.8"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 3.9;Early spermatids: 13.2;Late spermatids: 4.3;Muller glia cells: 16.9"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"LHCN-M2: 16.2;RH-30: 33.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	NA	NA		4800000			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	3.3	1.9	1.7	0.7	1.4	0.2	0.8	4.1	1.8	4.8	1.1	2.2	0.0	0.7	1.8	1.2	2.3	0.5	0.6	0.7	3.5	1.6	1.1	0.3	0.3	0.3	1.3	0.0	0.7	0.4	0.4	1.4	0.2	3.4	1.0	1.1	0.9	1.0	0.5	17.2	1.2	2.1	0.9	1.1	0.3	0.6	0.7	4.0	0.0	0.7	15.8	0.4	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	4.1	1.0	3.5	1.6	1.3	0.0	3.4	4.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.4	0.0	1.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0
MTRNR2L1		ENSG00000256618	"MT-RNR2-like 1"	P0CJ68	17	22523111-22524663	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	4	"blood: 249.5"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 14115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 249.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 249.5"	"Cell line enhanced"	"Detected in all"		"HeLa: 188.9;Hep G2: 129.8"														"Secreted to blood"	NA	NA						"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.21e-3)"	9.4	16.2	7.9	3.7	10.0	2.3	3.0	4.0	8.4	2.5	8.9	3.3	4.8	4.5	2.6	6.8	4.8	2.6	3.3	34.3	8.1	6.1	17.8	12.8	4.2	5.6	8.9	3.0	4.1	15.0	1.5	3.4	2.5	4.6	3.5	7.7	3.3	5.9	5.0	55.5	5.3	5.2	7.5	5.9	3.3	5.6	4.4	4.0	1.8	2.7	6.8	1.8	3.3	2.6	29.4	21.6	249.5	34.3	15.0	18.3	28.7	20.6	48.2	18.6	62.5	29.5	12.2	23.6	19.5	4.6	4.5	5.3	29.6	33.5	28.1	21.3	10.0	3.2	55.0	1.4	7.0	5.6	16.5	34.6	25.7	188.9	129.8	9.6	6.0	31.0	27.3	15.1	5.0	12.2	32.8	4.8	18.4	20.8	17.2	13.4	16.7	9.3	41.3	5.3	16.1	10.8	15.3	11.8	14.6	25.7	29.5	9.9	17.6	9.4	17.9	28.7	18.7	16.8	43.0	9.3	24.9	21.0	29.6	12.0	16.0	5.1	13.3	14.2	38.0	5.4	74.4	34.3	62.1	10.9	16.7	13.5	28.7	13.9	11.8	12.1	29.4	18.3	15.9	249.5	15.0	16.1	21.6	12.1	28.7	7.9	10.0	4.0	6.8	8.1	6.1	8.9	3.0	4.6	4.0	122.1	126.9	16.9	1081.8	75.0	0.0	14115.0	2.5	184.7	263.9	73.3	0.0	0.7	94.5	0.5	4.6	52.2	1.1	0.0	0.6	0.6	57.9	106.8	153.5	10.2	0.7	0.0	1.7	4.9	6.9	6.9	14.4	92.3	59.1	0.0	1.3	0.0	0.2	1.4	3.9	12.2	0.0	0.0	31.1	6.6	18.6	149.7	0.8	7.5	1.2	234.3
MTRNR2L10		ENSG00000256045	"MT-RNR2-like 10"	P0CJ77	X	55181391-55182920	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.2"	"Cell type enriched"	"Detected in many"	21	"Cardiomyocytes: 8067.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 60.2"	"Group enriched"	"Detected in many"	4	"A549: 22.8;HeLa: 83.8;Hep G2: 71.6"														"Secreted to blood"	NA	NA						"unprognostic (4.42e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.97e-4)"	4.2	3.8	3.2	0.6	4.6	0.0	1.0	1.3	4.4	1.2	4.5	1.2	0.6	0.6	1.0	4.7	2.2	1.5	1.5	19.8	4.1	2.2	14.3	8.5	2.0	5.1	2.6	0.6	1.2	2.4	0.0	2.5	1.0	2.7	1.1	8.4	0.6	3.0	0.6	16.9	1.1	1.0	2.6	2.1	1.0	1.1	3.7	1.0	0.6	1.0	1.6	1.7	1.0	1.0	6.1	3.9	60.2	6.9	3.5	3.4	7.4	1.3	22.8	0.3	6.5	0.5	0.3	1.6	2.0	0.1	0.1	0.0	1.4	3.3	3.1	0.4	0.1	0.2	4.8	0.0	0.1	0.0	0.9	4.7	1.5	83.8	71.6	0.1	0.5	0.8	0.8	0.3	0.0	0.2	5.6	0.0	2.4	2.7	1.8	0.2	8.4	0.4	3.6	0.1	0.1	1.8	1.2	1.3	1.4	0.5	13.9	0.3	1.3	0.6	0.5	2.2	3.2	1.9	2.7	3.3	2.4	0.5	0.8	0.2	0.6	0.3	0.2	1.5	0.6	0.5	16.9	6.9	19.1	1.5	3.8	1.8	5.8	2.4	2.0	3.2	6.1	3.1	3.4	60.2	3.5	3.5	3.9	2.4	7.4	3.2	4.6	1.3	4.4	4.1	2.2	2.6	0.6	2.7	1.0	0.0	0.0	8.0	376.7	7.2	0.0	8067.8	0.0	0.0	0.0	40.1	0.0	0.2	71.3	0.0	0.2	2.2	0.0	0.0	0.0	0.2	13.1	232.2	0.0	4.9	0.5	0.0	0.0	1.8	3.2	0.4	0.6	10.6	15.1	0.0	0.0	0.0	0.0	0.0	1.1	4.3	0.0	0.0	22.6	0.5	0.7	8.0	0.2	0.0	0.0	338.2
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1023.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.8;Hep G2: 42.8"														"Secreted to blood"	NA	NA										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.1	16.9	7.9	22.1	6.8	1.7	6.3	12.0	0.9	0.7	0.9	7.1	10.4	12.3	7.7	2.3	1.3	21.8	0.2	1.6	0.6	5.3	11.8	12.3	66.8	42.8	2.2	3.4	9.9	6.8	2.3	0.8	3.0	15.5	1.0	8.0	8.6	7.4	2.0	6.1	3.4	11.7	2.1	8.9	3.1	6.5	6.4	5.0	4.6	9.9	3.0	5.3	4.7	5.5	8.7	8.1	6.7	10.8	19.3	8.9	6.3	7.2	3.4	5.6	1.8	5.0	4.9	12.1	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0	0.0	0.0	0.0	22.2	3.5	0.0	1023.1	0.0	0.0	0.0	12.2	0.0	0.1	39.7	0.0	0.0	2.2	0.0	0.0	0.0	0.1	2.4	23.0	0.0	1.3	0.1	0.0	0.0	1.3	0.3	0.0	0.0	2.4	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.1	0.3	0.2	3.4	0.0	0.0	0.0	20.9
MTRNR2L12		ENSG00000269028	"MT-RNR2-like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"blood: 603.3"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 31937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 603.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 603.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 496.6"														"Secreted to blood"	NA	NA						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	18.0	29.1	32.5	5.2	31.0	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5.0	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11.0	5.3	6.0	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	99.3	122.4	91.7	329.0	142.5	76.9	84.3	129.6	26.5	25.0	32.3	67.2	160.7	219.2	105.6	48.9	14.5	274.9	6.4	54.7	34.2	64.2	118.4	232.2	496.6	283.0	54.2	46.0	128.5	139.1	65.6	26.3	72.2	153.1	27.8	99.1	164.5	75.6	84.7	52.0	39.7	145.5	26.7	60.3	36.9	63.6	88.2	67.6	149.9	74.0	41.8	81.5	84.4	85.9	111.3	85.1	88.3	134.4	122.9	103.5	86.0	115.6	36.6	40.2	25.1	108.9	64.2	290.2	27.9	183.7	81.8	153.2	28.1	44.0	37.0	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31.0	8.8	19.0	26.3	19.8	26.2	7.5	10.4	8.7	2513.2	2660.0	61.6	386.4	99.9	0.0	31937.7	112.1	2625.9	2640.0	80.3	0.0	6.1	53.0	0.7	11.2	82.6	5.6	163.5	1.6	7.5	167.2	335.7	1581.1	147.2	10.6	0.0	4.7	79.2	93.4	36.3	39.7	230.1	183.9	1.0	7.8	0.0	1.3	7.0	21.5	70.0	0.0	45.3	270.2	25.4	36.6	70.6	8.8	96.9	2.4	333.1
MTRNR2L13		ENSG00000270394	"MT-RNR2-like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 11.5"	"Cell type enriched"	"Detected in some"	39	"Cardiomyocytes: 161.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.9"	"Group enriched"	"Detected in some"	5	"HeLa: 8.3;Hep G2: 4.4"														"Secreted - unknown location"	NA	NA										"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0.0	2.9	0.5	0.6	1.0	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0.0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1.0	1.1	2.6	0.6	0.6	2.0	1.2	0.0	0.6	1.4	0.2	1.0	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.1	0.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.1	8.3	4.4	0.1	0.1	0.4	0.4	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.4	1.0	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0.0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2	0.0	0.0	0.0	4.2	0.1	0.0	161.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5
MTRNR2L3		ENSG00000256222	"MT-RNR2-like 3"	P0CJ70	20	57358442-57359980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.3"	"Cell type enriched"	"Detected in many"	94	"Cardiomyocytes: 2712.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.0;Hep G2: 1.6"														"Secreted - unknown location"	NA	NA						"unprognostic (1.55e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.44e-6)"	"unprognostic (2.56e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.52e-3)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-3)"	0.8	1.0	2.9	0.3	2.4	2.4	0.5	1.0	3.6	0.7	0.9	0.0	2.5	0.6	0.5	1.4	0.7	0.5	1.0	1.3	2.5	0.7	1.2	1.1	0.4	0.5	2.1	2.7	0.8	1.2	0.2	0.5	0.3	2.4	0.5	0.9	0.0	2.4	1.1	13.3	1.1	0.5	0.5	1.7	0.4	0.9	1.2	2.7	0.0	0.6	0.0	0.3	0.3	0.6	1.0	0.8	3.7	0.7	0.1	1.3	0.4	0.3	0.0	0.2	0.9	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.6	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.6	0.1	0.2	0.1	0.5	0.3	0.6	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.2	0.6	0.2	0.3	0.5	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.7	0.7	1.1	0.8	0.2	0.6	0.4	0.5	0.5	0.8	1.0	1.3	0.5	3.7	0.1	0.6	0.2	0.7	0.4	2.9	2.4	1.0	3.6	2.5	0.7	2.1	2.7	2.4	2.7	0.0	0.0	0.9	28.7	2.9	0.0	2712.0	2.5	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	1.3	0.0	0.0	0.0	0.3	5.1	15.0	0.0	2.4	0.6	0.0	0.0	1.8	1.6	0.4	1.4	0.4	6.8	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	8.5	0.2	0.8	2.8	0.5	0.0	0.0	16.2
MTRNR2L4		ENSG00000232196	"MT-RNR2-like 4"	P0CJ71	16	3370979-3372740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 49.5;skeletal muscle: 52.2"	"Cell type enriched"	"Detected in some"	24	"Cardiomyocytes: 125.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 49.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 49.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2"														"Secreted to blood"	NA	NA						"unprognostic (8.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	2.5	10.3	3.5	1.3	4.4	0.9	1.2	2.7	6.6	1.5	2.2	0.5	0.3	3.4	1.6	0.9	1.5	2.0	1.7	11.7	2.3	1.2	5.8	2.5	1.0	0.3	6.3	4.8	5.8	9.7	0.0	3.1	1.0	2.5	1.7	1.1	1.2	2.7	3.3	52.2	1.2	3.6	2.1	1.5	1.1	3.1	2.3	3.1	0.3	2.6	1.1	0.8	1.5	1.3	5.4	3.8	49.5	6.4	2.5	2.5	5.0	6.0	4.0	1.2	22.3	0.5	0.7	6.9	3.3	0.1	0.4	0.3	1.8	13.1	4.5	6.7	0.2	0.1	23.3	0.0	0.2	0.2	3.4	2.2	4.0	31.2	16.2	0.1	1.3	10.9	0.4	0.3	0.1	0.2	0.5	0.0	0.5	3.0	6.3	0.7	1.3	2.8	10.5	1.8	0.2	0.8	5.2	3.2	4.1	0.9	4.6	2.7	6.0	2.1	5.3	8.0	0.4	7.4	10.1	2.9	7.2	6.4	8.3	2.3	3.3	1.1	4.2	4.9	10.3	1.6	12.1	6.4	19.1	1.4	3.7	1.7	4.2	1.9	1.9	3.1	5.4	2.1	2.5	49.5	2.5	3.6	3.8	2.1	5.0	3.5	4.4	2.7	5.5	2.3	1.2	6.3	4.8	2.5	3.1	0.0	0.0	0.0	2.4	0.1	0.0	125.1	5.1	0.0	0.0	1.8	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	1.7	0.5	0.2	0.3	0.1	0.0	0.0	1.4
MTRNR2L5		ENSG00000249860	"MT-RNR2-like 5"	P0CJ72	10	55599303-55600041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6"	"Cell type enriched"	"Detected in single"	42	"Cardiomyocytes: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0"														"Secreted - unknown location"	NA	NA															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0.0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1.0	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0.0	4.7	7.0	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0.0	0.4	6.6	0.3	1.0	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.5	0.0	1.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0.0	0.1	1.5	2.5	0.4	2.3	1.0	0.5	1.4	0.6	0.6	0.9	0.0	0.0	0.0	0.1	0.6	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MTRNR2L6		ENSG00000270672	"MT-RNR2-like 6"	P0CJ73	7	142666272-142667718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.7;skeletal muscle: 39.1"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 849.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 81.7"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 81.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 50.0;Hep G2: 44.1"														"Secreted to blood"	NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.03e-2)"		"unprognostic (2.66e-2)"	"unprognostic (8.07e-3)"	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0.0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.6	9.6	3.3	22.6	3.8	2.0	5.5	6.0	0.5	0.6	1.0	3.1	10.3	4.9	8.2	1.1	0.5	19.9	0.1	1.1	0.5	3.1	3.7	6.8	50.0	44.1	1.2	1.4	7.3	3.4	1.4	0.5	1.6	12.7	0.5	6.1	5.8	7.3	1.8	3.1	2.8	15.2	1.2	3.1	1.1	4.5	2.8	3.7	3.9	8.3	2.2	8.2	1.6	3.8	11.5	4.9	5.3	9.6	6.9	6.5	6.6	7.8	2.0	2.9	1.3	3.1	3.9	8.7	1.6	20.0	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8	35.7	50.8	1.4	7.4	5.7	0.0	849.8	0.0	75.0	127.4	31.4	0.0	0.5	38.1	0.0	0.3	1.5	0.0	23.3	0.0	0.6	7.1	3.3	51.1	1.9	0.5	0.0	0.0	0.6	0.6	0.6	2.3	14.5	3.3	0.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	0.0	4.7	0.3	2.0	3.9	0.2	1.0	0.0	3.7
MTRNR2L7		ENSG00000256892	"MT-RNR2-like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9"	"Cell type enriched"	"Detected in single"	277	"Cardiomyocytes: 171.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.2;Hep G2: 1.6"														"Secreted - unknown location"	NA	NA															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.3	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.1	0.1	0.9	0.4	0.1	0.0	0.1		0.1	0.1	0.0	0.3	0.0		0.1	0.5		0.1	0.0	1.9	0.1	0.1	0.0	0.1	0.1	0.2	0.2			0.1		0.0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.3	0.0	0.3	0.2	0.0	0.1	0.0	0.7	0.0	0.6	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	3.2	1.6	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.5	0.0	0.1	0.3	0.5	0.4	0.3	0.0	0.2	0.8	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.8	0.0	1.2	0.2	0.6	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2											0.0	0.0	0.0	0.6	0.1	0.0	171.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6
MTRNR2L8		ENSG00000255823	"MT-RNR2-like 8"	P0CJ75	11	10507887-10509189	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 329.5;skeletal muscle: 107.4"	"Cell type enriched"	"Detected in many"	28	"Cardiomyocytes: 28256.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 329.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 192.6;Hep G2: 140.8"														"Secreted to blood"	NA	NA						"unprognostic (6.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-2)"	35.7	33.4	22.5	4.2	22.8	6.6	4.3	7.3	17.5	6.5	15.6	3.6	19.3	10.2	3.8	6.1	12.7	4.6	14.1	73.2	20.1	14.7	30.7	21.7	6.3	4.0	22.0	7.3	7.0	10.9	1.9	6.9	7.0	9.0	7.7	15.5	3.3	12.3	14.8	107.4	12.0	12.9	8.8	16.1	9.7	10.2	28.4	6.5	2.2	4.4	32.3	4.3	10.0	5.8	35.3	24.5	329.5	42.7	16.6	19.0	36.2	30.8	55.6	21.8	97.9	21.9	12.0	30.1	29.2	4.3	4.1	5.2	33.8	47.5	43.4	34.3	6.3	3.2	87.4	0.6	6.6	4.4	18.4	48.1	40.4	192.6	140.8	8.5	7.4	39.0	21.3	10.4	3.3	10.0	43.4	4.0	24.4	34.1	22.6	12.6	19.7	11.3	55.8	7.2	14.6	15.5	19.5	18.7	20.8	24.9	31.3	12.3	28.0	14.6	21.4	44.5	21.4	25.1	56.1	26.1	28.8	25.6	30.4	11.4	12.7	6.0	23.0	18.9	66.2	6.9	89.7	42.7	97.5	11.6	21.0	14.3	33.7	14.8	13.0	16.3	35.3	19.0	17.5	329.5	16.6	20.1	24.5	14.9	36.2	22.5	22.8	7.3	16.7	20.1	14.7	22.0	7.3	9.0	6.5	771.2	760.8	62.0	993.3	419.0	0.0	28256.5	137.6	867.3	881.5	54.1	0.0	5.8	61.3	0.0	12.2	397.4	0.0	140.2	0.0	5.0	628.6	627.3	501.1	277.9	11.0	0.0	0.0	103.2	108.7	41.9	60.7	803.5	686.7	0.0	0.3	0.0	0.1	0.0	42.1	73.2	0.0	64.7	701.4	22.4	27.9	427.3	9.4	68.2	0.6	948.0
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.4	0.7	1.9	0.0	139.4	0.0	10.1	1.1	0.3	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	1.5	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	65.3	0.2	0.2	0.0	3.4	107.0	0.1	0.6	0.2	3.3	5.9	0.1	0.5	47.0	0.6	0.2	0.4	0.8	1.3	0.1	2.1	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5	402.0	1308.2	0.9	16.1	0.6	1.0	0.4	384.7	92.3	252.5	465.9	3.9	0.1	29.9	144.7	27.3	3.5	49.2	0.0	994.6	1.2	3.1	11.6	45.2	0.5	0.2	1.6	29.4	1.3	3.4	68.9	2.3	2.6	5.0	42.3	249.7	1.1	807.2	66.2	1.4	0.9	0.2	0.0	1.9	6.2	0.8	1.0	0.2	0.0	132.5	164.3
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 334.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 474.6;Intestinal endocrine cells: 147.6;Mucus-secreting cells: 321.7;Paneth cells: 299.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 70.4"									HPA045163	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045163: AB_10960396"	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.5	0.6	0.5	16.4	0.5	0.0	0.5	0.5	0.5	0.5	83.1	0.0	0.0	79.9	0.5	0.3	0.5	0.5	16.7	0.5	0.5	0.5	3.3	8.7	0.5	0.0	0.5	0.0	0.5	1.8	0.0	0.5	0.1	0.1	0.5	40.6	0.1	0.5	0.0	0.5	0.5	334.4	1.0	0.5	0.5	4.1	0.5	0.0	0.1	0.5	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.0	4.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	70.4	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.6	0.1	474.6	0.0	28.4	0.0	0.0	2.1	9.2	0.0	0.0	0.0	147.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	321.7	0.0	14.3	299.5	0.7	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	111.9	0.1
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 49.5;Club cells: 10.3;Early spermatids: 11.7;Late spermatids: 12.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.9;CAPAN-2: 5.6;HaCaT: 5.4;HeLa: 27.6;SK-BR-3: 3.5"									"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.4	2.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.0	0.2	0.0	2.2	0.0	49.5	10.3	0.0	0.0	1.4	0.0	0.2	11.7	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	2.7	0.0	0.0	0.6
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 60.2;Urothelial cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 25.3"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		11000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.5	0.0	0.2	1.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	3.4	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	25.3	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.9	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1	32.8	14.7	0.0	8.8	1.5	20.2	0.5	10.2	60.2	37.5	21.0	33.4	0.0	1.7	32.3	0.0	1.3	15.6	0.0	8.7	0.1	1.5	12.8	1.1	6.4	0.4	11.1	13.3	1.8	0.6	0.0	4.9	0.9	3.3	0.0	7.2	5.6	13.7	18.6	6.0	1.4	22.0	0.0	1.6	1.1	0.7	1.6	0.0	0.5	13.5	102.7
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195812277	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.5;lymphoid tissue: 57.2"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 85.6;Club cells: 86.4;Mucus-secreting cells: 154.7;Undifferentiated cells: 114.6;Urothelial cells: 276.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"									"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.4	0.4	0.0	28.7	0.0	0.4	0.4	0.0	0.4	13.4	21.5	0.0	0.0	0.4	1.4	0.4	13.0	1.7	0.4	0.4	0.0	0.0	0.4	0.4	10.3	0.4	0.0	0.0	0.5	0.4	0.4	0.0	6.2	0.2	10.0	1.9	0.0	5.5	0.4	0.4	0.4	1.7	0.4	0.0	0.4	2.4	0.5	0.0	0.5	0.4	6.1	57.2	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	14.1	0.0	11.3	0.0	0.0	2.0	0.0	85.6	86.4	0.0	0.0	0.1	0.0	0.2	2.4	0.0	53.1	0.0	4.7	4.0	0.0	10.6	2.3	0.0	0.1	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.7	0.0	22.6	40.3	0.4	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.0	114.6	276.8
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 70.3;lung: 87.0;stomach 1: 68.3"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 6.7;Club cells: 25.0;Pancreatic endocrine cells: 5.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 61.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 19.5;OE19: 13.0"									"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	70.3	0.0	0.0		0.0	0.0	87.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.1	0.0	0.0	2.2	0.0	6.7	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell type enriched"	"Detected in some"	4	"Cholangiocytes: 591.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 41.8;PC-3: 45.1"									"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		590000	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	41.8	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	32.8	0.9	0.0	0.0	0.0	10.5	591.1	34.8	46.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.1	0.0	1.2	4.6	0.0	0.2	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.5	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	131.5	0.3
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012821-1036706	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 426.4;seminal vesicle: 478.2"	"Cell type enhanced"	"Detected in some"	27	"Cholangiocytes: 79.0;Exocrine glandular cells: 17.2;Pancreatic endocrine cells: 34.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 6.1"					"Not detected"	"Not detected"			CAB002165	Enhanced				"Secreted to digestive system"	NA	NA					"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.4	5.3	0.1	0.3	426.4	13.1	0.5	3.1	2.1	0.5	118.1	0.1	0.0	0.0	0.4	1.3	0.1	0.1	0.0	0.0	0.1	36.5	0.1	0.0	0.1	0.0	5.2	0.1	0.0	0.1	478.2	0.2	0.2	0.1	0.1	0.0	0.2	76.6	0.2	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	79.0	0.0	0.0	8.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 1562.5"	"Cell type enriched"	"Detected in single"	60	"Melanocytes: 11.8"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.2;GAMG: 1.4"									HPA006411	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1562.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830519-54858393	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	75	"breast: 283.5;salivary gland: 277.2;skin 1: 99.4"	"Cell type enriched"	"Detected in some"	6	"Melanocytes: 1005.5"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;hTCEpi: 2.2;MCF7: 3.7;SK-BR-3: 9.2;SuSa: 6.2"									HPA039093	Enhanced				"Secreted in other tissues"	NA	NA					"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	2.9	0.0	0.1	0.1	0.1	0.0	283.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	277.2	0.1	0.2	99.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.2	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.4	167.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1005.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.8	0.0	0.0	0.0	0.6
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9"									"HPA000508, HPA076518"	Uncertain		Uncertain	Mitochondria	"Secreted - unknown location"	NA	NA		1700000	Mitochondria		"HPA000508: AB_2147995, HPA076518: "	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.8	0.0	7.6	49.0	0.0	0.0	0.0	0.2	0.0	0.6	23.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3	0.0	0.0	0.0	3.9	34.2	0.0	1.6	0.0	1.4	5.7	29.6	0.0	0.0	0.0	1.7	0.0	2.2	0.0	0.0	53.2	0.2	19.5	0.1	0.0	0.0	0.3	0.0	0.0	17.2	0.8	0.0	0.0	0.0	16.9	1.0	0.0	0.0	47.4	0.0	1.4	0.0	0.1	0.0	9.2	0.0	0.0	19.1	0.2	0.0	0.0	1.4
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.4	5.7	36.1	29.3	26.4	25.8	10.2	0.4	0.0	16.4	49.9	27.6	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	37.0	3.0	0.8	34.4	23.9	30.6	25.2	59.4	38.8	1.6	4.6	0.1	60.8	0.7	0.3	2.1	3.6	4.0	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.6	34.0	7.1	3.9	47.5	59.7	12.7	24.3	37.9	3.4	0.6	0.1	93.7	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0	14.9	10.5	2.9	23.3	9.2	140.1	103.5	2.5	9.4	11.4	29.6	90.3	1.0	1.7	20.9	3.3	36.2	0.9	0.0	3.6	4.2	41.8	16.2	2.3	3.2	2.8	104.9	6.4	54.0	5.6	6.6	93.7	2.2	13.5	1.8	5.6	291.2	7.9	0.0	134.7	5.8	125.1	12.9	36.0	1.2	12.1	7.8	0.7	9.6	1.2	18.1
MYDGF	"C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20"	ENSG00000074842	"Myeloid derived growth factor"	Q969H8	19	4641374-4670370	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 582.4;Syncytiotrophoblasts: 486.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041872, HPA046744"	Approved				"Secreted to blood"	NA	NA	285000	3300000			"HPA041872: AB_2677718, HPA046744: AB_2679783"	"unprognostic (3.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (4.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.99e-12)"	"unprognostic (4.42e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	20.7	26.1	12.1	25.4	13.2	24.7	31.2	7.0	17.1	27.4	25.1	10.9	51.7	23.9	21.7	40.5	18.1	19.3	28.7	22.9	11.6	13.5	24.6	108.0	25.3	41.5	15.5	11.2	21.4	115.5	6.4	36.9	55.2	14.5	23.7	21.3	10.7	58.7	43.8	11.3	16.0	26.9	16.8	12.6	35.0	29.1	19.3	12.4	11.1	30.4	19.5	20.3	17.5	28.5	24.6	80.4	23.0	42.8	27.1	30.6	35.9	31.0	15.3	9.9	24.9	30.9	25.9	17.4	56.0	49.5	28.0	35.3	25.0	20.3	18.1	27.0	58.6	22.9	15.7	11.6	20.4	16.3	16.9	19.3	10.9	27.5	31.6	48.1	38.8	26.6	21.5	24.8	20.5	39.1	35.2	30.4	10.2	19.0	137.9	25.4	17.0	10.2	21.8	12.4	30.1	53.1	10.0	16.5	86.6	22.2	14.7	14.9	15.4	19.1	24.9	27.6	8.9	14.6	46.9	34.3	21.8	17.9	59.3	41.0	66.5	27.2	15.2	53.8	51.4	34.0	23.0	41.7	14.8	30.0	42.8	30.6	24.6	24.2	24.1	49.8	19.1	20.7	22.1	2.6	27.1	36.7	80.4	17.6	35.9	12.1	13.2	7.0	17.1	11.6	13.5	15.5	11.2	14.5	12.4	41.7	72.2	54.4	139.3	0.0	26.9	5.5	89.2	17.4	34.2	73.3	3.9	238.0	36.5	338.1	6.4	56.3	58.4	23.3	305.3	582.4	61.6	297.6	15.1	195.4	383.8	25.4	30.4	122.8	98.5	10.2	130.0	112.1	0.0	369.7	109.8	49.7	349.3	52.6	85.6	72.2	25.2	90.5	38.3	156.3	104.3	0.0	486.4	98.0	124.6	178.5
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 100.8"	"Cell type enriched"	"Detected in some"	4	"Peritubular cells: 35.3"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		12000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	26.9	0.8	0.0	0.5	0.0	0.0	8.4	0.0	0.0	5.4	6.0	0.0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0.0	0.2	0.1	3.7	0.0	0.0	0.0	3.9	2.1	0.2	0.1	0.1	0.2	9.0	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0.0	0.6	14.9	28.2	5.0	26.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387480-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 97.7;lymphoid tissue: 152.6"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 280.4;Melanocytes: 512.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 29.5;plasmacytoid DC: 97.7"	"Group enriched"	"Detected in many"	115	"B-cells: 29.5;dendritic cells: 97.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 66.2;RPMI-8226: 234.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		670000	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	2.2	1.9	0.6	37.8	0.6	6.2	4.4	0.5	0.6	5.7	25.5	0.4	0.3	21.6	1.2	0.6	13.6	2.9	5.6	0.8	0.6	0.6	4.2	2.6	6.7	54.7	0.6	0.3	1.7	2.1	0.0	0.8	0.4	0.4	2.4	9.8	2.0	30.2	7.1	0.7	0.7	13.3	0.5	0.6	92.6	15.0	3.7	0.3	152.6	3.3	3.1	54.3	26.6	2.0	29.5	97.7	0.5	0.0	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	66.2	0.0	0.0	25.6	0.2	0.0	0.0	0.0	10.6	0.0	234.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	31.7	1.8	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	29.5	0.1	0.1	0.0	11.0	0.0	0.0	0.5	0.3	0.0	97.7	0.0	4.5	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.3	0.4	0.3	6.0	18.0	63.0	0.6	2.3	0.0	0.8	5.1	1.4	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	280.4	0.0	0.0	1.0	2.4	2.3	1.6	0.1	0.0	1.2	12.3	4.7	0.7	0.0	0.7	512.8	0.0	0.7	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.1	2.0	1.8	7.9	0.8	0.3
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 2552.8"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	485.3	2552.8	8.0	0.4	0.1	1.3	0.4	0.0	29.4	84.2	43.6	3.9	0.4	8.3	0.4	34.9	0.1	0.9	0.0	0.7	0.2	0.2	0.6	64.0	0.0	0.3	0.0	0.0	0.0	0.3	4.5	0.9	4.0	0.0	0.0	0.9	1.3	0.1	2.8	0.4	230.9	0.7	0.0	0.3	0.5	0.7	0.5	0.1	0.0	0.8	0.0
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.6	42.0	13.4	24.0	17.9	12.3	16.0	10.9	16.7	18.7	19.8	34.9	21.3	21.5	33.2	13.9	16.2	30.9	13.4	26.1	13.3	22.7	29.3	17.8	24.0	23.1	20.5	22.3	18.3	12.3	33.8	23.8	22.2	15.0	25.4	29.0	18.1	19.6	19.1	56.3	24.5	27.2	16.6	43.8	32.8	24.7	12.6	56.8	25.3	26.3	32.5	31.0	26.2	50.1	38.5	19.8	48.6	32.9	14.8	13.5	21.1	19.1	23.8	50.8	30.7	20.5	18.6	13.3	20.8	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2	38.7	23.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	43.3	64.6	0.0	120.4	170.8	89.3	0.0	0.0	0.0	0.0	87.1	28.1	0.0	0.0	4.7	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	71.3	0.0	0.0	83.0	0.0	0.0	189.4	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0
NBL1	"D1S1733E, DAN, DAND1, NB, NO3"	ENSG00000158747	"Neuroblastoma 1, DAN family BMP antagonist"	P41271	1	19596979-19658456	"Predicted intracellular proteins, Predicted secreted proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 363.8;Leydig cells: 358.1;Peritubular cells: 335.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.3;HSkMC: 52.6;SK-MEL-30: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007394, CAB026132"	Uncertain				"Secreted in other tissues"	NA	NA		10000000			"CAB026132: , HPA007394: AB_10601272"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.26e-2)"	27.5	8.7	20.7	16.8	23.1	1.9	38.7	8.1	31.3	109.5	77.8	8.9	13.5	54.6	45.7	21.7	49.0	41.2	58.0	31.1	22.2	15.1	17.4	8.4	47.5	13.7	14.3	23.6	133.7	10.0	16.2	22.2	8.2	15.8	67.5	31.6	23.6	11.2	35.0	18.3	32.4	86.3	43.1	13.6	8.3	25.2	23.9	11.8	6.3	15.2	25.4	14.0	44.6	65.9	0.2	0.1	0.5	0.2	0.7	3.5	0.5	22.2	7.0	1.2	6.4	74.3	38.7	3.3	32.0	39.9	10.8	11.0	1.9	40.3	0.0	20.5	40.2	7.6	25.1	6.7	29.7	3.3	21.1	3.5	1.1	6.9	11.6	12.0	0.0	0.5	52.6	27.3	15.9	9.8	3.2	8.1	1.3	0.2	0.0	3.4	3.2	0.0	1.8	0.4	23.1	10.5	1.0	0.0	0.7	20.6	2.7	0.5	17.2	5.1	0.2	77.3	1.2	26.7	3.9	11.3	10.6	8.4	30.2	4.9	0.1	0.1	0.1	7.7	0.1	3.1	0.0	0.2	0.5	0.4	0.1	1.7	0.1	3.5	1.8	0.1	0.2	2.5	1.6	0.1	0.7	0.2	0.1	0.0	0.5	20.7	23.1	8.1	31.3	22.2	15.1	14.3	23.6	15.8	11.8	3.0	2.9	2.7	208.3	155.1	16.7	26.2	48.4	6.7	5.7	34.9	5.9	0.6	3.3	40.2	1.6	105.9	363.8	0.0	6.8	1.9	174.7	257.9	13.8	0.5	41.1	6.4	52.4	30.7	1.8	4.5	358.1	6.0	57.3	10.0	184.7	5.7	58.7	179.9	335.6	16.7	8.1	129.4	194.2	1.2	3.6	177.0	1.1	10.7	166.9	177.6
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211973-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"brain: 88.4"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 1.6;Spermatocytes: 1.0;Spermatogonia: 1.7"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;NTERA-2: 1.4;SCLC-21H: 6.5;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		340000			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	1.1	1.2	21.2	1.1	23.2	1.1	1.1	5.4	88.4	1.1	1.1	12.9	0.0	1.1	1.1	1.1	1.1	1.1	1.1	1.1	16.8	8.3	1.1	1.2	1.1	1.1	7.8	15.2	1.1	1.1	1.1	0.1	1.1	12.3	1.1	1.1	0.0	1.2	1.1	1.1	1.1	1.1	1.1	4.0	1.1	1.1	1.8	5.6	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.5	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	23.2	5.4	22.8	16.8	8.3	7.8	15.2	12.3	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.1	0.0	0.0	0.0	0.0
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.2	0.0	7.0	5.7	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	23.2	0.4	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.4	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.7	0.0	0.1	0.2	10.3	39.6	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8	229.3	38.7	0.0	0.0	1.0	69.0	1.6	15.3	22.7	52.4	12.2	17.7	0.2	0.0	0.0	225.6	11.7	0.0	0.0	0.2	0.0	3.1	0.0	2.3	0.0	0.1	1.6	1.7	4.3	0.0	164.5	3.1	0.4	5.0	0.0	0.2	15.1	0.1	0.0	0.7	0.0	18.7	0.0	3.3	7.5	4.7	0.6	0.5	0.0	1.2	0.0
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 100.6"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.1	1.1	0.7	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	41.2	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	12.4	0.0	0.0	0.0	0.0	100.6	0.7	0.0	9.2	0.0	3.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729084	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.3;skin 1: 73.5"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 7.9;Ductal cells: 6.5;Exocrine glandular cells: 10.7;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.2;hTCEpi: 36.9;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	NA	NA		97000000			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	3.1	3.0	7.7	3.0	11.1	11.9	5.3	8.4	20.8	6.6	7.3	27.3	2.4	9.6	2.3	2.0	55.3	2.9	2.5	3.0	16.1	8.2	3.0	2.4	2.5	1.7	12.7	10.6	1.8	10.8	2.4	4.1	8.2	10.1	5.9	7.8	6.3	8.7	4.4	1.6	73.5	6.9	3.1	14.3	2.2	3.2	1.3	12.4	2.5	1.8	25.3	20.8	17.3	14.8	0.1	4.8	1.0	1.5	0.1	0.1	0.2	4.1	3.4	3.3	4.7	1.7	0.5	23.2	1.6	1.5	1.4	1.0	7.3	14.2	5.5	6.9	1.9	2.8	59.2	8.4	30.2	0.6	12.9	1.3	0.7	1.1	3.3	0.7	3.7	9.3	0.5	36.9	4.4	16.5	0.5	4.2	1.6	0.1	29.4	1.8	10.8	0.0	2.2	10.8	14.0	4.8	0.3	19.8	6.6	1.3	40.1	8.0	18.0	5.6	14.9	0.5	5.2	13.5	0.5	2.3	1.2	4.7	10.2	1.5	5.4	6.8	0.0	0.4	3.0	2.8	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	1.0	0.1	1.5	4.8	0.0	0.2	7.7	11.1	8.4	20.8	16.1	8.2	12.7	10.6	10.1	12.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.9	1.8	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	10.7	0.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	12.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 321.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	0.0	18.2	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.3	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.1	23.7	0.0	3.3	15.3	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	6.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	18.7	14.8	15.7	0.0	24.1	0.0	34.7	0.0	0.0	0.0	0.0	26.2	43.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	321.3	0.0	0.0	0.0
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575681	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;kidney: 24.2"	"Cell type enhanced"	"Detected in some"	20	"Distal tubular cells: 5.0;Early spermatids: 20.1;Late spermatids: 16.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	NA	NA		120000			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.6	0.6	5.5	0.6	10.3	0.4	0.5	1.8	19.6	0.9	0.8	0.5	0.1	0.5	0.9	2.8	1.3	0.6	1.0	0.4	8.8	6.9	24.2	0.4	1.1	0.4	2.0	13.3	0.6	0.4	0.5	4.5	0.4	4.1	7.9	1.0	0.0	1.1	4.2	0.4	0.9	0.6	0.7	0.9	0.6	1.3	1.8	0.5	0.0	0.4	0.0	1.3	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.6	0.0	0.0	0.6	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	1.8	18.7	8.8	6.9	2.0	13.3	4.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.6	5.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.5	0.0	0.1	0.0	0.0	0.0	0.0	16.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	0.0
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Cell line enhanced"	"Detected in some"		"AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		4700000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	41.8	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	5.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	10.9	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	16.4	0.0	5.4	0.0	5.0	0.0	0.0	0.0	30.4	0.7	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.2	1.5	0.0	0.7	11.1	11.1	15.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4	0.0	2.2	0.0	0.0	1.0	38.4	0.4	0.0	40.2	11.4	0.0	31.4	0.1	0.0	0.0	0.2	0.5	5.4	0.0	0.2	0.2	1.4	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	5.2	0.3	0.0	0.4	0.1	43.8	0.0	1.4	1.5	3.4	1.0	0.1	5.3	0.6	0.0
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain				"Secreted - unknown location"	NA	NA		2400000			"HPA026763: AB_1854379, HPA028488: AB_2672638"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	23.0	12.2	6.6	29.9	48.8	36.9	11.8	11.7	28.7	20.9	20.6	14.2	14.8	8.9	9.0	27.8	20.8	15.0	16.4	17.0	17.1	13.5	32.8	5.7	7.9	4.1	18.5	5.7	20.7	26.4	25.1	14.5	12.1	23.6	13.5	16.3	17.6	12.0	18.2	9.5	13.2	26.9	11.5	21.7	38.3	11.7	11.9	14.9	21.3	4.1	13.3	23.2	12.1	27.6	20.9	13.1	21.0	22.3	2.6	16.4	15.2	22.7	21.5	11.3	18.1	6.9	17.9	8.1	12.5	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5	11.9	22.9	67.7	184.9	147.7	34.2	125.7	140.1	4.0	13.6	235.5	11.8	249.5	139.3	36.9	4.9	69.1	63.2	93.5	42.5	152.2	182.5	294.0	48.3	169.3	166.2	36.5	130.4	101.9	99.0	12.5	275.5	153.8	177.2	70.3	141.5	167.3	33.6	57.5	210.4	431.6	22.2	116.4	173.1	10.1	130.6	149.2	154.2	56.5	129.6	224.5
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285918-115338236	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	29	"Leydig cells: 27.0;Sertoli cells: 116.4;Smooth muscle cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.2;BJ hTERT+ SV40 Large T+: 12.9;GAMG: 20.0;hTEC/SVTERT24-B: 12.6;hTERT-RPE1: 20.9;U-2197: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA	40000					"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	9.1	2.3	1.3	2.8	1.6	0.2	6.5	0.6	2.8	7.5	3.4	0.6	2.3	0.3	11.4	5.9	1.5	10.6	6.6	16.5	3.2	0.6	3.4	2.7	1.4	1.5	2.3	1.6	17.8	0.7	0.3	2.1	2.0	1.7	3.7	1.2	7.0	3.8	2.0	1.8	0.6	1.4	7.0	2.1	3.8	1.6	3.2	1.1	0.0	2.9	3.0	0.3	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	36.2	4.1	12.9	9.5	0.0	0.0	0.0	0.8	8.5	20.0	1.4	0.0	0.2	5.8	0.0	0.1	0.0	0.2	0.0	5.4	0.0	0.0	0.0	0.2	12.6	9.4	20.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.7	0.2	0.0	1.7	0.0	0.0	0.3	0.8	1.5	25.2	1.4	0.0	0.0	0.0	1.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.6	2.8	3.2	0.6	2.3	1.6	1.7	1.1	0.0	0.0	0.0	0.4	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.8	0.0	0.6	0.0	0.0	0.0	1.1	4.5	0.6	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	27.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	116.4	31.9	0.0	0.7	1.9	2.1	0.0	0.0	0.1
NHLRC3		ENSG00000188811	"NHL repeat containing 3"	Q5JS37	13	39038306-39050109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013738	Uncertain				"Secreted - unknown location"	NA	NA		240000			"HPA013738: AB_1854455"	"unprognostic (7.92e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.81e-2)"	21.3	14.5	12.3	18.8	14.7	7.3	17.6	13.8	19.1	13.9	14.2	18.2	16.4	12.7	17.8	37.1	9.8	13.8	18.0	13.0	12.4	12.2	20.1	28.2	17.6	17.7	15.5	15.9	21.9	17.2	7.8	16.5	24.4	15.2	13.0	19.0	18.4	15.7	22.9	10.8	13.5	14.8	13.6	17.3	20.1	18.3	14.0	13.1	13.0	21.2	8.9	13.1	14.6	12.6	5.7	7.9	2.0	9.2	5.6	7.3	4.6	3.4	2.2	9.6	4.5	11.1	11.5	14.6	5.4	6.7	5.8	7.6	6.8	15.5	9.4	10.3	3.5	7.3	7.3	3.7	3.1	5.0	13.5	4.2	7.6	4.5	7.5	7.1	7.4	11.1	9.3	4.1	3.9	3.9	8.8	3.6	7.8	2.6	11.7	5.2	2.6	5.8	11.8	2.5	7.9	2.2	6.2	25.5	5.2	8.8	6.9	2.2	4.0	3.4	4.8	12.2	5.6	6.3	12.0	4.2	7.9	3.9	10.3	5.6	9.4	8.0	3.8	10.5	8.1	5.7	2.0	9.0	1.0	6.6	9.2	7.3	5.7	4.8	5.3	7.9	4.6	4.9	7.0	0.8	5.6	8.2	7.3	5.4	4.6	12.3	14.7	13.8	19.1	12.4	12.2	15.5	15.9	15.2	13.1	11.9	19.8	23.0	12.8	7.4	71.9	10.8	17.8	25.4	29.6	33.2	53.0	56.2	8.3	16.4	5.1	23.3	21.0	0.0	14.5	13.2	18.0	9.5	15.1	29.4	37.9	74.7	13.3	43.6	40.6	2.8	56.7	39.9	16.9	16.2	25.9	44.6	14.0	34.0	39.3	13.3	83.5	58.2	11.1	32.5	31.9	7.9	20.3	35.5	26.2	6.8
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065162	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ito cells: 249.8;Leydig cells: 164.3;Peritubular cells: 118.1;Sertoli cells: 239.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 5.4;intermediate monocyte: 11.3;myeloid DC: 4.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 4.5;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 178.5;ASC TERT1: 83.3;HHSteC: 33.7;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010044	Approved				"Secreted to extracellular matrix"	NA	NA		90000000			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	49.4	12.7	1.6	14.7	4.0	0.7	80.5	1.7	2.2	38.8	29.3	1.9	10.4	6.9	29.4	25.5	23.8	27.4	24.3	40.5	1.6	1.1	18.3	36.7	18.8	24.5	3.3	1.4	29.4	6.3	4.6	3.6	74.6	3.8	19.2	7.3	19.9	6.3	15.3	18.3	7.9	18.5	36.1	3.9	31.0	23.0	19.6	1.7	1.4	12.2	6.2	3.8	41.9	30.0	0.0	4.5	0.3	11.3	0.1	0.0	1.8	0.1	0.5	6.1	0.0	178.5	83.3	11.6	13.8	11.5	8.6	5.7	3.2	4.3	0.0	2.7	20.6	2.3	0.4	4.0	0.0	5.1	0.0	6.6	0.8	0.7	4.9	33.7	0.0	0.0	70.4	0.6	4.2	0.1	3.4	18.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	6.3	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	5.2	0.1	0.0	1.1	2.4	0.0	5.5	15.6	7.5	5.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	11.5	0.2	5.4	0.0	0.0	11.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.1	7.1	0.0	0.0	1.8	1.6	4.0	1.7	2.0	1.6	1.1	3.3	1.4	3.8	1.7	3.0	1.0	9.3	1.1	5.4	0.2	20.7	7.6	0.0	3.4	0.0	0.0	13.2	0.0	0.4	1.1	27.8	0.0	0.0	0.8	8.4	71.4	3.5	1.1	58.6	6.8	3.2	0.0	249.8	23.4	2.4	164.3	6.1	16.9	1.0	0.0	2.1	4.3	0.0	118.1	7.1	0.0	239.3	48.4	0.7	0.2	4.5	13.2	1.9	0.0	2.5
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 10.5;Fibroblasts: 9.3;Ito cells: 9.2;Peritubular cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.2;ASC TERT1: 21.2;BJ: 27.8;BJ hTERT+: 23.7;HHSteC: 29.5;HSkMC: 110.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2500000	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	15.0	5.1	0.9	5.3	1.8	0.1	7.6	0.9	1.7	12.9	8.5	5.1	9.0	1.0	9.5	7.6	9.8	6.0	10.2	17.5	1.2	0.9	6.4	2.9	5.1	3.0	1.3	1.2	16.8	13.9	10.2	2.4	32.5	2.5	13.4	3.6	17.4	4.3	8.9	3.9	1.8	3.0	11.4	1.5	1.1	6.6	4.4	0.8	0.7	18.8	3.6	2.2	10.7	5.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	13.9	0.0	53.2	21.2	0.0	27.8	23.7	2.6	2.7	0.0	0.0	0.0	4.1	3.0	0.0	1.9	1.7	0.0	0.7	0.0	0.3	0.0	0.4	0.0	29.5	0.0	0.0	110.2	0.0	10.8	0.0	15.1	1.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.9	4.1	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	10.1	0.1	6.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.8	0.9	1.7	1.2	0.9	1.3	1.2	2.5	0.8	0.0	0.0	0.0	0.2	0.6	1.2	1.7	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.1	10.5	3.7	1.1	0.0	0.0	1.0	9.3	0.1	1.1	0.0	1.3	0.0	0.0	9.2	0.0	2.5	5.8	0.0	3.3	1.8	2.8	0.0	0.3	0.0	8.1	0.0	0.8	6.5	5.7	0.0	0.0	0.9	0.7	0.0	3.3	0.1
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 91.4"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 28.0"	"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	28.0	10.7	2.0	0.4	5.5	2.5	0.2	1.7	3.3	3.8	5.2	3.7	7.7	1.2	4.5	4.4	0.0	5.0	10.7	2.2	2.2	10.5	13.5	4.3	4.2	17.4	1.4	2.9	4.7	2.5	0.9	5.9	2.3	2.5	5.5	7.7	0.0	0.4	2.1	16.4	2.7	9.5	7.9	5.9	3.1	8.4	0.0	12.4	3.6	2.2	1.1	12.2	2.8	1.6	12.7	2.1	1.9	11.2	1.4	0.7	3.7	3.5	2.7	0.2	3.0	2.6	8.7	16.2	4.5	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8	3.0	2.4	14.3	22.9	13.9	1.6	2.2	7.6	10.7	7.9	29.6	0.0	1.7	11.6	91.4	24.0	11.3	1.7	0.0	50.2	7.5	17.3	30.7	5.7	2.9	30.9	4.8	17.9	4.9	4.8	7.5	4.0	28.4	32.1	29.7	4.9	7.0	39.2	7.0	3.5	22.5	2.3	12.9	29.9	11.1	21.2	11.2	2.6	11.4	8.0	39.6
NMS		ENSG00000204640	"Neuromedin S"	Q5H8A3	2	100470482-100483280	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 3.2;testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HL-60: 12.6;HMC-1: 7.7"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.6;hypothalamus: 6.3;pons and medulla: 1.4"										"Secreted in brain"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	2.9			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in many"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.5	0.0	4.7	1.2	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	13.1	18.9	1.8	0.0	1.8	81.3	9.8	0.7	0.5	1.1	5.3	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	2.2	0.0	1.3	63.9	29.3	0.0	2.0	0.2	0.0	2.5	1.5	2.4	0.0	0.0	0.1	0.4	0.0	4.2	10.7	6.5	0.1	0.0	0.9	4.5	0.0	0.5	0.0	6.1	0.0	11.4	8.5	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0	0.0	2.9	1.5	0.6	14.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.2	0.2	0.0	23.3	0.2	0.1	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.5	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.6	64.4	0.1	0.0	1.7	8.0
NODAL		ENSG00000156574	"Nodal growth differentiation factor"	Q96S42	10	70432315-70447951	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;skeletal muscle: 5.1;testis: 5.2"	"Group enriched"	"Detected in some"	23	"Early spermatids: 14.4;Late spermatids: 24.3"	"Cancer enriched"	"Detected in some"	10	"testis cancer: 20.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.3;SH-SY5Y: 3.2;SuSa: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045201	Uncertain				"Secreted to blood"	NA	NA					"HPA045201: AB_2679252"	"unprognostic (3.07e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-5)"	"unprognostic (4.37e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.02e-1)"	1.2	0.1	1.1	0.3	2.4	2.0	0.9	2.4	5.0	0.9	0.5	3.8	0.3	0.8	0.7	0.3	1.4	0.4	1.0	0.7	1.2	1.0	0.3	0.3	1.0	0.7	1.5	0.3	0.9	0.3	0.0	0.3	0.9	2.9	0.8	0.0	0.3	0.5	0.3	5.1	3.5	0.6	0.3	0.4	0.9	0.9	5.2	0.3	0.8	0.3	0.3	0.3	0.7	0.7	1.2	0.4	1.1	0.6	0.0	2.2	0.3	0.8	0.5	1.8	2.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	4.3	0.5	1.4	0.1	0.0	0.0	0.1	0.0	1.6	0.0	1.2	0.1	0.0	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.6	0.0	0.5	0.2	0.5	1.2	0.5	0.1	0.5	0.5	1.2	0.0	0.2	0.3	3.2	0.9	0.4	0.0	8.5	0.9	0.4	0.0	0.0	0.5	0.3	0.2	1.0	2.3	2.7	0.0	0.4	0.2	0.0	0.6	0.0	0.2	0.5	0.7	0.2	1.2	2.2	0.4	1.2	0.8	0.6	1.1	0.0	0.4	0.0	0.2	0.3	1.1	2.4	2.4	5.0	1.2	1.0	1.5	0.3	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	"Disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8;placenta: 37.1;retina: 18.6"	"Cell type enriched"	"Detected in single"	11	"Extravillous trophoblasts: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1"	"Lineage enriched"	"Detected in single"	81	"T-cells: 32.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"	NA	NA					"HPA061318: AB_2684478"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favorable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.9	0.3	4.9	2.0	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1.0	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0.0	1.1	0.9	3.1	0.0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.4	0.5	0.5	0.1	0.4	0.0	51.0	0.6	2.0	0.2	0.8	0.1	1.4	0.0	0.9	0.0	1.9	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	15.5	0.0	0.4	11.3	1.0	0.0	15.4	6.7	4.7	0.0	1.2	0.0	0.1	0.0	2.6	0.0	0.0	4.3	0.0	0.2	0.3	0.9	15.8	0.1	1.1	0.0	0.0	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	1.9	0.2	0.0	0.0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	8.9	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.0
NOTCH2NL	N2N	ENSG00000264343	"Notch 2 N-terminal like"	Q7Z3S9	1	146146203-146229026	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 22.8"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 42.9;Melanocytes: 45.5;Suprabasal keratinocytes: 51.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 43.8"									CAB004669	Uncertain				"Secreted to blood"	NA	NA					"CAB004669: AB_426149"	"unprognostic (1.54e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-2)"	1.9	0.3		0.8		1.3	2.5		0.7	5.8	1.0			0.3	1.7	3.5	2.3	2.3	1.2	1.4			1.0	3.9	1.6	0.7			2.7	1.6	1.7		1.9		2.7	1.0		1.3	2.0	0.0	4.2	0.8	1.6		2.0	0.3	4.7			2.0		1.2	0.7		18.8	14.4	22.8	13.8	3.7	5.0	3.8	10.7	4.1	5.4	2.4	5.9	14.9	2.1	5.7	16.1	9.0	11.2	2.3	6.2	2.3	2.7	6.1	4.4	4.8	3.4	9.8	11.0	6.3	2.7	8.9	12.7	1.0	13.3	3.6	3.1	18.6	3.3	11.1	27.3	9.0	6.7	4.1	2.5	19.3	11.1	11.2	2.2	2.6	1.5	2.0	8.3	2.0	5.9	10.3	6.2	7.3	0.8	0.5	10.6	6.7	2.2	4.0	9.9	4.0	19.1	4.7	4.6	10.0	7.8	43.8	11.1	6.1	8.4	3.3	4.6	11.1	13.8	22.8	3.3	11.0	3.6	18.8	3.6	3.6	14.4	12.3	5.0	3.4	14.1	3.7	12.9	14.3	4.0	3.8											20.8	11.5	0.0	9.1	42.9	0.2	0.0	10.2	6.7	7.9	1.8	9.8	0.6	0.0	5.4	0.4	1.0	0.4	0.0	2.2	1.9	5.8	4.4	9.3	3.0	2.0	0.0	0.0	1.3	11.8	1.1	4.9	10.2	45.5	2.8	0.4	7.8	4.2	22.0	3.9	0.9	5.4	0.0	3.5	3.2	1.1	51.2	0.8	4.3	2.2	9.4
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell type enriched"	"Detected in some"	47	"Extravillous trophoblasts: 865.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 96.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		59000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	96.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	15.6	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.9	0.4	1.4	0.5	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5	0.0	3.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	865.2	2.3	0.0	0.0	0.9	17.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.0	18.4	0.0	0.0	0.0
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	4.0	1.0	0.0	5.8	43.7	5.3	3.0	0.0	0.1	0.0	4.6	7.3	4.1	3.6	0.2	0.0	1.8	0.0	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	13.6	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	5.6	0.0	1.3	0.0	2.1	0.0	8.1	0.0	0.0	0.0	0.0	3.8	5.8	45.2	1.2	0.0	0.0	0.0	6.0	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0	0.0	1.1	0.0	0.6	16.7	0.0	1.2	0.0	2.7	2.3	36.6	0.0	0.0	0.0	7.2	0.0	12.6	0.3	0.0	1.0	0.0	15.4	14.0	23.1	0.0	1.4	3.2	9.2	0.6	1.2	0.0	2.8	0.4	74.2	0.0	1.3	0.0	0.6	2.9	0.7	0.0	0.2	0.0	20.8	0.0	0.0	14.8	0.1	0.0	9.8	0.9
NPB	"PPL7, PPNPB"	ENSG00000183979	"Neuropeptide B"	Q8NG41	17	81900745-81902905	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.2"	"Group enriched"	"Detected in many"	8	"Spermatogonia: 28.8;Syncytiotrophoblasts: 81.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	14	"granulocytes: 2.1;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.2;PC-3: 5.6;RH-30: 4.3;SH-SY5Y: 4.7;U-2 OS: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (2.44e-2)"	"unprognostic (6.21e-2)"			"unprognostic (2.90e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.32e-1)"	1.5	0.6	4.7	5.2	5.1	1.1	2.2	3.4	6.9	2.3	1.3	3.8	0.1	0.4	2.8	2.4	0.6	2.1	0.8	1.0	2.7	10.3	1.3	1.2	1.1	4.4	6.1	2.7	2.4	0.9	1.1	0.7	8.0	4.5	1.4	1.2	1.9	0.8	1.8	1.6	2.5	1.3	1.9	13.2	2.8	1.0	2.0	1.4	1.9	0.7	0.0	3.7	0.8	2.5	0.1	0.0	2.1	0.0	0.0	2.2	0.0	0.7	2.1	1.5	0.4	0.3	0.4	1.3	0.6	0.4	0.4	0.0	1.0	0.2	0.4	0.2	0.3	1.3	0.0	0.9	0.3	0.6	4.2	0.2	0.9	0.1	0.0	0.3	0.1	0.6	0.0	1.7	0.6	0.5	1.2	0.1	1.0	1.3	0.2	0.2	0.4	0.1	1.1	0.5	0.6	5.6	0.4	4.3	0.0	0.3	1.1	0.9	4.7	0.4	0.6	0.9	3.0	0.1	0.1	0.5	0.8	5.3	0.2	0.6	0.6	0.5	0.0	0.1	1.3	0.4	0.2	0.0	2.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.1	3.4	6.9	2.7	10.3	6.1	2.7	4.5	1.4	0.0	0.0	0.0	0.4	2.3	0.9	0.0	2.5	0.0	0.0	0.0	0.0	1.8	1.7	0.8	1.3	0.0	0.6	0.0	0.2	2.2	3.3	0.9	0.0	0.0	1.1	0.0	0.0	1.8	1.9	2.8	4.6	0.0	5.0	0.0	0.2	0.3	1.3	3.2	2.5	1.8	1.3	0.0	1.5	6.9	28.8	1.0	81.1	0.0	0.3	0.4
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 982.9"	"Cell type enhanced"	"Detected in all"	7	"Alveolar cells type 2: 1546.9;Hofbauer cells: 2619.0;Kupffer cells: 1574.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		63000000			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	34.8	23.7	9.0	14.7	12.2	13.9	27.2	2.4	7.6	21.1	16.0	12.5	92.3	11.9	16.8	982.9	17.1	14.9	17.5	34.1	9.1	9.9	29.2	13.6	65.0	48.8	15.1	6.7	25.3	14.6	4.5	21.3	22.1	25.5	17.8	14.4	39.8	21.8	54.0	9.4	16.6	19.1	12.1	26.5	30.0	13.6	26.6	10.6	7.6	49.8	15.9	15.4	16.4	18.1	18.7	139.0	44.2	112.5	6.3	12.2	67.2	29.9	18.9	12.6	16.0	145.7	42.9	39.8	21.7	73.0	19.2	42.8	32.4	37.9	7.3	15.9	16.9	34.9	59.6	16.3	40.2	16.8	11.7	12.7	2.9	9.8	24.8	32.5	4.7	56.1	43.5	34.1	17.3	33.3	86.9	24.7	8.1	3.0	56.6	18.4	12.6	7.3	7.3	6.5	43.5	30.5	3.5	22.6	24.8	43.6	65.7	0.5	8.8	31.1	11.5	27.1	33.9	19.7	20.5	26.7	27.1	37.1	39.3	19.0	26.3	45.0	2.6	28.9	15.1	15.2	34.1	83.8	17.9	6.6	112.5	6.2	18.7	9.2	6.6	39.1	17.0	9.0	7.5	44.2	6.3	76.2	139.0	12.2	67.2	9.0	12.2	2.4	7.6	9.1	9.9	15.1	6.7	25.5	10.6	354.4	1546.9	199.4	441.4	332.9	6.2	41.4	180.9	202.1	410.6	314.0	21.6	204.0	258.6	495.5	43.7	268.3	275.4	46.7	246.5	603.6	321.0	334.4	324.3	159.5	2619.0	7.9	115.0	406.4	1574.1	41.8	524.7	1241.8	571.9	500.5	250.2	141.9	373.8	381.4	274.4	754.1	22.6	129.4	139.6	230.6	151.8	280.3	176.0	111.8	255.9	447.4
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"epididymis: 154.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HHSteC: 17.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 11.9"	"Region enriched"	"Detected in all"	7	"cerebellum: 143.2"						"Secreted in male reproductive system"	NA	NA																							0.3	0.1	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.5	0.2	0.1	1.1	0.2	0.1	154.7	0.1	0.2	0.1	0.1	0.1	1.4	0.1	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.5	0.2	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.7	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.3	0.1	2.0	0.4	0.0	0.8	0.3	0.0	0.3	0.2	0.5	2.0	0.1	0.0	0.2	0.0	0.7	0.2	2.4	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.0	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	15.2	0.1	0.0	0.0	0.0	7.6	9.9	0.1	0.4	0.1	0.0	0.9	3.8	0.0	0.0	0.0	3.9	0.4	17.2	13.7	0.0	0.0	0.1	1.7	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	12.2	0.2	0.7	0.1	0.0	6.2	0.0	0.0	0.1	20.0	0.8	0.9	0.3	0.9	7.4	0.0	2.3	26.8	0.6	0.0	0.3	0.2	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8	172.7	69.4	0.0	4.6	1.6	0.2	2.0	33.1	10.7	97.8	31.4	0.0	2.2	1.7	19.0	11.6	8.0	8.0	0.0	2.1	0.1	0.9	29.6	0.0	0.0	0.3	0.0	15.0	3.1	0.0	11.8	2.3	1.3	5.0	0.0	9.2	0.0	6.3	3.1	0.0	3.0	0.1	0.0	33.5	0.5	1.5	1.0	1.3	0.0	6.9	2.8
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell type enriched"	"Detected in some"	14450	"Cardiomyocytes: 19644.9"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.5;SH-SY5Y: 12.0"	"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Not detected"	"Not detected"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		190000			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.7	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.7	2.7	4.3	0.3	0.0	1.5	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.6	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.6	0.0	1.2	5.9	5.1	0.0	0.9	0.5	7.7	1.9	0.1	0.7	0.6	0.8	0.8	0.0	1.8	12.5	12.0	0.7	0.0	2.2	1.2	1.6	0.2	0.4	2.1	4.3	3.4	0.3	1.3	3.2	4.9	0.3	3.5	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19644.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	14	"Cardiomyocytes: 146.6;Ductal cells: 75.3;Pancreatic endocrine cells: 62.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 34.0;CACO-2: 88.4;SuSa: 17.8"					"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	9680								"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.5	0.2	88.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	146.6	0.0	1.4	0.0	0.0	0.0	3.3	0.0	75.3	0.0	0.0	0.0	0.0	6.9	1.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	62.5	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921820-231926403	"Predicted secreted proteins, Transporters"	Osteogenesis	"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.2;retina: 24.7"	"Cell type enhanced"	"Detected in many"	16	"Basal glandular cells: 28.5;Collecting duct cells: 10.4;Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 7.9;NTERA-2: 3.7;SCLC-21H: 5.2;SK-MEL-30: 22.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 33.4"	HPA035362	Uncertain				"Secreted to blood"	NA	NA	6140				"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	1.4	0.9	4.1	6.3	4.4	4.5	1.4	5.4	12.0	3.0	5.0	2.9	0.7	0.9	1.6	34.2	7.3	1.8	0.6	3.9	6.9	6.3	0.9	0.5	0.8	4.5	2.8	2.2	1.8	0.5	0.5	3.8	1.1	12.4	13.1	1.3	24.7	4.4	2.0	2.4	0.8	1.6	2.2	13.3	1.7	4.3	1.0	0.9	13.7	2.1	9.3	6.0	0.5	0.6	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.9	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.3	0.2	0.2	22.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	4.4	5.4	12.0	6.9	6.3	2.8	2.2	12.4	0.9	0.0	0.0	0.0	28.5	3.1	1.1	1.6	0.0	0.0	0.0	10.4	9.8	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.3	0.3	1.7	0.0	1.3	5.8	0.6	2.5	0.0	0.0	3.7	0.0	0.9	0.3	3.4	1.0	0.2	0.0	0.6	2.6
NPS		ENSG00000214285	"Neuropeptide S"	P0C0P6	10	127549369-127552639	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"head and neck cancer: 4.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"midbrain: 6.5;pons and medulla: 5.3"	"Region enriched"	"Detected in some"	8	"cerebral cortex: 5.8"	CAB020139	Uncertain				"Secreted - unknown location"	NA	NA					"CAB020139: AB_776718"					"unprognostic (2.83e-1)"													0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 164.9"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced	Approved			"Secreted in brain"	NA	NA		1000000			"HPA077062: AB_2732329"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	1.3	0.0	12.4	0.0	0.0	0.0	7.7	0.0	9.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.2	0.0	0.0	8.4	0.0	15.8	0.0	0.0	0.1	0.0	0.2	0.1	33.8	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0	0.0	0.0	0.0	0.1	1.3	8.7	2.8	0.0	0.0	1.2	0.0	164.9	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.9	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.1	0.0	2.6	0.0	0.9	1.1	0.5	2.6	0.1	0.0	0.0	0.0
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Group enriched"	"Detected in many"	6	"Peritubular cells: 306.6;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 128.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	NA	NA	2490000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0	0.0	1.1	0.0	0.4	3.4	17.7	2.8	5.1	0.0	2.3	0.0	3.9	0.0	0.0	5.8	9.7	2.9	2.4	0.0	11.0	0.2	6.2	3.2	0.0	0.2	0.4	0.0	15.3	6.2	0.0	19.9	13.0	0.0	11.8	0.0	0.0	0.8	4.7	0.0	306.6	0.0	2.4	148.8	3.8	14.0	40.1	2.6	0.1	0.0	0.4	0.5
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Cell type enriched"	"Detected in some"	44	"Muller glia cells: 336.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	336.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 49.0;placenta: 17.7"	"Cell type enriched"	"Detected in many"	5	"Intestinal endocrine cells: 152.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0"	"Low region specificity"	"Detected in single"							HPA064874	Approved				"Secreted to blood"	NA	NA					"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0.0	3.1	1.4	5.9	3.0	0.9	1.1	0.7	0.3	0.5	0.9	1.0	49.0	0.4	1.3	0.4	0.7	1.0	2.0	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6.0	4.3	0.4	3.7	0.8	0.9	1.0	0.6	1.3	1.6	2.0	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.1	0.1	0.0	0.2	0.3	0.1	0.2	0.4	1.9	0.6	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.2	0.7	1.0	0.0	1.2	0.6	0.8	0.1	0.0	0.5	0.5	0.3	0.8	0.0	0.0	0.9	2.9	0.6	0.0	0.5	0.1	17.1	0.7	0.6	9.5	3.3	0.0	29.9	0.1	0.0	52.0	4.2	0.4	0.9	0.1	0.2	2.2	1.4	0.6	0.1	0.2	0.1	0.0	1.4	0.4	0.4	0.2	0.4	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2.0	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4	0.0	0.0	1.9	2.8	1.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.6	0.1	2.6	0.0	0.2	0.6	0.8	6.4	9.2	30.0	2.1	0.0	152.5	0.6	0.3	1.7	2.0	0.1	3.3	0.0	23.4	0.0	2.2	3.6	2.1	0.5	0.3	0.0	1.0	3.8	26.6	1.9	1.4	0.8	3.0	3.2
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell type enriched"	"Detected in some"	5	"Glandular cells: 55.9"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000		"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.1	124.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9	0.0	0.0	0.0	1.3	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.2	0.2	55.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.5	0.3	0.0	1.7	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.5	0.0	0.0	2.3	2.1	0.0	4.2	0.0	0.0	0.7
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639386-32767959	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"classical monocyte: 22.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 22.8"	"Cell line enhanced"	"Detected in many"		"A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6"	"Low region specificity"	"Detected in all"							HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.7	2.1	4.6	5.0	3.3	1.2	8.8	14.8	8.1	10.6	4.2	0.3	2.1	3.5	2.5	1.1	3.7	2.0	4.8	2.2	4.7	15.4	11.5	23.6	5.7	0.6	6.2	3.5	2.9	0.9	0.8	23.9	0.2	28.3	3.2	5.4	3.6	2.5	1.6	0.2	4.3	5.7	1.1	2.5	1.7	3.1	6.4	0.8	0.2	13.8	7.2	2.2	7.2	3.5	0.0	4.9	0.8	22.8	0.0	0.0	4.6	0.1	38.0	0.6	0.0	0.3	0.7	0.0	26.0	18.4	21.6	16.6	0.0	0.8	0.0	4.8	29.1	40.0	20.5	0.1	10.4	25.6	0.0	0.2	0.5	0.5	0.5	0.1	0.0	0.0	0.3	1.1	27.3	28.6	1.9	12.4	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.0	1.1	1.1	1.3	1.9	0.0	0.0	2.1	0.0	0.0	9.0	15.0	4.6	23.9	14.5	0.0	0.0	0.2	7.7	0.0	1.8	0.0	22.8	0.2	0.0	2.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.6	4.6	3.3	14.8	8.1	4.7	15.4	6.2	3.5	28.3	0.8	35.7	2.4	0.5	36.6	23.1	11.2	1.7	10.2	4.0	13.6	3.5	7.9	0.0	8.3	1.8	31.2	1.4	0.0	0.0	0.2	0.0	0.7	14.3	1.1	6.6	0.5	27.0	0.0	6.7	16.0	14.6	0.3	1.8	1.7	0.0	0.0	4.8	0.8	0.0	0.4	14.6	3.0	0.0	0.9	1.4	1.0	5.4	0.0	0.0	0.0	5.6
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	2.0	0.2	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	4.0	2.4	0.4	0.2	0.1	4.8	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	0.2	0.0	5.6	0.0	0.4	0.0	0.0	0.1	0.0	14.8	0.1	0.0	0.0	7.5	1.8	5.6	3.4	0.0	3.2	3.3	0.0	0.0	0.0	0.2	2.6	0.4	0.0	1.6	1.1	0.0	0.0	3.7	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9	0.0	0.0	0.0	9.0	2.5	15.1	1.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.3	0.5	0.9	0.0	0.0	1.9	0.0	1.8	1.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.6	8.9	0.0	3.3	0.0	0.0	9.7	0.8	0.0	9.6	1.5	0.7	6.5	1.1	3.0	4.3	0.3	0.0	0.8	0.0	5.9
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875314-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"							HPA075789			Uncertain	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.9	1.5	15.6	1.2	8.2	0.6	2.8	1.9	30.6	0.8	0.9	4.8	0.0	0.8	0.7	0.7	0.9	8.0	5.3	0.9	14.5	6.2	1.2	1.5	1.6	0.8	4.9	8.0	0.7	0.9	0.7	1.6	1.2	6.5	0.9	0.9	3.1	5.0	1.1	0.7	0.8	0.9	0.9	5.6	0.8	0.8	3.3	6.0	0.0	0.9	0.0	0.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	7.3	0.5	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	8.2	1.9	12.8	14.5	6.2	4.9	8.0	6.5	6.0	0.0	0.0	0.0	0.0	0.0	13.7	0.8	5.1	0.0	0.0	0.0	2.0	0.0	0.0	0.9	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	7.9	0.6	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.7	0.0	1.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1
NRG4	HRG4	ENSG00000169752	"Neuregulin 4"	Q8WWG1	15	75935969-76059795	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 36.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 14.7;Cone photoreceptor cells: 13.7;Exocrine glandular cells: 20.5;Pancreatic endocrine cells: 14.0;Rod photoreceptor cells: 22.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 8.7;HL-60: 3.2;THP-1: 2.9;U-698: 2.9;U-937: 5.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 282.0"	HPA010957	Uncertain				"Secreted to digestive system"	NA	NA					"HPA010957: AB_1079504"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-5)"	"unprognostic (8.28e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.06e-1)"	0.4	0.5	3.5	0.2	1.3	0.8	0.3	6.9	2.7	0.3	0.4	0.5	0.0	0.2	0.3	2.1	0.8	2.2	0.2	0.4	1.4	1.0	0.5	1.1	0.7	0.2	0.5	1.8	0.3	36.6	0.2	2.5	0.8	2.1	1.2	0.3	0.0	1.5	0.3	4.8	0.6	0.3	0.2	0.5	0.4	3.0	6.3	0.3	0.0	0.4	0.5	0.2	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.8	0.0	0.0	1.3	0.4	0.1	0.0	0.1	1.5	0.1	8.7	0.4	0.0	3.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	2.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	5.3	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.3	6.9	2.7	1.4	1.0	0.5	1.8	2.1	0.3	0.0	0.0	2.2	0.9	6.6	2.2	0.2	0.0	14.7	3.4	1.8	13.7	2.0	1.7	0.2	12.2	0.3	0.3	0.0	20.5	1.9	0.4	1.7	2.3	2.9	0.3	6.4	1.2	1.3	0.0	7.0	0.6	0.3	1.7	0.0	0.0	1.5	14.0	2.9	0.0	0.0	22.2	0.0	0.1	6.1	0.7	1.1	0.7	0.0	0.3	3.8
NRN1L	"MRCC2446, UNQ2446"	ENSG00000188038	"Neuritin 1 like"	Q496H8	16	67884805-67888855	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.9"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 8.1;Bipolar cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"BEWO: 27.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041761	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041761: AB_10961155"										"unprognostic (2.79e-2)"				"unprognostic (3.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.85e-1)"	1.9	2.1	3.4	1.9	11.6	7.2	1.8	8.5	5.1	2.0	1.7	6.3	0.4	3.1	2.2	0.9	1.5	2.5	1.7	4.8	5.9	5.3	1.6	1.8	4.4	4.4	5.7	3.1	4.9	2.6	3.6	6.5	1.6	6.4	2.6	1.4	20.9	4.4	2.0	4.5	6.8	2.6	1.6	3.5	4.3	2.2	2.6	6.1	0.4	2.4	1.5	1.5	3.9	1.9	1.6	0.5	2.1	1.9	0.8	3.8	0.9	0.1	0.4	0.6	0.7	0.3	0.8	27.1	0.4	0.0	0.3	0.2	0.0	0.4	0.3	0.5	0.1	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.2	1.1	1.5	0.6	0.1	1.1	0.5	0.9	0.0	0.0	0.4	0.0	1.1	0.7	0.6	0.2	1.4	0.5	3.3	5.1	0.0	0.3	1.3	0.0	0.5	0.2	0.4	0.8	0.3	0.4	0.4	0.4	5.3	0.9	1.1	0.5	0.3	0.2	0.0	0.0	0.2	0.3	0.7	0.1	0.4	0.1	0.0	1.9	0.0	3.8	1.1	2.0	1.6	2.3	1.2	0.5	1.3	2.0	1.1	2.1	0.8	1.3	0.4	1.3	0.9	3.4	11.6	8.5	5.1	5.9	5.3	5.7	3.1	6.4	6.1	3.0	8.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 238.8;Sertoli cells: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 24.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 69.4;hTERT-RPE1: 59.9;TIME: 57.7;U-87 MG: 69.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		720000000			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	69.9	15.0	4.9	13.6	4.9	0.7	53.8	1.3	5.6	25.1	17.6	2.4	16.4	6.7	29.8	21.9	14.7	17.0	23.3	50.5	17.2	5.9	47.1	27.4	47.1	30.1	3.5	3.2	27.1	14.1	11.7	6.4	44.3	3.6	25.2	7.8	24.3	11.8	31.6	22.3	9.1	14.6	19.1	5.5	38.7	9.8	15.6	2.8	5.9	30.4	24.6	7.9	22.3	23.8	0.4	24.0	0.3	1.7	0.6	0.4	0.4	8.6	33.8	1.7	0.1	33.0	37.0	0.2	35.0	34.1	17.6	19.0	4.2	20.8	0.1	4.2	69.4	18.7	2.4	2.1	10.2	14.4	0.1	1.7	0.0	3.9	7.2	11.7	3.1	0.2	44.2	1.7	41.9	19.0	59.9	47.9	0.2	0.1	0.2	34.4	14.6	0.2	0.5	0.8	1.8	32.1	1.4	3.8	0.1	16.6	0.1	0.7	0.4	3.5	2.7	0.1	1.5	0.1	0.4	57.7	25.2	5.9	30.3	23.5	0.1	0.1	0.1	69.1	4.0	22.7	0.2	1.7	0.3	0.3	0.3	0.4	0.4	0.3	0.3	1.4	0.3	0.4	0.3	0.3	0.6	0.1	24.0	0.3	0.4	4.9	4.9	1.3	5.6	17.2	5.9	3.5	3.2	3.6	2.8	0.0	22.7	8.1	9.5	14.0	8.7	57.4	35.7	8.1	13.6	17.4	3.9	48.5	1.7	46.0	0.7	84.2	1.0	0.0	16.8	10.8	38.6	3.8	7.0	11.4	109.4	0.0	4.1	238.8	53.2	2.6	39.1	27.1	11.8	9.0	0.3	3.5	10.9	0.0	19.8	29.4	0.6	278.1	64.5	0.2	0.7	9.3	56.2	2.5	0.1	2.8
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ito cells: 162.7;monocytes: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		15000000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	24.3	14.5	8.7	11.4	7.4	2.6	7.8	1.2	7.0	34.4	35.4	3.9	8.4	3.5	33.7	4.6	24.8	13.1	25.8	4.4	11.5	8.3	3.4	6.2	15.8	4.9	8.9	3.9	33.0	1.4	2.5	6.6	29.9	9.0	18.6	7.0	27.7	2.6	21.0	2.5	3.3	8.2	44.7	8.6	4.7	17.1	3.4	5.2	2.6	7.3	6.0	3.0	39.3	24.6	1.4	0.5	0.0	1.8	0.0	0.0	0.5	0.7	14.2	9.1	0.0	8.2	2.6	2.7	2.2	4.3	2.8	2.7	13.4	34.5	0.0	3.4	7.1	5.6	5.5	0.4	4.4	4.7	0.0	1.9	0.1	0.6	0.1	22.4	0.0	0.5	19.7	3.4	3.9	3.5	17.4	30.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	11.4	0.0	2.5	0.0	0.5	3.1	5.7	0.0	8.2	0.3	0.3	0.0	20.3	24.3	0.0	0.1	28.8	12.5	0.1	3.2	58.9	0.0	0.0	0.8	27.8	0.0	26.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	7.4	1.2	3.8	11.5	8.3	8.9	3.9	9.0	5.2	83.4	48.1	3.9	13.9	17.2	25.2	4.8	7.6	64.3	72.8	1.8	0.0	68.2	0.0	2.1	5.6	84.5	0.0	0.0	3.3	4.0	46.3	4.7	3.5	0.9	113.5	0.0	1.2	162.7	27.7	10.2	2.6	22.5	18.6	389.5	0.1	4.3	31.6	0.0	4.6	0.6	2.4	0.0	10.3	1.7	0.7	11.0	21.5	0.7	0.0	44.5
NRTN	NTN	ENSG00000171119	Neurturin	Q99748	19	5823802-5828324	"Disease related genes, Predicted secreted proteins"		"Growth factor"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.3;pancreas: 12.3"	"Cell type enhanced"	"Detected in many"	18	"Cardiomyocytes: 10.8;Cone photoreceptor cells: 11.8;Hepatocytes: 10.6;Rod photoreceptor cells: 43.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.2;K-562: 7.1;REH: 18.6;SH-SY5Y: 10.0;U-266/70: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065260			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA065260: AB_2685448"	"unprognostic (4.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	"unprognostic (1.60e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.21e-3)"	"unprognostic (5.60e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.32e-2)"	0.0	3.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	4.9			1.5	0.3	0.6	2.1	0.4	0.5	15.3	0.0	0.0	1.8	7.6	0.0	0.0	0.0		0.0	12.3	0.6	0.3	0.0		1.3	0.0		6.8	1.2	0.0	3.0	1.5	0.9	0.0	0.0	5.0	0.3			0.0		0.0	1.8	1.3	0.7	1.9	0.0	0.1	0.0	1.7	0.3	0.5	0.7	0.8	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.9	0.0	0.5	0.1	2.9	0.0	0.0	7.2	5.2	0.0	0.0	2.3	0.9	0.1	1.9	0.1	0.8	0.0	0.0	0.0	0.0	2.5	7.1	0.0	0.0	1.5	0.6	0.7	2.4	1.1	1.8	18.6	2.4	4.3	0.3	0.0	0.5	10.0	0.1	0.9	1.0	0.3	0.3	0.6	0.0	0.0	1.6	0.0	0.0	10.7	2.2	0.5	0.0	1.2	0.7	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.1	0.4	0.7	0.3	0.3	0.0	0.0	0.0	1.9	1.7	0.3											0.0	2.6	0.0	1.5	1.6	4.7	10.8	2.5	0.0	0.0	3.5	11.8	0.1	3.3	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.6	1.1	0.0	10.6	0.2	0.0	1.2	4.3	0.0	0.2	0.9	0.0	5.0	0.0	0.0	5.1	1.0	0.0	0.0	0.3	43.6	0.0	0.9	0.3	2.3	4.0	0.1	0.0	0.6	0.9
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.0"					"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.3	6.0	3.5	4.0	4.9	3.9	6.5	5.5	3.3	3.9	2.5	4.1	0.9	5.6	1.1	6.5	4.3	3.8	4.9	10.9	5.7	4.1	4.0	7.0	2.2	4.7	2.8	3.7	1.9	3.4	2.4	5.0	22.0	8.0	2.3	2.9	11.0	2.9	8.7	3.0	3.2	6.0	4.3	4.8	6.5	4.5	6.1	2.1	6.2	2.3	4.7	1.9	4.6	5.2	6.5	3.3	2.9	3.5	3.0	3.9	4.7	5.3	11.0	2.6	3.1	4.2	3.7	5.7	5.6	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7	0.0	2.9	0.8	17.0	3.9	1.5	2.8	2.5	9.4	2.3	1.8	0.0	4.2	0.0	1.8	8.8	1.6	1.6	0.0	1.8	4.4	3.9	10.0	0.0	4.3	1.7	9.5	39.5	1.3	3.5	7.4	4.6	2.5	0.0	2.8	9.1	0.8	2.3	0.0	7.8	1.5	4.9	0.0	8.0	0.5	3.1	3.9	3.4	0.9	9.0	8.6
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432112-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.2"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8"	"Group enriched"	"Detected in many"	5	"amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3"	"Low region specificity"	"Detected in all"			HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	4.9	2.7	0.5	2.4	0.5	0.0	5.4	29.2	0.6	12.9	4.7	0.3	5.6	2.7	9.2	6.8	5.0	2.2	5.3	4.1	1.7	0.2	4.3	10.4	2.5	1.0	0.7	0.2	16.8	0.4	0.1	1.3	2.7	1.2	8.9	1.5	8.9	4.6	3.7	3.6	3.7	6.6	11.5	0.4	8.5	3.0	3.5	0.0	0.2	1.2	3.9	2.0	10.4	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.5	0.0	0.0	0.0	0.0	3.4	9.2	12.1	16.2	0.1	0.2	0.0	5.5	5.7	0.0	2.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	3.8	6.8	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	29.2	0.6	1.7	0.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	26.7	16.5	0.0	0.6	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	5.2	4.7	0.0	2.4	0.0	0.0	0.0	8.0	0.0	0.0	7.8	0.9	6.8	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	32.3	32.7	0.6	0.7	2.9	0.1	0.0	0.0	3.9
NTF4	"GLC1O, NT-4/5, NTF5"	ENSG00000225950	"Neurotrophin 4"	P34130	19	49061066-49065054	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.3"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 28.5;Club cells: 9.1;Cytotrophoblasts: 12.3;Urothelial cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.3;HaCaT: 18.8;HBEC3-KT: 7.0;hTCEpi: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049376			Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA049376: AB_2680735"	"unprognostic (4.15e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-4)"	"unprognostic (1.76e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.90e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.71e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.46e-3)"	0.3	0.0	0.3	0.3	0.3	0.0	3.6	0.3	1.0	2.8	0.3	0.3	5.7	0.0	0.3	8.0	7.1	1.7	0.3	0.3	0.3	0.0	0.3	0.3	3.3	0.3	0.3	0.3	0.3	0.3	0.0	2.3	3.0	0.3	11.9	0.0	0.3	5.7	6.1	11.9	24.3	0.3	1.4	0.3	0.3	0.0	1.3	0.3	1.4	0.9	2.3	2.2	6.2	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.2	1.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.0	8.3	0.0	2.1	0.0	0.3	18.8	0.0	7.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	31.0	0.0	1.0	1.9	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.4	0.1	0.0	2.8	4.9	0.1	0.1	1.1	2.2	0.1	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.3	0.3	0.3	3.0	0.0	0.0	28.5	6.3	0.0	0.4	0.0	1.4	9.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	3.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	2.8	2.3	0.0	0.0	9.9
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021542-9244000	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 20.9;Hepatocytes: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 20.2;T-47d: 12.0;U-2 OS: 10.7;U-251 MG: 15.6;WM-115: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056419	Approved				"Secreted to extracellular matrix"	NA	NA		150000			"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	3.9	1.1	1.2	3.6	1.6	0.0	4.3	1.3	5.7	6.3	10.4	2.7	0.8	5.0	5.6	3.2	21.2	8.1	16.7	20.8	1.5	1.6	1.8	5.3	3.8	0.1	2.8	0.3	1.9	1.4	0.0	1.8	0.5	6.9	3.2	3.0	15.6	7.0	1.5	1.6	2.7	9.4	6.8	4.4	1.0	6.4	1.6	1.5	0.0	1.5	6.0	8.0	7.1	4.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	3.3	3.1	0.1	20.2	0.2	0.3	0.2	0.3	0.0	4.1	0.0	4.6	0.0	6.6	0.1	0.9	0.6	0.0	4.4	7.5	1.0	0.0	0.0	0.1	0.4	0.1	0.1	1.5	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.4	1.3	0.0	0.0	2.4	3.5	0.0	0.0	0.2	0.0	0.0	0.1	3.4	0.8	3.4	12.0	0.2	0.0	4.9	10.7	0.0	15.6	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.3	1.6	1.5	1.6	2.8	0.3	6.9	1.5	0.0	0.0	0.0	5.1	3.0	2.8	20.9	0.0	5.3	6.8	1.8	0.0	0.2	0.0	2.8	7.9	2.1	0.2	0.0	1.6	0.9	3.5	2.7	0.0	14.0	0.1	0.0	0.0	1.3	0.6	3.6	0.3	0.0	1.7	1.0	1.1	0.2	1.9	0.0	0.0	0.0	0.1	0.0	5.7	1.1	1.5	2.5	0.5	0.0	0.6	2.8
NTN3	NTN2L	ENSG00000162068	"Netrin 3"	O00634	16	2471499-2474145	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 8.2;SCLC-21H: 10.5;SH-SY5Y: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050817	Uncertain				"Secreted in brain"	NA	NA					"HPA050817: AB_2681247"	"unprognostic (2.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.61e-2)"	1.2	0.7	5.8	0.5	6.0	0.8	0.5	1.4	3.8	1.8	0.6	1.6	0.0	0.3	1.9	0.5	0.4	0.8	0.6	0.8	6.3	2.4	0.6	1.5	0.5	0.7	1.8	3.0	0.3	2.1	0.3	1.3	0.5	4.7	0.6	0.3	1.3	1.0	0.9	1.0	0.3	0.9	0.3	2.3	1.1	0.5	3.1	3.3	2.5	0.8	0.0	0.4	0.4	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.2	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.3	1.2	0.1	2.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	1.2	0.3	0.0	0.1	8.2	0.1	0.2	0.0	0.0	10.5	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.5	0.1	0.1	0.6	0.4	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.0	1.4	3.8	6.3	2.4	1.8	3.0	4.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NTN4		ENSG00000074527	"Netrin 4"	Q9HB63	12	95657807-95791152	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.9"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 188.5;Ito cells: 457.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	49	"T-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.4;hTERT-HME1: 39.1;PC-3: 35.7;TIME: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049832	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA049832: AB_2680905"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (2.85e-1)"	"prognostic favorable (8.12e-9)"	"unprognostic (3.52e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (6.67e-5)"	11.1	8.5	4.0	4.4	6.3	0.0	22.8	1.2	9.0	9.9	8.9	2.5	7.3	3.4	8.2	11.9	10.7	10.7	13.0	27.2	3.9	2.4	35.8	13.6	21.7	0.7	4.1	6.1	28.5	18.2	6.6	4.5	7.7	2.8	24.1	5.4	8.4	14.7	19.6	7.2	3.8	8.7	7.2	2.2	76.9	14.5	6.5	2.2	1.5	6.7	9.7	4.2	14.1	11.9	0.0	0.0	0.0	0.0	0.0	4.9	0.0	4.8	13.3	0.3	0.0	5.4	8.7	0.5	9.2	94.4	12.6	15.1	10.4	9.2	0.0	0.6	19.5	17.2	7.7	0.1	2.7	6.4	0.0	0.8	0.4	2.4	2.0	0.3	0.0	0.0	0.2	8.1	14.5	39.1	13.9	24.7	0.0	0.0	0.0	4.7	3.6	0.0	0.0	0.2	1.4	35.7	0.0	0.1	0.0	12.2	24.8	0.0	0.1	11.2	14.4	0.2	0.4	4.2	0.0	53.7	4.9	1.8	19.1	0.9	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.3	1.2	9.0	3.9	2.4	4.1	6.1	2.8	2.2	38.7	99.7	15.7	94.2	4.1	1.9	36.7	40.8	14.7	17.0	188.5	0.0	3.8	5.0	34.9	7.2	20.0	1.7	0.0	24.2	2.0	15.0	61.0	1.1	6.8	0.3	0.0	0.0	457.9	41.5	3.1	2.0	2.5	6.8	1.0	41.2	0.2	37.2	2.9	3.2	38.3	0.0	25.8	33.3	1.9	0.5	1.9	1.4	4.9	5.3	78.5
NTN5		ENSG00000142233	"Netrin 5"	Q8WTR8	19	48661407-48673081	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.0"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 4.3;Early spermatids: 3.9;Horizontal cells: 7.9;Late spermatids: 8.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.1;Karpas-707: 4.1;U-266/70: 3.1;U-266/84: 2.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"						"Secreted in brain"	NA	NA						"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.26e-6)"	"unprognostic (4.48e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.89e-3)"	"unprognostic (9.40e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.60e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-3)"	0.3	0.8	1.1	0.3	1.6	0.6	1.5	1.6	0.9	1.1	0.3			0.3	2.6	1.6	0.8	3.9	1.8	0.1	0.9	0.6	0.6	0.1	0.3	1.9	0.7		3.7	0.0	2.1	7.0	0.0		3.1	0.0		3.2	2.4	0.6	3.5	0.4	0.1	0.7	1.3	0.6	0.3			2.3		0.7	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.7	0.1	0.1	0.1	0.4	0.0	1.0	0.0	0.0	0.5	0.9	1.8	0.7	0.0	0.0	2.0	0.0	0.8	3.1	0.3	0.0	0.0	1.1	0.7	1.3	0.0	4.1	0.0	1.2	0.9	0.8	0.0	0.3	2.2	0.6	0.0	0.0	1.1	0.7	0.3	0.4	0.0	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.2	0.0	3.1	2.6	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.3	0.5	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	7.9	0.0	0.0	0.0	8.1	0.6	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.4	0.0	2.1	0.0	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.1
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell type enhanced"	"Detected in some"	19	"Club cells: 27.3;Collecting duct cells: 8.7;Ito cells: 11.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 70.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		120000	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.3	0.0	0.5	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	70.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4	0.0	0.3	0.0	0.4	1.1	0.0	0.3	0.0	5.3	27.3	8.7	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.2	2.8	0.0	0.0	0.2	0.0	2.4	11.1	0.8	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	1.9	0.1	0.0	0.0	1.1
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900050-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		15000000	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	49.5	32.2	18.1	30.5	20.2	19.3	50.1	17.9	36.0	31.0	42.5	24.8	32.5	51.6	36.7	46.8	33.1	30.7	47.2	58.8	16.8	20.3	56.7	144.7	42.6	48.4	20.5	25.2	40.0	37.4	42.7	21.3	46.9	29.1	36.6	15.3	31.0	37.8	29.7	46.7	26.0	51.8	36.7	20.7	32.4	33.4	19.0	15.9	17.1	48.0	29.0	23.2	36.4	58.2	19.1	42.3	39.2	47.7	24.4	40.2	40.1	10.1	33.1	15.9	34.2	57.8	44.7	18.3	39.5	34.9	19.3	27.1	16.6	37.1	9.9	30.1	48.1	18.9	24.3	9.1	19.3	8.1	35.9	16.5	25.7	23.6	21.4	27.9	15.5	34.2	52.5	8.6	18.3	12.2	52.5	29.4	11.1	31.2	52.6	18.8	12.1	7.4	9.6	7.8	23.3	17.2	14.0	23.9	20.7	14.2	24.3	11.3	23.6	46.2	28.6	15.7	15.5	14.6	20.4	44.4	32.6	22.2	20.1	18.6	39.7	91.3	6.8	25.0	9.7	38.2	31.6	39.6	37.6	40.2	47.7	30.4	19.1	27.3	30.5	29.9	15.5	22.9	22.7	39.2	24.4	40.7	42.3	27.0	40.1	18.1	20.2	17.9	36.0	16.8	20.3	20.5	25.2	29.1	15.9	38.7	74.0	44.2	50.6	42.8	21.0	48.1	61.1	21.4	35.2	66.3	13.7	88.7	34.9	114.5	6.4	86.3	281.0	0.0	103.8	125.2	120.9	70.5	94.5	109.2	190.7	19.1	71.4	106.8	122.6	6.8	102.1	89.3	96.2	150.5	83.5	49.5	91.7	154.3	116.7	115.0	14.5	90.5	94.8	11.2	46.6	43.5	85.4	88.5	101.9	56.4
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"		11	17208153-17349980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"salivary gland: 160.3"	"Cell type enhanced"	"Detected in all"	8	"Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 188.9"	"Low region specificity"	"Detected in many"							"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000		"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	10.2	13.9	9.5	7.5	13.1	66.4	17.9	13.5	7.5	18.3	7.8	3.8	79.5	6.6	11.4	59.6	29.7	13.7	7.3	25.0	7.5	10.9	10.8	51.1	12.5	13.5	8.5	7.6	15.4	92.8	58.9	69.7	35.8	10.3	13.4	8.3	5.8	160.3	104.9	7.2	4.2	6.8	11.3	9.4	9.8	11.4	18.7	6.1	86.1	22.7	17.7	10.4	12.1	11.0	3.7	71.7	28.8	7.6	45.2	49.5	20.1	12.2	5.1	5.7	17.2	12.9	17.8	6.9	27.4	40.0	12.3	21.8	5.0	2.8	18.9	6.9	26.0	11.5	5.3	3.6	6.9	19.3	13.0	8.0	13.9	6.4	8.7	37.3	188.9	25.6	7.7	9.2	8.8	21.6	30.7	15.0	71.0	12.0	38.3	12.1	10.8	66.5	68.3	1.3	20.0	5.4	24.6	13.9	1.5	5.5	3.9	6.8	3.8	12.0	12.1	6.1	8.7	9.9	51.4	13.4	13.1	12.1	39.5	11.5	7.5	4.1	10.4	15.1	66.8	11.1	28.8	7.6	27.6	17.1	5.0	22.3	3.7	16.3	31.5	6.9	2.4	46.0	49.5	7.0	45.2	4.0	71.7	7.0	20.1	9.5	13.1	13.5	7.5	7.5	10.9	8.5	7.6	10.3	6.1	41.7	59.0	14.1	53.1	24.5	64.5	145.2	50.9	702.6	152.4	40.1	51.1	105.9	23.2	65.4	595.9	97.2	5.4	23.3	116.0	281.9	179.4	156.8	63.8	119.0	65.3	33.4	40.7	105.0	27.2	377.7	138.7	39.7	65.8	11.8	82.2	101.2	103.6	8.6	107.5	16.5	80.2	45.3	51.5	125.6	53.1	26.3	968.6	104.6	35.5	54.9
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.8	12.0	10.4	3.7	11.2	11.7	2.3	8.7	11.1	10.5	15.3	2.8	0.8	11.5	25.8	9.8	12.7	1.7	11.5	9.4	13.0	14.3	3.6	8.9	7.6	7.4	14.8	7.5	8.3	6.7	1.6	8.7	3.2	13.7	11.3	11.2	1.8	37.8	17.3	4.1	10.0	1.8	5.9	0.4	7.4	4.6	12.6	4.9	7.7	2.0	8.2	9.8	3.7	0.9	6.5	6.5	1.7	10.8	9.8	11.7	13.9	1.3	9.0	18.0	17.8	13.6	10.0	33.3	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2	23.8	6.1	9.7	1.9	3.3	23.7	37.8	5.1	2.7	3.4	0.0	7.9	0.7	0.0	2.6	1.0	11.7	0.0	0.0	2.2	1.2	7.8	0.8	12.7	1.6	6.3	46.1	6.9	40.5	18.4	1.3	8.6	9.5	6.8	10.8	0.5	22.7	2.0	0.0	7.1	0.5	15.7	19.4	7.6	9.3	15.2	2.6	0.6	10.9	0.4	1.0
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595762	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7"	"Cell type enhanced"	"Detected in some"	18	"Enterocytes: 29.3;Mucus-secreting cells: 101.9;Paneth cells: 37.4;Undifferentiated cells: 91.1"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA042801	Approved				"Secreted to digestive system"	NA	NA					"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.2	0.2	0.2	21.7	0.2	0.0	0.2	0.2	0.2	0.2	41.5	0.1	0.1	0.0	0.2	2.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	2.1	44.3	0.1	71.7	0.1	0.2	0.2	0.5	1.9	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	29.3	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.1
NXPH1		ENSG00000122584	"Neurexophilin 1"	P58417	7	8433955-8752963	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"adrenal gland: 41.1;brain: 30.1"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.1;Early spermatids: 4.3;Late spermatids: 1.3;Rod photoreceptor cells: 3.4"	"Group enriched"	"Detected in some"	62	"breast cancer: 2.3;glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 15.4;WM-115: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (2.84e-2)"		"unprognostic (1.30e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"			"unprognostic (1.39e-2)"			"unprognostic (1.46e-4)"	"unprognostic (1.47e-1)"		"unprognostic (3.01e-2)"	"unprognostic (5.32e-1)"		"unprognostic (9.46e-2)"	0.8	41.1	9.6	0.7	9.8	0.7	1.1	3.6	30.1	0.7	0.7	3.0	0.0	0.7	0.7	0.7	0.7	0.7	0.8	0.7	6.5	13.9	0.7	0.7	0.7	0.7	6.2	7.1	0.7	0.7	0.7	1.9	0.7	6.8	0.7	0.7	0.0	1.0	0.7	0.7	0.7	0.7	0.7	3.3	0.7	0.7	0.9	1.9	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.4	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.0	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	9.8	3.6	11.5	6.5	13.9	6.2	7.1	6.8	1.9	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 1.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	10.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575858-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"monocytes: 7.2;Muller glia cells: 8.9;Peritubular cells: 13.4;Smooth muscle cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 18.1;BJ: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 61.3"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	NA	NA			Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	4.5	2.4	3.2	2.9	7.4	0.3	3.9	23.5	16.4	18.9	8.9	3.4	0.0	1.2	11.3	3.8	4.5	8.0	4.0	5.0	4.7	3.4	0.8	0.4	5.1	1.3	2.7	7.7	9.2	1.6	0.7	7.2	4.1	5.1	11.2	1.6	6.8	6.0	12.3	2.6	2.1	1.7	11.0	1.7	1.2	3.6	3.5	3.2	0.0	1.4	3.9	1.2	15.9	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	18.1	5.7	0.6	0.4	0.2	0.9	0.0	0.0	0.3	0.1	1.2	0.1	0.6	0.2	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.2	0.1	0.5	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.7	1.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.4	23.5	11.4	4.7	3.4	2.7	7.7	5.1	3.2	0.0	2.2	0.0	0.2	0.3	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.9	2.5	0.3	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	4.0	0.0	1.7	7.2	0.0	8.9	0.0	0.0	13.4	0.0	1.1	0.0	12.5	0.1	0.6	1.0	0.1	0.0	0.0	0.1
NXPH4	NPH4	ENSG00000182379	"Neurexophilin 4"	O95158	12	57216795-57226449	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.1;skin 1: 17.7"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 12.9;Cytotrophoblasts: 24.5;Muller glia cells: 15.7;Syncytiotrophoblasts: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.1;RH-30: 28.7;RPMI-8226: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA						"unprognostic (1.08e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (7.83e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-3)"	2.8	1.4	2.6	0.8	3.8	0.9	1.9	18.1	9.4	1.9	0.4	0.0	0.0	0.3	0.3	0.7	2.5	0.4	0.4	4.6	1.6	3.7	0.7	1.1	0.4	1.1	2.6	6.2	0.3	1.6	0.7	0.7	4.8	10.9	8.2	0.3	2.7	3.2	0.4	0.6	17.7	0.4	0.5	3.4	0.8	0.4	1.3	0.0	0.0	1.0	0.7	1.7	0.5	2.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.6	0.1	35.1	4.0	1.0	3.2	2.2	5.2	1.0	1.2	2.2	0.4	8.6	3.5	2.3	1.5	7.3	4.7	1.0	0.3	1.5	9.4	0.0	0.3	0.1	3.5	0.3	1.1	0.9	1.8	0.9	1.5	1.1	0.0	0.5	0.3	9.1	0.7	8.2	0.0	0.0	0.3	0.1	6.1	0.4	28.7	18.8	0.0	1.4	5.7	0.3	5.0	10.3	10.0	0.1	10.2	0.2	0.0	2.5	8.4	1.0	2.5	5.0	1.0	3.0	1.6	4.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.8	18.1	5.7	1.6	3.7	2.6	6.2	10.9	0.0	0.0	0.0	1.3	0.2	12.9	2.7	0.6	0.0	0.0	0.0	0.0	7.9	24.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	1.6	0.2	2.9	0.0	0.0	1.7	1.6	6.9	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	15.7	0.9	0.0	0.4	0.0	0.3	0.0	2.0	0.0	4.9	9.2	24.5	0.0	0.0	0.3
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		65000000	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	7.0	2.2	8.4	4.2	13.1	14.8	0.5	13.8	14.3	5.6	8.2	2.2	11.0	0.0	35.0	9.3	9.2	7.4	2.3	3.5	2.2	5.1	5.7	5.8	1.4	54.7	11.7	12.8	2.3	18.4	2.1	5.3	14.9	10.8	16.0	3.5	3.7	6.7	1.3	2.6	0.0	36.7	3.4	1.9	11.2	3.3	0.2	6.8	8.4	3.9	0.4	3.0	4.0	4.5	11.4	2.4	1.4	21.3	9.7	12.0	4.4	12.2	1.3	0.2	0.1	0.1	9.2	21.4	4.1	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5	0.0	1.1	1.5	19.1	8.4	3.2	3.6	33.1	0.0	2.3	68.0	2.0	1.8	23.2	14.3	0.1	24.8	97.4	23.3	24.3	4.7	46.2	12.2	1.1	187.7	5.5	0.0	21.9	11.1	10.6	0.0	15.5	9.7	15.1	1.8	55.8	261.4	23.5	41.9	4.2	64.1	8.0	51.8	45.3	0.5	6.7	8.9	5.1	3.2	42.0	195.3
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546139-135549969	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 23.7;testis: 13.3"	"Group enriched"	"Detected in some"	6	"Late spermatids: 1.0;Leydig cells: 1.4;Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"U-266/70: 2.8;U-266/84: 10.6"									HPA055955	Uncertain				"Secreted in other tissues"	NA	NA					"HPA055955: AB_2682985"	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	23.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	1.2	0.4	0.1	0.4	0.0	0.1	0.1	0.1	0.1	2.9	0.1	0.1	0.1	0.2	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 3.6;skin 1: 3.0;testis: 12.1"	"Cell type enhanced"	"Detected in some"	13	"Late spermatids: 1.4;Leydig cells: 1.1;Melanocytes: 1.7"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 2.4"														"Secreted in other tissues"	NA	NA						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0			0.0	1.2	2.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"SK-MEL-30: 4.7"														"Secreted in other tissues"	NA	NA														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODAPH	"AI2A4, C4orf26, FLJ23657"	ENSG00000174792	"Odontogenesis associated phosphoprotein"	Q17RF5	4	75556048-75565885	"Disease related genes, Predicted secreted proteins"			"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 10.4;placenta: 34.3"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"basophil: 10.4"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 10.4"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 31.1"														"Secreted in other tissues"	NA	NA						"unprognostic (1.13e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-2)"		"unprognostic (1.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.17e-7)"	"unprognostic (8.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.40e-4)"	"unprognostic (6.53e-3)"	0.3	0.1	1.5	0.4	1.9	0.6	0.2	1.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.1	0.3	0.2	1.9	1.5	0.3	0.4	0.3	0.5	2.4	0.2	0.4	0.2	0.0	1.3	34.3	0.7	0.2	0.5	0.2	0.2	0.3	1.6	0.9	0.3	0.2	2.7	0.4	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.1	10.4	0.2	0.2	0.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	31.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	1.3	0.1	0.1	0.0	0.0	1.4	0.1	0.4	5.6	0.0	0.1	0.3	0.2	0.0	10.4	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	1.5	1.9	1.2	0.9	1.9	1.5	2.4	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	23.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8	6.0	1.0	0.0	0.0	3.8	0.6	2.4	0.0	5.3	13.6	3.5	0.0	1.6	0.0	0.0	1.2	3.5	0.0	0.0	0.0	1.5	137.8	0.2	1.1	0.0	4.2	0.0	0.0	30.7	0.3	1.3	153.9	1.2	1.7	0.0	0.0	0.0	0.0	0.0	199.4	0.0	0.2	6.5	11.8	0.6	0.3	4.0	4.8	0.0	0.0	0.1
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893581-72933033	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 49.1"	"Cell type enriched"	"Detected in some"	10	"Ito cells: 487.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 5.8;Hep G2: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		150000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	6.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	5.8	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.3	6.1	0.2	0.2	0.1	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	487.3	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.6	3.2	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	13.1	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.5	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	21.5	0.1	0.0	28.6	20.3	0.0	0.0	0.0	12.0	0.0	0.0	41.3	5.5	34.2	0.1	2.1	2.2	53.0	0.0	0.0	2.0	4.6	23.1	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8	0.0	9.3	0.0	2.8	8.7	20.7	5.8	7.6	0.0	3.4	0.0	41.2	0.0	0.0	7.4	5.8	26.1	0.0	0.0	2.3	0.0	8.2	6.1	2.3	0.5	0.3	36.5	2.4	74.3	4.5	8.9	41.1	2.8	20.3	0.0	1.7	32.6	3.6	2.9	27.6	0.0	12.0	0.0	11.7	0.6	3.4	5.5	0.0	0.0	5.5	0.9
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.4;skin 1: 60.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in many"	27	"granulocytes: 24.9;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2300000	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	20.9	12.2	37.2	2.7	39.7	0.8	5.8	9.1	51.4	4.5	1.9	11.6	0.3	2.1	7.9	3.8	3.9	6.6	4.9	3.9	26.2	21.6	1.8	23.5	3.2	5.0	19.6	17.9	3.5	7.9	1.1	4.4	5.2	15.4	5.2	1.4	3.2	7.1	10.3	1.7	60.2	2.0	5.1	9.0	2.2	1.4	5.2	4.6	16.0	8.4	1.1	3.7	2.6	3.2	0.0	0.0	24.9	0.0	0.6	8.9	1.7	0.0	2.2	1.8	15.7	14.9	9.2	1.0	3.4	11.3	0.8	0.9	0.1	1.5	0.0	1.4	2.5	1.3	0.9	6.0	1.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	2.7	4.8	0.9	0.1	0.1	0.4	0.0	2.9	0.1	0.2	0.0	4.9	0.1	0.1	9.7	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	15.2	0.6	0.0	3.1	6.3	0.6	0.0	0.1	6.6	18.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	15.7	9.6	0.0	24.9	3.5	0.0	3.8	0.0	4.1	3.1	0.0	0.0	8.0	5.1	0.3	0.6	0.0	0.0	8.9	1.7	37.2	39.7	9.1	38.0	26.2	21.6	19.6	17.9	15.4	4.6	0.0	0.0	0.0	4.6	111.0	2.9	0.6	5.1	0.0	0.0	7.0	0.0	0.1	1.7	0.6	6.8	0.5	0.0	0.0	2.0	0.0	9.6	5.0	4.6	16.1	0.2	1.6	1.2	0.6	0.3	38.1	12.7	0.3	16.9	0.0	0.0	72.1	6.6	0.0	9.2	0.0	2.5	0.0	18.7	2.1	9.3	103.3	0.1	7.5	0.0	2.3
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802574-101997030	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 25.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.7	3.2	5.0	1.4	13.7	0.7	0.8	24.2	30.0	0.9	1.8	0.4	0.0	1.0	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6.0	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1.0	0.9	0.7	0.0	1.2	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	3.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	13.7	24.2	26.7	4.8	7.4	6.0	11.9	16.6	0.7	0.0	0.0	0.0	0.0	0.0	25.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"	Yes	NA			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	21.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.3	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3	0.0	0.0	0.0	149.7	0.1	0.0	0.4	0.0	0.0	0.0	132.6	0.0	0.0	1.7	216.4	0.2	0.0	104.8	0.0	804.6	0.0	0.0	16.5	0.0	0.0	0.1	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	18.0	135.9	3.2	1519.9	238.2	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	937.7	2045.0
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 33.2;Leydig cells: 36.8;Peritubular cells: 37.1;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.3;HSkMC: 3.8;SuSa: 5.3;U-2197: 16.1"									HPA039735	Uncertain				"Secreted - unknown location"	NA	NA		270000			"HPA039735: AB_10673148"	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	16.8	3.0	0.8	6.2	1.3	0.0	9.4	1.8	2.1	32.2	6.4	2.5	7.6	2.0	28.0	19.9	17.1	10.5	15.3	11.8	1.7	0.8	4.2	5.1	12.4	5.3	1.6	1.8	32.1	2.8	0.6	2.6	3.1	4.5	27.9	4.8	14.6	5.1	11.8	5.4	5.4	6.9	12.9	1.2	8.3	4.5	8.0	0.6	0.7	6.8	14.3	5.4	12.9	15.4	2.7	0.6	0.9	3.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	1.5	1.5	24.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.1	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.9	0.3	0.9	0.3	1.7	0.3	0.0	0.2	2.7	0.5	0.5	0.9	0.2	3.0	0.6	0.1	0.1	0.8	1.3	1.8	2.1	1.7	0.8	1.6	1.8	4.5	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	33.2	0.1	0.0	0.2	0.6	0.0	0.0	6.7	0.0	0.2	36.8	0.3	6.8	0.0	0.0	0.0	0.1	0.0	37.1	0.1	0.0	25.8	7.7	0.3	0.1	3.1	0.2	0.0	0.0	0.0
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.6	0.8	8.4	16.0	0.0	0.8	4.1	1.7	4.6	0.0	0.0	0.0	0.1	9.7	1.7	0.0	0.2	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	45.3	0.0	2.0	0.0	0.8	0.2	0.0	0.0	0.4	7.4	0.0	0.0	0.1	0.8	0.0	0.4	0.0	34.6	3.3	0.6	0.0	0.3	0.1	3.4	0.0	0.2	8.0	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.9	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1	0.0	1.1	0.0	0.0	3.0	0.0	2.5	0.0	0.0	1.2	1.8	0.0	0.2	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.3	9.3	0.1	1.1	0.0	31.7	0.0	0.0	1.8	20.4	4.5	19.2	9.9	1.7	1.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	6.5	12.6	1.5	0.9	1.9	0.2	0.0	0.0	0.0
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 177.9;Ito cells: 73.6;Leydig cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 5.4"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.8;ASC TERT1: 46.4;BJ hTERT+: 52.9;HSkMC: 84.8;LHCN-M2: 84.6"	"Low region specificity"	"Detected in many"							HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		1500000	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	25.8	11.8	3.9	9.7	6.6	0.0	25.6	1.4	7.9	75.3	22.7	16.2	17.9	3.9	57.7	41.8	13.8	33.9	31.5	20.3	3.0	2.3	9.7	9.4	18.4	5.7	7.1	4.0	52.6	11.7	1.0	6.6	29.1	8.9	33.1	9.6	41.4	6.1	21.9	5.8	13.5	10.8	29.4	5.1	2.5	19.1	13.3	4.6	0.6	7.8	15.0	7.0	28.0	37.6	0.0	5.4	0.0	0.4	0.0	0.0	0.2	0.0	2.7	1.4	0.0	84.8	46.4	0.0	10.8	52.9	3.7	12.3	3.5	0.0	0.0	0.6	31.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.6	22.0	0.0	0.0	84.8	0.0	5.3	0.0	1.5	0.3	0.0	0.0	0.0	84.6	0.0	0.0	0.0	6.4	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.4	21.4	31.4	0.1	0.2	2.1	4.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	13.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	6.6	1.4	7.9	3.0	2.3	7.1	4.0	8.9	4.6	0.0	5.9	0.5	0.1	11.6	0.0	1.4	2.5	0.0	1.2	1.8	0.0	5.6	0.0	0.6	1.5	3.5	0.0	0.0	0.0	5.0	177.9	1.1	1.1	0.2	33.4	0.0	5.8	73.6	5.0	1.1	67.9	3.6	11.8	1.0	0.2	0.0	0.4	0.0	31.1	0.5	0.0	0.0	37.3	0.2	0.4	10.0	10.4	0.7	0.0	0.3
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 27.7;Leydig cells: 90.6;Peritubular cells: 103.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.6;ASC TERT1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.6	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3	0.0	0.0	0.0	0.2	2.4	0.6	1.1	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	27.7	0.1	0.0	0.0	0.3	0.0	0.0	16.5	0.3	1.3	90.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	103.6	0.0	1.3	0.0	3.4	0.2	0.1	2.4	0.0	0.0	0.0	0.1
OOSP2	"FLJ36198, PLAC1L, TMEM122"	ENSG00000149507	"Oocyte secreted protein 2"	Q86WS3	11	60040275-60048044	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 48.6"	"Cell type enriched"	"Detected in single"	4	"Late spermatids: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	32	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA050914	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA050914: AB_2681271"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397882-70410194	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"breast: 19.1;salivary gland: 59.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"GAMG: 1.0"									HPA065711	Approved				"Secreted in other tissues"	NA	NA		36000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"retina: 245.8"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.3	0.0	0.2	0.1	0.2	0.0	0.2	0.4	1.0	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0.0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.7	0.0	0.1	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell type enriched"	"Detected in some"	35	"Hepatocytes: 50531.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 161.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	120000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3											3.0	14.9	263.0	0.0	0.0	0.0	0.0	1452.2	0.0	1.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	794.3	4.5	0.1	0.0	31.6	0.0	50531.7	0.1	0.0	0.0	844.6	848.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 9578.7"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 136.6"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	61000000000	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	136.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1											0.0	8.0	42.8	0.0	0.0	0.0	0.0	224.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	0.0	70.0	5.4	0.0	0.0	2.1	0.0	9578.7	0.0	0.0	0.0	141.2	136.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266840	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Cytokine, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 24.9;bone marrow: 63.0"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 18.3;granulocytes: 14.0;Hofbauer cells: 72.9;Macrophages: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 24.9;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 16.2;HL-60: 3.9;HMC-1: 12.0;Karpas-707: 3.7;NB-4: 6.9"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	39700					"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	5.3	2.6	0.9	8.5	2.5	63.0	3.7	0.7	1.7	1.6	1.0	5.3	0.4	0.6	1.2	1.9	0.8	3.8	4.1	2.2	3.8	1.7	1.9	1.8	11.4	9.4	2.0	0.0	3.0	1.0	1.0	2.5	6.4	5.9	1.2	0.7	1.8	1.4	0.5	1.7	0.4	1.0	2.1	7.8	6.9	1.4	2.3	1.2	0.6	1.1	0.5	2.2	6.8	0.9	0.1	0.4	24.9	0.2	1.9	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.2	0.0	0.3	0.0	0.0	0.0	3.9	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	3.7	0.0	0.0	0.5	6.9	0.0	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.4	0.0	24.9	0.2	0.9	1.0	0.1	3.4	0.0	2.5	1.3	0.4	0.1	0.5	1.2	17.5	1.9	0.0	0.1	0.7	0.8	0.9	2.5	0.7	1.7	3.8	1.7	2.0	0.0	5.9	1.2	8.9	18.3	0.0	0.1	0.7	0.0	0.4	0.0	1.4	6.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.6	0.1	14.0	0.0	72.9	0.0	0.0	0.0	6.2	0.0	0.0	23.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	7.0	0.0	0.0
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.8;brain: 7.9;prostate: 8.0"	"Cell type enhanced"	"Detected in single"	31	"Early spermatids: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"memory B-cell: 7.8"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.8"	"Cell line enriched"	"Detected in some"	24	"U-2197: 30.2"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.9	0.4	1.9	1.6	2.1	0.0	0.6	0.2	7.9	7.1	0.4	0.0	0.0	0.0	0.2	4.4	0.1	1.9	1.9	1.5	1.8	1.9	0.5	1.6	1.0	1.3	1.5	2.4	0.5	0.1	0.0	0.3	1.1	0.4	8.0	0.1	0.0	0.4	0.2	2.3	3.4	0.3	2.3	1.1	0.5	0.6	1.1	0.0	0.0	0.6	0.7	0.0	3.7	1.0	7.8	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	1.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.9	2.1	0.2	7.9	1.8	1.9	1.5	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
OTOA	"CT108, DFNB22"	ENSG00000155719	Otoancorin	Q7RTW8	16	21663971-21761935	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 4.1;lymphoid tissue: 4.5;testis: 7.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 94.1;Kupffer cells: 35.6"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	10	"myeloid DC: 1.7;plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;THP-1: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041405	Approved				"Secreted in other tissues"	NA	NA		44000			"HPA041405: AB_10796344"	"unprognostic (7.96e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.18e-2)"	0.2	0.3	0.2	0.0	0.1	0.4	0.1	0.0	0.7	0.0	0.1			0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.3	0.3	0.1		0.0	0.0	0.0	0.8	0.0		0.1	0.1		0.1	0.0	0.0	0.0	0.0	0.0	0.9	4.5	0.0	7.8			0.0		0.1	0.0	0.0	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0											0.0	0.3	3.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.2	8.7	0.3	0.0	0.0	0.3	0.6	0.2	0.2	5.7	0.2	94.1	0.0	1.2	1.3	35.6	15.7	0.3	5.1	1.7	0.0	0.0	0.0	0.1	0.8	0.0	0.6	0.0	6.5	1.1	9.1	5.3	0.1	0.5	0.0	0.0	0.1
OTOG	"FLJ46346, mlemp, OTGN"	ENSG00000188162	Otogelin	Q6ZRI0	11	17547373-17647150	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pituitary gland: 4.8;testis: 3.5"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 10.1;Late spermatids: 21.0;Muller glia cells: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"CACO-2: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.85e-6)"	"unprognostic (1.89e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.14e-5)"	"unprognostic (1.78e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.57e-2)"		"unprognostic (4.72e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.48e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	4.8	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041030	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041030: AB_10795000"																		0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOR	"FDP, MIAL, MIAL1"	ENSG00000125879	Otoraplin	Q9NRC9	20	16748358-16770062	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;stomach 1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.0"	"Not detected"	"Not detected"							HPA024335	Uncertain				"Secreted in other tissues"	NA	NA					"HPA024335: AB_1854838"	"unprognostic (8.50e-3)"				"unprognostic (9.56e-2)"						"unprognostic (2.34e-1)"				"unprognostic (1.81e-1)"	"unprognostic (1.72e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0			0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3		0.3	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	17.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"pituitary gland: 39.1;thyroid gland: 41.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 6.5;thyroid cancer: 28.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.8"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.3	0.3	4.5	0.3	4.6	0.3	0.4	0.3	3.8	0.5	0.3	0.7	0.0	0.3	0.4	0.7	0.3	0.4	0.3	0.3	2.4	1.1	0.3	0.3	0.3	0.3	0.6	2.0	0.3	0.3	0.3	39.1	0.3	5.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.4	0.8	0.0	41.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.6	0.3	3.8	2.4	1.1	0.6	2.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVCH1	OVCH	ENSG00000187950	"Ovochymase 1"	Q7RTY7	12	29412474-29497686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 9.5;testis: 4.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.4;Late spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Daudi: 11.0"					"Low region specificity"	"Detected in many"								"Secreted in female reproductive system"	NA	NA						"unprognostic (3.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	0.6	0.4	0.0	0.4	0.3	0.1	0.5	0.0	0.1	0.4	0.2			0.0	0.2	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.2	0.3	9.5	0.2	0.1		0.3	0.0	0.0	0.6	0.0		0.1	0.3		0.0	0.0	0.3	0.5	0.1	0.0	0.2	1.9	0.2	4.6			2.1		0.0	0.1	0.2	0.5	0.2	1.3	0.5	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.8	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.2	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVCH2	OVTN	ENSG00000183378	"Ovochymase 2 (gene/pseudogene)"		11	7689438-7706421	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	23	"epididymis: 60.7"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 7.0;Rod photoreceptor cells: 17.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"REH: 22.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA						"unprognostic (1.59e-2)"	"unprognostic (3.74e-1)"		"unprognostic (8.03e-2)"		"unprognostic (9.77e-2)"		"unprognostic (1.85e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.27e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.6	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	22.3	0.0	0.1	0.2	2.3	0.0	0.2	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	17.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 9.2;Hepatocytes: 37.5;Late spermatids: 23.3;Proximal tubular cells: 10.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;HL-60: 1.3;HMC-1: 3.8;PC-3: 2.7"	"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	1042	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000				"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0	0.0	2.6	3.7	0.6	0.7	0.0	0.2	0.0	1.4	2.3	5.2	0.0	0.0	1.7	0.1	9.2	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.0	37.5	0.2	0.0	0.0	0.0	0.3	23.3	0.9	0.3	3.3	0.0	0.3	0.0	0.2	1.4	1.1	10.5	0.0	0.0	1.0	0.9	4.5	0.9	0.0	0.0	0.0	0.1
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3"	"Group enriched"	"Detected in some"	20	"Club cells: 7.9;Ductal cells: 4.2"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 22.0"									"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavorable (0.00e+0)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	1.3	0.1	0.0	176.9	0.2	79.9	0.1	0.1	5.0	0.0	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.1	0.0	0.8	0.1	0.0	0.2	105.3	0.0	1.1	0.0	0.0	0.2	13.9	0.1	1.1	0.1	0.0	0.1	0.2	2.0	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.3	1.3	5.8	0.9	0.8	0.8	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.6	2.3	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.2	3.1	0.5	0.0	0.3	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.5	0.2	0.1	0.2	22.0	0.7	0.4	0.2	0.0	0.1	1.1	0.3	0.1	1.0	2.1	0.2	0.3	0.4	0.5	5.8	0.9	0.6	0.6	0.5	0.5	0.6	0.8	0.6	0.3	1.3	0.7	0.8	4.0	0.8	0.8	1.3	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 16.9;Fibroblasts: 47.8;Suprabasal keratinocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.9;ASC TERT1: 74.1;BJ hTERT+: 72.1;fHDF/TERT166: 17.1;HSkMC: 25.5;U-87 MG: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA		3300000				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	14.1	9.9	11.9	0.7	10.5	0.4	10.2	0.7	12.8	40.1	6.6	9.7	5.1	3.1	37.0	12.7	6.8	12.1	12.7	11.1	9.5	7.3	2.6	8.0	3.5	1.1	9.9	5.4	4.4	3.4	0.8	3.4	34.0	18.1	12.7	4.6	0.8	2.7	12.1	3.1	12.5	4.7	14.6	13.8	3.7	3.1	5.8	5.7	0.6	3.4	6.0	2.9	18.8	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	74.1	0.0	9.1	72.1	1.0	1.7	6.4	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	10.8	0.0	0.0	25.5	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	10.5	0.7	12.8	9.5	7.3	9.9	5.4	18.1	5.7	0.0	0.0	0.0	1.5	16.9	0.0	1.2	0.0	1.4	3.4	1.8	0.0	1.5	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	47.8	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	8.2	2.9	0.0	0.0	0.2
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"neutrophil: 4.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		46000000	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	9.3	6.1	13.6	11.8	14.8	2.9	11.0	4.1	11.1	10.8	7.0	6.0	3.8	4.1	14.2	19.5	4.6	12.1	8.0	4.8	15.7	3.0	24.9	1.9	7.8	23.3	4.1	9.7	10.9	2.7	1.0	11.1	5.2	5.7	8.1	6.2	14.9	4.7	10.2	1.8	16.2	10.3	8.6	6.0	17.6	7.4	6.5	8.9	5.1	15.3	2.2	16.5	6.8	5.6	1.1	8.8	4.4	0.8	0.5	0.5	0.2	2.0	2.0	0.8	0.3	1.5	1.9	4.6	0.4	0.0	0.1	0.1	2.6	0.6	0.4	2.1	0.0	0.1	3.3	2.1	1.5	0.2	2.3	3.1	0.9	3.2	0.3	13.1	0.3	1.7	24.7	9.1	0.4	1.4	0.1	0.4	1.9	0.6	0.3	0.0	1.0	0.2	2.2	0.5	0.2	0.6	0.3	0.3	2.1	1.8	0.4	0.2	0.4	4.8	5.5	0.9	6.6	0.1	3.7	0.4	0.6	1.9	0.2	0.2	1.1	0.1	0.2	1.1	1.1	0.5	1.1	0.8	0.6	0.4	0.5	0.2	0.7	0.3	0.5	0.2	1.1	0.5	0.5	4.4	0.5	0.4	8.8	0.5	0.2	13.6	14.8	4.1	11.1	15.7	3.0	4.1	9.7	5.7	8.9	0.0	1.6	0.0	0.5	1.8	1.0	1.3	2.5	1.4	5.7	5.2	7.9	0.5	0.0	3.0	0.3	1.1	0.1	0.0	0.0	0.9	6.1	1.7	0.0	0.0	1.2	0.0	0.0	1.8	0.3	1.4	31.9	0.9	1.7	2.8	0.0	21.2	0.4	0.0	41.4	13.4	3.0	6.5	1.0	0.6	0.1	2.6	0.3	0.0	0.9	0.4
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Group enriched"	"Detected in many"	6	"Collecting duct cells: 157.1;Proximal tubular cells: 39.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.5	8.4	0.0	19.3	14.8	0.0	4.5	8.0	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.4	0.6	0.0	0.0	6.0	0.0	0.0	0.9	4.6	0.0	9.4	0.0	0.0	53.2	0.0	6.2	0.7	10.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	2.7	0.0	0.0	10.7	13.9	0.7	0.4	0.5	0.0	0.0	0.0	9.9	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5	0.0	1.0	0.0	0.2	2.6	5.0	2.2	0.0	0.0	2.3	157.1	11.8	0.3	8.3	5.8	14.3	0.7	0.0	0.0	0.8	7.4	16.4	0.6	1.1	0.0	0.4	0.0	0.0	5.5	0.0	12.7	13.3	0.3	1.7	0.0	0.0	2.3	0.5	0.0	8.1	39.6	2.7	0.0	8.2	1.7	0.4	1.0	11.7	0.0	0.0	0.1
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746293-125749867	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;NB-4: 6.6;RPMI-8226: 1.6;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"	NA	NA					"HPA076587: AB_2732316"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.2	0.0	426.3	0.0	0.2	222.7	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.2	185.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PATE2	"C11orf38, LVLF3112, PATE-M, UNQ3112"	ENSG00000196844	"Prostate and testis expressed 2"	Q6UY27	11	125776113-125778819	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Early spermatids: 3.8;Late spermatids: 8.2;Spermatocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA						"unprognostic (3.28e-1)"				"unprognostic (7.26e-2)"	"unprognostic (2.95e-1)"		"unprognostic (1.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"		"unprognostic (1.55e-2)"		"unprognostic (5.08e-1)"	"unprognostic (2.55e-1)"			0.1	0.1	0.4	0.0	1.0	0.1	0.1	0.7	0.6	0.1	0.2	0.0	56.1	0.0	0.1	112.4	0.0	0.1	0.0	0.2	0.5	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	44.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.2	1.6	0.6	0.2	1.0	0.0	0.9	0.0	0.2	0.7	0.4	0.0	1.7	0.5	0.2	0.6	0.3	0.4	0.8	0.2	0.7	0.5	0.8	0.4	0.1	0.3	0.8	0.7	0.3	0.8	1.1	0.0	0.0	0.7	1.4	0.0	0.1	0.7	0.5	0.6	0.0	0.3	0.6	1.8	0.1	1.7	0.5	4.5	1.6	0.6	1.6	1.2	0.1	1.9	0.8	0.7	0.5	0.5	2.6	1.6	0.3	0.7	1.4	2.0	2.7	0.9	0.6	0.9	0.6	0.9	0.5	0.8	1.6	0.8	1.5	0.7	0.6	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.2	0.5	1.0	0.3	1.6	0.2	0.3	0.2	0.3	0.0	0.4	1.0	0.7	0.6	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.7	0.0	0.0	0.0	0.0	0.0
PATE3	"HEL-127, PATE-DJ"	ENSG00000236027	"Prostate and testis expressed 3"	B3GLJ2	11	125788111-125791600	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.8;RPMI-8226: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.1	0.1	0.0	8.7	0.0	0.1	86.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	3.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840069	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"ductus deferens: 194.5;seminal vesicle: 232.9"	"Group enriched"	"Detected in some"	108	"Early spermatids: 16.9;Late spermatids: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"											HPA045632	Approved				"Secreted in male reproductive system"	NA	NA					"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.1	0.0	194.5	0.0	0.1	7.3	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.1	232.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	2.1	0.2	1.6	1.5	1.2	0.6	0.6	0.9	0.1	0.5	0.5	0.8	1.5	0.4	0.5	0.4	0.3	0.2	0.0	0.3	0.6	1.0	1.7	0.5	0.0	1.0	0.9	0.1	0.1	0.4	0.3	0.3	0.6	1.6	0.8	0.1	0.5	3.2	0.7	0.3	0.2	0.6	0.7	0.1	0.5	0.9	2.6	0.2	0.7	0.2	0.9	1.6	0.4	0.8	0.6	0.6	0.6	0.6	1.9	0.4	0.3	0.5	0.1	0.3	0.9	0.9	0.1	1.8	1.3	1.6	2.6	0.8	1.4	0.7	0.8	1.1	0.2	1.3	0.6	0.6	0.3	0.9	0.5	0.6	1.4	0.7	0.4	0.3	1.6	0.9	0.8	1.2	0.6	0.4	1.5	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943585-141969741	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 24.8;Hofbauer cells: 25.9;Ito cells: 56.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	35	"monocytes: 7.0"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 14.2;Karpas-707: 35.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"	NA	NA		720000			"HPA051242: AB_2681402"	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	7.9	2.9	0.5	0.7	0.6	0.0	3.1	2.2	0.6	1.3	0.8			0.7	1.3	0.0	0.7	1.2	1.8	4.6	0.5	0.4	3.7	2.1	9.0	0.7	0.4		0.9	0.6	1.4	2.5	17.9		1.1	0.4		0.6	1.0	1.6	0.5	1.0	2.6	0.3	11.3	1.0	0.1			4.8		0.1	2.1	1.1	0.1	0.2	0.0	7.0	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.2	14.2	0.1	0.0	35.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.1	1.5	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.9	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.2	5.7	1.2	0.0	0.4	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.1	0.2											0.0	1.4	0.0	0.0	0.6	1.0	4.4	0.0	0.0	0.0	0.0	2.0	0.2	3.3	0.0	1.4	24.8	0.0	0.0	0.0	0.2	0.2	0.0	1.1	0.0	25.9	0.0	0.0	56.4	7.5	0.8	0.0	0.1	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	0.3	14.4	0.5	0.0	1.6	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA10	"CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10"	ENSG00000250120	"Protocadherin alpha 10"	Q9Y5I2	5	140855883-141012344	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 20.2"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"	NA	NA						"unprognostic (4.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	2.1	1.7	6.1	1.1	6.6	0.6	2.4	8.0	20.3	3.0	0.9	4.9	0.9	1.1	4.5	6.3	0.5	2.7	3.1	0.8	7.1	2.7	4.3	0.6	2.1	0.7	7.2	3.6	2.8	7.8	0.8	11.2	0.5	6.1	1.6	0.9	1.9	3.2	1.0	0.5	0.7	1.8	4.0	6.9	0.7	1.1	1.9	8.2	0.0	5.0	0.0	0.5	0.7	0.7	0.6	0.4	1.5	0.3	0.6	0.3	0.0	0.0	0.2	0.4	2.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.3	1.6	0.8	0.0	0.1	0.0	4.1	0.3	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.1	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.6	0.2	0.3	1.5	0.6	0.2	0.4	0.1	0.0	6.1	6.6	8.0	6.9	7.1	2.7	7.2	3.6	6.1	8.2	0.0	1.0	0.0	0.3	0.0	7.0	0.5	2.5	0.0	0.0	0.0	7.9	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	7.9	1.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.4	2.6	0.0	0.3	1.0	0.2	0.0	0.0	0.0	0.0	0.2
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602177-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 347.3;Leydig cells: 130.0;Smooth muscle cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 85.2;BJ hTERT+: 63.5;HSkMC: 97.7;SH-SY5Y: 68.1;U-138 MG: 39.4;U-2197: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	29.5	16.7	0.6	18.1	1.3	0.0	29.3	1.0	2.0	90.4	11.2	1.6	22.8	2.0	42.1	89.9	23.1	29.6	34.3	47.3	0.7	0.7	14.6	73.0	24.5	51.1	3.7	1.9	38.8	7.9	1.2	11.4	23.8	2.9	49.4	4.5	54.6	16.0	19.8	10.0	16.0	7.4	26.1	6.9	10.5	9.1	20.8	0.5	2.4	17.8	20.1	18.4	28.2	34.0	0.8	1.0	1.6	1.0	1.1	1.1	0.1	0.0	0.0	0.1	0.2	30.1	85.2	0.2	34.9	63.5	15.8	13.9	1.3	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.5	1.7	8.4	0.0	0.2	97.7	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.2	7.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	68.1	0.0	0.1	0.1	0.7	0.1	0.0	0.2	39.4	10.9	120.2	0.0	0.0	0.0	0.0	13.7	0.0	6.6	0.0	0.3	1.6	0.5	1.0	1.1	0.8	0.9	0.6	1.0	0.2	0.6	0.3	0.4	1.1	0.8	0.0	0.4	0.1	0.6	1.3	1.0	2.0	0.7	0.7	3.7	1.9	2.9	0.5	8.9	3.2	0.8	2.9	35.5	3.0	15.7	2.5	4.0	5.7	5.2	0.0	13.9	23.2	5.0	10.4	10.5	0.0	0.0	4.5	10.7	347.3	1.6	1.1	16.1	18.8	15.9	1.7	53.4	1.3	18.5	130.0	4.4	30.4	0.0	0.7	10.8	4.7	0.2	47.4	1.9	1.6	32.3	134.4	21.6	14.0	29.0	21.1	7.2	0.4	2.6
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.3	1.4	0.0	25.9	7.2	0.0	0.3	0.1	1.2	1.5	0.2	0.5	0.0	1.2	1.9	6.4	0.0	5.1	0.0	1.4	0.0	8.5	0.9	2.8	0.0	0.0	0.5	0.0	2.9	0.0	2.6	0.7	5.9	0.0	0.7	0.2	0.0	0.5	0.7	1.5	0.4	2.1	0.1	9.0	0.0	3.2	13.5	1.3	0.0	2.7	1.7	6.7	0.0	2.5	1.9	0.0	1.8	0.0	2.3	5.2	29.0	2.1	28.7	13.2	0.0	6.4	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3	0.0	2.7	0.0	0.5	6.5	13.2	33.1	0.0	0.0	1.2	12.2	23.6	99.1	0.0	0.0	0.5	2.7	0.0	0.0	0.0	55.3	87.7	0.6	1.1	12.1	13.7	6.4	0.0	0.6	0.6	0.6	0.6	2.6	3.3	0.0	0.0	13.7	0.5	0.0	0.0	0.0	11.1	0.0	6.3	8.7	49.4	6.5	202.1	0.0	0.0	0.1
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390415-96434143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6"	"Cell type enriched"	"Detected in some"	39	"Intestinal endocrine cells: 215.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 19.0;U-138 MG: 16.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA					"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	2.3	8.5	1.3	6.0	10.1	0.5	1.3	0.5	36.6	1.2	3.3	0.5	0.0	6.7	0.5	8.8	0.4	0.4	0.6	1.0	2.8	27.1	0.5	0.4	0.8	0.4	3.1	14.0	0.6	9.8	0.3	10.9	0.4	7.5	0.5	3.3	0.1	2.8	0.5	0.5	1.7	4.6	1.0	1.3	0.5	8.4	0.5	0.4	0.0	1.9	0.0	0.3	0.9	0.6	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.0	1.7	0.9	0.3	0.1	0.1	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	1.0	16.1	0.5	0.2	0.1	0.0	0.0	0.1	13.4	0.0	0.3	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	10.1	0.5	36.6	2.8	27.1	3.1	14.0	7.5	0.4	0.0	0.0	0.0	0.1	0.0	5.5	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	215.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		5300000	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	0.0	1.4	0.2	0.0	0.3	0.0	0.0	20.0	0.0	0.0	3.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	2.7	0.0	50.7	0.0	0.0	0.1	0.4	0.0	20.1	18.6	17.6	0.0	1.4	0.2	0.0	0.0	0.0	0.0	7.8	0.0	1.6	4.6	23.4	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8	0.0	0.0	2.2	1.5	14.1	134.7	1.0	5.1	1.4	0.0	369.9	49.1	0.5	235.4	7.5	11.6	0.5	12.9	0.0	0.6	43.5	6.2	36.6	0.0	0.0	1.5	413.2	2932.5	0.0	0.0	41.9	3.1	2.7	54.0	0.0	16.6	54.9	36.6	411.7	6.7	1024.2	101.7	0.0	16.5	18.2	20.6	10.0	1.6	3.2	10.1	2.6
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.0;thyroid gland: 79.5"	"Cell type enhanced"	"Detected in many"	26	"Horizontal cells: 125.5;Melanocytes: 199.1;Muller glia cells: 518.9"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 14.6;thyroid cancer: 65.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	5	"AF22: 36.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	1.6	35.0	16.3	1.7	20.5	1.3	1.3	7.7	27.8	2.9	4.2	1.6	0.0	6.2	0.9	1.2	2.1	2.0	1.4	3.1	18.0	11.1	1.1	1.0	2.2	0.8	4.1	16.2	11.6	23.7	0.9	1.7	1.5	9.0	1.3	2.8	16.6	2.7	2.3	1.0	16.6	3.3	1.3	5.4	0.9	11.9	4.7	3.8	0.0	79.5	0.0	0.9	1.9	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	20.5	7.7	27.8	18.0	11.1	4.1	16.2	9.0	3.8	0.0	5.3	0.0	0.0	7.2	27.6	0.9	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	76.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	125.5	0.0	8.0	0.0	2.7	2.6	0.2	199.1	0.0	0.0	518.9	4.6	0.0	0.0	0.0	11.5	0.0	1.0	0.5	0.2	1.3	0.0	0.0	0.0	0.1
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.9	2.2	0.2	0.1	0.0	8.4	0.9	0.3	0.6	0.3	0.0	22.2	1.1	0.6	0.1	0.2	1.9	2.9	1.6	0.7	0.4	0.8	1.3	3.0	0.2	0.5	0.2	0.1	4.6	1.5	3.3	1.0	1.6	5.3	3.3	5.0	10.8	1.9	0.9	0.6	14.7	0.9	20.6	1.2	0.2	0.2	3.3	0.7	0.2	4.8	1.2	3.6	3.6	0.7	32.2	1.8	0.9	0.2	0.1	0.4	2.5	1.2	12.2	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4	6.0	4.5	0.0	4.1	5.8	4.4	3.7	10.2	17.4	20.5	5.2	0.0	1.4	0.0	5.2	19.6	8.9	67.7	0.0	5.4	25.1	17.5	1.4	0.0	0.9	2.8	52.4	1.2	14.1	4.0	31.4	19.0	3.4	1.7	3.6	8.8	43.7	7.8	17.5	23.7	3.3	1.2	19.4	8.2	1.1	1.5	2.6	2.1	6.4	16.1	0.7
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101297142-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.3;liver: 76.0;lymphoid tissue: 37.4"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 210.8;Horizontal cells: 185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 24.9;CACO-2: 17.4;HEK 293: 26.1;Hep G2: 23.3;OE19: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		38000			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	3.0	1.5	5.1	1.5	25.1	0.9	6.1	4.5	11.5	1.5	8.4	41.9	0.0	3.6	1.4	2.5	4.8	1.9	1.9	10.1	8.9	5.7	1.7	76.0	2.3	4.6	38.8	8.4	4.0	1.7	0.5	3.1	16.5	29.0	1.9	8.2	0.7	1.5	0.7	3.5	4.0	4.8	1.9	69.3	37.4	5.3	6.6	24.5	3.7	1.4	3.5	1.3	1.6	1.6	2.6	0.7	1.9	2.4	7.5	1.4	2.5	8.1	6.7	1.2	0.8	0.0	0.1	24.9	0.5	1.3	0.0	0.1	17.4	3.8	0.1	1.1	0.2	0.5	5.6	6.7	0.7	0.1	1.2	26.1	14.3	3.4	23.3	0.8	2.0	0.3	0.4	4.6	0.1	0.2	0.1	0.0	1.8	11.0	0.2	0.0	3.9	0.1	1.8	3.5	31.6	2.9	0.1	0.2	1.8	2.2	11.6	3.4	3.6	11.5	0.8	3.7	3.8	0.9	9.1	0.1	0.1	0.7	0.2	0.0	0.3	0.3	0.3	0.1	0.3	3.3	1.3	0.6	1.9	0.6	0.8	0.7	1.1	1.0	0.5	0.2	2.6	1.4	1.3	1.1	7.5	2.4	0.7	0.2	2.5	5.1	25.1	4.5	10.4	8.9	5.7	38.8	8.4	29.0	24.5	3.0	1.1	0.8	0.2	0.3	1.9	1.5	7.6	1.4	1.2	1.8	19.6	5.6	0.0	0.4	1.3	4.3	5.1	0.0	0.7	21.0	2.8	0.8	0.0	210.8	1.3	185.9	0.0	19.6	6.3	2.2	9.8	0.3	0.0	0.0	4.1	1.5	5.2	7.0	0.0	0.0	1.5	0.0	0.9	4.2	2.1	0.1	2.7	1.5	4.5	0.1
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	143000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	6.5	0.9	0.0	2.1	1.5	0.1	0.0	0.0	0.0	0.0	13.5	4.6	0.0	5.3	2.5	0.1	38.9	1.1	11.8	0.0	0.0	0.0	0.0	33.9	9.4	0.7	0.0	0.0	2.3	8.8	8.5	6.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	5.5	0.5	0.7	0.0	0.0	0.3	19.2	0.0	0.5	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0	14.9	15.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	1.3	0.0	0.4	0.1	0.0	17.0	0.1	0.0	4.1	1.8	1.6	0.2	0.0	0.0	1.7	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	2.9	0.2
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358007-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted - unknown location"	NA	NA		930000	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	4.8	6.6	4.5	7.2	13.5	6.9	4.0	15.9	19.0	6.5	4.4	8.2	2.7	2.3	6.2	2.7	4.6	7.9	5.8	5.2	4.6	8.9	3.7	1.2	4.2	9.6	5.5	9.9	7.9	6.7	27.0	6.4	6.2	13.7	6.4	2.1	9.4	3.4	6.6	1.6	6.6	5.6	6.0	4.6	6.3	5.8	11.5	2.4	5.8	3.3	3.1	7.4	5.0	4.7	1.8	13.5	3.9	9.6	4.5	7.2	4.5	2.1	1.5	2.9	6.3	2.4	1.5	2.1	5.1	1.0	2.5	5.3	0.4	3.5	9.7	15.4	1.6	14.7	4.3	3.2	7.2	0.3	4.7	4.7	4.5	0.0	0.3	7.0	2.9	4.2	6.4	1.2	5.0	4.4	3.4	7.9	8.4	2.6	19.2	0.2	3.4	2.7	4.2	2.7	3.2	9.2	5.2	2.3	25.7	1.0	0.6	5.9	7.7	10.0	3.6	7.9	1.4	9.5	5.5	4.6	2.9	3.1	7.2	2.0	11.3	15.2	5.5	6.1	17.8	7.4	3.0	7.1	3.9	3.0	9.6	4.0	1.8	5.7	2.3	13.5	1.2	6.8	4.7	1.2	4.5	9.1	1.3	7.2	4.5	4.5	13.5	15.9	19.0	4.6	8.9	5.5	9.9	13.7	2.4	8.9	1.7	0.0	1.1	0.9	4.5	4.5	5.1	1.4	2.3	1.8	0.0	4.0	0.0	2.2	2.8	3.8	0.9	0.0	2.1	6.2	2.8	0.7	2.3	0.0	6.4	11.1	0.0	2.5	4.7	1.1	3.1	4.8	1.7	3.6	1.7	6.8	1.7	1.1	2.5	0.3	12.8	0.0	1.2	0.9	3.3	1.4	1.0	2.1	2.2	0.6
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 15.1;monocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.1	0.0	0.0	0.0	1.8	2.1	0.0	25.9	40.8	12.5	15.2	0.0	0.1	0.0	0.1	10.5	1.8	0.2	0.0	3.5	12.5	31.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.9	0.0	5.8	6.9	3.6	8.2	0.0	0.0	3.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	18.0	9.0	0.5	4.3	7.1	0.4	0.0	0.0	5.1	0.0	1.1	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2	6.0	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.2	15.1	2.1	0.1	3.5	0.0	2.8	0.0	0.0	6.7	4.3	0.0	5.5	2.2	1.7	45.9	0.0	0.0	2.1	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.7	0.0	0.0	0.0
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 83.4;Paneth cells: 77.2;Smooth muscle cells: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		300000	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	9.5	6.1	13.1	6.6	20.4	2.1	16.5	9.0	16.6	11.1	14.8	33.4	5.8	16.3	15.5	11.2	8.5	12.1	10.0	14.0	14.9	14.2	10.4	5.4	16.5	8.1	29.8	12.5	6.6	54.7	5.7	6.1	21.5	21.1	14.4	12.7	7.4	16.6	10.2	63.1	10.6	20.3	10.7	26.4	11.8	20.9	4.5	22.7	1.6	6.0	8.6	2.7	11.0	12.7	3.0	3.3	11.6	4.6	5.3	3.6	2.9	5.8	4.0	0.4	5.7	1.1	0.2	13.6	1.3	0.7	1.7	1.2	6.2	6.7	0.1	2.3	1.1	0.7	14.9	0.4	18.1	0.9	3.3	0.6	0.1	3.3	2.2	7.4	0.6	0.7	0.8	7.2	0.8	5.7	2.3	3.3	0.3	0.5	0.8	4.1	7.3	0.8	1.3	10.7	2.3	0.8	2.9	0.4	0.6	2.3	1.4	0.6	0.5	20.1	1.1	3.4	13.4	2.8	0.7	9.7	3.7	10.3	2.1	7.9	0.2	0.3	0.2	3.3	1.8	82.4	11.6	2.6	3.5	2.7	2.9	3.6	3.0	2.7	2.5	2.3	3.0	3.3	3.3	7.6	5.3	4.6	3.3	2.8	2.9	13.1	20.4	9.0	14.5	14.9	14.2	29.8	12.5	21.1	22.7	83.4	11.0	0.0	18.2	24.8	15.7	25.0	5.1	6.7	17.0	14.0	7.9	7.8	5.0	14.2	0.3	19.6	51.1	0.0	46.6	3.8	15.1	23.5	10.4	0.6	1.9	30.2	12.5	22.1	1.5	0.0	2.0	1.6	13.5	1.8	28.3	0.5	52.4	77.2	6.0	8.0	1.9	38.8	97.6	0.2	1.1	8.5	2.4	0.0	20.3	14.5
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244751	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 22.4;Ito cells: 20.9;Pancreatic endocrine cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 10.8"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"A-431: 13.6;EFO-21: 29.7;HUVEC TERT2: 22.9;SK-BR-3: 22.7;TIME: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	98000	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	23.5	6.4	10.4	6.4	9.3	0.6	22.5	5.7	13.0	8.3	14.3	12.4	4.2	4.7	10.8	6.5	6.5	5.6	10.8	13.8	9.7	6.1	10.9	3.8	20.8	6.1	14.7	7.3	4.0	8.3	9.2	3.5	37.3	9.6	5.8	3.7	12.1	7.9	8.6	15.2	7.5	6.7	8.9	11.4	5.6	6.2	5.2	10.3	0.8	12.6	8.6	2.3	6.9	5.0	0.0	0.9	0.1	0.4	0.0	10.8	2.3	13.6	1.1	3.6	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	5.4	4.3	0.0	29.7	0.0	1.3	5.1	0.2	1.2	0.0	0.0	0.1	0.3	0.4	1.9	2.0	0.0	7.7	0.0	0.1	0.0	0.2	0.4	22.9	0.0	0.5	2.6	0.8	5.6	0.0	0.0	1.3	3.4	1.4	0.0	0.1	9.2	12.4	0.0	0.1	0.0	0.2	22.7	0.1	2.8	10.3	0.0	28.4	0.0	2.8	0.0	3.1	0.0	0.1	0.1	0.0	0.6	13.1	0.0	0.0	0.0	8.1	0.1	10.8	0.0	4.7	6.1	0.0	0.0	4.1	2.2	0.1	0.0	0.4	0.9	2.4	2.3	10.4	9.3	5.7	13.0	9.7	6.1	14.7	7.3	9.6	10.3	0.0	1.4	0.0	1.1	2.5	0.8	2.8	0.0	1.4	0.0	7.0	0.0	5.6	0.0	12.5	1.1	22.4	0.0	0.0	3.1	5.3	1.3	1.4	0.0	0.8	6.1	0.0	1.7	20.9	1.9	0.0	0.6	8.7	1.7	1.8	0.5	0.3	35.1	0.0	0.0	1.3	0.0	6.5	2.0	0.0	0.2	1.3	3.8	1.3	0.0	0.1
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.1;Cholangiocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	17.8	11.7	3.3	6.5	0.4	9.3	9.9	5.6	7.5	1.0	4.2	0.0	1.6	27.1	4.3	1.1	4.9	6.1	7.7	0.0	2.2	10.8	1.6	1.0	8.7	1.6	0.1	6.7	3.0	14.2	10.2	26.6	2.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	3.7	0.0	10.6	0.4	0.0	0.0	0.0	0.0	0.1	2.9	1.4	0.5	12.0	19.4	0.2	4.9	7.5	0.0	0.0	0.0	7.4	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7	6.0	13.9	0.0	18.3	44.1	0.3	13.7	45.9	0.0	7.9	12.2	0.0	0.4	0.0	13.8	31.1	4.9	0.4	0.0	6.2	0.2	15.8	6.7	1.1	13.0	10.6	0.0	0.0	11.6	21.7	18.1	4.9	14.8	10.1	16.2	2.0	6.7	12.6	0.0	21.5	14.9	0.3	6.5	17.3	0.2	2.2	11.8	0.5	0.5	1.3	4.3
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907186-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 48.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 30.6;Ductal cells: 17.7;Horizontal cells: 25.4;T-cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6"	"Group enriched"	"Detected in many"	27	"granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6"	"Group enriched"	"Detected in some"	6	"ASC diff: 56.8;HHSteC: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		24000	"Golgi apparatus, Vesicles"		"HPA046183: AB_2679573, HPA066271: AB_2685645"	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	26.1	48.2	1.1	10.1	1.5	0.1	21.2	0.6	1.8	13.8	5.6	1.1	15.0	1.5	9.8	10.2	2.7	5.3	20.6	13.9	0.9	1.9	4.3	1.8	2.3	3.5	0.8	1.6	33.4	32.8	5.0	14.4	8.5	6.4	8.5	4.0	16.7	6.0	16.2	9.8	5.1	2.2	4.0	2.1	2.3	8.6	5.4	0.0	1.1	11.5	4.4	4.6	13.5	10.0	0.4	0.0	7.1	0.0	12.6	13.6	2.9	0.0	3.0	1.6	0.0	56.8	1.7	0.0	0.3	0.3	0.2	0.3	0.0	0.5	2.8	0.5	2.8	2.0	0.1	0.0	0.1	0.1	0.0	1.2	0.0	0.6	0.1	17.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.8	0.0	2.6	0.0	0.0	3.8	0.0	5.4	1.2	0.7	0.0	0.7	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	7.1	13.6	0.0	1.1	0.4	1.5	5.8	0.0	0.0	0.1	5.1	0.2	12.6	0.0	0.0	0.1	2.9	1.1	1.5	0.6	1.8	0.9	1.9	0.8	1.6	6.4	0.0	0.0	0.0	1.7	5.5	2.7	1.0	3.1	30.6	0.0	1.2	5.2	0.0	0.1	0.0	17.7	7.6	7.1	0.0	0.0	3.8	0.1	7.6	1.2	0.0	0.0	0.3	25.4	1.7	3.7	0.3	9.4	0.3	0.0	0.0	1.0	0.7	1.1	3.7	0.0	2.1	0.1	0.3	6.5	2.1	0.3	1.7	1.8	0.0	18.5	0.6	3.1
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.5	0.2	49.5	1.5	0.6	3.2	0.9	40.1	1.8	8.0	0.2	0.0	0.0	0.2	0.6	6.0	0.0	2.7	0.2	1.0	0.0	3.0	0.0	1.4	1.0	3.8	0.0	0.0	21.9	0.0	2.2	0.0	0.0	3.3	0.4	0.0	0.6	0.2	3.2	0.0	0.1	2.4	0.2	0.7	0.0	0.0	0.1	0.2	2.9	0.1	0.3	0.3	0.3	0.8	3.0	0.1	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1											0.0	2.2	0.0	0.4	11.7	0.4	2.2	0.0	0.0	3.4	0.0	0.0	14.1	0.0	2.5	19.2	2.7	0.1	0.0	6.4	17.2	36.0	1.7	0.0	0.0	2.7	0.0	1.2	2.5	0.0	3.1	69.0	0.3	10.1	2.8	1.0	1.3	4.9	0.0	66.4	0.0	0.4	0.0	6.1	0.5	1.0	8.7	8.1	0.0	0.2	0.3
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Group enriched"	"Detected in some"	102	"Early spermatids: 39.7;Late spermatids: 87.7"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;NTERA-2: 2.8;THP-1: 2.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA					"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 85.8;skeletal muscle: 124.6"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 146.5;Cardiomyocytes: 105.2;Muller glia cells: 177.5"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 9.5"									HPA025064	Uncertain				"Secreted in other tissues"	NA	NA		200000000			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	2.7	0.9	2.2	0.2	4.9	0.2	0.9	1.0	1.9	0.3	0.2	2.4	0.8	0.1	0.3	85.8	1.6	0.5	0.6	43.8	2.2	5.1	0.6	0.7	31.8	0.3	10.8	0.8	0.4	7.4	0.4	4.7	0.2	7.8	10.4	0.2	18.9	12.3	0.8	124.6	0.3	0.2	0.2	1.0	0.2	1.7	1.4	2.5	0.0	22.3	16.6	2.3	0.2	0.0	2.7	0.1	2.7	0.0	2.6	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.7	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.0	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.5	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	2.7	2.6	0.0	0.1	0.0	0.0	2.2	4.9	1.0	1.9	2.2	5.1	10.8	0.8	7.8	2.5	101.3	146.5	0.0	0.9	1.6	10.4	105.2	0.0	5.3	13.6	1.8	2.0	0.6	3.3	0.0	27.5	2.1	0.0	0.0	8.3	0.1	1.0	11.1	7.0	0.6	1.1	9.5	0.0	3.1	0.0	19.3	3.1	1.1	1.7	0.0	0.0	177.5	0.3	0.0	10.3	1.8	7.3	0.0	3.1	2.2	0.7	0.6	0.0	0.7	0.0	0.9
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell type enhanced"	"Detected in some"	32	"Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in all"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.6	9.9	0.0	9.2	2.9	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	56.7	0.5	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.9	1053.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.0	6.5	0.4	309.0	17.5	0.4	0.0	0.0	0.0	0.0
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell type enhanced"	"Detected in some"	18	"Intestinal endocrine cells: 12.9;Pancreatic endocrine cells: 6.2;Undifferentiated cells: 5.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"	"Cell line enriched"	"Detected in some"	10	"HEL: 30.4"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000				"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.4	0.0	0.0	1.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	12.9	1.8	2.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.1
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 10.2;Club cells: 2.3;Intestinal endocrine cells: 5.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in some"		"BJ: 2.8;CAPAN-2: 3.6;EFO-21: 5.7;HHSteC: 2.2;HSkMC: 3.5;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"									HPA052485	Supported				"Secreted to blood"	NA	NA		1400000000			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.8	0.4	0.0	0.0	0.0	3.6	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.5	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.2	0.0	2.3	1.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
PGA3		ENSG00000229859	"Pepsinogen 3, group I (pepsinogen A)"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	28	"stomach 1: 1048.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Exocrine glandular cells: 5.8;Rod photoreceptor cells: 3.2"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enriched"	"Detected in single"	15	"cerebral cortex: 4.8"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HMC-1: 13.7;THP-1: 4.5"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.0	4.8	0.2	0.4	19.9	0.0	0.1	0.1	0.5	36.8	0.2	0.0	0.4	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.4	17.7	0.0	0.0	0.2	0.0	0.2	0.0	0.1	2.0	0.1	0.1	0.0	0.0	0.7	0.0	1.4	1048.8	0.1	0.0	0.0	0.1	3.8	0.0	0.1	0.0	0.3	0.3	1.1	6.7	0.5	1.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.3	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	4.3	0.2	1.5	6.7	0.9	0.2	0.5	1.4	0.3	0.3	0.2	1.4	1.1	0.5	1.7	0.2	0.1	3.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PGA4		ENSG00000229183	"Pepsinogen 4, group I (pepsinogen A)"	P0DJD7	11	61222216-61231927	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	120	"stomach 1: 924.0"	"Cell type enriched"	"Detected in single"	128	"Exocrine glandular cells: 100.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"classical monocyte: 7.6;intermediate monocyte: 5.9;non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	23	"monocytes: 7.6"	"Group enriched"	"Detected in some"	8	"BJ hTERT+: 17.6;THP-1: 8.9"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	924.0	0.0			0.0		0.0	0.0	0.0	0.0	0.3	0.1	7.6	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	1.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGA5		ENSG00000256713	"Pepsinogen 5, group I (pepsinogen A)"	P0DJD9	11	61241042-61251448	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	38	"stomach 1: 296.9"	"Cell type enriched"	"Detected in some"	278	"Exocrine glandular cells: 4020.2"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"					"Group enriched"	"Detected in some"	50	"classical monocyte: 3.4;intermediate monocyte: 7.7;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	77	"monocytes: 7.7"	"Cell line enriched"	"Detected in some"	14	"BJ hTERT+: 25.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.9	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4020.2	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.3	1.3	0.9	0.3	0.0	1.0	0.0	14.5	5.9	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Group enriched"	"Detected in some"	11	"Hep G2: 69.6;OE19: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.6	42.3	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	23.8	270.0	0.0	3.1	0.3	0.0	0.2	150.3	5.3	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	117.5	1.0	0.1	95.4	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	843.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.0	2.6
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in many"	16	"Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"BEWO: 93.4;HUVEC TERT2: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.3	0.4	0.0	93.4	0.8	0.8	0.4	0.5	2.2	0.1	0.0	2.0	0.6	0.0	0.1	0.4	4.2	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.1	1.0	1.7	0.4	0.1	44.0	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.4	0.0	0.7	0.0	11.6	0.0	0.1	0.2	7.0	3.8	0.0	0.1	1.6	5.9	0.0	0.1	8.9	0.0	2.3	0.0	3.7	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0	8.9	5.8	0.8	13.0	21.9	0.8	2.8	0.0	1.4	7.9	0.0	13.7	75.1	0.0	0.9	0.1	15.8	0.5	0.0	0.4	1478.5	42.9	3.3	5.8	0.0	33.1	0.0	6.8	7.4	0.3	0.6	12.0	4.5	20.3	0.0	1.1	1.9	0.6	0.2	18.4	0.4	7.5	103.5	62.6	0.2	3.4	17.1	1775.1	0.9	1.7	4.7
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell type enhanced"	"Detected in single"	35	"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HEK 293: 4.1;HeLa: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		47000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.3	1.2	0.8	0.0	0.0	2.0	0.6	0.0	0.0	0.0	1.2	0.6	2.0	0.2	0.0	0.6	2.7	0.0	0.0	0.0	1.9	4.1	0.8	3.5	0.3	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.7	0.6	0.0	0.5	0.4	2.2	0.4	0.0	2.7	1.6	0.2	0.2	0.0	2.6	0.8	0.2	0.5	0.1	0.0	0.6	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.6	1.3	0.8	1.1	1.7	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.8;HDLM-2: 3.5;hTCEpi: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025879			Approved	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	5.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.1
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824537-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Basal glandular cells: 31.8;Glandular cells: 15.4;Urothelial cells: 11.4"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 16.1;SH-SY5Y: 15.9;SK-MEL-30: 21.2;U-266/70: 5.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	4.2	1.4	3.7	33.4	6.5	0.2	23.4	0.5	2.2	17.3	8.8	0.0	6.5	0.3	26.5	33.8	1.8	18.5	1.2	18.8	1.3	0.9	2.5	0.4	2.3	4.6	3.5	0.0	28.7	0.5	0.2	0.7	0.4	5.9	21.4	3.3	0.0	1.9	5.2	0.6	0.5	8.3	30.7	6.0	15.2	1.0	2.6	1.7	0.1	0.8	0.9	0.3	7.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	15.9	0.0	0.0	21.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.1	5.5	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.5	0.5	2.2	1.3	0.9	3.5	0.0	5.9	1.7	0.0	0.0	0.0	31.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	11.4
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 87.2"	"Cell type enhanced"	"Detected in many"	20	"Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 29.9"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 26.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076574	Approved				"Secreted to blood"	NA	NA		3600000000			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	22.2	1.7	2.9	1.4	8.8	0.3	27.9	0.7	4.5	62.7	4.5	21.4	22.5	0.8	11.1	27.0	10.5	5.3	17.4	43.1	4.6	3.5	0.8	0.5	3.7	1.1	9.0	3.9	2.8	2.5	0.6	3.3	1.2	9.3	15.0	3.4	87.2	4.0	14.2	5.5	19.8	2.0	55.5	13.7	0.8	8.5	8.3	9.3	0.1	8.3	8.7	4.8	32.7	49.8	0.7	0.2	0.2	0.0	5.7	29.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	26.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.3	9.8	2.9	0.0	0.7	3.4	1.0	0.2	5.7	0.0	0.2	29.9	1.7	2.9	8.8	0.7	4.5	4.6	3.5	9.0	3.9	9.3	9.3	0.0	1.0	0.0	0.1	19.2	0.0	3.2	0.0	0.0	1.2	1.8	0.0	0.0	1.7	0.0	10.5	2.7	0.0	0.0	0.0	0.0	45.7	0.1	0.0	0.0	0.1	0.0	0.0	17.2	0.0	14.4	190.7	1.0	10.1	0.0	0.0	0.0	0.1	0.0	140.7	0.2	0.0	0.0	2.2	1.9	1.1	16.2	0.1	0.0	0.0	0.1
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Cell type enhanced"	"Detected in many"	21	"Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"	"Group enriched"	"Detected in some"	5	"EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	26.6	0.0	0.3	32.3	0.0	6.6	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.3	5.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	29.6	55.0	0.0	0.2	0.0	6.3	0.1	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	11.3	0.5	5.2	0.1	0.0	0.0	7.6	0.0	13.6	17.4	0.0	0.0	0.0	14.9	0.1	0.1	69.5	0.0	290.8	0.0	0.3	25.8	4.6	0.0	0.1	0.0	16.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.4	0.0	135.9	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	33.5	18.7
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782059-73016461	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 246.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"	NA	NA			"Centriolar satellite"		"HPA052269: AB_2681779, HPA066120: AB_2685621"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	14.3	12.1	8.6	17.5	11.3	11.6	15.9	17.3	12.7	20.0	15.3	6.7	14.1	8.9	15.0	14.6	13.2	14.3	10.8	12.7	8.5	8.2	14.5	12.0	13.4	11.5	9.0	8.9	19.0	9.8	10.1	43.9	16.6	11.6	17.4	11.4	6.6	13.7	16.7	12.1	10.8	13.8	13.1	14.8	19.2	10.8	17.2	11.9	30.8	22.7	10.6	10.3	18.6	14.9	7.9	6.5	8.2	4.7	11.0	12.3	3.4	8.6	2.8	11.6	6.7	10.1	17.8	4.4	7.9	10.7	8.1	9.9	3.8	14.7	7.8	9.5	8.9	4.3	7.5	6.1	7.9	13.0	7.9	5.9	5.4	7.5	4.4	13.1	20.1	5.2	11.5	6.5	8.7	21.5	10.3	10.5	5.5	7.5	4.0	10.8	2.4	9.8	12.3	6.0	15.5	2.6	7.9	8.3	8.1	16.6	4.7	6.5	10.6	6.1	4.3	10.5	9.7	7.1	14.6	7.8	4.1	4.3	6.4	4.7	6.6	4.8	3.9	12.5	11.5	8.9	8.2	4.5	7.5	8.3	4.7	8.9	7.6	8.9	8.7	3.9	7.9	12.3	10.0	4.4	11.0	4.4	6.5	6.7	3.4	8.6	11.3	17.3	12.7	8.5	8.2	9.0	8.9	11.6	11.9	29.8	25.0	4.7	14.0	9.2	16.3	22.2	7.6	62.9	39.8	5.2	15.7	7.4	11.6	10.4	246.2	13.5	5.8	0.0	9.7	8.1	9.4	9.7	23.1	6.4	6.0	17.5	6.9	9.8	6.9	31.9	17.8	8.1	8.5	6.4	8.8	10.6	9.6	6.0	14.5	5.3	29.5	12.9	10.3	56.7	35.3	7.9	5.0	14.9	8.6	8.9
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400099	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 138.4"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 138.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 138.4;monocytes: 87.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2"									HPA056132	Approved				"Secreted to blood"	NA	NA					"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	18.6	5.4	7.2	32.3	7.2	19.4	8.2	15.6	6.2	6.1	4.5	10.6	2.3	3.8	4.8	10.0	2.6	7.5	8.4	6.5	7.7	4.4	8.5	8.0	31.9	30.1	11.0	2.6	5.7	5.1	4.3	9.2	13.2	11.9	6.6	4.9	7.1	3.1	4.1	2.5	2.6	3.9	8.6	18.4	29.5	3.1	6.4	10.7	3.3	5.3	1.1	3.3	9.8	5.4	0.1	24.0	138.4	87.3	0.5	0.2	22.9	0.2	0.3	0.4	0.5	21.0	1.4	0.1	0.1	1.0	0.1	0.3	0.0	0.3	0.4	1.2	0.3	0.2	0.6	0.1	0.1	0.0	1.0	0.7	0.4	0.8	0.1	0.2	0.8	18.8	1.5	0.3	0.1	0.4	0.0	0.2	1.7	0.2	1.2	0.1	0.6	1.4	14.2	0.4	0.3	0.2	0.4	0.0	0.3	0.8	0.4	0.5	0.2	0.0	5.2	0.4	0.1	0.1	4.3	0.4	0.9	0.9	0.6	0.2	1.8	1.4	0.4	0.2	1.6	0.3	21.3	48.4	1.4	0.2	70.2	0.1	0.1	0.0	0.0	24.0	0.0	0.0	0.1	138.4	0.5	87.3	0.4	0.1	22.9	7.2	7.2	15.6	6.2	7.7	4.4	11.0	2.6	11.9	10.7	3.0	14.3	5.9	0.2	1.5	3.3	0.4	5.1	4.0	5.7	1.8	3.9	0.4	23.2	0.1	0.4	1.4	0.0	0.0	0.3	0.6	1.3	0.5	9.3	1.5	82.8	1.6	0.0	3.1	85.3	1.5	48.6	111.8	1.7	19.8	1.1	1.9	0.3	0.0	20.1	0.6	2.4	0.0	0.3	0.5	1.3	0.6	0.7	0.8	0.9	0.2
PINLYP		ENSG00000234465	"Phospholipase A2 inhibitor and LY6/PLAUR domain containing"	A6NC86	19	43576800-43583964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 19.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 17.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 33.8;HMC-1: 22.6;JURKAT: 17.5;REH: 13.7;THP-1: 17.0"									HPA061218	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA061218: AB_2684453"	"unprognostic (6.72e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.60e-2)"	3.6	2.0	5.6	1.8	6.5	1.2	4.0	3.7	2.5	7.4	3.9			0.6	6.8	7.1	5.0	13.1	6.6	4.2	4.4	4.6	7.9	0.3	2.9	2.9	4.2		13.1	0.6	0.0	5.6	1.6		4.5	2.0		2.3	8.1	0.0	2.0	1.7	8.3	2.9	3.0	2.1	1.8			4.0		3.3	2.7	4.4	3.2	17.4	6.6	1.2	0.9	3.3	1.5	0.3	0.1	0.9	0.0	1.6	2.2	0.1	0.4	0.6	0.8	2.1	0.0	0.0	0.0	0.1	8.9	0.8	2.0	0.0	0.0	0.8	0.0	0.1	33.8	0.3	0.0	5.1	0.0	22.6	5.0	0.3	5.1	0.0	2.4	1.4	17.5	0.4	0.4	0.3	0.2	4.0	0.5	0.8	0.0	0.3	13.7	0.1	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	17.0	0.6	2.2	0.4	0.0	1.5	0.0	0.0	2.0	7.8	0.0	0.1	6.6	1.2	0.5	2.6	0.8	3.2	1.4	0.8	2.1	1.8	3.2	0.2	3.3	0.0	0.9	0.2	17.4	1.6	1.5											11.9	2.7	1.3	8.9	3.2	5.6	2.2	12.7	17.4	7.9	8.7	5.9	0.4	19.9	1.0	4.7	4.5	0.0	0.0	0.3	0.4	6.7	3.3	0.0	0.0	4.1	6.4	0.0	6.2	0.6	4.2	10.6	1.8	5.0	5.4	0.5	5.5	0.3	0.0	9.2	14.0	3.4	0.0	5.1	2.6	0.9	2.8	0.1	0.0	0.4	6.4
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 105.7;Melanocytes: 383.0"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"	"Cell line enriched"	"Detected in single"	330	"T-47d: 126.4"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	NA	NA		89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	126.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.3	0.0	1.1	9.6	0.0	0.0	0.0	105.7	6.8	1.8	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.1	0.0	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	383.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.8
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048020-42058528	"Enzymes, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Intestinal endocrine cells: 69.1;Leydig cells: 127.4;Peritubular cells: 105.4;Rod photoreceptor cells: 93.6;Undifferentiated cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.2;ASC diff: 24.8;CACO-2: 36.9;HHSteC: 21.3;RH-30: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"	NA	NA		10000			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	21.4	5.7	1.9	8.4	1.8	0.8	18.9	0.3	4.7	20.8	13.7	1.7	6.3	9.3	17.6	16.0	9.2	10.0	29.6	17.0	2.3	0.7	4.7	3.5	8.0	3.7	3.7	0.3	43.6	3.3	0.9	3.2	3.2	2.6	13.0	5.2	17.0	38.6	5.6	40.2	1.7	7.7	26.2	2.3	4.6	4.8	14.1	2.3	4.2	3.1	13.1	2.1	22.8	23.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	5.5	31.2	24.8	0.3	2.0	0.1	0.0	0.4	0.6	36.9	0.0	0.0	0.1	0.6	0.7	0.0	0.5	0.0	0.0	3.0	1.3	0.0	1.3	9.8	21.3	0.0	0.4	2.1	0.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.1	9.1	2.5	0.6	0.0	10.8	0.0	0.0	0.0	1.1	1.9	0.5	0.0	0.0	6.7	0.0	0.2	0.0	0.2	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.3	4.7	2.3	0.7	3.7	0.3	2.6	2.3	17.9	0.3	0.5	0.2	2.9	2.1	8.1	2.5	0.0	0.0	1.8	15.7	0.4	0.0	1.8	1.1	1.9	11.8	0.0	1.2	1.2	21.1	0.9	0.0	2.6	0.6	0.0	69.1	3.7	0.3	2.6	127.4	0.2	1.7	0.0	11.8	20.3	1.2	14.0	105.4	3.2	93.6	12.9	8.5	0.5	1.2	1.6	0.2	0.0	34.2	0.1
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	0.3	0.5	0.1	0.0	0.2	0.0	0.0	23.9	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5	0.0	1.7	0.0	0.3	0.6	0.0	1.2	2.5	2.7	1.2	14.0	0.0	0.1	1.7	2.7	5.2	8.7	0.0	0.0	1.9	0.0	0.6	0.3	1.1	21.7	1.6	0.0	1.7	4.9	0.3	2.2	0.3	5.3	1.7	7.2	0.0	0.0	2.2	0.0	13.4	4.9	0.0	0.0	0.3	0.0	0.2	0.5	1.6	0.0	0.0	0.3
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672545-14694669	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;stomach 1: 13.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 54.8;Exocrine glandular cells: 106.2;Extravillous trophoblasts: 45.9;Mucus-secreting cells: 110.3;Paneth cells: 80.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 4.2;OE19: 4.6;SK-BR-3: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	9.4			2.4	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0		0.0	4.2	0.0	0.0	0.0		0.2	7.2		0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.0	2.1			0.0		0.0	2.8	0.0	0.9	0.5	2.0	0.5	0.1	0.4	0.1	0.1	0.9	0.1	0.1	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.6	4.2	0.3	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.7	0.0	1.9	0.3	0.2	0.4	4.6	0.1	0.8	0.3	0.2	0.0	0.3	0.6	0.5	1.0	2.6	0.3	0.3	0.4	0.4	0.8	0.0	0.3	0.1	0.0	0.7	2.1	0.7	0.6	0.1	0.1	0.1	0.5	0.5	0.3	0.4	0.3	0.1	0.2	0.4	0.5	0.9	0.3	0.3	2.0	0.1	0.3	0.3	0.1	0.1											32.8	17.2	0.0	0.7	0.0	0.0	0.0	10.2	32.1	9.1	1.8	0.0	0.4	0.0	0.3	0.3	0.0	54.8	0.0	106.2	45.9	0.0	1.9	0.0	0.0	0.8	0.0	12.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	110.3	0.0	15.5	80.4	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	23.8	12.6
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730077	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA					"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	9.8	9.9	13.1	4.4	16.2	5.6	12.9	14.5	14.3	9.6	12.2	13.4	7.3	11.9	8.9	8.2	12.6	9.2	9.2	21.0	13.0	11.4	15.3	20.6	7.8	4.9	16.8	11.7	11.9	38.8	22.8	19.0	10.4	12.7	16.4	12.0	10.7	12.1	8.3	21.1	9.8	16.3	8.1	20.3	5.5	10.0	5.7	12.4	4.9	19.0	9.2	6.2	7.5	7.7	4.9	8.7	3.6	4.6	4.9	10.2	13.8	9.6	3.6	2.8	4.2	9.0	9.0	5.5	8.9	7.1	5.0	5.3	8.9	17.0	13.8	6.7	6.5	8.4	5.4	8.6	11.5	7.7	5.1	13.4	4.9	10.4	5.3	8.9	10.6	3.5	9.1	13.4	5.1	12.6	9.1	5.0	13.0	27.0	6.4	8.5	17.0	8.6	4.8	5.0	22.0	14.0	5.2	8.5	10.9	9.4	14.3	18.1	6.0	7.8	20.7	6.7	7.6	12.4	2.3	5.9	7.3	6.1	7.5	6.1	10.9	19.6	10.2	8.2	6.2	9.1	3.6	4.6	2.7	7.2	2.9	6.6	4.2	9.0	6.9	8.7	4.9	10.2	9.2	2.2	4.9	4.4	7.6	8.7	13.8	13.1	16.2	14.5	14.3	13.0	11.4	16.8	11.7	12.7	12.4	23.8	17.9	15.2	28.9	32.5	46.8	53.4	30.6	10.7	13.6	21.0	47.1	33.9	23.2	12.4	18.0	12.7	27.4	23.3	22.2	44.9	23.9	62.2	13.9	86.9	17.1	25.4	103.4	18.4	19.4	7.1	30.8	8.9	28.7	1.8	52.7	39.7	13.5	35.1	32.5	14.6	39.5	19.4	19.1	55.2	41.1	37.3	28.8	13.8	59.3	35.7
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 47.8"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 12.1;Hep G2: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA					"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	20.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	1.8	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.9	0.0	9.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322111-120327789	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	933	"pancreas: 2360.6"	"Cell type enriched"	"Detected in many"	10	"Exocrine glandular cells: 17927.2"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	19	"NK-cells: 1.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 6.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	1.1	2360.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	2.5	0.9	0.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.6	0.0	1.0	0.2	4.7	0.6	0.6	0.0	1.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.3	0.0	0.0	2.5	0.9	0.0	1.3	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.9	65.5	0.0	0.1	0.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	0.0	1.7	16.1	7.5	0.0	0.7	0.0	17927.2	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.2	0.0	0.0	27.8	2.8	0.3	0.0	76.7	1.0	0.0	1839.8	1.1	3.2	2.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	1.2	0.0
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Hep G2: 23.4;OE19: 64.1;RT4: 21.5"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	290000			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.6	0.0	21.5	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.1	6.7	10.0	12.4	0.0	7.2	5.1	2.7	6.8	0.0	0.0	2.8	1.7	0.0	3.0	8.4	366.3	0.0	945.9	3.3	308.9	937.5	4.6	51.6	8.2	0.0	59.8	35.0	6.0	7.5	158.5	4.9	13.5	0.0	270.5	0.0	3.6	354.3	1.1	0.0	0.0	0.0	11.3	0.5	0.1	14.6	5.7	8.4	591.0	9.1
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.6;Late spermatids: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HL-60: 4.5;NB-4: 1.4;SK-BR-3: 1.3;U-698: 5.0;U-937: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"	NA	NA						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.3	0.1	0.3	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	5.0	0.4	4.8	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	10	"Kupffer cells: 2.2;Melanocytes: 5.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	13.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.2	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"	NA	NA					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1	0.0	2.2	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.6	0.0	0.0	0.0	0.4
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell type enriched"	"Detected in some"	13	"Hofbauer cells: 332.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;NTERA-2: 3.9;PC-3: 7.9;RT4: 3.6;U-2 OS: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.2	1.6	0.0	0.1	0.0	0.2	2.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.9	0.0	7.9	0.0	0.0	0.1	0.0	3.6	0.1	0.5	0.0	0.0	0.0	1.1	1.0	1.0	0.0	0.0	3.7	0.1	0.9	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0	0.0	2.2	0.0	3.6	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.9	8.7	0.0	0.0	332.5	1.6	3.4	0.0	19.0	0.0	0.0	25.7	10.1	22.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	3.3
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 31.4;Muller glia cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		99000	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.3	0.0	9.2	12.5	0.0	4.1	9.9	0.8	1.1	0.0	2.1	0.0	0.2	4.3	0.9	2.0	0.0	3.0	0.8	0.0	0.0	0.0	6.9	0.0	0.7	0.0	0.0	5.0	3.3	1.2	1.3	16.5	5.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.2	1.3	0.0	1.1	1.6	0.1	28.7	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2	6.0	3.2	0.0	2.2	8.4	0.8	3.6	5.1	6.7	2.3	31.4	0.0	4.3	0.0	0.7	0.0	3.6	2.6	0.0	1.8	1.1	6.7	2.3	1.1	0.0	0.5	15.9	1.2	8.0	0.0	0.9	15.0	0.0	6.8	0.0	6.1	30.3	3.2	5.8	15.6	1.1	1.1	6.5	2.2	0.0	0.6	4.6	1.3	0.0	6.5	2.2
PLAC1	"CT92, OOSP2L"	ENSG00000170965	"Placenta specific 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 90.4"	"Cell type enhanced"	"Detected in some"	14	"Leydig cells: 5.2;Peritubular cells: 7.4;Spermatogonia: 2.7;Syncytiotrophoblasts: 8.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 18.7;hTCEpi: 14.7;hTERT-HME1: 6.0"					"Not detected"	"Not detected"			HPA063425	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA063425: AB_2685012"	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.2	1.1	0.3	0.3	1.0	0.0	1.7	0.2	0.1	1.7	0.3	0.4	18.7	0.0	0.1	0.2	2.3	0.0	0.0	0.8	14.7	0.1	6.0	0.1	2.2	0.1	0.1	1.6	0.1	0.9	0.0	0.2	0.0	1.2	2.4	0.0	0.3	3.2	0.0	0.0	2.9	0.0	0.0	3.5	0.6	2.2	0.1	0.0	0.0	0.4	0.7	0.2	0.0	0.4	0.0	0.3	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.0	0.0	0.0	0.9	2.7	0.0	8.9	0.0	0.0	0.0
PLAC9		ENSG00000189129	"Placenta specific 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 709.2;Leydig cells: 808.9;Peritubular cells: 620.2;Sertoli cells: 291.1;Smooth muscle cells: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.7;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.2;ASC TERT1: 36.0;BEWO: 13.2;HSkMC: 11.9"					"Low region specificity"	"Detected in all"			HPA043469	Uncertain				"Secreted - unknown location"	NA	NA					"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	43.8	5.5	2.1	4.9	1.9	0.8	38.7	0.7	2.0	38.8	7.3	2.1	16.1	2.5	9.7	27.8	20.3	7.4	20.7	32.5	2.6	1.4	3.8	1.4	15.1	8.5	1.7	0.7	6.0	3.0	0.9	1.0	7.3	6.4	27.8	2.9	46.8	6.4	8.1	7.8	13.0	5.9	25.3	3.3	1.6	5.7	8.4	1.0	0.6	12.3	24.5	6.0	14.1	23.0	0.3	0.6	3.7	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	41.2	36.0	13.2	4.2	3.5	0.3	0.5	0.0	0.3	0.0	0.1	2.3	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	6.8	0.0	0.9	11.9	0.0	0.8	0.4	4.3	1.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.0	0.5	0.3	0.0	0.0	0.1	1.3	2.7	1.5	8.3	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.3	0.2	3.7	0.0	0.3	0.5	0.3	0.3	0.6	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.6	0.4	0.0	2.1	1.9	0.7	2.0	2.6	1.4	1.7	0.7	6.4	1.0	3.0	2.6	0.0	0.5	112.4	0.2	17.3	0.0	1.4	0.0	0.0	0.0	5.5	0.0	0.4	3.6	61.2	0.0	0.0	0.2	10.6	709.2	0.7	1.1	0.2	12.4	0.0	1.7	90.9	0.0	10.0	808.9	1.1	129.9	0.0	0.0	50.0	0.7	0.0	620.2	0.0	1.6	291.1	378.1	2.6	2.5	110.4	9.6	0.0	0.0	1.8
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell type enhanced"	"Detected in many"	22	"Basal glandular cells: 379.6;Glandular cells: 176.4;granulocytes: 158.4;Urothelial cells: 792.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.9;HMC-1: 55.1;hTERT-RPE1: 61.0;LHCN-M2: 55.7;U-2197: 58.1;WM-115: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.1	32.0	7.7	6.6	0.2	85.9	0.0	0.6	2.3	3.7	1.4	0.0	4.0	15.9	7.9	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	61.0	14.4	0.0	0.5	0.1	55.7	0.0	0.0	0.0	5.6	0.0	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.6	8.2	0.1	0.0	27.5	1.5	5.7	58.1	1.8	0.0	0.1	0.0	1.2	0.0	115.5	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8	0.0	20.2	2.4	379.6	9.6	4.1	7.6	0.0	5.3	11.4	0.0	3.9	0.5	0.0	0.6	0.8	82.6	0.0	0.0	0.6	1.1	19.9	176.4	158.4	1.0	1.5	1.6	0.0	36.8	0.6	0.8	3.4	7.8	21.9	2.8	0.0	2.0	30.5	0.0	2.5	0.1	3.7	12.9	17.6	0.7	0.4	11.8	0.6	3.8	0.4	792.4
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917497	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 48.4"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 550.8;Pancreatic endocrine cells: 366.2;Urothelial cells: 779.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 4.5;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.3;LHCN-M2: 67.8;RPTEC TERT1: 257.8;U-251 MG: 69.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported				"Secreted to blood"	NA	NA	647000	58000			"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	26.7	2.4	1.0	15.5	2.1	11.3	9.7	1.6	1.5	6.9	5.8	2.9	4.9	3.8	10.7	21.2	9.1	6.5	10.7	14.3	1.3	1.0	23.3	2.3	23.4	5.5	1.6	1.5	6.8	3.7	3.6	1.8	48.4	3.1	7.5	6.7	4.5	10.6	5.0	12.2	9.0	8.1	8.4	2.5	23.8	7.8	5.8	1.3	4.8	10.9	11.6	8.2	16.3	9.3	0.1	4.5	4.5	0.4	0.0	0.0	0.3	13.3	7.1	3.0	0.1	0.2	5.1	0.1	8.1	37.9	3.3	5.2	0.1	70.3	0.0	15.0	1.1	35.0	9.2	0.0	13.5	3.8	0.7	0.0	0.0	0.3	0.1	6.2	1.2	2.6	13.5	1.6	22.6	8.7	37.6	9.4	0.0	0.0	0.0	67.8	0.0	0.0	1.7	0.8	0.0	18.7	0.0	9.2	0.0	257.8	10.5	0.0	0.0	0.0	0.3	0.2	2.2	0.0	1.8	23.8	0.2	1.7	1.7	69.2	0.0	0.1	0.1	18.2	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.3	1.0	2.1	1.6	1.5	1.3	1.0	1.6	1.5	3.1	1.3	3.0	5.8	0.5	550.8	33.2	0.0	2.4	0.0	1.4	10.3	27.9	0.0	17.1	58.0	65.4	0.5	11.7	0.0	0.0	18.1	16.5	18.1	169.7	31.1	0.0	38.5	0.0	3.4	6.2	3.9	0.0	2.3	31.5	6.8	41.5	0.0	0.0	366.2	0.0	0.0	0.7	0.0	6.5	25.9	0.0	0.1	25.7	14.6	0.5	0.9	779.6
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1391.0"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6"									"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.9	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	2.2	0.0	0.0	0.0	0.6	28.1	2.7	0.0	1.8	0.0	0.0	16.6	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	1.1	1391.0	0.1	0.0	0.0	26.4	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen-like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in many"	5	"liver: 66.8"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 67.6"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA						"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	0.3	1.3	2.0	0.7	3.4	1.7	0.7	14.3	2.1	0.4	0.5			0.7	1.3	2.1	0.3	0.8	1.0	0.6	1.9	2.1	1.0	66.8	0.6	1.5	1.4		1.5	0.4	0.7	1.6	0.3		1.0	0.3		1.1	0.5	1.9	3.4	0.8	0.2	1.1	1.3	0.7	0.8			1.1		0.5	0.7	0.5	2.7	1.6	5.1	0.8	0.9	2.7	0.4	2.9	4.2	4.8	2.6	4.5	5.4	5.1	3.4	2.5	2.1	2.8	3.3	7.6	7.6	3.4	1.2	1.5	2.5	1.3	0.6	2.1	9.1	3.5	6.6	6.4	3.5	3.1	4.1	1.6	5.6	4.6	5.6	5.7	8.3	0.9	8.7	3.1	6.6	2.6	4.4	13.3	11.3	6.9	2.4	2.7	2.2	2.1	4.5	4.6	3.0	3.8	4.2	2.9	2.6	3.0	5.1	1.2	7.0	5.5	3.8	2.5	2.2	2.1	6.9	5.3	3.4	2.1	5.5	2.6	5.1	0.4	0.9	1.9	0.2	1.2	2.7	2.0	1.4	0.2	2.2	2.7	1.6	1.9	0.9	0.8	1.6	2.6	0.4											0.0	4.3	0.8	0.2	1.0	10.8	1.8	2.5	2.7	2.3	0.0	5.9	0.2	0.0	0.7	0.5	1.5	0.1	0.0	0.2	0.2	0.9	0.4	0.0	67.6	0.2	4.8	1.2	1.8	1.8	0.0	1.1	0.9	3.3	1.0	2.3	2.4	0.2	0.0	1.8	0.6	14.1	0.0	0.9	0.3	0.2	1.1	0.0	0.8	0.7	0.3
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen-like B2"	Q02325	2	87748087-87758793	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	28	"liver: 105.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 67.4"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7;T-reg: 3.7"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 6.1;U-266/84: 4.9"														"Secreted to blood"	NA	NA						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	105.2	0.0	0.1	0.1		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.7	0.2	0.0	1.3	4.3	1.4	0.0	1.3	0.0	3.7	2.2	0.6	2.5	0.0	1.4	2.7	2.6	0.5	0.1	1.0	0.5	0.0	0.8	0.0	1.1	0.9	3.2	0.0	0.3	0.6	0.5	0.0	0.0	0.3	0.4	6.1	0.5	2.6	0.3	0.0	0.9	0.0	2.5	0.0	0.0	0.4	0.0	2.4	0.0	0.0	4.3	0.3	0.0	3.2	0.8	1.0	0.1	0.6	0.2	1.7	0.0	0.0	1.9	0.9	1.3	2.8	4.9	0.4	1.5	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.8	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.1	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 19.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.9;BEWO: 38.7;HHSteC: 47.5;HSkMC: 61.9;U-87 MG: 65.7"	"Low region specificity"	"Detected in all"							CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	200000000			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	126.5	44.6	20.2	21.8	20.1	5.4	27.0	10.3	21.1	41.5	35.4	30.9	6.9	11.8	28.0	74.6	23.9	41.5	49.9	37.8	18.1	15.9	32.2	13.9	22.6	96.5	15.1	12.2	38.6	83.6	7.4	9.0	117.5	19.5	28.7	12.5	36.4	36.8	22.5	19.8	17.7	14.4	50.1	11.1	25.7	18.7	30.9	11.5	74.7	13.7	11.4	9.5	40.5	26.7	4.7	10.4	19.6	6.7	2.5	1.0	1.6	2.6	0.3	18.6	0.0	44.9	13.7	38.7	1.0	3.2	3.7	2.2	15.2	3.0	0.6	31.2	4.5	0.0	30.7	5.7	0.1	1.7	0.3	0.0	5.5	0.6	7.0	47.5	0.0	6.9	61.9	1.5	9.6	0.1	14.7	8.1	0.6	1.7	8.7	1.2	0.7	0.5	22.9	3.3	2.3	15.2	0.2	0.0	0.3	0.0	0.0	2.0	7.0	0.7	21.6	31.1	3.2	0.2	21.6	1.7	9.2	0.2	4.7	0.1	3.8	0.9	0.9	65.7	6.3	1.5	19.6	1.6	16.1	1.0	3.8	0.8	4.7	0.2	1.0	1.4	2.1	0.0	0.6	0.7	2.5	6.7	10.4	0.4	1.6	20.2	20.1	10.3	18.2	18.1	15.9	15.1	12.2	19.5	11.5	0.0	2.9	0.0	24.8	36.1	0.4	0.8	5.1	41.5	7.9	26.2	0.0	13.0	1.7	2.5	12.9	11.7	0.0	0.0	90.6	73.4	153.4	2.1	0.0	1.9	1270.7	3.2	0.0	117.9	171.6	15.0	285.1	24.8	33.7	6.4	0.8	12.7	13.7	0.0	187.0	8.2	0.5	32.3	27.1	4.9	6.6	31.2	26.5	4.3	0.6	11.3
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.6"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	NA	NA		3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197845	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 124.8"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 1.6;monocytes: 1.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enriched"	"Detected in some"	27	"hypothalamus: 124.8"	"Cell type enriched"	"Detected in some"	8	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	81	"T-cells: 11.3"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 31.3"	"Group enriched"	"Detected in some"	131	"hypothalamus: 737.6;thalamus: 373.6"	"Region enriched"	"Detected in some"	30	"hypothalamus: 98.6"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	NA	NA	274000				"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.1	0.0	0.3	2.1	2.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.1	1.0	0.0	0.2	0.6	0.8	124.8	0.1	0.1	0.2	6.4	0.4	0.1	0.1	0.1	0.0	1.4	0.2	4.5	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.1	0.1	0.9	1.1	2.0	0.2	0.7	1.0	0.1	0.1	1.7	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.3	0.1	0.3	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	31.3	0.1	0.5	0.6	0.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.2	3.8	0.4	0.7	0.1	0.0	0.0	0.6	1.0	0.5	0.5	1.2	0.3	0.6	1.2	0.0	0.2	0.3	0.4	0.4	0.6	0.1	0.3	0.2	0.1	0.4	0.4	0.4	0.1	0.5	0.1	0.6	0.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	0.3	2.0	0.1	0.1	0.8	124.8	0.4	0.1	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 3478.1"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.5	0.0	0.0	0.0	3478.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	826.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 576.9"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA		210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	576.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.6	0.1	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 86.9"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 47.9;brain: 22.6;lymphoid tissue: 18.1"	"Cell type enriched"	"Detected in some"	5	"B-cells: 64.0"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory B-cell: 46.6;naive B-cell: 47.9;plasmacytoid DC: 33.7"	"Group enriched"	"Detected in many"	17	"B-cells: 47.9;dendritic cells: 33.7"	"Group enriched"	"Detected in some"	6	"Daudi: 24.6;Karpas-707: 19.4;RPMI-8226: 7.1;U-698: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300				"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.4	0.6	4.0	7.2	7.4	2.0	0.5	0.9	22.6	0.3	2.3	1.0	0.0	3.3	0.2	0.0	1.2	13.5	0.9	0.3	3.1	8.4	1.2	0.4	0.9	18.1	5.9	3.2	2.2	0.2	0.1	0.2	0.0	7.5	0.3	1.3	0.0	2.5	0.1	0.2	0.2	6.5	0.4	4.3	16.9	2.4	0.7	0.0	0.6	0.6	0.0	18.1	5.2	0.4	47.9	33.7	0.4	2.4	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.7	2.7	14.8	0.1	0.1	0.0	0.0	2.4	0.4	0.0	1.5	0.0	46.6	0.0	0.0	0.2	47.9	0.0	0.0	0.2	0.2	0.6	33.7	0.1	2.4	4.0	7.4	0.9	15.7	3.1	8.4	5.9	3.2	7.5	0.0	0.0	3.4	64.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	1.8	0.3	0.0	13.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1
PODN	"MGC24995, PCAN, PODOCAN, SLRR5A"	ENSG00000174348	Podocan	Q7Z5L7	1	53062052-53085502	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Leydig cells: 248.8;Peritubular cells: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"gdT-cell: 8.5;memory CD8 T-cell: 2.4;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	85	"T-cells: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;BJ: 17.4;fHDF/TERT166: 10.3;HHSteC: 43.1;HSkMC: 6.8;U-2197: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		190000				"unprognostic (8.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (5.91e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-2)"	39.0	4.1	2.1	15.2	1.5	0.0	48.1	1.1	1.3	33.4	23.5	1.0	21.5	4.6	29.1	57.8	28.4	29.0	96.8	32.3	1.7	1.2	3.3	4.0	18.5	4.0	2.6	0.7	65.7	8.4	1.4	5.2	7.2	3.0	47.1	3.4	6.1	10.9	15.0	14.0	10.9	7.5	46.5	3.4	1.0	20.4	35.5	1.6	4.4	19.6	19.4	4.3	50.5	55.1	0.0	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	10.5	1.4	0.0	17.4	2.3	0.2	0.1	0.0	0.0	0.0	0.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	6.8	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.6	2.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.1	2.1	1.5	1.1	1.3	1.7	1.2	2.6	0.7	3.0	1.6	0.0	3.5	0.0	0.4	5.7	0.1	1.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.4	42.1	0.4	0.0	0.0	0.5	0.0	0.0	7.4	0.0	4.0	248.8	1.1	5.0	0.0	0.0	0.2	0.0	0.0	245.4	0.0	0.5	0.0	13.2	0.6	0.6	5.3	0.5	0.0	0.0	0.1
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042807	Approved				"Secreted - unknown location"	NA	NA					"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.49e-4)"	2.4	1.6	2.2	3.5	4.1	2.2	4.5	7.9	3.2	6.7	2.3	3.0	2.2	1.9	1.7	2.5	8.7	1.7	5.9	4.4	2.0	7.5	1.4	1.0	3.8	1.3	4.2	2.3	3.1	2.5	0.7	4.7	24.5	5.0	6.1	1.5	11.1	4.2	4.1	3.7	12.7	2.7	2.6	3.8	1.3	3.0	7.6	2.1	0.8	2.4	14.9	3.9	4.8	9.9	0.9	3.4	1.3	1.7	1.0	0.8	0.6	0.4	0.5	0.5	0.3	0.8	2.1	0.1	5.5	3.3	1.1	2.2	0.4	0.6	0.3	0.4	8.8	0.2	2.1	0.2	0.2	0.6	2.0	0.9	1.1	0.4	0.1	6.8	0.3	0.7	16.2	1.0	1.5	0.2	25.7	0.0	0.1	0.5	0.4	2.2	3.5	0.3	0.3	0.2	0.4	0.5	0.2	0.1	0.0	0.4	0.1	1.0	0.6	13.0	0.1	0.4	0.6	0.1	0.6	1.0	2.7	9.4	0.7	0.3	0.4	0.0	0.1	1.1	1.2	0.2	0.7	1.7	0.7	0.8	1.4	0.3	0.9	0.6	0.3	3.4	0.5	0.4	0.3	1.3	1.0	0.2	0.5	0.2	0.6	2.2	4.1	7.9	3.2	2.0	7.5	4.2	2.3	5.0	2.1	0.0	0.3	0.0	0.8	1.1	34.2	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.1	1.2	1.0	1.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	7.5	1.6	0.0	0.6	1.5	1.6	17.0	1.1	1.7	0.0	1.3	1.6	0.4	6.2	35.7	0.0	4.0	0.0	0.5	0.7	0.5	3.8	0.7	0.0	1.1	1.2
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000				"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.2	1.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3	0.0	2.1	11.0	1.4	3.9	1.8	2.6	0.0	0.0	1.2	0.0	0.0	0.3	13.3	7.0	92.7	6.9	0.0	0.0	14.7	5.6	3.3	3.9	6.9	1.3	29.5	6.4	0.0	9.8	6.3	265.2	4.4	7.2	16.9	8.2	0.0	4.1	9.1	0.0	12.4	2.1	7.1	12.9	3.1	70.4	22.9	4.8	0.3	8.7	0.0	3.0
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 399.2"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	399.2	0.0	0.0	2.9	8.0	8.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404863-95435329	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"myeloid DC: 22.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	17.0	42.2	54.1	7.5	59.1	3.3	23.1	25.4	52.2	16.5	24.0	29.7	7.4	28.2	16.6	22.7	10.2	15.0	18.9	13.1	57.2	31.4	23.9	81.0	33.1	4.5	41.4	31.0	10.6	7.2	10.9	15.0	34.3	34.8	14.7	31.1	9.9	8.5	17.2	4.3	19.4	19.1	18.4	44.2	7.3	8.8	9.6	40.1	1.8	13.6	5.1	11.2	13.7	8.1	0.9	22.1	0.5	5.2	5.0	3.5	3.0	9.6	60.7	49.4	26.7	6.9	15.3	13.9	19.8	23.2	15.4	16.8	13.7	22.2	0.0	27.8	19.5	29.6	6.5	9.0	15.2	17.6	0.1	11.8	4.9	36.5	45.2	11.0	0.0	6.8	22.1	17.6	8.3	11.3	31.6	31.9	0.0	3.2	0.2	45.4	8.8	0.0	5.4	9.7	25.9	14.1	0.0	23.3	2.3	47.7	7.6	3.4	10.6	28.2	31.5	19.0	29.8	9.3	3.2	34.7	23.2	16.9	7.8	19.0	5.2	6.0	0.0	21.7	4.5	30.2	0.0	5.2	0.5	3.5	2.6	3.1	0.9	1.3	3.2	22.1	0.4	1.9	2.4	0.0	5.0	1.2	5.3	0.6	3.0	54.1	59.1	25.4	34.3	57.2	31.4	41.4	31.0	34.8	40.1	119.1	85.8	10.2	37.2	14.9	3.9	25.4	71.4	37.5	67.1	80.3	0.0	66.3	8.3	132.9	1.4	51.7	71.3	70.0	44.3	257.9	23.1	23.4	13.9	127.1	35.6	36.5	12.1	36.8	21.8	2.0	15.0	30.4	106.3	20.8	37.6	174.2	71.8	87.7	20.5	39.6	7.9	19.4	40.1	1.9	5.5	14.1	42.1	9.2	65.6	18.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 460.4"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6.0	32.1	1.4	0.7	0.8	0.0	0.3	25.5	8.1	14.8	3.5	0.0	1.5	1.7	0.2	9.0	0.5	4.0	0.0	1.8	1.9	2.6	2.2	0.0	460.4	0.2	0.0	0.0	8.6	7.0	3.6	7.5	0.0	13.5	0.0	2.3	3.0	1.5	0.0	2.8	5.2	0.0	0.0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 262.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	13.3	8.0	0.0	3.4	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	14.2	0.0	75.1	0.3	2.4	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.1	0.0	0.0	96.0	0.0	65.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1	6.0	18.3	0.0	1.4	262.6	0.0	19.4	0.0	9.4	33.0	0.0	0.0	1.5	0.0	0.0	0.4	27.7	0.0	0.0	0.0	0.2	42.9	0.3	3.5	0.0	3.2	0.0	0.0	16.5	0.0	0.2	6.1	0.2	28.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	62.4	1.1	0.2	42.3	2.9	0.0	0.0	0.0
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Ductal cells: 3.4;Kupffer cells: 8.8;Pancreatic endocrine cells: 4.1"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;HEL: 12.0;RPTEC TERT1: 2.8"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0	3.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	1.3	8.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		420000000			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.4	114.8	145.8	105.8	122.2	185.9	48.1	125.3	196.9	240.8	236.3	127.3	131.1	193.3	64.6	159.6	265.6	116.9	187.4	240.0	222.2	110.5	136.7	78.1	132.3	121.2	99.2	158.2	81.5	136.0	164.8	170.6	187.5	123.7	244.4	134.0	160.4	156.3	247.6	121.7	173.3	280.1	166.4	289.1	158.3	124.5	88.3	245.9	326.5	120.9	109.2	90.5	105.6	303.0	82.3	181.0	162.4	216.0	108.6	124.1	119.7	83.0	164.2	114.1	225.3	326.2	108.2	180.1	187.2	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8	738.4	649.6	630.7	788.0	769.8	81.7	43.6	573.3	655.8	728.0	572.3	17.7	772.4	1198.7	1053.9	61.2	614.7	668.4	210.2	1054.9	1359.4	612.8	450.0	590.8	641.5	1374.9	104.9	508.7	685.7	1073.8	53.8	539.0	844.5	656.3	1506.8	976.8	169.9	1130.2	533.1	576.3	1183.4	66.5	388.1	545.9	364.4	288.3	865.6	509.5	657.9	1124.8	784.3
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PPY	PNP	ENSG00000108849	"Pancreatic polypeptide"	P01298	17	43940804-43942468	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"pancreas: 275.8"	"Group enriched"	"Detected in some"	23	"Intestinal endocrine cells: 38.8;Pancreatic endocrine cells: 40.9"	"Cancer enriched"	"Detected in some"	132	"pancreatic cancer: 630.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 4.1"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 4.1"	"Group enriched"	"Detected in some"	4	"BEWO: 7.1;EFO-21: 6.6;U-2 OS: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016735, HPA032122"	Enhanced				"Secreted to blood"	NA	NA	70300				"CAB016735: , HPA032122: AB_2674164"		"unprognostic (5.12e-3)"			"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"			"unprognostic (1.65e-2)"		"unprognostic (7.56e-3)"			"unprognostic (8.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.42e-1)"	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	275.8	7.5	0.1	0.1	0.1	0.1	2.5	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.6	1.0	0.0	7.4	0.8	0.9	0.0	0.5	1.4	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	38.8	0.0	0.0	1.7	0.0	0.0	1.7	0.0	0.2	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.0	0.1	0.0
PRADC1	"C2orf7, hPAP21, MGC13004, PAP21"	ENSG00000135617	"Protease associated domain containing 1"	Q9BSG0	2	73228006-73233238	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.4"	"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051066	Approved				"Secreted to blood"	NA	NA					"HPA051066: AB_2681333"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.23e-2)"	10.3	12.0	11.6	5.6	13.9	4.2	22.5	9.3	13.3	6.2	12.3	6.7	6.6	13.6	4.5	9.5	9.1	4.1	6.4	37.3	10.6	7.7	11.8	23.3	6.4	14.4	10.6	7.3	3.9	39.7	4.8	8.3	4.7	10.9	6.6	12.0	6.9	25.6	8.7	59.4	6.7	16.2	13.1	9.6	8.5	8.7	9.6	7.0	4.1	7.8	22.2	5.8	7.5	5.7	6.2	25.6	11.6	33.8	13.3	10.5	15.0	8.2	7.0	7.0	13.4	22.0	8.6	9.3	13.8	6.5	14.2	8.2	19.5	8.8	9.1	8.0	16.1	12.8	7.8	11.1	9.6	10.1	13.7	10.0	13.7	10.0	14.6	6.8	7.2	13.7	11.1	5.9	12.7	6.8	4.1	13.1	16.6	11.9	20.0	16.2	17.5	20.0	13.7	2.1	39.3	28.2	11.6	27.3	28.6	7.9	8.1	14.6	4.8	6.6	18.3	6.4	7.9	9.7	6.5	6.8	16.5	6.5	14.1	12.4	21.0	15.8	8.2	10.6	15.9	6.7	4.1	12.3	11.6	9.1	28.9	7.4	6.1	8.9	8.5	12.7	6.2	8.4	7.4	1.6	13.3	33.8	25.6	10.5	15.0	11.6	13.9	9.3	13.3	10.6	7.7	10.6	7.3	10.9	7.0	8.9	5.8	9.3	10.2	13.9	13.7	52.0	15.3	6.7	5.7	14.0	7.9	22.4	61.3	20.8	39.5	14.7	47.7	0.0	40.8	39.3	23.7	7.9	28.8	55.1	42.8	11.1	31.0	30.7	18.1	109.7	15.5	14.2	15.1	1.0	41.5	20.9	19.4	28.1	15.2	56.4	20.4	32.3	14.7	23.2	19.6	21.0	11.3	11.3	48.1	8.2
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347146-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 196.7;liver: 112.7"	"Group enriched"	"Detected in many"	7	"Enterocytes: 2498.9;Hepatocytes: 739.9;Paneth cells: 1500.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 72.9;liver cancer: 348.8"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.1"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9;NK-cell: 3.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;NK-cells: 3.6"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 45.4"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		330000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.2	0.1	145.3	0.2	0.4	111.1	0.1	2.4	0.1	0.2	3.4	0.1	0.1	0.1	24.4	112.7	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	1.1	0.1	3.1	3.6	0.2	0.1	0.1	0.1	196.7	0.1	0.1	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.7	2.9	0.2	3.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	10.7	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	45.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	0.6	0.1	1.4	0.0	0.2	0.3	0.5	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.3	0.0	0.0	0.0	2.9	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.8	0.4	0.4	1.8	3.6	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	11.0	0.1	0.0	0.0	0.0	10.2	0.0	0.0	8.7	0.0	0.2	28.2	0.0	1.2	0.0	2498.9	0.0	0.2	0.2	0.0	0.1	9.2	739.9	0.2	0.0	17.6	11.6	15.9	6.1	1.1	0.0	0.0	0.0	55.9	0.0	0.2	1500.0	1.4	220.6	0.0	0.0	0.0	37.1	2.0	0.0	0.2	6.9	48.3	0.1
PRB1	"PM, PMF, PMS, PRB1L, PRB1M"	ENSG00000251655	"Proline rich protein BstNI subfamily 1"		12	11351823-11395566	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	80	"salivary gland: 605.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.7"														"Secreted to digestive system"	NA	NA																							0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRB2	"cP7, PRPPRB1, Ps"	ENSG00000121335	"Proline rich protein BstNI subfamily 2"	P02812	12	11391540-11501041	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 544.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.8"	"Cell type enriched"	"Detected in single"	23	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.2"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.3"														"Secreted to digestive system"	NA	NA										"unprognostic (1.36e-1)"	"unprognostic (1.01e-2)"		"unprognostic (2.61e-1)"	"unprognostic (2.07e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.51e-3)"			"unprognostic (1.97e-4)"	"unprognostic (1.51e-1)"			0.1	0.0	1.3	0.1	5.8	0.0	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	544.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.8	0.1	2.9	2.3	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRB3	PRG	ENSG00000197870	"Proline rich protein BstNI subfamily 3"	Q04118	12	11265924-11269805	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"salivary gland: 2125.3"	"Group enriched"	"Detected in some"	15	"Early spermatids: 8.3;Late spermatids: 3.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.9;RT4: 1.3;SuSa: 2.5;U-2 OS: 1.2"														"Secreted to digestive system"	NA	NA						"unprognostic (4.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-1)"		"unprognostic (7.46e-3)"		"unprognostic (4.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2125.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.1	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.5	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
PRB4		ENSG00000230657	"Proline rich protein BstNI subfamily 4"		12	11307083-11310435	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	273	"salivary gland: 3472.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"lung cancer: 2.0;melanoma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"CACO-2: 7.8"														"Secreted to digestive system"	NA	NA															"unprognostic (1.05e-1)"				"unprognostic (8.25e-2)"				0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3472.8	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.7	0.5	0.5	7.6	1.0	0.2	0.2	0.0	0.2	1.2	0.7	11.5	0.2	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	2.1	0.1	0.4	0.3	0.5	1.4	0.1	0.2	0.5	0.5	0.3	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	5.6	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3	0.0	8.0	0.5	0.9	16.3	2.9	4.3	0.0	2.7	1.2	0.0	2.0	0.0	0.0	0.0	0.6	10.9	0.0	0.0	0.0	0.1	65.7	0.5	4.7	0.0	0.3	1.6	0.0	30.7	0.0	2.3	93.2	1.9	182.2	0.0	0.0	156.5	0.0	0.0	187.7	0.0	4.7	25.8	26.8	2.7	0.8	8.7	0.2	0.0	0.0	0.7
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 31.6;lymphoid tissue: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	48	"HMC-1: 68.2"	"Not detected"	"Not detected"							HPA064183	Enhanced				"Secreted in other tissues"	NA	NA		240000			"HPA064183: AB_2685205"																		0.1	0.0	0.0	0.0	0.0	31.6	0.1	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	68.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 298.2"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 81.7"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"	NA	NA		4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	81.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1	20.8	14.4	8.2	0.0	0.6	0.0	0.8	7.6	20.1	38.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.2	0.1	15.1	298.2	0.1	0.0	0.0	7.4	8.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.1
PRH2	Pr	ENSG00000134551	"Proline rich protein HaeIII subfamily 2"	P02810	12	10929236-10932341	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	128	"salivary gland: 2507.3"	"Group enriched"	"Detected in some"	207	"Early spermatids: 34.1;Late spermatids: 83.4"	"Cancer enriched"	"Detected in some"	11	"head and neck cancer: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;hTERT-HME1: 1.2;PC-3: 1.1"														"Secreted to digestive system"	NA	NA						"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.43e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.8	0.0	0.1	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2507.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	4.6	2.9	0.0	0.0	0.4	0.3	0.1	0.2	0.5	0.9	0.2	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.7	0.4	0.1	0.0	0.0	0.4	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.3	0.3	0.9	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.7	0.2	0.9	0.4	0.3	0.7	0.1	0.2	0.3	0.5	0.1	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 11.3;Late spermatids: 17.4;Rod photoreceptor cells: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;SCLC-21H: 6.7;U-937: 3.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	17.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;heart muscle: 4.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4"	"Group enriched"	"Detected in some"	58	"hypothalamus: 13.4;pons and medulla: 22.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 5.1"	HPA014976	Approved				"Secreted - unknown location"	NA	NA					"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.8	0.0	4.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.1	0.0		1.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429246	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 137.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 348.7"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 29.2"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 29.2"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 58.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Supported				"Secreted to blood"	NA	NA		6400000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	29.2	3.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.3	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	2.8	58.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	29.2	0.0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0.0	0.0	0.0	4.3	0.6	0.7	0.0	0.3	40.8	1.4	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	2.6	0.0	0.2	0.0	0.2	0.0	0.0	348.7	3.9	0.0	9.9	9.8	4.5	0.0	0.0	1.7	0.0	0.0	8.1	0.0	1.2	8.7	0.0	78.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	1.5	0.1
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Group enriched"	"Detected in some"	50	"Leydig cells: 160.2;Peritubular cells: 627.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.8"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	627.9	0.0	0.0	0.0	0.0	3.1	1.1	0.0	0.8	0.0	0.0	0.1
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Group enriched"	"Detected in some"	7	"Kupffer cells: 15.8;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.0;NB-4: 7.8;NTERA-2: 5.5;U-266/70: 12.4;U-266/84: 20.1;U-937: 8.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"	NA	NA					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.5	0.0	0.0	0.0	0.2	7.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.1	0.0	0.0	8.3	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.5	0.0	0.0	0.0	15.8	1.9	0.3	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	3.1	0.0	0.0
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 266.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	3400000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.3	42.8	31.9	0.8	1.5	3.5	0.8	3.1	6.1	0.9	0.2	9.3	2.3	7.8	0.1	0.8	0.6	1.1	0.1	2.7	16.6	1.1	17.0	3.6	0.6	0.8	28.9	0.6	1.8	0.6	24.2	3.5	2.1	11.5	0.2	16.6	0.2	0.1	0.0	2.0	1.5	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	46.2	0.8	0.1	8.1	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.2	10.6	9.9	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2	59.6	29.8	3.7	2.9	13.2	0.6	40.3	12.7	76.3	12.5	1.8	9.8	0.6	3.3	5.6	2.3	47.0	2.6	0.0	4.0	0.6	62.0	4.7	29.0	266.4	9.9	1.6	15.1	69.3	24.7	4.0	26.4	7.7	18.6	1.0	14.6	22.0	3.9	7.0	34.6	36.2	7.8	12.9	26.2	0.2	0.5	29.1	1.4	4.5	13.3	2.0
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158654-113172383	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 45.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 56.9"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;T-reg: 1.5"	"Group enriched"	"Detected in many"	12	"monocytes: 2.7;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 4.9;Hep G2: 7.7"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	510000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	9.3	45.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	2.7	0.0	1.5	0.2	0.9	1.5	0.7	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	3.0	1.8	0.8	0.0	0.0	0.3	4.9	0.0	0.0	0.0	0.8	2.4	1.0	2.9	7.7	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	2.5	1.1	0.6	0.0	1.0	0.6	0.8	1.8	3.1	0.4	1.3	0.2	0.3	0.0	1.1	2.9	0.2	0.0	0.3	1.3	1.7	0.0	1.0	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0.0	0.0	0.0	0.3	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 669.3"	"Group enriched"	"Detected in some"	32	"Early spermatids: 11.0;Late spermatids: 7.0"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"									"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.5	0.2	2.4	0.3	0.5	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.2	1.3	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.2	0.5	0.0	0.7	0.1	0.4	0.5	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.1	0.0	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.2	0.2	2.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4 (lacrimal)"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"salivary gland: 1184.0"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 85.6;Cone photoreceptor cells: 131.6;Horizontal cells: 81.0;Rod photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 7.7"									HPA042133	Supported				"Secreted to digestive system"	NA	NA		25000000			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1184.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	20.0	38.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.8	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.3	7.7	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	7.8	6.3	2.7	85.6	0.6	5.1	0.0	2.3	1.8	131.6	13.2	1.7	0.1	8.2	9.6	6.0	0.0	0.3	2.1	10.1	8.9	9.2	5.5	6.6	81.0	15.5	11.6	7.0	10.2	20.1	2.2	27.0	0.0	5.3	27.5	1.9	13.1	23.0	0.0	108.4	12.9	10.3	8.1	7.0	1.9	3.3	8.7	8.3	3.1
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.9;RPMI-8226: 10.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	3.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	3.4	4.6	0.0	0.7	0.0	0.0	1.5	2.5	3.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	0.5	0.0	19.9	0.0	4.0	0.5	0.0	1.6	2.3	1.9	0.0	1.2	0.4	0.0	0.7	1.9	0.5	0.0	0.0	10.7	2.3	3.4	0.0	0.0	1.3	3.0	0.0	4.6	1.9	0.8	0.0	0.0	0.8	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	8.9	7.7	0.8	9.8	5.7	0.0	0.4	7.6	2.7	3.4	14.0	0.0	36.3	1.7	6.8	0.5	0.3	16.0	0.0	15.6	21.7	0.4	6.6	5.7	0.0	3.4	0.0	4.1	0.0	0.3	0.0	0.6	0.0	5.0	0.0	17.5	1.0	10.5	19.8	0.0	0.2	0.0	0.0	0.7	1.0	5.3	5.6	26.5	0.0	14.5	7.4
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 92348.3"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	2.4	0.2	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.0	0.0	0.0	0.0	0.0	92348.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	608.7	0.0	0.0	14696.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	13.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	187.4	20.6	0.0	0.2	33.1	8.1	23.9	15.7	0.0	30.9	1.7	101.8	0.0	0.0	4.2	0.0	86.5	19.4	0.8	63.4	0.0	0.0	2.0	0.0	3.5	0.0	0.0	0.0	0.0	0.9	6.8	1.8	5.3	0.0	242.0	10.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	24.1	8.8	0.0	5.2	517.3
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 178.1;Endothelial cells: 254.7;Ito cells: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.4"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.2;T-cells: 36.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 114.9;hTERT-RPE1: 136.8;TIME: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		290000			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	19.5	8.7	2.3	10.8	4.1	0.4	40.7	1.2	2.6	89.0	33.8	2.1	37.2	5.1	44.9	27.4	14.5	9.6	45.6	17.2	5.0	3.0	17.5	10.4	36.2	15.9	3.7	4.4	16.2	14.3	9.6	6.3	30.2	12.5	36.7	14.4	15.2	17.6	37.3	19.1	7.2	12.4	100.2	4.9	7.3	22.0	19.5	1.4	3.8	15.3	10.5	5.8	68.6	31.1	0.0	0.0	0.5	0.7	10.2	36.4	10.9	6.2	15.6	16.8	0.1	7.5	18.5	0.0	27.5	25.2	30.7	24.6	36.2	49.8	0.0	21.9	42.1	114.9	12.9	0.2	20.9	7.4	0.0	1.3	2.1	8.0	0.1	3.8	0.0	0.1	14.7	2.8	14.9	17.1	136.8	62.2	0.0	0.1	0.0	23.0	8.5	0.0	0.0	1.0	21.2	1.7	0.0	0.0	0.0	11.5	8.3	0.1	0.1	6.1	0.4	1.8	43.6	0.6	0.0	116.0	18.4	0.2	36.6	15.5	0.1	0.1	0.0	13.1	0.0	18.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	6.6	20.5	0.0	0.0	1.8	18.5	0.5	10.2	0.7	0.0	0.0	10.9	2.3	4.1	1.2	2.6	5.0	3.0	3.7	4.4	12.5	1.4	26.8	22.1	5.2	74.7	13.7	0.6	3.7	33.1	52.2	75.1	50.6	2.0	6.2	6.6	178.1	2.4	254.7	6.2	0.0	73.0	14.9	79.1	74.7	2.3	5.9	4.5	0.0	13.3	438.3	42.1	5.2	13.3	6.4	69.2	1.8	24.0	0.8	162.9	73.7	7.1	3.5	0.7	38.8	37.9	1.4	6.6	8.5	3.8	17.5	9.1	44.4
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 8.9;Horizontal cells: 11.1;Urothelial cells: 9.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;SK-BR-3: 22.3;T-47d: 13.1;U-266/70: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"	NA	NA			Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.6	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.5	0.0	1.7	0.0	0.9	1.3	0.1	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.7	0.0	22.3	0.5	0.1	13.1	1.5	0.0	0.4	0.0	0.0	0.0	4.6	3.2	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1	8.9	8.0	0.0	2.4	1.5	5.2	1.1	0.0	5.3	5.7	1.8	3.9	0.5	0.0	1.2	1.5	1.0	0.4	0.0	1.2	0.3	1.1	1.6	3.5	0.8	0.3	11.1	0.0	0.6	0.0	0.4	0.3	1.3	1.7	1.0	0.0	3.2	0.9	0.2	0.0	0.5	4.7	0.0	1.5	2.1	3.8	2.0	2.7	0.0	0.6	9.7
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell type enhanced"	"Detected in many"	19	"Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"	"Group enriched"	"Detected in some"	5	"OE19: 46.2;PC-3: 121.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	1.9	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	0.0	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.2	121.2	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0	0.0	0.0	2.2	0.2	50.7	0.2	0.9	48.4	0.0	0.0	1.8	0.0	0.0	3.3	13.8	29.4	1.1	998.3	0.0	1691.4	0.0	0.4	7.0	9.2	1.0	0.0	0.0	184.8	1.3	0.3	56.5	1.4	1.2	6.8	10.0	156.0	0.0	545.2	388.3	0.7	6.7	0.0	0.0	3.1	0.5	0.4	117.2	0.1	0.0	282.9	19.5
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 1.8;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.7;hTERT-RPE1: 8.5;SK-MEL-30: 9.5;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Cell type enriched"	"Detected in some"	55	"Muller glia cells: 458.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.2	5.2	0.5	1.0	42.7	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	4.1	0.0	0.0	0.0	12.6	0.0	0.0	0.5	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3	3.0	0.3	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.1	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	6.4	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	458.8	0.0	0.0	8.1	0.0	7.1	6.5	1.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138925-31150094	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 22.2;Hofbauer cells: 15.2;Paneth cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.2;HeLa: 6.5;HMC-1: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036079	Uncertain				"Secreted - unknown location"	NA	NA					"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	3.0	2.0	0.4	1.0	1.2	1.1	6.2	0.4	1.8	1.6	1.8	0.4	0.4	3.2	0.4	1.8	1.2	0.5	0.4	2.1	0.4	0.5	0.5	0.7	2.3	0.4	0.4	0.4	1.7	0.4	0.4	6.5	2.5	0.4	1.0	0.9	0.4	3.5	0.4	1.3	3.4	2.1	1.2	0.4	0.4	1.0	0.7	0.4	0.4	0.6	0.4	1.0	2.0	0.4	0.0	2.1	4.3	0.8	0.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.2	0.1	0.4	1.4	0.0	0.9	0.4	0.4	1.4	0.1	0.2	0.0	0.2	0.6	2.2	6.5	1.2	0.1	0.3	2.9	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.3	0.4	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.3	0.0	0.6	0.7	0.0	0.0	0.1	1.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	4.3	0.2	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.1	0.4	2.6	0.2	0.0	0.6	0.1	0.1	0.4	1.2	0.4	1.8	0.4	0.5	0.4	0.4	0.4	0.4	0.0	1.4	0.0	2.5	1.6	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	1.4	1.3	0.6	22.2	0.0	2.5	1.0	0.4	2.1	0.0	2.6	15.2	0.0	0.0	1.3	4.1	0.4	2.6	2.3	0.0	7.2	2.0	0.5	1.3	17.5	2.5	1.1	0.0	0.0	0.3	0.7	2.5	2.3	0.5	0.0	2.3	1.7
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836286-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	127	"testis: 39.1"	"Group enriched"	"Detected in some"	164	"Early spermatids: 641.3;Late spermatids: 239.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.3;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020541	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	641.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0
PRSS38	MPN2	ENSG00000185888	"Serine protease 38"	A1L453	1	227815693-227846470	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"blood: 2.2;testis: 8.4"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 9.6;Spermatogonia: 8.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	18	"gdT-cell: 1.4;NK-cell: 2.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 2.2;T-cells: 1.4"	"Cell line enriched"	"Detected in single"	20	"U-266/84: 5.2"	"Not detected"	"Not detected"							"HPA028003, HPA055809"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA028003: AB_1853572, HPA055809: AB_2682931"										"unprognostic (9.54e-3)"					"unprognostic (3.61e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	8.5	0.0	0.0	0.0	0.0	0.0
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7"									HPA046925	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	4.0	0.4	0.0	0.1	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.4	3.7	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	1.2	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 3.2;Late spermatids: 2.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;CAPAN-2: 1.6;OE19: 1.7;T-47d: 1.9;U-2 OS: 5.1"														"Secreted - unknown location"	NA	NA						"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.0		0.0		0.4	3.4		1.4	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.1	0.0	2.3			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell type enhanced"	"Detected in some"	10	"Leydig cells: 1.7;Peritubular cells: 1.1;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA034955: AB_2674380, HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.2	1.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.1	1.3	0.3	1.6	0.8	0.0	2.0	1.6	0.0	0.0	0.0	0.0	10.0	0.8	0.9	0.0	1.0	0.0	0.8	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8											0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.1	0.0	0.3	0.0	0.3	0.0	0.0	1.3	0.0	0.7	0.1	0.3
PRSS54	"CT67, FLJ25339, KLKBL4"	ENSG00000103023	"Serine protease 54"	Q6PEW0	16	58279997-58295047	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 35.1"	"Group enriched"	"Detected in some"	63	"Early spermatids: 433.8;Late spermatids: 185.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041549	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA041549: AB_10795640"	"unprognostic (1.13e-1)"			"unprognostic (3.24e-2)"	"unprognostic (3.09e-2)"				"unprognostic (3.08e-1)"	"unprognostic (4.88e-2)"			"unprognostic (1.23e-1)"					0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	2.2	0.0	0.0	0.0	0.0	0.0
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 61.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"NB-4: 87.1;THP-1: 43.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA						"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.3	0.2	0.0	0.0	0.0	61.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	3.9	0.0	0.1	0.2	0.8	4.0	0.1	0.1	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	0.2	0.0	9.3	0.3	0.0	0.9	0.0	0.2	0.0	2.2	8.7	1.6	3.1	4.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	87.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.7	1.6	0.0	0.6	0.3	0.0	0.0	0.0	4.5	2.2	0.0	0.0	0.8	1.0	3.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS58	TRYX3	ENSG00000258223	"Serine protease 58"	Q8IYP2	7	142252143-142258058	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 27.2"	"Group enriched"	"Detected in some"	128	"Early spermatids: 636.2;Late spermatids: 161.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"RH-30: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	636.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	38.3	26.3	0.0	0.3	0.0	0.0	17.3	0.0	16.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	15.5	0.1	0.3	4.8	18.3	0.0	0.1	0.0	0.2	1.8	3.0	0.2	0.1	0.0	44.2	0.0	4.7	10.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3	92.3	62.1	0.9	60.6	33.7	0.6	0.3	53.5	9.4	53.4	40.1	0.0	127.8	24.9	145.8	0.0	0.7	330.0	23.3	197.1	497.6	3.6	80.0	6.9	12.8	20.5	0.0	9.2	0.0	0.3	0.0	0.6	2.5	3.3	7.2	109.4	0.3	182.1	150.8	0.0	24.9	0.0	0.0	3.1	0.0	0.1	47.2	376.9	1.3	110.4	79.5
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 2.5;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 151.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		120000	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell type enriched"	"Detected in single"	14	"Suprabasal keratinocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	362	"placenta: 497.6"	"Cell type enriched"	"Detected in some"	130	"Syncytiotrophoblasts: 173.1"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	18	"U-2197: 98.0"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"					"unprognostic (2.02e-1)"	"unprognostic (3.54e-1)"							"unprognostic (2.44e-7)"			"unprognostic (2.28e-2)"		1.3	0.0	0.1	0.0	0.1	0.0	0.6	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	497.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	1.4	0.3	0.5	0.0	0.0	0.0	0.0	4.8	1.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.4	0.0	0.0	0.1	0.0	0.0	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	173.1	0.0	0.0	0.0
PSG11	"MGC22484, PSG13, PSG14"	ENSG00000243130	"Pregnancy specific beta-1-glycoprotein 11"	Q9UQ72	19	43007656-43026512	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	220	"placenta: 151.1"	"Cell type enriched"	"Detected in single"	172	"Syncytiotrophoblasts: 135.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-2197: 19.7"									"HPA042240, HPA046327"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA042240: AB_10797384, HPA046327: AB_2679624"					"unprognostic (2.58e-1)"													0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	151.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.4	0.0	0.0	0.0
PSG2	"CEA, PSBG2, PSG1, PSGGB"	ENSG00000242221	"Pregnancy specific beta-1-glycoprotein 2"	P11465	19	43064211-43083045	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	102	"placenta: 75.3"	"Cell type enriched"	"Detected in some"	35	"Syncytiotrophoblasts: 671.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0"														"Secreted in female reproductive system"	NA	NA																			"unprognostic (1.02e-2)"				0.4	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	75.3	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.1	0.6	2.9	0.0	0.0	0.0	0.0	14.0	0.8	0.3	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.8	0.2	0.0	0.0	0.0	0.0	19.2	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	671.0	0.0	0.0	0.6
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	146	"placenta: 495.8"	"Cell type enriched"	"Detected in some"	171	"Syncytiotrophoblasts: 1321.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"																		0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	495.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.7	0.4	0.1	0.0	0.0	0.0	0.5	0.6	0.6	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.5	6.3	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1321.0	0.0	0.0	0.0
PSG4		ENSG00000243137	"Pregnancy specific beta-1-glycoprotein 4"	Q00888	19	43192702-43207299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 348.5"	"Cell type enriched"	"Detected in some"	54	"Syncytiotrophoblasts: 463.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 107.6;U-2197: 29.2"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"	"unprognostic (4.29e-2)"	"unprognostic (5.18e-2)"		"unprognostic (9.49e-2)"		"unprognostic (2.52e-2)"		"unprognostic (3.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.57e-1)"	0.6	0.4	0.2	0.5	0.2	0.0	1.4	0.2	0.2	0.2	8.2	0.2	0.2	0.0	0.2	0.2	1.2	0.0	0.2	0.2	0.2	0.0	2.0	0.2	0.2	0.2	0.2	0.2	0.2	2.0	49.1	0.6	348.5	0.2	0.6	5.8	0.2	4.4	0.2	0.2	6.3	0.2	0.2	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.3	107.6	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	11.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.1	3.0	0.0	0.0	0.8	0.4	1.1	29.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	4.9	0.0	0.0	0.0	0.0	0.0	8.5	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	463.1	0.0	0.0	0.3
PSG5	"FL-NCA-3, PSG"	ENSG00000204941	"Pregnancy specific beta-1-glycoprotein 5"	Q15238	19	43166256-43186536	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	73	"placenta: 171.3"	"Cell type enriched"	"Detected in some"	41	"Syncytiotrophoblasts: 605.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"BJ: 52.4;fHDF/TERT166: 180.6"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-2)"				"unprognostic (4.69e-2)"		"unprognostic (1.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (7.92e-2)"	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.1	171.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	2.0	0.5	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	52.4	15.1	0.8	7.3	0.0	0.0	0.0	0.0	180.6	0.2	2.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.4	0.7	0.4	0.5	0.6	0.5	0.5	0.2	1.0	0.7	0.5	2.0	0.6	0.4	0.5	0.4	0.0	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.8	0.0	5.3	0.0	4.3	0.8	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	605.9	0.0	0.0	0.0
PSG6		ENSG00000170848	"Pregnancy specific beta-1-glycoprotein 6"	Q00889	19	42902079-42919563	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"placenta: 330.8"	"Cell type enriched"	"Detected in some"	204	"Syncytiotrophoblasts: 304.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	27	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 2.6"	"Cell line enriched"	"Detected in some"	17	"U-2197: 57.9"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"						"unprognostic (4.23e-1)"												0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	330.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.2	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	57.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	304.0	0.0	0.0	0.0
PSG7		ENSG00000221878	"Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)"		19	42924132-42937178	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	8	"placenta: 23.1"	"Cell type enriched"	"Detected in some"	105	"Syncytiotrophoblasts: 135.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.9;U-2197: 4.8"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"																		0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.9	0.2	1.3	0.0	0.0	0.0	0.0	2.8	0.9	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.5	0.0	0.0	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	88	"placenta: 142.2"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 28.7"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	142.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"placenta: 299.0"	"Cell type enriched"	"Detected in some"	109	"Syncytiotrophoblasts: 231.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.2	299.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	2.8	4.4	2.3	0.1	0.1	0.0	0.2	1.3	16.0	0.3	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	11.0	4.2	0.0	0.2	0.1	2.1	9.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	231.8	0.0	0.0	0.0
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Group enriched"	"Detected in some"	15	"Melanocytes: 8.5;Suprabasal keratinocytes: 6.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061228	Enhanced				"Secreted in other tissues"	NA	NA					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.5
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	"Predicted secreted proteins"		"Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 18.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB025366	Uncertain				"Secreted in other tissues"	NA	NA					"CAB025366: "	"unprognostic (3.21e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.54e-6)"	"unprognostic (5.39e-3)"	"unprognostic (1.01e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	1.0	1.7	2.5	1.1	2.7	1.6	1.1	6.4	3.4	1.8	1.4			1.1	1.6	3.5	1.3	2.5	1.3	1.1	2.3	2.1	2.5	2.2	1.1	1.2	1.5		2.8	1.6	2.7	2.4	1.1		1.8	1.5		1.8	1.6	1.3	1.7	1.8	1.4	0.8	1.9	1.5	1.5			2.5		1.5	1.1	1.0	2.6	2.8	4.6	2.6	1.8	3.0	1.6	1.6	3.8	2.2	5.5	5.1	3.4	1.2	1.9	1.9	2.1	2.3	3.7	1.4	2.0	3.1	2.4	1.9	2.4	3.7	1.4	2.4	3.0	2.9	2.0	2.2	2.9	3.7	1.6	2.9	4.0	4.3	1.7	2.8	5.7	1.4	3.2	2.4	2.5	2.4	2.9	3.7	3.3	2.2	3.8	4.3	3.2	2.6	1.3	3.5	2.2	3.0	4.6	3.2	3.0	2.5	3.0	3.4	1.9	1.8	2.7	2.6	4.7	1.2	4.4	7.0	1.1	5.0	3.3	2.6	4.6	2.1	1.8	2.1	1.6	3.0	2.0	1.5	2.6	1.2	2.6	2.3	2.3	3.6	1.8	2.6	2.8	1.7	1.6											0.0	1.7	0.0	0.8	0.6	1.8	1.5	0.0	0.0	0.0	1.8	0.0	0.8	0.0	1.0	3.6	1.2	4.1	0.0	0.2	0.6	1.3	1.4	1.1	2.6	1.8	1.6	2.9	1.8	2.2	18.9	0.9	0.2	1.7	1.0	2.0	1.5	1.1	2.9	2.1	2.2	1.8	0.0	0.9	1.4	0.7	0.9	1.1	0.5	2.4	0.9
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.2	4.8	5.5	5.0	12.8	8.8	5.0	5.5	12.2	6.5	9.1	4.9	12.6	12.1	3.7	9.0	3.8	6.2	7.4	6.3	10.3	6.0	2.1	4.0	12.5	6.0	13.7	13.5	6.9	6.0	17.6	8.2	10.6	27.6	9.1	7.7	3.0	32.9	5.9	7.8	7.6	24.6	2.0	8.9	0.0	11.8	2.9	8.9	10.1	5.8	2.0	9.0	7.3	3.5	9.2	4.6	9.7	19.6	7.9	21.4	5.0	8.3	4.4	10.8	14.0	13.8	6.6	12.8	1.2	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5	32.8	55.3	40.2	50.0	49.8	113.3	39.2	40.8	25.4	28.4	27.9	37.3	22.6	28.2	23.2	57.0	44.4	33.9	0.0	25.8	44.5	52.3	36.9	25.3	58.6	31.3	42.9	30.0	47.9	167.4	70.7	52.6	69.1	59.1	27.9	44.1	54.1	30.2	24.6	51.2	30.8	55.8	90.5	118.8	24.9	24.0	52.6	47.9	35.7	39.2	51.2
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 35232.9;Peritubular cells: 61248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"	"Group enriched"	"Detected in some"	6	"HHSteC: 106.3;HSkMC: 51.8"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	NA	NA		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	106.3	0.0	0.2	51.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	13.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2	0.0	1.1	0.0	3.5	62.5	41.8	283.2	0.0	0.0	0.0	130.9	49.1	12.3	58.0	0.3	163.9	98.7	0.0	0.0	0.0	31.2	935.4	19.2	1.1	1.6	48.0	20.6	0.0	51.5	2.8	458.6	35232.9	41.1	199.1	1.8	0.0	4317.3	1.2	0.0	61248.9	0.6	110.6	161.7	44.3	116.5	105.1	70.0	29.6	37.4	0.0	14.4
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492055-13496181	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 963.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"	NA	NA	28000				"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	963.9	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	129.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTH2	TIP39	ENSG00000142538	"Parathyroid hormone 2"	Q96A98	19	49422414-49423441	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"blood: 2.4;brain: 4.1;testis: 1.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 1.6;Late spermatids: 1.1;Muller glia cells: 2.6;Spermatocytes: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;REH: 3.8;SCLC-21H: 3.3;U-266/84: 1.1;U-937: 1.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 3.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 36.9"						"Secreted in brain"	NA	NA																				"unprognostic (3.41e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	1.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972705	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.6"	"Cell type enhanced"	"Detected in some"	15	"Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Group enriched"	"Detected in some"	4	"HaCaT: 64.7;HBEC3-KT: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	2.9	1.0	6.5	3.5	5.3	0.0	20.2	1.4	8.7	11.0	2.3	1.4	2.1	2.4	11.2	2.0	17.0	1.2	45.6	4.0	4.3	3.5	0.4	0.2	1.3	1.1	1.4	4.3	2.6	1.7	0.7	2.3	3.6	3.1	5.5	1.8	2.4	5.3	2.6	0.7	1.5	1.6	13.4	0.8	3.6	1.9	1.3	1.0	0.1	1.4	15.8	3.4	8.0	12.3	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.0	0.2	0.1	0.2	0.0	1.7	0.0	0.1	0.5	2.1	64.7	0.2	80.0	0.0	1.6	0.3	0.1	0.4	0.0	0.2	0.0	0.1	0.0	4.4	2.0	7.9	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.3	0.1	7.7	0.0	0.0	0.0	3.6	0.0	0.4	2.7	0.1	0.0	1.2	0.3	2.0	1.1	17.0	1.0	0.0	2.6	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	6.5	5.3	1.4	6.2	4.3	3.5	1.4	4.3	3.1	1.0	0.0	0.0	0.0	1.1	4.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	4.2	1.3	0.0	0.0	7.9	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.9	0.2	21.9	1.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	6.5	2.8	0.4	0.1	1.3	0.0	0.0	0.0	0.1
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.0	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	0.2	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0.0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53.0	18.9	1.7	19.2	314.6	1.0	0.2	0.0	6.2	1.9	31.6	10.9	1.1	0.0	3.1	0.0	20.7	1.8	0.0	38.8	17.0	1.1	15.1	1.0	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 190.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	190.8	2.3	0.0	0.1	15.6	4.9	14.6	2.7	3.8	0.0	0.0	0.0	0.0	6.4	1.7	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	2.7	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	13.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	3.7	0.2	10.6	0.0	0.0	0.0	13.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3	0.0	0.0	0.0	1.3	20.6	19.5	14.2	0.0	2.7	4.5	1.8	5.9	182.0	8.3	1.2	11.9	8.4	0.0	0.0	0.0	368.5	184.0	17.1	0.0	0.0	18.1	497.4	0.0	8.6	0.3	8.3	159.9	1.4	42.2	0.0	0.0	523.9	0.2	0.0	174.3	5.1	27.0	58.2	33.4	1.8	1.5	12.2	161.7	0.0	0.0	2.0
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell type enhanced"	"Detected in some"	10	"Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	310000	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	52.1	0.0	86.4	125.2	0.0	9.0	82.2	3.9	4.2	0.0	0.5	0.0	32.1	10.6	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	160.8	0.1	0.0	167.5	0.0	88.5	30.1	7.7	18.2	0.0	0.0	0.0	26.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	119.2	17.7	0.8	111.1	1.5	0.0	0.0	0.0	3.7	0.4	5.0	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2	0.0	1.7	0.0	1.1	1.4	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	6.0	1.9	2.0	0.0	0.0	0.0	0.0	10.1	0.4	0.0	0.0	2.6	0.0	0.0	3.1	4.6	0.8	0.3	5.9	13.5	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.4	0.9	0.2	0.0	0.0	0.1
PTX4	C16orf38	ENSG00000251692	"Pentraxin 4"	Q96A99	16	1485886-1488981	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;bone marrow: 4.0;testis: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"intermediate monocyte: 1.1;non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	31	"monocytes: 3.0"	"Group enriched"	"Detected in some"	6	"HL-60: 19.5;NB-4: 14.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA073694	Supported				"Secreted - unknown location"	NA	NA					"HPA073694: AB_2732237"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-4)"	"unprognostic (3.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.23e-3)"	"unprognostic (4.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.03e-1)"	0.2	1.0	0.6	0.2	0.8	4.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.4	0.3	0.2	0.8	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.4	0.0	0.4	0.4	0.2	0.9	0.1	3.9	0.2	1.5	0.2	0.2	0.2	0.4	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	14.5	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.6	0.8	0.8	0.3	0.8	1.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"TIME: 53.4"									"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.8	15.3	1.5	6.1	1.9	2.3	2.6	36.9	10.3	12.1	13.9	8.9	9.3	0.0	21.2	10.7	21.2	14.4	5.2	14.0	8.1	2.6	10.1	3.9	9.6	6.0	12.9	1.5	8.4	2.9	6.9	10.7	21.0	12.1	13.1	2.3	1.8	0.0	5.6	1.9	1.3	1.3	3.4	7.4	11.3	0.0	7.0	2.0	26.0	6.7	6.6	7.7	23.4	14.7	5.2	1.7	8.3	3.7	53.4	14.7	18.1	10.8	28.8	0.0	2.1	0.0	11.7	7.5	8.3	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2	14.9	28.0	4.5	12.8	3.2	6.9	11.2	20.4	2.7	18.2	1.8	2.0	2.4	3.3	43.0	8.5	13.5	11.9	0.0	30.3	30.1	5.4	11.3	1.1	36.5	7.4	1.6	12.6	7.4	9.2	10.2	5.2	7.8	1.7	25.2	9.7	1.3	48.8	14.4	14.9	2.8	3.3	0.0	17.8	3.4	1.5	4.8	0.8	0.0	10.6	6.5
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 40.8;Ito cells: 86.5;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 57.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		4000000			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.6	2.3	12.6	0.0	35.7	32.8	9.6	39.9	31.7	17.5	19.2	0.0	0.1	0.0	57.3	39.4	0.8	1.4	0.0	24.5	22.3	0.1	0.4	0.0	24.9	0.0	35.4	0.1	0.0	36.1	7.2	19.7	14.9	53.1	42.9	6.2	0.0	0.0	24.7	3.9	1.1	1.3	10.2	0.0	9.1	2.2	44.1	0.1	20.5	0.0	0.0	23.3	0.0	12.9	0.0	26.4	4.7	0.1	41.6	28.9	14.3	1.0	30.7	0.0	33.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2	6.0	2.9	0.0	2.3	2.6	1.4	5.3	7.6	2.7	0.0	1.8	0.0	0.6	0.0	7.9	33.3	40.8	0.0	0.0	0.0	7.7	15.2	12.9	1.1	0.8	1.6	0.0	1.7	86.5	9.7	24.5	24.7	1.1	6.8	1.0	0.8	11.2	0.8	0.0	14.2	0.0	0.7	45.3	26.2	1.8	10.1	2.5	1.1	0.0	0.0	1.0
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 40.0"	"Cell type enriched"	"Detected in some"	360	"Intestinal endocrine cells: 18684.3"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.9"	"Region enriched"	"Detected in single"	22	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	0.8	0.1	2.0	0.2	0.0	0.2	0.1	0.1	0.1	40.0	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0.0	24.8	0.1	0.1	0.1	0.1	1.0	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.6	0.7	1.3	1.0	1.7	0.2	1.2	0.3	1.4	0.8	1.3	0.9	0.7	1.6	1.4	1.1	0.7	1.1	0.4	0.9	3.2	0.6	1.8	0.5	0.2	1.2	0.5	7.9	2.3	0.4	1.3	0.6	1.7	0.3	0.7	0.4	1.3	1.2	1.7	0.5	1.0	1.6	1.2	0.7	0.4	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0.0	2.1	1.1	1.2	0.1	1.3	1.6	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	27.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	18684.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	51.9	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	2.3	4.5	0.1	0.0	0.0	32.3	0.0
PZP	CPAMD6	ENSG00000126838	"PZP, alpha-2-macroglobulin like"	P20742	12	9148840-9208370	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 56.9"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 32.1;Early spermatids: 22.5;Hepatocytes: 23.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.5"	"Group enriched"	"Detected in some"	8	"HeLa: 9.9;SiHa: 5.2"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	NA	NA		13000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.0	0.9	0.6	0.0	56.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	3.5	0.0	0.7	0.9	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.6	0.0	0.0	1.4	0.6	3.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	32.1	4.5	0.0	2.0	0.0	0.0	0.0	22.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	1.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.0	0.0
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Group enriched"	"Detected in many"	6	"Intestinal endocrine cells: 208.4;Melanocytes: 501.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	8.0	0.0	0.0	1.1	2.7	0.0	1.1	17.9	1.3	2.1	0.5	1.4	0.0	0.6	6.0	15.2	0.0	0.5	0.0	2.1	0.1	15.6	3.6	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.9	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	8.8	2.2	24.3	0.0	1.3	0.0	81.6	1.6	0.1	0.6	3.8	0.0	0.0	0.0	0.1	3.1	63.8	0.0	5.5	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5	3.0	2.9	8.2	9.7	34.7	10.9	1.1	2.5	1.4	0.0	21.0	2.0	0.5	1.7	45.4	0.4	7.3	2.0	0.0	2.1	4.3	11.0	9.5	55.3	0.2	21.3	41.3	208.4	22.7	29.2	2.2	2.8	35.6	501.0	10.8	5.8	1.2	25.4	1.9	22.3	4.7	2.9	12.9	15.5	2.1	0.6	12.7	3.9	1.9	6.9	5.5
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892702-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	20	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	10	"classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 7.5"	"Region enriched"	"Detected in single"	18	"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"	NA	NA					"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.9	0.3	0.0	0.9	0.1	0.6	0.3	0.0	0.4	1.4	3.7			0.7	1.1	0.0	4.2	0.8	1.1	0.5	0.1	0.2	0.4	0.0	0.5	0.4	0.0		1.0	4.9	0.0	1.8	0.4		3.2	0.2		0.3	0.0	0.4	0.7	1.3	0.0	0.2	0.2	1.7	1.8			1.1		0.0	3.0	1.0	0.0	0.0	0.0	3.3	0.0	0.2	0.5	1.3	0.7	0.5	3.3	0.0	0.0	1.7	1.3	0.0	0.0	0.0	2.1	0.8	0.5	0.5	0.0	2.1	0.5	0.0	0.0	0.0	0.2	0.4	0.1	1.8	1.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	2.7	0.0	0.0	4.4	0.5	3.0	2.9	0.4	0.4	3.1	1.9	1.3	0.0	1.1	1.1	1.4	1.1	0.4	1.3	1.0	1.8	1.0	0.4	7.5	1.9	3.0	3.5	0.3	1.2	1.5	1.3	0.9	3.8	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5											3.0	0.6	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 1528.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 197.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		3200000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	42.1	6.0	1.4	18.0	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13.0	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12.0	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68.0	23.6	13.2	0.0	189.3	48.3	38.6	47.7	0.0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15.0	96.4	58.0
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44336986-44351235	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;intestine: 5.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;CACO-2: 3.6;OE19: 3.6;U-2 OS: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA					"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.0	1.5			5.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.5	0.2	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.8	1.4			0.1		0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.3	1.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.6	0.8	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.0	0.2	3.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.4	2.7	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.5	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6"									HPA062673			Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.8	0.0	0.6	2.4	1.1	1.5	0.0	1.2	0.0	0.5	1.3	1.1	2.0	0.7	4.1	0.8	0.2	1.3	0.4	23.4	0.0	0.5	0.0	0.0	2.7	18.7	2.8	1.3	1.3	0.4	0.6	0.2	0.2	0.4	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	2.5	0.3	0.2	9.2	0.4	0.0	0.1	0.3	0.3	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2	0.0	0.0	0.0	4.2	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	9.5
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Cell type enhanced"	"Detected in all"	17	"Exocrine glandular cells: 588.4;Hepatocytes: 2447.4;Muller glia cells: 685.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Group enriched"	"Detected in some"	6	"AF22: 27.8;Hep G2: 40.2;HHSteC: 36.4;NTERA-2: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.3	2.2	5.2	0.8	3.6	0.2	1.6	0.2	3.2	0.6	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.5	40.2	36.4	0.4	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.5	84.7	0.2	0.0	0.0	3.7	0.0	0.6	0.2	0.1	0.3	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4	62.5	30.1	23.0	74.0	31.1	4.9	79.7	318.5	28.1	67.1	78.5	2.0	9.5	87.9	15.0	2.3	24.8	16.7	23.3	588.4	5.3	340.2	52.4	11.5	2447.4	10.5	9.5	93.8	86.5	50.8	10.2	420.5	12.9	42.2	1.8	172.4	685.2	332.8	31.7	183.2	228.5	19.9	12.9	165.1	3.3	5.4	25.2	12.2	17.8	286.2	21.6
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Transport		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 1949.7;Rod photoreceptor cells: 1076.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 2.7;HDLM-2: 2.5;SH-SY5Y: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	125.3	0.3	0.0	0.0	0.0	0.0	1949.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.8	0.0	0.0	0.0	0.0	1076.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 897.1"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 11448.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"classical monocyte: 1.2;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.5;monocytes: 1.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 155.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	420000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	39.0	2.0	1.4	2.4	3.1	0.3	27.0	0.0	2.1	0.3	1.8	0.0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1.0	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0.0	0.0	0.3	0.5	0.2	0.6	1.6	0.0	1.5	0.0	1.2	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	37.5	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	155.4	0.0	1.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.2	0.3	17.6	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	3.1	0.0	2.1	1.4	2.2	0.2	1.1	0.4	0.0	0.0	3.4	60.7	0.2	0.7	0.0	0.4	853.5	1.4	1.2	22.7	5.9	0.2	82.9	7.1	2.2	0.7	2.1	46.7	0.2	11.9	6.8	1.7	0.0	11448.6	18.7	0.0	60.0	171.2	183.3	1.9	2.8	2.0	1.7	0.0	33.0	0.7	46.4	10.5	5.3	393.5	0.2	0.0	0.8	2.8	13.4	0.6	1.1	19.1	1.1	0.9
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123419	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"pancreas: 1772.6"	"Group enriched"	"Detected in some"	77	"Exocrine glandular cells: 99849.5;Pancreatic endocrine cells: 36721.8"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;EFO-21: 11.9;HDLM-2: 9.4;NB-4: 6.8;OE19: 6.6;RPMI-8226: 19.2;SH-SY5Y: 8.3;U-2 OS: 19.2;U-251 MG: 6.4;U-266/84: 6.4"									"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	NA	NA		61000000			"CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			0.3	0.1	0.3	2.8	0.4	0.0	0.3	0.3	0.3	0.3	37.9	0.3	0.3	129.0	0.3	0.3	0.3	0.1	1.3	0.3	0.3	0.0	14.6	0.3	0.3	0.3	0.3	0.3	0.3	1772.6	0.0	0.3	0.3	0.3	0.3	4.5	0.3	0.3	0.4	0.3	0.1	74.7	2.5	0.3	0.3	15.9	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.3	6.6	0.0	0.0	0.0	19.2	0.0	0.0	0.9	8.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.2	1.3	6.4	0.0	6.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.7	590.9	0.1	0.0	50.9	0.0	99849.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	885.5	47.9	0.0	36721.8	17.3	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
REG1B	"PSPS2, REGH, REGI-BETA, REGL"	ENSG00000172023	"Regenerating family member 1 beta"	P48304	2	79085030-79088019	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 969.2"	"Group enriched"	"Detected in some"	70	"Exocrine glandular cells: 30392.9;Pancreatic endocrine cells: 13036.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 201.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.4;HDLM-2: 4.6;RPMI-8226: 3.3;U-2 OS: 17.4;U-251 MG: 4.3;U-266/84: 3.9"									"HPA045549, HPA045579"	Supported				"Secreted to digestive system"	NA	NA		37000000			"HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (4.08e-1)"								"unprognostic (1.09e-1)"		"unprognostic (3.51e-3)"	"unprognostic (9.20e-2)"				0.5	0.1	0.3	3.7	0.4	0.7	0.3	0.3	0.3	0.3	14.3	0.3	0.3	88.2	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.1	0.5	0.3	0.3	0.3	0.3	0.3	0.3	969.2	0.0	0.3	0.3	0.3	0.3	13.2	0.3	0.3	0.3	0.3	1.6	56.3	13.0	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.1	4.3	0.0	3.9	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	7.4	0.0	30392.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	311.0	16.1	0.0	13036.6	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell type enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 8841.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		22000000	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.2	0.0	0.0	0.0	15.7	0.0	0.0	1.2	10.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.4	3.8	7.2	0.0	10.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.8	4.3	0.0	5.2	0.0	1666.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	97.4	19.1	0.0	8841.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 262.6"	"Group enriched"	"Detected in some"	25	"Exocrine glandular cells: 161.0;Pancreatic endocrine cells: 87.4"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;RPMI-8226: 1.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3"									"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			0.1	3.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.8	0.6	0.1	61.1	0.1	0.0	0.1	0.1	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	262.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	2.8	0.3	0.1	0.1	0.0	19.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	1.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	161.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.0	0.0	1.0	0.0	0.0	87.4	0.0	0.7	2.4	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794018-119811660	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 55.1;intestine: 121.9"	"Group enriched"	"Detected in some"	14	"Intestinal endocrine cells: 425.3;Mucus-secreting cells: 633.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 18.1"	"Lineage enriched"	"Detected in single"	115	"T-cells: 18.1"	"Cell line enriched"	"Detected in some"	58	"OE19: 350.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		400000			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.2	0.1	0.2	4.2	0.2	0.0	0.2	0.2	0.2	0.2	55.5	0.3	0.2	36.3	0.2	0.2	1.2	0.1	55.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	23.8	0.0	0.2	0.2	0.2	0.6	43.1	0.2	0.6	0.2	0.2	0.1	121.9	0.8	0.2	0.2	2.2	0.7	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	18.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	350.7	6.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	18.1	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	38.0	0.0	0.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	425.3	0.0	0.0	18.8	0.6	0.0	0.0	0.0	633.6	0.0	2.0	28.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	21.8	0.1
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 182.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		59000000	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	2.4	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.4	0.0	0.0	0.0	8.4	9.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	11.3	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	2.6	0.0	0.0	1.0	0.1	2.4	0.3	0.0	2.4	0.2	0.0	0.0	182.3	9.4	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.5	0.2	0.0	0.0	0.0
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 63.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 6.1;Late spermatids: 19.3"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Region enriched"	"Detected in single"	12	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000				"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	0.4	0.3	0.0	0.0	1.2	0.0	0.5	0.0	0.0	3.1	0.2	0.0	0.8	0.1	4.4	13.5	0.1	0.3	0.0	0.6	0.0	0.0	63.6	0.4	0.3	0.0	0.0	0.0	11.6	0.0	0.0	0.4	14.4	0.0	0.3	0.1	0.4	0.3	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.2	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	4.6	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.2	6.1	0.0	0.0	0.0	1.0	0.2	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	2.7
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 97.8;Kupffer cells: 67.2;Macrophages: 72.2"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Group enriched"	"Detected in some"	11	"NB-4: 102.5;U-937: 47.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	102.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5	11.9	13.5	2.7	0.0	0.2	0.0	0.0	0.0	2.7	7.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	3.5	0.0	97.8	0.0	0.0	0.6	67.2	0.0	0.0	72.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 1.9;Intestinal endocrine cells: 1.7;Late spermatids: 3.5;Mucus-secreting cells: 4.5"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 6.6"					"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000				"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Group enriched"	"Detected in many"	5	"Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		1400000	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	31.0	0.5	6.5	3.6	9.1	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	0.0	2.0	5.2	0.1	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.1	3.8	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.6	9.2	0.1	13.9	0.0	0.0	8.0	7.1	0.0	0.0	0.3	3.3	1.8	0.3	0.1	0.0	1.7	2.5	1.6	0.1	0.0	6.7	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1	0.0	1.0	0.0	15.6	4.8	0.2	3.2	0.0	1.4	2.3	0.0	2.0	3.8	0.0	4.7	0.8	1.1	0.0	0.0	0.6	1.0	7.4	13.3	0.0	0.0	1.8	0.0	0.0	3.1	3.7	2.6	110.1	1.1	3.3	0.0	0.0	4.1	0.6	0.0	110.0	0.0	1.1	12.9	12.3	0.7	37.2	2.5	2.1	0.7	0.0	12.0
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 6.8;Intestinal endocrine cells: 4.6;Spermatocytes: 2.3;Spermatogonia: 2.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;HEL: 4.8;SK-BR-3: 1.1"														"Secreted to blood"	NA	NA						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	1.2	0.0	0.0	0.0	0.4	0.2	0.0	6.8	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.3	2.0	0.1	0.9	0.5	0.2	0.0
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299868-5304969	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 44.0"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 8.6;Spermatocytes: 10.5;Syncytiotrophoblasts: 11.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.7"	"Region enriched"	"Detected in single"	64	"basal ganglia: 44.0"	"Group enriched"	"Detected in many"	39	"gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0"	"Group enriched"	"Detected in many"	47	"B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;HEL: 20.2;T-47d: 5.8;U-266/84: 9.2"														"Secreted to blood"	NA	NA	24400					"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.6	0.0	0.6	1.6	44.0	0.0	3.2	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	7.5	0.6	0.6	0.6	0.6	2.0	0.6	0.7	3.5	0.6	0.6	0.6	0.9	5.2	5.8	0.7	0.6	6.2	0.3	0.6	0.6	0.7	0.6	0.4	0.8	0.6	0.6	1.4	0.4	4.2	0.6	0.6	0.9	0.6	3.0	0.6	0.6	2.8	0.0	0.0	0.0	4.9	6.5	1.4	2.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.3	1.5	5.2	0.4	0.0	0.0	0.9	0.0	2.7	0.7	4.1	1.9	20.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.6	2.7	2.9	0.0	0.6	0.1	0.2	5.8	0.1	0.2	0.0	0.5	0.0	0.1	1.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.5	2.8	4.3	3.5	0.0	2.1	6.2	4.6	0.0	4.9	0.0	0.0	2.0	1.4	0.6	44.0	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	3.0	1.1	0.5	2.3	0.5	1.5	1.6	0.0	4.0	1.2	1.8	0.0	6.0	6.6	2.5	7.4	0.3	0.0	0.0	1.4	1.7	0.2	1.3	0.0	0.0	0.5	3.2	3.5	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.2	8.6	0.7	0.0	0.4	0.8	1.8	0.0	0.1	10.5	2.8	1.1	11.3	2.9	1.0	0.3
RLN3	"H3, RXN3, ZINS4"	ENSG00000171136	"Relaxin 3"	Q8WXF3	19	14028148-14031042	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;parathyroid gland: 5.6;testis: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;K-562: 4.1;SCLC-21H: 1.5;THP-1: 2.3;U-266/70: 1.0;U-698: 1.2"	"Group enriched"	"Detected in some"	11	"midbrain: 14.0;pons and medulla: 28.5"	"Region enriched"	"Detected in many"	10	"pons and medulla: 34.0"						"Secreted to blood"	NA	NA	60000000												"unprognostic (1.96e-2)"		"unprognostic (2.54e-2)"					"unprognostic (3.94e-1)"			0.3	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.9	1.3		0.1	0.0	5.6	0.2	0.0		0.7	0.0		0.8	0.0	0.1	0.0	0.3	0.0	0.0	1.0	0.1	5.0			0.0		0.4	0.2	0.0	2.7	1.8	0.0	1.3	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.9	0.9	1.8	2.7	2.0	1.2	0.0	0.0	0.3	0.0	0.2	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1500000000	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	7.2	0.1	0.0	0.0	0.0	0.5	0.3	16.9	0.0	0.0	0.0	0.3	0.0	29.1	0.3	0.3	0.0	0.2	0.0	0.5	0.0	0.0	38.7	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1	863.6	748.9	16.1	0.9	31.6	0.0	58.9	40.8	58.9	295.7	15.7	0.0	12.0	0.0	8.2	17.6	308.3	107.7	0.0	270.1	10.2	30.9	1.4	23.3	4.9	1257.5	1.6	46.9	532.2	311.7	43.1	29.7	100.6	38.8	4.6	398.3	0.8	308.4	78.7	10.3	0.3	1.8	97.0	15.6	7.0	5.3	24.6	21.6	7.5	165.1	1.7
RNASE10	"RAH1, RNASE9"	ENSG00000182545	"Ribonuclease A family member 10 (inactive)"	Q5GAN6	14	20505537-20511169	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Fertilization"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.0;testis cancer: 1.8"					"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 9.0;U-2 OS: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052593	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA052593: AB_2681878"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.03e-3)"	"unprognostic (5.58e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.88e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.62e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.58e-1)"	3.1	3.2	0.9	2.3	1.1	1.4	1.2	1.4	2.0	1.5	1.0			2.5	3.5	1.6	2.0	3.0	0.7	0.9	1.0	1.0	1.5	2.4	2.5	0.9	1.1		2.6	1.1	0.5	1.7	1.1		1.8	0.2		1.4	0.9	3.0	4.2	2.7	0.5	1.3	1.9	1.7	3.4			1.6		0.2	1.8	1.7	0.9	1.3	3.5	1.3	0.6	0.5	0.1	5.5	2.7	1.1	2.6	0.3	0.6	3.6	0.3	0.6	0.1	0.4	1.8	1.6	0.8	1.8	0.7	0.8	2.9	0.0	0.3	0.2	2.3	0.9	0.1	1.9	0.9	0.8	0.3	2.8	0.9	2.0	0.2	3.0	0.5	1.4	1.0	1.3	3.2	0.0	1.5	0.9	1.6	0.8	0.8	0.4	4.3	0.4	3.3	0.9	2.3	1.6	1.9	9.0	2.3	1.0	1.3	2.2	0.9	0.6	1.0	14.8	1.2	1.1	3.1	1.4	0.4	1.1	0.8	1.2	3.5	0.5	0.0	0.5	0.4	0.4	0.9	0.4	0.2	0.1	0.8	0.2	0.5	2.1	0.6	1.3	1.3	0.1	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
RNASE11	"C14orf6, RAJ1"	ENSG00000173464	"Ribonuclease A family member 11 (inactive)"	Q8TAA1	14	20583559-20609884	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	18	"epididymis: 106.3;testis: 33.6"	"Group enriched"	"Detected in some"	53	"Early spermatids: 32.3;Late spermatids: 41.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.8;RPMI-8226: 1.5;SH-SY5Y: 1.4;U-937: 1.2"									HPA003724	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA003724: AB_1079817"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	106.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RNASE12	RAI1	ENSG00000258436	"Ribonuclease A family member 12 (inactive)"	Q5GAN4	14	20590193-20590823	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	43	"epididymis: 143.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NB-4: 3.7;SH-SY5Y: 1.2"									"HPA044175, HPA059465"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA044175: AB_10960390, HPA059465: AB_2732638"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.6	0.0		0.3	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE13	RAL1	ENSG00000206150	"Ribonuclease A family member 13 (inactive)"	Q5GAN3	14	21032820-21034785	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"epididymis: 95.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA						"unprognostic (2.54e-1)"				"unprognostic (2.52e-1)"		"unprognostic (2.86e-1)"			"unprognostic (8.40e-2)"	"unprognostic (1.93e-1)"		"unprognostic (7.15e-2)"	"unprognostic (1.63e-3)"		"unprognostic (5.20e-4)"	"unprognostic (1.47e-2)"	0.5	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	95.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.8	0.5	0.2	0.2	0.2	0.2	0.9	0.0	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	0.5	0.5	0.2	0.2	0.2	1.9	0.0	1.8	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955452-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 137.2;bone marrow: 236.7"	"Cell type enriched"	"Detected in some"	11	"Kupffer cells: 219.4"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 37.8;eosinophil: 137.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 137.2"	"Group enriched"	"Detected in some"	318	"HL-60: 54.9;NB-4: 54.8;THP-1: 147.0;U-937: 133.3"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		300000000			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	2.7	3.2	4.8	2.0	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0.0	20.0	137.2	11.5	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	54.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	147.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	133.3	0.0	37.8	11.5	137.2	0.0	2.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	1.0	0.0	0.2	0.2	0.0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7	3.0	0.3	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	13.1	0.0	0.0	1.8	219.4	1.1	0.3	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNASE3	"ECP, RAF1, RNS3"	ENSG00000169397	"Ribonuclease A family member 3"	P12724	14	20891399-20892348	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"blood: 60.9;bone marrow: 154.1"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 18.6;Kupffer cells: 6.6;Late spermatids: 7.4;Rod photoreceptor cells: 3.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	21	"eosinophil: 60.9"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 60.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 37.1;NB-4: 12.6;THP-1: 16.0;U-937: 75.8"									HPA056183	Enhanced				"Secreted to blood"	NA	NA	4200000				"HPA056183: AB_2683059"	"unprognostic (2.54e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.21e-2)"		"unprognostic (6.45e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"		"unprognostic (8.62e-7)"	"unprognostic (6.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.37e-1)"	0.2	0.4	1.0	0.2	3.6	154.1	0.1	1.0	3.1	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.2	0.8	0.9	0.1	0.5	3.2	0.2	4.4	0.0	0.2	0.1	0.1	0.3	0.6	1.5	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.1	0.3	2.9	11.8	0.1	1.7	1.9	1.0	0.1	0.0	0.1	0.2	0.0	0.0	2.8	60.9	1.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.8	0.0	1.8	1.8	60.9	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.7	1.0	3.6	1.0	3.1	0.8	0.9	4.4	0.0	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.6	7.4	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684100-20701215	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 366.2"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 43.7;Intestinal endocrine cells: 64.6;Mucus-secreting cells: 108.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;ASC TERT1: 34.3;Hep G2: 42.7;HSkMC: 20.4;OE19: 28.5"	"Low region specificity"	"Detected in all"												"Secreted to blood"	NA	NA		27000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	29.6	1.7	1.5	5.7	1.8	0.2	28.7	1.0	1.2	25.2	16.3	2.5	12.3	4.9	19.2	18.4	14.7	15.7	23.4	10.3	2.3	1.0	18.9	366.2	12.8	5.2	3.0	1.4	30.8	16.3	3.8	3.0	4.4	2.7	30.4	15.0	10.5	35.0	14.2	7.1	10.6	13.6	17.4	3.8	3.2	19.2	13.2	1.9	0.3	8.4	10.5	7.3	25.1	26.3	4.0	9.7	0.5	17.0	0.4	2.5	5.0	0.8	4.0	0.8	0.0	30.3	34.3	0.1	3.3	7.5	0.5	1.4	1.0	1.1	0.0	0.8	7.5	1.9	0.7	0.4	0.8	0.6	5.3	0.4	0.0	0.9	42.7	3.4	0.4	0.1	20.4	1.9	0.5	3.4	10.9	3.9	1.2	0.0	3.7	2.2	0.5	0.2	0.0	0.1	28.5	3.3	0.1	0.6	1.1	0.7	0.7	0.0	0.1	1.2	0.6	0.8	1.4	0.9	0.1	4.0	0.9	0.5	1.2	0.1	0.7	0.9	0.1	1.4	0.3	0.8	0.1	17.0	0.0	0.6	0.9	0.8	4.0	1.1	0.4	9.7	2.2	0.2	0.4	0.5	0.4	0.1	2.3	2.5	5.0	1.5	1.8	1.0	1.2	2.3	1.0	3.0	1.4	2.7	1.9	35.7	15.5	4.2	1.3	2.5	0.0	0.3	22.9	16.0	6.8	3.5	0.0	0.2	0.0	22.2	0.1	1.3	33.7	0.0	19.7	0.3	4.8	1.8	1.1	43.7	1.7	0.0	64.6	5.5	10.3	0.0	11.5	1.9	3.3	1.0	108.1	0.8	15.7	14.0	3.9	8.4	0.2	0.0	7.2	0.2	0.0	3.6	0.3	1.0	34.8	1.0
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781051-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.6"	"Cell type enhanced"	"Detected in many"	23	"B-cells: 117.8;Hofbauer cells: 181.1;Kupffer cells: 514.5;Macrophages: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 117.6"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 33.8"	"Low region specificity"	"Detected in many"							HPA000698	Approved				"Secreted to blood"	NA	NA		2300000			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.0	10.8	7.8	19.3	10.3	7.3	11.9	1.8	7.7	10.7	9.1	7.9	4.6	5.7	5.5	25.9	4.7	7.2	14.6	11.2	7.0	6.5	10.6	8.2	16.4	51.0	10.9	3.3	4.3	4.9	1.3	4.1	13.9	9.8	6.0	10.8	6.9	9.5	5.6	2.7	4.9	23.4	7.2	24.0	49.3	5.8	5.7	10.3	12.8	4.2	3.3	25.5	14.7	4.5	42.2	117.6	33.8	52.0	3.6	1.4	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.8	2.5	0.3	0.1	0.0	0.0	1.0	2.2	0.0	0.0	0.0	0.1	0.0	33.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	33.8	52.0	1.1	0.5	12.2	1.2	28.9	1.4	0.6	49.4	42.2	0.6	0.1	19.0	3.6	0.1	117.6	0.1	26.8	7.8	10.3	1.8	7.7	7.0	6.5	10.9	3.3	9.8	10.3	6.0	12.7	117.8	0.1	3.9	0.0	0.4	22.9	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	2.2	0.8	23.3	0.0	1.5	2.7	0.3	0.0	2.1	181.1	0.0	0.0	11.1	514.5	0.7	2.6	188.7	20.3	1.8	0.3	0.0	0.0	10.5	0.7	0.4	0.4	12.9	0.7	0.0	0.8	3.3	1.8	8.9	2.8	0.8
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042226-21044234	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 23.3;Cholangiocytes: 12.7;Urothelial cells: 17.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.4;hTCEpi: 6.7;hTERT-HME1: 33.4"									"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.3	38.3	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.5	0.2	0.0	3.5	0.2	0.2	14.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	21.4	41.0	0.6	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	15.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.8	0.0	0.4	12.7	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.5	0.0	0.0	17.0
RNASE8	RAE2	ENSG00000173431	"Ribonuclease A family member 8"	Q8TDE3	14	21057822-21058455	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	146	"salivary gland: 38.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SuSa: 1.0"														"Secreted to digestive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE9	"h461, RAK1"	ENSG00000188655	"Ribonuclease A family member 9 (inactive)"	P60153	14	20556093-20560931	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	63	"epididymis: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.6;NB-4: 1.8"														"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	56.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166929504-166957191	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.7"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 343.2;Kupffer cells: 367.0;Macrophages: 275.2;Paneth cells: 280.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 40.0;THP-1: 99.3"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		16000000			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	13.0	9.9	27.8	21.9	23.7	29.4	13.9	3.7	18.6	46.0	21.0	26.3	35.5	15.4	13.8	40.5	10.6	37.6	22.9	8.8	24.9	18.7	12.3	14.3	15.1	45.7	36.0	9.2	13.4	39.5	11.6	12.1	12.9	24.9	18.0	25.0	9.1	30.7	53.1	2.9	10.1	24.6	7.5	43.2	84.7	25.7	5.7	34.5	16.7	22.2	6.3	25.0	13.2	13.9	20.9	56.6	105.7	57.0	4.5	28.0	22.3	3.2	2.7	2.5	7.5	11.7	8.3	2.3	3.3	4.1	1.4	1.4	6.5	4.0	2.4	40.0	8.0	3.3	8.9	4.1	3.6	0.8	4.1	8.0	1.9	4.1	15.9	3.9	31.8	8.9	4.8	6.7	0.8	0.5	6.1	1.9	4.3	5.0	18.6	2.1	8.4	2.7	24.7	1.4	26.9	2.9	6.0	3.4	29.8	26.9	1.9	1.0	7.0	6.9	20.1	1.6	4.7	2.5	99.3	3.9	3.0	2.2	9.6	3.2	4.0	4.5	0.2	6.6	30.6	2.0	16.6	28.7	105.7	5.0	44.5	9.2	20.9	28.0	12.5	36.7	17.6	21.5	6.8	78.7	4.5	57.0	56.6	13.9	22.3	27.8	23.7	3.7	18.6	24.9	18.7	36.0	9.2	24.9	34.5	17.9	34.3	199.1	101.2	38.5	10.0	8.7	48.4	20.1	19.4	36.6	0.0	45.4	19.9	56.6	8.7	19.9	139.7	0.0	24.1	40.5	36.8	50.6	70.4	20.7	343.2	12.7	72.4	20.9	367.0	8.0	32.8	275.2	55.6	38.7	135.0	25.1	53.1	280.5	27.6	13.9	6.8	25.8	14.1	7.1	12.2	30.2	23.2	107.8	184.1	89.4
RNLS	"C10orf59, FLJ11218, renalase"	ENSG00000184719	"Renalase, FAD dependent amine oxidase"	Q5VYX0	10	88273864-88584530	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 13.2;fHDF/TERT166: 12.9;HSkMC: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	10500000000					"unprognostic (3.27e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.71e-1)"	7.1	20.6	3.9	4.9	6.6	2.1	10.2	16.7	10.5	8.9	8.2	5.4	7.5	6.3	8.4	9.4	7.7	6.4	7.2	13.4	3.9	6.4	25.1	13.6	4.0	10.4	4.9	5.7	8.9	10.5	10.9	17.3	2.5	7.5	8.5	9.1	15.1	8.2	5.3	10.0	5.1	7.0	5.6	5.3	7.1	8.7	5.8	3.9	2.1	10.9	6.8	5.0	6.0	6.4	5.3	6.1	2.6	7.0	4.7	5.0	3.4	13.2	6.1	0.3	0.1	2.1	3.0	0.0	3.6	0.4	3.0	2.5	0.8	5.4	0.0	7.4	12.9	0.0	1.9	0.0	0.9	3.0	2.8	0.1	2.2	4.0	0.1	9.7	0.0	0.3	15.5	1.5	8.3	0.0	0.2	4.5	0.1	1.0	7.2	0.1	5.6	0.0	3.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.2	3.4	0.0	0.2	3.1	9.9	4.1	1.8	8.0	1.0	2.2	3.5	5.6	2.9	5.0	5.9	0.1	0.1	7.5	0.0	0.0	4.0	2.6	5.0	7.0	3.6	5.3	3.8	3.5	6.1	4.5	3.9	3.1	0.2	4.7	4.6	5.6	1.7	3.4	3.9	6.6	16.7	10.5	3.9	6.4	4.9	5.7	7.5	3.9	3.0	1.0	2.2	5.9	2.9	6.0	15.9	7.6	1.4	2.3	1.8	2.0	1.5	19.9	5.0	5.1	1.1	6.3	0.0	8.4	0.4	2.7	6.2	1.1	9.6	5.7	4.8	5.2	2.5	4.5	3.6	1.4	2.8	3.3	4.6	5.7	6.3	4.6	8.7	6.0	32.7	5.2	0.0	4.1	2.3	6.1	4.8	1.4	2.2	6.6	5.7
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;hTCEpi: 1.9"									"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	71.0	33.2	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639910-18672109	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 54.9"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 121.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA059546	Enhanced				"Secreted in other tissues"	NA	NA					"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.1	0.0	1.0	0.1	2.3	0.0	0.1	0.6	3.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.4	0.1	5.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	54.9	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.1	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.0	1.0	2.3	0.6	2.4	1.0	0.4	0.1	0.1	0.1	0.1	6.0	0.0	0.0	0.0	0.0	12.9	0.8	0.0	0.0	0.0	0.0	151.2	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	121.9	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634923	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 17.3;endometrium 1: 26.6"	"Cell type enhanced"	"Detected in some"	18	"Fibroblasts: 4.7;Melanocytes: 1.7;Smooth muscle cells: 4.1"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 1.8;NTERA-2: 4.6;THP-1: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.0	0.1	0.2	1.9	0.3	0.0	5.8	0.5	0.6	17.3	2.1	0.2	0.2	0.6	26.6	3.0	1.8	15.8	12.2	0.4	0.2	0.0	0.7	0.2	4.5	1.9	0.2	0.2	7.5	1.6	0.0	0.2	1.3	0.4	3.0	0.2	2.3	1.5	1.4	0.2	4.0	3.1	10.9	0.2	0.7	2.0	1.0	0.2	0.2	0.2	1.3	6.1	1.3	8.8	0.4	0.3	0.7	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	4.7	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.7	0.0	0.5	0.3	0.3	0.0	0.2	0.3	0.5	0.6	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083648	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.0;placenta: 20.1"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 1.4;Late spermatids: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	17	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.6;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.6;U-266/70: 10.7"	"Group enriched"	"Detected in some"	7	"amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2"	"Group enriched"	"Detected in many"	5	"amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031"	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	3.9	1.4	6.3	0.5	0.2	1.9	27.0	3.6	12.0	4.2	3.6	5.1	0.3	3.6	8.9	0.2	4.8	0.5	5.8	10.5	0.2	1.1	9.3	0.2	15.7	5.4	1.1	0.2	0.2	2.8	20.1	2.0	11.6	10.1	15.5	0.2	3.4	0.3	0.3	5.8	0.7	1.3	0.2	8.3	2.0	1.7	0.0	0.2	0.0	0.2	2.2	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	0.2	0.1	0.0	10.7	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.3	1.9	27.0	5.8	10.5	15.7	5.4	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118604-127197765	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Fibroblasts: 10.4;Ito cells: 16.0;Leydig cells: 25.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.7;hippocampal formation: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.5;BJ hTERT+: 4.1;hTERT-RPE1: 7.8;U-138 MG: 5.2;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 32.5"	HPA029957	Uncertain				"Secreted to blood"	NA	NA					"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	18.5	10.5	2.8	12.1	0.8	0.0	40.7	5.7	2.3	12.9	8.5	0.0	23.8	1.2	50.3	32.5	23.7	14.9	7.6	4.2	20.5	1.7	3.3	4.2	3.8	10.2	0.8	2.4	13.2	1.5	0.0	2.6	24.1	0.8	10.2	4.7	8.6	3.9	15.3	19.7	2.2	6.7	34.1	0.6	1.4	10.8	12.4	0.0	0.2	2.9	2.1	0.9	9.3	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.2	0.5	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	7.8	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	5.2	2.0	0.7	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.8	5.7	2.2	20.5	1.7	0.8	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	10.8	2.8	0.0	0.0	0.0	1.0	10.4	0.6	0.0	0.0	1.3	0.0	0.0	16.0	0.3	1.1	25.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	2.7	0.0	0.1	0.1	1.4	0.0	0.0	0.1
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002264	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;lung: 12.0"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 6.3;Fibroblasts: 1.8;Late spermatids: 4.5;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;EFO-21: 3.3;fHDF/TERT166: 3.5;NTERA-2: 9.1;SK-BR-3: 6.3;U-2 OS: 10.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA048887	Uncertain				"Secreted in other tissues"	NA	NA					"HPA048887: AB_2680545"	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	1.0	0.8	2.0	1.7	6.2	0.2	1.7	0.5	2.4	2.0	0.3	1.6	0.0	0.7	0.3	4.2	2.3	3.1	1.5	1.1	2.8	9.0	0.3	0.5	12.0	0.4	4.5	0.8	0.4	0.4	0.4	1.7	0.9	17.5	0.6	0.3	3.7	0.3	0.9	0.2	3.1	0.4	1.8	2.0	0.3	0.5	3.4	1.4	0.0	5.4	0.6	1.3	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.7	0.0	0.1	0.0	0.0	0.0	1.2	3.3	3.5	0.4	0.1	0.0	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.3	0.0	0.0	0.1	0.1	0.0	0.0	10.8	0.0	0.0	2.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.5	1.6	2.8	9.0	4.5	0.8	17.5	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.1	1.1	0.4	0.2	0.0	0.0	0.0
RSPRY1	KIAA1972	ENSG00000159579	"Ring finger and SPRY domain containing 1"	Q96DX4	16	57186137-57240475	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003729	Approved				"Secreted to blood"	NA	NA					"HPA003729: AB_10964215"	"unprognostic (2.73e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.81e-3)"	19.7	15.5	15.6	11.8	17.8	7.2	15.5	15.7	16.5	22.5	17.2	21.0	22.5	18.2	25.2	15.2	17.4	14.5	18.9	11.0	14.8	14.7	22.2	24.3	12.7	17.1	14.4	15.4	18.7	22.8	21.2	17.4	24.4	11.4	16.8	19.2	17.6	16.6	21.0	14.2	15.6	28.4	20.6	12.7	15.7	16.6	24.0	14.3	25.4	20.8	13.7	19.3	20.6	15.1	24.5	23.5	26.5	29.7	22.5	26.1	15.8	8.3	13.1	20.7	10.5	13.1	16.5	12.2	15.1	15.5	20.5	16.4	13.9	11.1	12.0	19.6	20.2	14.2	11.1	17.9	14.7	23.5	7.6	7.4	6.4	9.7	19.6	17.1	11.2	17.3	20.0	14.4	20.2	28.3	15.5	27.6	13.9	10.4	5.0	17.7	4.7	18.8	7.4	13.2	14.1	14.5	24.3	14.1	11.0	24.2	8.7	6.9	15.5	24.3	9.2	6.3	12.2	8.9	11.0	19.1	14.7	14.2	9.1	12.1	13.0	11.6	19.4	12.8	10.8	15.5	19.8	20.3	26.5	23.8	22.4	22.0	24.5	22.2	22.2	23.5	21.6	26.1	24.7	22.6	22.5	29.7	14.9	26.0	15.8	15.6	17.8	15.7	16.5	14.8	14.7	14.4	15.4	11.4	14.3	29.8	9.6	18.5	19.8	30.2	16.3	15.3	40.8	14.7	14.8	17.4	9.8	23.8	21.6	21.7	98.2	20.4	22.3	23.3	20.3	32.5	30.1	22.7	10.4	37.0	14.8	14.3	20.6	17.8	21.1	39.1	18.7	15.4	13.5	25.2	30.4	21.1	21.2	21.0	20.1	22.5	18.3	6.5	23.4	39.5	56.2	32.4	23.3	17.0	21.9	16.6
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373706-153375649	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7"	"Cell type enriched"	"Detected in some"	33	"Kupffer cells: 1264.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"classical monocyte: 91.9;neutrophil: 139.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 139.8;monocytes: 91.9"	"Group enriched"	"Detected in some"	7	"hTCEpi: 6.6;SK-BR-3: 2.2;THP-1: 4.2"					"Not detected"	"Not detected"			"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	NA	NA	28500000	6200000			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1.0	3.5	1.1	0.2	0.0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4.0	34.4	27.4	3.3	0.0	1.5	5.0	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36.0	0.2	9.6	139.8	91.9	0.0	0.1	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	91.9	0.3	0.1	3.3	0.0	0.2	0.0	0.1	9.6	0.0	0.0	0.0	139.8	0.0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1.0	0.7	0.8	3.3	0.0	2.8	0.5	17.9	38.5	0.0	0.2	0.1	0.0	0.4	7.6	13.4	10.3	1.8	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	12.8	3.0	9.0	0.0	0.0	11.1	1264.6	0.7	0.0	35.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 94.7;SuSa: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	21.1	17.7	20.5	13.0	18.1	53.1	7.4	29.4	46.6	17.8	20.5	17.2	23.6	0.5	55.9	49.8	2.6	20.2	8.5	18.2	15.8	0.0	7.9	1.3	22.2	14.6	12.0	0.6	4.6	42.7	6.9	15.9	17.2	52.5	40.2	0.1	6.8	0.0	55.3	74.9	0.0	0.3	16.5	18.2	53.5	3.3	21.2	0.1	94.7	16.2	6.3	0.2	62.8	32.4	63.5	111.1	26.4	0.7	56.9	12.3	6.9	16.4	35.3	0.2	0.5	0.9	22.0	0.3	7.2	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5	26.8	88.4	17.1	154.8	98.1	2.0	108.1	175.8	60.2	93.3	441.4	0.0	118.0	210.5	277.9	6.5	300.3	126.3	46.7	281.2	170.7	294.9	188.4	23.1	34.1	128.8	0.0	119.8	371.4	32.4	21.5	714.6	43.9	226.0	20.8	107.7	97.5	336.0	115.8	295.2	330.9	5.7	0.0	84.3	7.5	18.3	66.1	62.5	8.6	64.8	157.7
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 7.4;SK-BR-3: 17.3"									"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	NA	NA		17000000	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.8	17.3	0.0	1.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	78.3	22.1	0.0	0.0	0.4
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Cell type enriched"	"Detected in many"	13	"Kupffer cells: 10543.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Group enriched"	"Detected in some"	28	"hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	530000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.7	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	28.2	0.0	0.9	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.4	103.3	0.0	0.0	0.7	54.9	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9	208.4	808.2	43.2	0.7	17.4	0.0	2.9	56.0	117.8	215.0	14.0	0.0	4.1	0.0	0.1	217.1	1.6	0.0	23.3	0.8	8.6	1.6	0.4	209.3	16.4	431.8	0.0	0.0	84.7	10543.8	69.5	3.7	783.2	0.0	0.0	0.0	0.0	0.9	0.0	1.4	14.7	0.0	0.0	1.0	2.2	0.5	99.0	5.6	20.3	0.0	19.6
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 11072.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 233.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	36.6	0.0	0.0	2.2	0.0	15.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.7	0.0	0.8	0.0	0.0	0.0	0.7	0.3	0.0	2.9	0.0	0.3	0.0	0.2	0.0	0.0	0.5	7.7	0.0	9.5	0.1	0.0	0.3	233.1	0.1	0.1	3.6	29.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.7	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4	214.4	574.2	57.1	52.5	17.7	0.0	2.5	66.2	112.4	185.4	34.9	0.0	111.0	5.0	49.4	1.3	7.0	0.5	23.3	32.9	44.2	7.1	19.6	151.1	16.4	1627.6	0.0	0.0	71.2	11072.0	2.2	5.5	1162.8	0.0	4.6	2.1	0.0	10.3	0.8	0.0	16.3	0.2	0.0	2.5	0.3	1.3	29.1	1033.7	24.9	1.9	291.7
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266174-18269977	"Disease related genes, Predicted secreted proteins"	"Acute phase"	Heparin-binding	Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 216.6;liver: 849.2"	"Cell type enriched"	"Detected in many"	26	"Hepatocytes: 59557.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;monocytes: 2.6;T-cells: 1.1"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 163.9"														"Secreted to blood"	NA	NA	300000000	22000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	216.6	4.3	0.8	17.4	0.8	0.0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0.0	0.8	1.1	1.0	1.0	2.9	1.0	0.8	0.0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0.0	1.0	0.9	0.8	1.1	0.3	0.8	50.3	1.0	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1.0	1.0	1.1	1.1	1.1	1.3	2.1	0.3	0.0	2.6	0.0	1.1	0.0	11.1	0.0	0.0	0.0	8.1	0.0	4.4	0.3	0.2	0.0	0.0	0.0	3.9	0.0	9.0	0.0	3.0	10.5	0.0	163.9	0.0	0.1	0.0	0.1	0.0	0.0	35.7	0.2	0.0	14.5	19.5	0.0	18.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.2	0.0	0.0	0.9	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.6	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8	6.0	3.2	650.1	44.2	8.2	0.0	0.0	1340.1	38.8	118.3	52.4	0.0	0.9	0.0	161.5	0.0	0.0	2.5	1565.2	69.5	20.1	0.8	164.4	2.3	59557.7	0.9	0.0	1.7	2316.5	1468.3	0.0	0.0	0.1	49.0	4.6	0.0	0.0	82.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.7	34.8	0.0	187.8
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248643	"Disease related genes, Predicted secreted proteins"	"Acute phase"		Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 752.1"	"Cell type enriched"	"Detected in many"	23	"Hepatocytes: 22104.6"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 15.5;EFO-21: 11.9;GAMG: 11.3;HaCaT: 14.6;HBEC3-KT: 31.6;HSkMC: 10.3"														"Secreted to blood"	NA	NA		11000000000				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	68.6	1.7	0.7	16.3	0.7	0.0	9.8	0.7	0.7	33.1	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.3	1.2	0.7	0.7	0.0	0.7	752.1	0.8	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.8	0.0	0.7	46.0	0.7	5.2	0.3	0.7	0.7	0.7	0.7	0.2	0.7	0.7	1.1	0.7	0.7	0.7	1.1	0.7	2.0	1.0	3.1	1.2	0.6	0.9	0.4	15.5	0.0	0.1	0.1	0.6	0.0	2.2	0.0	0.5	0.0	0.2	0.0	6.9	0.1	11.9	0.1	11.3	14.6	0.0	31.6	0.1	0.6	0.0	0.5	0.2	0.0	4.6	0.4	0.1	10.3	4.4	0.0	5.2	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	7.1	0.7	0.1	0.0	1.1	4.9	0.0	0.3	0.2	0.3	0.1	0.1	0.7	0.3	0.6	0.2	0.4	1.0	0.0	0.6	0.2	3.0	1.2	1.0	0.6	0.6	0.9	0.8	0.6	0.4	0.3	2.0	0.4	0.6	3.1	0.6	1.0	1.0	0.9	0.4	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.7	0.0	1.0	517.5	4.2	0.9	0.0	0.2	578.4	18.7	30.7	3.5	0.0	0.2	0.0	35.2	1.3	0.0	1.4	864.3	29.6	1.8	0.2	32.1	0.0	22104.6	0.3	0.0	0.0	951.4	647.2	0.4	0.0	0.4	8.5	1.8	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	4.8	0.0	62.9
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231349-18236893	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	132	"liver: 263.3"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 1790.2"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	72000000000			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	0.7	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	22.6	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	14.7	0.0	0.0	0.0	0.0	25.5	0.0	4.5	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	23.3	1.1	0.0	0.0	0.1	0.0	1790.2	0.1	0.0	0.0	32.5	38.1	0.7	0.0	0.0	1.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 889.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5"					"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		62000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.2	35.2	0.0	1.6	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	47.6	2.6	9.5	2.3	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	5.9	1.2	16.3	0.4	0.1	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	13.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	889.6	0.2	0.0	0.0	0.1
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064540-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.7;urinary bladder: 47.9"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 40.1;Muller glia cells: 43.4;Peritubular cells: 25.1;Smooth muscle cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 10.0;RPTEC TERT1: 18.1;SuSa: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		19000	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.7	3.0	0.6	1.7	0.7	0.3	6.7	2.6	0.7	6.5	4.2	2.9	16.5	0.8	4.9	18.1	9.6	8.2	3.0	3.5	1.1	0.8	14.4	0.6	5.0	2.4	2.5	0.9	9.0	1.2	0.0	1.7	9.3	5.4	19.4	1.1	4.3	4.3	25.4	1.1	1.8	2.6	66.7	15.7	1.1	9.9	5.6	0.7	0.1	3.2	2.5	0.9	47.9	7.6	0.9	1.2	1.1	0.4	1.5	0.8	0.3	0.3	0.2	0.5	0.6	0.0	0.0	1.4	10.0	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.3	0.0	0.0	0.4	0.3	1.0	0.5	0.2	0.2	0.2	0.0	18.1	0.1	0.6	0.5	1.1	0.4	0.1	3.6	0.2	0.1	0.5	0.2	1.7	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.7	0.4	0.4	0.6	0.0	0.1	0.4	0.6	0.7	0.1	0.9	0.4	0.8	1.1	1.5	0.4	1.2	0.2	0.3	0.6	0.7	2.6	0.7	1.1	0.8	2.5	0.9	5.4	0.7	8.9	0.0	0.0	4.1	1.1	2.6	1.1	7.6	0.0	0.0	40.1	2.0	0.2	1.7	1.0	5.8	1.5	0.0	0.0	0.0	0.2	14.3	1.6	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.6	11.2	0.0	3.3	0.0	0.0	43.4	0.8	0.0	25.1	0.7	1.8	6.5	30.8	10.3	2.1	1.1	0.3	0.0	0.0	0.3
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 124.4;Intestinal endocrine cells: 272.8"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	4.0	1.1	25.5	0.1	0.2	0.9	1.8	4.7	0.2	0.4	0.0	0.4	0.3	2.9	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.3	0.3	2.1	21.8	0.1	2.7	0.9	21.8	0.0	0.0	0.1	0.2	2.3	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	22.2	9.7	0.0	0.2	1.1	0.8	0.0	0.0	0.0	2.5	1.0	0.1	1.6	0.0	0.0	0.1	0.7	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0	6.0	0.0	0.0	0.2	0.0	124.4	0.2	0.0	1.4	2.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.1	7.9	272.8	1.3	0.8	0.0	0.6	0.0	1.7	0.0	0.7	11.9	24.2	2.9	0.4	0.0	12.7	0.0	0.5	0.1	0.2	0.1	0.1	0.0	0.3	0.6
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681353-51721031	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 118.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 115.1;Cone photoreceptor cells: 96.2;Horizontal cells: 139.8;Intestinal endocrine cells: 142.5;Rod photoreceptor cells: 63.1"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NTERA-2: 20.4;SCLC-21H: 48.9;SH-SY5Y: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		4800000	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	1.7	12.9	29.6	2.1	25.4	1.7	1.7	33.4	118.3	1.5	2.4	6.5	0.0	2.9	1.5	1.6	1.6	1.6	1.6	1.5	22.6	23.5	1.5	1.5	1.8	1.7	13.6	37.7	1.5	11.5	1.4	23.7	1.5	27.1	1.6	2.8	1.3	1.5	1.4	1.5	1.8	2.6	1.7	13.2	1.5	8.7	2.9	7.3	0.0	2.1	0.0	1.5	1.6	0.1	0.9	1.2	1.9	0.5	0.3	0.8	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	20.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	48.9	23.1	0.1	0.1	0.0	6.6	0.0	1.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.1	4.3	0.4	0.4	0.6	0.8	0.2	0.5	0.9	0.6	0.4	0.4	0.7	0.5	0.6	1.9	0.3	0.5	1.2	0.2	0.2	29.6	25.4	33.4	40.6	22.6	23.5	13.6	37.7	27.1	7.3	0.0	0.0	0.0	0.0	0.2	115.1	0.2	0.0	0.0	0.0	0.0	96.2	0.0	1.7	0.4	13.3	0.6	0.0	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.4	139.8	142.5	1.8	0.0	9.2	0.0	0.0	1.7	11.8	0.2	11.7	8.7	0.0	0.4	0.0	63.1	0.0	0.1	15.8	4.9	0.0	0.0	0.0	0.2	0.0
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell type enriched"	"Detected in many"	6	"Intestinal endocrine cells: 452.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 15.0;HSkMC: 18.6;NTERA-2: 8.4;SCLC-21H: 17.2;SH-SY5Y: 19.9;U-87 MG: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.1	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.1	0.0	0.2	1.1	0.2	0.9	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	15.0	0.1	0.4	18.6	0.1	0.4	0.2	0.5	0.3	0.5	0.1	0.3	0.4	0.0	0.1	0.2	8.4	0.0	0.4	0.0	0.2	0.3	0.2	0.0	17.2	19.9	0.1	0.0	0.1	0.2	0.0	0.2	0.0	2.9	1.9	0.1	0.2	0.3	1.2	0.2	26.1	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5	0.0	0.3	0.0	0.2	0.6	53.1	0.3	0.0	0.0	4.5	0.0	2.0	0.1	0.0	0.5	43.4	0.1	0.4	0.0	71.7	0.2	2.6	1.8	2.3	13.0	6.3	47.7	452.1	0.6	1.2	72.8	2.0	1.2	3.3	1.0	3.1	11.2	35.0	0.0	7.4	0.0	20.6	0.0	0.4	6.4	0.9	0.3	0.2	0.0	0.7	0.1
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"lung: 508.4"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 14233.6;Club cells: 50441.2"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	69	"HaCaT: 212.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	NA	NA		17000000			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	28.7	0.0	0.1	0.0	0.1	0.0	0.0	508.4	0.0	0.1	0.0	9.4	0.2	0.0	7.4	0.0	0.1	7.6	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.3	4.8	0.1	0.1	0.0	0.8	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	1045.2	3052.9	0.0	40.1	0.0	0.0	0.0	0.0	14233.6	50441.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	57.7	637.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	571.9
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193080-194573	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 7.0;pancreas: 5.9;salivary gland: 7.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"basophil: 5.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.2;U-266/70: 2.0;U-266/84: 1.0"														"Secreted - unknown location"	NA	NA															"unprognostic (5.09e-3)"								0.1	0.7	0.1	0.1	0.1	2.5	0.4	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.7	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	5.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	7.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137526-139067	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"blood: 4.5;pancreas: 3.6"	"Cell type enhanced"	"Detected in single"	34	"Muller glia cells: 2.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Group enriched"	"Detected in some"	18	"basophil: 2.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	6	"PC-3: 1.4;U-266/70: 2.2"														"Secreted - unknown location"	NA	NA															"unprognostic (4.65e-2)"								0.0	0.0		0.7		0.6	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.6			0.0	0.0	0.1	0.0			0.0	3.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 11.9"														"Secreted in other tissues"	NA	NA									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	5.4	0.1	0.1	0.1	0.0	1.1	0.1	1.4	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 781.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.7"									HPA035318	Approved				"Secreted in other tissues"	NA	NA					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.7	0.2	0.0	2.5	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5	0.0	0.0	0.0	5.0	24.4	0.5	6.5	0.0	0.0	0.0	7.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	31.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	781.1	0.0	0.0	17.0	0.0	0.0	0.0	13.2	0.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	1.0
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	14	"Early spermatids: 8.7;Late spermatids: 7.4"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HL-60: 3.2;Karpas-707: 1.0;RPMI-8226: 1.8"														"Secreted in female reproductive system"	NA	NA									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208668-62213939	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 191.8;epididymis: 135.9"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 61.1;Ciliated cells: 107.1;Glandular cells: 36.8;Intestinal endocrine cells: 35.6;Mucus-secreting cells: 60.0"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 971.9;ovarian cancer: 208.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 14.0"									HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (1.22e-4)"	"prognostic favorable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.2	0.5	0.2	0.0	6.8	0.2	0.3	191.8	1.0	0.3	20.8	0.0	40.8	135.9	1.0	28.7	2.5	0.4	0.2	0.3	1.2	0.4	0.9	0.2	0.2	0.3	5.6	2.2	0.0	1.5	0.7	0.5	1.2	1.3	0.2	18.8	1.4	0.2	2.3	0.3	0.2	0.2	0.2	4.3	4.5	0.2	0.3	0.8	1.1	3.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.1	0.0	1.1	0.2	0.0	2.6	0.6	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.2	0.0	3.7	0.0	4.1	0.1	0.0	0.0	61.1	107.1	11.4	15.7	0.0	0.1	3.3	4.8	0.0	0.0	2.6	0.0	4.7	0.0	0.0	36.8	0.0	0.0	3.7	0.0	35.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	60.0	0.0	14.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	3.9
SCGB2A2	"MGB1, MGC71974, UGB2"	ENSG00000110484	"Secretoglobin family 2A member 2"	Q13296	11	62270155-62273156	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 300.8"	"Cell type enriched"	"Detected in some"	38	"Melanocytes: 1671.9"	"Cancer enriched"	"Detected in many"	23	"breast cancer: 823.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	118	"SK-BR-3: 20.3"									CAB026270	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB026270: AB_912980"	"unprognostic (2.38e-1)"	"unprognostic (7.28e-2)"		"prognostic favorable (9.57e-8)"						"unprognostic (4.17e-1)"				"unprognostic (3.75e-1)"				2.9	0.0	0.2	0.2	0.2	0.0	300.8	0.2	0.2	34.4	0.2	0.2	0.2	0.0	0.6	0.2	7.2	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	13.9	0.2	0.2	75.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.6	5.9	0.2	0.9	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1671.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 7.3;Late spermatids: 26.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.4"									HPA046806	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.4	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.7	0.1	0.6	0.7	1.4	1.2	0.3	1.5	0.6	0.7	2.2	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	1.4	0.0	2.1	0.2	4.4	0.4	1.3	0.6	2.0	0.5	1.1	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	0.7	1.3	0.5	0.8	1.5	1.1	1.0	0.3	3.9	1.8	1.4	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Group enriched"	"Detected in many"	8	"Ciliated cells: 4434.1;Club cells: 12751.6"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 6.4;T-47d: 2.3;U-2197: 2.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	6.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1	160.8	1144.5	0.0	27.2	0.5	0.0	0.3	677.7	4434.1	12751.6	0.0	0.0	0.0	0.0	2.1	0.1	5.5	0.0	0.0	1.4	0.2	0.3	164.9	32.5	0.0	0.3	0.0	0.0	35.6	0.0	0.0	0.6	6.2	5.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	4.3	0.0	398.4
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 248.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 3186.5;Club cells: 12064.6"	"Cancer enriched"	"Detected in some"	10	"lung cancer: 211.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Cell type enriched"	"Detected in single"	40	"basophil: 30.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 22.2;EFO-21: 13.9;NTERA-2: 15.9;PC-3: 78.6;SuSa: 33.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (3.85e-1)"	"unprognostic (1.77e-1)"			"unprognostic (2.99e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.84e-2)"		"unprognostic (3.17e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.90e-8)"	"unprognostic (9.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.11e-2)"	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	248.0	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.1	1.0	0.1	0.0	0.1	1.7	0.4	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.2	0.3	30.1	0.5	0.7	0.2	0.0	22.2	0.3	0.3	0.5	0.3	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.3	0.1	13.9	0.0	0.2	0.2	0.6	0.3	0.1	0.0	0.4	0.8	2.4	0.0	0.0	0.1	0.8	0.3	0.2	0.1	0.0	0.5	0.0	0.0	0.6	0.3	0.0	0.4	0.2	0.2	15.9	0.0	78.6	0.0	0.2	0.0	0.3	0.1	1.1	0.3	3.1	0.3	0.0	33.3	0.3	0.1	0.4	0.3	9.3	0.4	0.3	0.4	0.3	0.1	0.1	0.3	1.0	30.1	0.5	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.1	574.7	3186.5	0.0	0.0	0.0	0.0	0.0	0.0	1145.6	12064.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	97.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978105-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 113.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 80.9;U-266/70: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	29.5	54.1	14.7	12.6	10.2	17.8	25.8	8.8	14.8	21.5	17.6	12.8	50.1	8.8	17.5	24.1	25.9	14.6	20.7	25.0	10.2	11.8	24.8	8.7	25.6	24.5	12.2	14.3	19.9	9.4	113.9	13.6	7.6	14.2	24.6	9.5	13.4	31.5	37.6	6.4	17.8	15.9	23.2	13.9	22.3	20.8	7.7	10.8	2.4	62.7	14.1	25.3	24.7	20.8	14.1	23.4	60.8	44.8	4.6	3.0	20.3	9.7	6.0	9.3	8.6	80.9	18.1	5.2	4.7	23.7	8.3	16.6	2.8	6.2	13.2	27.6	11.2	14.4	9.5	4.4	21.2	8.8	17.7	7.7	3.9	6.0	1.6	18.5	8.1	40.3	21.9	9.1	10.7	8.3	7.7	13.8	5.0	1.1	47.3	11.9	4.2	3.6	20.2	4.2	3.0	8.7	5.1	11.4	8.5	1.8	30.2	2.9	7.2	11.9	9.0	7.0	11.2	4.0	20.7	7.4	25.2	6.7	14.8	5.3	53.4	39.1	7.2	17.6	5.8	6.9	0.3	44.8	60.8	3.0	27.1	1.9	12.9	2.1	1.9	23.4	14.1	2.9	2.9	7.3	4.6	25.3	4.5	2.5	20.3	14.7	10.2	8.8	14.8	10.2	11.8	12.2	14.3	14.2	10.8	41.7	48.6	36.6	158.5	21.1	14.6	27.4	12.7	200.8	135.4	90.7	15.7	8.4	16.6	13.6	0.9	22.1	2.6	23.3	6.1	13.6	64.4	62.4	8.1	19.2	144.9	9.5	23.4	64.4	136.9	1.1	59.5	105.4	23.6	80.2	3.1	27.2	6.2	1.5	64.0	24.5	16.3	51.8	42.2	3.2	7.9	17.3	9.3	20.8	3.5	121.2
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 148.4"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"HSkMC: 6.8;WM-115: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA					"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	5.8	3.1	19.2	2.6	18.6	2.2	2.3	6.0	30.6	2.1	2.9	15.9	4.0	2.5	2.5	7.7	2.3	2.1	5.1	3.6	19.9	12.0	1.5	1.4	1.5	1.5	24.9	12.9	1.6	1.8	1.2	1.1	1.6	20.5	6.4	2.7	0.0	3.4	11.6	1.9	2.0	2.0	15.6	33.4	2.4	2.8	16.3	22.5	0.0	1.5	0.3	1.3	4.1	1.0	1.4	1.3	4.4	1.8	1.6	1.0	0.4	0.1	0.0	0.9	0.3	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.8	0.2	0.2	6.8	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.1	19.8	3.9	1.8	1.2	0.8	1.2	0.6	0.8	0.6	0.7	0.7	1.4	0.8	1.0	4.4	1.6	1.3	1.3	0.5	0.4	19.2	18.6	6.0	16.7	19.9	12.0	24.9	12.9	20.5	22.5	0.0	4.0	0.5	1.0	3.2	11.8	0.8	0.0	1.4	1.2	0.0	35.3	0.2	0.0	0.2	14.9	2.0	0.0	0.0	0.0	0.2	5.2	1.4	9.2	0.0	0.5	15.9	1.2	6.2	3.1	21.8	24.2	1.6	21.9	0.0	0.0	148.4	0.1	0.0	19.4	0.0	30.2	12.9	10.9	1.9	2.2	2.3	0.6	3.9	0.2	0.7
SCT		ENSG00000070031	Secretin	P09683	11	626431-627143	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 39.8;intestine: 52.3"	"Cell type enriched"	"Detected in some"	44	"Intestinal endocrine cells: 257.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	152	"plasmacytoid DC: 39.8"	"Lineage enriched"	"Detected in single"	152	"dendritic cells: 39.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;HSkMC: 5.5;U-266/70: 2.9"					"Low region specificity"	"Detected in many"			HPA050961	Enhanced				"Secreted to blood"	NA	NA	571000				"HPA050961: AB_2681291"	"unprognostic (5.28e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.45e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-1)"	0.2	0.1	0.2	0.4	0.3	0.5	0.2	0.5	0.4	0.2	52.3	0.3	0.2	30.4	0.3	0.5	0.2	0.1	0.2	2.3	0.3	0.4	0.4	0.4	3.1	1.1	0.3	0.2	0.3	0.2	0.0	2.6	0.5	0.4	1.0	0.1	3.6	1.4	0.2	11.5	0.1	10.5	0.2	0.5	3.9	0.7	3.5	0.2	0.2	0.6	1.6	0.7	0.4	0.2	0.0	39.8	0.0	0.0	0.2	0.0	0.1	0.4	2.3	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.6	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.5	0.0	0.7	0.0	0.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.0	0.2	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.7	0.6	0.2	0.2	0.0	0.0	0.6	1.0	0.0	0.4	2.9	1.0	0.3	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.8	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.4	0.3	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	3.5	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.2	0.0	257.8	0.6	0.0	0.6	1.4	0.0	0.0	0.0	3.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.2	0.4	1.6	0.1	0.0	0.0	1.2	0.1
SCUBE1		ENSG00000159307	"Signal peptide, CUB domain and EGF like domain containing 1"	Q8IWY4	22	43197283-43343388	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.8;retina: 48.1"	"Cell type enriched"	"Detected in many"	5	"Peritubular cells: 42.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Group enriched"	"Detected in some"	4	"HMC-1: 32.9;THP-1: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003190	Approved				"Secreted to blood"	NA	NA	2170000	130000			"HPA003190: AB_1079882"	"unprognostic (5.29e-2)"	"unprognostic (7.15e-6)"	"unprognostic (6.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-3)"	3.3	5.3	0.4	1.1	2.0	0.1	3.5	0.3	2.3	1.3	5.5	0.9	1.3	5.9	1.3	0.7	14.8	1.2	0.8	1.0	0.5	0.7	3.4	4.6	7.5	0.1	3.4	1.9	35.8	0.4	0.3	3.8	3.5	1.9	6.4	2.0	48.1	5.3	0.5	8.0	0.6	7.6	1.0	3.5	6.9	7.3	8.5	0.1	0.0	3.1	0.5	0.1	4.2	6.3	0.3	0.3	2.4	0.3	0.5	0.3	0.1	0.0	0.0	1.4	5.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.2	0.0	13.0	0.0	0.2	0.1	0.4	0.0	1.4	2.5	0.0	0.3	0.0	0.1	2.4	0.2	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.2	0.1	0.4	2.0	0.3	2.3	0.5	0.7	3.4	1.9	1.9	0.1	8.9	1.7	0.0	0.0	0.2	0.0	1.1	0.0	1.4	1.2	0.0	0.0	0.1	1.7	0.0	2.3	0.6	0.0	0.0	0.0	8.9	0.9	0.0	1.1	1.1	0.7	0.0	0.0	0.6	0.0	2.6	7.2	0.0	0.0	0.0	0.0	5.2	0.1	0.0	42.8	0.1	0.2	0.0	0.0	3.0	1.5	0.1	0.3	0.0	0.0	0.0
SCUBE2	"Cegb1, Cegf1, FLJ16792"	ENSG00000175356	"Signal peptide, CUB domain and EGF like domain containing 2"	Q9NQ36	11	9020391-9138114	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 55.2;Glandular cells: 24.6;Melanocytes: 18.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 54.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"non-classical monocyte: 3.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;SK-MEL-30: 7.2;T-47d: 25.1"	"Group enriched"	"Detected in some"	4	"olfactory region: 5.7;thalamus: 2.9"					"HPA006353, HPA029871"	Uncertain				"Secreted to blood"	NA	NA		280000			"HPA006353: AB_1856642, HPA029871: AB_10602299"	"prognostic favorable (2.41e-4)"	"unprognostic (5.72e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-4)"	"unprognostic (3.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-4)"	"unprognostic (4.35e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-1)"	10.4	1.2	2.8	2.5	3.0	0.0	15.6	3.3	1.9	14.3	5.9	1.3	11.8	1.1	6.7	23.8	2.5	8.5	5.6	2.0	3.5	1.6	1.0	0.7	3.2	4.9	1.3	2.1	0.9	12.9	10.4	14.1	9.4	4.1	24.6	1.6	5.7	1.6	10.0	2.9	5.0	6.9	13.2	3.6	2.1	8.7	1.5	0.8	0.7	1.9	2.3	3.8	25.5	6.0	0.0	0.7	0.0	3.6	0.0	0.0	0.3	0.0	0.0	1.4	0.8	0.5	0.5	0.2	1.5	0.7	0.8	0.6	0.3	0.0	0.0	0.6	3.4	0.1	0.0	5.1	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	1.2	0.0	0.3	0.0	0.3	0.5	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.2	0.4	2.6	0.6	0.9	0.9	0.1	7.2	1.2	25.1	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.3	2.8	3.0	3.3	1.9	3.5	1.6	1.3	2.1	4.1	0.8	14.9	11.6	0.0	55.2	6.5	0.3	0.4	0.0	2.7	10.3	1.8	0.0	0.2	0.0	0.0	3.0	2.1	0.2	0.0	1.5	0.2	4.7	24.6	0.0	0.0	0.8	12.7	1.2	0.0	0.0	2.0	0.3	0.7	18.6	0.0	2.3	0.0	0.1	3.5	0.7	0.0	0.2	0.0	1.0	0.4	0.7	1.6	0.3	0.0	3.2	10.2
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	110000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.6	0.1	32.4	43.5	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.4	6.2	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	12.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.3	0.7	4.4	0.2	0.0	0.6	12.1	0.5	0.0	0.1	0.0	0.0	0.0	1.9	0.0	10.2	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0	0.0	1.1	0.0	0.2	0.0	2.5	3.3	0.0	1.4	3.4	1.8	2.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	1.0	0.1	1.1	0.0	0.3	9.5	10.4	0.0	1.2	2.2	0.9	0.0	1.7	0.0	0.0	2.0	0.1	0.0	3.5	0.0	6.1	0.0	4.7	0.2	1.9	0.0	0.6	0.0	0.0	0.1
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 450.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	23.0	3.0	1.6	0.1	41.2	25.4	71.1	29.5	40.3	33.5	24.0	35.1	58.9	0.0	13.2	37.1	33.8	30.0	1.2	75.0	40.8	6.6	1.1	0.7	2.4	13.7	44.9	0.1	1.2	34.1	50.4	13.8	33.8	18.6	4.4	0.5	1.1	0.0	19.2	22.9	0.0	2.0	3.0	20.1	9.3	0.0	14.9	0.0	55.0	30.8	0.6	2.3	40.6	25.2	7.2	19.6	18.2	1.4	8.2	25.6	21.3	2.5	19.0	1.2	0.9	0.1	40.2	2.3	15.2	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7	271.0	364.7	7.8	299.2	332.0	10.3	49.5	201.2	113.8	195.7	179.7	11.8	27.4	54.7	239.6	0.5	9.0	87.8	0.0	450.4	202.4	50.9	254.2	12.8	232.3	18.5	0.0	52.9	14.7	15.1	2.9	3.7	36.5	72.6	56.9	103.4	8.5	443.3	93.4	4.9	128.2	23.3	0.0	42.6	0.9	2.8	413.3	56.3	18.8	79.5	364.0
SECTM1	K12	ENSG00000141574	"Secreted and transmembrane 1"	Q8WVN6	17	82321024-82334074	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.9;intestine: 103.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 42.8;Kupffer cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.9"	"Group enriched"	"Detected in many"	13	"granulocytes: 45.9;monocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.3;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;PC-3: 21.8;SiHa: 37.5;SK-BR-3: 20.4;U-2197: 28.6"									HPA051214	Approved				"Secreted - unknown location"	NA	NA		26000000			"HPA051214: AB_2732565"	"unprognostic (2.42e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.55e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	13.5	1.8	1.1	15.7	2.1	3.7	10.6	0.7	2.1	6.4	33.2	1.0	1.3	26.2	6.1	4.9	6.1	6.5	4.7	6.1	2.3	0.8	16.8	3.9	11.2	21.7	1.5	0.6	7.8	2.5	0.0	1.3	6.1	3.5	8.6	9.4	2.1	20.2	2.2	4.9	6.6	103.1	5.5	4.2	24.0	9.4	2.1	1.4	2.3	5.1	7.0	7.7	7.8	16.2	0.0	2.3	45.9	16.2	0.0	0.1	1.1	6.0	1.3	0.0	0.4	10.7	27.3	0.5	3.0	27.5	21.2	20.9	0.6	12.5	0.0	0.1	8.9	0.3	18.5	0.0	1.2	0.8	1.9	0.0	2.5	9.5	1.7	8.3	0.0	0.0	11.6	2.8	1.1	0.5	1.5	0.6	0.0	0.0	0.0	13.4	0.2	0.0	0.0	0.0	1.6	21.8	0.0	0.1	0.3	6.1	0.0	1.4	0.1	37.5	20.4	0.4	0.0	1.6	0.5	0.1	2.3	0.2	28.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	9.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	45.9	0.0	14.8	1.0	0.0	1.1	1.1	2.1	0.7	2.1	2.3	0.8	1.5	0.6	3.5	1.4	11.9	3.7	3.9	4.6	8.4	0.0	0.8	0.0	2.7	2.3	1.8	0.0	0.1	0.0	5.2	0.0	1.6	42.8	0.0	8.3	0.7	6.8	16.9	1.1	0.0	6.9	0.0	0.0	1.8	39.9	0.2	4.9	17.6	1.7	1.8	2.3	0.0	8.7	17.5	0.0	2.2	0.0	0.0	3.3	0.0	0.2	3.0	0.2	0.0	1.0	12.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 92.9;HSkMC: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	2300000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.4	0.1	7.7	2.1	1.4	0.6	1.9	0.0	0.0	2.0	11.0	0.3	6.9	0.2	0.2	0.3	0.0	0.0	0.0	0.4	8.9	0.5	0.0	92.9	4.7	0.5	0.0	81.3	0.1	0.0	0.0	0.3	0.0	0.3	1.0	2.2	4.0	0.2	0.1	1.1	5.4	3.1	0.1	0.2	0.3	15.9	2.1	1.3	0.3	0.5	0.5	2.8	0.2	10.6	21.7	0.1	0.1	0.5	0.3	0.9	0.1	1.5	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3	416.9	429.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	187.7	118.7	0.0	169.8	167.5	38.5	0.0	0.0	0.0	0.0	45.9	18.4	0.0	0.0	24.4	0.0	658.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.8	0.0	0.0	47.6	0.0	0.0	719.9	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.7	10.2	42.8	0.0	1.3	1.0	2.8	33.3	19.6	2.8	1.7	3.6	10.0	0.0	1.6	36.2	0.3	18.5	0.1	7.9	3.9	0.0	1.4	0.0	1.9	0.0	1.1	0.8	0.0	1.3	0.0	6.0	1.4	8.7	10.4	0.0	0.0	0.0	1.1	0.2	0.0	0.0	16.0	0.1	3.7	0.7	18.2	1.0	6.2	0.2	3.3	1.7	0.2	0.0	0.3	7.1	0.2	0.3	5.8	3.7	3.9	10.7	4.8	2.5	1.7	0.0	3.8	1.4	7.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8	3.0	1.7	0.0	0.0	0.8	10.3	4.1	0.0	18.7	20.5	0.0	43.2	0.3	0.0	0.0	0.1	2.7	0.0	0.0	1.8	0.1	4.7	0.3	1.1	0.0	1.0	3.2	0.0	0.6	0.3	0.0	2.3	0.0	1.7	0.0	0.0	16.0	3.2	0.0	0.0	0.0	65.3	0.0	1.0	1.6	1.7	1.1	0.2	0.0	0.0	0.3
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA030651	Uncertain				"Secreted in other tissues"	NA	NA		29000			"HPA030651: AB_10602224"	"prognostic favorable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	3.3	18.8	2.5	2.0	7.4	0.0	1.0	0.3	9.2	9.2	6.0	18.6	2.3	13.3	4.4	3.5	2.5	3.4	5.6	3.4	3.6		7.7	0.0	8.1	0.0	12.9	4.9	2.6	5.6	3.5	0.0	147.6	8.2	2.8	2.8	8.5	1.2	6.8	1.5	0.5	19.7	3.9	5.9	0.3	11.9	0.5	9.5	0.0	1.6	0.6	0.0	1.9	0.6	0.0	0.4	3.3	0.0	0.0	0.0	0.0	4.0	2.6	0.2	2.6	0.2	0.3	0.6	5.3	7.3	1.5	2.6	2.0	10.1	0.0	4.9	5.1	0.0	0.6	0.1	8.5	0.6	0.0	0.2	0.0	23.0	34.8	5.8	0.0	0.2	1.7	0.1	1.7	1.3	6.8	0.0	0.0	0.0	0.6	0.2	7.2	0.0	0.2	0.3	7.5	1.4	0.1	0.4	0.1	2.5	0.4	0.3	1.2	1.3	18.1	2.7	0.8	1.3	0.0	0.1	0.4	5.3	1.4	1.7	1.4	0.0	0.0	2.7	0.0	56.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0											151.8	18.1	2.7	7.9	0.0	3.7	11.6	43.3	9.4	34.2	61.1	0.0	3.3	1.7	32.0	9.1	3.6	193.7	0.0	20.4	0.9	22.9	9.4	11.5	0.9	1.7	0.0	9.9	8.0	2.6	14.9	3.7	1.3	0.0	1.0	31.6	18.8	31.2	56.1	2.8	45.3	1.6	6.5	2.1	4.9	4.7	0.0	93.4	0.0	25.9	27.1
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.1	14.6	30.4	0.1	6.8	16.5	0.0	9.9	11.4	5.0	6.4	2.3	27.6	0.0	0.4	3.3	49.5	5.9	0.1	8.9	8.2	0.0	3.0	1.8	13.1	0.1	8.2	0.1	0.0	7.2	5.9	12.4	12.2	43.2	0.0	0.0	0.1	0.0	8.4	21.1	0.0	0.0	0.2	4.1	2.3	0.0	14.7	0.2	26.3	45.2	0.1	15.7	27.8	7.2	1.7	13.5	51.2	0.0	23.8	27.5	12.6	66.4	17.4	0.2	0.0	0.0	10.4	0.0	27.2	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0	8.9	12.8	0.0	33.4	23.5	0.0	35.1	0.0	109.7	19.4	7.0	5.9	0.3	1.7	3.6	0.4	3.5	25.9	0.0	5.8	0.5	25.3	36.0	4.7	0.0	9.3	0.0	5.8	1.3	2.6	1.7	7.2	8.6	52.3	4.6	16.2	1.3	40.1	15.8	49.1	0.1	0.3	0.0	16.2	0.3	0.2	16.6	0.2	0.0	23.4	52.9
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	4.6	5.0	5.4	2.6	0.0	0.0	0.0	1.4	17.0	0.1	17.3	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	6.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	4.5	1.2	5.5	4.0	1.7	0.0	0.1	0.6	0.0	0.0	0.2	8.9	0.2	0.0	26.5	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5	0.0	3.5	0.8	2.3	3.2	1.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	137.5	5.2	0.0	0.0	0.2	0.0	6.7	7.1	2.3	0.0	0.9	1.6	25.4	1.8	0.0	14.9	48.6	0.8	11.8	0.0	0.0	0.9	0.0	0.0	58.7	4.5	4.1	0.0	2.1	0.7	0.7	2.0	0.0	0.0	0.1	0.4
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649113	"Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 146.0;Ciliated cells: 62.9;Club cells: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.0;SK-BR-3: 20.6;U-2 OS: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	4.0	1.1	2.4	1.0	12.2	0.6	7.8	2.0	12.2	5.5	6.4	1.9	0.5	2.2	5.4	1.4	4.7	2.3	6.5	0.9	4.0	4.7	1.0	1.0	6.1	0.6	5.9	6.4	0.9	9.6	0.7	1.4	1.1	5.1	15.0	4.9	2.4	6.2	9.1	1.0	2.2	3.6	10.3	6.6	0.7	3.8	0.9	3.1	0.9	2.2	0.5	0.8	9.8	3.3	0.5	0.3	1.4	0.6	0.7	0.5	0.2	0.2	1.1	0.2	0.0	0.5	3.3	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	3.5	0.0	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.5	1.2	0.0	2.1	0.0	0.0	0.8	0.1	0.0	0.0	20.6	0.0	3.6	1.6	0.0	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	1.4	0.3	0.5	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.5	0.5	0.8	0.7	0.6	0.3	0.3	0.2	2.4	12.2	2.0	8.7	4.0	4.7	5.9	6.4	5.1	3.1	163.8	146.0	0.0	1.0	1.0	41.8	1.2	17.8	62.9	75.1	1.8	0.0	0.7	0.0	4.2	0.9	0.5	0.0	0.0	1.0	0.2	2.1	3.6	22.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	1.1	1.7	1.8	0.0	39.8	4.4	0.0	0.0	0.1	2.7	0.0	1.0	0.3	0.4	0.4	0.2	0.0	0.0	1.1
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.1;Collecting duct cells: 17.4;Ito cells: 28.3;Rod photoreceptor cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 24.3;HUVEC TERT2: 42.3;RT4: 24.6;SK-BR-3: 39.5;TIME: 76.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	4000000			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	17.4	3.7	2.8	5.0	3.6	1.5	26.5	3.5	5.0	12.2	7.5	2.5	45.3	8.1	9.2	10.5	42.6	9.7	8.2	12.3	3.1	3.1	15.1	4.9	20.4	5.8	2.9	0.5	5.5	4.2	2.9	5.7	28.9	6.4	14.8	4.1	19.3	12.5	22.1	7.9	44.4	9.3	5.7	2.6	57.6	10.2	3.1	3.6	2.7	13.8	19.5	21.5	14.7	22.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	0.7	0.1	3.2	0.0	0.3	0.6	1.7	5.5	1.5	2.3	1.2	1.4	0.1	17.7	0.2	0.1	10.5	1.5	22.8	0.5	0.0	0.4	0.1	24.3	4.0	1.3	0.3	0.7	1.5	12.7	3.4	10.5	21.1	42.3	0.2	0.6	0.0	0.3	2.6	0.3	1.6	1.9	1.4	2.2	2.5	0.0	0.1	1.6	24.6	0.2	0.6	2.8	39.5	0.0	2.5	15.4	1.6	76.0	0.9	7.5	6.7	1.2	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.6	3.5	5.0	3.1	3.1	2.9	0.5	6.4	3.6	0.0	1.4	0.0	3.0	6.1	23.1	1.4	2.5	1.4	2.3	17.4	9.8	8.2	0.0	0.2	0.0	13.5	5.0	0.0	0.7	0.3	1.5	2.5	0.0	0.5	1.2	6.4	0.0	28.3	0.8	0.0	0.3	0.0	0.0	0.0	9.1	8.1	4.0	3.5	0.0	0.6	18.6	0.0	2.3	0.0	0.4	7.9	5.3	0.0	5.0	6.7
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 8.2;Endothelial cells: 9.0;Intestinal endocrine cells: 9.2;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.9;Hep G2: 6.3;HUVEC TERT2: 6.7;THP-1: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	NA	NA		4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.9	0.2	2.7	0.0	0.0	0.0	0.0	0.7	0.4	3.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.5	0.2	6.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.7	2.4	0.0	0.3	0.0	0.2	0.2	4.1	1.2	0.6	0.1	0.0	0.0	3.8	0.0	0.2	0.6	0.6	0.0	0.3	0.5	0.1	2.0	5.9	2.5	0.0	2.5	0.0	0.0	0.5	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1	3.0	2.2	0.0	0.0	0.3	0.5	8.2	0.0	0.0	0.0	3.5	0.0	1.4	0.0	0.0	2.1	9.0	0.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.2	0.0	9.2	1.3	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	6.3	0.0	0.1	0.0
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin I"	P04279	20	45206997-45209772	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"ductus deferens: 2077.7;seminal vesicle: 1931.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	192	"eosinophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.9"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	NA	NA		1700000			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	2077.7	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	76.5	0.0	0.0	0.2	1931.9	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	19.5	0.1	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SEMG2	SGII	ENSG00000124157	"Semenogelin II"	Q02383	20	45221300-45224458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"ductus deferens: 1137.0;seminal vesicle: 1095.3"	"Cell type enhanced"	"Detected in single"	34	"Collecting duct cells: 3.5"	"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	NA	NA		920000			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1137.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	46.2	0.0	0.0	0.1	1095.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	8.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 29973.4"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 326.1"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	210000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.9	41.0	0.1	1.1	0.0	0.1	0.1	0.0	0.8	0.0	5.0	0.0	0.2	0.1	326.1	0.0	1.1	0.1	0.3	0.4	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.5	0.1	1.1	0.1	22.1	0.2	0.0	0.1	0.4	0.1	0.1	0.0	19.4	0.2	0.1	0.1	5.1	0.1	0.6	0.2	0.1	0.5	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8	32.8	233.5	435.3	1.1	2.1	0.0	2.8	4603.8	45.5	60.3	143.1	0.0	1.4	58.0	1848.5	0.1	6.6	53.3	817.7	189.3	1.7	1.6	5.0	1.1	29973.4	171.4	0.0	11.6	922.6	1276.8	0.0	0.0	188.6	1.7	107.4	659.1	0.3	1376.2	37.4	0.0	447.0	0.2	0.0	5.1	0.0	0.1	1.5	5.4	46.5	24.7	7.1
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 200.2"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1.0	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1.0	1.1	0.9	0.6	0.7	1.0	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.4	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	200.2	0.0	0.0	6.3	4.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452790	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"liver: 189.6"	"Cell type enriched"	"Detected in some"	50	"Hepatocytes: 255.3"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		460000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	189.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	255.3	0.0	0.0	0.0	3.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 81.9"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 4.6;Suprabasal keratinocytes: 18.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.8;melanoma: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 7.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 0.2"						"Secreted in other tissues"	NA	NA		570000				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	81.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612377-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 1244.8"	"Cell type enhanced"	"Detected in some"	17	"Ductal cells: 13.4;Exocrine glandular cells: 28.2;Pancreatic endocrine cells: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 98.6"									"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	95000000000			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	11.1	2.1	5.4	5.7	17.6	1.2	26.0	1.9	16.1	43.8	2.3	10.0	1.4	2.3	2.2	2.4	3.3	4.3	18.1	10.7	13.4	6.5	61.9	1244.8	4.9	53.0	16.3	0.8	8.3	182.4	1.0	14.0	2.7	34.2	18.3	2.6	10.2	62.1	7.9	6.8	1.5	2.3	10.2	47.2	8.2	9.7	9.5	7.4	0.0	3.5	0.5	1.7	7.6	11.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	1.0	0.0	0.7	0.2	0.0	0.9	0.0	0.6	0.0	0.2	0.0	98.6	13.4	0.4	0.1	12.2	14.7	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.1	0.1	0.3	0.0	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.4	0.5	14.4	0.1	0.5	0.0	0.1	0.0	1.8	0.0	4.2	0.2	0.3	0.4	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.4	17.6	1.9	9.6	13.4	6.5	16.3	0.8	34.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	28.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.8	0.0	0.2	28.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561091-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 24.8;liver: 118.6;pancreas: 36.2"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 219.1;Exocrine glandular cells: 80.9;Hepatocytes: 412.0;Pancreatic endocrine cells: 77.0"	"Group enriched"	"Detected in many"	8	"liver cancer: 94.8;pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 22.9"					"Not detected"	"Not detected"			HPA003607	Approved				"Secreted to blood"	NA	NA	14500000000	22000000000			"HPA003607: AB_1079914"	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	3.2	0.3	0.1	7.9	0.1	0.1	24.8	0.1	0.0	0.0	1.4	118.6	0.0	0.0	0.0	0.0	0.1	36.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	219.1	0.0	0.0	3.5	0.0	0.0	10.0	21.6	0.0	0.0	0.0	0.0	80.9	0.0	0.0	0.0	0.0	412.0	0.0	0.0	0.0	4.9	9.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	77.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 267.5;Exocrine glandular cells: 111.0;Hepatocytes: 195.1;Late spermatids: 228.6;Peritubular cells: 135.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 76.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078846	Enhanced				"Secreted to blood"	NA	NA		2300000000			"HPA078846: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.2	0.0	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.5	267.5	0.0	0.0	31.4	2.0	0.0	54.7	58.2	75.6	1.6	0.0	0.0	111.0	0.0	3.9	0.2	0.0	195.1	0.0	7.9	0.0	3.7	2.9	228.6	52.9	0.0	0.0	1.0	0.0	1.8	23.8	0.0	135.8	3.8	1.1	6.5	0.4	3.5	2.2	0.5	0.2	0.0	0.0	0.0
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323394	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 223.9"	"Group enriched"	"Detected in some"	11	"Cholangiocytes: 163.1;Hepatocytes: 335.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"T-47d: 119.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	59000000000			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	1.0	0.0	2.3	10.3	0.1	0.0	0.0	5.2	223.9	0.1	0.0	0.0	0.0	0.8	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	119.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.2	163.1	0.0	0.0	0.0	0.0	0.0	1.7	10.5	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	335.8	0.0	0.0	8.6	8.6	7.2	0.0	0.0	0.0	0.0	1.0	0.4	0.0	1.5	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032442-106038738	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	414	"liver: 101.8"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	478	"Hep G2: 48.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	49000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	101.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	6.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA9	"CENTERIN, GCET1, SERPINA11b"	ENSG00000170054	"Serpin family A member 9"	Q86WD7	14	94462717-94479689	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 37.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.2"	"Cell line enriched"	"Detected in single"	64	"Daudi: 39.7"	"Region enriched"	"Detected in single"	18	"basal ganglia: 64.3"										"Secreted to blood"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.05e-1)"				"unprognostic (1.94e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.67e-2)"		"unprognostic (1.38e-2)"			"unprognostic (1.16e-1)"				0.1	0.1	0.1	37.6	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.8	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.2	20.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	6.0	2.7	0.0	0.1	0.6	0.1	0.1	0.0	0.4	0.3	0.3	36.0	0.1	0.2	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903804-173917378	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	203	"liver: 450.5"	"Cell type enriched"	"Detected in some"	54	"Hepatocytes: 2236.3"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	35	"Hep G2: 42.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		210000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	450.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	42.6	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	14.0	0.0	0.0	0.0	0.1	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2236.3	0.2	0.0	0.0	37.4	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20773879-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 170.8"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 223.1"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 64.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		94000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.6	0.9	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	170.8	0.3	0.0	0.0	0.7	0.3	0.0	3.6	0.1	0.2	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	64.2	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	5.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.4	0.0	0.4	0.0	1.0	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0.0	2.3	0.6	0.9	0.0	0.0	0.0	0.7	2.6	0.5	0.0	13.7	0.0	0.0	0.0	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.7	0.0	1.1	223.1	0.1	0.0	0.0	4.9	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell type enhanced"	"Detected in many"	22	"Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.6	0.0	0.2	32.7	65.2	3.7	142.8	27.0	72.1	63.0	0.3	0.2	0.1	34.2	45.4	99.7	0.7	0.0	11.0	74.4	0.1	0.0	0.0	0.2	2.4	65.8	0.0	0.1	25.5	4.4	110.5	58.1	39.1	165.7	0.0	0.2	0.1	160.0	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.7	3.2	0.3	18.0	0.1	0.4	409.8	195.1	8.5	66.4	171.5	0.0	0.1	0.1	48.7	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2	0.0	11.4	0.0	30.0	35.5	0.4	1.9	7.6	8.1	7.9	5.2	0.0	34.4	0.0	22.9	0.0	53.9	0.0	0.0	3.8	35.1	24.7	5.4	10.3	90.0	15.2	0.0	5.1	60.2	4.7	0.4	16.4	7.5	6.8	1.8	0.0	0.3	138.9	0.0	11.3	0.0	0.2	38.8	16.5	0.0	0.0	21.7	545.0	0.7	0.0	5.9
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975112-224039319	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 257.0"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 422.0;Fibroblasts: 240.4;Leydig cells: 371.6"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5"	"Group enriched"	"Detected in many"	13	"NK-cells: 16.5;T-cells: 10.5"	"Cell line enhanced"	"Detected in many"		"BJ: 84.0;fHDF/TERT166: 358.5;SK-MEL-30: 159.8;WM-115: 123.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in female reproductive system"	NA	NA		490000				"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.48e-5)"	8.0	5.8	34.7	18.0	30.6	2.2	4.8	14.9	35.2	8.6	6.1	13.0	0.1	7.4	5.1	4.4	9.7	6.0	11.9	24.5	21.9	25.3	10.6	3.3	3.2	7.7	33.0	14.4	38.4	2.9	1.3	2.0	257.0	25.2	6.6	6.2	4.9	3.1	2.8	3.2	3.5	6.0	28.1	23.0	7.8	2.7	14.2	11.9	1.6	6.2	3.2	10.8	18.3	6.9	1.0	0.1	0.3	0.0	16.5	10.5	2.2	0.1	4.5	1.6	1.8	69.0	26.0	0.2	84.0	48.1	6.8	6.5	0.2	0.3	0.0	1.8	358.5	10.8	0.2	0.2	5.7	5.9	0.0	1.4	0.9	3.0	1.2	3.4	0.7	0.0	7.5	3.9	19.4	29.3	17.6	0.5	0.3	0.0	0.0	23.4	0.2	0.1	0.2	3.1	1.7	5.0	0.5	1.4	3.4	63.0	5.2	2.4	0.4	15.9	0.0	159.8	23.3	0.0	0.3	59.2	40.2	5.5	12.2	3.9	0.3	0.7	0.0	25.7	0.6	123.2	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.4	0.5	0.0	1.0	10.5	5.3	0.3	16.5	0.0	0.1	0.5	2.2	34.7	30.6	14.9	29.8	21.9	25.3	33.0	14.4	25.2	11.9	0.0	0.6	0.0	11.6	20.7	2.8	2.5	0.0	0.0	3.4	7.0	0.0	84.2	10.0	10.3	2.1	23.4	3.1	0.0	28.7	422.0	240.4	9.5	2.3	0.0	40.3	0.0	23.1	26.4	0.0	4.7	371.6	4.6	135.0	5.4	4.1	1.5	16.3	13.3	93.0	144.4	3.3	12.9	15.9	4.3	27.4	12.7	112.0	10.9	1.8	5.4
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 49.3"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 1.7;Spermatocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;TIME: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA051904: AB_2681659, HPA055804: AB_2682928"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	2.6	0.9	0.6	1.2	0.8	0.2	0.6	1.9	1.7	0.6	0.8	0.6	0.6	0.8	1.1	2.0	1.1	0.9	1.4	1.9	0.7	0.5	0.8	1.2	0.6	1.4	0.6	0.6	1.0	5.7	0.1	0.6	0.6	1.2	0.6	0.1	49.3	0.9	0.6	0.6	4.0	3.2	0.6	1.1	0.8	0.8	1.0	0.6	0.6	1.1	0.6	0.6	0.9	0.9	1.6	0.0	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.2	0.8	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.9	0.1	0.9	2.7	0.2	0.0	2.0	0.9	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.3	0.9	0.9	2.3	0.0	0.3	0.0	0.0	1.3	1.1	0.3	2.1	0.1	0.2	0.2	1.1	2.2	2.9	0.7	1.9	0.2	1.4	0.4	0.7	0.2	1.5	0.2	1.4	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.9	0.6	0.7	0.5	0.6	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1761959-1777574	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 360.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 695.7;Fibroblasts: 677.8;Hepatocytes: 664.1;Leydig cells: 1683.3;Peritubular cells: 982.9;Syncytiotrophoblasts: 447.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 105.5"	"Cell type enriched"	"Detected in some"	18	"plasmacytoid DC: 143.3"	"Lineage enriched"	"Detected in many"	119	"dendritic cells: 143.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2;ASC TERT1: 96.9;Hep G2: 56.6;HHSteC: 41.5;HSkMC: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	85000000000			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	70.0	7.5	2.3	15.1	4.5	1.1	61.6	0.7	13.9	84.1	16.4	20.8	14.8	5.0	48.9	71.9	24.3	75.3	66.8	50.3	11.6	1.9	6.9	190.1	20.1	30.6	1.9	5.9	68.1	54.7	0.6	11.0	38.6	105.5	53.2	6.5	360.1	17.8	14.2	51.4	21.5	15.7	27.6	2.4	21.2	17.8	86.3	1.4	6.0	27.4	38.5	14.6	32.1	37.9	0.8	143.3	0.1	1.2	0.1	0.5	1.3	0.0	0.4	0.3	0.2	124.2	96.9	2.0	5.8	4.8	0.0	0.0	1.0	0.0	0.2	0.2	6.8	0.0	0.3	8.2	0.4	0.0	0.0	4.4	0.1	0.0	56.6	41.5	0.1	0.1	131.8	0.7	0.1	0.1	1.1	0.0	0.4	11.6	0.0	6.0	0.0	0.7	0.7	3.2	0.0	0.1	0.3	22.8	0.1	0.0	0.6	0.1	4.2	0.0	0.0	5.8	0.3	0.7	17.4	0.2	0.0	1.9	1.4	0.1	0.0	0.2	2.9	0.1	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.0	0.8	0.0	0.1	7.9	0.4	0.2	0.5	0.1	0.1	0.0	143.3	0.0	1.3	2.3	4.5	0.7	13.9	11.6	1.9	1.9	5.9	105.5	1.4	3.0	7.2	12.3	167.2	84.3	39.9	7.8	10.2	101.7	131.9	1.8	210.1	695.7	0.0	0.3	9.0	23.3	0.0	23.3	21.6	72.9	677.8	14.0	23.0	664.1	130.4	3.2	0.0	36.2	38.0	21.6	1683.3	71.6	102.9	131.7	0.0	6.1	9.4	0.0	982.9	12.9	32.6	19.4	143.0	6.5	5.6	68.6	447.3	7.5	0.0	47.8
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755268	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 417.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 830.3"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 19.8"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 19.8"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 57.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	110000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	0.9	0.0	0.2	0.6	0.2	0.0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0.0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0.0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0.0	0.2	0.2	0.8	2.1	0.0	1.8	0.5	9.0	0.2	0.4	1.0	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0.0	0.4	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	57.1	0.4	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	19.8	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.2	3.0	15.8	13.7	5.7	1.3	0.1	0.6	25.5	5.3	4.5	1.8	5.9	0.1	8.3	0.0	0.5	0.6	1.0	23.3	4.4	0.1	1.9	2.5	1.1	830.3	7.4	0.0	4.1	10.4	21.5	0.0	31.4	11.4	1.7	16.2	1.0	0.0	5.7	3.5	25.1	73.8	0.4	0.0	2.3	0.2	0.5	1.4	0.2	4.4	1.7	1.0
SERPING1	"C1-INH, C1IN, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57614853	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 693.2"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 749.1;Hepatocytes: 2308.4;Leydig cells: 680.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	143	"dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0"	"Group enriched"	"Detected in some"	6	"ASC diff: 148.4;ASC TERT1: 76.8;HSkMC: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		38000000000			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	88.8	16.3	3.6	18.2	5.4	1.6	75.0	3.8	6.3	62.7	37.8	7.3	16.7	6.2	63.4	58.8	58.3	63.4	61.6	55.5	3.4	3.0	53.4	693.2	73.8	22.4	5.7	4.1	116.4	38.1	8.0	18.4	33.1	14.9	70.3	11.9	82.6	20.7	33.2	36.5	23.1	20.3	38.7	17.3	42.7	30.3	39.2	3.6	1.8	41.5	24.4	16.8	68.7	122.2	0.0	28.5	32.1	11.0	0.1	0.0	2.8	0.0	0.0	5.6	0.0	148.4	76.8	1.0	9.4	6.7	2.0	3.6	0.3	0.0	0.0	11.3	4.8	0.0	0.0	0.0	0.6	1.2	0.0	0.0	4.6	0.0	0.2	19.6	0.2	0.9	127.4	1.9	0.7	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.0	0.0	0.7	0.5	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.1	5.1	0.1	0.4	0.0	0.3	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	0.1	0.0	11.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	32.1	0.1	4.4	28.5	0.0	2.8	3.6	5.4	3.8	6.3	3.4	3.0	5.7	4.1	14.9	3.6	110.2	95.0	7.0	53.1	67.3	0.6	19.8	749.1	34.8	102.4	150.1	0.0	17.1	36.5	333.2	3.5	154.2	0.0	0.0	39.3	87.1	278.1	25.0	7.0	2308.4	40.1	0.0	0.0	231.4	85.9	8.5	680.9	41.3	86.0	12.6	0.0	52.7	58.0	0.0	215.0	42.4	4.4	265.1	282.5	2.4	3.0	51.9	21.1	39.9	0.0	30.8
SERPINI1	"neuroserpin, PI12"	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825568	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 96.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		200000	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	5.9	8.2	31.9	2.4	27.9	1.3	6.1	3.6	96.0	4.2	2.8	7.1	0.4	1.5	4.3	4.3	3.2	3.9	3.4	6.4	35.9	35.3	14.5	2.5	3.4	2.3	36.9	35.7	4.0	16.3	3.7	10.3	3.5	22.9	5.8	2.5	2.4	9.9	3.6	1.7	2.1	2.5	3.1	51.6	4.1	3.6	7.0	15.9	0.0	5.2	0.3	3.8	3.1	1.6	15.4	4.4	1.0	0.4	6.0	16.0	3.4	0.4	2.0	3.2	0.2	6.0	1.6	0.2	1.2	1.8	0.8	1.3	0.7	3.9	15.9	6.1	0.8	2.7	0.9	2.1	2.2	0.9	5.0	4.5	5.4	16.5	6.7	0.4	0.8	0.6	2.3	0.8	0.4	0.8	1.8	0.2	6.1	10.1	18.5	0.7	1.5	0.4	1.1	2.0	2.5	2.5	1.8	0.1	2.0	6.9	0.5	1.3	8.4	2.3	4.3	5.1	7.8	6.6	2.4	0.5	3.5	0.3	0.3	5.7	13.9	17.1	11.6	2.9	4.1	2.0	1.0	0.2	0.5	6.2	0.4	4.5	12.7	6.5	6.6	0.3	15.4	4.7	5.7	0.6	6.0	0.3	4.4	16.0	3.4	31.9	27.9	3.6	78.9	35.9	35.3	36.9	35.7	22.9	15.9	6.0	1.0	8.0	12.2	3.3	71.8	7.3	0.0	13.4	7.9	5.2	13.7	5.0	6.6	1.5	0.3	9.2	0.0	0.0	15.6	4.7	5.2	9.8	2.3	0.6	2.3	4.8	4.6	3.1	0.8	1.8	3.7	1.9	6.8	1.8	0.1	71.6	4.6	0.0	2.5	31.2	31.4	25.8	68.9	1.8	13.2	1.5	4.2	5.3	0.0	1.6
SERPINI2	"MEPI, PANCPIN, PI14, TSA2004"	ENSG00000114204	"Serpin family I member 2"	O75830	3	167441789-167479004	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"pancreas: 184.7"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 29.4;Exocrine glandular cells: 82.5"	"Cancer enriched"	"Detected in some"	6	"pancreatic cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.5"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.5"	"Cell line enriched"	"Detected in some"	6	"THP-1: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to digestive system"	NA	NA						"unprognostic (1.88e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.14e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.17e-2)"		"unprognostic (1.29e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.76e-5)"	"unprognostic (5.35e-2)"	"unprognostic (4.16e-2)"			0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	14.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	2.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	29.4	10.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	"Nucleoli rim,Cytosol"	"Secreted in other tissues"	NA	NA		54000000	Cytosol	"Nucleoli rim"	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	70.1	11.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.3	37.1	0.6	3.1	0.0	0.0	110.7	0.0	170.4	0.0	16.7	0.5	0.0	11.8	12.5	0.0	0.0	0.1	0.0	114.4	0.0	29.9	0.0	0.0	0.0	0.1	0.4	0.0	15.0	0.0	0.0	0.2	12.2	19.7	0.0	0.0	3.9	26.5	16.2	0.0	0.0	16.9	3.0	0.1	0.2	7.9	0.1	0.0	0.0	32.4	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4	166.7	216.2	0.5	1339.8	6884.3	0.0	0.3	33.1	30.8	122.8	15.7	0.0	6.7	3.3	52.1	0.0	0.6	409.5	0.0	68.0	45.3	37.0	487.4	31.2	0.0	1.6	0.0	64.7	0.6	0.3	0.0	0.0	15.6	506.2	1.8	78.2	0.0	315.2	136.8	0.0	0.0	0.0	0.0	110.7	0.0	0.2	9365.4	5.0	0.0	146.1	2426.4
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 270.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.1	5.7	0.3	1.2	10.9	57.4	16.6	15.8	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.8	4.4	23.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.0	21.4	1.6	1.6	270.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	17.1	0.0	0.0	0.0	1.3	0.0	35.3	0.0	0.3	1.5	0.4	0.0	3.3	23.2	0.0	0.1	0.1	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7	0.0	0.0	0.0	104.7	10.0	1.5	175.8	0.0	0.0	1.2	59.3	2.0	0.7	68.0	3.1	4.8	6.7	0.0	0.0	0.0	55.3	47.0	19.9	0.0	0.0	1.7	1.6	0.0	15.4	0.0	13.0	535.6	1.4	94.5	0.0	0.0	51.5	0.1	0.0	122.4	3.5	1.5	0.0	4.1	1.6	20.6	4.8	0.7	0.0	0.0	8.5
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	15	"Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	53.5	0.0	20.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0	3.0	1.1	0.0	0.6	102.6	0.0	0.3	0.0	5.3	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	163.9	0.3	1.1	0.0	3.3	0.0	0.0	0.0	0.0	0.2	3.7	2.2	113.1	1.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	47.4	0.0	0.2	92.6	0.1	0.0	0.0	1.0
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0"	"Cell type enriched"	"Detected in some"	5	"Peritubular cells: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;HSkMC: 5.5;U-937: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		1500000			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	4.6	2.3	0.5	0.9	0.9	0.0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0.0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4.0	0.4	1.3	4.9	0.2	123.0	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0.0	0.0	2.6	2.9	0.0	14.1	0.6	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	3.0	0.4	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.2	2.0	0.1	0.4	0.0	5.5	0.7	0.6	0.0	1.0	0.2	0.2	0.0	0.3	0.2	0.4	0.0	1.7	0.1	0.0	0.0	0.2	1.7	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.2	1.7	0.2	0.5	0.1	0.2	0.3	5.3	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3	0.0	2.6	0.0	1.7	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.4	0.1	8.6	1.6	0.0	0.0	0.2	0.0	0.0	4.3	0.0	0.9	38.6	0.8	0.0	0.0	0.0	2.7	0.1	0.0	177.1	2.1	0.1	0.0	3.1	0.2	0.5	1.4	0.2	0.0	0.0	0.0
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell type enriched"	"Detected in some"	15	"Cholangiocytes: 226.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 16.3;RPMI-8226: 5.8;SCLC-21H: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	5.8	0.0	0.0	2.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3	3.0	2.2	0.0	0.0	0.0	0.2	6.7	226.7	0.0	1.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	1.7	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	6.1	0.0	0.0	0.0	0.0	0.0
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"lung: 104.5"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 13.8;CAPAN-2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.2	0.1	0.1	0.5	0.0	0.2	0.1	13.6	1.4	6.3	0.2	0.1	0.0	1.6	0.1	104.5	0.1	0.1	0.1	0.3	1.1	0.4	0.1	0.6	0.2	0.2	0.0	0.1	1.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	2.0	1.3	0.1	0.1	1.0	0.4	0.3	0.1	5.4	1.7	0.1	0.1	0.0	0.0	1.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	7.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	1.5	0.5	0.1	1.7	1.3	1.7	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	497.3	624.9	0.0	0.1	0.1	0.4	0.0	170.7	14.7	204.8	50.6	0.0	0.0	3.3	18.0	2.9	0.7	0.0	0.0	32.4	0.0	0.2	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.3	0.2	0.0	0.0	0.0	1.1	57.0	0.0	0.4	0.3	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	1.3
SFTA3	"NANCI, SFTPH"	ENSG00000229415	"Surfactant associated 3"	P0C7M3	14	36473288-36513829	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	16	"lung: 45.2;thyroid gland: 55.4"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 321.6;Alveolar cells type 2: 451.3;Club cells: 171.8"	"Group enriched"	"Detected in some"	238	"lung cancer: 18.4;thyroid cancer: 52.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	173	"SCLC-21H: 21.5"														"Secreted in other tissues"	NA	NA													"prognostic favorable (8.29e-4)"				"unprognostic (3.95e-1)"				"unprognostic (3.21e-3)"		0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	321.6	451.3	0.0	0.0	0.0	0.0	0.0	0.0	53.5	171.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Predicted secreted proteins"	"Gaseous exchange"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	66	"lung: 411.8"	"Cell type enriched"	"Detected in some"	12	"Alveolar cells type 2: 12618.9"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 30.8"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"	NA	NA					"CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	411.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1077.9	12618.9	0.0	0.0	0.0	0.0	0.0	0.0	156.6	337.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	418.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560402	"Disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	225	"lung: 501.0"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 2: 14379.1"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Group enriched"	"Detected in some"	21	"BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	501.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.8	0.4	0.0	0.0	0.2	0.0	21.7	0.0	0.3	0.2	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	13.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1479.9	14379.1	0.0	0.0	0.0	0.0	0.0	0.0	248.9	606.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.0	1.0	397.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"lung: 757.8"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 1: 3391.6;Alveolar cells type 2: 11695.8;Club cells: 3546.5"	"Group enriched"	"Detected in many"	149	"lung cancer: 1306.7;thyroid cancer: 270.2"	"Region enriched"	"Detected in single"	17	"pons and medulla: 2.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;NB-4: 5.6;U-2197: 11.5;U-266/70: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		71000000			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	757.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	1.1	1.4	2.6	4.1	0.8	1.5	1.2	0.2	0.4	0.4	0.8	0.5	0.9	4.9	0.4	0.3	0.1	0.1	0.5	1.1	0.2	0.4	0.1	0.5	3.3	0.4	0.1	0.1	0.6	0.4	0.5	1.1	0.4	0.1	0.2	2.4	0.0	0.5	0.3	0.2	0.9	0.0	0.7	0.4	0.8	0.2	0.5	1.8	5.6	2.7	0.8	0.7	2.1	0.4	0.5	0.3	0.5	0.7	0.5	0.1	0.8	0.3	0.6	0.6	0.5	0.1	0.3	1.1	11.5	0.2	4.2	0.9	0.3	1.0	0.8	0.2	0.9	2.5	0.8	0.9	4.1	0.7	1.0	1.0	0.8	1.4	1.1	1.4	0.8	2.6	0.8	2.5	0.7	1.5	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	3391.6	11695.8	0.0	0.1	0.0	0.0	0.4	0.0	341.3	3546.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	241.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	718	"lung: 664.5"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 2: 80228.9"	"Cancer enriched"	"Detected in some"	218	"lung cancer: 226.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010928	Enhanced				"Secreted in other tissues"	NA	NA					"HPA010928: AB_1857425"		"unprognostic (1.84e-1)"			"unprognostic (1.96e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.13e-1)"	"unprognostic (2.97e-1)"		"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.32e-2)"		0.1	0.8	0.2	0.3	0.5	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.1	0.1	0.1	664.5	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.4	0.1	0.9	0.1	7929.7	80228.9	0.0	0.0	1.5	0.0	0.3	0.0	623.7	2602.4	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	909.1	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937740-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lung: 127.0"	"Group enriched"	"Detected in many"	14	"Alveolar cells type 1: 408.0;Alveolar cells type 2: 1544.2"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.4;non-classical monocyte: 21.6"	"Lineage enriched"	"Detected in many"	17	"monocytes: 21.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.6;MCF7: 3.4;U-2197: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	NA	NA		5500000			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	0.3	0.3	0.6	0.3	1.1	3.9	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.3	0.3	127.0	0.3	0.3	0.3	0.3	0.9	0.3	0.7	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	1.6	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	1.2	0.4	0.3	0.3	0.3	0.0	1.2	0.4	21.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.2	0.8	0.0	2.4	0.3	0.1	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	2.7	0.0	7.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	3.4	0.1	1.8	0.8	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.6	0.0	0.4	1.0	0.7	1.5	0.0	0.2	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	6.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.5	0.6	1.1	0.3	0.6	0.5	0.5	0.3	0.3	0.3	0.3	408.0	1544.2	0.0	0.8	0.8	1.8	0.5	0.0	17.4	68.2	5.2	0.0	0.0	1.7	1.0	5.2	0.3	0.0	0.0	5.2	2.3	1.9	0.8	18.6	0.8	0.1	0.0	0.0	0.0	0.0	8.9	1.1	1.4	0.0	0.0	0.0	2.3	2.0	0.0	0.4	0.2	0.3	0.0	0.2	0.4	0.1	1.6	0.1	0.0	0.0	0.3
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633383	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 14.2;liver: 51.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 42.1;Late spermatids: 103.5"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.9;Hep G2: 5.1;HSkMC: 7.7"	"Region enhanced"	"Detected in single"		"olfactory region: 0.4"										"Secreted to blood"	NA	NA		15000000000				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.5	0.9	1.0	0.0	1.3	0.1	0.2	0.4	0.8	0.6	2.7	0.4	0.0	3.5	0.3	0.6	0.2	0.5	0.4	0.9	0.9	0.5	2.3	51.1	0.3	0.1	0.8	0.7	0.5	0.8	0.3	1.4	0.3	1.1	0.3	0.2	1.1	0.3	0.3	0.5	0.0	14.2	0.2	1.1	0.2	0.2	8.0	1.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.2	4.1	3.9	0.6	7.9	3.7	0.2	1.0	1.6	1.7	0.9	1.6	0.6	0.0	0.9	1.4	2.2	0.6	0.2	0.3	0.9	0.2	0.6	0.0	1.0	5.1	2.5	0.0	0.1	7.7	0.6	2.9	1.4	1.4	0.1	0.0	0.4	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.1	0.3	0.5	0.6	0.5	0.2	0.6	3.2	0.0	0.4	1.6	0.7	0.0	1.4	0.8	0.0	0.0	0.3	0.6	0.6	0.3	1.9	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.8	0.9	0.5	0.8	0.7	1.1	1.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.4	42.1	0.0	0.3	0.0	0.2	0.1	0.3	0.4	0.0	9.6	0.3	0.0	0.0	1.3	0.3	103.5	0.9	0.0	0.0	0.0	0.2	2.3	0.1	0.2	0.7	9.8	1.1	6.5	0.0	3.1	0.9	0.0	0.2	0.0	0.3	0.3
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502113	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 54.7;Ito cells: 72.4;Spermatocytes: 36.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 33.8;TIME: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037417	Approved				"Secreted - unknown location"	NA	NA					"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	22.0	6.5	4.7	4.3	4.9	1.0	28.4	2.3	4.2	7.7	7.1	3.2	5.2	3.3	12.3	8.4	6.9	7.6	6.8	14.1	3.7	2.4	6.1	5.5	19.0	11.6	4.8	2.0	8.8	2.2	6.6	2.5	16.3	4.3	9.6	4.3	5.0	3.5	4.6	7.6	4.1	5.4	8.3	3.1	17.3	3.5	15.8	2.5	2.0	26.8	6.2	3.3	7.6	17.7	1.9	7.7	4.6	2.8	3.3	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.7	9.2	0.0	0.2	0.9	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.6	0.4	3.1	2.8	2.3	1.9	1.4	1.3	0.2	1.9	1.8	2.0	4.6	3.3	2.0	7.7	0.0	0.9	4.7	4.9	2.3	4.2	3.7	2.4	4.8	2.0	4.3	2.5	0.0	18.9	0.0	0.5	3.0	0.0	2.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	10.0	54.7	0.0	0.0	0.0	0.0	2.2	0.5	3.5	1.1	1.1	0.0	0.0	72.4	20.1	13.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	36.3	16.4	1.4	0.1	0.0	0.0	0.1
SIRPD	"dJ576H24.4, PTPNS1L2"	ENSG00000125900	"Signal regulatory protein delta"	Q9H106	20	1534251-1558843	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"blood: 19.9;testis: 64.2"	"Group enriched"	"Detected in some"	90	"Early spermatids: 387.0;Late spermatids: 441.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 19.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;HMC-1: 3.5;NB-4: 4.6;THP-1: 9.9;U-937: 2.2"									HPA042663	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA042663: AB_2678102"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-2)"			"unprognostic (3.01e-2)"	"unprognostic (4.47e-1)"		"unprognostic (2.49e-1)"		"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.66e-8)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.44e-2)"	0.1	0.1	0.1	1.9	0.1	1.7	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.3	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.0	64.2	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.0	4.0	19.9	12.5	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.5	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	12.5	11.2	0.0	7.3	0.1	0.0	0.0	0.1	4.0	0.0	0.0	0.0	19.9	0.0	3.1	2.3	0.1	3.6	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.6	441.6	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.8	1.7	0.0	0.0	0.0	0.0	0.0
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608100-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 97.8"	"Cell type enhanced"	"Detected in some"	18	"Melanocytes: 13.5;monocytes: 38.7;T-cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.1"	"Group enriched"	"Detected in many"	10	"B-cells: 8.8;T-cells: 24.1"	"Cell line enriched"	"Detected in single"	111	"HDLM-2: 58.4"									"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	NA	NA		590000			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	2.5	0.3	0.3	14.2	0.3	4.4	1.4	0.2	0.3	1.2	2.3	0.4	0.5	2.2	0.5	1.2	2.2	0.8	2.3	1.3	0.2	0.2	2.0	1.0	4.0	14.8	0.2	0.1	0.6	0.9	0.0	0.5	2.3	0.3	1.1	2.1	0.6	4.1	0.6	0.8	1.1	7.6	1.0	0.5	10.6	2.4	0.4	0.2	97.8	1.5	1.9	26.3	3.5	1.1	8.8	1.6	0.2	0.1	0.0	24.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.0	4.2	0.0	24.1	6.2	17.2	12.1	0.1	8.8	6.6	1.6	0.2	0.0	0.0	1.6	21.5	3.5	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.0	6.9	8.1	0.1	1.8	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.3	0.0	0.0	0.0	1.2	6.2	0.0	5.0	13.5	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.1	20.2	0.0	0.0
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.2;Late spermatids: 15.4"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"JURKAT: 12.4;MOLT-4: 41.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"	NA	NA			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.3	0.0	0.1	41.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.7	0.0	0.3	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20253260-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 46.7;Fibroblasts: 64.7;Leydig cells: 24.5;Peritubular cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 28.5;BJ hTERT+: 57.2;BJ hTERT+ SV40 Large T+: 27.8;fHDF/TERT166: 32.3;HBF TERT88: 32.2;HEK 293: 25.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	4.7	18.1	2.8	3.8	9.8	0.0	6.3	0.6	11.5	18.3	7.1	1.2	5.0	1.5	16.7	6.5	6.9	9.1	6.3	5.2	4.5	6.7	8.6	1.0	22.8	1.2	2.4	6.2	6.1	1.7	0.5	6.5	16.8	4.2	9.1	3.6	3.5	4.5	11.6	1.5	2.4	3.0	17.1	1.5	23.1	6.5	3.3	1.0	0.6	6.3	0.7	1.2	8.6	11.0	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	11.0	10.2	0.5	28.5	57.2	27.8	10.5	0.1	0.0	0.0	0.9	32.3	0.0	0.3	4.2	2.1	32.2	0.0	25.5	0.0	0.1	0.0	2.2	0.2	0.0	2.4	0.0	18.0	5.4	0.6	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	0.0	2.0	16.4	0.1	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.5	10.4	1.4	10.0	15.5	0.0	0.0	0.0	0.2	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.1	2.8	9.8	0.6	11.5	4.5	6.7	2.4	6.2	4.2	1.0	0.0	13.6	0.0	1.8	7.1	46.7	3.7	0.0	13.4	2.3	0.0	0.0	1.0	1.7	1.5	0.4	1.8	0.0	0.0	0.4	0.9	64.7	1.6	2.3	0.0	1.7	0.0	1.2	6.2	1.0	1.1	24.5	0.7	8.5	0.0	0.0	0.7	0.2	0.0	25.1	11.4	1.1	6.5	8.2	0.1	1.0	5.8	1.7	0.0	0.0	1.8
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301129	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 32.9;Melanocytes: 33.7;Sertoli cells: 84.1;Smooth muscle cells: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.4;fHDF/TERT166: 28.9;RT4: 25.2;SH-SY5Y: 18.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	38.5	12.5	6.7	6.3	7.9	0.2	31.8	20.3	10.8	28.0	13.2	1.8	13.0	3.2	21.6	22.4	18.2	14.8	32.5	28.3	6.2	4.6	12.0	1.5	24.9	6.7	2.2	7.1	29.4	4.6	37.6	3.8	12.4	10.7	28.5	5.9	7.7	10.7	9.8	4.9	17.5	7.1	44.4	2.0	7.7	8.2	6.3	0.3	11.8	16.6	10.8	6.2	36.8	32.1	0.1	0.0	0.5	0.1	4.1	0.0	0.0	0.0	2.7	0.0	0.0	81.4	1.5	0.0	4.5	0.7	1.0	2.1	0.0	0.0	0.0	1.1	28.9	3.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.0	0.1	1.0	11.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.3	18.9	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.5	6.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	6.7	7.9	20.3	10.8	6.2	4.6	2.2	7.1	10.7	0.3	0.0	2.9	0.0	1.6	23.7	2.4	22.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	9.7	3.1	0.0	0.0	0.0	0.4	32.9	0.6	1.1	0.0	1.1	0.0	0.0	2.5	0.0	6.2	0.9	1.5	33.7	0.0	0.0	12.3	0.0	0.0	0.4	1.7	0.2	84.1	67.6	0.5	1.6	15.4	0.9	0.0	0.0	0.7
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882393	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 30.6"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 6.6"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074835	Enhanced				"Secreted in brain"	NA	NA		270000			"HPA074835: "	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.9	1.3	16.7	0.9	9.5	0.9	1.0	2.0	30.6	1.2	1.0	6.3	0.0	1.0	1.0	1.0	0.9	0.9	1.0	0.9	16.9	7.3	1.0	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1.0	0.1	1.0	1.4	1.0	0.9	0.9	0.9	3.7	0.9	1.0	1.0	8.5	0.0	0.9	0.0	0.9	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.2	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	9.5	2.0	21.5	16.9	7.3	7.3	14.9	5.8	8.5	0.0	0.0	0.0	0.0	0.0	6.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1679.4;Alveolar cells type 2: 2934.9;Basal glandular cells: 1025.0;Cholangiocytes: 1719.7;Ciliated cells: 2255.1;Club cells: 3002.8;Collecting duct cells: 3252.2;Urothelial cells: 2991.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 157.0;hTCEpi: 184.3;OE19: 67.0;SiHa: 55.2;THP-1: 46.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	2600000	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	28.4	0.0	157.0	0.0	2.1	11.7	0.0	5.6	0.0	0.7	0.0	0.0	21.0	0.0	30.3	0.0	0.0	0.8	184.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	67.0	10.7	0.0	0.0	0.0	32.0	1.2	0.0	0.0	55.2	11.8	0.1	0.0	0.2	46.6	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0	1679.4	2934.9	5.2	1025.0	89.4	0.0	0.9	1719.7	2255.1	3002.8	3252.2	0.0	1.3	0.0	285.2	390.2	5.3	69.3	23.3	231.9	0.9	101.8	495.3	70.9	353.5	5.8	0.0	192.4	19.6	6.7	55.8	23.6	30.6	37.1	9.0	72.4	0.0	552.6	410.1	0.0	1.1	0.0	0.0	22.7	1.0	1.6	121.5	1.7	5.3	161.1	2991.2
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Cell type enriched"	"Detected in some"	24	"Suprabasal keratinocytes: 57.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.4;hTCEpi: 2.3;MCF7: 3.8;RT4: 2.7;T-47d: 6.6"	"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	NA	NA		5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.7
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769844	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HaCaT: 24.7"														"Secreted in other tissues"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	112.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	105.8	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	5.5	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 81.2;Pancreatic endocrine cells: 87.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 3.3;RPTEC TERT1: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.3	0.2	0.8	0.2	0.4	0.9	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.2	0.8	0.1	0.4	0.1	0.3	0.4	0.1	0.4	0.3	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.1	0.0	0.5	0.5	1.5	0.0	0.6	0.4	1.4	0.4	1.7	0.1	0.6	0.2	1.4	4.5	0.6	0.5	0.2	0.4	0.5	0.6	0.5	0.4	0.7	0.4	0.5	0.2	0.8	0.5	1.8	0.4	0.7	0.8	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	17.0	3.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;liver: 48.0"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 78.8;Peritubular cells: 125.2;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"AF22: 19.8;HeLa: 54.5;HSkMC: 16.0;SiHa: 32.1;SK-BR-3: 14.1;U-266/70: 20.3;U-87 MG: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	7.4	10.7	23.0	1.4	10.8	1.1	2.9	5.2	62.2	8.6	2.2	32.0	19.4	3.0	2.2	10.3	1.3	7.1	1.5	4.7	22.6	16.2	2.1	48.0	1.4	1.8	23.8	8.5	1.8	26.4	1.1	2.4	9.0	21.7	42.9	2.0	14.7	3.6	35.8	8.7	1.2	2.3	1.9	15.0	19.5	3.5	24.7	16.9	0.0	2.9	0.6	1.5	1.7	3.6	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	19.8	0.0	4.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	7.7	0.0	54.5	8.0	0.0	0.0	0.0	16.0	4.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.1	32.1	14.1	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.0	0.0	20.3	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.0	10.8	5.2	11.2	22.6	16.2	23.8	8.5	21.7	16.9	0.0	0.0	0.9	0.0	0.2	1.5	1.7	10.2	1.4	0.0	0.0	15.7	18.5	0.0	0.2	4.1	1.3	0.0	0.0	1.9	0.8	4.2	0.0	0.0	78.8	2.5	0.0	15.0	2.5	2.7	13.2	7.2	0.0	0.0	0.0	0.0	0.2	5.8	0.0	125.2	0.0	0.2	0.0	0.7	1.5	3.3	0.4	33.6	0.0	0.0	0.0
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Leydig cells: 298.0;Peritubular cells: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	17.9	3.4	1.9	17.2	5.0	0.0	26.2	0.8	2.3	37.3	11.7	2.5	5.0	5.1	57.7	40.6	17.9	34.4	73.2	25.3	1.9	1.7	3.0	1.3	5.3	4.8	2.7	2.9	45.0	8.5	1.8	1.5	5.4	6.0	22.3	6.4	76.2	6.9	15.1	21.8	8.0	9.4	53.9	1.6	1.3	50.0	31.1	1.3	2.3	13.6	12.3	3.5	36.8	11.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.2	0.0	0.0	0.0	0.0	12.6	4.5	0.0	2.0	0.4	0.0	0.4	0.1	11.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	5.0	0.8	2.3	1.9	1.7	2.7	2.9	6.0	1.3	0.0	1.7	0.0	6.1	9.8	2.8	7.0	0.0	4.0	3.4	10.4	0.0	2.0	0.0	0.0	2.3	3.5	1.6	0.0	0.0	1.6	18.5	5.5	0.0	0.0	1.2	0.0	18.9	4.3	0.0	5.7	298.0	0.6	3.3	0.0	3.0	0.4	0.1	0.0	723.1	0.0	0.6	45.3	73.7	2.7	4.5	2.4	2.2	0.0	12.5	0.6
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390431-6394998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;fHDF/TERT166: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2000000				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	14.7	21.4	12.4	10.9	18.7	5.4	10.7	17.2	32.4	14.5	17.4	30.6	15.7	14.3	12.2	15.0	11.6	7.9	18.5	26.8	14.5	13.2	47.1	77.5	17.1	10.7	17.4	15.9	12.9	19.9	35.4	23.8	23.1	21.6	17.6	12.9	23.3	21.5	18.5	20.9	19.7	15.8	14.9	17.8	11.7	13.3	7.4	14.1	18.8	20.2	10.3	11.8	12.5	11.4	3.2	1.8	3.4	2.7	6.8	11.4	3.1	4.6	3.7	2.8	7.6	41.6	21.7	5.0	17.6	27.3	8.0	9.7	6.4	3.3	1.2	8.2	41.0	17.4	1.9	2.4	3.6	3.8	5.9	2.8	1.4	6.0	1.7	18.6	1.0	11.0	28.6	6.9	7.4	5.0	29.6	17.6	0.5	2.5	8.8	17.1	4.7	0.0	1.8	1.1	6.5	6.6	0.3	1.6	1.9	6.9	1.7	4.9	2.8	7.9	5.5	10.8	3.8	2.1	1.9	15.2	29.9	3.2	17.3	4.1	11.3	12.0	0.9	27.7	3.0	13.3	1.8	2.7	3.4	6.9	2.1	5.6	1.6	5.9	5.5	1.4	3.2	11.3	11.4	2.7	6.8	0.6	1.8	4.8	3.1	12.4	18.7	17.2	32.4	14.5	13.2	17.4	15.9	21.6	14.1	23.8	15.6	18.0	17.3	7.0	11.9	31.1	22.9	2.7	9.1	24.4	23.6	33.4	10.0	42.6	42.2	13.5	58.4	0.0	33.0	11.7	31.4	37.7	10.4	72.3	30.5	19.1	22.8	27.6	12.7	155.2	10.6	8.6	52.3	4.6	17.5	16.4	24.7	17.5	12.7	60.8	4.9	0.0	24.5	1.2	1.8	6.9	28.7	20.3	10.9	12.0
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 208.6;Proximal tubular cells: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.2	3.0	1.4	22.3	10.1	9.6	5.0	13.5	1.5	3.3	1.6	1.3	0.0	0.7	3.1	4.1	2.4	0.8	2.5	1.3	0.0	2.6	1.1	5.1	4.2	14.3	0.0	0.0	12.3	18.3	1.4	2.7	6.0	2.7	0.0	1.8	0.0	6.2	4.4	0.0	0.1	0.5	28.0	3.9	0.0	5.3	0.1	7.4	2.0	2.2	0.0	0.7	9.1	12.7	2.0	1.5	0.7	5.2	3.0	1.7	0.3	3.2	0.0	0.0	0.0	4.3	2.3	6.7	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2	3.0	16.2	2.2	20.4	47.7	2.8	3.6	22.9	5.3	3.4	5.2	3.9	117.9	48.0	19.1	0.1	5.8	208.6	0.0	22.5	35.4	27.9	13.5	9.3	67.1	54.3	3.2	46.8	24.5	86.5	1.1	14.4	9.9	33.7	1.0	51.3	11.4	17.1	87.7	13.4	122.4	5.9	12.9	8.3	0.9	3.9	66.5	96.2	4.3	33.0	12.8
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		330000	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.6	1.2	0.0	0.1	0.0	0.0	23.1	0.0	0.5	0.3	1.7	5.9	17.8	0.8	4.2	0.0	0.3	2.9	1.9	1.6	0.3	0.0	11.8	3.8	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.5	0.2	0.5	0.5	0.1	0.5	0.2	0.0	9.3	0.0	0.4	13.7	2.0	2.1	0.2	0.1	14.3	12.4	4.6	11.9	0.2	0.0	23.0	0.6	2.5	16.6	0.7	0.0	0.0	3.9	0.0	0.0	0.1	6.0	0.3	0.4	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3	8.9	13.2	2.2	2.4	0.1	0.0	0.3	2.5	4.0	15.9	8.7	0.0	2.2	0.0	24.4	0.2	0.1	33.4	0.0	19.9	0.1	0.0	5.5	0.0	0.0	0.3	0.0	19.7	0.6	0.0	0.0	0.0	0.8	0.0	0.0	23.2	0.0	24.8	43.2	0.0	6.7	0.0	0.0	0.8	0.0	0.1	0.1	6.4	1.3	29.8	2.5
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360761-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"salivary gland: 186.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"									HPA044567	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	186.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2372	"salivary gland: 6520.0"	"Group enriched"	"Detected in some"	60	"Early spermatids: 8.1;Late spermatids: 3.8"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"EFO-21: 9.8"														"Secreted to digestive system"	NA	NA		4500000																			"unprognostic (3.72e-1)"		0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	6520.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNED1	"FLJ00133, Snep, SST3"	ENSG00000162804	"Sushi, nidogen and EGF like domains 1"	Q8TER0	2	240998838-241095568	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ito cells: 27.6;Leydig cells: 88.1;Peritubular cells: 66.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	28	"B-cells: 5.3;monocytes: 1.7;T-cells: 1.3"	"Group enriched"	"Detected in some"	5	"ASC TERT1: 94.4;HSkMC: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA036414, HPA036415"	Uncertain				"Secreted - unknown location"	NA	NA		15000000			"HPA036414: AB_10960852, HPA036415: AB_10964128"	"unprognostic (1.41e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.62e-2)"	"unprognostic (7.77e-4)"	"unprognostic (3.49e-2)"	"unprognostic (4.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.95e-3)"	18.8	8.3	4.6	10.3	3.7	1.3	23.7	21.9	7.4	21.7	7.0	7.6	19.1	4.9	19.1	23.9	6.8	17.4	19.2	8.4	5.6	2.5	6.0	5.4	9.5	6.3	5.8	3.9	23.2	7.8	2.4	5.5	2.2	11.8	12.9	3.9	15.6	11.0	11.1	14.3	9.0	6.8	8.2	7.7	11.0	4.2	11.9	7.3	2.7	29.1	8.4	5.7	9.0	17.1	5.3	0.0	0.0	1.7	0.0	1.3	0.2	0.0	0.1	0.0	1.0	13.9	94.4	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.9	0.0	0.5	0.0	0.1	47.8	0.0	0.1	0.0	6.3	2.0	0.0	0.0	0.6	2.5	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.8	0.0	1.2	0.1	0.1	0.0	0.4	1.8	0.9	0.1	0.3	0.1	5.1	1.9	0.1	11.1	0.3	0.1	0.0	0.3	2.6	0.0	0.5	0.0	0.1	0.0	0.0	0.9	1.0	5.3	1.3	0.7	0.0	2.0	0.7	0.7	0.0	0.0	1.7	0.0	1.3	0.2	4.6	3.7	21.9	7.4	5.6	2.5	5.8	3.9	11.8	7.3	6.0	8.3	3.2	0.8	3.2	2.6	2.0	2.5	5.3	14.8	5.2	0.0	0.1	0.0	0.7	1.1	7.0	0.0	0.0	1.1	0.2	6.6	3.6	0.0	4.9	0.2	1.6	2.4	27.6	1.9	1.9	88.1	0.5	1.7	0.0	0.0	9.9	0.6	0.0	66.8	0.1	1.4	25.8	2.7	0.5	1.9	2.3	0.3	0.0	0.0	0.4
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 392.7;Peritubular cells: 343.7;Smooth muscle cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.9;BJ: 11.0;PC-3: 16.0;RPTEC TERT1: 67.3;T-47d: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	830000000			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	90.0	9.9	3.7	13.8	5.0	0.8	31.9	1.6	8.3	46.4	24.7	14.7	8.0	10.4	34.4	21.1	52.1	39.5	55.1	61.9	6.4	1.9	40.4	3.9	40.1	6.7	3.4	6.2	36.1	41.0	1.6	4.6	30.4	24.3	40.0	8.1	45.0	13.7	15.5	16.1	19.9	13.7	53.6	5.4	8.4	25.4	25.9	2.1	4.4	68.0	25.2	17.7	61.1	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	5.2	0.6	11.0	4.8	0.6	0.4	0.1	0.0	0.0	3.5	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	4.6	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.3	0.0	16.0	0.0	0.0	0.1	67.3	0.2	0.0	0.0	0.0	0.3	0.0	0.6	10.0	0.0	0.0	2.6	0.3	0.4	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	1.6	8.3	6.4	1.9	3.4	6.2	24.3	2.1	11.9	17.8	0.8	63.7	80.6	0.3	15.1	79.0	0.0	13.6	85.5	0.0	93.1	13.3	64.9	10.0	6.8	5.1	0.0	1.5	13.0	180.5	65.7	0.0	0.0	14.9	0.0	33.3	15.4	0.0	24.2	392.7	4.3	75.9	0.0	50.3	19.4	5.0	86.3	343.7	114.0	1.0	194.1	404.7	27.7	3.7	61.5	158.9	2.2	57.8	8.9
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes			"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.5	10.3	12.5	13.5	7.3	6.7	3.3	6.6	7.2	9.5	5.6	4.1	1.2	3.3	2.5	11.6	8.2	10.2	10.0	6.2	10.0	0.5	2.0	5.4	9.6	5.4	3.8	1.2	5.3	3.8	7.6	9.0	6.4	4.1	6.1	3.7	3.8	0.7	10.3	7.3	3.8	2.8	3.2	0.8	8.0	9.0	11.7	1.3	5.5	2.3	15.0	9.4	13.8	15.2	4.4	5.8	19.3	8.1	9.3	23.8	4.6	11.6	14.4	1.4	0.3	3.4	10.1	1.6	15.0	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7	0.0	2.6	1.4	4.8	11.2	18.8	12.1	0.0	2.7	7.9	19.2	35.3	12.5	1.7	3.4	0.4	10.5	1.7	0.0	1.3	8.6	11.0	5.2	10.4	0.2	8.5	22.3	5.8	9.8	5.3	1.5	11.2	6.0	5.0	1.0	1.3	19.4	1.8	0.0	17.7	1.2	3.7	12.9	11.3	0.7	1.0	14.1	2.7	1.0	2.5	2.5
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452203-121633693	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 365.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 44.0;Daudi: 20.6;OE19: 28.1;RT4: 31.1;U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA					"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	5.6	5.0	17.3	17.0	24.9	30.7	10.5	28.3	40.8	34.8	12.7	36.0	9.9	8.6	4.5	7.2	5.7	29.4	5.8	3.0	22.4	18.7	15.0	41.4	10.0	14.8	28.6	21.9	7.3	6.1	19.9	17.7	2.1	24.0	16.0	12.7	6.4	14.7	20.0	1.5	3.9	13.0	3.8	27.8	21.3	7.9	4.1	23.4	11.1	10.3	0.2	16.3	15.8	6.7	2.0	5.6	43.8	5.4	6.7	10.8	6.1	0.4	2.4	2.2	0.3	0.0	0.0	2.3	0.1	0.7	0.1	0.0	3.6	44.0	20.6	2.6	0.5	3.3	14.6	2.8	2.1	0.0	0.0	0.8	0.0	3.2	5.0	0.0	8.7	0.0	0.0	2.4	0.0	8.1	1.2	0.0	2.6	0.0	0.2	0.0	2.9	2.0	4.5	2.7	28.1	3.3	2.3	0.1	0.4	4.9	31.1	1.6	0.4	4.6	6.6	0.0	5.2	6.5	2.8	0.1	0.0	1.6	0.3	0.0	0.0	0.0	42.8	0.0	11.7	0.1	13.0	5.4	19.1	8.0	2.3	10.8	0.7	9.0	7.2	2.2	2.0	8.6	7.6	43.8	6.7	2.8	5.6	6.3	6.1	17.3	24.9	28.3	40.8	22.4	18.7	28.6	21.9	24.0	23.4	6.0	24.6	10.4	32.9	3.9	40.9	9.0	25.5	10.7	27.3	75.0	365.2	0.4	0.0	6.5	0.9	3.2	87.9	0.0	0.6	0.6	5.9	40.6	11.5	98.3	41.1	47.7	5.8	27.0	56.2	1.8	72.2	49.6	3.3	19.8	48.5	34.5	4.5	87.7	54.5	0.9	28.0	0.0	12.0	0.7	21.5	2.0	0.3	55.8	35.3	25.8
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell type enriched"	"Detected in single"	6	"Collecting duct cells: 1.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	34	"HaCaT: 10.2;SuSa: 6.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
SPACA3	"ALLP17, CT54, LYC3, LYZL3, SLLP1"	ENSG00000141316	"Sperm acrosome associated 3"	Q8IXA5	17	32970376-32997877	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 15.0;testis: 45.6"	"Group enriched"	"Detected in some"	70	"Early spermatids: 974.2;Late spermatids: 721.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.9"	"Cell line enriched"	"Detected in some"	17	"U-266/70: 47.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023633	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA023633: AB_1857407"	"unprognostic (6.48e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.31e-2)"		"unprognostic (3.37e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.70e-4)"			"unprognostic (3.86e-2)"	"unprognostic (1.79e-1)"		"unprognostic (4.63e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	15.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	45.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.9	0.9	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	974.2	0.0	0.7	0.0	0.9	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	721.4	12.0	0.0	1.7	0.0	0.6	0.0	0.7	0.3	4.6	0.0	0.0	6.5	0.0	8.8	5.1	0.0	0.0	0.0	0.6	0.0
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.1"	"Cell type enriched"	"Detected in single"	29	"Early spermatids: 2.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;JURKAT: 1.3;NB-4: 3.9;U-266/70: 1.2;U-266/84: 2.1"									"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA					"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.4	0.0	0.0			0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.4		0.3	1.4	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	15.1			1.3		0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.3	3.9	0.9	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.5	1.1	0.0	0.0	0.4	0.0	0.7	0.0	1.2	2.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.9	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 18.3"	"Cell type enriched"	"Detected in single"	12	"Early spermatids: 1.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA					"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA7	C13orf28	ENSG00000153498	"Sperm acrosome associated 7"	Q96KW9	13	112376319-112434689	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 68.5"	"Group enriched"	"Detected in some"	137	"Early spermatids: 1028.4;Late spermatids: 637.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.6"									HPA048349	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048349: AB_2732548"							"unprognostic (3.97e-2)"											0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	68.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.5	4.5	0.8	0.6	0.5	0.2	0.6	0.9	0.5	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.0	0.0	0.8	0.5	0.0	0.3	0.0	0.8	0.0	0.6	1.7	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.1	2.2	1.1	0.0	1.0	1.1	0.7	0.6	0.3	0.9	0.8	0.1	0.3	0.0	0.8	2.6	0.8	0.3	0.8	0.9	0.3	0.5	1.2	0.0	0.7	0.4	1.8	0.3	0.9	1.1	1.0	0.2	0.2	0.4	3.2	0.8	0.7	0.5	0.5	0.2	0.2	0.2	0.2	0.2	0.7	0.3	0.5	4.5	0.6	0.5	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1028.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	637.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	5.4	3.4	0.0	0.0	0.0	0.0	0.0
SPAG11A	"EDDM2A, HE2"	ENSG00000178287	"Sperm associated antigen 11A"	Q6PDA7	8	7847876-7868867	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	225	"epididymis: 332.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 10.4"									"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA			"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	332.8	1.4	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAG11B	"EDDM2B, EP2, EP2C, EP2D, HE2"	ENSG00000164871	"Sperm associated antigen 11B"	Q08648	8	7442684-7463674	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	232	"epididymis: 362.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 5.7;NB-4: 12.6;RPMI-8226: 5.8;SH-SY5Y: 5.1"									"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA			"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0			0.0	0.4	362.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPARC	ON	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151687165	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 896.1;Ito cells: 958.1;Peritubular cells: 1044.4;Sertoli cells: 2315.4;Smooth muscle cells: 1190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 9.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.3;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 234.0;BJ: 191.0;fHDF/TERT166: 302.0;WM-115: 222.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		190000000	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	178.3	58.3	50.2	47.4	93.3	3.4	68.6	33.8	131.3	115.6	42.8	92.3	22.9	13.2	89.0	65.9	36.9	38.5	177.8	65.5	68.3	100.3	46.3	25.0	66.8	25.4	124.7	18.0	55.1	14.1	36.7	16.8	249.1	153.5	46.3	22.4	47.5	15.8	45.3	31.2	40.2	20.6	144.0	202.0	43.8	20.4	75.2	68.8	7.4	38.6	39.4	14.8	104.6	35.9	0.0	0.8	9.3	3.0	0.0	0.3	40.6	0.2	0.2	56.5	2.6	234.0	79.4	5.3	191.0	63.0	79.1	81.6	0.2	0.1	0.0	45.3	302.0	12.9	2.6	7.1	14.5	27.3	0.2	2.6	2.5	0.0	5.2	70.1	0.1	0.2	123.9	20.9	58.2	8.1	93.3	108.6	0.6	2.3	2.0	44.9	0.0	0.2	1.6	26.1	0.0	0.2	0.1	56.1	0.1	0.0	0.0	2.1	4.2	0.1	0.0	25.4	95.1	0.2	6.2	128.2	37.0	57.1	16.7	59.9	0.1	0.2	0.2	32.3	0.1	222.0	2.2	3.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	9.3	0.0	0.0	0.7	0.0	40.6	50.2	93.3	33.8	24.6	68.3	100.3	124.7	18.0	153.5	68.8	77.4	37.5	11.1	26.9	146.3	50.1	28.0	7.6	9.4	30.7	15.7	2.0	100.4	0.0	4.6	11.1	490.8	0.0	23.3	0.3	315.9	896.1	5.2	11.5	5.5	99.3	1.6	0.0	958.1	70.8	28.8	295.7	31.0	222.7	5.4	0.0	10.6	8.6	0.0	1044.4	35.4	63.7	2315.4	1190.8	7.0	6.8	94.6	123.1	5.1	0.0	4.4
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	20	"Endothelial cells: 1521.8;Peritubular cells: 2372.1;Sertoli cells: 4598.4"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 17.8;SuSa: 25.3;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		660000000			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	102.2	21.9	110.3	18.8	139.9	0.9	52.1	42.9	212.1	123.2	58.0	17.9	23.8	19.7	148.7	74.6	56.4	92.8	74.7	80.9	98.8	40.9	13.2	4.5	58.7	14.6	67.5	106.4	45.2	13.0	15.8	38.3	48.8	69.7	97.0	30.4	7.9	31.5	166.0	35.2	13.1	27.4	185.6	82.5	23.9	40.8	29.2	53.9	1.2	38.8	24.4	15.6	103.9	50.3	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.5	0.0	17.8	0.2	0.1	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.0	1.9	0.0	0.0	1.4	0.0	0.2	0.8	0.3	0.8	0.2	1.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.4	0.1	2.7	0.4	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.6	1.4	0.1	0.1	0.1	25.3	0.3	0.3	0.0	0.2	0.2	1.0	0.1	7.0	0.9	0.4	2.7	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.3	0.0	0.0	110.3	139.9	42.9	136.4	98.8	40.9	67.5	106.4	69.7	53.9	11.9	84.8	13.7	145.4	41.1	7.3	256.0	2.5	13.4	79.6	7.0	2.0	1.7	11.6	0.5	9.5	1521.8	0.0	0.0	0.4	4.4	128.5	36.6	7.0	7.4	8.4	3.2	0.0	459.7	4.1	21.4	610.7	30.6	54.0	0.0	0.0	177.6	0.1	0.0	2372.1	11.0	29.9	4598.4	816.1	4.7	6.6	34.9	2.1	4.9	0.0	107.5
SPATA20	"FLJ21347, SSP411, Tisp78"	ENSG00000006282	"Spermatogenesis associated 20"	Q8TB22	17	50543058-50555852	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"Early spermatids: 516.6;Late spermatids: 1225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.1;MCF7: 26.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022023, HPA027144, HPA031442"	Enhanced		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557"	"unprognostic (9.27e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.63e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.12e-3)"	"unprognostic (4.93e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (9.69e-5)"	9.7	29.0	14.9	15.2	13.1	4.6	8.2	17.7	22.8	11.7	13.4	11.4	16.8	9.8	16.0	21.1	10.7	13.5	25.4	36.3	9.8	14.3	15.7	13.1	11.2	8.7	15.0	18.3	20.4	22.4	11.9	10.4	6.9	13.3	15.4	5.8	29.0	18.9	15.0	17.9	8.7	9.9	12.7	13.0	14.1	22.8	62.7	6.8	2.5	22.3	8.5	9.9	13.1	7.9	3.2	8.9	1.1	4.7	9.3	2.6	2.9	3.4	16.0	0.9	10.5	2.4	7.5	2.9	5.9	6.8	2.8	2.2	11.9	5.1	3.7	14.3	4.2	3.1	2.7	0.6	2.9	1.4	5.0	2.3	2.5	3.5	27.1	11.1	0.9	7.4	11.9	3.9	1.5	4.4	3.7	3.6	0.6	0.3	6.9	2.5	26.8	0.0	0.9	1.1	7.3	7.0	1.5	2.5	1.0	13.7	17.0	1.8	4.3	5.2	3.9	6.3	1.1	7.5	0.4	8.1	2.8	8.9	1.6	1.2	13.2	4.0	0.0	5.9	0.5	2.9	0.0	4.5	1.1	2.0	4.7	2.6	3.2	1.5	1.5	8.9	2.2	2.0	2.2	0.3	9.3	4.0	2.0	0.8	2.9	14.9	13.1	17.7	22.8	9.8	14.3	15.0	18.3	13.3	6.8	6.0	5.3	3.4	11.9	9.5	3.4	26.6	17.8	4.0	12.5	22.7	3.9	14.5	23.2	29.1	516.6	10.5	20.1	0.0	34.6	8.5	19.4	14.3	17.3	19.8	30.3	11.1	36.5	9.8	22.6	1225.1	35.4	15.4	20.3	19.0	31.6	24.6	24.1	25.9	35.7	30.1	1.9	6.5	20.6	8.1	10.4	7.8	8.2	10.2	20.5	12.0
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor, Kazal type 1"	P00995	5	147824568-147831786	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"pancreas: 1767.1"	"Group enriched"	"Detected in many"	15	"Exocrine glandular cells: 43924.5;Pancreatic endocrine cells: 22474.2"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 44.0;RT4: 120.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	NA	NA		7900000			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favorable (2.15e-5)"	0.3	0.0	0.3	1.6	0.3	0.0	0.3	0.3	0.3	0.3	6.0	0.3	0.3	6.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.0	2.0	13.3	0.4	0.3	0.3	0.3	0.3	1767.1	0.0	0.3	0.3	0.3	1.4	6.4	0.3	0.3	0.3	0.3	0.0	6.9	1.0	0.3	0.3	25.8	0.4	0.3	0.3	0.3	0.3	0.3	13.1	2.2	0.7	0.5	1.9	0.5	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	17.3	0.1	0.0	0.0	0.2	0.0	120.9	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.4	0.5	0.2	2.2	0.0	0.0	1.9	0.4	0.2	0.4	0.5	0.2	0.4	0.4	0.3	0.1	0.7	0.5	0.6	1.8	0.3	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	2.2	23.4	11.4	0.0	0.0	0.1	2119.8	1.4	19.4	357.6	0.0	0.0	72.9	1009.7	0.1	0.0	492.7	23.3	43924.5	0.1	0.0	96.7	4.6	2225.9	0.1	0.0	496.7	62.0	39.3	0.0	0.0	0.0	0.0	470.7	1572.1	0.0	22474.2	345.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.6	978.8	64.4
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Group enriched"	"Detected in some"	7	"Leydig cells: 36.8;Peritubular cells: 25.1"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"HeLa: 102.0"									HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	102.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor, Kazal type 2"	P20155	4	56809860-56821742	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 376.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 772.8;Late spermatids: 1064.2;Spermatocytes: 1687.5"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 43.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 43.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 44.5"									"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.2	0.1	0.2	0.5	0.2	0.7	0.3	0.1	0.3	0.4	0.4	0.0	85.2	0.0	0.2	376.2	0.1	0.2	0.0	2.2	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.0	1.4	0.0	1.1	1.1	0.1	0.0	0.6	49.9	0.5	0.2	0.5	0.0	0.2	0.6	0.2	85.5	0.0	0.3	0.2	0.0	0.2	1.3	1.3	3.9	0.4	1.3	0.0	43.3	7.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	1.3	8.6	0.2	0.0	0.0	0.0	0.0	2.0	0.0	2.8	0.1	1.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	44.5	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	0.2	2.3	1.7	1.8	0.4	3.9	3.9	7.3	0.3	43.3	0.0	0.2	0.1	2.0	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.0	1.1	0.0	0.0	0.0	4.5	12.1	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	772.8	0.1	0.2	0.0	0.0	0.2	0.5	9.5	1.1	0.0	0.1	0.0	1.7	0.0	0.0	1064.2	35.1	0.2	11.8	0.0	5.3	1.4	0.0	9.3	23.0	0.0	0.0	12.9	1.0	1687.5	136.3	0.3	0.0	7.5	1.7	2.2
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor, Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3"	"Cell type enriched"	"Detected in some"	24	"Mucus-secreting cells: 2251.6"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 38.2;OE19: 100.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Not detected"	"Not detected"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	0.2	0.4	0.2	24.3	0.3	0.0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0.0	0.0	5.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	6.2	0.2	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.4	0.0	100.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	3.2	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	5.2	11.8	0.0	0.0	0.1	0.7	0.0	94.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	84.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2251.6	15.3	0.1	40.3	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.1
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 45.0;Basal keratinocytes: 47.7;Cholangiocytes: 58.6;Mucus-secreting cells: 32.9;Paneth cells: 66.2;Suprabasal keratinocytes: 56.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.3;HeLa: 18.1;Karpas-707: 16.0;SuSa: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		28000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	0.0	12.3	0.0	1.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.7	16.0	0.0	1.7	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	4.7	2.4	0.0	0.5	0.0	0.0	5.9	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	8.9	45.0	0.0	1.4	47.7	0.0	0.8	58.6	6.7	9.1	0.0	0.0	1.7	0.0	0.0	9.3	6.4	13.4	0.0	1.1	1.6	1.0	0.6	1.1	0.0	0.1	0.0	4.1	1.3	0.6	2.7	0.6	0.6	3.3	0.0	32.9	0.0	4.6	66.2	0.0	0.0	0.0	0.0	0.9	0.6	1.9	56.2	1.3	0.0	20.3	2.3
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 1.3;Hofbauer cells: 2.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	84	"HeLa: 244.9;SiHa: 117.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	244.9	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor, Kazal type 7 (putative)"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 161.8;tongue: 124.0;vagina: 79.6"	"Cell type enhanced"	"Detected in single"	34	"Urothelial cells: 1.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;HeLa: 2.2;hTCEpi: 3.9;PC-3: 3.2;SiHa: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted - unknown location"	NA	NA		90000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	39.1	0.1	0.0	0.0	0.1	2.8	0.1	161.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	16.9	0.1	0.2	1.1	0.1	0.1	0.0	0.1	1.3	0.1	0.0	0.6	0.1	124.0	30.6	0.2	79.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8
SPINK8		ENSG00000229453	"Serine peptidase inhibitor, Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"breast: 33.5"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 1.1;Exocrine glandular cells: 1.2;Glandular cells: 2.2"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"					"Group enriched"	"Detected in some"	10	"eosinophil: 3.3;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.5"	"Cell line enriched"	"Detected in single"	62	"SK-BR-3: 41.2"	"Region enriched"	"Detected in some"	9	"hippocampal formation: 80.7"					HPA053151	Uncertain				"Secreted to blood"	NA	NA					"HPA053151: AB_2682059"	"prognostic unfavorable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	1.4	0.0	1.0	7.3	33.5	0.3	0.6	0.0	0.0			0.0	0.0	1.8	4.1	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	1.5		0.0	0.2	0.0	0.2	0.0		0.4	0.0		1.8	0.1	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	41.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4
SPINK9		ENSG00000204909	"Serine peptidase inhibitor, Kazal type 9"	Q5DT21	5	148321203-148339849	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"tongue: 65.0"	"Group enriched"	"Detected in some"	54	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.5;U-266/84: 19.6"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.0	2.3	2.3	2.2	4.0	6.2	1.0	1.3	3.2	1.0	1.2	1.0	1.0	1.1	2.0	1.5	1.5	0.5	1.0	2.3	2.2	3.3	1.3	1.0	1.0	1.9	1.5	1.0	1.4	1.4	0.5	1.4	2.5	1.0	1.8	1.2	1.0	1.0	1.0	2.4	2.7	1.7	1.0	1.1	1.1	2.0	3.8	1.0	2.7	1.0	65.0	1.1	1.2	1.0	3.4	2.7	10.7	2.9	5.8	2.8	0.2	11.1	2.1	2.9	3.0	0.4	1.1	2.4	3.0	0.1	0.2	0.5	4.6	8.6	3.3	18.5	0.2	1.6	2.3	0.9	0.6	0.8	4.7	2.2	6.5	6.9	2.0	0.2	2.3	2.7	0.1	0.6	0.3	0.1	1.7	0.0	2.3	3.9	14.4	0.4	9.5	2.2	3.4	11.4	4.2	4.4	2.9	2.9	3.6	1.4	9.1	5.2	6.0	3.0	6.5	2.0	8.3	10.6	2.1	7.0	3.4	10.7	3.3	3.5	9.1	19.6	3.3	2.8	2.0	4.6	10.7	2.9	1.3	1.8	1.6	2.1	1.3	2.0	2.1	0.7	3.4	2.6	2.8	10.5	5.8	2.8	2.7	1.3	0.2	2.3	4.0	1.3	3.2	2.2	3.3	1.5	1.0	1.0	1.0	14.9	27.5	0.0	0.1	0.0	0.0	0.3	0.0	26.8	27.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	19.0	0.1	0.0	0.1	0.0	0.0	52.1	0.3	0.4	0.6	0.3	30.4	32.0	0.0	22.8	0.0	0.5	59.5	4.9	28.6	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	15.1	0.0	42.4	0.6	2.7	0.5	2.3	1.9	0.4	0.1	0.0	14.8	0.1	2.5	5.9	32.2	2.8	1.9	0.0	3.7	28.8	48.2	12.8	0.6	1.4	89.3	2.3	9.6	42.7	2.5	0.0	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.1	2.5	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7	53.6	17.1	2.7	86.0	67.5	0.0	0.4	109.5	4.0	18.2	127.4	0.0	913.5	21.6	354.0	0.5	0.7	428.8	0.0	224.2	67.1	7.5	132.0	10.3	0.4	125.6	0.0	141.5	0.0	13.6	0.8	3.4	17.8	13.5	101.8	147.7	0.0	241.9	199.9	0.0	40.0	0.1	0.0	5.2	0.6	5.2	76.9	1399.8	2.2	145.0	168.6
SPINT3	HKIB9	ENSG00000101446	"Serine peptidase inhibitor, Kunitz type 3"	P49223	20	45512461-45515624	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 113.9"	"Cell type enhanced"	"Detected in some"	19	"Suprabasal keratinocytes: 1.9;Urothelial cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"Karpas-707: 1.4;NTERA-2: 1.3"									HPA026852	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA026852: AB_2732434"																		0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	113.9	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	16.7	0.0	4.8	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3
SPINT4	"C20orf137, dJ601O1.1"	ENSG00000149651	"Serine peptidase inhibitor, Kunitz type 4"	Q6UDR6	20	45722351-45725830	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 134.6"	"Cell type enriched"	"Detected in single"	11	"Rod photoreceptor cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NB-4: 4.6;U-87 MG: 2.0"									HPA046703	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA046703: AB_2732530"														"unprognostic (3.61e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	11.5	0.0	0.1	134.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.2"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.5;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	11.3	31.0	20.6	4.0	30.4	1.5	9.3	68.2	92.2	20.5	7.4	36.0	5.1	2.1	20.5	26.1	5.6	6.8	14.3	38.6	29.9	16.6	18.0	1.4	1.9	1.7	35.5	29.0	3.2	3.7	1.4	3.7	7.6	19.6	48.9	3.6	5.2	2.9	20.7	5.6	3.2	2.6	23.2	21.7	6.8	3.7	15.9	36.0	0.1	3.3	0.0	1.6	8.1	11.5	0.0	1.6	0.4	2.5	0.0	0.0	0.6	0.5	0.1	38.2	0.0	75.8	15.5	0.0	12.4	11.5	27.0	15.2	0.0	0.0	0.0	0.0	25.9	6.8	0.5	0.1	8.9	8.4	2.1	0.0	0.0	2.3	0.0	0.5	0.0	0.0	27.0	3.6	16.6	2.9	144.5	75.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	18.0	1.2	0.4	1.8	6.1	0.1	0.0	4.8	0.0	0.1	12.1	38.5	1.3	13.1	3.5	0.0	0.0	0.0	20.9	0.5	17.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	20.6	30.4	68.2	28.5	29.9	16.6	35.5	29.0	19.6	36.0	0.0	0.0	0.0	1.7	1.5	5.0	54.3	0.0	0.0	0.0	21.0	2.0	0.4	1.7	0.7	8.2	2.1	0.0	0.0	1.2	0.4	9.5	48.4	0.0	0.0	0.8	7.9	33.7	1.3	2.4	8.9	16.1	1.1	6.8	1.0	0.0	252.1	1.5	0.0	141.1	1.7	3.2	12.9	12.8	7.5	5.9	1.3	0.1	0.0	0.1	2.1
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059035-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.1;brain: 70.7;lung: 52.1"	"Group enriched"	"Detected in many"	9	"Alveolar cells type 1: 268.0;Bipolar cells: 102.9;T-cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 47.1"	"Group enriched"	"Detected in some"	7	"Hep G2: 25.4;SCLC-21H: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		42000			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	4.2	29.8	31.9	24.9	47.8	27.9	2.0	70.7	63.2	2.5	4.2	9.8	0.0	6.2	2.5	2.7	2.8	4.7	9.9	4.7	27.5	49.5	18.8	2.5	52.1	36.4	36.0	32.1	3.7	1.5	1.7	12.8	2.9	47.9	3.0	4.1	5.4	2.8	4.5	3.6	1.9	9.3	3.4	22.3	16.9	8.3	13.6	9.2	43.4	3.3	0.6	27.0	8.0	1.4	5.6	0.7	2.9	0.2	2.8	47.1	10.3	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.4	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.1	0.6	25.4	0.9	0.2	0.6	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	36.2	2.2	0.0	0.8	0.2	0.2	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.4	0.8	3.8	0.1	0.0	0.1	0.0	0.1	0.0	27.5	0.2	47.1	5.6	27.7	21.9	0.0	4.5	21.5	21.2	2.9	2.8	0.0	0.7	37.5	10.3	31.9	47.8	70.7	42.0	27.5	49.5	36.0	32.1	47.9	9.2	268.0	14.3	16.4	0.2	3.4	102.9	2.5	0.0	2.7	5.7	14.0	5.9	0.1	0.0	0.4	6.3	9.0	0.7	0.0	0.7	0.0	2.4	0.4	3.5	0.0	0.2	3.2	4.7	6.7	2.6	8.2	4.9	2.0	5.0	0.0	0.3	3.8	0.0	0.0	5.6	0.0	12.4	0.0	4.2	3.6	0.6	3.9	0.3	96.9	0.0	0.3
SPOCK3	testican-3	ENSG00000196104	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.8;parathyroid gland: 184.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 45.8;Ciliated cells: 12.0;Club cells: 18.2;Early spermatids: 12.6;Horizontal cells: 14.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.5;monocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;hTERT-RPE1: 9.9;PC-3: 3.9;RH-30: 10.4;SCLC-21H: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	1.2	10.0	21.7	1.3	30.4	1.1	1.1	5.8	23.2	1.4	1.4	32.2	2.2	1.4	2.2	8.0	1.2	1.5	1.2	1.2	31.3	21.4	1.2	1.2	1.2	1.2	45.4	15.9	7.8	1.3	184.6	0.3	1.1	27.4	28.1	1.3	0.0	1.2	14.1	1.2	1.1	1.6	2.1	46.8	1.2	1.4	1.3	42.9	0.0	1.1	0.9	1.2	1.9	0.3	0.0	4.5	0.0	3.3	0.3	0.0	1.1	0.0	2.4	0.3	0.0	0.0	0.0	0.4	0.0	3.2	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	0.6	0.2	0.3	0.0	1.6	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	9.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	3.9	0.0	10.4	0.6	0.0	1.5	4.5	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	3.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	1.1	21.7	30.4	5.8	22.8	31.3	21.4	45.4	15.9	27.4	42.9	0.0	0.0	0.0	1.1	0.0	45.8	0.9	0.0	12.0	18.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.1	0.0	0.1	14.3	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.4	0.0	5.1	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 163.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Group enriched"	"Detected in some"	35	"EFO-21: 42.0;RPTEC TERT1: 118.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	118.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3											0.0	2.9	10.4	12.6	0.0	8.9	1.2	2.5	1.4	0.0	0.0	2.0	2.6	3.3	3.3	1.3	1.0	19.8	0.0	1.8	3.1	18.3	5.0	2.3	0.0	1.6	1.6	16.0	3.7	0.3	1.2	4.0	0.0	0.0	0.0	18.6	163.5	4.5	10.5	28.3	0.8	29.7	6.5	5.4	0.2	0.6	0.0	4.1	5.0	35.1	8.0
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 238.3;Fibroblasts: 91.2;T-cells: 101.5"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 54.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 54.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.2;HSkMC: 97.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1600000	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	18.5	10.2	0.9	11.7	4.2	7.2	27.9	10.7	3.4	63.7	18.0	1.0	6.4	8.5	46.7	25.7	13.9	11.6	26.6	14.4	1.8	0.0	19.3	35.7	13.9	1.6	0.5	1.5	24.2	4.8	0.1	3.2	44.9	1.9	39.4	3.2	3.4	6.3	7.6	8.9	9.1	14.2	23.1	0.6	6.7	9.6	10.6	0.9	1.1	3.5	21.0	3.0	20.1	22.8	0.2	8.7	2.1	0.4	10.0	54.2	22.7	0.0	0.1	0.0	0.0	1.8	13.2	0.5	1.1	0.7	0.1	0.2	0.0	0.0	0.3	1.9	4.5	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	55.2	0.0	0.3	97.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.9	2.5	0.6	1.7	0.1	0.1	0.6	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	4.0	0.0	0.2	0.4	0.1	0.0	1.3	0.0	0.8	0.1	0.1	54.2	0.2	1.1	0.1	7.6	22.3	0.1	0.2	3.4	22.0	2.1	10.0	0.4	8.7	0.0	22.7	0.9	4.2	10.7	3.4	1.8	0.0	0.5	1.5	1.9	0.9	0.0	6.4	5.2	1.9	32.6	1.7	4.2	12.7	13.4	2.3	1.8	0.0	3.1	1.7	3.0	0.2	4.5	10.7	0.0	1.2	238.3	91.2	11.8	5.8	32.1	11.2	0.0	13.3	20.3	2.4	0.0	27.6	6.6	25.3	8.2	8.5	0.9	1.4	3.5	8.9	15.1	0.2	6.5	7.1	0.2	0.4	18.7	32.5	101.5	5.8	11.2
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell type enriched"	"Detected in many"	9	"Hofbauer cells: 50179.8"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	54000000	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	218.9	0.1	17.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	107.8	0.0	0.3	0.2	0.0	0.0	1.5	0.0	5.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.1	0.0	51.4	477.9	0.0	0.0	0.0	0.0	0.0	14.4	21.2	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	20.0	0.0	20.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9	3.0	6.6	20.0	2.2	1.3	34.3	4.3	1834.4	2.7	0.0	2071.0	25.5	256.7	850.5	3124.6	0.0	17.5	0.0	0.0	59.8	221.1	15.4	0.3	0.0	2.9	50179.8	742.1	0.0	6.7	63.8	0.4	0.9	93.6	1.7	120.8	0.0	3889.3	343.9	0.0	0.0	5328.4	135.9	0.0	4.4	0.3	0.2	0.9	558.5	1.5	0.0	12.7
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	879	"liver: 113.0"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 258.9"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;RH-30: 3.5;RPTEC TERT1: 1.0;U-698: 1.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		540000000										"prognostic favorable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	3.5	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	3.5	0.9	0.0	0.0	0.0	0.3	7.6	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.7	258.9	0.1	0.0	0.0	5.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPTY2D1OS	SPTY2D1-AS1	ENSG00000247595	"SPTY2D1 opposite strand"		11	18588781-18610255	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	18	"testis: 70.2"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 5.2;Distal tubular cells: 19.9;Proximal tubular cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 7.0;HeLa: 10.2"														"Secreted in male reproductive system"	NA	NA						"unprognostic (1.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	"unprognostic (5.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.44e-7)"	"unprognostic (1.75e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.41e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.48e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	1.4	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0.0	70.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.6	2.6	1.0	1.0	2.4	0.8	0.7	7.0	2.8	3.8	2.5	3.7	3.5	0.5	0.8	1.4	1.7	5.2	2.0	1.2	0.4	0.6	1.5	1.4	0.0	0.0	0.0	2.1	2.5	0.7	10.2	6.5	0.4	0.9	2.3	1.4	0.5	0.3	2.3	1.9	1.4	0.0	1.9	0.6	0.5	2.4	0.4	2.6	1.9	1.6	4.3	0.3	0.9	0.4	2.8	2.8	0.9	0.5	2.6	0.1	0.1	1.0	1.4	0.4	1.4	2.7	2.2	1.5	0.3	0.1	0.3	0.0	1.1	1.3	1.8	1.3	1.0	2.6	1.0	0.2	2.4	0.3	0.6	0.3	0.2	0.9	0.4	0.6	2.4	1.0	0.5	0.6	1.5	0.8											3.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	5.2	0.0	0.8	19.9	2.9	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	2.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526307-21537377	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.3;brain: 14.4;breast: 23.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 72.9;Proximal tubular cells: 131.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.1;HBEC3-KT: 7.2;hTERT-HME1: 9.8;SuSa: 11.2;U-2 OS: 4.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3"						"Secreted to blood"	NA	NA	2650000					"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	34.3	0.0	0.2	0.0	0.3	0.0	23.1	0.1	1.4	0.0	2.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.5	0.4	0.7	7.1	0.7	0.2	0.5	1.5	0.0	0.0	7.8	0.0	0.0	12.7	14.4	0.0	0.0	0.0	6.4	0.0	1.3	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.3	2.7	0.4	0.0	0.1	0.0	0.1	0.6	0.5	0.0	0.0	0.2	1.5	0.0	0.5	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.8	14.1	0.0	0.5	0.2	0.0	0.2	0.0	0.0	7.2	0.8	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.0	3.0	0.3	0.1	9.8	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	11.2	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	1.5	0.2	0.3	0.1	0.3	0.4	0.7	1.5	0.0	14.4	0.2	0.0	0.0	0.5	0.0	0.0	3.4	24.8	0.0	0.0	0.0	24.4	0.0	0.0	72.9	0.2	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	1.0	0.0	1.7	4.0	0.0	0.0	131.0	0.5	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.0	0.0
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 130.2;Ito cells: 322.8;Leydig cells: 102.1;Melanocytes: 70.9;Peritubular cells: 89.5"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 285.2;ASC TERT1: 63.7;HSkMC: 95.9;HUVEC TERT2: 59.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	285.2	63.7	0.0	2.5	5.0	0.8	1.5	0.0	0.2	0.0	0.0	5.3	8.9	0.1	0.1	2.2	0.7	0.0	1.0	0.0	0.0	0.0	12.8	0.2	0.0	95.9	0.2	8.5	4.3	9.9	59.1	0.1	0.0	0.0	9.5	0.1	0.0	0.0	0.7	0.1	1.8	0.0	3.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.9	2.4	0.0	0.0	25.3	6.2	3.2	8.0	7.4	0.0	0.0	0.0	17.9	0.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3	3.0	2.2	0.0	2.5	13.6	0.1	10.0	0.0	0.0	0.0	1.8	0.0	3.2	0.0	0.3	0.4	25.6	0.5	0.0	0.3	3.5	130.2	1.2	0.0	1.0	5.4	0.0	0.0	322.8	15.8	1.9	102.1	1.6	70.9	0.0	1.4	0.2	1.0	0.0	89.5	0.1	0.1	25.8	30.6	0.5	0.7	6.4	5.9	0.0	0.4	0.7
SRPX2	SRPUL	ENSG00000102359	"Sushi repeat containing protein, X-linked 2"	O60687	X	100644166-100675788	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.2;breast: 57.3"	"Cell type enhanced"	"Detected in many"	20	"Fibroblasts: 13.4;Leydig cells: 14.7;Urothelial cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.6;ASC TERT1: 32.3;HSkMC: 29.0;HUVEC TERT2: 20.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038786	Approved				"Secreted to blood"	NA	NA					"HPA038786: AB_10672724"	"unprognostic (4.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.59e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-3)"	"unprognostic (1.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.85e-1)"	60.2	5.2	0.4	8.0	2.4	0.3	57.3	0.9	1.1	10.2	5.7	0.9	3.8	1.6	5.6	8.4	15.4	5.0	4.3	10.9	0.9	0.4	5.0	3.5	10.3	2.2	4.3	1.0	9.9	2.9	0.4	1.3	11.6	2.2	7.7	3.0	2.7	3.9	5.5	6.0	2.6	3.4	6.2	5.0	10.1	3.4	5.6	1.2	0.1	7.1	9.1	5.8	17.4	17.8	0.5	0.5	1.2	0.8	0.3	0.3	0.5	3.0	0.5	0.7	0.0	75.6	32.3	0.0	6.8	5.1	2.1	6.7	0.4	4.7	0.0	0.2	4.1	2.0	0.1	0.0	3.9	2.2	0.0	0.0	0.0	0.2	0.7	7.7	0.0	0.2	29.0	0.0	7.2	0.2	6.4	20.4	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.6	0.0	2.9	11.5	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	10.9	4.5	3.2	2.9	0.2	0.0	0.0	0.0	5.3	0.0	2.4	1.1	0.7	0.2	0.3	0.8	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	1.2	0.3	0.6	0.5	0.1	0.5	0.4	2.4	0.9	1.1	0.9	0.4	4.3	1.0	2.2	1.2	0.0	1.1	0.0	2.2	0.3	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.2	0.0	1.1	2.8	1.4	0.0	0.0	0.0	0.2	13.4	1.1	0.0	0.0	0.8	0.0	0.0	8.0	0.0	2.1	14.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	5.6	0.0	0.0	0.0	2.1	0.2	0.0	0.4	0.5	0.0	0.2	46.0
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 10.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Group enriched"	"Detected in some"	12	"EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	9.9	0.1	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.5	0.0	0.0	0.0	10.4	0.0	0.2	3.3	1.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.3	0.0	2.1	2.7	1.6	0.0	1.3	1.2	0.0	0.9	0.8	0.0	0.0	0.0	2.0	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.5	3.0	0.0	0.2	0.0	0.0	0.3
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519098	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 16.7;Peritubular cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		44000000	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	10.7	2.1	3.3	4.9	1.8	0.1	8.1	3.5	1.9	33.0	18.4	1.6	6.3	2.1	33.1	15.2	9.8	11.0	30.9	10.6	1.4	0.6	2.5	1.8	5.8	1.2	1.2	1.6	17.0	1.8	0.3	13.4	2.5	3.0	6.8	3.2	4.7	1.9	15.7	4.7	3.8	5.8	23.8	3.2	7.3	6.9	5.7	1.4	0.5	2.4	4.2	1.6	19.3	10.9	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.2	18.9	0.0	17.8	4.0	2.5	3.0	0.2	0.0	0.7	0.2	18.0	0.8	0.0	0.0	0.0	1.3	0.0	0.1	3.1	0.8	0.0	3.7	0.1	5.6	8.9	0.0	3.3	0.0	17.6	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.4	0.6	0.0	0.1	0.4	0.9	0.1	2.0	0.0	1.9	0.2	0.2	0.0	0.3	0.3	0.2	0.7	7.2	0.8	1.0	0.7	2.8	0.2	0.0	0.1	19.3	0.2	3.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	1.8	3.5	1.9	1.4	0.6	1.2	1.6	3.0	1.4	3.0	1.1	0.0	0.2	1.6	5.4	1.8	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.1	0.4	1.5	1.6	0.0	0.0	0.1	6.0	0.3	0.0	0.0	1.2	3.2	0.0	3.7	0.0	0.4	16.7	1.1	1.7	1.0	0.6	3.2	0.1	0.0	14.9	0.0	1.9	0.0	5.7	0.7	1.1	1.6	0.0	0.0	1.7	0.1
SSPO	"FLJ36112, KIAA0543, SCO-spondin"	ENSG00000197558	SCO-spondin		7	149776042-149833979	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.7;salivary gland: 1.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	13	"midbrain: 44.5"						"Secreted in brain"	NA	NA						"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.95e-4)"	"unprognostic (5.81e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.41e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-10)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.46e-2)"	0.6	0.0		0.3		0.2	0.1		1.7	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.1	0.0			0.2	0.0	0.0	0.0			0.1	0.3	0.0		0.0		0.2	0.0		1.7	0.1	0.1	0.3	0.0	0.0		0.4	0.2	0.2			0.2		0.0	0.0		0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.7	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.5	0.7	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	2.7	0.1	0.0	0.4	0.5	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	24.9	3.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	15.9	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell type enriched"	"Detected in some"	213	"Intestinal endocrine cells: 1353.8"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 15.6;U-2 OS: 29.0;U-251 MG: 4.8;U-698: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	29.0	0.3	4.8	0.0	1.7	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1353.8	0.0	0.0	0.0	0.0	0.0	0.0	6.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930485-187078553	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.4"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	580000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	10.6	6.5	11.8	16.7	15.4	4.0	10.5	2.8	11.8	19.1	11.4	22.7	4.2	4.3	8.6	4.3	4.4	8.6	5.7	10.6	10.7	7.6	19.1	161.4	10.9	27.6	18.2	7.6	4.5	4.1	20.5	5.7	5.5	13.7	19.5	14.2	5.4	17.7	4.6	5.7	4.5	12.6	5.8	22.3	27.0	8.5	2.4	15.1	19.4	19.4	4.0	41.6	13.2	14.3	33.6	4.6	6.9	8.9	8.5	29.3	16.9	0.7	0.7	3.1	2.3	0.2	0.0	4.8	0.2	0.4	0.1	0.3	0.2	0.2	32.6	2.7	0.0	1.2	1.4	19.2	2.0	0.2	1.6	0.8	1.3	0.1	15.9	0.1	3.0	10.3	0.2	4.1	0.0	1.8	2.8	11.3	3.3	6.6	3.1	1.0	1.4	2.2	2.1	6.9	1.6	1.0	5.3	0.0	1.0	1.4	0.0	5.0	0.5	0.2	3.7	8.5	4.7	5.4	2.2	4.3	0.0	0.4	0.0	0.3	104.1	133.1	48.5	0.1	6.1	11.3	6.9	2.7	1.1	16.5	5.2	15.0	32.7	18.2	13.8	4.6	33.6	29.3	20.2	1.3	8.5	8.9	4.2	14.2	16.9	11.8	15.4	2.8	11.8	10.7	7.6	18.2	7.6	13.7	15.1	41.7	20.6	118.9	14.7	3.5	0.0	22.2	86.6	24.1	44.3	225.1	0.0	0.3	0.0	14.5	0.3	29.9	4.1	23.3	0.8	3.1	1.9	58.6	10.4	512.9	16.4	0.0	90.6	264.6	52.6	0.7	0.3	13.4	6.8	5.4	3.3	0.0	6.7	5.8	0.7	0.5	1.1	0.0	5.1	0.0	0.2	1.4	0.6	20.0	28.1	28.2
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 2.1"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HHSteC: 1.4"									HPA044569	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STC1	STC	ENSG00000159167	"Stanniocalcin 1"	P52823	8	23841915-23854807	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.3"	"Cell type enhanced"	"Detected in many"	18	"Collecting duct cells: 92.5;Endothelial cells: 179.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.1;hTEC/SVTERT24-B: 35.4;U-251 MG: 24.5;U-87 MG: 110.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB018625, HPA023918"	Approved				"Secreted in other tissues"	NA	NA		120000			"CAB018625: AB_2197536, HPA023918: AB_1857566"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.44e-5)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.23e-6)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.95e-3)"	62.3	2.0	3.5	1.9	8.3	0.3	27.4	2.9	15.9	37.8	6.6	0.7	2.5	1.3	22.8	8.3	7.0	4.2	10.6	23.3	1.6	3.4	9.5	2.9	5.8	0.6	3.5	0.0	7.1	9.5	7.7	19.6	19.3	11.0	8.8	1.5	10.9	6.8	6.0	12.7	2.2	2.0	5.3	8.2	0.6	6.2	4.6	3.2	0.0	38.2	8.8	2.7	20.9	22.4	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	2.3	2.5	0.0	3.5	60.1	1.1	5.6	0.0	0.0	0.0	5.3	1.1	20.6	0.2	0.1	0.8	10.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	11.7	0.0	35.4	0.0	17.0	0.4	0.0	0.1	0.1	5.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.1	0.0	5.4	0.3	0.3	0.4	3.7	0.0	4.6	14.6	0.5	0.2	24.5	0.0	0.0	0.0	110.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	3.5	8.3	2.9	15.9	1.6	3.4	3.5	0.0	11.0	3.2	3.0	12.8	0.0	0.4	20.1	1.2	3.0	25.5	0.0	3.4	92.5	0.0	0.9	0.0	26.0	0.0	179.1	0.0	0.0	0.2	1.4	36.7	5.4	1.1	0.0	2.0	7.9	0.0	11.6	0.8	0.0	4.6	0.0	16.9	0.0	0.0	0.8	4.7	0.0	0.0	0.0	1.3	0.0	9.9	0.0	0.0	18.1	1.6	0.0	0.0	2.5
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 33.9;Ductal cells: 28.6;Extravillous trophoblasts: 43.0;Leydig cells: 21.3"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.7;T-47d: 109.8;U-138 MG: 45.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.8	0.3	1.5	5.6	2.4	15.4	26.4	26.3	6.7	13.0	8.4	4.3	0.0	4.0	15.6	34.7	2.4	3.9	8.2	11.8	0.0	2.2	0.0	2.8	5.6	35.2	1.8	0.5	5.1	13.2	15.6	1.1	31.3	1.8	5.5	0.2	0.0	115.7	4.7	0.0	0.0	0.9	2.5	8.9	0.0	3.9	3.0	0.0	0.4	4.2	1.1	1.1	0.1	4.6	1.2	109.8	1.8	16.8	45.4	0.1	26.4	5.5	5.1	2.7	1.2	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0	0.0	0.0	0.0	0.2	4.4	10.0	12.1	0.0	0.0	0.0	0.0	0.0	33.9	0.0	28.6	0.5	10.5	0.0	0.0	11.2	43.0	20.0	0.3	0.0	0.0	4.5	0.0	6.9	3.1	0.0	1.1	21.3	0.2	10.1	0.0	0.0	1.1	12.1	0.0	0.4	4.1	2.2	0.0	2.7	0.9	1.0	5.5	18.3	0.0	0.0	0.0
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817252	"Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 164.4;Spermatogonia: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	20.1	14.1	25.6	11.1	18.9	32.3	20.1	24.0	20.4	16.2	15.7	17.6	10.4	9.7	20.5	23.9	13.0	20.1	15.5	19.6	21.8	19.7	16.0	15.9	13.8	17.8	23.5	22.3	34.4	9.1	10.7	20.0	23.5	20.4	16.8	14.5	13.6	11.6	14.5	21.1	10.1	11.8	17.1	26.9	14.3	11.5	38.2	18.7	29.2	15.5	16.1	19.4	16.2	15.1	24.5	16.0	30.2	16.8	14.3	44.8	9.7	10.2	4.9	32.3	11.6	13.1	20.9	15.7	8.8	7.3	12.0	12.4	9.0	8.2	11.1	9.7	11.8	9.4	7.1	5.7	9.4	16.2	19.7	9.8	22.3	4.9	17.9	10.6	16.7	14.6	13.1	15.1	6.7	6.9	13.0	12.1	22.4	17.3	6.0	15.3	4.8	16.7	20.0	17.7	9.8	6.0	12.2	24.6	7.8	12.7	11.2	19.3	17.3	10.5	6.1	12.6	35.9	4.8	47.3	9.2	10.6	12.0	8.5	14.2	5.8	7.1	8.0	6.8	11.4	10.0	20.8	16.6	30.2	11.4	15.9	10.3	22.1	20.4	14.0	16.0	24.5	19.2	16.4	29.3	14.3	16.8	13.4	44.8	9.7	25.6	18.9	24.0	20.4	21.8	19.7	23.5	22.3	20.4	18.7	8.9	4.6	32.1	27.2	0.0	5.5	0.0	28.1	13.4	17.0	19.2	2.0	47.5	46.4	41.3	113.1	20.3	12.5	93.5	21.4	53.4	17.5	19.3	10.5	31.8	64.1	6.4	17.5	31.3	40.5	49.2	39.7	28.7	0.0	64.1	23.7	13.2	34.6	28.5	50.5	34.8	13.5	58.2	0.0	164.4	149.9	0.0	51.5	20.0	30.2	25.4
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97731908-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 61.3;lymphoid tissue: 62.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 7.6;Glandular cells: 3.3;Proximal tubular cells: 8.4;Smooth muscle cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-266/70: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 557.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 312.7"	HPA014429	Enhanced				"Secreted to blood"	NA	NA					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	1.8	6.5	4.1	7.7	61.3	0.3	1.7	0.3	39.8	0.7	3.7	0.1	0.0	6.0	0.9	1.6	0.3	0.7	4.9	0.5	9.3	21.5	1.6	0.6	0.3	0.3	8.0	4.5	0.3	0.7	0.3	0.3	0.3	24.5	1.0	2.9	0.3	4.5	2.0	0.4	1.2	7.6	5.3	6.7	62.9	0.9	0.6	9.4	0.0	1.6	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	61.3	0.3	9.2	9.3	21.5	8.0	4.5	24.5	9.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	2.1	0.1	0.4	0.1	0.0	0.0	0.5	0.1
TAC3	"NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 133.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 15.0;SuSa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.5	0.6	3.9	1.5	20.0	0.8	0.5	0.0	11.0	0.5	1.2	0.1	0.0	1.5	0.6	0.5	0.5	0.5	0.6	0.5	4.4	9.5	0.5	0.5	0.5	0.5	0.8	2.1	0.5	0.7	0.5	0.0	133.5	1.5	0.5	1.0	0.3	0.5	0.5	0.5	0.7	3.2	2.0	9.4	0.5	8.1	0.8	0.2	0.0	0.5	0.0	0.6	2.2	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.4	0.0	1.1	0.3	0.0	2.9	0.0	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	15.0	0.4	0.0	0.0	0.0	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	2.5	0.7	0.0	0.9	0.0	15.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.0	0.0	11.0	4.4	9.5	0.8	2.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	15.3	0.0	1.7	0.0
TAC4	"HK-1, PPT-C, Pptc"	ENSG00000176358	"Tachykinin 4"	Q86UU9	17	49838309-49848017	"Predicted secreted proteins"		"Hypotensive agent"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 4.7;pituitary gland: 10.4"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 1.1;Smooth muscle cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;BEWO: 10.7;CACO-2: 6.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.19e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	0.4	0.6	0.4	0.5	0.4	1.2	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	1.4	0.2	0.4	2.2	0.4	0.1	0.4	4.7	0.5	0.7	0.4	0.4	0.4	0.4	0.0	10.4	0.4	0.4	0.4	0.0	0.4	1.0	0.4	0.4	4.0	0.4	0.4	0.4	1.3	0.7	0.5	0.4	0.4	1.1	0.4	0.4	0.9	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	4.5	0.1	0.7	0.0	0.0	10.7	0.0	0.0	0.0	0.0	6.2	0.4	0.0	1.9	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.2	0.2	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.2	1.0	0.3	0.4	0.6	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.1	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	1.7	0.6	0.5	0.0	0.9	0.4	0.3	0.2	0.3	1.0	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73568932-73578791	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA007477: AB_1080214, HPA051533: AB_2681523"	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	8.9	12.1	3.7	5.4	3.3	1.8	5.9	2.7	5.3	8.7	6.6	3.4	11.6	6.1	6.5	10.9	7.3	5.5	6.3	5.4	2.5	2.5	6.1	14.2	6.5	4.7	3.5	2.1	10.7	27.0	8.5	7.0	13.0	3.4	6.5	6.9	5.1	16.3	8.0	4.9	6.9	6.3	5.4	3.0	5.4	8.2	70.5	3.7	6.2	11.8	4.2	5.2	8.5	6.2	4.2	14.4	13.2	11.4	8.3	6.7	7.6	12.2	14.0	4.8	7.1	13.2	12.8	6.0	14.7	11.0	5.6	10.1	21.4	13.2	10.0	3.3	12.9	11.9	9.4	10.2	5.9	11.1	3.9	6.9	3.6	7.4	14.0	19.0	7.3	13.3	7.9	10.2	17.1	13.7	10.9	6.4	1.9	14.7	7.9	8.5	11.9	7.1	7.2	5.0	15.0	11.5	4.6	8.7	22.1	7.2	8.6	5.1	8.2	14.6	40.0	9.2	6.6	10.5	5.6	10.8	10.6	5.2	9.8	14.8	15.9	9.9	11.3	13.6	9.0	12.3	13.2	11.4	5.2	6.6	7.9	6.5	3.4	5.6	6.0	14.4	4.2	6.7	4.2	1.0	8.3	7.0	10.8	6.5	7.6	3.7	3.3	2.7	5.3	2.5	2.5	3.5	2.1	3.4	3.7	23.8	9.4	12.3	11.1	4.0	10.0	4.5	12.7	6.7	7.9	5.2	7.9	39.4	1.7	21.8	291.7	9.8	10.9	0.0	26.3	45.4	11.5	14.0	13.9	15.3	26.0	3.2	9.1	12.9	7.5	375.4	21.9	7.9	6.8	23.4	15.7	7.8	21.3	14.4	25.1	5.0	12.9	6.5	8.0	284.6	22.2	3.1	36.3	3.3	14.3	7.5
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866575	"Plasma proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 152.9;salivary gland: 172.4"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 340.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	95	"basophil: 152.9"	"Lineage enriched"	"Detected in single"	1202	"granulocytes: 152.9"	"Cell line enriched"	"Detected in some"	21	"OE19: 59.1"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3300000				"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.2	0.1	0.1	0.1	0.1	27.6	2.1	0.1	0.2	5.5	0.2	0.1	0.0	1.3	1.5	0.0	4.6	0.2	26.7	1.1	0.1	0.1	0.7	0.4	1.8	0.0	0.2	0.0	0.2	3.8	0.1	0.4	0.2	0.1	0.4	0.0	0.1	172.4	0.3	0.2	0.3	0.2	0.1	0.2	1.0	12.7	0.2	0.0	0.3	0.2	28.4	10.0	3.8	1.9	0.0	0.0	152.9	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	59.1	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.8	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.2	61.1	12.0	3.4	22.7	0.0	0.0	0.0	17.4	0.3	0.0	0.0	0.0	340.9	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	1.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	40.3
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30606838-30627278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8"	"Lineage enriched"	"Detected in many"	8	"monocytes: 29.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	NA	NA		13000000	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	39.8	15.2	6.5	7.2	8.1	2.2	30.0	3.4	10.9	13.1	14.8	9.2	9.6	10.9	15.0	23.9	7.0	11.2	31.7	15.8	6.6	7.3	73.2	8.7	21.7	43.3	8.6	8.5	7.8	6.3	5.7	7.9	8.7	10.7	9.6	13.5	13.5	6.8	23.0	5.4	4.5	30.4	17.6	9.0	24.8	8.4	9.7	5.1	1.9	12.8	4.8	4.6	11.6	10.9	0.0	3.4	0.6	29.0	0.0	0.3	6.5	0.0	2.6	12.1	0.0	7.2	35.3	0.4	0.8	8.8	2.2	3.7	1.2	6.1	0.1	13.4	1.7	0.2	0.4	1.0	0.6	0.7	0.0	0.6	0.0	0.3	0.5	17.3	0.1	9.9	5.8	0.7	1.7	1.5	2.5	41.4	0.0	0.2	53.8	3.6	0.0	0.0	0.9	4.7	3.3	0.3	1.3	1.7	18.1	20.9	0.3	4.2	0.5	0.0	0.1	3.5	0.8	0.1	0.5	24.2	7.8	1.0	0.9	0.3	1.4	0.3	0.0	2.7	0.4	0.1	0.0	19.2	0.0	0.0	29.0	0.3	0.0	0.3	0.2	3.4	0.0	0.1	0.2	0.6	0.0	9.8	0.6	0.1	6.5	6.5	8.1	3.4	10.9	6.6	7.3	8.6	8.5	10.7	5.1	3.0	3.8	6.0	0.8	4.6	7.3	5.0	35.7	2.7	4.5	12.2	19.6	0.4	6.6	5.9	0.8	59.1	104.9	0.0	5.2	0.7	11.2	2.0	4.6	5.0	40.3	1.6	6.4	111.1	140.0	1.0	9.8	32.3	21.9	7.2	23.3	6.0	5.6	49.1	9.2	115.0	28.1	12.9	4.7	0.7	7.8	4.5	0.3	2.1	10.0	2.4
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 102.8"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0"	"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	9.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.2	1.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	5.2	0.0	0.0	102.8	0.1	4.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	2.4	0.0	0.0	0.7	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0
TECTA	"DFNA12, DFNA8, DFNB21"	ENSG00000109927	"Tectorin alpha"	O75443	11	121101173-121191493	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 5.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 3.0;Cone photoreceptor cells: 3.9;Early spermatids: 5.6;Ito cells: 9.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.5;SH-SY5Y: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018870	Approved				"Secreted in other tissues"	NA	NA					"HPA018870: AB_1857879"	"unprognostic (1.12e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-6)"	"unprognostic (1.22e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.19e-2)"	0.6	1.6	1.1	0.4	3.5	0.4	0.6	2.9	5.5	0.4	0.5			0.2	0.6	1.8	0.1	0.6	0.7	2.1	1.3	2.6	0.7	0.9	1.1	0.2	1.4		1.6	0.7	4.2	2.5	0.6		0.9	0.3		0.5	1.6	1.0	0.2	0.2	0.6	1.0	0.4	0.4	2.0			1.4		0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	3.5	1.8	0.1	0.2	0.5	0.5	0.3	0.1	0.2	0.3	0.0	0.2	1.7	0.2	0.2	0.0	0.7	0.0	0.2	0.7	0.9	0.5	0.1	0.0	0.3	0.5	0.3	0.4	0.6	0.1	0.0	0.5	0.4	0.7	0.0	1.2	0.4	0.2	0.2	1.3	0.7	0.0	0.1	0.1	0.6	0.1	0.5	0.1	2.4	5.5	0.3	0.2	0.3	2.3	0.3	0.5	0.0	0.4	0.5	0.2	0.4	1.3	1.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3											3.0	0.3	0.0	0.1	0.0	1.9	1.7	0.0	0.0	1.2	0.0	3.9	0.0	0.0	0.3	5.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	9.8	0.3	1.6	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
TECTB		ENSG00000119913	"Tectorin beta"	Q96PL2	10	112283400-112305035	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"retina: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 7.4;U-2197: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"	NA	NA								"unprognostic (3.14e-2)"		"unprognostic (2.84e-2)"		"unprognostic (9.75e-3)"				"unprognostic (1.65e-1)"	"unprognostic (1.32e-2)"		"unprognostic (5.54e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.10e-2)"		0.1	0.0	0.8	0.1	1.3	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	3.5	0.1	0.0	0.1	0.1	0.4	0.2	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	15.8	0.1	0.1	0.1	0.0	0.3	0.1	0.5	0.1	0.0	0.2	0.1	0.1	1.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.1	0.3	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TEPP		ENSG00000159648	"Testis, prostate and placenta expressed"	Q6URK8	16	57976435-57988116	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 46.3"	"Group enriched"	"Detected in many"	11	"Early spermatids: 286.9;Late spermatids: 318.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 4.5"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062092	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA062092: AB_2684679"	"unprognostic (4.86e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.59e-1)"	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.6	0.1	0.3	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.3	0.7	0.1	0.0	0.1	0.1	0.4	0.3	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.3	0.1	0.0	46.3	0.2	0.1	2.6	0.1	0.2	1.6	0.5	0.7	0.2	0.3	0.0	0.2	4.5	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.4	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.5	0.1	3.0	2.0	0.0	0.7	2.9	4.5	0.0	0.2	0.0	0.2	1.4	1.3	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.3	0.4	0.2	11.9	5.1	0.0	8.2	0.1	0.0	27.4	2.5	1.4	11.4	1.8	0.0	2.1	0.0	0.0	286.9	0.7	0.0	0.0	0.5	3.1	1.5	0.6	2.3	0.0	0.4	0.0	0.0	1.8	0.0	318.3	3.4	0.2	1.7	0.0	0.0	0.6	0.1	0.0	0.4	0.0	1.3	0.0	1.4	2.1	2.3	0.0	0.9	0.0	0.0	3.3
TEX101	"CT131, MGC4766, SGRG, SPATA44"	ENSG00000131126	"Testis expressed 101"	Q9BY14	19	43401496-43418597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"blood: 24.5;testis: 56.6"	"Cell type enriched"	"Detected in some"	15	"Spermatocytes: 911.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	246	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	246	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.9"									"HPA041915, HPA042513"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA041915: AB_10795268, HPA042513: AB_10795507"	"unprognostic (2.50e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.64e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.78e-4)"		"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.67e-7)"	"unprognostic (8.83e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.04e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.0	56.6	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.9	0.6	1.3	0.7	1.0	2.4	0.7	0.4	0.6	1.0	1.0	0.2	0.4	0.4	1.0	1.6	1.1	0.4	0.4	1.0	0.7	1.2	0.0	0.3	1.3	0.4	2.0	0.4	0.9	1.2	1.6	0.1	1.0	0.9	2.0	1.1	0.3	1.0	1.1	0.2	0.6	1.0	0.7	0.8	1.0	2.7	0.2	1.3	2.3	0.2	0.9	0.4	0.3	0.8	2.3	0.7	0.3	4.9	0.4	0.8	0.8	0.8	1.4	1.0	1.2	0.6	0.9	0.7	0.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	32.3	0.0	911.6	62.4	0.0	0.0	0.0	0.0	0.0
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133745956-133796640	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 711.5"	"Group enriched"	"Detected in many"	34	"Hepatocytes: 5940.2;Muller glia cells: 11013.4"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	48	"Hep G2: 132.2"					"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	120000000000			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	7.8	1.3	6.7	1.2	26.7	1.3	1.9	3.7	20.4	1.4	1.3	57.2	0.0	1.2	1.3	1.3	1.8	1.3	1.3	2.4	11.3	7.4	1.5	711.5	1.3	1.3	50.8	12.3	1.4	1.6	1.4	0.8	1.3	40.2	1.5	1.3	14.0	4.0	1.3	1.3	1.3	1.2	1.3	46.9	1.3	1.3	2.4	39.9	0.0	1.4	0.0	1.4	1.3	0.6	1.1	1.0	2.6	1.1	0.9	0.8	0.4	0.3	0.2	0.3	0.2	0.9	0.6	0.1	0.3	0.3	0.1	0.1	0.5	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.1	2.7	0.4	132.2	0.2	0.7	0.4	0.4	0.6	0.1	0.3	0.3	0.3	0.1	1.0	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.5	0.3	0.2	0.4	0.4	1.0	0.2	0.3	0.2	0.4	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.3	0.2	0.2	2.6	1.1	0.7	0.6	0.7	0.6	0.6	0.6	0.6	0.6	1.1	0.8	0.8	2.4	0.9	0.7	1.0	0.4	0.4	6.7	26.7	3.7	19.6	11.3	7.4	50.8	12.3	40.2	39.9	14.9	26.7	55.9	6.2	0.9	74.3	2.5	132.5	40.2	35.2	0.0	86.4	0.1	1.7	0.7	5.3	0.5	0.0	46.7	1.0	0.1	0.2	14.8	16.3	5940.2	0.1	44.5	0.0	93.9	109.2	2.5	0.3	0.9	0.0	1.0	0.0	11013.4	0.9	0.0	0.4	0.2	250.7	0.0	0.4	0.4	0.1	0.0	0.2	6.9	0.0	2.0
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366594	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"gallbladder: 247.7;stomach 1: 375.3"	"Cell type enriched"	"Detected in many"	10	"Pancreatic endocrine cells: 8493.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	41	"MCF7: 478.7;OE19: 196.0"	"Not detected"	"Not detected"							"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		990000			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	1.0	0.2	0.0	3.5	0.1	0.1	0.5	4.9	1.4	0.1	1.4	0.1	0.1	1.1	0.1	247.7	0.1	0.1	0.0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	1.9	4.7	0.1	5.0	0.2	0.1	0.0	5.6	0.1	0.1	0.1	375.3	0.1	0.1	0.1	0.2	1.1	9.2	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	478.7	0.1	0.0	0.2	196.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	830.5	0.0	0.0	33.2	0.0	0.0	0.0	88.4	0.0	0.0	116.3	0.0	741.5	3.0	0.0	273.3	13.8	0.0	0.2	0.0	413.6	0.0	0.0	0.0	0.0	0.0	0.0	18.0	404.2	0.0	8493.3	152.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	47.2	76.6
TFF2	SML1	ENSG00000160181	"Trefoil factor 2"	Q03403	21	42346357-42351128	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 361.8;stomach 1: 332.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 3630.5"	"Group enriched"	"Detected in many"	11	"pancreatic cancer: 320.9;stomach cancer: 244.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CAPAN-2: 14.7;OE19: 21.5;PC-3: 52.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025834, HPA036705"	Enhanced				"Secreted to digestive system"	NA	NA		670000			"CAB025834: , HPA036705: AB_2675263"	"unprognostic (3.95e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"			"prognostic unfavorable (1.99e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.55e-2)"		"unprognostic (1.27e-9)"	"unprognostic (1.99e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.26e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	62.9	0.1	0.1	0.5	0.0	361.8	0.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	3.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	332.4	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.7	21.5	52.9	0.2	0.0	2.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3630.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	85.8	0.2	0.0	0.6	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	1.0	17.1	0.0	484.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell type enriched"	"Detected in many"	21	"Mucus-secreting cells: 36697.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Not detected"	"Not detected"			"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.5	0.1	44.4	4.3	0.0	3.2	0.3	0.0	0.0	8.7	0.1	0.0	0.8	0.0	0.0	13.3	0.0	36.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17.0	37.0	0.0	13.4	1110.8	464.4	316.2	21.0	0.0	0.3	0.0	9.0	0.0	51.4	1768.3	0.0	62.1	0.6	20.3	103.0	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0.0	36697.4	0.0	28.0	1779.2	7.4	0.0	0.0	0.0	6.1	0.3	0.3	33.8	0.7	1.0	1243.2	29.6
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 1654.1;Ito cells: 765.5;Syncytiotrophoblasts: 735.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 56.4;HUVEC TERT2: 106.1;LHCN-M2: 65.0;TIME: 63.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	NA	NA		95000000			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.1	3.6	4.1	0.1	32.9	39.4	0.0	9.3	22.2	6.1	9.4	3.3	27.6	0.0	3.7	7.2	11.0	0.3	1.2	0.4	15.9	0.2	1.0	1.6	11.1	28.0	56.4	0.1	0.0	18.0	0.7	32.8	8.8	13.6	106.1	0.0	4.1	0.1	65.0	4.8	0.6	0.1	2.6	0.0	9.0	0.0	5.8	0.0	10.3	0.2	0.0	0.0	7.6	0.2	0.4	12.7	0.1	0.0	63.5	4.4	4.1	8.6	1.8	0.0	0.1	0.0	35.4	0.0	5.0	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6	32.8	262.9	24.4	2.5	18.4	0.7	8.4	191.1	58.9	112.6	36.6	0.0	45.9	11.6	114.4	16.0	204.3	1.7	23.3	242.7	1654.1	163.0	4.2	12.8	338.6	44.3	1.6	101.1	765.5	77.7	9.8	159.0	19.5	25.3	57.7	1.2	31.4	108.2	2.9	65.7	100.4	1.1	213.4	163.5	1.1	0.4	16.2	735.3	15.4	1.3	6.0
TFPI2	"PP5, REF1, TFPI-2"	ENSG00000105825	"Tissue factor pathway inhibitor 2"	P48307	7	93885397-93890991	"Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"placenta: 1024.1"	"Group enriched"	"Detected in many"	4	"Ductal cells: 708.9;Syncytiotrophoblasts: 1826.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 65.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 182.0;hTEC/SVTERT24-B: 90.4;U-138 MG: 87.8;U-2197: 78.3;U-87 MG: 148.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010142, HPA049158"	Enhanced				"Secreted to extracellular matrix"	NA	NA					"CAB010142: AB_628166, HPA049158: AB_2680659"	"prognostic favorable (8.33e-7)"	"unprognostic (2.20e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (5.19e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.86e-2)"	"unprognostic (7.54e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.91e-2)"	21.5	14.6	0.6	5.1	0.7	0.0	4.8	0.6	0.6	1.0	1.0	0.6	0.9	0.0	4.8	1.3	0.7	5.4	2.2	3.3	0.6	1.5	4.7	3.1	3.5	0.6	0.6	0.6	14.9	10.0	0.0	4.4	1024.1	0.9	2.2	0.1	58.2	0.7	0.8	1.0	0.0	0.6	1.2	0.6	0.7	1.5	0.8	0.6	1.5	0.6	0.7	0.6	1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.9	3.1	0.0	7.1	1.2	0.0	13.0	2.3	1.3	1.0	0.0	0.0	0.0	182.0	3.0	3.0	1.0	0.0	13.9	2.0	0.1	0.0	0.0	0.8	0.0	37.0	0.0	0.0	0.6	0.7	90.4	6.5	15.2	31.1	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.0	3.5	0.3	0.0	8.1	0.0	1.0	0.0	2.4	0.0	0.1	44.9	87.8	0.7	78.3	0.1	0.0	0.1	0.3	148.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.7	0.6	0.6	0.6	1.5	0.6	0.6	0.9	0.6	3.0	3.8	0.8	195.2	0.6	15.8	0.4	5.1	5.3	43.3	301.8	37.3	13.6	0.0	708.9	0.0	24.6	0.0	0.0	35.5	197.3	81.4	72.9	0.0	0.8	15.1	3.2	0.0	115.4	5.6	0.0	1.4	1.0	3.3	29.7	0.0	14.5	39.4	0.0	0.0	1.0	104.5	0.0	40.6	0.1	0.2	1.3	1826.6	0.0	0.0	22.3
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"thyroid gland: 994.3"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 4.7;Cardiomyocytes: 2.8;Club cells: 2.3;Early spermatids: 2.1;Proximal tubular cells: 2.1"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;HSkMC: 4.3;Karpas-707: 9.9;PC-3: 4.9;U-266/70: 3.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Not detected"	"Not detected"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	NA	NA		1000000			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	994.3	0.1	0.1	0.1	0.1	0.3	1.2	4.0	0.6	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.9	1.4	0.6	0.0	1.8	0.0	0.1	0.9	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.3	3.0	1.1	0.0	0.9	0.0	1.3	0.0	9.9	0.2	0.0	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.4	0.2	2.8	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.6	0.0	3.6	3.0	0.0	0.2	1.3	0.0	0.0	0.6	0.7	0.2	0.0	0.9	0.0	0.4	0.0	0.0	0.3	0.3	0.2	4.0	0.0	0.3	1.2	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	4.7	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	1.4
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447280-70554193	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.0	0.5	8.4	4.3	10.7	1.2	6.2	3.5	7.9	5.7	9.4	21.4	0.3	7.4	1.2	2.8	23.8	5.7	14.6	0.8	10.7	6.9	12.4	4.0	3.5	4.2	10.9	5.2	0.5	12.0	1.0	0.8	1.7	9.4	2.2	7.3	9.7	6.3	1.2	0.4	10.8	13.7	1.3	22.5	5.1	7.6	2.3	12.8	0.2	7.4	17.4	12.1	5.4	10.8	0.0	0.6	14.7	0.4	0.2	2.7	0.4	24.0	3.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	29.7	0.0	15.3	0.1	4.1	12.9	0.2	25.9	0.0	0.0	0.6	0.0	0.6	2.0	0.0	0.3	0.0	0.0	10.4	0.0	10.2	1.2	0.0	1.9	0.0	0.1	0.0	0.9	0.0	0.5	0.4	19.0	7.3	0.0	0.1	6.3	26.1	9.3	0.2	0.0	2.0	0.0	0.0	0.0	3.3	0.2	0.2	0.1	1.8	0.0	5.3	0.1	0.1	0.0	24.6	0.8	8.9	6.3	0.4	14.0	1.0	0.1	2.7	0.0	0.6	0.6	0.6	0.0	0.3	0.2	14.7	0.2	0.0	0.0	0.0	0.4	8.4	10.7	3.5	7.9	10.7	6.9	10.9	5.2	9.4	12.8	6.0	2.4	0.0	6.5	14.3	1.4	1.4	28.1	12.0	6.8	24.4	0.0	0.0	1.7	36.6	14.8	1.2	14.9	0.0	8.8	0.0	0.5	11.0	5.7	1.5	3.0	0.0	1.2	0.0	2.2	1.4	0.3	3.1	0.0	30.7	5.8	8.6	47.6	8.5	0.0	6.1	0.7	0.0	0.9	0.0	0.2	21.8	0.0	2.2	4.7	56.3
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"	P01137	19	41301587-41353911	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 377.2;Hofbauer cells: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000	38000000	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	24.3	14.4	7.7	29.8	11.9	53.1	19.0	2.2	8.2	27.8	15.3	14.3	11.5	11.4	24.1	12.8	24.5	13.0	15.6	17.6	8.8	6.5	19.2	10.4	32.4	33.3	12.0	4.1	15.3	8.2	6.9	9.7	54.7	11.7	17.2	5.8	10.3	10.9	15.9	8.7	14.0	17.6	14.6	12.8	55.8	12.8	9.5	12.3	30.6	10.3	9.1	30.6	28.7	24.6	0.7	1.4	7.5	2.2	0.5	1.7	1.3	14.5	22.9	1.2	0.2	10.6	9.4	2.9	21.1	19.0	6.8	4.6	9.7	9.1	14.4	22.8	28.6	6.7	7.9	4.2	13.5	2.4	19.2	4.5	48.6	5.5	12.3	13.8	13.4	33.2	12.2	4.3	13.2	8.4	33.9	34.2	6.0	26.0	36.4	6.3	10.7	11.4	19.5	2.5	2.9	13.7	12.3	3.2	21.7	12.1	6.3	0.2	1.6	5.8	0.3	4.1	7.4	0.5	12.0	43.2	26.8	20.9	5.6	23.0	20.1	7.8	9.5	26.2	26.8	4.7	1.5	1.9	7.5	1.7	2.2	1.3	0.4	0.9	0.9	1.4	0.7	0.7	0.9	4.7	0.5	2.0	1.4	0.5	1.3	7.7	11.9	2.2	7.6	8.8	6.5	12.0	4.1	11.7	12.3	0.0	0.0	38.4	25.0	39.4	0.1	1.6	5.1	2.7	0.0	15.7	0.0	2.6	0.0	11.9	0.4	42.2	0.0	0.0	14.4	377.2	50.3	9.8	66.6	2.1	124.5	0.0	0.0	65.1	113.9	1.1	11.2	100.1	21.9	10.8	0.3	0.3	34.0	11.6	17.0	7.9	0.5	38.8	45.3	1.7	7.8	16.6	46.6	119.6	0.1	27.1
TGFB2		ENSG00000092969	"Transforming growth factor beta 2"	P61812	1	218346235-218444619	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 71.5;Muller glia cells: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 21.0;hTERT-RPE1: 56.1;U-2 OS: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	4890000					"unprognostic (7.24e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.86e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.04e-2)"	2.9	2.6	13.4	3.2	11.4	0.8	7.0	5.2	13.7	12.3	5.2	10.0	7.0	1.6	10.8	7.5	3.6	6.9	3.9	9.5	13.3	6.7	2.9	1.6	12.4	1.6	5.9	9.9	8.1	3.5	4.3	6.3	20.1	10.2	27.8	2.1	11.6	16.9	18.7	6.9	3.8	1.8	8.5	19.0	4.4	2.8	2.1	8.2	0.0	4.8	2.8	1.9	5.2	7.4	2.6	0.5	0.0	0.0	0.0	0.1	0.0	1.3	7.0	0.6	5.5	1.6	0.8	0.0	1.0	0.1	11.2	8.0	1.8	16.9	0.0	21.0	0.0	9.3	3.6	0.4	0.9	11.6	0.0	0.1	0.0	0.6	0.0	17.4	0.0	0.0	0.7	1.9	1.5	5.9	56.1	3.0	0.0	0.0	0.0	10.6	0.1	0.0	0.0	0.5	0.0	0.6	0.0	3.1	0.0	3.6	0.0	0.1	0.0	11.6	1.4	0.2	15.1	1.0	0.4	13.0	7.9	20.8	6.5	10.6	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	11.4	5.2	13.7	13.3	6.7	5.9	9.9	10.2	8.2	71.5	4.6	0.0	5.8	7.7	6.2	3.0	12.7	12.0	14.8	5.2	0.0	0.3	0.0	30.1	16.2	3.5	0.0	0.0	15.1	10.2	15.5	11.6	1.1	0.0	1.2	1.6	0.0	3.1	0.6	22.2	7.5	1.7	11.8	1.8	0.0	97.9	15.5	0.0	13.1	0.3	2.0	0.0	22.4	0.2	0.4	2.5	0.5	0.0	0.0	2.0
TGFB3	"ARVD, ARVD1"	ENSG00000119699	"Transforming growth factor beta 3"	P10600	14	75958099-75982991	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 31.7;Glandular cells: 27.5;Late spermatids: 36.7;Leydig cells: 25.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in many"	5	"SK-BR-3: 50.4;T-47d: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063582			Approved	Vesicles	"Secreted to blood"	NA	NA	44800		Vesicles		"HPA063582: AB_2685049"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (4.01e-7)"	"unprognostic (6.38e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.27e-3)"	6.9	4.7	10.6	8.4	14.0	0.4	7.8	3.2	8.6	29.2	4.1	6.7	13.1	2.3	10.4	21.4	4.4	4.9	21.5	17.9	11.9	6.6	4.8	12.2	8.6	4.2	16.8	7.0	3.1	11.1	6.8	4.6	31.0	8.4	25.8	3.2	10.0	5.0	12.0	13.3	1.5	2.9	20.7	13.0	2.2	4.5	3.8	8.8	4.2	4.4	5.7	8.2	11.6	6.4	0.4	0.1	0.0	0.0	0.0	1.8	0.2	0.4	0.1	0.5	5.5	1.0	1.3	0.1	0.2	0.4	0.2	0.2	0.3	1.3	0.0	0.4	1.0	0.1	0.3	1.1	0.1	0.1	0.3	0.5	0.0	1.1	0.6	1.3	0.2	0.3	4.6	0.1	0.4	0.1	1.0	1.3	1.1	0.5	2.5	0.3	2.5	0.2	0.2	0.1	0.3	1.9	1.2	1.6	0.2	0.5	0.2	9.1	2.1	1.6	50.4	0.3	0.7	35.3	0.0	0.3	0.8	1.8	0.8	2.2	0.2	0.2	0.1	1.4	0.3	1.3	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.6	0.0	0.4	1.8	0.5	0.0	0.0	0.0	0.1	0.3	0.2	10.6	14.0	3.2	8.6	11.9	6.6	16.8	7.0	8.4	8.8	0.0	3.2	0.0	1.2	3.9	0.7	3.4	0.0	6.7	2.3	1.8	3.9	0.5	0.0	0.4	17.1	7.5	1.1	0.0	1.2	0.3	31.7	27.5	0.0	0.2	0.8	0.0	0.0	8.0	0.6	36.7	25.0	1.2	10.1	1.0	0.6	1.7	0.4	0.0	12.0	0.3	2.9	32.3	20.6	0.2	1.0	2.8	1.1	1.3	0.4	0.7
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028895-136063818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 254.4;Kupffer cells: 259.4;Macrophages: 225.7;Pancreatic endocrine cells: 363.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 19.7"	"Group enriched"	"Detected in many"	30	"classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 61.2;monocytes: 41.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 157.9;GAMG: 129.4;HSkMC: 164.8;hTCEpi: 114.6;LHCN-M2: 131.0;U-2197: 114.5;U-87 MG: 219.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	51.3	16.6	1.8	30.4	3.9	4.3	32.2	1.1	6.5	14.1	24.2	5.2	16.2	9.2	30.2	71.9	21.1	15.2	94.9	53.0	4.1	2.9	21.7	47.5	42.5	65.1	3.7	2.4	27.0	10.5	3.3	23.7	90.0	19.7	27.0	16.9	21.8	21.1	13.1	24.1	63.8	22.4	56.5	10.1	41.6	21.2	18.2	2.1	21.2	12.0	40.1	18.8	46.3	24.4	0.2	61.2	0.9	41.9	1.2	0.3	15.1	5.7	23.6	0.0	0.2	66.7	22.0	0.0	17.6	2.2	12.1	7.3	10.6	74.2	0.0	10.8	157.9	129.4	28.5	0.0	56.7	10.8	0.1	0.0	0.0	28.3	28.6	44.6	0.0	0.2	164.8	114.6	4.5	5.1	43.6	10.3	0.0	0.0	0.2	131.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.2	0.1	5.7	0.5	0.0	0.0	27.8	0.9	0.2	24.0	0.2	6.3	43.5	82.5	3.5	114.5	62.9	0.0	0.0	0.0	219.3	0.0	62.9	0.2	41.9	0.1	0.1	27.0	0.2	0.2	0.2	0.3	28.6	0.0	0.0	0.2	0.9	1.2	20.6	61.2	0.1	15.1	1.8	3.9	1.1	3.0	4.1	2.9	3.7	2.4	19.7	2.1	3.0	25.0	13.3	3.2	106.1	0.1	6.4	7.6	4.0	9.1	1.8	0.0	6.6	0.0	39.9	1.8	14.7	0.0	23.3	98.6	5.6	70.4	0.9	4.7	21.2	254.4	1.6	3.4	32.5	259.4	1.3	9.5	225.7	47.2	8.2	2.0	0.0	363.6	0.0	2.1	1.6	0.2	25.8	143.8	0.2	0.8	48.7	16.2	2.5	0.4	2.0
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.7	4.1	0.7	67.2	32.8	13.0	2.0	10.2	2.4	2.9	1.2	0.4	0.0	0.5	3.7	1.9	0.4	1.0	0.3	1.8	9.5	2.2	0.0	3.4	11.3	1.4	0.1	0.0	7.9	1.3	5.2	1.2	0.3	1.2	0.0	6.5	0.2	0.7	0.0	0.0	0.0	1.7	1.2	0.9	0.1	1.4	0.5	0.9	16.4	0.1	0.0	1.0	0.0	5.7	1.7	0.3	1.0	3.6	4.0	1.0	22.8	0.4	10.1	0.9	0.0	0.8	0.5	0.5	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0	8.9	11.9	3.0	10.4	33.4	0.2	17.3	28.1	6.7	6.8	29.6	2.0	23.5	3.3	1.7	48.3	64.2	0.7	23.3	4.2	9.3	105.0	7.3	2.3	17.8	9.7	0.0	23.1	311.2	19.6	18.5	135.4	3.8	33.7	0.0	0.5	2.2	3.5	0.0	70.0	15.9	0.2	12.9	35.4	0.7	1.7	29.7	48.5	30.5	2.3	5.4
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 194.3;granulocytes: 164.5;Smooth muscle cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.7;HUVEC TERT2: 160.1;LHCN-M2: 119.5;TIME: 233.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.7	4.0	3.1	1.1	13.3	15.7	0.0	68.0	55.6	18.7	12.3	11.6	8.9	0.0	25.7	164.7	3.6	41.9	0.1	33.2	9.5	3.0	0.0	3.0	2.3	2.9	2.9	0.0	0.9	35.0	2.4	15.5	35.1	73.9	160.1	0.1	0.1	0.1	119.5	0.9	0.0	0.2	0.5	1.1	1.4	0.0	8.3	0.0	28.1	29.9	0.0	0.0	19.3	1.1	1.1	4.1	11.9	0.2	233.4	65.5	15.5	77.1	78.1	0.1	0.1	0.1	2.1	0.0	70.0	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2	23.8	25.3	10.7	130.6	85.1	0.0	35.0	25.5	14.7	26.1	66.3	5.9	2.2	0.0	18.5	0.2	39.3	91.3	0.0	111.9	1.8	194.3	54.9	164.5	7.2	5.9	0.0	3.5	67.5	123.1	0.0	1.7	83.3	37.1	3.6	27.1	0.0	117.5	21.5	0.4	50.2	0.8	6.5	246.9	0.2	0.3	44.5	1.7	5.7	29.3	27.8
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.6	0.3	83.6	57.4	0.0	15.9	21.9	22.1	27.8	0.1	0.0	0.0	0.0	19.0	0.1	0.0	0.7	0.8	12.6	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	31.0	0.0	29.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	10.1	0.1	22.5	1.9	0.0	0.3	0.0	6.2	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2	6.0	0.0	0.0	1.2	77.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	41.1	1.1	0.0	0.0	0.2	0.0	0.0	25.2	0.0	0.0	7.5	0.9	54.0	0.0	0.0	0.3	0.8	0.0	15.2	0.3	0.3	0.0	28.6	0.0	0.0	36.9	0.1	0.0	0.0	0.7
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"Early spermatids: 241.6;Late spermatids: 766.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		4100000	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	10.5	5.5	6.2	12.2	19.5	5.4	15.4	4.7	10.0	20.7	12.6	8.5	8.2	3.4	34.4	24.7	15.1	13.8	19.2	14.4	5.8	3.3	10.1	8.1	8.5	3.2	9.5	6.1	17.5	11.4	12.8	9.5	8.6	7.0	11.4	7.5	8.1	7.5	11.4	5.7	12.9	8.0	24.5	6.1	6.4	8.1	8.3	4.2	1.1	14.3	23.5	7.4	14.4	11.4	1.7	3.5	2.2	4.1	0.9	4.3	2.0	1.4	3.6	13.3	13.5	7.3	8.5	0.8	6.1	9.1	2.8	5.2	0.4	11.0	1.0	6.9	13.4	0.8	3.6	0.3	2.3	2.1	2.4	0.8	0.8	3.9	0.5	7.8	0.7	1.8	14.6	8.1	4.2	5.8	36.1	5.1	2.2	0.7	2.1	2.5	5.3	0.5	1.3	3.0	3.1	1.8	11.8	0.5	2.3	5.9	3.7	19.7	11.2	1.5	3.0	3.1	20.1	8.9	1.8	3.9	9.5	2.2	1.7	2.1	5.2	0.6	0.2	8.6	0.7	0.8	0.0	4.1	1.6	1.8	2.2	1.1	1.7	2.7	2.2	3.5	0.9	3.0	1.0	2.2	0.9	0.7	0.5	4.3	2.0	6.2	19.5	4.7	10.0	5.8	3.3	9.5	6.1	7.0	4.2	0.0	14.7	0.0	2.1	7.0	2.7	1.2	2.5	2.7	1.2	0.0	0.0	1.1	1.7	3.7	241.6	6.3	2.6	0.0	2.3	1.5	11.7	2.2	0.0	3.9	10.0	7.9	4.6	1.8	4.8	766.9	21.6	4.9	10.1	1.0	4.8	1.7	4.0	2.9	9.6	2.8	2.7	0.0	8.1	21.2	2.5	4.5	1.1	0.7	3.1	1.3
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell type enriched"	"Detected in many"	9	"Sertoli cells: 485.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		420000000	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	1.3	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.8	0.0	0.1	1.6	0.3	0.1	0.3	0.5	0.0	0.1	0.0	0.3	0.3	0.7	0.1	0.1	3.9	0.0	0.1	0.0	1.6	0.0	0.4	0.1	4.0	1.2	0.1	0.0	0.4	2.3	0.0	10.9	0.0	0.1	4.7	0.3	0.3	4.2	0.1	0.7	1.8	3.5	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6	0.0	0.6	0.0	0.0	0.2	1.2	5.0	0.0	0.0	1.2	3.5	53.0	0.0	0.0	0.1	28.0	2.2	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	0.1	1.6	8.6	0.6	0.0	3.2	0.9	0.0	1.7	0.0	0.0	1.9	0.0	0.0	41.1	0.6	1.9	485.0	2.2	16.9	1.4	0.9	0.0	0.0	0.0	0.0
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727203-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.9;RT4: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	11.9	13.9	9.4	5.6	13.4	6.0	21.6	9.0	20.7	10.8	11.8	12.8	16.6	14.4	5.6	7.1	14.9	12.5	15.0	12.6	10.7	11.5	16.7	35.2	11.0	7.4	8.8	11.7	4.5	30.7	13.4	10.0	10.7	11.6	9.8	6.7	10.0	18.5	15.3	11.3	11.7	14.3	4.8	9.3	8.7	15.1	3.0	7.5	10.3	14.4	15.6	10.6	19.7	7.9	6.5	3.8	4.5	7.4	8.4	14.6	7.5	9.9	8.3	1.2	8.7	4.1	1.4	6.1	5.1	4.3	7.9	5.5	5.0	15.0	4.2	11.8	1.9	2.9	23.2	3.7	11.1	1.3	3.4	10.2	3.2	4.7	10.1	4.5	1.8	3.4	2.0	4.0	1.5	2.2	1.6	6.7	6.0	1.5	2.1	1.3	28.9	7.5	0.4	2.0	18.7	27.1	8.8	0.9	9.6	9.4	40.7	19.6	7.7	7.9	23.7	6.5	1.2	11.6	1.5	3.8	3.4	2.5	9.8	0.9	1.4	1.9	1.8	3.5	9.1	4.2	4.5	4.0	2.0	9.7	7.4	14.6	4.6	10.3	12.5	3.8	6.5	12.5	11.5	0.5	8.4	7.1	2.9	9.1	7.5	9.4	13.4	9.0	20.7	10.7	11.5	8.8	11.7	11.6	7.5	8.9	4.3	2.7	7.4	3.2	9.8	5.3	12.7	0.0	3.4	17.4	5.9	12.1	5.0	10.2	1.7	8.1	19.3	0.0	10.2	9.4	4.1	8.0	0.0	18.1	10.2	15.9	30.6	11.6	1.2	12.4	2.6	2.6	5.0	1.8	12.9	14.6	8.4	3.5	3.9	12.3	11.5	0.0	4.2	2.3	7.2	6.8	2.9	8.5	20.4	21.1
THNSL2	"FLJ10916, SOFAT, TSH2"	ENSG00000144115	"Threonine synthase like 2"	Q86YJ6	2	88170295-88186636	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 49.7;Proximal tubular cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 16.8;hTCEpi: 10.3;MCF7: 10.7;SuSa: 16.9;T-47d: 15.7"	"Low region specificity"	"Detected in all"							HPA035395	Approved				"Secreted - unknown location"	NA	NA					"HPA035395: AB_10601600"	"unprognostic (1.51e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.24e-2)"	8.6	9.5	5.5	6.0	8.1	0.7	12.0	3.3	10.8	8.7	10.5	17.3	16.3	7.8	11.5	27.0	11.2	11.1	15.1	10.9	5.0	7.1	24.0	29.9	11.7	3.6	7.2	8.6	10.4	8.7	32.4	16.2	14.4	11.3	12.5	3.7	21.1	15.4	9.6	28.7	7.0	12.8	13.7	7.5	4.7	6.6	13.6	1.0	0.9	18.0	9.3	3.8	6.5	5.8	3.4	1.5	0.9	1.1	0.5	1.3	0.8	0.9	0.0	0.0	0.0	2.0	1.3	1.6	4.6	3.4	5.5	6.9	7.0	5.4	0.0	2.1	0.0	0.0	0.2	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	16.8	0.0	0.9	3.1	10.3	1.7	0.0	0.3	0.0	0.0	0.0	0.0	3.2	10.7	0.0	0.0	4.2	8.0	0.7	0.0	0.0	0.0	3.3	0.3	2.0	0.0	5.4	0.8	8.8	16.9	15.7	1.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.9	1.3	1.0	0.9	1.6	0.4	1.0	1.5	3.4	0.7	0.3	0.4	0.5	1.1	0.0	0.0	0.8	5.5	8.1	3.3	10.8	5.0	7.1	7.2	8.6	11.3	1.0	3.0	12.4	3.2	7.8	6.0	10.9	17.3	20.4	4.0	2.3	14.0	0.0	33.4	49.7	12.1	1.3	1.8	8.8	0.0	2.6	14.3	8.0	7.3	0.0	39.2	4.1	12.7	2.4	7.4	9.4	3.4	8.3	2.2	13.5	19.0	7.2	34.2	8.4	7.0	9.2	73.9	6.9	0.0	6.1	2.8	11.0	4.4	20.0	0.0	8.9	5.7
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"liver: 55.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 11.1;Proximal tubular cells: 6.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.9;Hep G2: 17.7;K-562: 3.1;RPMI-8226: 4.6;SuSa: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	1070000					"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.7	1.3	2.3	0.5	0.7	0.0	1.4	4.3	3.3	1.5	0.7	0.4	0.4	0.1	2.6	1.7	0.4	0.9	0.4	1.7	1.5	0.0	8.6	55.5	0.4	0.4	0.4	0.4	1.5	2.7	0.0	1.3	0.6	0.4	0.7	0.3	0.5	0.9	0.7	6.0	0.1	0.4	2.1	0.7	0.9	0.2	2.4	0.4	0.4	0.7	0.7	0.5	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.1	0.0	6.9	0.0	0.0	0.4	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.8	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	4.3	3.3	1.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	11.1	0.4	0.0	0.0	0.0	1.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 60.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA						"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	2.4	4.6	1.5	3.6	2.7	0.2	8.5	1.4	3.0	60.5	8.7	2.4	5.1	4.3	19.9	12.8	36.9	20.3	18.7	17.4	2.1	2.0	5.1	3.3	5.0	2.3	2.7	4.2	8.0	8.7	1.2	4.5	12.4	5.3	19.0	4.0	29.7	6.5	8.8	1.6	4.4	8.4	10.6	6.4	1.2	6.2	3.9	1.4	0.0	6.6	13.3	5.3	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.3	0.3	5.6	3.0	18.1	0.0	9.4	23.0	4.9	2.5	0.1	3.7	0.0	7.8	3.3	17.0	7.2	0.7	3.9	3.0	0.8	0.8	0.0	2.0	0.0	1.9	0.0	0.0	1.3	2.9	2.9	11.8	13.4	8.9	0.0	0.0	0.2	4.0	3.8	0.0	0.0	1.7	0.0	3.4	0.0	0.3	0.3	13.0	2.6	0.3	2.4	3.7	4.7	0.0	2.3	18.8	0.0	28.5	0.1	0.4	19.4	5.0	0.0	0.1	0.0	4.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	1.4	3.0	2.1	2.0	2.7	4.2	5.3	1.4	17.9	7.0	0.0	104.8	12.4	2.6	53.7	45.9	13.4	5.7	5.2	5.9	0.3	1.7	16.1	6.1	11.9	10.5	0.0	1.6	0.2	10.3	73.8	0.0	10.6	0.2	0.0	2.9	6.7	0.0	11.4	16.1	0.9	8.5	0.0	3.6	0.0	8.6	5.8	70.0	0.3	0.8	0.0	3.8	1.0	1.5	9.5	0.7	0.0	10.9	25.5
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370357-11832198	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	76	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"	NA	NA		3000000			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	9.6	2.2	4.7	2.1	5.7	0.6	5.2	2.0	7.2	8.4	2.7	1.0	0.9	1.2	8.3	2.7	1.7	4.8	6.2	2.1	3.8	4.7	17.7	2.0	3.0	1.2	4.6	3.6	6.4	1.4	2.6	9.4	22.5	3.5	8.4	2.1	4.4	1.7	5.5	0.9	1.7	1.5	5.9	4.3	2.3	1.7	2.2	1.9	0.0	4.9	2.5	1.1	4.5	6.8	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	6.6	0.0	0.0	0.3	0.1	0.7	9.9	0.0	0.3	0.0	1.6	0.1	17.9	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.7	2.0	7.2	3.8	4.7	4.6	3.6	3.5	1.9	20.8	8.0	0.0	1.6	2.4	104.8	1.1	22.9	0.0	4.5	52.4	106.0	14.0	6.6	5.5	1.0	31.5	0.0	0.0	1.9	4.9	9.8	2.1	0.0	1.0	2.0	197.0	40.1	21.5	1.9	0.2	22.5	0.8	11.8	0.0	0.0	22.3	4.4	1.5	1.4	8.6	7.4	0.0	1.4	1.7	0.4	2.0	43.4	0.0	0.5	0.6
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 2535.0;Leydig cells: 1644.5;Macrophages: 2104.1;Peritubular cells: 1468.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 164.6;ASC TERT1: 220.3;HSkMC: 150.9;U-87 MG: 142.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	127000000	750000000	"Golgi apparatus"		"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.6	16.1	7.9	93.2	164.6	220.3	1.9	104.6	86.5	32.6	26.4	6.3	18.1	0.1	13.8	134.5	18.9	9.5	4.3	44.4	21.1	19.5	10.2	9.9	11.8	9.8	109.5	6.6	126.8	150.9	11.4	99.4	21.2	38.0	14.6	0.0	15.3	7.3	54.0	18.8	0.1	25.5	8.8	11.5	33.8	0.1	16.2	8.6	52.6	6.7	0.1	0.4	62.0	0.4	13.2	15.3	0.8	12.9	14.1	48.9	51.5	57.6	10.2	3.1	6.5	0.3	142.1	16.0	31.7	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6	101.3	235.0	76.3	526.8	205.4	19.6	8.1	374.5	117.8	310.5	125.6	0.0	21.5	0.0	407.2	18.1	600.1	19.3	0.0	372.2	201.1	871.1	751.9	475.1	110.9	305.2	0.0	266.3	2535.0	691.3	38.8	1644.5	2104.1	485.9	250.7	58.9	120.3	535.0	52.1	1468.0	7.0	6.7	679.1	606.7	17.9	10.8	152.7	37.6	115.1	45.8	406.7
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 269.8"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 344.4;Leydig cells: 327.4;Peritubular cells: 724.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.3;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 126.3;ASC TERT1: 155.4;BJ hTERT+: 88.3;fHDF/TERT166: 96.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		83000000			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	75.2	35.1	30.9	17.7	18.9	3.4	45.6	4.6	25.8	95.8	40.5	36.8	28.2	12.9	87.9	41.5	37.4	39.8	72.3	38.5	23.2	29.6	21.1	12.2	38.4	15.4	25.3	23.2	182.4	14.4	15.8	17.2	269.8	34.0	44.6	20.3	49.7	16.9	51.6	24.5	38.4	22.0	70.7	32.6	37.9	24.2	51.7	26.1	28.4	25.3	24.0	11.3	60.2	58.1	0.2	2.1	13.3	5.0	0.2	0.3	0.8	15.0	7.6	8.6	16.4	126.3	155.4	4.6	53.3	88.3	26.1	20.8	2.7	26.4	0.0	18.8	96.8	28.7	3.0	2.6	2.3	27.4	0.3	1.5	0.0	15.4	4.2	37.5	0.2	0.1	61.0	1.1	25.7	4.1	67.7	34.5	4.9	0.0	0.0	26.8	1.7	15.4	2.6	1.5	3.0	11.3	10.5	19.8	6.4	16.6	0.2	4.4	27.1	33.3	15.8	67.9	10.9	8.0	3.7	40.9	70.0	13.4	40.6	9.2	7.8	6.4	0.1	16.0	2.8	33.7	0.0	5.0	6.8	0.0	3.3	0.0	0.1	0.1	0.0	2.1	0.2	0.3	0.3	13.3	0.2	3.8	1.4	0.1	0.8	30.9	18.9	4.6	25.8	23.2	29.6	25.3	23.2	34.0	26.1	104.2	39.6	4.5	8.0	87.8	30.2	35.8	50.9	0.0	22.7	24.4	7.9	2.7	0.0	76.1	113.2	98.4	11.2	0.0	19.1	82.6	213.2	14.6	6.9	3.2	177.9	3.2	7.5	284.2	170.2	344.4	327.4	101.4	261.5	11.8	7.5	36.2	71.2	1.5	724.5	0.6	11.7	90.5	173.1	5.9	4.5	66.4	12.4	4.9	1.5	6.0
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801701-32863043	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 392.5;retina: 247.1"	"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 1295.0;Peritubular cells: 1818.1;Sertoli cells: 2289.5;Smooth muscle cells: 1077.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.0;BJ: 127.4;BJ hTERT+: 56.3;fHDF/TERT166: 115.8;WM-115: 97.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	130.4	44.6	8.7	15.8	10.1	0.1	103.3	5.1	12.1	68.3	25.4	13.5	27.8	4.5	65.1	47.4	40.2	51.9	39.9	75.0	10.2	8.5	54.0	14.1	115.4	31.3	11.4	8.7	25.3	11.8	15.6	21.6	392.5	19.1	44.2	12.6	247.1	24.3	55.0	22.7	22.9	16.2	58.3	7.2	35.1	22.9	43.2	7.1	1.2	48.9	29.4	10.1	37.5	38.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	1.8	0.3	57.0	32.1	0.1	127.4	56.3	10.4	12.4	2.2	0.0	0.0	3.1	115.8	0.4	1.9	0.3	5.2	15.1	0.0	1.5	15.7	2.7	5.5	22.4	0.0	6.6	5.3	13.3	18.5	1.0	0.3	0.0	0.0	0.0	0.1	4.8	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	10.4	1.3	1.8	2.6	0.0	33.5	31.0	0.0	0.1	0.0	0.8	2.8	27.1	2.0	0.0	0.0	0.0	26.0	0.0	97.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.7	10.1	5.1	12.1	10.2	8.5	11.4	8.7	19.1	7.1	339.5	47.1	4.5	518.2	68.7	3.1	194.1	5.1	12.0	26.1	48.8	3.9	374.1	3.3	1.3	11.5	516.3	0.0	0.0	0.6	213.4	444.0	99.6	85.6	98.5	105.1	3.2	1.7	734.7	49.2	29.3	1295.0	27.8	72.6	1.0	0.0	169.4	1.1	0.0	1818.1	11.1	3.5	2289.5	1077.9	6.5	5.1	49.3	676.6	10.0	0.2	134.4
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9"	"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.0	0.2	0.0	54.7	13.7	6.7	0.2	2.2	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.5	0.2	8.5	0.0	0.0	23.7	0.5	1.4	0.0	0.4	0.0	0.0	0.1	4.4	0.0	0.1	0.0	0.0	13.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.9	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2	0.0	0.0	0.0	1.2	0.1	0.3	4.8	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.7	1.1	2.9	0.7	23.3	2.4	1.9	1.4	5.6	0.0	0.0	2.9	0.0	6.3	14.7	0.6	4.8	11.2	0.1	3.3	0.0	2.6	0.7	2.7	2.8	2.5	0.3	0.0	32.3	3.4	0.0	0.0	0.1	0.1	0.0	2.3	2.0
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Group enriched"	"Detected in some"	6	"Enterocytes: 52.3;Proximal tubular cells: 176.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 46.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.0	0.0	0.0	19.9	0.0	0.7	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	1.3	10.5	0.0	176.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.4"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		170000			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	43.0	8.4	2.2	11.6	3.4	0.8	60.0	0.8	4.4	30.2	22.0	2.9	14.2	12.0	25.7	23.4	23.7	17.0	36.1	52.6	3.4	2.3	53.3	14.7	24.4	12.8	3.9	3.3	15.5	7.4	3.2	5.6	128.4	5.0	19.4	7.9	12.0	24.2	20.0	19.6	7.6	15.9	22.5	2.7	34.3	16.3	10.3	2.1	0.8	30.7	11.0	6.4	39.8	20.0	1.1	0.6	4.8	0.5	1.5	0.8	0.0	16.7	0.0	0.0	0.1	0.1	0.0	58.8	2.6	0.3	0.1	0.0	7.9	32.1	0.0	74.1	2.3	1.2	32.2	0.0	37.9	0.0	0.1	0.0	0.0	1.4	2.0	0.8	0.0	0.1	0.0	6.9	0.0	1.4	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	9.1	1.0	0.0	0.0	0.0	10.2	12.9	0.0	0.1	6.8	22.7	0.7	3.6	1.3	0.0	67.1	0.0	17.0	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.6	4.8	0.5	0.5	0.8	0.3	0.5	0.4	0.6	0.5	0.1	1.1	0.8	0.8	2.7	1.5	0.5	0.6	0.5	0.0	2.2	3.4	0.8	4.4	3.4	2.3	3.9	3.3	5.0	2.1	8.9	7.2	5.3	91.5	9.7	0.0	41.9	38.2	1.4	7.9	125.6	0.0	1103.3	1.7	361.6	1.2	133.2	75.1	0.0	83.6	184.7	19.9	41.9	14.9	1.1	78.0	0.0	10.9	249.8	10.8	0.4	6.9	5.7	21.9	3.6	27.7	0.3	206.9	37.7	3.9	67.7	0.4	420.4	356.4	0.2	0.9	5.6	1627.5	6.4	49.2	157.0
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.8;Early spermatids: 5.2;Late spermatids: 3.4;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.1	0.4	0.0	21.7	0.1	0.8	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7	0.0	0.6	0.0	0.4	0.1	0.0	4.8	2.5	0.0	1.2	0.0	0.0	2.2	0.0	0.3	5.2	0.5	0.0	0.0	0.5	0.0	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.4	0.3	1.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.4	2.9	0.0	0.0	0.4
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192195709	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;prostate: 46.3;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 96.9;Leydig cells: 24.5"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 17.3;LHCN-M2: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"	NA	NA					"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	1.1	3.8	20.2	1.1	14.7	1.0	1.1	7.4	29.6	1.1	2.0	18.4	1.7	1.7	1.0	11.1	2.4	1.1	3.0	1.4	17.7	18.5	1.0	1.0	1.1	1.0	15.7	17.7	1.1	1.1	1.1	0.4	1.0	11.1	46.3	2.8	2.8	1.1	17.5	1.3	1.1	1.7	1.1	11.1	1.1	1.4	1.8	15.9	0.0	1.1	0.0	1.2	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	17.3	0.0	2.7	2.8	0.0	0.0	0.3	0.8	1.0	0.0	0.0	0.0	0.0	4.7	2.1	0.0	1.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.5	0.0	0.9	5.1	4.2	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	1.3	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	14.7	7.4	22.7	17.7	18.5	15.7	17.7	11.1	15.9	0.0	0.0	0.0	0.1	0.1	9.9	1.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	96.9	0.0	0.0	0.0	0.7	24.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.1	0.0	1.3	6.5	0.4	1.2	2.5	0.3	0.0	0.0	0.0	0.0
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.1"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3"									HPA077585	Approved				"Secreted in brain"	NA	NA					"HPA077585: AB_2732353"	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.3	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	3.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	10.5	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	3.8	0.0	0.0	0.0
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019578-115118257	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 47.4;Basal glandular cells: 45.4;Smooth muscle cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 85.5;hTEC/SVTERT24-B: 69.9;U-138 MG: 58.8;U-251 MG: 51.6;U-87 MG: 78.4;WM-115: 134.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	760000000			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	20.6	2.5	1.4	50.9	11.4	0.5	12.6	0.4	6.4	19.4	63.6	18.6	24.1	5.3	42.4	23.9	18.5	12.0	16.9	13.6	3.4	2.8	16.4	2.6	21.0	66.3	4.3	3.3	10.6	1.8	0.6	3.3	3.2	14.7	13.0	9.3	0.0	8.5	10.8	10.8	10.3	21.2	111.4	5.7	26.9	31.3	5.4	6.8	4.7	5.5	15.4	16.1	20.4	6.6	0.3	0.3	1.9	0.3	0.2	0.3	0.1	2.5	0.6	0.7	0.1	4.2	1.1	0.0	22.0	85.5	46.6	23.0	0.5	6.0	0.0	3.4	31.0	0.7	9.2	0.0	1.3	28.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.6	0.1	69.9	32.5	4.8	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	7.2	0.1	9.4	0.0	49.4	0.0	42.4	0.0	0.0	0.6	9.2	0.0	2.2	16.9	0.0	0.1	0.0	58.8	9.7	10.1	51.6	1.6	0.0	0.0	78.4	0.0	134.1	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.2	1.9	0.2	0.0	0.2	0.0	0.1	1.4	11.4	0.4	3.9	3.4	2.8	4.3	3.3	14.7	6.8	11.9	47.4	0.0	45.4	10.8	0.0	1.1	0.0	1.4	14.8	1.8	0.0	0.7	0.0	19.5	15.8	5.4	0.0	0.0	4.1	0.2	24.2	6.4	2.3	0.0	1.0	0.0	0.0	3.7	0.6	12.7	3.1	2.6	5.0	0.0	0.0	0.5	3.4	0.0	0.4	0.1	0.2	0.0	91.7	0.4	0.2	4.0	0.8	0.7	0.0	5.1
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 32.8;Macrophages: 42.1;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.2;HMC-1: 9.8;NB-4: 29.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100				"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	1.9	0.0	0.0	0.0	0.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5	0.0	4.0	13.4	0.2	7.4	0.1	2.0	5.1	1.4	2.3	0.0	2.0	0.3	0.0	6.7	0.1	2.8	0.0	0.0	2.9	1.5	2.1	0.9	11.6	0.0	32.8	0.0	0.0	1.3	8.7	0.0	0.3	42.1	5.0	1.0	0.1	0.1	10.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	3.6	0.9	34.1	0.0	0.3
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380048	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 341.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 50.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 31.1;HHSteC: 19.3;HSkMC: 9.3;hTEC/SVTERT24-B: 25.7;SH-SY5Y: 10.2;U-2197: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Approved				"Secreted to blood"	NA	NA		15000			"CAB032719: AB_2204650, HPA050884: AB_2681261"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (9.16e-5)"	14.0	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2.0	4.0	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1.0	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0.0	0.0	50.9	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	7.4	0.0	1.1	31.1	1.2	5.8	0.0	0.0	0.0	0.4	0.5	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	9.3	0.0	25.7	1.8	1.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.5	0.0	0.0	0.0	0.0	10.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.0	2.1	20.6	0.3	0.0	0.0	0.0	2.3	0.3	1.5	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.5	0.0	0.0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8	3.0	1.7	0.5	0.5	57.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	341.4	1.0	0.0	0.0	0.0	0.7	52.2	1.5	2.3	0.0	1.4	0.0	0.0	2.5	5.0	13.5	2.3	37.7	70.9	7.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	34.0	1.4	2.0	46.3	1.5	0.0	0.0	4.6
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118952200	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 18.6;thyroid gland: 52.8"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 69.8;Ductal cells: 23.2;Proximal tubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Group enriched"	"Detected in some"	4	"BJ: 50.9;BJ hTERT+: 189.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034939	Approved				"Secreted in other tissues"	NA	NA					"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (3.88e-4)"	3.0	3.0	2.2	2.8	2.8	0.2	4.4	2.9	5.2	1.2	1.5	0.7	0.5	0.9	5.5	4.1	1.0	1.7	3.2	7.3	2.8	1.4	18.6	7.6	8.1	5.3	1.7	0.8	0.5	2.8	0.3	1.9	4.0	12.0	1.1	2.0	1.8	1.4	0.8	0.6	0.7	1.4	1.5	7.9	1.5	0.8	0.3	2.7	0.9	52.8	0.8	1.7	1.7	1.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.5	0.0	50.9	189.3	2.4	0.7	0.5	0.1	0.0	13.7	28.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	1.0	0.0	0.0	0.0	0.0	7.1	1.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.8	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.2	2.8	2.9	5.2	2.8	1.4	1.7	0.8	12.0	2.7	3.0	0.0	0.5	0.5	1.9	0.0	3.1	5.1	0.0	1.2	69.8	0.0	0.0	8.3	23.2	0.1	4.5	1.4	0.0	1.2	0.1	6.9	7.9	0.0	1.0	0.4	0.0	9.1	6.2	0.0	0.0	0.3	0.0	0.0	14.4	8.8	0.7	6.9	0.0	0.0	89.5	0.0	0.0	2.2	0.0	0.3	1.0	0.0	0.0	2.1	0.3
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206691	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 46.6;skin 1: 28.9"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 46.6"	"Group enriched"	"Detected in many"	11	"NK-cells: 46.6;T-cells: 19.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 62.6;SCLC-21H: 45.0"									HPA008025	Approved				"Secreted to blood"	NA	NA					"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.4	0.5	1.0	8.9	1.0	1.9	4.2	4.9	2.5	14.3	8.3	0.3	0.1	5.7	2.1	1.1	4.7	1.0	3.7	0.2	0.5	0.3	1.1	1.7	3.0	9.1	0.4	2.4	0.3	2.7	9.4	3.8	1.3	1.7	1.9	1.2	0.5	9.0	2.6	1.0	28.9	5.0	0.2	0.3	6.7	3.8	0.8	0.1	4.4	0.9	2.7	8.2	1.5	2.2	2.9	0.0	0.2	0.0	46.6	19.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	4.7	0.0	0.0	62.6	0.1	0.0	45.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.6	1.3	8.5	1.2	0.0	2.9	0.3	0.4	0.2	46.6	0.0	0.0	19.0	2.1	1.0	1.0	4.9	2.5	0.5	0.3	0.4	2.4	1.7	0.1	0.0	2.2	7.5	10.8	167.9	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.5	0.9	11.2	7.3	46.0	0.0	0.8	0.0	3.4	1.3	0.8	0.0	0.0	1.8	47.2	21.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	131.6	0.0	20.8	0.0	3.3
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 86.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	NA	NA		170000			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (2.19e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.14e-2)"	"prognostic favorable (8.22e-4)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.74e-1)"	55.1	43.9	16.8	28.9	16.8	13.7	40.6	7.2	15.6	40.3	41.5	14.1	22.6	39.2	38.2	27.5	39.4	34.2	37.1	26.8	14.0	7.5	49.3	61.6	40.9	37.2	19.2	6.4	59.5	21.4	20.3	19.9	45.3	18.3	37.0	23.0	31.1	25.7	22.2	34.2	30.9	81.7	38.8	25.1	43.6	28.2	21.8	15.7	31.6	42.7	25.4	22.3	49.1	58.5	0.0	20.8	86.5	27.1	1.8	11.6	15.9	7.4	57.8	8.1	11.5	56.0	57.3	15.3	15.9	27.5	21.4	18.6	6.9	29.7	0.6	5.5	34.3	17.1	20.8	2.5	18.6	14.8	0.1	4.8	4.1	16.0	15.3	49.7	19.3	13.0	59.0	18.7	17.7	26.1	49.7	26.0	8.0	6.2	5.7	24.5	10.6	6.1	18.2	19.7	27.7	16.9	5.3	12.9	5.7	16.5	13.5	0.0	0.4	22.5	11.8	11.8	21.7	3.2	21.1	28.3	16.8	14.4	12.6	14.7	0.0	1.8	2.4	20.1	18.0	20.8	2.2	27.1	15.0	11.6	21.8	11.1	0.0	4.9	9.5	20.8	0.0	4.5	6.6	86.5	1.8	17.5	6.0	4.8	15.9	16.8	16.8	7.2	15.6	14.0	7.5	19.2	6.4	18.3	15.7	47.6	42.8	9.0	92.6	109.3	0.1	8.4	63.7	10.7	42.1	26.2	0.0	53.2	13.3	86.6	0.6	80.7	166.1	23.3	104.3	104.8	112.3	113.8	7.0	128.2	148.0	0.0	32.3	138.1	133.7	3.3	94.6	103.1	67.4	101.0	44.9	16.3	93.0	210.5	61.9	94.3	0.3	122.9	122.4	0.5	1.1	117.7	124.3	45.7	42.3	123.4
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.1	0.0	5.6	7.7	4.4	0.5	1.0	2.0	2.2	0.8	17.5	0.1	0.3	1.8	2.9	0.0	0.4	0.0	1.1	6.9	0.0	0.0	0.1	0.0	13.2	0.1	1.9	7.6	0.0	7.0	0.0	3.6	10.6	0.1	21.4	3.2	0.9	0.0	0.0	4.0	0.1	2.7	0.6	0.5	0.2	12.3	0.0	0.4	0.0	0.0	0.3	0.1	0.6	3.3	0.0	25.1	3.7	3.0	0.1	13.3	0.0	1.0	0.0	0.0	17.2	18.1	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1	8.9	22.3	30.3	2.5	14.9	0.1	2.8	7.6	2.7	11.4	3.5	0.0	0.7	0.0	0.4	0.3	40.2	11.8	23.3	0.5	4.3	9.7	4.3	2.3	14.0	63.4	0.0	0.0	22.7	168.8	0.4	2.0	143.1	15.1	73.9	3.1	0.3	0.5	1.4	0.4	0.3	1.0	32.3	13.7	0.0	0.9	9.3	25.2	58.9	3.9	9.8
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696651-63698684	"Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.4;lymphoid tissue: 56.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 17.4"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 11.7;RPTEC TERT1: 46.0;TIME: 28.5"					"Not detected"	"Not detected"			HPA047154	Approved				"Secreted to blood"	NA	NA	406000				"HPA047154: AB_2679959"																		11.8	2.0	10.0	39.2	17.6	2.5	7.0	5.4	8.1	4.5	6.0	2.1	0.0	2.0	3.0	2.0	6.6	2.5	3.6	2.0	11.6	6.6	4.4	2.5	39.4	9.8	5.9	0.0	3.6	2.2	2.0	4.2	2.1	23.6	2.7	2.3	0.0	2.9	2.0	10.0	4.8	3.8	4.6	13.0	56.3	10.0	2.1	5.3	2.7	6.5	3.3	12.1	11.6	2.3	0.0	17.4	0.0	0.9	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	28.5	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.9	17.4	0.0	0.1	10.0	17.6	5.4	8.1	11.6	6.6	5.9	0.0	23.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523507	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 50.3;monocytes: 39.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054938	Uncertain				"Secreted to blood"	NA	NA	67400				"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	30.9	22.1	3.4	14.6	4.7	2.0	23.3	3.0	5.4	31.4	25.8	4.4	17.1	20.6	13.0	10.3	33.3	9.6	10.7	9.9	3.8	3.2	115.1	44.4	91.5	23.5	5.5	3.4	13.5	11.6	10.9	6.7	100.8	6.7	37.6	19.5	12.0	50.6	12.9	13.9	13.0	54.0	7.9	5.6	35.8	9.5	6.0	4.6	8.3	28.2	17.7	16.1	22.4	24.0	3.4	9.5	50.3	39.5	9.3	7.0	11.9	3.4	0.1	0.0	0.0	2.4	1.8	21.0	0.0	0.1	1.0	1.6	0.0	14.9	2.1	10.1	0.0	0.9	14.7	0.0	1.8	0.2	5.3	0.0	0.0	0.4	0.3	0.1	3.9	69.1	2.4	2.4	0.4	0.0	0.0	7.6	0.4	0.0	2.5	0.0	0.0	0.5	5.2	0.0	0.1	0.1	0.8	0.0	0.9	34.8	1.3	0.1	0.1	7.7	0.3	0.1	0.1	4.2	2.2	0.3	0.0	0.0	0.0	0.2	2.6	0.3	2.6	0.2	2.2	0.0	42.4	25.6	2.7	2.3	39.5	3.1	3.2	6.4	3.5	9.5	3.4	4.7	1.8	50.3	9.3	38.3	0.6	7.0	11.9	3.4	4.7	3.0	5.4	3.8	3.2	5.5	3.4	6.7	4.6	65.5	119.9	15.2	153.0	19.6	0.1	4.5	63.7	99.0	113.7	62.8	0.0	1.1	38.1	542.5	3.9	163.8	223.5	23.3	368.6	166.3	27.9	96.6	248.5	58.7	22.3	1.6	46.3	140.0	77.7	2.8	17.0	51.4	6.8	16.2	96.5	21.7	249.5	190.0	4.6	449.0	0.8	0.0	10.3	0.0	0.2	22.3	9.2	43.6	68.5	109.1
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 14.3;lymphoid tissue: 19.8"	"Cell type enhanced"	"Detected in some"	22	"Ductal cells: 3.3;Early spermatids: 5.8;Late spermatids: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 14.3"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HSkMC: 5.4;NTERA-2: 7.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	NA	NA	17200				"CAB009193: , HPA045142: AB_2679231"	"unprognostic (3.97e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.94e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.74e-2)"	0.5	0.2	0.2	19.5	0.2	0.0	4.6	0.1	0.2	0.8	0.8	0.1	2.4	0.2	0.2	0.1	3.7	0.2	1.3	0.3	0.1	0.7	0.6	5.3	0.4	19.8	0.1	0.1	0.1	0.6	0.0	0.3	0.3	0.4	0.5	2.2	0.1	1.6	1.0	0.2	0.5	6.0	0.1	0.1	0.8	0.3	3.3	0.1	2.8	0.4	0.1	5.2	2.3	0.7	0.0	0.1	1.8	0.0	14.3	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.6	0.0	0.1	5.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7548891-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.8;BJ hTERT+: 11.2;fHDF/TERT166: 9.7;HDLM-2: 9.9;HSkMC: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	853000	150000	Vesicles		"HPA035984: , HPA052967: AB_2682000"	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	32.9	16.7	23.0	14.0	16.9	2.9	20.4	15.7	21.8	22.1	27.4	9.5	18.0	9.5	17.6	18.6	24.5	19.8	30.1	23.3	16.3	13.3	15.0	8.8	23.8	16.8	14.8	13.9	31.3	20.6	9.0	8.4	13.4	7.8	27.8	6.2	19.7	26.7	32.7	12.8	8.2	11.3	24.2	9.1	21.6	18.0	7.4	8.5	2.6	11.3	9.6	11.0	26.0	37.7	2.6	2.4	10.5	5.7	2.4	6.9	0.8	0.0	0.0	0.5	0.0	9.1	11.8	2.5	4.0	11.2	4.5	2.7	0.0	1.4	0.0	3.5	9.7	0.4	0.9	0.4	0.4	0.4	9.9	1.7	0.6	0.3	0.8	8.9	0.0	0.0	10.3	1.1	1.5	0.1	2.1	7.3	0.0	0.1	0.0	3.9	0.0	0.0	0.3	0.4	0.0	5.0	0.1	0.0	0.1	7.2	0.0	0.0	4.7	1.3	0.0	3.8	0.1	0.7	0.4	7.0	6.1	0.5	0.0	2.1	0.0	0.0	0.0	1.1	0.0	5.4	4.0	3.1	10.5	5.2	5.7	6.9	2.6	3.8	2.8	1.8	2.5	4.4	4.1	2.2	2.4	1.4	2.4	4.1	0.8	23.0	16.9	15.7	21.8	16.3	13.3	14.8	13.9	7.8	8.5	8.9	9.8	8.7	9.8	5.5	7.7	3.8	12.7	0.0	4.5	15.7	0.0	1.2	6.6	12.4	0.4	20.4	1.1	0.0	10.6	0.8	13.3	9.0	34.5	2.9	40.2	19.1	1.2	28.8	42.6	0.0	46.9	42.4	18.6	28.9	1.7	29.4	7.9	0.0	47.4	29.4	2.2	58.2	36.0	0.2	1.2	6.6	0.7	21.4	3.7	4.6
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 102.8"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 7.2;Ciliated cells: 2.7;Club cells: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.5;eosinophil: 22.8;intermediate monocyte: 62.7;myeloid DC: 43.0;non-classical monocyte: 37.3;plasmacytoid DC: 19.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 43.0;granulocytes: 22.8;monocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.8;RPTEC TERT1: 47.5;U-937: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	29000			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	12.1	14.4	18.7	15.4	24.2	18.3	12.9	5.7	15.3	15.7	20.4	8.7	27.4	32.0	7.7	12.8	6.1	14.4	29.1	9.5	11.1	10.7	34.1	11.9	43.0	39.0	14.3	9.4	14.0	20.7	5.7	10.8	6.4	31.6	13.7	18.7	22.0	102.8	69.4	3.0	5.3	18.5	10.9	13.1	16.2	23.4	5.0	9.0	3.3	14.1	8.2	11.5	10.4	8.4	4.1	43.0	22.8	63.5	1.3	0.4	30.6	8.5	3.5	1.2	2.3	1.4	0.7	1.4	1.5	1.1	0.6	0.5	1.9	5.3	3.8	18.8	1.5	2.2	5.5	0.0	1.5	0.6	6.6	2.9	2.4	7.7	4.0	2.9	2.1	2.5	1.5	1.5	0.4	2.5	3.8	2.0	2.7	1.8	1.5	0.5	1.2	0.9	6.7	1.1	8.3	2.5	6.7	1.4	16.2	47.5	5.6	2.2	2.1	3.0	8.0	1.0	1.8	10.7	5.1	1.0	2.0	2.5	0.9	3.3	0.3	1.1	0.9	0.8	18.2	4.0	9.0	63.5	22.8	0.1	62.7	0.1	2.0	0.0	0.1	43.0	4.1	0.4	0.2	8.6	1.3	37.3	19.8	0.1	30.6	18.7	24.2	5.7	15.3	11.1	10.7	14.3	9.4	31.6	9.0	6.0	7.2	0.0	0.2	0.0	0.0	0.0	0.0	2.7	3.4	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	2.3	0.0	0.4	0.0	1.2	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	23	"Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Cell line enriched"	"Detected in some"	7	"U-937: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	530000	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.1	3.8	0.1	0.0	3.9	61.0	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9	14.9	17.5	3.7	0.7	6.4	0.3	0.5	12.7	2.7	5.7	5.2	0.0	0.5	1.7	2.0	1.0	1.3	0.5	0.0	29.2	0.9	13.3	1.6	4.7	1.5	88.9	0.0	1.2	4.9	144.9	0.2	4.9	141.3	8.5	457.1	0.2	0.4	1.9	0.0	1.8	1.0	0.0	6.5	5.0	0.1	0.1	4.1	0.9	6.2	1.2	1.3
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;liver: 50.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 22.9;granulocytes: 26.4;T-cells: 51.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 50.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 50.8;T-cells: 16.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.6;NB-4: 4.8;THP-1: 3.4;U-937: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA012700	Approved				"Secreted to blood"	NA	NA	41000				"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	11.2	0.9	0.6	4.6	0.6	2.5	1.3	1.2	1.5	0.8	2.4	0.4	0.2	2.8	2.7	2.3	1.8	3.6	2.0	2.1	0.6	0.1	1.0	50.6	4.3	8.3	3.8	0.2	2.9	2.5	0.0	0.9	1.8	1.4	1.2	1.8	1.9	1.4	1.5	0.2	0.7	3.8	1.6	0.3	8.2	1.8	1.6	0.2	1.5	1.4	0.9	5.9	2.1	14.1	0.3	1.7	50.8	4.5	7.2	16.6	2.9	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	0.0	0.0	21.6	0.0	0.1	0.2	1.1	0.0	0.6	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	12.3	0.0	28.3	4.5	27.4	11.4	1.0	16.6	0.1	4.9	9.2	1.7	0.3	0.8	4.2	50.8	7.2	0.1	0.1	3.9	2.9	0.6	0.6	1.2	1.5	0.6	0.1	3.8	0.2	1.4	0.2	8.9	22.9	0.9	0.5	2.6	0.0	0.8	10.2	1.4	7.9	0.0	0.0	0.1	0.0	2.3	1.0	0.3	0.0	0.0	3.2	0.2	2.4	0.5	26.4	10.6	13.5	0.0	0.0	1.8	3.0	0.0	0.3	8.4	3.3	2.8	0.0	0.0	9.8	0.0	0.0	0.3	0.0	0.0	1.6	0.2	0.2	2.9	0.0	51.1	0.0	0.3
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.5	1.3	0.0	0.0	0.4	11.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.3	0.0	0.0	14.0	0.0	0.0	0.8	0.4	0.5	0.0	0.0	0.2	13.1	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.0	0.6	0.0	5.0	1.0	0.0	6.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1	11.9	8.9	0.0	4.4	0.5	0.1	0.5	0.0	0.0	1.2	7.0	0.0	0.5	0.0	4.0	0.2	0.0	6.9	0.0	1.8	0.1	0.8	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	9.0	1.8	0.2	1.1	0.0	0.4	9.6	0.1	0.0	1.0	0.0	0.0	0.5	0.2	0.0	3.9	5.1
TNN		ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067858-175148066	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.2;gallbladder: 14.2"	"Cell type enhanced"	"Detected in some"	14	"Ito cells: 2.5;Smooth muscle cells: 2.7;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;NB-4: 4.7;THP-1: 14.4;U-266/70: 3.7;U-937: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		11000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	15.2	0.2	0.1	1.5	0.2	0.0	7.9	0.4	0.8	0.3	0.8	0.1	0.1	1.0	0.1	0.5	0.3	0.0	14.2	0.6	0.1	0.0	0.4	1.8	1.8	0.1	0.1	0.9	0.1	0.3	1.8	3.7	0.1	0.6	0.1	0.1	4.8	6.4	0.1	0.1	5.3	1.0	0.8	0.7	0.6	0.5	0.1	0.3	0.3	2.6	7.5	0.3	0.1	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.0	0.1	0.9	0.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.7	1.6	0.1	0.0	0.0	0.0
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743770	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 56.4"	"Cell type enriched"	"Detected in some"	168	"Horizontal cells: 548.2"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 5.8;THP-1: 2.3;U-937: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		230000			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	1.2	3.0	21.8	1.4	14.2	1.3	1.2	9.1	56.4	1.2	1.2	17.2	0.0	1.2	1.3	1.4	1.3	1.2	1.3	1.2	18.1	14.4	1.2	1.7	1.7	1.4	16.5	13.3	1.2	1.7	1.2	2.0	1.2	16.1	1.2	1.3	0.1	1.2	1.2	1.2	1.2	1.3	1.3	8.2	1.4	1.6	1.6	14.3	0.0	1.3	0.0	1.6	1.3	0.1	0.4	0.1	0.6	0.0	1.9	0.1	0.0	0.0	0.3	1.2	0.2	0.1	0.1	0.7	0.3	0.2	0.3	0.1	0.8	0.2	0.4	0.7	1.1	0.1	0.7	0.0	0.6	0.2	0.3	0.0	0.1	0.6	0.4	0.0	0.4	0.1	0.5	0.8	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.3	5.8	0.6	0.3	0.2	0.4	0.4	2.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.5	4.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.1	0.4	1.9	0.0	0.1	0.0	0.0	21.8	14.2	9.1	23.7	18.1	14.4	16.5	13.3	16.1	14.3	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	548.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041154-32115334	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 29.2;Endothelial cells: 24.3;Erythroid cells: 23.3;Fibroblasts: 26.1;Ito cells: 12.9;Leydig cells: 25.0;Melanocytes: 30.4;Suprabasal keratinocytes: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.3;ASC TERT1: 18.5;U-2197: 14.9;U-87 MG: 7.4"														"Secreted to extracellular matrix"	NA	NA		1100000000				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	45.1	66.2	1.0	12.2	1.8	3.8	61.5	7.7	1.5	28.3	14.5	0.6	17.6	4.2	31.6	38.0	25.7	7.5	33.3	39.3	1.0	1.4	3.3	5.4	22.3	8.7	2.2	0.4	41.0	3.1	1.5	1.8	7.6	1.4	9.0	2.7	3.0	7.1	7.9	17.9	8.4	10.2	49.2	4.4	7.9	5.4	11.4	0.3	0.4	6.7	36.6	4.5	33.0	32.2	0.0	0.0	0.1	0.1	0.0	0.2	1.7	0.1	0.2	0.2	0.1	11.3	18.5	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.5	0.0	2.6	0.0	0.3	0.2	0.1	0.4	0.0	0.4	0.0	0.4	0.6	0.3	0.0	0.1	0.0	0.1	0.3	0.0	3.4	0.2	0.0	0.2	0.0	0.1	0.1	0.2	1.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	14.9	0.0	0.4	0.3	0.2	7.4	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	1.0	1.8	7.7	1.5	1.0	1.4	2.2	0.4	1.4	0.3	3.0	3.7	0.0	0.1	29.2	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	2.7	24.3	0.0	23.3	0.0	0.9	26.1	0.2	0.0	1.0	0.7	0.0	0.0	12.9	0.3	2.0	25.0	1.3	30.4	0.0	0.0	1.0	0.0	0.0	4.2	0.2	0.5	0.0	4.7	3.0	1.8	23.2	0.8	0.0	0.2	0.2
TOR2A	"FLJ14771, TORP1"	ENSG00000160404	"Torsin family 2 member A"	"Q5JU69, Q8N2E6"	9	127731524-127735317	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071229	Approved				"Secreted to blood"	NA	NA					"HPA071229: AB_2732175"	"unprognostic (1.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.82e-2)"	7.3	10.1	6.2	11.8	6.2	33.3	10.9	11.3	9.1	7.2	13.5	6.1	8.2	16.4	6.3	10.1	9.9	7.9	11.8	5.8	5.8	5.6	10.2	16.2	12.8	22.8	4.9	7.3	7.9	18.3	3.2	8.3	15.0	5.1	7.1	8.4	6.1	9.7	10.2	2.8	8.3	20.9	4.5	4.0	18.9	12.6	16.9	5.6	18.6	8.0	6.8	10.9	7.2	6.3	6.2	26.3	34.5	28.8	10.0	13.1	13.4	4.0	6.2	5.4	6.6	2.7	2.6	7.1	3.1	3.5	4.4	3.5	4.2	6.9	7.5	4.3	2.4	3.4	12.9	1.7	3.5	1.2	11.9	6.1	2.9	5.5	5.1	4.4	5.9	15.4	4.2	6.5	4.1	2.2	2.2	6.3	8.9	8.6	20.6	2.6	22.9	7.5	18.5	4.8	12.9	5.8	12.9	2.5	16.2	4.6	3.8	11.7	4.7	2.6	9.1	2.6	3.1	20.3	11.5	3.9	2.8	3.4	5.1	3.2	13.3	11.4	3.0	3.6	9.6	2.8	8.8	25.3	34.5	13.1	28.8	10.2	4.8	7.6	12.6	26.3	6.2	5.8	10.2	17.1	10.0	26.6	6.1	11.6	13.4	6.2	6.2	11.3	9.1	5.8	5.6	4.9	7.3	5.1	5.6	3.0	6.1	19.7	3.6	1.3	12.3	0.6	12.7	4.0	3.4	3.5	0.0	32.4	1.7	16.6	51.5	3.5	22.2	46.7	24.4	32.1	2.9	4.9	5.7	6.4	49.3	7.9	21.9	14.7	28.1	6.2	10.6	16.9	3.3	16.2	20.3	12.8	13.5	21.0	10.6	7.3	12.1	0.0	3.1	30.4	7.5	1.3	43.4	15.0	18.5	4.0
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240696-1242554	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	24	"granulocytes: 5492.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	308	"basophil: 30.8"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 30.8"	"Cell line enriched"	"Detected in some"	173	"HMC-1: 301.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA					"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	22.4	0.2	1.6	5.8	1.6	0.0	10.6	1.6	1.6	13.9	17.1	1.6	1.6	17.7	18.7	10.4	15.2	6.1	33.1	4.7	1.6	0.0	4.4	2.8	29.2	16.8	1.6	1.6	2.9	4.5	0.0	1.6	1.9	1.6	24.1	10.0	5.1	14.6	6.3	3.6	29.9	31.0	15.0	1.6	1.6	24.5	5.1	1.6	3.1	3.7	3.8	6.9	21.6	16.0	0.0	0.0	30.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	301.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.6	1.6	1.6	1.6	0.0	1.6	1.6	1.6	1.6	23.8	231.9	0.0	1.4	16.6	0.0	0.2	0.0	9.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	17.1	2.5	5492.7	0.0	5.5	0.0	0.0	0.0	0.3	0.0	0.0	9.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.1	8.7	0.2	1.0	0.0	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2 (gene/pseudogene)"	P20231	16	1227272-1230184	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.2"	"Cell type enriched"	"Detected in some"	18	"granulocytes: 8345.3"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	84	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.4"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 83.3"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		7500000			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	1.8	0.0	0.9	1.9	0.9	0.0	4.1	0.9	0.9	8.8	5.3	0.9	0.9	4.9	2.9	0.9	7.7	0.1	16.2	0.9	0.9		0.9	0.9	12.3	2.4	0.9	0.9	0.9	1.3	0.0	0.9	0.9	0.9	2.7	2.3	0.9	6.2	1.2	0.9	3.4	9.7	4.4	0.9	0.9	13.6	0.9	0.9	0.9	0.9	0.9	0.9	4.2	0.9	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	83.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											35.7	468.0	0.0	1.9	0.0	0.0	1.3	0.0	6.7	30.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.9	8345.3	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	4.6
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 4.6"									HPA065044	Uncertain				"Secreted - unknown location"	NA	NA					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell type enriched"	"Detected in some"	31	"Muller glia cells: 222.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"REH: 2.6;SuSa: 4.0;T-47d: 2.4"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	4.0	2.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0	0.0	0.0	0.0	0.5	0.7	6.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	222.3	0.0	0.0	0.0	0.0	7.1	0.0	0.4	0.4	0.4	0.1	0.1	0.0	0.0	0.5
TSHB		ENSG00000134200	"Thyroid stimulating hormone beta"	P01222	1	115029824-115034309	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	77	"pituitary gland: 192.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;SH-SY5Y: 1.0;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"	NA	NA					"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.0	0.1	0.9	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	1.4	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.3	0.1	1.4	0.1	0.1	0.1	0.1	1.6	0.0	192.4	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.1	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.1	2.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 41.4;ASC diff: 70.9;OE19: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	NA	NA		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3.0	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2.0	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8	0.0	0.3	0.0	13.0	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0.0	42.8	0.0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0.0	7.5	8.6	9.5	1.2	34.5	1.6	5.0	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0.0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17.0
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078024	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 24.2;Basal keratinocytes: 49.6;Club cells: 45.5;Early spermatids: 30.8;Late spermatids: 20.5;Suprabasal keratinocytes: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.3;HHSteC: 11.7;hTCEpi: 6.9;hTEC/SVTERT24-B: 14.7;hTERT-HME1: 8.4;hTERT-RPE1: 26.0;U-87 MG: 9.5"									HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	5.1	1.7	0.7	2.0	1.1	0.2	19.1	0.5	0.8	5.4	4.6	1.4	6.6	1.5	4.2	0.7	14.1	1.1	14.1	18.7	1.4	0.8	1.6	17.3	4.6	1.8	1.2	1.7	1.1	0.8	0.2	1.5	0.4	2.3	16.4	1.7	1.0	3.5	6.8	2.3	1.7	2.7	12.6	4.6	1.0	2.6	7.9	1.1	0.3	4.1	3.2	2.3	10.0	6.0	0.0	0.0	0.0	0.5	0.0	2.1	0.3	0.0	0.0	0.0	1.2	1.6	10.3	0.0	0.0	1.5	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.3	0.5	0.0	1.6	1.8	0.1	0.0	11.7	0.3	0.0	0.2	6.9	14.7	8.4	26.0	0.0	4.3	0.1	0.0	2.1	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.6	0.0	0.0	2.7	0.0	0.0	9.5	0.2	0.4	0.0	0.5	0.0	0.9	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.5	0.8	1.4	0.8	1.2	1.7	2.3	1.1	0.0	1.9	0.0	24.2	49.6	0.0	5.2	0.0	2.7	45.5	0.0	0.0	0.0	0.0	0.1	30.8	4.7	0.0	0.0	0.0	0.0	2.1	4.0	0.0	8.3	0.2	0.0	0.0	4.9	0.0	20.5	0.6	0.2	3.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	3.1	0.3	0.4	22.0	0.0	0.0	0.0	2.1
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497892-44711580	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 14.9"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 3.4"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	10	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.6;SH-SY5Y: 5.1;U-2 OS: 3.6"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Region enhanced"	"Detected in some"		"olfactory region: 2.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.3	0.1	0.2	0.3	2.5	0.0	0.5	0.2	0.9	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.2	1.1	0.2	2.7	0.2	0.1	0.5	1.4	1.4	0.8	0.2	0.2	0.2	0.2	2.6	14.9	0.2	1.0	0.2	0.0	0.2	0.2	0.2	0.2	3.9	0.5	0.2	0.2	0.6	0.3	4.6	0.2	0.5	2.8	0.2	0.4	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.0	1.1	5.1	0.0	0.1	0.0	0.4	0.1	0.3	1.4	0.0	3.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	0.9	0.2	0.1	0.2	0.2	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell type enhanced"	"Detected in some"	26	"Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	25.1	1.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0	0.0	0.0	0.0	0.0	0.0	37.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	17.5	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.7	0.0	7.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.2	0.1
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 22945.1"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	180000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.6	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	48.2	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	14.5	0.0	1.1	0.0	0.6	4.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6	0.0	0.0	32.7	0.0	0.5	25.4	1.4	973.2	0.0	0.0	5.2	153.2	0.2	5.0	2.7	5.4	0.1	1.1	163.5	1.6	0.6	0.6	0.2	0.0	22945.1	2.3	25.4	342.4	228.9	289.5	6.6	0.3	0.0	0.0	0.0	1.5	13.2	212.8	2.9	0.0	1.1	45.2	0.0	0.4	3.4	0.6	0.1	3.3	0.5	1.6	0.0
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 54.9"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 72.2"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	3.4	4.0	2.7	3.3	2.5	3.8	11.6	8.5	4.5	13.3	8.1	1.1	6.7	4.6	5.9	6.9	23.4	3.1	9.7	3.0	2.0	4.0	9.4	3.9	5.3	2.2	1.9	3.9	5.4	9.3	7.8	5.7	33.1	3.3	7.5	8.3	3.3	18.8	9.4	1.7	54.9	9.8	9.6	1.8	1.1	7.4	5.0	1.5	0.5	3.6	12.0	14.4	11.9	12.2	1.2	1.6	6.5	1.1	0.2	6.0	0.9	14.6	5.0	3.7	4.3	0.8	0.7	23.9	3.9	3.5	15.7	15.1	15.9	11.7	1.3	24.6	4.6	7.4	17.2	6.5	6.0	11.5	9.7	3.2	0.8	8.5	2.4	12.5	0.3	1.8	2.5	7.1	12.3	27.4	9.3	1.2	1.8	1.3	10.1	4.8	6.0	0.7	0.2	4.4	10.8	4.3	0.0	10.6	5.0	13.0	22.7	7.4	3.0	25.2	17.2	3.0	11.7	13.7	0.7	3.2	2.8	19.8	17.4	26.1	2.5	4.8	0.1	2.4	0.3	1.7	6.5	1.1	1.1	0.7	0.3	1.4	1.2	1.9	1.0	1.6	0.6	1.7	0.6	4.5	0.2	0.6	0.2	6.0	0.9	2.7	2.5	8.5	4.5	2.0	4.0	1.9	3.9	3.3	1.5	23.8	1.3	0.0	41.3	61.5	1.8	8.9	7.6	1.4	9.1	14.0	0.0	22.2	11.6	15.0	2.1	0.7	37.6	0.0	13.3	12.0	7.4	24.8	4.6	9.3	3.5	0.0	30.9	1.8	0.0	1.9	2.3	2.6	8.5	2.8	21.4	2.0	31.3	21.6	4.9	9.1	0.5	6.5	5.6	0.7	3.4	58.2	47.5	3.2	17.0	26.9
TULP2	"CT65, TUBL2"	ENSG00000104804	"Tubby like protein 2"	O00295	19	48880965-48898733	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;testis: 25.5"	"Group enriched"	"Detected in some"	43	"Early spermatids: 174.6;Late spermatids: 168.8"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9"					"Not detected"	"Not detected"			HPA075828			Approved	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA075828: "	"unprognostic (9.97e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.69e-4)"	"unprognostic (6.79e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.94e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.59e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.97e-1)"	0.2	0.3	0.2	0.2	0.2	4.3	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.8	0.8	0.5	0.6	0.5	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	1.3	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.0	0.2	25.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	6.6	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	1.1	1.9	0.9	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.9	0.9	1.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.7	0.0	0.9	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.4	6.9	0.3	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	6.6	0.0	0.0	0.2	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.8	168.8	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.1	1.4	0.4	0.0	0.0	0.0	0.0
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.1	7.8	14.9	12.3	15.0	22.4	14.1	14.4	24.2	15.6	17.3	9.9	8.5	6.8	2.2	21.2	13.3	7.7	8.8	9.3	18.1	8.8	6.5	4.1	9.7	6.3	19.4	4.3	4.7	13.1	11.0	23.6	32.3	19.2	12.0	8.7	3.8	6.4	13.0	8.2	6.4	3.8	20.1	7.3	5.8	6.9	14.6	2.5	9.8	7.7	3.8	10.0	12.6	7.5	8.2	28.4	9.4	4.3	9.6	11.5	13.9	23.3	13.9	2.0	2.4	5.9	11.6	2.4	17.5	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8	6.0	8.0	4.2	14.7	18.0	5.6	5.0	12.7	52.2	17.0	1.8	2.0	7.8	19.9	14.2	2.5	13.6	3.2	0.0	6.4	8.8	23.1	19.1	0.0	3.8	4.6	38.1	3.5	19.0	2.2	2.4	37.7	4.7	18.6	9.0	5.0	46.7	9.7	0.0	23.3	13.5	9.5	38.8	23.7	30.7	52.5	17.7	9.7	5.3	5.6	11.1
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 91.3;Peritubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	15.0	5.5	15.8	7.8	31.3	28.3	7.3	28.9	36.0	15.9	22.8	5.8	19.9	2.1	14.7	38.1	10.3	5.3	15.5	11.4	29.3	5.9	4.3	3.9	4.7	2.8	27.8	2.8	8.1	28.7	9.4	13.3	6.4	21.8	24.6	2.1	5.9	4.0	40.6	4.6	3.0	3.4	5.1	8.9	4.5	5.4	16.2	1.3	18.0	20.2	2.1	5.5	22.7	6.3	6.0	6.9	7.1	6.6	20.3	29.2	14.6	27.3	17.9	5.8	5.1	4.1	17.9	3.9	10.2	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1	23.8	20.2	4.8	20.9	35.1	4.7	6.5	10.2	6.7	18.2	71.5	0.0	5.0	1.7	8.5	91.3	12.0	2.6	0.0	6.8	11.9	72.5	30.5	5.8	7.4	13.6	3.2	5.8	14.1	6.2	20.4	34.8	9.2	21.9	19.0	7.2	15.6	8.5	10.5	89.5	10.7	4.7	71.1	66.9	21.6	4.9	23.5	3.9	7.5	14.3	15.0
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430590-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.1;Rod photoreceptor cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted - unknown location"	NA	NA			Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	7.0	5.2	10.2	5.9	12.5	5.4	8.6	20.5	15.0	12.1	7.0	7.4	16.1	5.1	8.5	18.4	4.8	5.4	6.5	5.6	9.2	9.4	6.4	8.9	6.1	5.0	9.5	11.3	13.4	7.8	8.6	9.4	7.0	8.9	32.8	7.4	8.1	5.6	24.2	4.2	6.5	5.9	5.6	14.0	11.5	7.4	8.2	10.5	9.7	5.1	3.4	4.8	7.8	7.3	1.2	5.3	3.6	6.3	1.1	4.7	2.2	6.1	0.6	6.9	3.8	5.1	3.8	5.4	2.0	2.7	3.5	6.8	2.2	5.0	10.0	6.9	1.6	2.1	5.8	7.9	2.8	5.4	4.1	10.3	4.6	5.1	2.0	3.7	5.4	2.2	7.0	2.6	4.4	3.3	3.1	3.8	4.4	5.8	15.6	3.0	2.9	6.7	3.8	7.6	4.1	3.7	13.6	13.0	9.0	4.4	6.3	22.5	7.8	9.9	10.4	2.8	6.0	6.6	4.0	2.1	4.7	2.4	5.3	3.4	4.3	5.8	10.1	1.3	5.7	2.7	2.4	6.3	2.5	2.7	4.8	2.9	1.2	2.8	2.0	5.3	0.8	1.4	1.4	3.6	1.1	5.2	2.2	4.7	2.2	10.2	12.5	20.5	15.0	9.2	9.4	9.5	11.3	8.9	10.5	8.9	5.4	5.2	5.3	6.0	35.7	7.9	7.6	5.3	6.8	7.0	7.9	1.7	1.7	3.1	3.3	6.3	5.2	23.3	3.5	1.5	3.3	19.5	2.3	10.5	3.0	9.5	17.7	12.9	15.9	2.7	25.6	5.0	1.7	1.0	17.2	8.4	1.5	9.5	49.1	2.6	45.5	0.0	4.4	9.8	8.4	7.3	0.9	5.7	8.7	3.5
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;THP-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 20.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	133000		"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.7	0.4	0.8	1.2	1.1	5.3	0.4	1.1	0.4	0.4	0.2	2.1	1.0	0.6	0.4	1.2	0.4	0.5	0.3	0.0	3.3	4.5	2.4	1.7	2.1	3.1	0.2	2.7	1.6	2.1	0.2	2.5	2.7	0.0	2.0	2.3	1.9	0.1	2.0	1.3	7.1	4.5	0.1	2.9	3.4	2.4	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.8	0.3	1.1	3.2	0.2	0.9	5.0	1.5	1.9	20.1	2.1	0.7	3.9	5.7	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2											0.0	0.3	0.0	0.2	0.5	2.7	0.4	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.5	0.0	3.2	0.6	0.5	0.7	0.0	0.8	0.7	1.6	0.0	1.3	1.9	0.0	1.4	1.3	0.0	0.0	0.2	2.0	0.9	0.0	0.7	0.3	3.3	0.0	0.1	0.9	0.6	0.0	0.7	1.0	0.6	0.1
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell type enriched"	"Detected in single"	5	"Basal keratinocytes: 2.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	98600		Vesicles		"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.5	5.4	6.8	3.4	2.5	0.0	0.0	0.0	0.2	1.3	4.1	1.0	0.0	6.5	1.8	5.0	0.1	0.1	8.9	0.8	1.1	0.0	0.3	0.7	15.7	12.4	2.5	2.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	1.0	0.4	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.8	0.0	8.1	1.0	0.1	0.2	0.0	1.5	1.0	0.1	11.4	0.0	0.1	0.0	5.1	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5365009-5374692	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6"	"Cell type enriched"	"Detected in some"	89	"Intestinal endocrine cells: 233.1"	"Group enriched"	"Detected in many"	5	"lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 5.5"	"Region enhanced"	"Detected in some"		"hypothalamus: 5.9"	"Region enriched"	"Detected in single"	7	"hypothalamus: 4.7"	HPA038281	Uncertain				"Secreted to blood"	NA	NA					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.1	0.9	0.1	0.1	0.4	0.0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0.0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0.0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	233.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.0;U-2197: 23.1"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.6	5.6	10.1	8.3	3.5	5.3	0.0	14.7	10.9	14.5	6.6	3.6	8.8	5.8	4.2	1.9	0.5	1.4	0.0	3.6	0.0	0.7	1.3	6.8	8.9	3.9	8.2	5.7	8.0	1.1	0.0	7.4	6.4	0.8	0.0	0.0	1.7	4.9	1.4	2.2	0.0	14.3	2.7	0.3	0.0	32.0	0.7	0.9	1.6	0.9	4.0	8.9	6.6	8.3	23.1	11.0	0.0	0.0	0.4	9.5	5.1	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1	0.0	2.2	0.0	5.4	3.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.9	6.3	3.8	0.0	0.0	7.4	0.2	0.9	0.9	0.0	0.0	1.8	0.0	0.0	9.2	1.2	6.4	0.0	1.7	1.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	1.0	2.3	3.2	2.5	0.0	2.9	0.0	3.2
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333052-20356301	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	417	"kidney: 237.4"	"Group enriched"	"Detected in some"	383	"Collecting duct cells: 235.5;Distal tubular cells: 805.7"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"EFO-21: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	NA	NA	55000000	83000000			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	235.5	0.0	0.0	805.7	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 25.4;brain: 19.8"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 40.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	19	"hypothalamus: 5.2;pons and medulla: 19.8"	"Cell type enriched"	"Detected in many"	6	"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.8;HEL: 5.9;HMC-1: 5.0;THP-1: 21.5"									HPA017000	Uncertain				"Secreted to blood"	NA	NA	2590000				"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	1.0	6.3	0.3	0.6	0.3	5.2	0.3	0.3	0.3	0.5	1.2	0.4	1.2	1.1	0.3	0.3	0.3	0.6	0.9	0.3	0.6	5.2	0.3	0.3	0.6	2.9	0.3	0.3	0.4	0.3	0.0	0.3	0.3	19.8	2.0	2.4	0.3	0.3	0.3	0.3	0.5	1.0	2.3	12.7	2.1	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.9	0.3	0.0	0.4	4.1	0.0	3.2	25.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.3	3.0	0.0	4.0	0.0	2.7	2.8	0.4	0.0	0.2	0.8	0.0	3.2	0.0	0.0	25.4	0.9	0.3	0.3	0.3	0.3	0.6	5.2	0.3	0.3	19.8	0.3	0.0	3.4	0.8	0.0	1.3	1.8	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	40.4	0.0	0.1	4.8	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.8	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.1	6.9	8.4	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"amygdala: 19.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.2;naive B-cell: 3.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 7.2"									HPA026992	Uncertain				"Secreted - unknown location"	NA	NA					"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.1	1.5	19.0	0.7	0.8	0.2	1.6	0.5	2.5	0.6	0.6	0.8	0.5	7.7	1.5	0.5	0.6	1.0	3.0	0.9	1.5	1.2	0.5	4.8	0.6	0.9	0.8	0.5	1.7	4.1	0.0	0.5	0.5	1.0	0.5	0.1	0.5	0.5	0.5	0.5	1.3	4.2	0.5	1.1	1.1	1.9	2.9	0.5	0.5	0.5	0.5	0.8	0.9	0.7	6.2	1.2	0.1	0.1	0.0	0.1	0.1	0.9	2.1	2.9	1.4	0.8	3.7	0.9	2.1	1.2	0.8	0.4	1.5	1.1	1.4	1.1	1.0	5.8	1.1	0.9	0.0	3.5	1.4	1.0	1.3	2.8	6.1	0.7	1.6	0.8	1.5	0.4	0.5	0.6	1.9	0.8	1.2	0.9	1.4	1.1	1.2	0.4	1.2	1.6	2.7	7.2	1.8	3.4	0.5	0.4	3.6	1.6	1.0	1.3	1.5	0.8	1.3	1.2	1.0	3.0	1.6	0.9	2.8	0.8	2.3	1.3	1.4	1.9	1.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	3.0	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	19.0	0.8	0.5	2.5	1.5	1.2	0.8	0.5	1.0	0.5	3.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.9	0.3	0.2	0.0	0.0	0.0
VASH1	KIAA1036	ENSG00000071246	"Vasohibin 1"	Q7L8A9	14	76762189-76783015	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"	"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 131.6;Early spermatids: 69.4;Late spermatids: 74.4;Rod photoreceptor cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;monocytes: 5.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 23.2;HEL: 16.7;HUVEC TERT2: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000653	Uncertain				"Secreted to blood"	NA	NA					"HPA000653: AB_1080551"	"unprognostic (1.47e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (6.56e-6)"	"unprognostic (8.84e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.73e-1)"	9.6	10.7	12.9	9.6	11.2	1.8	10.4	12.3	16.6	4.7	3.7	16.0	2.7	4.4	6.5	3.7	3.5	4.5	7.5	18.4	14.9	11.5	6.0	3.4	14.0	9.1	17.6	5.7	10.3	4.7	3.5	7.6	16.8	12.0	5.1	4.3	13.6	4.5	3.7	5.4	3.7	5.5	9.6	22.3	12.7	4.0	6.8	6.3	4.4	5.7	8.6	5.2	6.6	3.4	0.8	5.1	0.1	5.3	0.5	1.5	0.9	0.5	2.7	23.2	6.8	6.0	4.4	1.2	1.9	0.6	1.6	0.7	0.8	1.6	1.0	1.4	1.5	2.1	0.7	3.6	0.6	0.5	11.4	2.6	16.7	1.5	0.7	3.6	0.7	1.7	2.3	0.1	0.6	0.1	5.3	42.4	3.1	0.7	0.2	0.5	3.6	0.6	1.4	2.3	0.7	1.4	0.6	2.3	0.5	0.4	1.3	9.5	7.4	2.2	1.0	1.1	4.8	4.0	3.6	11.7	2.2	4.9	2.5	0.9	1.0	0.5	0.6	3.1	5.5	4.0	0.0	1.8	0.0	1.5	4.3	1.1	0.3	0.7	0.7	2.8	0.8	0.6	0.9	0.1	0.5	5.3	5.1	0.4	0.9	12.9	11.2	12.3	11.6	14.9	11.5	17.6	5.7	12.0	6.3	0.0	2.9	3.5	0.0	0.6	9.8	8.3	2.5	0.0	1.2	1.8	131.6	0.3	0.0	1.0	69.4	14.3	0.0	0.0	0.0	0.2	1.7	0.0	11.5	0.5	15.1	0.0	6.4	32.5	8.0	74.4	1.7	14.8	1.7	1.8	0.0	13.1	0.4	0.0	2.8	0.0	102.6	12.9	6.2	0.9	0.9	0.1	0.2	1.5	0.0	0.0
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.2"	"Group enriched"	"Detected in some"	12	"Early spermatids: 75.2;Late spermatids: 59.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	3.1	0.7	2.6	5.8	6.0	1.4	3.7	1.1	4.8	3.3	1.4	0.1	1.0	1.3	4.2	3.8	7.8	1.5	4.9	2.8	1.5	1.8	1.1	0.8	2.2	3.8	1.2	1.7	1.8	0.8	1.8	7.7	1.4	3.6	7.7	1.2	5.7	1.6	1.6	1.6	1.2	2.0	3.5	1.1	2.1	1.3	23.2	1.1	9.7	1.2	3.1	3.7	2.9	6.3	0.2	3.2	0.0	0.0	0.0	0.4	0.0	0.1	0.6	9.6	11.7	0.1	0.0	1.5	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.2	0.0	3.9	0.0	0.4	7.7	1.4	0.7	0.5	0.5	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.2	0.1	4.4	0.0	2.3	0.8	0.1	4.9	0.6	18.4	0.0	1.4	2.9	54.2	0.5	0.0	0.7	2.2	3.4	1.2	0.1	0.1	5.2	1.8	0.3	0.0	0.4	1.1	0.2	0.5	1.3	2.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.4	0.0	2.6	6.0	1.1	4.8	1.5	1.8	1.2	1.7	3.6	1.1	0.0	0.6	0.0	0.7	1.3	1.9	0.8	0.0	1.4	0.0	0.0	2.0	0.1	0.0	0.5	75.2	0.3	0.0	0.0	0.2	0.2	5.8	1.4	0.0	0.0	0.2	1.6	1.2	0.0	0.3	59.3	0.3	1.3	0.0	1.0	0.0	0.8	0.1	0.0	0.7	0.3	2.1	0.0	1.7	1.0	1.0	1.4	0.0	0.0	0.0	0.4
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471465-83582303	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 557.1;Kupffer cells: 784.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 55.5;myeloid DC: 21.3"	"Group enriched"	"Detected in many"	31	"dendritic cells: 21.3;monocytes: 55.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.6;HSkMC: 29.6;hTERT-RPE1: 140.3;RPTEC TERT1: 55.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		5200000	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	33.3	18.3	14.8	53.2	10.3	20.1	12.3	4.8	16.2	25.2	8.4	17.9	1.7	3.6	14.5	23.5	9.0	7.6	23.2	35.7	19.8	8.9	8.5	3.1	25.8	21.2	13.9	9.8	5.3	3.2	3.7	2.0	52.0	14.4	8.9	8.9	3.3	6.5	4.1	9.0	9.3	4.7	33.9	18.2	18.4	6.2	8.7	19.4	1.1	5.7	6.5	2.3	24.4	9.8	0.0	21.3	1.2	55.5	0.1	0.1	17.7	0.0	0.8	43.6	0.0	17.7	12.2	0.0	0.3	0.8	0.3	0.2	0.4	0.0	0.0	6.7	15.7	0.5	0.0	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.3	0.8	0.0	0.0	29.6	0.0	18.5	0.1	140.3	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	7.4	0.0	1.4	0.0	9.1	0.0	55.4	0.0	0.5	2.2	0.0	0.0	0.0	5.0	0.0	0.0	16.8	13.3	0.0	24.4	25.0	0.0	0.0	0.0	6.1	0.0	2.3	1.2	55.5	0.1	0.1	7.7	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.9	0.1	0.8	0.4	0.0	17.7	14.8	10.3	4.8	9.8	19.8	8.9	13.9	9.8	14.4	19.4	17.9	29.9	3.0	4.4	34.3	0.0	6.8	30.6	25.4	30.7	24.4	0.0	7.1	0.0	1.6	0.8	12.1	0.0	0.0	0.6	5.1	557.1	1.5	11.6	2.1	24.5	0.0	0.0	23.4	784.4	0.7	17.3	132.2	42.2	5.4	0.0	0.0	19.5	0.0	110.7	1.2	0.0	0.0	33.9	0.3	0.4	25.1	9.6	4.4	0.0	0.8
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 324.6;Muller glia cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;eosinophil: 1.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.9;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 65.7;U-87 MG: 103.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000				"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	35.0	17.5	16.6	11.4	20.1	12.8	39.5	6.5	32.3	11.8	25.9	8.7	15.0	16.0	54.1	9.4	19.4	10.4	27.5	57.0	13.4	5.4	25.8	58.6	30.0	2.9	15.8	3.7	16.4	25.1	20.6	7.3	16.7	19.8	40.5	7.2	24.4	15.1	23.8	52.9	11.9	26.3	19.2	35.1	19.0	20.5	4.5	15.4	0.3	87.9	19.6	13.6	47.5	15.7	0.0	0.1	1.9	1.2	0.0	0.0	0.0	11.8	2.1	2.0	11.6	3.5	5.5	13.7	7.3	13.0	4.8	9.6	6.8	1.6	3.9	5.9	4.4	50.2	4.9	5.4	14.7	8.6	4.2	1.7	2.9	2.8	4.5	36.9	3.2	6.6	9.7	29.3	47.4	47.2	65.7	1.2	3.3	5.5	19.7	17.6	4.9	0.3	4.4	1.2	34.8	3.3	0.3	1.9	9.3	18.7	10.0	3.6	7.6	10.5	7.2	25.2	2.7	2.8	11.9	1.7	20.2	5.4	29.1	11.9	11.2	6.6	7.6	103.7	7.5	7.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.6	20.1	6.5	32.3	13.4	5.4	15.8	3.7	19.8	15.4	324.6	89.9	11.2	34.6	62.6	31.5	146.9	81.5	4.0	93.3	21.0	29.5	1.1	1.7	39.1	0.0	22.8	60.6	23.3	35.0	3.1	45.9	128.0	107.6	99.1	13.4	170.0	26.2	18.4	22.8	0.0	1.7	44.4	27.0	11.8	42.9	340.3	70.3	34.8	3.2	15.2	37.5	0.0	52.8	0.9	0.9	68.4	6.6	6.9	40.0	115.1
VEGFB	"VEGFL, VRF"	ENSG00000173511	"Vascular endothelial growth factor B"	P49765	11	64234538-64238793	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 177.8;Peritubular cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in all"		"U-266/70: 53.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	186000					"unprognostic (4.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.31e-3)"	98.5	23.4	25.9	15.3	22.7	5.2	77.1	9.1	21.6	21.4	27.6	16.6	31.3	15.3	21.7	21.2	19.4	13.8	26.2	56.9	20.4	23.1	16.8	8.1	19.1	22.5	25.0	15.4	23.3	43.0	15.6	22.3	13.4	15.5	27.1	5.9	32.2	29.5	34.5	94.0	18.4	15.4	29.9	14.9	18.1	17.4	12.7	14.1	10.3	22.9	26.9	11.8	28.8	33.8	3.3	31.7	0.6	0.1	0.4	1.8	0.4	9.0	12.5	5.2	17.5	26.5	19.1	7.1	8.5	14.4	7.1	8.2	6.7	20.0	11.3	16.5	7.7	16.6	12.3	7.3	6.2	1.3	11.0	6.7	9.8	16.0	6.2	26.1	2.8	11.8	21.5	6.2	10.1	6.1	17.1	9.2	11.8	10.5	19.8	10.5	15.1	14.6	7.1	4.4	6.2	11.0	18.9	12.8	27.6	5.5	9.7	7.9	26.1	6.8	25.2	32.9	4.2	16.8	3.2	8.1	30.8	19.6	14.0	5.1	53.9	25.5	8.4	28.8	3.2	16.3	0.4	0.1	0.6	1.1	0.0	0.9	3.3	0.8	1.0	0.5	2.7	1.1	1.8	0.0	0.4	0.0	31.7	0.4	0.4	25.9	22.7	9.1	21.6	20.4	23.1	25.0	15.4	15.5	14.1	17.9	31.2	13.7	6.1	11.3	45.9	177.8	7.6	6.7	6.8	14.0	31.4	8.1	33.2	10.0	1.1	14.7	15.1	0.0	11.1	13.1	16.9	10.1	18.4	11.9	43.1	62.0	51.2	14.1	19.1	3.2	56.4	23.8	33.7	26.2	12.0	67.9	15.7	5.8	102.6	21.4	29.5	6.5	20.6	0.3	1.2	12.2	7.4	10.1	10.2	6.4
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 10.5;Fibroblasts: 7.4;Ito cells: 5.5;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BJ: 41.6;HBF TERT88: 33.9;hTEC/SVTERT24-B: 34.0;LHCN-M2: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	383000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.8	0.5	0.0	7.6	7.6	0.0	41.6	25.1	23.2	18.5	0.0	0.2	0.0	0.0	23.5	9.7	1.2	0.3	15.7	33.9	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	34.0	23.8	23.3	14.3	0.0	0.0	0.0	37.6	0.6	0.0	0.0	0.3	0.0	13.6	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.2	0.0	6.9	24.7	2.6	6.0	11.7	0.0	0.0	0.0	10.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1											3.0	0.0	0.0	1.2	2.2	0.6	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	2.6	10.5	0.0	0.0	0.0	0.0	7.4	1.9	0.0	0.0	0.3	1.6	0.0	5.5	0.0	1.0	12.7	0.9	3.3	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.0	1.7	1.8	0.0	0.0	0.0	2.2
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345591-15384376	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Club cells: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 6.0;EFO-21: 2.7;HSkMC: 6.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA027342	Uncertain				"Secreted to blood"	NA	NA	592000	340000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	9.5	7.4	0.6	1.8	1.0	0.1	19.5	1.1	0.7	10.5	7.6	0.2	4.1	1.1	10.1	12.9	15.4	2.7	3.5	27.8	0.6	1.1	1.0	1.3	39.0	0.7	0.8	0.2	7.3	2.6	0.2	4.4	0.2	0.8	22.2	1.9	0.2	1.5	1.8	12.0	0.5	4.3	9.8	0.6	2.3	3.4	14.9	0.1	0.0	2.0	17.5	1.2	12.3	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	1.8	7.3	6.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.7	0.0	0.8	0.5	0.5	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.4	0.0	0.8	6.1	0.7	0.0	0.0	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.5	0.6	0.4	0.3	0.1	0.6	1.4	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.4	1.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.1	0.7	0.6	1.1	0.8	0.2	0.8	0.1	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Group enriched"	"Detected in many"	7	"Horizontal cells: 212.9;Intestinal endocrine cells: 123.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 36.7;SK-MEL-30: 99.1;U-2 OS: 18.0;WM-115: 29.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	2.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	4.7	0.0	0.4	3.7	0.2	0.4	0.1	0.0	0.0	0.0	0.0	3.0	36.7	0.0	0.1	99.1	0.2	0.1	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.1	0.9	2.9	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5	0.0	0.0	0.0	1.0	1.3	8.5	2.4	0.0	0.0	0.0	0.0	0.0	1.3	24.9	0.3	0.0	0.3	1.3	0.0	0.0	6.3	0.2	2.8	0.0	0.0	0.5	212.9	123.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	1.4	9.5	2.9	0.0	1.0	4.5	0.0	0.2	0.2	4.2	1.9	1.1	0.0	0.9	0.5
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.7;Melanocytes: 27.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	2.0	0.2	0.2	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	4.2	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Leydig cells: 106.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;memory CD8 T-cell: 2.3;naive CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 13.5;ASC TERT1: 26.5;BJ: 12.7;fHDF/TERT166: 43.0;SuSa: 25.7;THP-1: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		120000				"unprognostic (5.34e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.32e-2)"		"unprognostic (1.81e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.66e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.41e-2)"	25.5	1.2	0.2	0.6	0.4	0.9	10.3	2.5	1.0	7.4	2.1	0.3	6.3	0.6	1.9	11.4	17.1	5.0	2.7	14.2	0.2	0.1	0.5	0.2	1.2	2.3	3.4	0.7	30.0	2.2	1.0	2.0	6.8	1.0	15.3	1.7	18.1	7.8	2.9	11.6	8.3	1.5	20.5	5.1	0.3	3.4	10.5	0.0	0.0	7.9	22.0	3.9	21.4	10.9	0.0	0.0	0.0	0.1	0.4	5.3	1.1	0.0	0.0	0.0	0.0	13.5	26.5	0.0	12.7	3.0	4.1	1.7	0.0	0.0	0.0	0.0	43.0	0.0	0.0	2.4	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	25.7	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	3.4	0.0	0.4	0.1	0.0	0.0	1.1	0.2	0.4	2.5	0.6	0.2	0.1	3.4	0.7	1.0	0.0	0.0	0.0	0.0	1.0	3.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	1.1	0.3	0.0	0.0	0.0	6.9	7.4	0.1	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.2	106.7	0.0	6.8	0.0	0.3	0.0	0.0	0.0	21.9	0.0	0.0	6.5	2.1	1.1	0.2	3.0	3.5	0.0	0.0	0.1
VMO1		ENSG00000182853	"Vitelline membrane outer layer 1 homolog"	Q7Z5L0	17	4785285-4786433	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.9"	"Cell type enriched"	"Detected in many"	14	"monocytes: 1494.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"non-classical monocyte: 37.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 37.9"	"Cell line enhanced"	"Detected in many"		"A549: 6.1;MCF7: 7.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA023038	Uncertain				"Secreted to blood"	NA	NA		1200000			"HPA023038: AB_10964632"	"unprognostic (1.30e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.65e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.69e-1)"	3.8	1.3	1.6	5.9	1.4	1.5	1.9	1.2	2.8	2.6	1.4	1.7	0.4	4.4	1.1	1.9	1.1	0.5	2.8	7.1	1.8	2.1	2.1	9.2	7.4	4.9	1.9	1.4	1.1	2.3	21.2	19.9	1.9	3.6	1.7	0.5	13.1	2.9	1.4	8.8	1.3	4.6	1.0	3.3	21.1	0.8	0.9	1.9	1.4	0.7	2.8	1.2	3.5	1.8	0.0	4.4	0.0	37.9	0.1	0.0	1.1	0.5	6.1	0.6	3.6	0.8	1.6	0.7	1.1	2.2	0.3	0.7	1.9	2.3	0.2	0.1	0.3	0.5	1.0	0.0	0.9	0.4	4.4	0.9	0.2	1.1	1.5	1.3	0.0	2.8	1.0	0.9	0.2	0.9	1.3	0.0	0.9	0.6	1.0	1.2	7.9	0.0	1.8	1.6	1.3	2.4	1.3	2.8	0.6	0.0	1.4	0.6	0.9	0.5	0.5	0.6	0.6	2.3	0.2	0.6	2.7	0.2	0.7	0.4	0.1	0.5	0.1	1.0	1.3	1.7	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	37.9	0.0	0.0	1.1	1.6	1.4	1.2	2.8	1.8	2.1	1.9	1.4	3.6	1.9	3.0	10.6	6.9	8.3	7.6	6.1	0.8	2.5	17.4	42.1	0.0	0.0	0.3	1.7	0.8	3.5	1.6	1.7	0.0	1.3	0.2	1.5	9.1	13.9	3.2	17.0	0.0	1.2	104.3	52.6	25.1	0.3	82.9	5.0	1494.2	1.0	0.8	1.1	0.0	1.1	1.4	2.5	12.9	3.4	0.5	1.0	6.4	0.2	0.7	1.0	9.2
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 69.6;Club cells: 19.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3"														"Secreted to blood"	NA	NA	150000000					"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	69.6	19.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	9.7	0.1	0.0	0.0	0.6	9.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 15.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6"									HPA059365			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.7;brain: 51.7;prostate: 13.7"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 38.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6.0	1.4	0.0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3.0	0.0	0.7	0.0	0.7	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3.0	0.0	0.0	0.0	0.0	0.0	38.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
VSTM2L	"C20orf102, dJ1118M15.2"	ENSG00000132821	"V-set and transmembrane domain containing 2 like"	Q96N03	20	37903104-37945350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 26.6;Cholangiocytes: 66.2;Ciliated cells: 34.8"	"Group enriched"	"Detected in all"	5	"lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 26.9;HDLM-2: 36.8;hTCEpi: 9.5;SH-SY5Y: 8.9;SK-BR-3: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043832	Uncertain				"Secreted - unknown location"	NA	NA					"HPA043832: AB_10968449"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (8.14e-4)"	1.6	7.5	29.3	1.6	22.7	0.8	1.4	7.0	44.8	14.0	1.8	1.8	21.4	2.0	1.6	11.5	1.6	17.5	18.9	25.6	34.9	23.5	1.1	2.5	4.5	1.2	10.7	17.6	0.9	3.5	0.9	6.9	1.6	9.7	6.0	1.3	3.6	3.8	19.8	1.0	1.0	1.4	1.7	6.2	18.6	8.9	2.5	1.5	0.0	1.3	0.0	1.8	1.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	26.9	0.0	0.1	0.2	0.1	0.1	0.0	1.2	0.0	36.8	0.6	0.0	0.0	0.0	1.5	0.0	1.0	1.3	9.5	0.0	0.3	1.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.9	7.9	0.0	0.0	0.1	0.0	0.0	1.0	8.9	1.1	32.9	0.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	22.7	7.0	44.8	34.9	23.5	10.7	17.6	9.7	1.5	6.0	2.6	0.0	1.5	0.3	7.5	26.6	66.2	34.8	10.3	0.0	7.9	0.2	0.0	3.8	0.3	0.5	0.0	0.0	0.2	0.1	0.4	8.4	0.0	0.8	0.0	12.7	17.9	0.0	0.3	0.4	4.9	0.2	0.0	0.0	0.9	0.8	4.7	0.2	15.2	0.4	3.1	0.0	1.0	0.2	0.4	0.5	0.1	0.0	0.0	0.6
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014245-49115509	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	13.0	31.6	7.2	3.4	6.7	0.4	10.5	3.3	7.1	18.2	6.2	9.3	3.1	2.0	13.2	5.9	6.1	6.5	11.7	10.3	7.2	4.4	9.3	3.0	8.9	7.0	8.9	5.4	27.2	1.3	22.8	4.6	7.7	10.1	11.2	4.4	15.1	2.8	9.2	3.8	4.2	4.1	12.5	7.9	2.8	5.4	7.8	6.0	2.9	20.8	6.9	3.4	9.4	8.6	1.8	0.9	2.7	0.9	1.7	0.7	0.2	0.0	0.1	2.7	0.1	1.1	0.6	0.1	2.1	3.5	0.8	0.2	0.1	0.1	0.1	0.1	5.0	2.9	0.1	0.1	0.0	0.4	2.6	1.2	0.1	0.0	0.1	0.1	0.1	0.0	4.1	0.0	3.6	0.0	0.0	0.0	0.7	6.9	0.1	0.6	0.1	0.0	0.1	0.5	0.0	0.0	0.0	8.0	4.1	0.0	0.1	0.1	6.8	0.1	0.1	0.0	0.3	0.1	0.2	0.0	9.1	1.1	20.4	0.1	0.0	5.5	0.0	10.0	0.1	0.1	1.9	0.9	0.4	0.6	0.3	0.5	0.8	0.4	0.3	0.2	1.8	0.7	0.6	2.7	1.7	0.5	0.9	0.3	0.2	7.2	6.7	3.3	7.1	7.2	4.4	8.9	5.4	10.1	6.0	3.0	17.4	0.0	1.7	5.8	5.0	12.1	0.0	6.7	17.0	0.0	2.0	0.4	1.7	0.1	81.0	6.4	0.0	0.0	0.0	0.3	22.4	0.7	11.6	3.2	0.5	4.8	0.0	3.7	1.9	104.4	8.9	4.0	6.8	1.0	0.0	10.9	0.2	0.0	13.8	6.1	2.7	58.2	30.0	1.4	3.4	3.8	0.3	1.3	0.0	0.6
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 4765.6"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"CACO-2: 168.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	168.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.7	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	15.5	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1											0.0	0.6	55.9	0.0	0.0	10.7	14.7	1151.5	0.0	0.0	0.0	72.6	2.6	3.3	14.8	0.0	0.7	0.0	233.6	17.1	1.6	7.6	0.0	0.0	4765.6	4.3	36.5	0.0	116.0	117.8	0.0	0.0	0.0	0.0	35.1	0.0	4.8	38.2	0.0	1.4	2.2	24.6	0.0	2.0	0.3	0.4	0.0	8.0	0.7	0.0	0.0
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 125.2"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 241.9;Syncytiotrophoblasts: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 16.0;CACO-2: 16.2;CAPAN-2: 48.0;EFO-21: 15.4;Hep G2: 28.6;SCLC-21H: 17.0;T-47d: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		190000				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	13.9	6.4	13.1	17.5	16.2	1.3	9.4	2.7	19.6	12.4	26.3	46.1	34.8	9.4	18.1	13.9	15.7	13.2	15.6	8.9	17.5	9.5	14.0	71.3	13.6	9.0	22.4	12.1	13.9	23.2	5.0	5.1	23.9	15.7	47.0	4.2	11.4	23.9	125.2	6.0	8.6	8.9	34.7	29.8	4.7	17.8	11.8	21.5	0.4	16.6	3.9	4.9	30.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.7	5.5	0.1	0.5	8.7	1.0	0.0	0.8	0.0	16.2	48.0	0.0	15.4	0.4	1.8	4.2	5.6	2.8	0.1	1.0	3.9	0.5	0.0	28.6	1.3	0.0	1.9	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	4.0	0.0	0.3	2.1	5.6	1.5	0.2	0.3	0.7	0.9	2.7	17.0	2.6	0.0	14.8	1.9	1.4	21.6	0.2	0.5	0.0	0.2	0.1	5.2	0.1	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	16.2	2.7	19.6	17.5	9.5	22.4	12.1	15.7	21.5	17.9	29.7	1.4	20.2	5.8	5.1	3.4	17.8	12.0	15.9	50.6	3.9	241.9	6.6	64.8	0.4	55.0	8.6	0.0	57.3	79.4	13.4	33.7	1.1	43.2	19.6	14.3	12.0	7.4	0.6	1.5	31.7	1.4	23.6	4.6	7.2	53.6	40.5	9.0	55.5	5.0	3.9	6.5	13.2	0.5	1.9	7.4	242.8	0.0	6.7	15.4
VWA2	"AMACO, CCSP-2, FLJ16213, FLJ45857, NET42"	ENSG00000165816	"Von Willebrand factor A domain containing 2"	Q5GFL6	10	114239330-114291513	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.3"	"Group enriched"	"Detected in some"	5	"Basal glandular cells: 3.7;Early spermatids: 9.8;Late spermatids: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 11.6;HaCaT: 5.5;SCLC-21H: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037847	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA037847: AB_10670961"	"unprognostic (6.03e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.14e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	1.5	2.2	1.8	0.4	3.9	1.0	3.2	5.3	2.0	2.1	3.6	2.5	1.4	14.3	5.5	10.8	2.6	0.3	2.2	1.6	1.0	0.3	8.4	0.4	4.1	1.7	2.3	6.0	0.1	4.1	0.6	2.4	7.4	1.1	0.1	16.3	1.6	0.4	6.7	2.1	0.1	2.3	1.6	12.4	2.3	2.2	1.2	0.8	1.3	1.5	2.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	11.6	0.0	0.4	0.0	0.0	5.5	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	1.8	1.0	3.2	2.2	1.6	4.1	1.7	2.4	2.2	0.0	0.0	0.0	3.7	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	1.2	0.0	1.6	9.8	0.0	0.0	0.0	1.4	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.0	0.3	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.6	0.0	0.1	1.1
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156966	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.8;fallopian tube: 27.0"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 101.7;Club cells: 27.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.5;WM-115: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favorable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	1.0	1.1	3.6	0.7	8.3	1.1	0.9	0.3	12.2	8.1	0.8	13.2	0.0	0.8	2.3	9.6	0.8	27.0	0.7	0.9	4.8	5.8	0.9	0.7	5.5	0.8	0.7	6.7	3.0	1.0	0.9	10.0	0.8	26.8	0.9	0.8	0.0	0.8	0.8	0.8	2.3	1.1	0.7	3.8	1.0	0.9	5.0	3.6	0.0	0.9	0.0	0.9	0.9	0.1	0.2	0.1	0.0	0.5	0.0	0.4	0.0	0.1	1.1	0.6	0.7	0.3	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.2	2.5	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	3.6	8.3	0.3	12.2	4.8	5.8	0.7	6.7	26.8	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	101.7	27.3	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 7.7;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.5	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.2	0.5	0.7	0.3	0.1	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.4	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.2	0.0	0.6	0.2	3.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.3	0.0	2.1	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.5	1.3	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3	0.0	0.6	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.4	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773661-49921950	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;heart muscle: 12.8;ovary: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 26.4;Cardiomyocytes: 44.9;Paneth cells: 9.7;Rod photoreceptor cells: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055243	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA055243: AB_2682755"	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.5	0.3	3.6	0.4	3.9	0.4	0.5	17.0	6.9	0.6	0.5	1.4	0.0	0.5	1.9	0.4	0.5	0.8	0.5	12.8	1.7	2.8	0.4	0.3	0.6	0.4	2.1	1.8	12.5	0.3	0.3	0.2	0.3	3.8	0.4	0.5	0.6	0.4	0.5	0.4	1.2	0.7	1.5	0.8	0.6	0.4	0.5	0.8	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.9	0.4	1.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.9	1.0	0.2	0.0	0.0	0.0	3.6	3.9	17.0	6.9	1.7	2.8	2.1	1.8	3.8	0.8	0.0	0.0	0.0	0.0	0.5	26.4	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	12.3	0.0	0.3	0.0	0.4	1.8	0.0	0.0	0.2	0.1
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing protein 2 like"	B2RUY7	2	214411065-214578959	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.9;pituitary gland: 2.3"	"Cell type enriched"	"Detected in single"	9	"Bipolar cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA044815: AB_10962359, HPA059414: AB_2684007"	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0.0	0.0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1.0	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.8	0.0	0.3	5.7	0.0	0.3	0.0	0.4	0.1	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	19.3	1.1	0.0	0.1	11.4	0.5	0.5	0.0	0.1	1.8	2.6	0.2	0.3	0.3	0.1	4.2	0.0	1.6	0.0	0.0	10.9	0.1	0.0	0.1	0.1	0.4	0.9	0.0	0.1	0.6	2.0	0.7	0.0	0.5	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5	3.0	1.7	0.0	1.5	1.5	3.2	0.7	0.0	5.3	2.3	0.0	27.5	0.9	0.0	0.1	0.4	2.2	0.0	0.0	0.4	2.2	1.4	0.4	3.5	14.0	1.1	0.0	1.7	3.1	4.0	0.0	6.4	2.2	1.7	1.8	0.0	3.2	0.0	0.0	1.8	0.3	17.1	0.0	0.5	0.9	3.0	1.9	3.7	0.5	0.1	0.7
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Cytosol	Nucleoplasm	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.8	0.0	2.1	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.7	0.4	2.1	2.0	0.6	4.0	2.2	3.5	4.8	0.0	0.0	1.1	2.4	0.1	0.3	0.0	1.2	2.7	0.8	1.2	10.8	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.6	0.0	0.0	1.6	0.0	1.3	8.7	1.4	0.0	1.7	0.0	1.4	0.0	1.1	0.1	0.0	1.0	0.0	0.9	3.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0	0.0	1.0	0.0	1.7	0.2	0.0	4.7	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.4	1.6
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948874-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease mutation, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 91.7"	"Cell type enhanced"	"Detected in many"	24	"Cardiomyocytes: 99.1;Endothelial cells: 414.7;Ito cells: 229.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 113.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	NA	NA	28300000000	6400000000			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	91.7	3.1	6.1	9.7	8.1	0.8	41.5	3.7	8.6	19.7	13.9	7.3	6.8	6.6	21.5	16.7	14.4	15.1	15.3	38.7	7.4	5.0	4.6	1.5	41.2	9.9	9.4	7.1	13.6	5.8	17.7	2.6	36.4	10.2	18.7	5.1	26.3	7.2	10.5	28.9	8.1	11.8	22.1	7.4	19.0	9.6	12.7	5.9	1.8	18.6	13.2	6.5	18.9	35.0	0.0	0.0	1.3	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	113.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	6.1	8.1	3.7	8.6	7.4	5.0	9.4	7.1	10.2	5.9	11.9	41.6	0.0	0.4	6.0	0.0	99.1	2.5	1.4	2.3	10.4	0.0	0.8	0.0	0.3	5.0	414.7	0.0	0.0	0.0	0.7	3.3	0.7	5.7	1.5	0.4	0.0	0.0	229.6	2.1	10.0	5.5	0.8	5.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.8	0.0	3.3	1.8	3.4	3.8	0.8	2.2	0.0	1.6
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.9	10.9	10.8	5.0	13.5	7.9	9.5	14.4	14.8	15.2	8.3	11.2	5.4	6.8	11.1	9.4	7.6	14.0	7.2	7.6	10.8	9.4	7.6	9.0	7.5	6.8	8.6	13.3	11.0	16.2	7.7	13.4	7.2	9.4	9.2	5.7	10.9	11.9	9.7	11.4	6.1	5.8	7.3	7.5	6.8	8.4	15.0	11.3	6.4	17.3	4.4	6.6	7.4	6.6	9.9	11.9	19.5	13.9	4.2	10.8	10.0	3.3	5.9	4.1	15.2	6.7	6.3	3.4	6.2	9.9	7.2	7.3	2.7	6.3	4.8	7.8	5.1	2.0	6.0	3.9	7.6	3.8	4.7	2.8	3.2	6.7	4.6	12.3	3.7	3.7	9.4	9.0	5.2	7.9	6.3	5.2	5.8	3.9	7.1	4.7	12.7	5.5	4.2	3.2	4.0	10.5	4.0	5.8	3.3	5.5	2.7	9.7	10.2	5.0	1.9	8.3	4.1	7.0	1.3	8.8	2.7	3.2	10.6	3.5	4.8	2.4	2.4	9.6	2.8	5.2	19.5	13.9	19.5	7.5	11.8	7.8	9.9	10.0	8.0	11.9	7.2	10.8	7.9	7.3	4.2	12.4	9.2	9.7	10.0	10.8	13.5	14.4	14.8	10.8	9.4	8.6	13.3	9.4	11.3	0.0	5.4	3.4	3.8	2.9	8.0	2.0	0.0	9.4	3.4	3.5	9.8	7.2	8.3	9.6	8.2	6.7	5.9	0.0	29.6	4.1	6.6	2.6	3.5	7.2	5.9	4.8	5.2	5.5	4.4	4.2	6.4	3.5	5.0	5.4	6.1	12.1	13.6	3.5	10.6	13.5	15.2	12.9	8.0	10.9	15.2	2.6	5.8	5.3	6.8	1.8
WFDC1	PS20	ENSG00000103175	"WAP four-disulfide core domain 1"	Q9HC57	16	84294646-84329851	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 64.5"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 68.7;Peritubular cells: 241.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.1;BJ: 13.0;HEL: 10.9;HeLa: 17.4;THP-1: 6.3;U-937: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031411	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA031411: AB_10600921"	"unprognostic (6.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.04e-1)"	3.9	12.0	6.3	4.2	5.5	0.9	1.9	7.0	5.9	15.8	28.8	2.2	12.0	3.9	11.4	8.3	10.6	3.4	64.5	2.8	5.5	5.0	8.7	1.9	16.0	2.5	3.7	4.3	3.3	0.6	0.3	2.2	40.7	1.9	29.9	7.5	43.8	4.2	50.6	1.2	1.1	6.6	47.5	1.7	1.9	8.9	9.4	0.7	0.0	2.0	4.6	2.2	30.3	5.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	19.1	0.0	0.1	0.1	13.0	1.6	0.0	0.0	0.0	0.0	0.0	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	17.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.2	0.0	0.0	1.4	0.0	0.0	3.6	0.1	0.0	0.3	2.1	0.0	0.1	6.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.3	5.5	7.0	5.9	5.5	5.0	3.7	4.3	1.9	0.7	3.0	0.3	0.0	0.9	1.5	68.7	1.1	0.0	1.4	0.0	1.8	0.0	1.8	10.0	0.0	23.3	2.0	0.2	0.0	0.0	1.7	14.3	1.2	0.0	0.0	5.5	4.8	4.1	19.0	0.0	20.9	14.7	0.0	0.0	0.0	4.2	1.2	0.1	0.0	241.9	1.0	3.9	0.0	30.9	0.7	0.9	0.4	3.2	0.0	3.3	0.8
WFDC10A	"C20orf146, dJ688G8.3, WAP10"	ENSG00000180305	"WAP four-disulfide core domain 10A"	Q9H1F0	20	45629526-45631196	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 62.4"	"Group enriched"	"Detected in some"	4	"granulocytes: 4.6;Late spermatids: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;CACO-2: 2.5"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA								"unprognostic (1.76e-1)"											"unprognostic (2.95e-1)"				0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	62.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	1.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC10B	WAP12	ENSG00000182931	"WAP four-disulfide core domain 10B"	Q8IUB3	20	45684653-45705019	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 27.3;testis: 5.9;urinary bladder: 8.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.4;Late spermatids: 7.3;Rod photoreceptor cells: 8.7;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.3;hTEC/SVTERT24-B: 1.8;PC-3: 5.7;U-87 MG: 2.6"														"Secreted in male reproductive system"	NA	NA						"unprognostic (1.14e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.81e-2)"		"unprognostic (4.30e-3)"		"unprognostic (5.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.36e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.2	0.0	0.3	27.3	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	1.0	0.5	0.2	0.2	0.2	0.2	1.5	0.2	0.3	0.2	0.2	0.4	5.9	0.2	0.2	0.2	0.2	0.2	8.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	2.0	2.7	0.1	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	1.8	0.0	1.7	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.8	1.8	5.7	0.0	0.3	0.0	0.6	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	8.7	0.0	0.0	3.2	0.2	0.0	0.1	0.0	0.0	0.3
WFDC11	WAP11	ENSG00000180083	"WAP four-disulfide core domain 11"	Q8NEX6	20	45648563-45670270	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 46.2"	"Cell type enriched"	"Detected in some"	25	"Early spermatids: 50.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HeLa: 13.0;RPMI-8226: 7.9"														"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	46.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.4	0.0	0.8	0.7	4.7	0.4	1.3	0.8	0.1	0.2	1.1	0.1	0.2	0.6	0.8	1.2	1.1	0.1	0.0	0.0	0.7	0.3	0.7	0.4	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.8	1.1	13.0	0.8	0.0	0.6	0.8	0.3	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.2	0.0	0.2	0.5	1.1	1.1	0.4	0.6	0.2	0.5	7.9	0.0	0.4	0.1	0.0	0.0	0.4	0.0	1.0	0.1	1.1	0.0	0.2	0.7	0.3	0.1	0.5	0.5	0.0	0.1	2.2	0.3	4.7	0.4	0.2	0.4	0.2	0.4	0.3	0.3	0.3	0.1	0.8	0.4	0.8	1.2	1.3	0.2	0.7	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0
WFDC12	"C20orf122, dJ211D12.4, WAP2"	ENSG00000168703	"WAP four-disulfide core domain 12"	Q8WWY7	20	45123425-45124465	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 26.9;skin 1: 30.5"	"Cell type enhanced"	"Detected in some"	33	"Alveolar cells type 2: 1.6;Collecting duct cells: 5.2"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 18.9;melanoma: 14.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"																"Secreted - unknown location"	NA	NA		20000					"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-2)"		"unprognostic (5.42e-2)"		"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.70e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (4.49e-2)"		"unprognostic (3.91e-1)"	"unprognostic (5.50e-3)"	0.1	0.0	0.1	0.1	0.1	0.5	1.9	0.1	0.1	1.5	0.1	0.1	26.9	0.2	0.1	1.2	6.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	1.3	0.0	0.1	1.8	4.1	0.2	30.5	0.1	0.1	0.1	0.1	0.0	1.0	0.1	2.2	0.1	6.4	0.9	0.1	10.0	0.8	0.3	0.9	0.4	0.0	1.1	0.0	0.9	0.6	0.3	0.6	3.5	0.4	1.3	0.3	1.8	0.2	1.6	0.6	0.4	0.9	0.3	0.4	0.7	0.6	0.3	0.9	2.3	1.5	0.0	0.0	1.1	1.3	1.4	0.0	1.3	0.0	0.3	1.4	0.9	1.5	1.1	0.6	0.9	1.2	1.1	0.4	0.4	1.3	1.7	1.5	0.4	0.3	2.0	0.4	2.1	0.6	0.0	0.2	0.0	1.0	0.0	1.0	0.6	2.6	0.0	0.2	0.4	1.2	1.2	1.4	1.3	1.3	0.9	3.2	0.6	0.1	0.4	0.9	0.1	0.4	1.1	0.3	0.1	0.2	0.1	0.8	0.4	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0
WFDC13	"C20orf138, dJ601O1.3, WAP13"	ENSG00000168634	"WAP four-disulfide core domain 13"	Q8IUB5	20	45702016-45708817	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"epididymis: 92.8"	"Group enriched"	"Detected in some"	17	"Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RT4: 3.4;U-87 MG: 2.7"														"Secreted in male reproductive system"	NA	NA						"unprognostic (2.53e-1)"		"unprognostic (1.30e-2)"					"unprognostic (7.84e-3)"		"unprognostic (7.96e-3)"	"unprognostic (2.04e-1)"		"unprognostic (1.02e-11)"	"unprognostic (1.17e-1)"		"unprognostic (1.44e-2)"	"unprognostic (2.22e-2)"	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	8.3	0.0	0.1	92.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.4	0.0	3.1	1.3	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.3	0.0	3.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 1206.7;Ciliated cells: 1080.1;Club cells: 1101.0;Collecting duct cells: 1886.1;Mucus-secreting cells: 1147.4;Urothelial cells: 3035.7"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	9	"A-431: 26.9;CAPAN-2: 50.2;EFO-21: 42.0;HaCaT: 36.6;RPTEC TERT1: 38.9"					"Low region specificity"	"Detected in some"			HPA042302	Enhanced				"Secreted in other tissues"	NA	NA		1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	50.2	0.0	42.0	0.0	0.1	36.6	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.6	4.4	0.1	0.0	0.0	0.0	0.0	38.9	0.3	1.2	0.2	2.5	0.0	0.2	0.5	0.7	0.1	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5	157.8	201.9	2.7	1206.7	7.9	23.5	1.2	107.0	1080.1	1101.0	1886.1	21.6	0.7	187.3	214.0	0.9	0.6	87.9	0.0	117.6	0.6	4.1	847.7	9.3	1.1	1.6	0.0	406.4	3.1	1.2	2.7	33.4	5.6	10.1	10.0	1147.4	14.8	130.4	454.8	0.0	77.8	4.2	6.5	11.9	11.6	11.0	12.3	0.6	1.3	278.2	3035.7
WFDC3	"dJ447F3.3, WAP14"	ENSG00000124116	"WAP four-disulfide core domain 3"	Q8IUB2	20	45747944-45791932	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	16	"skin 1: 14.9;testis: 45.2"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 81.6;Late spermatids: 127.9;Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HUVEC TERT2: 1.0;PC-3: 5.0"														"Secreted in male reproductive system"	NA	NA						"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.75e-2)"	"unprognostic (9.30e-4)"	"unprognostic (6.63e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.36e-8)"	"unprognostic (8.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.27e-3)"	"unprognostic (3.03e-2)"	0.4	0.1	0.2	0.3	1.1	0.0	1.8	0.2	1.0	0.1	0.2	1.4	1.3	0.5	0.2	1.1	0.1	0.9	0.1	0.3	0.5	0.2	0.1	0.1	0.2	0.0	0.5	0.4	0.1	0.2	0.0	1.1	0.1	0.6	0.2	0.2	0.0	0.0	0.6	0.1	14.9	0.1	1.2	0.5	0.1	0.1	45.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.5	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	5.0	0.2	0.5	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.2	1.0	0.5	0.2	0.5	0.4	0.6	0.4	0.0	1.6	0.0	4.4	1.0	1.0	0.8	0.0	5.3	11.4	3.5	5.9	0.3	10.0	1.3	81.6	0.1	2.9	0.0	8.9	0.6	2.2	4.2	1.1	0.4	1.0	0.0	3.5	3.1	1.2	127.9	1.4	0.0	0.0	0.0	6.8	1.4	7.6	2.5	2.5	3.0	30.4	0.0	1.4	67.1	2.5	2.8	0.0	0.0	0.9	11.2
WFDC5	"dJ211D12.5, WAP1"	ENSG00000175121	"WAP four-disulfide core domain 5"	Q8TCV5	20	45109452-45115172	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 99.0"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 49.6;Early spermatids: 17.0;Suprabasal keratinocytes: 37.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBEC3-KT: 2.4;Karpas-707: 3.8;RT4: 3.5"	"Not detected"	"Not detected"												"Secreted in other tissues"	NA	NA							"unprognostic (1.32e-1)"				"unprognostic (3.22e-2)"		"unprognostic (3.05e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-4)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (4.12e-2)"		"unprognostic (2.17e-1)"	"unprognostic (5.96e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.4	0.7	0.2	99.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	22.6	11.4	0.2	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.7	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.3	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.4	49.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	37.8	0.0	0.0	0.0	0.3
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539495	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"epididymis: 79.9;testis: 25.5"	"Cell type enriched"	"Detected in some"	16	"Ciliated cells: 56.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-87 MG: 7.8"														"Secreted in male reproductive system"	NA	NA						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	7.6	0.0	0.2	79.9	0.1	2.8	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.0	25.5	0.1	0.1	0.3	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	3.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.1
WFDC8	"C20orf170, dJ461P17.1, WAP8"	ENSG00000158901	"WAP four-disulfide core domain 8"	Q8IUA0	20	45551153-45579326	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 103.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"U-87 MG: 7.8"					"Not detected"	"Not detected"			"HPA042710, HPA071119"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA042710: AB_2732501, HPA071119: AB_2732172"				"unprognostic (5.63e-3)"						"unprognostic (1.09e-2)"				"unprognostic (2.34e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.07e-2)"		0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	5.6	0.0	1.0	103.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.1	0.1	1.0	0.6	1.0	0.9	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.8	0.0	0.1	0.6	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	1.0	0.4	0.4	1.0	0.7	0.4	0.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC9	"dJ688G8.2, WAP9"	ENSG00000180205	"WAP four-disulfide core domain 9"	Q8NEX5	20	45607939-45631268	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 162.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NB-4: 4.8;SH-SY5Y: 2.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 0.5;thalamus: 0.9"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.5	0.1	0.1	0.0	10.1	0.0	0.1	162.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFIKKN1	"C16orf12, RJD2, WFDC20A, WFIKKN"	ENSG00000127578	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1"	Q96NZ8	16	629239-634116	"Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;lymphoid tissue: 5.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 3.0;Horizontal cells: 9.5;Melanocytes: 3.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.9;Hep G2: 2.1;NTERA-2: 2.9;SuSa: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (3.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.70e-5)"	0.7	0.2	1.3	0.3	2.4	0.4	0.3	5.8	1.9	0.7	1.4	0.3	0.3	0.2	1.3	0.3	0.3	0.2	0.3	0.3	1.0	0.2	1.3	0.6	1.3	0.3	0.4	2.3	0.5	1.2	0.2	1.5	0.5	0.3	0.6	0.2	0.3	0.5	0.3	1.0	0.7	0.4	0.3	0.3	1.6	1.2	1.0	0.3	5.1	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.6	0.7	0.0	0.0	0.4	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	2.9	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.1	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.3	2.4	5.8	1.9	1.0	0.2	0.4	2.3	0.3	0.3	0.0	0.3	0.0	0.2	0.8	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.2	0.1	0.4	0.6	1.1	0.5	0.1	9.5	1.2	1.3	0.8	0.0	0.0	0.0	3.3	0.0	1.3	1.0	0.5	2.9	0.7	0.2	0.0	0.0	0.0	1.0	0.6	1.4	0.2	0.0	0.9	0.4
WFIKKN2	"WFDC20B, WFIKKNRP"	ENSG00000173714	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2"	Q8TEU8	17	50834650-50842348	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 89.1;ovary: 56.4"	"Group enriched"	"Detected in some"	7	"Leydig cells: 8.3;Peritubular cells: 22.6"	"Group enriched"	"Detected in some"	5	"glioma: 0.7;testis cancer: 2.2"	"Region enriched"	"Detected in some"	10	"pons and medulla: 89.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;T-47d: 3.8;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 6.0;pons and medulla: 13.1;thalamus: 6.8"						"Secreted in other tissues"	NA	NA		1700000				"unprognostic (7.31e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.54e-3)"		"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.14e-1)"	0.1	0.5	0.2	0.1	0.3	0.0	0.0	0.8	0.5	0.2	0.3	6.8	0.0	0.1	0.7	0.4	0.2	0.6	0.2	0.3	9.1	0.2	0.1	0.0	1.0	0.0	0.4	0.0	56.4	0.3	0.1	0.8	0.0	89.1	0.3	0.1	4.5	0.1	0.5	1.3	0.6	0.1	0.2	0.3	0.1	0.1	1.6	0.5	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.5	9.1	0.2	0.4	0.0	89.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121566	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;lung: 67.7;retina: 29.6"	"Cell type enriched"	"Detected in many"	15	"Muller glia cells: 2337.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 16.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1.0	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1.0	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1.0	3.5	0.0	0.6	3.6	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.5	0.1	0.0	0.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5	32.8	159.2	0.0	31.4	11.2	20.4	1.1	0.0	62.9	48.9	1.8	7.9	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	1.9	16.0	7.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	3.1	21.9	0.0	0.0	2337.6	0.0	0.0	0.4	0.8	66.4	0.0	3.6	0.5	0.2	9.3	0.0	0.0	0.0	0.5
WISP1	"CCN4, WISP-1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"WNT1 inducible signaling pathway protein 1"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 1.6;Fibroblasts: 2.1;Sertoli cells: 6.5;Smooth muscle cells: 2.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.1;HSkMC: 45.6;hTEC/SVTERT24-B: 26.0;U-2197: 24.9"	"Region enriched"	"Detected in single"	6	"olfactory region: 11.9"	"Low region specificity"	"Detected in single"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.2	11.0	0.6	7.7	1.6	0.0	2.3	0.6	2.9	14.7	3.9	1.0	0.0	1.2	18.5	6.4	2.2	6.5	8.5	4.0	0.7	0.3	18.0	2.9	8.9	13.4	0.8	0.4	13.0	1.0	0.2	2.7	3.5	1.2	3.4	0.9	4.5	1.3	4.2	2.0	1.6	3.9	14.4	6.2	14.6	3.8	3.7	0.4	0.3	1.3	2.7	4.2	14.4	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	1.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	45.6	0.0	26.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	6.0	0.3	24.9	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	1.6	0.6	2.9	0.7	0.3	0.8	0.4	1.2	0.4	0.0	0.3	0.0	0.7	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4
WISP2	"CCN5, CT58, CTGF-L"	ENSG00000064205	"WNT1 inducible signaling pathway protein 2"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 109.7"	"Cell type enriched"	"Detected in many"	12	"Leydig cells: 367.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.0;ASC TERT1: 26.9;HeLa: 15.0;HSkMC: 10.9;U-2197: 85.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB019273	Approved				"Secreted to extracellular matrix"	NA	NA		400000			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	57.0	6.5	0.2	2.0	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7.0	12.4	47.1	5.5	8.4	29.7	0.3	0.0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0.0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18.0	30.6	1.4	22.0	0.2	0.5	1.4	37.7	0.4	0.0	2.5	3.7	0.6	18.2	18.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	10.0	26.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.1	0.5	0.3	0.0	0.1	1.4	0.2	0.4	0.0	2.2	0.0	1.3	28.4	0.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	14.4	1.3	0.0	0.0	0.1	0.0	0.0	25.8	0.8	4.0	367.7	1.5	23.6	0.0	0.0	2.0	0.2	0.0	30.1	0.0	0.0	12.9	24.7	1.7	0.8	19.6	0.0	0.0	0.0	2.0
WISP3	CCN6	ENSG00000112761	"WNT1 inducible signaling pathway protein 3"	O95389	6	112054072-112070969	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;cerebellum: 5.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 11.2;THP-1: 3.6;U-2197: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA			Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0.0	0.3	0.4	0.3	1.1	0.0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2.0	0.5	1.7	1.2	0.2	0.1	0.0	0.3	1.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.3	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.7	0.3	0.1	0.0	0.2	0.9	0.4	0.1	0.2	0.3	0.1	0.3	0.0	11.2	0.5	0.6	0.1	0.2	0.9	0.4	0.2	3.6	0.2	0.2	0.2	2.6	0.3	0.3	0.0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2.0	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9	0.0	0.0	0.0	2.7	0.7	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	82.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	6.5	0.0	0.6	0.7	0.6	0.1	0.0	0.0	2.1
WNT1	INT1	ENSG00000125084	"Wnt family member 1"	P04628	12	48978453-48981676	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 6.5;placenta: 17.5"	"Cell type enriched"	"Detected in single"	36	"Cardiomyocytes: 3.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	24	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;JURKAT: 2.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.02e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.76e-2)"	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0.0	0.3	17.5	0.3	0.3	0.0	0.3	1.2	0.3	0.3	0.0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.0	7.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	7.7	0.3	3.0	4.8	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880363-218899581	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 24.8"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 11.1;Basal glandular cells: 7.2;Basal keratinocytes: 15.1;Bipolar cells: 15.4;Collecting duct cells: 8.7;Melanocytes: 6.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 47.3;HDLM-2: 19.5;RPTEC TERT1: 9.1;U-266/70: 24.8"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	HPA013898	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.9	0.4	0.5	10.6	2.5	0.6	0.8	0.1	1.7	2.0	4.2	0.3	2.3	5.5	0.3	1.7	10.5	1.8	0.9	0.6	1.5	0.9	3.6	0.3	1.9	3.3	0.3	0.0	1.0	0.1	0.0	6.0	5.0	0.1	2.2	1.5	3.4	8.0	7.5	0.9	12.4	3.0	1.1	0.1	4.2	3.7	0.6	0.6	2.1	0.3	24.8	10.2	8.0	3.7	1.1	8.4	0.0	0.0	0.0	1.4	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.4	0.9	3.7	0.0	1.2	47.3	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	24.8	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	1.1	0.4	0.1	0.0	0.0	0.0	8.4	1.4	0.1	0.5	2.5	0.1	1.7	1.5	0.9	0.3	0.0	0.1	0.6	0.0	0.0	11.1	7.2	15.1	15.4	1.2	0.0	0.0	0.0	8.7	2.0	0.2	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.4	2.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.5	0.6	4.1	0.1	1.9	0.0	1.3
WNT10B	"SHFM6, WNT-12"	ENSG00000169884	"Wnt family member 10B"	O00744	12	48965340-48971763	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enriched"	"Detected in some"	11	"Extravillous trophoblasts: 12.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"K-562: 8.1;T-47d: 9.7;U-266/84: 8.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055048, HPA062539"	Enhanced		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA055048: AB_2682683, HPA062539: AB_2684793"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.73e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.99e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.39e-6)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.25e-1)"	2.3	0.6	10.9	2.6	23.4	2.1	1.8	0.0	14.3	0.5	1.7	0.5	3.0	2.8	0.4	3.2	1.5	0.6	1.1	1.2	7.3	4.9	0.2	0.3	1.3	3.0	3.0	7.2	1.2	0.0	0.1	1.1	7.0	4.1	1.0	1.6	0.7	1.7	1.4	1.6	5.0	3.3	2.0	0.8	2.9	2.0	1.7	0.3	0.2	0.5	1.2	2.9	1.8	1.6	0.0	0.0	0.0	0.0	0.0	1.6	0.2	2.1	1.4	0.0	2.0	0.0	0.0	5.4	1.5	2.8	0.6	0.2	4.2	4.7	0.0	0.4	0.3	1.8	2.6	5.6	0.4	0.2	1.2	7.4	2.4	1.8	0.1	0.0	0.8	3.5	0.0	0.4	0.1	2.5	4.9	0.0	1.8	8.1	0.3	0.8	2.8	0.1	2.8	0.0	1.5	3.0	0.0	0.7	2.6	0.0	0.5	0.1	0.0	0.3	0.2	0.7	2.8	9.7	3.1	0.0	3.1	6.0	0.4	0.7	3.1	8.7	0.0	1.2	6.2	0.2	0.0	0.0	0.0	1.6	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.2	10.9	23.4	0.0	13.9	7.3	4.9	3.0	7.2	4.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	1.1	0.9	0.0	0.0
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.9;Extravillous trophoblasts: 2.7;Fibroblasts: 5.2;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.8;CACO-2: 6.7;CAPAN-2: 10.0;EFO-21: 33.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA050101	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA050101: AB_2681015"	"prognostic favorable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.8	0.0	0.0	0.0	0.1	6.7	10.0	0.0	33.0	0.0	0.1	3.1	0.6	0.0	0.0	3.0	1.2	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.5	0.0	1.6	0.2	0.0	1.2	0.1	0.0	1.5	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5	0.0	0.0	0.0	0.2	1.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.7	5.2	0.0	0.0	2.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	3.5	0.7	0.0	0.0	0.0	1.8	0.3	0.1	0.6	1.1	0.0	1.4	0.0
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4"	"Group enriched"	"Detected in some"	49	"Basal keratinocytes: 9.0;Suprabasal keratinocytes: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	125	"memory B-cell: 13.1;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	132	"B-cells: 13.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;HEK 293: 10.0;hTEC/SVTERT24-B: 3.0;U-2197: 4.9;U-266/70: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.3	0.5	0.8	0.7	1.0	0.2	2.0	0.9	2.2	19.7	1.0	0.2	11.7	0.2	2.1	7.9	0.3	0.4	0.3	0.2	0.8	0.4	0.2	0.4	0.4	1.3	0.8	0.9	0.1	0.2	0.1	0.6	0.8	1.6	1.0	0.3	0.0	0.5	4.0	0.3	24.4	0.7	0.3	2.3	1.2	0.3	0.6	0.8	0.0	0.2	0.0	0.6	0.5	5.5	13.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.3	4.2	0.3	0.0	0.9	0.2	1.0	0.0	0.0	0.1	0.0	10.0	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	4.9	0.5	3.0	0.1	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	0.9	2.2	0.8	0.4	0.8	0.9	1.6	0.8	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.0	0.0
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 21.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.8	0.0	0.0	24.8	0.4	0.0	0.0	0.0	2.9	9.4	0.2	0.0	0.0	6.8	0.0	0.0	11.1	1.0	7.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	1.6	0.1	2.4	7.6	0.0	0.0	0.1
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 74.2;Peritubular cells: 185.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	0.4	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	13.0	1.2	0.6	0.2	1.9	1.7	0.5	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.1	0.5	0.1	0.5	0.0	2.4	0.4	0.5	0.5	1.3	0.2	1.1	5.3	0.1	0.4	5.2	0.5	2.0	1.3	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8	11.9	3.5	0.5	1.6	9.0	13.0	3.9	2.5	4.0	2.3	1.8	25.5	1.6	0.0	0.7	3.5	8.4	2.3	0.0	1.2	0.7	7.8	1.5	2.3	0.0	1.0	4.8	8.1	4.9	1.6	2.8	74.2	5.7	3.3	1.8	1.7	8.2	1.6	4.2	185.6	0.6	30.4	0.0	2.8	4.2	4.2	12.2	1.6	1.9	1.5	2.0
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 7.8;skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 39.5;Early spermatids: 27.0;Late spermatids: 45.9;Suprabasal keratinocytes: 15.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.3;U-698: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA066281: AB_2685647"	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.5	0.6	1.0	0.6	3.9	0.4	0.4	1.4	4.7	0.2	0.2	3.8	0.1	4.7	0.3	0.4	0.6	0.4	0.4	0.6	1.4	2.9	0.6	7.8	0.3	2.9	2.1	3.5	0.6	0.3	6.0	0.9	0.7	4.1	0.8	0.6	0.1	1.2	0.3	0.5	17.2	1.4	0.5	1.6	0.5	0.4	2.4	2.3	0.1	0.6	1.4	0.5	0.2	0.3	1.0	1.4	0.2	0.3	0.0	1.2	0.1	2.6	0.0	10.3	0.0	0.0	0.0	0.9	0.8	0.6	1.8	0.0	2.6	2.0	1.9	1.1	0.4	2.0	1.2	0.4	0.0	2.3	0.0	0.2	0.0	0.5	2.3	0.0	0.0	0.3	0.0	1.4	0.3	0.6	1.7	0.5	0.2	1.6	0.0	0.3	0.4	0.0	1.6	0.1	1.0	1.2	1.1	1.9	0.1	0.1	0.0	0.2	0.7	1.4	0.0	0.5	0.8	0.0	2.5	0.0	3.2	1.4	0.5	0.7	0.3	0.2	11.3	0.5	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.3	1.4	1.2	0.1	1.0	3.9	1.4	4.7	1.4	2.9	2.1	3.5	4.1	2.3	0.0	1.0	0.0	0.5	39.5	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.7	27.0	0.1	1.0	0.0	2.1	0.1	0.9	1.1	0.0	3.9	0.2	7.9	0.0	0.0	0.0	45.9	0.3	0.0	1.7	1.0	0.5	0.2	1.9	0.6	0.4	0.3	0.6	0.0	0.6	0.4	1.1	15.4	0.2	0.0	0.6	0.3
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HEK 293: 2.8;U-2 OS: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA066281: AB_2685647"	"unprognostic (9.84e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	11.9	0.0	0.0	2.4	3.1	0.0	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	2.4	0.0	0.0	0.5
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.1	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.3	10.2	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.4	0.2	0.4	0.0	0.0	0.0	1.9	12.5	0.0	0.1	10.6	0.7	0.8	4.2	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8	3.0	7.5	0.0	3.4	14.8	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.9	3.8	0.0	0.4	0.1	0.0	28.3	1.3	0.0	0.0	0.0	0.0	5.0	0.0	10.2	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.2	0.0	0.5	2.6
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Club cells: 47.8;Peritubular cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 43.0;BJ hTERT+: 59.3;HeLa: 45.3;SiHa: 67.1;U-87 MG: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.1	0.8	3.4	3.8	2.0	0.0	3.4	2.5	3.8	6.1	2.3	1.6	6.8	2.2	19.6	2.8	15.8	4.8	5.0	2.3	2.6	2.0	2.7	1.6	3.6	4.6	2.3	1.3	8.2	5.3	0.1	1.9	25.6	2.0	5.0	2.1	1.0	26.8	18.2	1.1	2.3	2.5	4.2	4.8	2.5	2.2	1.6	2.5	1.9	2.7	13.1	6.8	21.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	3.0	7.3	0.0	43.0	59.3	8.8	15.5	0.2	0.0	1.2	0.1	24.4	3.7	0.0	1.8	0.0	9.2	0.0	1.2	1.2	45.3	0.0	6.8	0.0	0.0	4.8	1.1	26.6	1.4	4.3	0.0	0.0	0.0	21.0	21.3	0.0	0.0	0.0	2.1	0.1	2.6	0.0	2.7	0.1	1.1	1.4	0.0	0.2	67.1	8.2	0.0	3.6	0.0	0.0	0.0	14.9	2.6	13.5	3.4	5.0	0.0	0.4	48.3	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.0	2.5	3.8	2.6	2.0	2.3	1.3	2.0	2.5	47.6	18.0	0.0	1.7	1.3	6.9	3.2	0.0	1.4	47.8	12.2	0.0	2.4	0.0	0.2	16.8	1.7	0.3	0.0	0.2	0.4	8.6	0.8	2.3	2.5	1.2	0.0	0.0	1.8	2.2	3.6	18.1	1.1	0.0	7.2	0.0	1.5	0.4	0.0	28.3	0.8	1.3	0.0	0.3	0.0	0.9	1.4	1.3	0.0	0.9	6.7
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647243	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Muller glia cells: 42.4;Urothelial cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ: 51.9;BJ hTERT+: 32.6;BJ hTERT+ SV40 Large T+: 38.0;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 36.2;HBF TERT88: 33.4;hTEC/SVTERT24-B: 33.2;U-138 MG: 33.0"	"Low region specificity"	"Detected in many"							HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	4.1	1.7	1.6	6.5	3.4	0.1	4.1	1.0	1.7	8.0	14.1	1.3	19.4	3.0	6.3	6.2	11.9	4.8	3.6	2.9	1.4	3.0	2.7	3.3	2.7	4.0	1.8	0.5	5.3	0.7	13.6	7.1	2.7	2.3	23.4	4.4	5.8	14.2	16.5	0.7	3.4	5.2	17.8	1.4	4.3	4.0	1.7	1.0	2.9	1.2	5.1	5.0	23.3	14.3	0.0	2.1	3.5	4.6	0.0	0.2	1.3	0.0	0.0	0.3	0.0	8.1	14.4	0.0	51.9	32.6	38.0	31.6	1.9	0.2	0.6	0.1	36.2	25.6	0.7	0.7	0.0	33.4	12.0	1.7	2.8	0.0	0.0	2.0	0.0	0.0	12.0	0.7	33.2	9.5	15.4	0.0	0.0	2.0	11.8	8.9	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	0.8	0.4	0.0	0.2	0.7	1.1	0.1	0.0	4.2	0.0	0.2	0.0	33.0	1.3	12.9	26.4	3.2	0.4	0.1	3.2	0.0	0.3	0.0	4.6	3.5	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.3	1.6	3.4	1.0	1.7	1.4	3.0	1.8	0.5	2.3	1.0	0.0	1.1	0.0	10.4	0.8	1.1	1.6	0.0	4.0	3.4	0.0	0.0	0.8	0.0	0.8	0.1	0.5	1.0	0.0	0.6	0.7	3.3	9.8	0.0	1.5	4.1	0.0	0.0	0.6	1.9	0.2	2.0	1.3	3.3	5.4	2.2	42.4	1.7	4.8	2.5	0.0	2.8	6.5	2.3	0.5	5.3	1.1	0.6	0.0	1.9	15.0
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859821-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enriched"	"Detected in some"	9	"Sertoli cells: 90.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Group enriched"	"Detected in many"	7	"basal ganglia: 23.4;thalamus: 7.4"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.1;NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"BEWO: 28.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	2.5	3.5	0.8	1.4	23.4	0.6	15.0	0.9	2.1	4.0	5.7	0.2	1.1	1.3	2.3	2.0	3.1	2.3	2.1	4.8	0.9	0.3	1.6	0.7	0.7	1.3	2.1	0.1	2.9	1.7	0.6	1.7	9.8	1.4	4.0	0.9	4.3	1.9	2.1	2.4	2.3	2.3	2.0	2.4	6.4	2.3	3.7	7.4	0.0	0.7	0.8	1.2	1.5	11.1	0.7	1.1	0.0	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	28.1	0.0	0.0	0.0	0.0	2.6	0.4	0.0	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	4.1	1.3	0.0	0.0	3.2	0.1	3.7	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.8	23.4	0.9	0.9	0.9	0.3	2.1	0.1	1.4	7.4	0.0	0.0	0.5	10.5	0.5	0.8	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	1.6	0.0	0.0	0.0	0.0	1.5	0.8	3.2	0.0	0.0	0.7	1.6	0.0	3.1	0.0	3.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.8	90.5	3.3	2.1	0.3	0.1	0.6	0.0	0.0	0.9
WNT7A		ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880121	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;gallbladder: 8.7;placenta: 19.4"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.4	0.4	7.8	0.6	6.1	0.7	0.4	1.2	11.5	1.1	0.4	2.1	0.0	0.4	3.4	1.0	1.6	0.7	8.7	0.4	3.3	2.8	0.7	0.5	5.7	1.4	3.1	3.2	0.4	0.8	0.4	0.2	19.4	3.9	0.5	0.4	0.0	0.5	1.4	0.4	2.8	0.4	0.5	4.4	3.1	0.4	2.3	2.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.5	3.4	0.0	0.3	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	23.8	0.0	0.0	4.6	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.6	42.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	7.8	6.1	1.2	7.2	3.3	2.8	3.1	3.2	3.9	2.3	11.9	0.0	0.0	2.3	5.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	48.0	0.0	13.3	14.3	0.0	0.0	0.0	8.2	129.2	0.5	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	1.1	155.3	0.5	0.0	4.7
WNT7B		ENSG00000188064	"Wnt family member 7B"	P56706	22	45920362-45977129	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 25.9"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 29.9;Club cells: 23.9;Pancreatic endocrine cells: 25.3;Urothelial cells: 38.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 40.7;HeLa: 36.2;RPTEC TERT1: 14.4;SK-BR-3: 17.8;U-87 MG: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.02e-3)"	"unprognostic (7.83e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.58e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.22e-2)"	0.5	0.4	9.6	0.5	4.7	0.5	2.3	2.4	7.6	4.2	0.4	1.2	0.7	0.5	0.6	2.0	10.8	2.2	10.9	0.4	6.4	5.4	2.4	0.6	4.9	0.4	2.0	2.2	0.5	2.1	0.4	0.3	1.1	1.3	4.4	0.4	0.0	2.0	3.5	0.5	25.9	0.4	0.7	0.7	0.4	0.5	0.9	1.4	0.1	0.8	4.9	5.3	10.0	10.0	1.4	0.8	1.3	0.4	0.2	0.5	0.0	7.7	40.7	0.1	0.0	0.0	0.0	5.3	0.1	0.4	0.0	0.0	0.1	5.3	0.0	1.3	0.0	0.4	8.8	0.3	5.2	0.0	0.0	0.3	0.0	36.2	0.2	0.0	0.0	0.0	0.0	3.6	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	3.2	7.7	0.0	0.0	0.4	14.4	11.5	1.5	0.0	3.5	17.8	0.0	0.0	2.9	4.6	0.0	0.7	0.6	0.0	0.3	0.0	0.0	0.0	33.0	0.0	0.0	0.6	0.4	0.3	0.4	0.3	0.5	0.7	0.5	0.3	0.2	1.4	0.5	0.5	1.3	0.2	0.2	0.8	0.3	0.0	9.6	4.7	2.4	7.6	6.4	5.4	2.0	2.2	1.3	1.4	6.0	17.0	0.0	18.3	29.9	0.3	1.2	10.2	13.4	23.9	12.2	3.9	2.7	0.0	5.2	0.2	0.3	0.0	0.0	0.4	0.2	1.7	12.4	2.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.0	1.8	0.0	0.0	25.3	0.0	0.4	0.0	1.1	0.0	2.5	0.0	1.6	17.9	0.6	0.0	0.0	38.3
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083892-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;testis: 3.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 1.4;SuSa: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038539	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.1	0.0	0.2	0.1	2.5	0.1	0.4	0.7	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	2.5	0.7	0.8	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463041-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.3;parathyroid gland: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;JURKAT: 7.3;RPMI-8226: 2.2;SCLC-21H: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036570	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.2	3.3	0.2	0.2	0.5	0.0	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.4	2.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	3.8	0.5	0.2	0.2	0.7	0.0	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	2.6	0.2	2.2	0.2	0.2	0.2	1.6	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.3	0.0	0.0	5.6	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.5	1.1	0.0	0.0	0.2	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.3	0.0	7.3	0.0	0.6	0.0	1.5	1.9	0.0	0.0	0.1	0.3	0.6	0.0	2.2	0.0	1.6	2.6	0.7	0.0	0.0	0.1	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.7	0.0	0.0	0.3	0.0	0.3	0.2	0.5	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947898	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 9.4;Club cells: 5.7;Leydig cells: 4.0;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;PC-3: 8.8;RH-30: 13.5;SCLC-21H: 12.3;SiHa: 11.9;U-2197: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	2.4	1.4	1.0	13.1	0.5	0.2	2.6	1.4	1.0	4.0	14.1	2.6	2.2	1.9	6.3	4.7	9.5	5.4	15.3	14.6	0.7	0.9	0.8	0.4	9.2	2.1	0.8	0.1	8.9	7.5	0.8	4.3	4.3	3.1	4.7	1.6	4.9	4.9	4.2	20.2	1.0	6.8	8.3	0.6	1.2	5.7	1.8	1.0	0.6	1.8	10.6	4.0	7.1	3.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.7	2.6	0.3	0.1	0.3	0.6	6.7	0.9	0.8	0.1	0.0	0.0	7.1	0.0	3.9	1.2	2.7	13.1	0.3	0.6	0.0	1.3	0.5	0.0	4.4	0.2	0.3	0.0	0.4	0.1	3.3	0.1	0.1	0.2	0.8	0.0	0.0	0.1	1.5	1.7	0.0	0.0	0.8	0.0	8.8	0.2	13.5	1.3	3.7	0.8	12.3	0.0	11.9	5.4	0.0	4.5	6.8	1.4	0.5	1.8	1.1	8.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.5	1.4	0.7	0.7	0.9	0.8	0.1	3.1	1.0	3.0	1.1	0.0	1.1	0.8	0.0	1.1	0.0	9.4	5.7	1.8	0.0	0.1	0.0	0.4	0.1	0.4	0.0	0.0	1.2	0.1	1.8	1.3	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	1.6	0.0	4.2	0.0	0.0	0.0	0.4	0.0	2.3	0.3	0.0	0.0	0.0	3.3
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 1.1;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"AF22: 1.9;SuSa: 5.7"	"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.0	0.3	1.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	5.7	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.0	0.6	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576473-168582077	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 33.8;lymphoid tissue: 29.6"	"Group enriched"	"Detected in some"	9	"Melanocytes: 37.1;T-cells: 113.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 33.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 33.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.4;Hep G2: 5.5;SCLC-21H: 5.3;SuSa: 9.7;U-266/70: 7.5;U-266/84: 2.7"									HPA057725	Approved				"Secreted to blood"	NA	NA					"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	1.7	0.4	0.6	8.8	0.6	5.0	1.3	0.7	0.5	1.5	1.1	0.2	0.0	1.4	4.8	2.8	1.4	1.8	1.6	2.6	0.6	0.9	1.8	3.9	4.1	10.7	0.8	0.0	1.0	2.4	0.0	0.7	3.7	0.3	1.6	1.5	1.6	3.7	0.6	0.4	0.6	2.6	1.0	1.1	10.6	1.7	0.5	0.1	29.6	1.3	2.2	5.9	2.9	1.3	0.0	0.0	0.8	0.0	33.8	3.3	0.7	1.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.3	0.0	0.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	7.5	2.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.1	0.0	0.5	3.3	0.0	0.0	0.1	2.5	0.1	33.8	0.0	0.0	0.0	0.7	0.6	0.6	0.7	0.5	0.6	0.9	0.8	0.0	0.3	0.1	3.0	8.5	0.0	0.0	3.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.4	0.2	0.0	0.2	0.8	4.3	0.1	2.3	0.4	0.3	0.0	0.0	1.3	1.2	0.0	0.0	0.8	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	3.8	0.7	113.6	0.3	0.0
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540765-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 73.4"	"Group enriched"	"Detected in some"	23	"Melanocytes: 32.1;T-cells: 124.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 73.4"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 73.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 7.2;HSkMC: 1.3;RT4: 3.0;SuSa: 1.6"									HPA057725	Approved				"Secreted to blood"	NA	NA					"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.9	0.6	0.5	10.0	0.5	11.8	3.0	0.4	0.4	1.2	1.4	0.2	0.9	2.6	5.4	2.8	0.9	1.4	4.7	2.0	0.5	0.5	1.2	4.6	6.7	4.4	0.6	0.4	0.6	1.9	0.0	0.7	7.0	0.3	2.2	1.1	2.4	4.8	0.9	0.4	0.6	3.9	1.0	1.1	19.3	2.3	0.4	0.0	10.6	1.3	1.4	3.9	2.3	1.2	0.0	0.0	0.3	0.0	73.4	9.5	2.9	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	1.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.0	0.7	9.4	0.0	0.0	0.4	7.6	0.3	73.4	0.0	0.0	0.0	2.9	0.5	0.5	0.4	0.4	0.5	0.5	0.6	0.4	0.3	0.0	0.0	1.4	0.8	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.6	0.3	0.0	0.0	1.3	3.4	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	124.6	0.0	0.0
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.7	0.0	19.2	11.9	3.3	8.5	4.3	1.0	0.4	0.2	0.2	2.1	0.0	10.3	0.3	0.2	0.0	1.7	1.5	4.1	0.2	2.6	0.0	0.0	0.2	3.7	3.5	4.4	0.2	5.5	0.8	1.6	0.0	0.2	0.3	8.0	1.0	0.3	0.0	4.0	2.9	1.4	0.0	1.2	0.0	0.4	0.0	3.9	0.7	5.2	0.6	2.6	0.5	2.1	0.7	2.3	0.0	9.0	1.0	19.7	0.0	9.0	0.5	3.9	10.0	4.2	7.6	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1	3.0	4.5	7.5	1.5	7.0	13.3	2.7	0.0	0.0	1.2	0.0	92.3	9.8	0.0	1.2	0.4	2.2	5.1	0.0	1.4	16.8	16.2	3.4	2.3	0.0	3.3	0.0	12.1	2.5	8.5	0.4	11.8	8.0	3.3	2.8	3.8	1.3	2.6	7.0	47.0	0.2	4.1	6.5	5.7	0.2	2.5	16.2	11.0	4.4	6.5	4.2
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346092-50363138	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 53.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 305.8;Late spermatids: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		990000				"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	6.9	8.5	5.8	11.3	10.6	4.1	7.4	10.3	10.9	10.7	9.2	5.4	15.8	10.0	9.6	12.2	8.5	10.4	14.9	9.4	5.3	4.8	9.2	6.1	6.1	10.2	4.7	8.8	11.8	13.5	9.1	5.8	9.0	5.4	12.1	3.9	13.1	12.7	11.7	7.9	15.6	6.9	17.0	3.8	8.4	53.4	5.8	3.7	10.2	9.5	6.7	10.4	11.7	9.0	5.3	4.9	6.6	4.0	7.8	7.8	4.3	9.9	12.7	3.5	2.9	4.9	4.8	9.1	9.3	8.6	8.4	9.5	13.5	7.5	5.2	23.7	8.3	7.4	7.7	1.1	13.1	1.7	25.7	9.1	11.7	3.9	5.8	6.7	3.6	6.3	6.5	8.1	6.7	3.1	8.4	7.1	4.6	2.0	4.3	5.5	13.0	6.7	5.0	3.1	6.6	9.0	3.4	10.2	4.3	4.7	5.2	1.9	4.4	6.2	5.9	9.8	4.1	28.2	3.5	8.4	19.2	9.8	10.4	8.3	23.9	10.9	1.8	20.3	5.9	5.2	6.6	4.0	3.2	5.9	2.8	6.3	2.9	5.9	7.8	4.9	5.3	6.0	5.3	4.7	7.8	2.5	3.4	5.2	4.3	5.8	10.6	10.3	10.9	5.3	4.8	4.7	8.8	5.4	3.7	8.9	6.7	4.2	4.0	5.0	8.2	6.4	15.3	0.0	2.3	1.8	27.5	6.0	0.0	6.2	305.8	7.4	4.2	0.0	5.5	4.7	9.1	1.4	1.1	7.2	3.4	6.4	10.4	8.6	4.1	85.8	11.5	3.8	6.8	1.8	9.9	5.7	5.8	0.0	16.3	2.1	5.6	25.8	7.2	1.4	4.5	2.8	1.3	3.1	11.8	0.6
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778240-29782973	"Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 84.6"	"Cell type enriched"	"Detected in some"	11	"Mucus-secreting cells: 6838.5"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.9;SK-BR-3: 7.0"	"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	NA	NA		250000			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.2	0.0	0.2	13.3	0.2	0.0	0.2	0.2	0.2	0.2	67.8	0.2	0.2	9.9	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.2	3.6	0.2	0.2	0.2	0.2	0.2	8.9	0.0	0.2	0.2	0.2	0.2	84.6	0.2	0.2	0.2	0.2	0.0	51.6	2.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.7	1.1	1.0	0.1	0.8	0.2	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1.3	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.2	0.4	0.0	7.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.5	0.3	0.6	0.3	0.6	0.5	0.0	0.7	0.9	1.0	0.4	1.1	0.3	0.2	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.4	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	602.0	0.0	10.5	0.0	0.0	0.2	41.3	24.1	0.0	0.0	139.9	0.6	0.6	0.0	0.0	0.0	0.0	0.0	6838.5	0.0	0.5	331.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	287.1	0.1
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"salivary gland: 1069.4"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8"									"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0	1.6	0.3	0.0	1069.4	0.2	0.1	0.8	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	78.5	3.7	0.2	0.2	0.0	1.1	1.7	11.4	1.1	0.4	1.7	0.0	0.6	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	1.2	0.0	2.5	0.0	0.0	0.0	5.0	1.4	1.3	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	2.1	0.1	15.2	0.0	0.2	0.1	32.4	2.9	0.0	0.0	4.8	0.1	3.6	0.0	0.0	0.0	14.0	0.0	0.1	12.8	0.0	1.8	0.0	0.3	1.1	0.0	0.0	0.2	0.2	0.2	3.7	0.1	1.7	6.7	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	1.1	7.3	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	8.0	0.0	0.0	89.2	1.4	5.7	1.8	0.0	0.0	0.0	3.6	5.3	0.1	36.1	0.0	25.2	2.7	0.8	457.9	5.7	0.0	13.1	0.0	55.9	0.6	2.9	3.1	0.0	2.6	79.2	1.8	224.9	0.0	30.0	80.9	0.0	0.0	0.0	0.0	0.3	1.0	0.1	21.0	0.2	0.0	68.0	223.9
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.5;epididymis: 2.2;pituitary gland: 3.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 25.5;Late spermatids: 62.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 16.2;SK-BR-3: 4.6"	"Region enriched"	"Detected in single"	7	"basal ganglia: 0.7"										"Secreted in female reproductive system"	NA	NA						"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0			0.0	0.0	2.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.8	3.3	0.0		1.3	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1											0.0	2.2	0.0	0.0	0.1	1.4	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	6.5	2.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	22	"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"HDLM-2: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA011296	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	1.1	35.2	0.1	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	1.6	0.0	0.1	0.0	3.1	0.0	0.0	0.1	1.5	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZP3	"ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC"	ENSG00000188372	"Zona pellucida glycoprotein 3"	P21754	7	76397518-76442071	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 36.5;Late spermatids: 52.3;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5;hTCEpi: 17.6;Karpas-707: 24.4;MCF7: 32.5"									HPA054061	Supported				"Secreted in female reproductive system"	NA	NA					"HPA054061: AB_2682363"	"unprognostic (6.48e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.13e-1)"	2.4	5.6	3.3	1.9	13.9	4.3	6.7	1.7	4.4	3.1	5.1	3.2	1.8	4.2	2.6	5.3	7.4	8.7	1.5	1.4	2.1	2.4	2.0	2.0	1.2	6.9	2.6	2.2	5.8	11.9	1.4	3.1	1.4	4.6	3.3	5.7	5.6	3.7	3.4	2.7	8.7	2.6	2.5	2.8	3.6	2.5	2.3	4.0	0.8	2.0	4.4	4.7	1.7	4.1	2.8	10.3	0.9	9.9	0.3	5.2	3.4	7.9	16.5	0.1	8.5	0.4	0.5	0.4	0.5	1.3	0.1	1.5	0.6	7.1	0.0	0.3	2.0	0.2	2.0	1.7	0.5	0.1	4.3	4.1	1.3	4.6	0.1	3.7	0.3	2.4	0.7	17.6	1.7	0.5	0.0	0.3	4.3	1.8	24.4	0.0	32.5	0.7	4.1	1.8	13.4	4.7	0.0	0.7	1.7	0.7	0.1	3.6	0.0	2.2	11.1	0.2	0.2	7.3	1.3	1.0	0.1	0.9	0.1	0.1	7.4	6.0	0.1	0.7	9.2	1.4	0.5	9.9	0.1	0.2	3.9	0.5	2.8	1.3	0.6	10.3	1.5	5.2	3.7	0.9	0.3	4.2	2.2	0.2	3.4	3.3	13.9	1.7	4.4	2.1	2.4	2.6	2.2	4.6	4.0	3.0	2.2	2.2	3.6	7.6	1.4	0.8	5.1	5.3	1.2	1.8	0.0	5.5	0.0	2.7	36.5	1.6	2.0	0.0	3.6	3.3	2.8	1.8	0.0	1.0	6.3	1.6	4.1	2.5	6.5	52.3	4.0	4.8	3.3	1.8	3.8	4.6	3.0	8.4	5.3	1.6	1.6	6.5	1.2	26.6	14.0	8.7	7.8	2.2	7.4	12.0
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.5"					"Not detected"	"Not detected"			HPA008547	Supported				"Secreted in female reproductive system"	NA	NA					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZPBP	"SP38, ZPBP1"	ENSG00000042813	"Zona pellucida binding protein"	Q9BS86	7	49850421-50121329	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 90.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 705.4;Spermatocytes: 420.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.7;U-698: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058673	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA058673: AB_2683794"	"unprognostic (1.16e-1)"							"unprognostic (6.46e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.15e-7)"		"unprognostic (9.49e-2)"	"unprognostic (2.34e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	705.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	10.3	0.0	0.0	0.0	0.0	2.0	0.2	0.0	7.4	0.3	19.4	6.5	0.0	420.4	8.1	0.3	0.0	0.0	0.0	0.1
ZPBP2	"MGC41930, ZPBPL"	ENSG00000186075	"Zona pellucida binding protein 2"	Q6X784	17	39868164-39877896	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 85.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 159.4;Spermatocytes: 377.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;U-698: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027997, HPA053070"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA027997: AB_1859488, HPA053070: AB_2682033"		"unprognostic (2.14e-2)"						"unprognostic (3.38e-1)"				"unprognostic (1.62e-1)"		"unprognostic (2.87e-1)"	"unprognostic (5.39e-1)"		"unprognostic (2.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	85.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	0.1	0.1	0.2	0.0	1.0	0.2	0.1	0.1	1.0	0.4	0.3	0.6	0.1	0.3	0.2	0.2	0.5	0.4	0.2	2.9	0.2	0.4	0.2	0.1	0.6	0.2	0.5	0.6	1.3	0.4	0.4	0.0	0.3	0.4	0.2	0.2	0.7	0.1	0.2	0.4	0.3	0.3	0.3	0.9	0.0	0.1	0.1	0.6	1.0	0.7	0.7	0.4	0.9	2.2	0.3	0.3	1.0	0.3	0.1	0.6	0.3	1.3	0.3	0.0	0.4	0.3	0.3	0.6	0.1	1.0	0.2	10.4	0.3	0.4	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.8	0.4	1.0	0.0	2.6	1.0	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	6.5	0.0	377.5	8.5	0.0	0.0	0.0	0.0	0.0
